data_2m1i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m1i _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.7 mttp . . . . . 0 C--O 1.242 0.678 0 CA-C-O 120.586 0.232 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.487 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 70.6 mt -107.49 131.66 57.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' NZ ' ' CZ ' ' A' ' 58' ' ' TYR . 27.6 mtpp -91.92 106.2 18.28 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -145.81 168.34 21.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -176.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.502 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 4.2 m -129.27 146.95 51.08 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.353 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.461 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -147.21 151.39 36.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.299 0.571 . . . . 0.0 112.346 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.506 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 85.2 mt -122.12 124.6 71.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.534 HD12 ' CE1' ' A' ' 91' ' ' HIS . 6.1 tt -107.83 127.74 53.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.465 HG21 ' N ' ' A' ' 23' ' ' ALA . 27.6 m -137.11 153.61 29.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.431 0.634 . . . . 0.0 111.212 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -67.54 -39.96 85.0 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.475 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -103.48 148.89 25.39 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.478 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 86.0 mt-30 -62.09 -39.98 94.3 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.79 -38.27 91.8 Favored Glycine 0 CA--C 1.509 -0.281 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -65.54 -41.84 92.57 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -62.11 -42.35 99.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.849 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.47 -40.98 98.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.782 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.0 -49.47 71.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.738 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG21 ' N ' ' A' ' 27' ' ' GLN . 19.0 m -66.29 -42.49 90.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.198 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 81' ' ' SER . 99.1 mt-30 -61.66 -44.12 97.56 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.01 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.44 -44.85 74.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.066 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.515 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 43.0 ttt85 -66.63 -40.16 88.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.507 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.04 -24.7 26.06 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.312 0.577 . . . . 0.0 109.677 -178.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -62.35 -32.6 73.41 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.841 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.98 -7.99 20.19 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.722 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.84 25.84 40.06 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.515 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 87.1 mt-10 -81.54 157.23 24.87 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.506 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.06 131.6 50.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.545 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 58.1 t80 -56.96 -43.28 81.41 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.589 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -59.21 -36.8 90.31 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.707 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' HZ3' ' CD ' ' A' ' 42' ' ' GLU . 58.6 tttm -58.26 -48.0 81.81 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.027 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.44 -40.07 96.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.275 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.27 -43.21 95.53 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.758 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -64.15 -41.27 97.24 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.719 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' CD ' ' HZ3' ' A' ' 38' ' ' LYS . 96.3 mt-10 -77.76 -59.79 2.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.412 -175.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -49.46 6.34 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -172.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 t -56.53 138.25 52.18 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.903 -169.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.6 pt -92.79 -1.74 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.814 0.34 . . . . 0.0 110.227 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 50' ' ' ALA . 60.1 t0 -80.22 96.51 6.61 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.1 -53.43 44.98 Favored Glycine 0 C--N 1.321 -0.278 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.815 -173.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.38 -45.01 84.93 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 54' ' ' GLY . 17.5 m -70.41 -32.57 70.25 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.472 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' ASP . . . -62.79 -38.36 90.33 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 75.7 mmtt -60.79 -34.3 74.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HE ' ' HA ' ' A' ' 49' ' ' SER . 89.6 mtm180 -95.48 19.48 10.89 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.913 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.589 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 97.3 m-20 59.85 30.2 19.75 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 70.87 -7.75 5.14 Favored Glycine 0 C--N 1.305 -1.149 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 53' ' ' ASP . 2.3 m -70.72 91.09 0.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.433 0.635 . . . . 0.0 110.353 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.424 HD13 ' SG ' ' A' ' 12' ' ' CYS . 96.9 mt -62.35 -38.23 88.74 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 76.91 -133.15 13.01 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.483 ' CZ ' ' NZ ' ' A' ' 11' ' ' LYS . 57.4 m-85 -83.98 135.59 34.39 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 117.111 0.455 . . . . 0.0 109.897 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.487 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.9 p90 -144.18 149.32 36.25 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.779 168.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.82 174.89 55.12 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 -174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.543 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 47.6 mtm180 -74.54 145.66 43.26 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.8 60.17 8.11 Favored Glycine 0 C--O 1.246 0.905 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 61' ' ' ARG . 34.7 mmtm -133.25 -35.62 1.03 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.017 0.437 . . . . 0.0 110.458 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.408 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 77.7 mtm -119.44 159.83 23.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.99 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.1 133.57 7.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.277 -174.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.523 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -44.02 -47.34 22.45 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.901 -174.153 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 24.7 Cg_endo -57.87 -38.31 93.0 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 CA-C-N 118.767 0.595 . . . . 0.0 111.862 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.408 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 58.9 t80 -62.73 -49.97 72.96 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.771 177.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.62 -39.31 93.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.316 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.443 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 12.6 t70 -57.35 -48.68 78.38 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.115 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.62 95.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.783 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.07 83.21 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.09 0.472 . . . . 0.0 110.253 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -63.67 -42.85 98.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.879 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -63.54 -47.57 81.08 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.172 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' A' ' 77' ' ' VAL . 97.3 mt -98.04 33.41 2.15 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.501 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 71.8 mt-30 -54.28 -19.17 4.87 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.502 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 2.4 m -60.11 -40.73 84.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.332 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.475 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 121.66 7.36 8.15 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.893 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 149.37 41.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.5 t -71.35 128.97 35.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.598 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 11.3 p -79.24 155.72 28.45 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 123.29 0.369 . . . . 0.0 111.411 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' A' ' 82' ' ' GLU . 1.7 mp0 -66.52 161.95 54.45 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.531 ' N ' HE22 ' A' ' 27' ' ' GLN . 47.5 Cg_exo -55.37 129.74 36.82 Favored 'Trans proline' 0 C--N 1.295 -2.279 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.8 t -106.13 114.87 46.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -85.37 138.54 32.21 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.753 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.2 p -136.05 176.36 8.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -61.79 -32.7 73.01 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.67 -38.79 80.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.036 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.61 -146.97 16.06 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -176.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.478 ' CE1' ' HG2' ' A' ' 20' ' ' GLN . 82.9 m-85 -106.4 133.86 50.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.941 0.371 . . . . 0.0 110.709 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.534 ' CE1' HD12 ' A' ' 16' ' ' LEU . 3.9 m-70 -115.12 147.34 40.36 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.382 176.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 76.5 t -117.97 127.55 75.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 167.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.506 ' N ' ' OG ' ' A' ' 81' ' ' SER . 81.5 mt -115.97 130.7 70.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -171.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -120.61 149.89 41.76 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.383 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.502 ' NH2' ' O ' ' A' ' 77' ' ' VAL . 8.7 tmm_? -79.05 143.87 35.19 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.7 tp -117.15 135.42 53.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.382 0 CA-C-O 118.556 -1.135 . . . . 0.0 110.747 -177.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.0 mttm . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.499 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 45.6 mm -106.84 131.68 56.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' CG ' ' CE2' ' A' ' 58' ' ' TYR . 56.5 mtpt -87.95 105.91 17.77 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.6 ' SG ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -148.37 168.22 23.17 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.498 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 4.9 m -130.81 133.04 45.61 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.339 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.483 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -124.58 149.56 46.88 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.457 -176.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.578 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 95.2 mt -125.31 128.19 72.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.1 tp -103.47 128.56 50.63 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.472 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.516 ' CG1' HD11 ' A' ' 43' ' ' LEU . 28.8 m -129.1 154.4 39.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 123.743 0.652 . . . . 0.0 110.818 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -67.76 -41.08 83.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.187 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -127.5 156.43 42.18 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -169.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -60.59 -38.86 86.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.36 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.54 -38.42 91.14 Favored Glycine 0 N--CA 1.464 0.502 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.65 -42.12 91.8 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.14 82.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.686 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.57 -42.26 98.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.85 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.04 74.2 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.9 m -66.03 -41.07 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.749 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -59.31 -46.12 89.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.054 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 73.7 mm-40 -67.82 -38.59 83.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.158 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.445 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 22.7 ttp85 -64.9 -38.11 89.87 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.418 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -27.16 61.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 33.2 mmtp -61.11 -31.6 71.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.19 -21.73 48.7 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.176 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.82 20.69 53.09 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.34 164.36 13.76 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -65.6 130.5 43.5 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 56.6 t80 -55.92 -42.88 76.76 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -57.12 -39.3 89.64 Favored Glycine 0 C--N 1.311 -0.836 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.835 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -59.91 -45.7 91.71 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -62.16 -41.2 98.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.938 173.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.449 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -61.83 -42.84 99.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.425 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -65.21 -44.84 87.04 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.454 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 95.0 mt-10 -70.23 -43.66 70.16 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -169.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.537 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -117.24 -40.49 3.08 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -169.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 m -45.82 133.54 8.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.1 pt -83.12 -14.95 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.571 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 33.2 t0 -80.4 92.42 5.82 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.308 174.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.8 -46.82 93.38 Favored Glycine 0 CA--C 1.507 -0.447 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.191 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.19 -46.99 84.56 Favored Glycine 0 C--N 1.319 -0.364 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.571 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 20.1 m -63.41 -34.05 76.88 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.322 174.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.98 85.86 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.359 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 18.6 mmtp -60.53 -40.21 90.68 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -96.67 16.09 19.95 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.281 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.569 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.9 m-20 63.1 32.91 14.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.663 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 70.65 -29.7 0.49 Allowed Glycine 0 C--N 1.31 -0.871 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 53' ' ' ASP . 53.6 m -55.31 98.59 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.717 0.77 . . . . 0.0 111.382 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.6 HD13 ' SG ' ' A' ' 12' ' ' CYS . 97.6 mt -65.07 -36.52 84.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.835 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 88.67 -145.05 18.61 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 -170.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.466 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 89.9 m-85 -83.09 134.03 35.03 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.499 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.3 p90 -144.04 150.23 37.88 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.629 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.53 165.55 22.49 Favored Glycine 0 C--O 1.24 0.493 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.485 ' HD2' ' CE1' ' A' ' 73' ' ' PHE . 76.9 mtp180 -81.05 160.54 24.5 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.641 0.376 . . . . 0.0 110.879 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.07 -51.61 1.13 Allowed Glycine 0 C--N 1.315 -0.615 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -64.23 -38.02 89.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.968 -0.616 . . . . 0.0 109.645 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.446 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 25.5 mmm -88.67 153.02 21.44 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.36 141.76 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.294 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.536 ' HZ2' ' CD ' ' A' ' 69' ' ' GLU . 15.8 mmtm -43.7 -51.28 16.78 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 36.3 Cg_endo -61.4 -32.49 89.09 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 120.231 0.62 . . . . 0.0 111.571 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 93' ' ' ILE . 47.7 t80 -62.62 -46.66 87.24 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' CD ' ' HZ2' ' A' ' 66' ' ' LYS . 93.9 mt-10 -63.9 -47.23 81.42 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.241 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.06 -41.82 93.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.74 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.431 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -64.59 -46.62 81.93 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.86 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.27 89.21 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.951 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.485 ' CE1' ' HD2' ' A' ' 61' ' ' ARG . 17.7 m-85 -61.82 -28.17 69.28 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.972 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 74' ' ' ARG . 2.1 mtm105 -64.46 -36.75 85.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.345 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.511 HD11 ' N ' ' A' ' 81' ' ' SER . 10.3 mt -87.91 21.84 2.55 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -167.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 73' ' ' PHE . 75.6 mt-30 -54.26 -34.56 61.07 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.84 -27.54 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.279 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.02 6.05 7.83 Favored Glycine 0 N--CA 1.475 1.278 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.435 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.419 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 80.2 mt-10 -55.57 173.94 0.11 Allowed 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.4 t -106.76 132.57 53.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 167.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.511 ' N ' HD11 ' A' ' 75' ' ' LEU . 99.7 p -66.32 163.21 18.56 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.227 0.537 . . . . 0.0 111.842 -172.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.69 161.19 70.18 Favored Pre-proline 0 N--CA 1.422 -1.866 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -56.94 133.89 60.94 Favored 'Trans proline' 0 C--N 1.294 -2.329 0 N-CA-C 109.784 -0.891 . . . . 0.0 109.784 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 42.6 t -117.97 125.64 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.534 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.8 tptp -88.98 137.47 32.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.94 0.4 . . . . 0.0 109.963 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.534 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 14.1 p -140.89 175.17 9.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -59.59 -39.77 85.25 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -65.15 -42.64 93.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.517 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.32 -137.34 5.75 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 4.6 m-85 -105.01 132.78 50.82 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 117.107 0.453 . . . . 0.0 111.963 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.446 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 44.5 m-70 -114.27 141.74 47.18 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.391 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.02 128.28 75.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 167.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.56 HG23 ' SG ' ' A' ' 12' ' ' CYS . 88.5 mt -121.1 131.22 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 116.917 -0.129 . . . . 0.0 110.76 -173.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -116.08 147.86 40.85 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 167.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.441 HH21 ' CA ' ' A' ' 97' ' ' GLY . 2.6 ttp180 -77.57 143.46 38.31 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.34 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.405 ' HB3' ' C ' ' A' ' 11' ' ' LYS . 46.5 tp -100.68 145.58 28.26 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.441 ' CA ' HH21 ' A' ' 95' ' ' ARG . . . . . . . . 0 C--O 1.207 -1.576 0 CA-C-O 118.356 -1.247 . . . . 0.0 110.683 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm . . . . . 0 N--CA 1.441 -0.904 0 CA-C-O 120.765 0.317 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 44.4 mm -106.34 129.87 58.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.599 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 62.2 mtpt -90.93 104.11 16.74 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -145.1 169.59 17.86 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.515 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 9.2 m -126.51 145.63 50.43 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.871 174.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.482 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -134.63 149.57 50.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.921 0.391 . . . . 0.0 111.597 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.513 HG13 ' CE2' ' A' ' 36' ' ' PHE . 94.4 mt -129.41 128.06 65.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.23 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 13.9 mt -94.61 128.68 41.41 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.412 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.13 154.72 35.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.704 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -66.28 -40.7 90.27 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.358 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -121.6 152.48 39.23 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.332 0.587 . . . . 0.0 112.502 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.48 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 53.6 tt0 -61.14 -40.95 95.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.489 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.06 -36.68 92.69 Favored Glycine 0 C--O 1.238 0.368 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.76 -42.14 97.86 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.76 -47.95 82.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.966 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 24' ' ' LEU . 4.5 mm? -61.52 -41.79 97.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.074 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.27 -51.83 66.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.574 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -68.97 -39.46 79.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.273 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.599 HE22 ' N ' ' A' ' 83' ' ' PRO . 67.8 mt-30 -55.4 -46.12 76.63 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 72.4 mm-40 -71.13 -35.29 71.67 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 175.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.587 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 74.9 ttt180 -60.28 -37.76 81.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.984 0.421 . . . . 0.0 110.025 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.12 -34.62 73.76 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 31.7 mmtp -62.53 -33.18 74.4 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.74 -24.72 64.25 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.441 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.82 -2.6 31.95 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.587 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 23.9 mt-10 -67.7 147.05 53.17 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.76 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.56 139.27 51.47 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CE2' HG13 ' A' ' 15' ' ' ILE . 52.3 t80 -58.21 -45.88 86.84 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.48 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.49 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.35 -35.66 91.98 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.263 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 25.3 tttm -60.22 -47.73 84.73 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.4 HD13 ' NH1' ' A' ' 29' ' ' ARG . 4.0 mm? -62.06 -40.81 97.03 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.501 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.502 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.11 -45.47 79.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -65.5 -38.83 90.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.558 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 78.3 mt-10 -69.78 -54.17 14.88 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.18 -17.5 6.15 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -169.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.502 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.1 m -48.99 127.26 13.94 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.311 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.9 pt -76.74 -14.05 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -86.72 92.17 8.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.17 -42.72 99.35 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.13 -48.18 69.57 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.482 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 38.4 m -64.58 -33.37 75.77 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.513 -0.404 . . . . 0.0 110.315 175.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.09 71.21 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.574 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -61.28 -39.87 92.03 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 81.3 mtp180 -97.23 19.68 12.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.404 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.49 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 47.8 m-20 58.72 31.79 21.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.16 -14.44 3.9 Favored Glycine 0 C--N 1.31 -0.904 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 53' ' ' ASP . 20.2 m -69.19 90.88 0.49 Allowed 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.816 0.817 . . . . 0.0 111.313 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.401 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 93.9 mt -62.94 -38.76 92.34 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.216 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.94 -144.14 17.01 Favored Glycine 0 CA--C 1.503 -0.698 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.11 130.73 34.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.658 0.266 . . . . 0.0 110.827 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.491 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.8 p90 -144.89 152.87 40.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.876 0.369 . . . . 0.0 111.525 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.15 -173.31 37.33 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -81.96 154.78 25.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.69 -37.79 3.32 Favored Glycine 0 C--N 1.311 -0.852 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -63.0 -36.6 84.08 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.481 0.658 . . . . 0.0 109.476 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.433 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 3.7 mmm -104.62 155.64 18.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.281 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.74 154.35 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.463 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 13.7 mmtm -44.0 -55.0 10.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 40.0 Cg_endo -60.05 -34.69 94.54 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 CA-C-N 118.925 0.652 . . . . 0.0 111.074 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 64' ' ' MET . 10.5 t80 -63.12 -46.6 86.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.076 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.96 -41.72 99.61 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.714 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.9 -50.21 71.3 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.789 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.08 98.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.459 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.47 73.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.149 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -67.6 -38.73 84.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.039 0.447 . . . . 0.0 111.297 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.511 HH22 ' CD ' ' A' ' 82' ' ' GLU . 78.7 mtp180 -63.99 -41.18 97.6 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.429 ' CD1' ' CA ' ' A' ' 81' ' ' SER . 43.0 mt -97.92 23.58 7.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -171.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.421 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 88.5 mt-30 -54.03 -25.54 21.86 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.91 -29.64 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.032 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 122.12 -0.34 10.66 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.203 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -70.64 174.28 6.1 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -98.49 131.23 46.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.574 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.484 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 43.1 t -64.34 162.09 15.58 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.708 -176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' CD ' HH22 ' A' ' 74' ' ' ARG . 0.0 OUTLIER -72.91 163.11 70.84 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 165.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.599 ' N ' HE22 ' A' ' 27' ' ' GLN . 72.1 Cg_endo -61.82 140.19 84.21 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 N-CA-C 110.214 -0.725 . . . . 0.0 110.214 -175.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.3 t -123.16 100.47 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.813 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.5 tptp -80.05 130.23 35.1 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.481 174.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.596 ' HG ' ' CD2' ' A' ' 91' ' ' HIS . 52.8 p -129.14 -176.25 3.81 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.362 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -62.61 -39.78 94.87 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -66.37 -41.62 89.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.315 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.79 -150.63 21.9 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 20' ' ' GLN . 77.7 m-85 -99.16 118.88 36.87 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.596 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 34.9 m-70 -99.33 139.54 34.82 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 123.341 0.401 . . . . 0.0 110.319 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.0 t -114.93 125.44 72.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 168.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.2 mt -123.62 127.44 74.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.129 -170.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -120.79 143.36 48.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.458 ' HD2' ' N ' ' A' ' 96' ' ' LEU . 5.6 tmm_? -78.5 142.21 37.6 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.458 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -121.98 151.3 40.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.124 -179.113 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.627 0 CA-C-O 118.364 -1.242 . . . . 0.0 110.25 -178.786 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.9 mttm . . . . . 0 N--CA 1.433 -1.316 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.568 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 66.0 mt -105.34 127.61 59.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.604 ' HZ2' ' C ' ' A' ' 97' ' ' GLY . 9.2 mtpm? -94.87 107.51 19.53 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -147.54 169.64 19.15 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.914 -173.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.536 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.7 m -130.45 146.27 51.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.068 173.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.556 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -138.6 149.34 45.15 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.876 -178.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.515 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 94.9 mt -127.91 125.96 65.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.825 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' SER . 42.3 tp -97.88 115.45 28.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.37 152.34 18.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.527 0.68 . . . . 0.0 112.294 -174.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -66.87 -42.92 84.82 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.904 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.447 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 31.3 mmtp -119.37 150.42 40.19 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.817 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -60.03 -38.03 81.52 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.079 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.79 -36.09 92.23 Favored Glycine 0 C--N 1.322 -0.234 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 95.8 mt-10 -64.53 -43.64 93.36 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.4 ' CB ' HG21 ' A' ' 92' ' ' VAL . . . -58.43 -46.7 85.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.001 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.49 -41.03 98.57 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.281 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.95 92.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 m -68.39 -34.44 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.103 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 49.4 tt0 -59.32 -46.47 88.5 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.155 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.76 -41.65 74.9 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.472 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.575 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 76.1 ttt180 -60.77 -39.23 88.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.861 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.99 -39.82 91.12 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.954 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HZ1' ' CD ' ' A' ' 79' ' ' GLU . 17.7 mmtp -65.47 -9.54 26.58 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.34 -3.51 58.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.152 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.48 11.04 75.79 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.587 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.575 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 13.2 mt-10 -78.85 154.21 29.99 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.473 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 21.3 tptm -62.29 126.4 27.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.233 -176.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 58.2 t80 -58.04 -44.47 87.43 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.638 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -60.11 -37.74 93.3 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.942 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.49 ' CB ' ' HB3' ' A' ' 35' ' ' LYS . 44.6 tttp -61.23 -44.28 97.52 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.404 HD12 ' HD3' ' A' ' 29' ' ' ARG . 4.4 mm? -62.02 -41.46 98.11 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.295 172.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.415 ' C ' ' HG ' ' A' ' 44' ' ' SER . . . -57.17 -51.91 67.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.38 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -65.54 -39.43 91.75 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' A' ' 38' ' ' LYS . 92.2 mt-10 -70.08 -48.08 59.22 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.5 mp -98.26 -50.49 4.32 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 1.2 m -50.81 139.21 17.26 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.1 -1.409 . . . . 0.0 113.093 -161.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.1 pt -97.42 -2.34 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.672 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.605 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 32.2 t0 -89.19 94.11 9.81 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.828 174.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -62.26 -42.29 99.72 Favored Glycine 0 C--O 1.234 0.136 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.3 -42.09 63.27 Favored Glycine 0 N--CA 1.454 -0.136 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.605 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 15.9 m -72.46 -33.08 66.78 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.635 -0.282 . . . . 0.0 111.569 175.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.18 74.63 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.161 0.505 . . . . 0.0 110.512 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 10.4 mmtp -61.98 -41.85 98.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.29 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -98.67 9.1 44.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.406 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.638 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.5 m-20 63.63 33.12 13.46 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.078 0.466 . . . . 0.0 110.395 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.4 -14.61 5.13 Favored Glycine 0 C--N 1.31 -0.897 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -63.19 89.32 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.0 0.428 . . . . 0.0 110.955 -179.355 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.457 HD11 ' SG ' ' A' ' 12' ' ' CYS . 96.4 mt -63.4 -40.29 96.83 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 87.19 -151.31 23.47 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.91 131.07 34.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.028 0.414 . . . . 0.0 110.004 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.568 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 52.5 p90 -142.79 148.72 37.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.345 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.18 150.92 34.31 Favored Glycine 0 C--N 1.314 -0.67 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.94 144.32 52.43 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.56 0.219 . . . . 0.0 110.734 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.542 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 106.95 -20.77 33.01 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -175.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -62.69 -42.5 99.66 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.597 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 75.0 mtm -120.0 160.66 22.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.931 0.396 . . . . 0.0 111.961 -174.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.4 m -43.49 128.16 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.012 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.597 ' NZ ' ' O ' ' A' ' 64' ' ' MET . 1.9 mmtm -45.08 -46.5 30.35 Favored Pre-proline 0 C--N 1.308 -1.198 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.058 -173.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 30.0 Cg_endo -59.82 -35.3 94.52 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 CA-C-N 119.311 0.79 . . . . 0.0 111.451 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' A' ' 93' ' ' ILE . 54.3 t80 -61.76 -49.07 77.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.959 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 99.1 mt-10 -66.11 -41.49 90.49 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.572 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.85 -46.65 81.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.813 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.99 -38.5 88.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.854 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.33 -41.23 84.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.897 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -64.69 -35.25 80.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.018 0.437 . . . . 0.0 111.386 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -58.8 -23.19 59.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.506 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.56 HD13 ' N ' ' A' ' 81' ' ' SER . 84.2 mt -96.92 4.94 51.34 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -171.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 95' ' ' ARG . 67.4 mm-40 -47.16 -20.41 0.18 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.57 -40.55 86.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 120.814 0.34 . . . . 0.0 110.124 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.95 48.49 0.24 Allowed Glycine 0 N--CA 1.465 0.615 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.472 ' CD ' ' HZ1' ' A' ' 31' ' ' LYS . 1.2 mm-40 -122.31 175.78 6.22 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.034 0.445 . . . . 0.0 112.166 -173.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -108.99 131.37 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.56 ' N ' HD13 ' A' ' 75' ' ' LEU . 6.4 p -75.51 163.19 27.64 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -173.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.33 165.33 45.47 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -55.84 130.96 43.18 Favored 'Trans proline' 0 C--N 1.293 -2.392 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.1 t -117.88 124.4 73.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 41.7 tttp -91.51 131.89 36.65 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.67 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.562 ' HG ' ' CD2' ' A' ' 91' ' ' HIS . 97.1 p -118.85 -172.05 2.21 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.2 pm0 -66.8 -38.8 87.2 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 6.0 m-30 -64.39 -46.89 81.33 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.978 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.85 -150.88 21.11 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 85' ' ' LYS . 10.9 m-85 -96.5 129.41 43.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.837 0.351 . . . . 0.0 111.381 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.562 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 41.9 m-70 -110.85 146.68 36.03 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.029 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.4 HG21 ' CB ' ' A' ' 23' ' ' ALA . 2.1 t -117.4 121.03 66.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 167.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.441 HG12 ' CE2' ' A' ' 68' ' ' PHE . 87.3 mt -113.1 127.82 70.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.428 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -115.43 145.13 42.86 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.409 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.475 ' HD2' ' O ' ' A' ' 75' ' ' LEU . 68.4 ttt-85 -79.5 139.37 37.62 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.024 177.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 55.8 tp -112.66 129.1 56.51 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.604 ' C ' ' HZ2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.206 -1.633 0 CA-C-O 118.376 -1.236 . . . . 0.0 112.152 -173.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 44.3 mmtm . . . . . 0 N--CA 1.444 -0.764 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.92 129.13 62.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 48.7 mtpt -92.7 106.88 18.79 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -138.22 166.04 25.17 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.779 0.799 . . . . 0.0 112.933 -177.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.467 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 3.9 m -133.35 138.53 46.37 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.895 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.444 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -132.8 150.28 52.18 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.372 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.526 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 95.7 mt -125.09 127.22 72.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.621 177.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 44' ' ' SER . 51.2 tp -98.72 125.01 43.92 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 33.6 m -118.06 151.85 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.389 0.614 . . . . 0.0 111.275 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -66.71 -40.62 88.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.201 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -133.77 158.84 42.31 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.866 -169.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.11 -39.75 87.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.488 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.81 -39.74 91.93 Favored Glycine 0 CA--C 1.507 -0.444 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.457 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 97.0 mt-10 -65.07 -43.59 91.7 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.836 176.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.36 81.94 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.124 0.488 . . . . 0.0 110.125 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.57 -42.93 99.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.214 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.87 80.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.75 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.442 HG21 ' N ' ' A' ' 27' ' ' GLN . 12.6 m -63.54 -41.39 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.778 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.463 HE22 ' HA ' ' A' ' 82' ' ' GLU . 94.7 mt-30 -55.92 -44.05 77.95 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -70.08 -41.71 73.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.322 0.582 . . . . 0.0 110.371 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 75.9 ttt180 -61.6 -38.36 87.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.941 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.75 -37.58 79.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 18.7 mmtm -62.72 -30.71 71.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.03 -23.94 56.3 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.876 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.22 13.09 25.71 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.02 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.531 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 33.0 mt-10 -80.74 150.2 29.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.151 0.475 . . . . 0.0 110.705 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -65.78 137.17 57.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.046 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.526 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 59.2 t80 -56.77 -45.19 82.25 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.597 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.64 -37.63 95.09 Favored Glycine 0 C--N 1.317 -0.503 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 65.6 tttm -58.31 -46.71 85.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.454 ' N ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -62.43 -41.14 98.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.529 174.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.455 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.48 -49.64 76.63 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.317 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.41 ' HZ2' ' CG ' ' A' ' 53' ' ' ASP . 43.1 mttp -64.68 -41.24 96.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.646 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 58.6 mt-10 -71.25 -44.2 65.76 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.489 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -113.1 -38.2 4.54 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -169.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.5 m -54.78 142.83 27.48 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.81 -173.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.3 pt -95.89 6.59 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.923 0.868 . . . . 0.0 109.449 171.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.632 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 25.2 t0 -91.53 113.96 26.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.02 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.74 -65.39 2.82 Favored Glycine 0 C--N 1.318 -0.46 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.59 -44.78 78.79 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.632 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 15.0 m -66.63 -34.32 77.62 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.808 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.92 90.56 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.174 0.512 . . . . 0.0 110.685 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -63.55 -33.68 76.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.007 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.0 16.72 21.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.103 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.597 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 19.6 m-20 60.02 35.5 21.47 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.447 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.45 -28.76 1.23 Allowed Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -56.38 91.41 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.918 0.39 . . . . 0.0 110.808 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.18 -39.05 93.54 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 104.32 -148.03 16.67 Favored Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.494 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 21.6 m-85 -84.54 130.67 34.72 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.471 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 44.4 p90 -146.65 149.98 34.54 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.989 174.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.82 -170.23 36.98 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -73.76 154.3 39.64 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 122.737 -0.273 . . . . 0.0 110.338 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.19 -33.96 5.6 Favored Glycine 0 C--N 1.313 -0.75 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.041 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -64.42 -41.28 96.69 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.791 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -108.57 160.64 15.76 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.302 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 18.4 m -64.04 152.13 8.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.429 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.5 OUTLIER -43.76 -57.55 5.7 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.465 -175.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 38.0 Cg_endo -58.91 -32.19 96.92 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 N-CA-C 110.557 -0.593 . . . . 0.0 110.557 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.454 ' CD2' HD13 ' A' ' 93' ' ' ILE . 27.1 t80 -61.74 -47.57 84.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.513 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -62.84 -45.41 92.74 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.115 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.29 -40.28 95.76 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.281 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.57 -41.47 96.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.932 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.04 -49.43 77.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.581 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -65.17 -38.03 89.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.226 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -64.93 -39.5 93.6 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.515 HD11 ' CA ' ' A' ' 81' ' ' SER . 44.0 mt -94.02 16.99 13.16 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.148 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.557 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 50.2 mt-30 -55.09 -19.67 7.91 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.958 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.24 -27.04 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.646 175.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.534 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 123.81 3.04 8.53 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 121.672 -0.299 . . . . 0.0 112.536 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.24 174.43 3.24 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -110.85 132.29 59.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 93' ' ' ILE . 0.3 OUTLIER -73.32 160.69 31.46 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -174.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.463 ' HA ' HE22 ' A' ' 27' ' ' GLN . 0.7 OUTLIER -70.73 175.84 2.35 Favored Pre-proline 0 N--CA 1.444 -0.733 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.94 134.25 61.17 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 CA-C-N 119.538 0.871 . . . . 0.0 109.868 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.47 126.67 74.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.567 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.9 tptp -97.56 135.58 39.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.25 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.567 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 60.5 p -135.03 169.89 16.74 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.581 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.7 pm0 -61.47 -34.02 74.74 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -63.35 -42.35 98.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.506 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.79 -146.17 13.35 Favored Glycine 0 C--N 1.321 -0.297 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.408 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -103.52 130.79 50.98 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 122.266 0.226 . . . . 0.0 110.522 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.534 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 35.9 m-70 -116.12 144.57 43.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.956 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.01 127.35 75.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 167.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.537 ' N ' ' OG ' ' A' ' 81' ' ' SER . 86.0 mt -120.16 129.49 75.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 122.572 -0.08 . . . . 0.0 110.833 -173.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.534 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 63.7 tttp -120.65 159.65 24.89 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.557 ' NE ' ' O ' ' A' ' 76' ' ' GLN . 27.7 ttt-85 -75.84 143.9 41.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.449 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 50.6 tp -108.77 142.06 39.87 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.198 -2.124 0 CA-C-O 118.09 -1.394 . . . . 0.0 112.135 -174.734 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 mttm . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.581 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 21.1 mt -106.42 128.52 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -172.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.544 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 41.5 mtpt -90.72 104.57 17.14 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.603 ' SG ' HD11 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -148.11 167.38 25.14 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -175.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m -124.83 132.98 53.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.206 174.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.418 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -127.58 149.44 50.16 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.396 -175.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.531 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 92.6 mt -124.33 125.94 71.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.708 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 44' ' ' SER . 51.3 tp -103.67 125.74 50.36 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.86 155.13 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 121.107 0.479 . . . . 0.0 111.264 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.55 -22.85 34.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.462 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HB2' ' CG ' ' A' ' 22' ' ' GLU . 53.4 mmtt -112.14 140.92 46.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.896 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -64.05 -39.5 94.21 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.491 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.67 -35.76 90.24 Favored Glycine 0 N--CA 1.459 0.212 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.504 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 89.8 mt-10 -65.26 -42.83 92.88 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.56 -47.04 87.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.089 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.21 -41.93 98.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.955 0.407 . . . . 0.0 110.381 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.31 -50.68 72.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.193 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 27' ' ' GLN . 10.7 m -64.7 -41.78 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.777 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 81' ' ' SER . 80.7 mt-30 -58.75 -50.84 72.44 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.145 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -65.78 -37.91 87.59 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.319 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.493 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 67.1 ttt180 -63.42 -37.49 87.48 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.316 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 30' ' ' LEU . 1.3 mm? -61.56 -40.9 96.37 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 19.8 mmtp -63.32 -34.96 78.83 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.313 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.56 -24.24 65.26 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.538 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.52 6.93 26.67 Favored Glycine 0 N--CA 1.463 0.483 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.157 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 6.2 mt-10 -82.77 150.92 26.37 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.236 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -67.25 137.26 56.02 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.704 0.764 . . . . 0.0 112.021 -174.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.531 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 54.2 t80 -55.01 -43.0 73.23 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.602 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -59.35 -37.42 91.94 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.263 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.02 -47.82 84.26 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.67 -41.93 99.35 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.619 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.485 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -62.46 -43.47 98.74 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.053 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -63.3 -41.77 98.99 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -75.1 -82.11 0.07 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -174.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.23 -42.8 96.38 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -170.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.1 m -56.57 133.43 53.56 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.736 -162.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.3 pt -87.98 -7.47 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.131 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.41 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 54.4 t0 -84.34 94.45 8.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.513 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -59.51 -50.68 65.1 Favored Glycine 0 C--N 1.315 -0.618 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.31 -44.69 93.35 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.529 ' OG ' ' NH2' ' A' ' 52' ' ' ARG . 39.6 m -62.79 -33.7 75.74 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.467 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.43 -36.74 84.72 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 47.4 mmtm -61.8 -33.69 74.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.529 ' NH2' ' OG ' ' A' ' 49' ' ' SER . 76.5 mtm-85 -96.52 6.61 48.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.288 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.602 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 70.7 m-20 65.98 36.76 5.69 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.963 0.411 . . . . 0.0 110.152 -174.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 79.3 -20.66 4.75 Favored Glycine 0 C--N 1.317 -0.483 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -54.48 99.13 0.03 OUTLIER 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.374 0.607 . . . . 0.0 111.349 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.603 HD11 ' SG ' ' A' ' 12' ' ' CYS . 90.1 mt -68.73 -38.72 80.38 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.79 -145.17 17.73 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.544 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 11.1 m-85 -83.99 132.65 34.73 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.581 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 52.3 p90 -142.51 149.39 39.09 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.448 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.95 173.67 28.18 Favored Glycine 0 C--O 1.238 0.36 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -81.63 159.73 23.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.566 0.222 . . . . 0.0 110.937 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.67 -77.15 0.38 Allowed Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -61.73 -39.31 91.1 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.229 0.538 . . . . 0.0 109.873 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 41.8 mmm -66.2 147.74 52.88 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.876 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.07 136.91 22.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.097 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.569 ' HZ1' ' CD ' ' A' ' 69' ' ' GLU . 9.3 mmtm -43.9 -50.24 19.69 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 29.5 Cg_endo -57.55 -36.61 98.59 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 CA-C-N 118.999 0.678 . . . . 0.0 110.797 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CE1' ' CE ' ' A' ' 64' ' ' MET . 31.8 t80 -63.13 -47.99 80.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.862 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.569 ' CD ' ' HZ1' ' A' ' 66' ' ' LYS . 98.0 mt-10 -64.26 -46.61 82.98 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.288 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 10.9 t70 -57.07 -48.26 78.99 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.236 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.57 96.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.27 -45.83 90.17 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.573 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.413 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 59.1 m-85 -63.16 -36.4 83.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.227 0.537 . . . . 0.0 111.126 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 94.7 mtt-85 -65.03 -22.34 66.97 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.289 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.556 HD11 ' N ' ' A' ' 81' ' ' SER . 73.0 mt -96.34 9.4 41.31 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.505 ' OE1' ' NH1' ' A' ' 95' ' ' ARG . 15.8 mm100 -43.42 -24.76 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 117.936 0.335 . . . . 0.0 111.75 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.98 -23.38 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.111 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 114.29 3.94 22.42 Favored Glycine 0 N--CA 1.47 0.91 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.91 175.48 7.29 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -172.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.21 131.09 56.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.147 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.556 ' N ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -74.34 153.21 39.4 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.161 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.406 ' C ' HE22 ' A' ' 27' ' ' GLN . 2.4 mp0 -68.1 171.3 5.83 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 167.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.507 ' N ' HE22 ' A' ' 27' ' ' GLN . 52.6 Cg_exo -54.51 132.66 52.41 Favored 'Trans proline' 0 C--N 1.289 -2.566 0 C-N-CA 120.399 0.733 . . . . 0.0 111.067 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.94 107.29 22.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.545 ' CG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 tmtp? -79.33 134.38 36.61 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.84 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 p -137.95 168.73 19.11 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.534 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -60.46 -34.28 73.78 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -67.25 -38.77 85.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.909 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.49 -154.83 25.85 Favored Glycine 0 C--N 1.314 -0.651 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.545 ' CE2' ' CG ' ' A' ' 85' ' ' LYS . 84.7 m-85 -104.69 126.86 52.19 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.418 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 7.7 m-70 -105.06 143.13 33.67 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.641 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.15 125.78 74.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.531 ' N ' ' OG ' ' A' ' 81' ' ' SER . 81.2 mt -115.9 129.41 72.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -110.05 140.81 43.68 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 168.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 76' ' ' GLN . 4.7 tpt180 -77.9 135.32 37.86 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.455 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 53.7 tp -121.7 145.63 47.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.616 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.211 -1.282 0 CA-C-O 118.342 -1.255 . . . . 0.0 110.859 -179.337 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.7 mttm . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.599 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 21.2 mm -105.86 126.6 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.581 ' HZ1' ' C ' ' A' ' 97' ' ' GLY . 56.8 mtpt -88.34 104.08 16.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.1 OUTLIER -148.77 168.31 23.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -175.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.423 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.9 m -131.13 146.35 52.31 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.594 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -140.18 150.31 44.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.516 HG13 ' CE2' ' A' ' 36' ' ' PHE . 91.3 mt -127.1 128.8 70.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.08 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -101.19 116.61 33.21 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -120.83 154.66 24.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.502 0.668 . . . . 0.0 111.29 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -65.9 -40.62 91.68 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.657 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -119.15 148.9 42.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.448 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -62.4 -40.69 97.32 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.124 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.52 -40.76 94.91 Favored Glycine 0 CA--C 1.511 -0.209 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -63.76 -44.45 93.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.0 83.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.978 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.11 -41.01 99.28 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.138 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.05 -47.99 81.46 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.729 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.4 m -70.44 -32.89 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 81' ' ' SER . 48.6 tt0 -59.46 -48.18 82.62 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 77.9 mm-40 -71.12 -36.42 72.12 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.118 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -60.55 -37.94 82.9 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -27.15 64.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.252 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 33.6 mmtp -61.75 -38.73 89.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.12 -24.27 58.09 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.799 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.33 15.38 30.29 Favored Glycine 0 C--N 1.32 -0.356 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -58.9 140.82 54.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 17.0 tptm -56.1 127.38 30.31 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CE2' HG13 ' A' ' 15' ' ' ILE . 61.6 t80 -57.06 -43.52 82.15 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -60.45 -33.8 82.75 Favored Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.836 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 87.2 tttt -59.9 -48.64 80.88 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.04 -41.94 98.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.435 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.48 -48.68 76.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.444 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -64.38 -39.66 94.3 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.25 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.33 -45.17 66.71 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.77 -24.06 4.56 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -177.041 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 3.7 m -50.98 137.82 20.49 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.53 -173.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.4 pt -98.69 -5.22 9.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.317 0.579 . . . . 0.0 109.501 172.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.524 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 67.3 t0 -87.82 107.85 18.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.661 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.34 -43.64 96.58 Favored Glycine 0 C--N 1.318 -0.428 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.32 -49.46 68.37 Favored Glycine 0 CA--C 1.504 -0.654 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.594 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 16.2 m -60.58 -34.53 74.33 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.798 0.332 . . . . 0.0 110.409 174.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.14 85.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.261 0.553 . . . . 0.0 110.743 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.12 -39.45 94.06 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 55' ' ' SER . 80.2 mtp180 -98.09 25.47 6.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.086 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.462 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.6 OUTLIER 35.94 42.44 0.16 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.781 0.8 . . . . 0.0 112.659 -178.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.38 -15.87 4.17 Favored Glycine 0 C--N 1.315 -0.63 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.474 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ARG . 4.9 m -73.41 77.7 1.39 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.26 0.552 . . . . 0.0 110.796 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.58 -38.44 91.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.153 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.26 -141.67 21.6 Favored Glycine 0 CA--C 1.501 -0.786 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.8 139.99 30.83 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 55.2 p90 -144.77 152.89 41.04 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.802 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.5 172.66 36.28 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 72.1 mtm-85 -84.69 148.68 26.27 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.017 0.437 . . . . 0.0 111.991 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.81 -56.13 0.48 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.019 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -61.4 -39.42 90.67 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.081 0.467 . . . . 0.0 111.129 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.442 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 76.0 mmm -79.99 153.74 28.69 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.67 -176.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 m -68.4 137.95 23.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.362 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -44.29 -52.5 16.47 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -173.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 31.3 Cg_endo -60.21 -32.44 94.42 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 CA-C-N 118.639 0.55 . . . . 0.0 111.284 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -62.19 -47.22 85.46 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 76.7 mt-10 -63.78 -43.19 97.09 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.817 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -56.25 -49.18 74.91 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.793 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.4 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -63.44 -42.72 98.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.859 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.67 -49.09 77.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.27 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 69' ' ' GLU . 32.1 m-85 -63.62 -38.96 93.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -61.64 -33.42 73.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.316 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 81' ' ' SER . 90.9 mt -89.12 5.71 43.33 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.517 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 15.5 mm100 -42.83 -24.08 0.06 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 118.219 0.463 . . . . 0.0 112.01 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -63.28 -26.22 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 120.798 0.332 . . . . 0.0 111.878 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 114.19 11.39 12.22 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -85.71 174.42 9.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.3 t -95.78 131.46 42.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.534 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 28.5 p -72.92 160.89 31.41 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 123.138 0.273 . . . . 0.0 111.71 -172.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.443 ' HA ' HE22 ' A' ' 27' ' ' GLN . 2.9 mt-10 -64.12 168.91 5.29 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 166.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -57.94 136.08 72.89 Favored 'Trans proline' 0 C--N 1.292 -2.422 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 45.2 t -117.52 130.04 73.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.45 ' HD2' ' CE1' ' A' ' 90' ' ' TYR . 82.9 tttt -110.65 131.75 54.78 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.989 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 p -143.72 -171.58 3.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.972 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 2.1 pm0 -66.09 -31.81 72.9 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -64.1 -37.92 89.2 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.805 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.85 -139.41 9.0 Favored Glycine 0 C--O 1.242 0.608 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.45 ' CE1' ' HD2' ' A' ' 85' ' ' LYS . 87.4 m-85 -106.98 126.89 52.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.447 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 2.0 m-70 -105.35 147.28 28.35 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.59 0.233 . . . . 0.0 111.097 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.3 t -117.5 126.69 74.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 167.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.4 mt -115.37 127.32 72.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.65 -176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -106.22 128.74 54.16 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.517 ' CD ' ' HA ' ' A' ' 76' ' ' GLN . 76.3 ttt-85 -77.65 139.22 39.44 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 118.644 -1.222 . . . . 0.0 109.266 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 50.6 tp -110.08 133.37 53.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.262 -175.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.581 ' C ' ' HZ1' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.573 0 CA-C-O 118.28 -1.289 . . . . 0.0 110.845 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.5 mttp . . . . . 0 CA--C 1.5 -0.964 0 CA-C-O 120.537 0.208 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.5 mm -106.02 128.24 60.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 11.8 mtpp -89.43 107.07 18.86 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.5 167.26 22.92 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.874 -177.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.528 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.4 m -130.6 147.56 52.3 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.122 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.5 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -134.55 149.74 50.68 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.449 -179.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.556 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 96.1 mt -123.61 128.77 74.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.332 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.1 tp -103.11 123.5 46.79 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.412 ' CG1' HD11 ' A' ' 43' ' ' LEU . 16.2 m -124.1 147.9 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 123.657 0.598 . . . . 0.0 111.132 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -66.76 -42.54 86.0 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.403 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 25.9 mmtp -112.77 151.1 30.7 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -174.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -64.36 -34.89 79.2 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.871 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.22 -37.78 95.1 Favored Glycine 0 CA--C 1.509 -0.317 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.454 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 98.3 mt-10 -64.94 -41.92 95.1 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.75 -46.98 83.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.269 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.09 -42.54 99.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.366 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.07 73.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.3 m -65.18 -40.7 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.964 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 74.2 mt-30 -60.08 -47.3 86.43 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.712 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.516 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 57.0 mm-40 -66.48 -37.14 84.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.034 0.445 . . . . 0.0 110.827 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HD3' ' CD1' ' A' ' 39' ' ' LEU . 77.6 ttt180 -61.06 -41.11 96.0 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.417 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.09 -38.87 84.22 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.512 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 17.5 mmtp -61.04 -34.72 75.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.16 -10.03 37.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.116 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.68 -0.42 39.46 Favored Glycine 0 N--CA 1.462 0.379 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.771 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.478 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 7.3 mm-40 -65.38 142.52 58.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 29.9 mttm -72.58 141.83 48.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.283 0.564 . . . . 0.0 111.13 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 53.1 t80 -58.67 -45.45 89.36 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.02 -34.91 89.72 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.972 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 88.7 tttt -61.04 -47.35 86.77 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.485 ' CD1' ' HD3' ' A' ' 29' ' ' ARG . 4.2 mm? -62.96 -41.11 99.43 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.732 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 44' ' ' SER . . . -60.0 -50.05 75.27 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.85 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.441 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 68.2 mttm -65.85 -45.27 82.77 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.848 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.485 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 86.5 mt-10 -71.99 -44.59 63.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.524 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -112.43 -39.11 4.47 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -168.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 67.6 m -52.59 135.83 33.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.334 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.5 pt -87.88 -5.75 10.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.543 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -85.97 91.39 8.37 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.12 -43.59 99.22 Favored Glycine 0 C--N 1.313 -0.718 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.6 -44.21 78.87 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 54' ' ' GLY . 45.3 m -71.8 -33.63 68.71 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.733 175.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.78 91.55 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.787 0.803 . . . . 0.0 109.854 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.33 -37.33 82.89 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.206 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -97.58 20.57 11.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.944 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.0 OUTLIER 57.75 30.53 19.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.648 177.382 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 70.69 -8.1 4.63 Favored Glycine 0 C--N 1.306 -1.106 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -69.95 85.31 0.51 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.147 0.498 . . . . 0.0 110.58 -178.254 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.06 -39.86 95.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.826 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 89.46 -143.44 17.28 Favored Glycine 0 CA--C 1.507 -0.428 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.484 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 95.3 m-85 -83.61 132.92 34.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.409 ' CD1' ' HG3' ' A' ' 64' ' ' MET . 44.8 p90 -146.25 150.28 35.49 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.001 170.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.43 178.38 27.68 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HB3' ' NH1' ' A' ' 61' ' ' ARG . 8.4 mtm105 -75.38 154.78 37.02 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.59 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.81 -31.94 8.12 Favored Glycine 0 C--N 1.309 -0.957 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -11.14 54.54 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.494 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.409 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 10.0 mmm -125.08 156.61 37.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.94 150.77 6.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.849 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.464 ' NZ ' ' HB2' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -44.42 -54.5 12.03 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 38.0 Cg_endo -61.94 -34.14 81.99 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 120.163 0.575 . . . . 0.0 111.119 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -62.43 -47.87 82.17 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.476 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.63 -39.99 94.68 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.895 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.464 ' HB2' ' NZ ' ' A' ' 66' ' ' LYS . 27.6 t70 -56.03 -51.24 68.48 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.871 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.64 95.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.15 -50.98 70.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.342 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.451 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 59.2 m-85 -69.15 -38.45 78.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.773 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -66.61 -40.96 89.05 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 mt -98.1 33.46 2.15 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.478 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 71.0 mt-30 -51.24 -24.54 4.49 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.83 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.83 -31.88 48.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.508 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 123.47 -4.72 9.4 Favored Glycine 0 N--CA 1.469 0.873 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.086 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -60.69 147.33 42.49 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.897 0.379 . . . . 0.0 111.938 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 t -78.59 130.99 35.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 93' ' ' ILE . 10.5 p -74.3 153.44 39.35 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.6 mp0 -59.57 164.69 5.04 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.67 129.03 31.92 Favored 'Trans proline' 0 C--N 1.292 -2.43 0 N-CA-C 109.865 -0.86 . . . . 0.0 109.865 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 59.2 t -104.25 113.97 42.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.533 ' NZ ' ' OH ' ' A' ' 90' ' ' TYR . 41.7 tttp -81.85 138.27 35.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.441 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 19.3 p -150.6 166.47 30.19 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.44 -32.41 71.35 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.441 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 65.7 m-85 -64.48 -40.4 95.61 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.328 176.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.97 -149.85 21.91 Favored Glycine 0 C--N 1.318 -0.418 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.533 ' OH ' ' NZ ' ' A' ' 85' ' ' LYS . 82.7 m-85 -104.38 127.39 52.04 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.362 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.5 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.9 m-70 -111.35 151.18 28.72 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.224 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.67 114.09 44.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 168.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.402 ' N ' ' OG ' ' A' ' 81' ' ' SER . 75.7 mt -111.4 124.03 67.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.244 -172.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 30.1 tttp -114.56 139.01 49.94 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.514 172.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.478 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 1.4 tmm_? -78.9 141.58 37.5 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.398 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.407 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 50.2 tp -109.45 124.06 50.4 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.055 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.204 -1.725 0 CA-C-O 118.296 -1.28 . . . . 0.0 110.248 -177.366 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 68.0 mt -104.72 126.32 59.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HZ3' ' C ' ' A' ' 97' ' ' GLY . 7.8 mtpm? -94.85 104.42 16.32 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.48 171.86 13.77 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -171.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.54 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 3.9 m -131.4 146.07 52.1 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.305 174.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -140.15 150.96 44.88 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.99 126.77 74.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.288 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 44' ' ' SER . 50.5 tp -101.85 122.37 43.86 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 23' ' ' ALA . 34.8 m -130.39 155.02 41.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.418 0.628 . . . . 0.0 111.106 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -66.38 -41.74 88.97 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.704 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.442 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 27.8 mtpp -118.81 151.6 37.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.447 -172.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -60.9 -37.23 81.52 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.29 -39.94 97.92 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 88.8 mt-10 -63.84 -46.02 86.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.44 ' N ' HG22 ' A' ' 17' ' ' VAL . . . -60.0 -49.37 77.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.443 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.72 -41.05 98.14 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.789 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.51 -49.35 75.0 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.885 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG12 ' CD2' ' A' ' 43' ' ' LEU . 9.4 m -68.21 -40.57 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.406 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.482 HE21 ' C ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -56.05 -42.81 77.18 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.079 -179.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 51.9 mm-40 -71.71 -35.03 70.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.183 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.413 ' CG ' ' HG3' ' A' ' 34' ' ' GLU . 12.3 ttm180 -62.07 -37.32 84.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.311 176.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.57 -36.25 78.05 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.871 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 28.4 mmtm -59.98 -36.65 77.62 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.68 -10.44 36.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.894 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.64 62.62 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.413 ' HG3' ' CG ' ' A' ' 29' ' ' ARG . 12.2 mm-40 -62.3 147.04 49.39 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 74.4 tttt -63.01 128.64 36.81 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -58.11 -45.16 87.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -58.25 -39.48 92.55 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.783 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 35' ' ' LYS . 49.2 tttp -59.46 -45.72 90.81 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 39' ' ' LEU . 4.2 mm? -61.66 -42.15 98.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.583 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.89 -49.84 74.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.324 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -64.64 -40.45 95.47 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.46 -47.02 58.3 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.69 -13.14 7.54 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.0 m -58.35 138.59 56.37 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.047 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.3 pt -90.65 -4.12 10.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.581 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 60.1 t0 -89.24 101.91 14.57 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.787 173.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.28 -45.3 96.77 Favored Glycine 0 C--N 1.317 -0.484 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.33 -43.38 89.73 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.581 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 63.6 m -63.49 -34.79 78.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.822 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.25 93.31 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.172 0.511 . . . . 0.0 109.973 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -64.37 -40.34 95.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.559 0.695 . . . . 0.0 109.248 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 84.0 mtp180 -97.27 10.3 39.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.051 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.54 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 21.3 m-20 57.68 29.86 17.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 71.67 0.85 42.72 Favored Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 m -68.45 83.07 0.26 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.119 0.485 . . . . 0.0 110.899 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.531 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 90.0 mt -63.4 -39.7 95.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.541 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 86.81 -149.08 22.1 Favored Glycine 0 C--N 1.318 -0.44 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.95 129.3 34.93 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.8 p90 -146.14 149.47 34.07 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.677 0.275 . . . . 0.0 110.767 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.86 -179.46 38.86 Favored Glycine 0 C--N 1.315 -0.636 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -78.27 153.28 31.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.433 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.41 -34.54 5.21 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.19 -36.85 85.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.051 0.453 . . . . 0.0 110.475 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.533 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 3.5 mmm -110.82 154.18 24.34 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.258 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 27.4 m -64.91 141.13 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.596 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.4 mtpm? -44.2 -48.81 24.06 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -172.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 30.4 Cg_endo -60.66 -32.2 92.95 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 CA-C-N 119.059 0.7 . . . . 0.0 111.264 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 64' ' ' MET . 37.9 t80 -61.85 -46.94 87.29 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -61.49 -45.31 94.76 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.465 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.43 ' OD2' ' NH2' ' A' ' 74' ' ' ARG . 13.0 t70 -56.93 -50.33 72.9 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.408 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.05 93.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.046 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.66 88.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.806 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -66.31 -40.43 89.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.464 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.43 ' NH2' ' OD2' ' A' ' 70' ' ' ASP . 50.9 mtm180 -64.07 -42.14 97.1 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.7 mt -97.95 31.77 2.59 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.473 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 48.6 mt-30 -55.81 -18.15 7.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.262 0.553 . . . . 0.0 109.943 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 p -58.1 -29.16 36.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.037 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.78 -3.01 15.03 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -69.51 161.21 29.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.887 0.375 . . . . 0.0 111.17 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.55 127.66 42.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.482 ' C ' HE21 ' A' ' 27' ' ' GLN . 10.5 p -77.53 159.28 29.43 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.265 0.555 . . . . 0.0 112.206 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -69.6 168.39 17.36 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.38 135.18 68.78 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 N-CA-C 110.136 -0.756 . . . . 0.0 110.136 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 40.4 t -116.49 126.82 74.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.506 ' HD3' ' CZ ' ' A' ' 90' ' ' TYR . 9.8 tptm -85.06 131.3 34.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.074 -177.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.8 p -135.53 170.07 16.53 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -56.26 -37.51 69.88 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -64.11 -43.82 94.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.152 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.04 -140.06 7.0 Favored Glycine 0 N--CA 1.465 0.601 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.506 ' CZ ' ' HD3' ' A' ' 85' ' ' LYS . 43.9 m-85 -106.28 130.88 54.05 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -110.45 146.27 36.2 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.124 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 67.4 t -117.54 127.51 74.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.473 ' N ' ' OG ' ' A' ' 81' ' ' SER . 82.8 mt -119.71 128.08 75.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.984 -173.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -120.13 141.26 50.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -79.1 143.84 35.14 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.941 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.415 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 52.2 tp -112.64 131.14 55.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.486 0.66 . . . . 0.0 110.216 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.483 ' C ' ' HZ3' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--N 1.293 -1.82 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 mttp . . . . . 0 N--CA 1.443 -0.798 0 CA-C-O 120.761 0.315 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.546 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 61.1 mt -111.46 131.49 62.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.511 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 46.3 mtpt -91.29 107.16 19.02 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' SG ' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -147.59 167.02 25.6 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.908 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.454 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 14.1 m -135.02 149.9 50.22 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.432 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.418 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -139.08 149.9 45.11 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 119.512 -0.875 . . . . 0.0 113.112 -177.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.486 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 96.5 mt -124.11 123.34 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.0 tp -94.41 127.2 40.16 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -129.89 150.64 34.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.129 0.49 . . . . 0.0 110.588 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -66.14 -40.64 90.77 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.296 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -121.17 152.32 38.9 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -172.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -62.06 -41.15 97.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.665 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.09 95.67 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.97 -42.09 98.75 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.37 92.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.742 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.64 -42.46 99.61 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.029 0.442 . . . . 0.0 110.412 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.69 79.61 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.887 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.42 -40.75 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.926 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.452 ' NE2' ' C ' ' A' ' 81' ' ' SER . 81.0 mt-30 -59.5 -47.05 87.02 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.275 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -64.3 -44.49 91.45 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.567 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 71.4 ttt180 -65.58 -39.3 91.48 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.69 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.61 -28.92 61.5 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 69.0 mmtt -62.9 -30.12 71.29 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.79 -22.17 45.76 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.533 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.84 13.39 56.67 Favored Glycine 0 C--O 1.236 0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.135 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.567 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 73.9 mt-10 -66.31 154.46 39.93 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -60.19 126.71 28.56 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 66.0 t80 -59.11 -44.95 92.01 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -60.87 -37.77 94.25 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.472 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 60.1 tttm -60.23 -46.46 89.69 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -60.9 -36.91 80.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.932 178.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . -56.04 -50.86 69.76 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.501 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 45.4 mttp -62.76 -37.81 88.09 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 80.3 mm-40 -69.82 -46.65 65.19 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.422 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.45 -41.44 3.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 6.6 p -54.99 138.11 44.52 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.481 -168.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.3 pt -97.85 -5.03 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.134 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.521 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 57.3 t0 -84.45 93.09 8.22 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.19 -45.53 96.33 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.2 -44.91 74.76 Favored Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.521 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 73.9 m -70.74 -34.08 71.49 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.604 175.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -63.69 -25.32 68.16 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.886 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 30.6 mmtp -63.14 -36.97 85.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 8.3 mtm-85 -96.77 15.47 21.87 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.165 174.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.52 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 22.6 m-20 58.94 29.48 18.98 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.72 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 77.89 -5.15 54.78 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.95 84.06 1.73 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.501 0.667 . . . . 0.0 110.186 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 96.4 mt -62.91 -39.75 95.49 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.153 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.38 -142.92 18.35 Favored Glycine 0 CA--C 1.503 -0.667 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.511 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 19.8 m-85 -83.9 132.91 34.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.546 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 46.9 p90 -145.07 152.02 39.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.89 165.54 26.94 Favored Glycine 0 C--N 1.316 -0.53 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HD2' ' CZ ' ' A' ' 73' ' ' PHE . 60.0 mtp180 -77.32 157.96 30.42 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.496 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 129.11 -77.03 0.4 Allowed Glycine 0 N--CA 1.462 0.394 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -61.21 -38.01 85.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.393 0.615 . . . . 0.0 109.623 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.569 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 75.6 mmm -63.84 145.8 55.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.213 -176.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 m -73.71 130.66 35.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.657 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.611 ' HZ2' ' CD ' ' A' ' 69' ' ' GLU . 5.7 mmtm -45.05 -40.35 10.56 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.118 -174.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 32.8 Cg_exo -56.09 -41.57 75.47 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 120.445 0.763 . . . . 0.0 110.434 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 23.0 t80 -62.84 -47.1 84.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.598 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.611 ' CD ' ' HZ2' ' A' ' 66' ' ' LYS . 96.4 mt-10 -62.13 -43.2 99.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.59 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.03 -51.36 69.58 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.793 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.21 96.79 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.278 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.6 84.5 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.492 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.473 ' CZ ' ' HD2' ' A' ' 61' ' ' ARG . 55.7 m-85 -66.62 -37.03 84.0 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.546 HH12 ' CD ' ' A' ' 82' ' ' GLU . 49.3 mtm180 -63.6 -35.92 82.12 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.563 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.501 HD11 ' CA ' ' A' ' 81' ' ' SER . 74.5 mt -97.24 21.38 10.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -171.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.509 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 70.0 mt-30 -52.27 -24.99 8.28 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.893 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 p -61.31 -26.51 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.647 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.17 5.43 19.64 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.489 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 1.8 mm-40 -75.6 173.85 10.49 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 t -104.22 127.5 58.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.584 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.501 ' CA ' HD11 ' A' ' 75' ' ' LEU . 60.0 p -68.14 151.02 47.63 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.546 ' CD ' HH12 ' A' ' 74' ' ' ARG . 1.2 mp0 -63.86 164.03 19.17 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 167.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -54.32 128.29 29.42 Favored 'Trans proline' 0 C--N 1.29 -2.521 0 N-CA-C 109.71 -0.919 . . . . 0.0 109.71 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 t -98.32 117.51 43.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -77.45 136.87 38.41 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.086 0.47 . . . . 0.0 110.844 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 10.3 p -153.89 167.35 30.01 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -57.02 -31.29 64.98 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.45 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 68.3 m-85 -63.58 -42.8 98.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.676 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.43 -132.81 4.45 Favored Glycine 0 C--O 1.239 0.426 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -107.42 127.66 53.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -108.03 140.71 40.8 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.889 172.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.98 115.88 51.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 171.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.4 mt -111.82 125.34 69.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.854 -171.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -113.1 139.74 48.46 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 3.2 tmm_? -78.87 141.78 37.37 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.238 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.505 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 58.6 tp -109.91 134.41 52.11 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.167 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.418 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.204 -1.735 0 CA-C-O 118.126 -1.374 . . . . 0.0 110.63 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 mttm . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.462 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 39.8 mm -105.49 129.45 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' GLY . 36.0 mtpt -88.98 104.32 16.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 176.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.53 170.36 16.2 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.815 -176.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.52 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 3.6 m -128.29 137.69 52.08 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 114.319 -1.31 . . . . 0.0 107.743 175.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.49 149.6 51.72 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.994 -0.682 . . . . 0.0 112.459 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.504 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 90.0 mt -122.94 124.84 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 44' ' ' SER . 41.6 tp -104.85 123.54 47.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.79 154.29 40.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.25 0.547 . . . . 0.0 111.556 -176.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -70.43 -40.38 73.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.818 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.61 144.49 37.88 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -169.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.47 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 27.4 mt-30 -62.78 -39.35 93.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.614 175.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.25 -38.86 95.21 Favored Glycine 0 CA--C 1.509 -0.307 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -64.99 -44.5 89.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.223 0.535 . . . . 0.0 109.77 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.46 81.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.423 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 27' ' ' GLN . 91.4 mt -64.32 -40.06 95.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.13 -49.17 74.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.35 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.447 ' CG1' ' CD1' ' A' ' 43' ' ' LEU . 21.1 m -64.93 -38.05 81.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.944 176.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.645 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 2.2 mm-40 -54.23 -48.16 71.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.428 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -70.67 -43.44 69.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.251 0.548 . . . . 0.0 110.766 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.46 ' NE ' ' OE1' ' A' ' 34' ' ' GLU . 65.0 ttt180 -61.63 -39.43 91.28 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.001 -174.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -60.75 -34.29 74.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.153 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.645 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 23.9 mmtm -62.97 -34.12 76.84 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.82 -23.62 63.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.425 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.09 1.45 54.68 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.103 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.46 ' OE1' ' NE ' ' A' ' 29' ' ' ARG . 55.1 mt-10 -65.58 155.78 34.74 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.35 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -61.62 126.58 27.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.082 -172.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.504 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 61.8 t80 -58.18 -45.24 87.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 174.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.09 -39.16 95.41 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.385 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -60.7 -43.58 97.63 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.031 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 39' ' ' LEU . 4.4 mm? -63.48 -40.96 98.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.697 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.445 ' CB ' ' C ' ' A' ' 53' ' ' ASP . . . -60.68 -43.32 97.83 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 31.6 mmtt -64.56 -36.46 84.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -70.44 -59.34 2.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.075 -172.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.447 ' CD1' ' CG1' ' A' ' 26' ' ' VAL . 1.8 mt -93.42 -57.4 2.61 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 43' ' ' LEU . 5.5 m -29.47 120.02 0.15 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.956 -1.474 . . . . 0.0 113.493 -165.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.5 pt -82.34 -12.0 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.482 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 53.0 t0 -82.16 95.08 7.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.8 174.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.05 -42.84 99.75 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.04 -45.36 81.95 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.482 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 54.1 m -69.16 -32.6 72.04 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.574 0.226 . . . . 0.0 110.724 175.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.424 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -63.12 -37.35 86.85 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.041 0.448 . . . . 0.0 109.999 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -63.73 -27.69 69.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.897 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 55' ' ' SER . 68.7 mtt-85 -95.94 5.61 50.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.081 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.445 ' C ' ' CB ' ' A' ' 40' ' ' ALA . 0.6 OUTLIER 58.06 33.0 22.72 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 79.65 -16.85 9.7 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -66.15 81.38 0.08 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.61 0.719 . . . . 0.0 110.932 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.6 mt -61.87 -41.07 97.42 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.417 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 91.19 -137.38 13.81 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 71.2 m-85 -84.16 137.82 33.32 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.462 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.0 p90 -146.66 148.29 31.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.872 0.367 . . . . 0.0 111.197 169.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.0 169.53 23.04 Favored Glycine 0 C--N 1.313 -0.715 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -80.38 156.32 26.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.673 0.273 . . . . 0.0 110.551 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.48 -52.27 0.75 Allowed Glycine 0 C--N 1.31 -0.862 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -60.93 -45.0 96.43 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.144 0.497 . . . . 0.0 110.387 174.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.6 mmm -88.25 148.09 24.51 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.659 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.51 139.15 21.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HZ1' ' CD ' ' A' ' 69' ' ' GLU . 11.2 mmtm -44.36 -40.97 9.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.53 -44.7 45.85 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 N-CA-C 110.37 -0.665 . . . . 0.0 110.37 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -62.6 -46.29 88.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.407 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.538 ' CD ' ' HZ1' ' A' ' 66' ' ' LYS . 99.3 mt-10 -62.21 -45.9 91.31 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.871 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 38.3 t70 -59.12 -45.99 89.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.099 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.56 90.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.245 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.03 -49.25 76.78 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -67.16 -38.16 85.01 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 51.8 mtp180 -61.52 -47.08 87.23 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.333 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.7 mt -100.28 34.58 2.32 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.484 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 49.4 mt-30 -53.52 -20.17 4.6 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.817 0.341 . . . . 0.0 110.845 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.73 -26.55 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.492 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.93 6.13 21.17 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -78.39 153.68 31.36 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.41 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 16.6 t -75.2 130.78 35.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.527 ' C ' HE21 ' A' ' 27' ' ' GLN . 89.4 p -72.2 154.17 41.18 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.359 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -63.5 165.19 12.29 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -56.1 131.3 45.05 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 N-CA-C 109.513 -0.995 . . . . 0.0 109.513 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 42.0 t -105.86 109.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -80.48 134.12 35.93 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 8.6 p -153.18 168.49 25.78 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -60.6 -29.96 69.53 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.422 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 56.2 m-85 -66.79 -38.79 87.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.479 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.03 -150.28 22.5 Favored Glycine 0 C--N 1.316 -0.579 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.47 ' CE1' ' HG2' ' A' ' 20' ' ' GLN . 58.5 m-85 -101.95 125.96 48.75 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -107.21 144.68 33.62 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.288 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.75 126.43 74.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 168.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.438 HG22 ' SG ' ' A' ' 12' ' ' CYS . 98.8 mt -117.64 129.33 74.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.804 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -119.68 140.67 50.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.484 ' HG3' ' HA ' ' A' ' 76' ' ' GLN . 2.5 tmm_? -78.85 143.96 35.47 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.997 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.419 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 57.2 tp -113.05 140.67 47.65 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.917 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.556 0 CA-C-O 118.267 -1.296 . . . . 0.0 110.571 -179.435 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.487 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -107.38 128.1 62.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.537 ' HZ1' ' C ' ' A' ' 97' ' ' GLY . 62.3 mtpt -93.72 104.6 16.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -149.13 169.21 21.21 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.719 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.486 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 48.1 m -132.78 147.34 52.31 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.58 175.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.489 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -130.39 150.91 51.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -177.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.549 HG13 ' CE2' ' A' ' 36' ' ' PHE . 96.2 mt -127.82 124.4 62.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.521 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.4 tp -90.84 129.09 36.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.04 143.1 41.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 O-C-N 123.577 0.548 . . . . 0.0 110.834 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -65.6 -42.41 91.66 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.191 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -126.38 151.97 46.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.681 -169.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -60.25 -35.08 74.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.722 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.09 -38.3 94.13 Favored Glycine 0 C--N 1.321 -0.265 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.61 -41.7 92.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.66 -47.4 84.57 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.135 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.68 -41.93 99.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.168 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.02 72.67 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.726 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.17 -39.78 86.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.101 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.485 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 4.6 mm-40 -58.69 -47.8 83.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.958 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -65.71 -46.46 78.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.502 0.668 . . . . 0.0 110.097 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.463 ' NH1' ' OE1' ' A' ' 42' ' ' GLU . 72.8 ttt180 -63.65 -40.83 97.86 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.886 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.63 -32.64 65.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.485 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 29.6 mmtm -63.41 -13.05 35.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.466 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.16 -14.08 60.52 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.57 -1.92 60.37 Favored Glycine 0 C--O 1.243 0.667 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.58 148.72 32.42 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.322 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -71.78 142.19 49.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.958 0.885 . . . . 0.0 112.593 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.549 ' CE2' HG13 ' A' ' 15' ' ' ILE . 57.1 t80 -56.97 -45.04 83.16 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.116 -177.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.07 -37.5 94.01 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.69 -46.36 90.03 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.423 ' N ' HD21 ' A' ' 39' ' ' LEU . 3.0 mm? -61.62 -39.64 91.98 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.291 173.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . -58.77 -50.99 71.88 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.317 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -61.15 -42.56 98.77 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.106 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.463 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 70.7 mt-10 -70.23 -41.37 73.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -173.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.519 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.64 -28.53 3.86 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 10.1 p -59.92 135.54 57.73 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.681 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.0 pt -105.26 -6.78 9.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.293 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.432 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 59.0 t0 -83.85 97.2 9.07 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -55.98 -46.09 85.2 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -43.85 -56.37 5.13 Favored Glycine 0 C--O 1.237 0.313 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.491 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . 1.5 p -71.04 -32.92 69.8 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.44 73.75 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.147 0.498 . . . . 0.0 109.904 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 99.4 mttt -58.74 -36.01 73.63 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 177.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.443 ' NE ' ' O ' ' A' ' 55' ' ' SER . 61.1 mtp85 -98.3 7.57 46.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.396 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.445 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 79.9 m-20 58.71 31.76 21.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -173.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 49' ' ' SER . . . 75.85 -6.68 31.99 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.443 ' O ' ' NE ' ' A' ' 52' ' ' ARG . 1.1 m -66.59 72.86 0.09 Allowed 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.434 0.635 . . . . 0.0 110.913 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 54' ' ' GLY . 94.5 mt -63.69 -40.33 96.53 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.593 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.59 -145.04 22.6 Favored Glycine 0 N--CA 1.464 0.54 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.95 129.08 34.93 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.517 ' CE1' ' HG3' ' A' ' 64' ' ' MET . 55.4 p90 -141.0 153.7 45.68 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.465 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.54 169.98 32.03 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.5 mtm105 -78.02 148.92 34.13 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 120.883 0.373 . . . . 0.0 111.004 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.16 -32.78 6.91 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -64.5 -37.35 87.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.842 0.353 . . . . 0.0 110.776 175.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.517 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 2.8 mmm -101.94 160.04 14.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.369 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 m -75.07 153.66 6.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -44.3 -50.0 22.82 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.99 -41.28 80.4 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 120.962 1.108 . . . . 0.0 110.828 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -62.36 -47.78 82.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.777 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.66 -38.68 91.83 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.227 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.06 -51.27 66.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.998 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.2 -41.49 94.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.196 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.83 78.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 -177.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -67.46 -35.47 79.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 0.0 111.258 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.537 HH21 ' CD ' ' A' ' 82' ' ' GLU . 43.9 mtp180 -60.38 -39.18 86.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.155 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.548 HD12 ' CB ' ' A' ' 81' ' ' SER . 44.8 mt -96.87 17.11 17.48 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.461 ' HA ' ' HD2' ' A' ' 95' ' ' ARG . 82.4 mt-30 -54.08 -22.46 10.9 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 117.943 -1.503 . . . . 0.0 110.842 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -59.4 -27.31 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.113 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 121.51 -2.17 11.24 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.44 174.26 9.85 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -173.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.4 t -96.89 133.41 38.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.325 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.548 ' CB ' HD12 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -68.36 152.74 44.99 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.193 -178.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.537 ' CD ' HH21 ' A' ' 74' ' ' ARG . 2.8 mp0 -65.16 177.25 0.66 Allowed Pre-proline 0 N--CA 1.427 -1.587 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 167.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -56.54 134.55 65.09 Favored 'Trans proline' 0 C--N 1.287 -2.694 0 N-CA-C 109.765 -0.898 . . . . 0.0 109.765 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 50.5 t -120.95 129.59 75.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -109.3 132.38 54.18 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.064 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.5 p -115.0 -171.25 1.91 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.107 171.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -67.04 -35.04 79.02 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 172.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 8.6 m-30 -63.36 -44.39 94.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.635 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.34 -143.82 9.96 Favored Glycine 0 C--N 1.321 -0.261 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 28.1 m-85 -102.14 134.28 45.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.943 0.401 . . . . 0.0 111.987 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.44 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 16.9 m-70 -118.4 150.1 40.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.023 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.8 t -117.51 125.7 74.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 164.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.496 ' O ' ' CD1' ' A' ' 75' ' ' LEU . 89.1 mt -123.55 131.86 72.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -171.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HG2' ' N ' ' A' ' 95' ' ' ARG . 43.4 tttm -123.53 152.32 41.91 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.485 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 79.1 ttt180 -77.35 137.77 38.94 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.7 tp -119.91 130.47 54.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.537 ' C ' ' HZ1' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.572 0 CA-C-O 118.769 -1.017 . . . . 0.0 112.188 -174.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 mttp . . . . . 0 N--CA 1.441 -0.9 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.451 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 58.4 mt -104.96 127.11 59.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -173.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 62.5 mtpt -91.94 106.05 18.16 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.431 ' SG ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -146.54 164.79 31.44 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.914 -175.176 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.8 m -127.51 135.67 50.68 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.079 -1.418 . . . . 0.0 108.354 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.457 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -130.61 149.23 52.37 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.698 -177.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.512 HG13 ' CE2' ' A' ' 36' ' ' PHE . 95.9 mt -128.44 127.72 67.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.142 176.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 44' ' ' SER . 41.4 tp -98.68 123.96 43.2 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.93 154.71 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.665 0.745 . . . . 0.0 111.052 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 6.7 mtmp? -65.75 -41.89 91.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.742 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -123.51 154.06 39.69 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.526 -167.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.404 ' HG3' ' CB ' ' A' ' 83' ' ' PRO . 58.2 tt0 -60.47 -40.84 92.7 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.032 175.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.44 -39.53 97.42 Favored Glycine 0 CA--C 1.508 -0.345 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 98.3 mt-10 -63.85 -42.78 97.5 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.89 99.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.364 177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.27 -41.61 99.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.851 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.67 -45.5 81.65 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.867 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG21 ' N ' ' A' ' 27' ' ' GLN . 21.0 m -70.82 -36.27 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.461 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 51.7 tt0 -58.49 -45.78 88.01 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.71 -41.01 88.65 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.503 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 15.9 tpt180 -59.94 -40.84 90.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.818 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.403 HD21 ' N ' ' A' ' 30' ' ' LEU . 1.4 mm? -61.7 -41.44 97.59 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.047 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 25.5 mmtp -67.72 -11.75 59.02 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.723 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.56 -11.17 59.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.1 10.84 63.88 Favored Glycine 0 C--O 1.238 0.372 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.52 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 91.2 mt-10 -86.15 155.86 20.59 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 57.0 mttm -67.37 139.02 57.16 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.381 0.61 . . . . 0.0 112.58 -175.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.512 ' CE2' HG13 ' A' ' 15' ' ' ILE . 52.7 t80 -58.42 -45.84 87.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.056 174.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.21 -35.07 91.02 Favored Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.53 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 49.1 tttm -60.65 -48.87 79.84 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.79 -41.57 99.33 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.064 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.467 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.49 -50.49 73.56 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.685 -176.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 67.8 mttm -65.23 -40.13 93.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.943 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' OE2' ' NZ ' ' A' ' 38' ' ' LYS . 95.8 mt-10 -71.0 -44.42 65.95 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -172.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.465 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -124.51 -19.35 5.45 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -174.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.467 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.7 m -55.73 140.21 42.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.38 -173.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.8 pt -86.03 -11.65 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.516 0.674 . . . . 0.0 109.227 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -88.2 115.17 25.49 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.068 173.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.24 -32.88 77.99 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.57 -42.83 85.36 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 54' ' ' GLY . 41.2 m -61.27 -35.44 77.29 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.538 176.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.64 -43.23 60.07 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.474 0.654 . . . . 0.0 110.525 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -66.29 -39.71 89.56 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.905 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.459 ' O ' ' N ' ' A' ' 55' ' ' SER . 21.5 mmm180 -96.05 4.25 52.75 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.425 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.0 OUTLIER 53.09 35.41 19.58 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -173.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 76.68 -36.85 1.41 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.461 -173.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -54.27 89.36 0.01 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.547 0.739 . . . . 0.0 112.041 -178.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.431 HD11 ' SG ' ' A' ' 12' ' ' CYS . 93.0 mt -63.65 -40.3 96.5 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.238 176.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 97.27 -147.45 18.66 Favored Glycine 0 CA--C 1.503 -0.693 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.502 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 4.8 m-85 -83.71 132.48 34.85 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.552 ' CD2' ' CE ' ' A' ' 64' ' ' MET . 54.7 p90 -146.56 150.65 35.93 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.807 173.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.99 -168.0 34.72 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.7 mtp85 -85.31 148.83 25.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.607 0.241 . . . . 0.0 110.876 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.82 -17.53 56.25 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 116.44 -0.346 . . . . 0.0 112.345 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -67.37 -37.88 83.86 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.181 0.515 . . . . 0.0 111.781 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.552 ' CE ' ' CD2' ' A' ' 59' ' ' PHE . 3.5 mpp? -118.43 161.73 19.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.322 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.8 m -58.01 136.64 21.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HZ2' ' CG ' ' A' ' 70' ' ' ASP . 8.0 tmtm? -44.76 -42.88 16.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -173.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.37 -43.42 58.84 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 CA-C-N 118.894 0.641 . . . . 0.0 110.608 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -63.09 -50.81 69.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.804 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.05 -41.15 87.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.501 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.488 ' CG ' ' HZ2' ' A' ' 66' ' ' LYS . 22.7 t70 -59.01 -44.3 91.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.957 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.31 84.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.493 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.05 89.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.48 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.444 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 46.6 m-85 -62.52 -29.74 70.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.637 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -65.3 -37.16 86.27 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' CA ' ' A' ' 81' ' ' SER . 76.8 mt -95.75 21.52 8.36 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -168.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.455 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 71.9 mt-30 -45.26 -24.98 0.32 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.469 0.176 . . . . 0.0 111.031 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.93 -31.24 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 123.02 0.42 9.71 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.387 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -68.14 174.46 3.86 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.34 129.67 62.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.431 ' CA ' HD12 ' A' ' 75' ' ' LEU . 82.5 p -64.47 155.41 32.82 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.113 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.16 169.46 16.4 Favored Pre-proline 0 N--CA 1.432 -1.354 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 164.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.404 ' CB ' ' HG3' ' A' ' 20' ' ' GLN . 67.5 Cg_exo -54.62 129.4 34.73 Favored 'Trans proline' 0 C--N 1.292 -2.398 0 CA-C-N 118.923 0.651 . . . . 0.0 110.482 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.9 t -107.66 108.28 24.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.215 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.407 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 65.7 tttp -81.95 133.46 35.31 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.581 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.502 ' HG ' ' CD2' ' A' ' 91' ' ' HIS . 60.1 p -138.29 179.79 6.25 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -61.08 -37.61 83.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 10.4 m-30 -63.29 -43.59 97.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.772 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.83 -139.27 6.72 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.407 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 26.2 m-85 -104.92 130.12 53.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.98 0.39 . . . . 0.0 111.038 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.502 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 15.7 m-70 -113.22 148.68 35.01 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.215 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 72.1 t -117.72 126.98 75.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 167.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.4 mt -118.46 123.39 71.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -107.76 140.83 40.24 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 169.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.628 ' NH1' ' O ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -78.74 138.75 38.39 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.91 176.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.628 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 53.3 tp -103.15 124.84 49.34 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.368 0 CA-C-O 118.272 -1.293 . . . . 0.0 112.005 -171.273 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.8 mttp . . . . . 0 N--CA 1.437 -1.108 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.613 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 71.8 mt -105.08 128.48 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -91.57 109.49 20.79 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.44 ' SG ' HD11 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -141.04 164.61 29.82 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -174.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.8 m -127.39 140.7 52.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.479 173.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.43 ' CD2' ' C ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -136.33 150.77 49.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.316 0.579 . . . . 0.0 112.488 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.417 HG13 ' CE2' ' A' ' 36' ' ' PHE . 96.1 mt -128.98 126.52 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.323 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 13.8 mt -95.56 132.69 40.43 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.77 153.63 39.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 O-C-N 123.58 0.55 . . . . 0.0 109.684 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -65.07 -41.29 95.23 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.083 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 9.0 mtmp? -124.55 149.52 46.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -173.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 52.7 tt0 -63.0 -37.35 86.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.05 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.96 -38.73 93.2 Favored Glycine 0 C--O 1.242 0.645 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 93.6 mt-10 -63.77 -41.68 97.93 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 176.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.16 -47.22 84.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.168 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.83 -41.98 98.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.544 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.9 -50.72 72.65 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.752 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.38 -39.22 84.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.059 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 81' ' ' SER . 91.2 mt-30 -57.9 -46.81 84.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.217 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -63.42 -36.54 84.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.598 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 77.0 ttt180 -63.15 -39.42 94.62 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.493 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.41 -40.43 94.4 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 66.2 mmtt -60.83 -28.39 68.78 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.692 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.11 -21.22 66.45 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.419 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.93 -4.32 38.94 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.143 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.598 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 18.9 mt-10 -62.8 149.72 43.36 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.211 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 41.1 tttm -63.68 134.3 55.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.214 0.53 . . . . 0.0 110.927 -174.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.417 ' CE2' HG13 ' A' ' 15' ' ' ILE . 64.9 t80 -56.85 -45.24 82.55 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.562 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.03 -34.84 89.44 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.319 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 88.4 tttt -59.95 -46.65 88.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.57 -41.33 98.86 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.571 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.505 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.44 -47.43 84.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.442 ' HZ1' ' CG ' ' A' ' 53' ' ' ASP . 31.5 mmtp -65.69 -40.6 92.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.077 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 42.2 mt-10 -70.68 -54.12 13.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -172.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -118.21 -29.09 5.65 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -166.607 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.3 m -42.25 137.94 1.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.3 pt -83.32 -12.74 11.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.518 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 64.9 t0 -88.59 97.5 11.13 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.717 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -67.45 -45.89 74.64 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.74 -45.68 78.06 Favored Glycine 0 C--O 1.236 0.267 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.518 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 15.9 m -69.68 -32.67 71.43 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.562 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.62 68.81 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.419 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 48.9 mmtm -62.34 -37.68 86.59 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.431 HH21 ' HA ' ' A' ' 56' ' ' LEU . 89.7 mtm-85 -97.63 20.82 11.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.809 176.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.562 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 16.4 m-20 60.41 32.44 20.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.153 0.502 . . . . 0.0 109.733 -177.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 78.71 -8.54 41.99 Favored Glycine 0 C--N 1.307 -1.04 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.92 89.08 0.07 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.398 0.618 . . . . 0.0 110.36 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD11 ' SG ' ' A' ' 12' ' ' CYS . 91.5 mt -63.1 -41.3 99.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.874 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.39 -154.18 18.97 Favored Glycine 0 C--O 1.236 0.265 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -83.97 135.05 34.61 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.613 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 53.8 p90 -143.2 154.38 43.8 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.558 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.89 173.76 25.94 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH1' ' CZ ' ' A' ' 73' ' ' PHE . 51.5 mtp85 -71.33 138.62 49.41 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.512 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 86.65 -5.76 84.06 Favored Glycine 0 C--N 1.305 -1.16 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -68.42 -40.54 81.17 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.21 0.528 . . . . 0.0 109.734 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.444 ' HE1' ' CG ' ' A' ' 59' ' ' PHE . 76.4 mtm -123.41 161.95 23.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.707 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.5 m -51.67 140.04 6.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 -176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -44.54 -46.26 25.07 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.538 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.88 -46.26 34.66 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 120.643 0.896 . . . . 0.0 110.742 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -61.7 -49.23 77.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.454 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 96.1 mt-10 -65.72 -40.32 92.07 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.339 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.92 -44.49 91.3 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.85 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.39 -38.44 84.69 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.856 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.37 96.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.132 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.584 ' CZ ' ' NH1' ' A' ' 61' ' ' ARG . 39.3 m-85 -61.86 -32.02 72.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 120.794 0.33 . . . . 0.0 111.73 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -61.68 -37.28 83.5 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.741 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.608 HD13 ' N ' ' A' ' 81' ' ' SER . 72.0 mt -90.58 6.85 42.02 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.438 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 85.4 mt-30 -50.78 -27.35 7.05 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.962 -177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 p -62.95 -33.55 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.455 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 119.89 49.76 0.3 Allowed Glycine 0 N--CA 1.475 1.28 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.643 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.64 174.37 9.47 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -175.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.48 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 97.2 t -95.77 130.64 44.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.608 ' N ' HD13 ' A' ' 75' ' ' LEU . 6.2 p -78.61 163.3 25.6 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.019 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.408 ' CB ' ' HD2' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -68.77 169.78 10.13 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 82' ' ' GLU . 69.5 Cg_endo -62.46 141.5 86.97 Favored 'Trans proline' 0 C--N 1.297 -2.141 0 CA-C-N 118.885 0.638 . . . . 0.0 110.707 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.76 130.84 73.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.495 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 29.6 tptp -107.67 135.59 48.85 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.243 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.3 p -145.63 177.16 9.09 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.49 -31.38 70.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -62.1 -42.28 99.06 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.983 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 85' ' ' LYS . . . 152.09 -143.54 10.52 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.495 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 3.2 m-85 -105.24 129.5 53.6 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -109.37 147.5 32.64 Favored 'General case' 0 CA--C 1.501 -0.931 0 O-C-N 123.41 0.444 . . . . 0.0 110.148 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.6 t -118.11 126.55 75.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 163.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.434 ' HB ' ' OG ' ' A' ' 81' ' ' SER . 89.2 mt -115.62 129.92 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.668 -174.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -124.9 143.12 51.02 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.438 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 1.7 tmm_? -78.58 143.83 36.11 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.317 -174.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.402 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 53.8 tp -109.06 139.04 44.48 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.737 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.675 0 CA-C-O 118.249 -1.306 . . . . 0.0 110.332 -179.854 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp . . . . . 0 C--O 1.241 0.62 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.551 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 40.5 mm -106.96 128.35 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.196 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.55 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 46.0 mtpt -95.66 106.9 19.05 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -148.03 168.24 22.84 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.873 -1.131 . . . . 0.0 113.947 -175.003 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.509 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 19.4 m -135.31 143.97 46.47 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.235 173.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.486 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -138.97 151.77 47.14 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.499 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 89.1 mt -121.03 126.7 75.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -98.5 119.52 37.35 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.11 146.68 32.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.187 0.518 . . . . 0.0 111.605 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.33 -40.89 90.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.508 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 22.3 mmtp -109.96 148.24 31.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.869 -171.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -37.55 87.74 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.665 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.98 -37.1 93.85 Favored Glycine 0 C--O 1.227 -0.305 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.446 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 97.9 mt-10 -64.09 -44.69 91.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -49.68 76.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.495 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.99 -41.48 97.48 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.263 0.554 . . . . 0.0 110.216 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.51 -47.19 82.63 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.521 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.1 m -70.2 -32.11 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.967 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.481 HE22 ' HA ' ' A' ' 82' ' ' GLU . 48.8 tt0 -61.35 -47.08 87.53 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -67.86 -43.43 79.46 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.939 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.523 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 75.0 ttt180 -60.7 -39.17 87.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.329 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -41.1 78.55 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.71 -26.9 68.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.737 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.72 -1.1 2.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.27 19.02 61.39 Favored Glycine 0 C--O 1.236 0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.143 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.523 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 28.3 mt-10 -87.1 144.68 26.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.526 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -64.12 139.89 58.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.413 0.625 . . . . 0.0 112.304 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.499 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 48.2 t80 -57.77 -45.53 85.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.24 -36.72 93.43 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.0 177.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -60.76 -44.64 96.49 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.426 HD11 ' NH1' ' A' ' 29' ' ' ARG . 4.6 mm? -62.66 -40.43 97.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.693 172.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.15 97.87 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.972 0.415 . . . . 0.0 110.144 -177.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.456 ' HZ3' ' CG ' ' A' ' 53' ' ' ASP . 13.1 mmtm -65.86 -44.09 86.46 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.897 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.451 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 74.6 mt-10 -71.4 -41.79 69.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.9 -70.39 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -170.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.4 t -33.59 128.48 0.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.449 -168.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.2 pt -91.05 -3.3 10.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.777 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 50' ' ' ALA . 54.6 t0 -79.09 94.73 5.39 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.09 -51.08 61.03 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -46.21 -53.41 9.34 Favored Glycine 0 C--N 1.322 -0.235 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.532 ' OG ' ' NH2' ' A' ' 52' ' ' ARG . 21.9 m -71.7 -32.24 67.59 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 46' ' ' ASP . . . -62.63 -38.35 89.89 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -61.79 -25.48 67.51 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.756 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.532 ' NH2' ' OG ' ' A' ' 49' ' ' SER . 93.1 mtm-85 -97.69 7.71 45.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.367 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.531 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER 59.71 34.1 22.0 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.536 0.684 . . . . 0.0 109.649 -173.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 79.27 -8.59 45.55 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.336 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 m -65.4 128.46 35.97 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.589 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -109.01 -28.77 8.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.985 0.421 . . . . 0.0 110.064 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 78.63 -146.87 30.41 Favored Glycine 0 CA--C 1.516 0.124 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.55 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 44.0 m-85 -84.32 133.27 34.55 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.551 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 52.1 p90 -144.43 145.91 32.18 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.76 179.25 38.39 Favored Glycine 0 C--N 1.316 -0.535 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -71.05 137.73 49.22 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.085 -0.558 . . . . 0.0 109.778 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.17 -22.76 32.31 Favored Glycine 0 C--N 1.305 -1.182 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.46 -41.4 84.75 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mmm -113.85 160.73 18.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.369 -170.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -63.73 142.67 16.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -43.43 -50.26 16.6 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.997 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.26 -42.18 69.71 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 N-CA-C 110.393 -0.657 . . . . 0.0 110.393 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -62.4 -47.93 81.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.454 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.1 -42.88 93.6 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.584 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.68 -40.68 93.05 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.241 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.07 -41.96 90.04 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.006 0.431 . . . . 0.0 110.114 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.87 97.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.395 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.412 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 46.5 m-85 -66.82 -34.13 77.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -62.99 -33.86 76.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 81' ' ' SER . 73.9 mt -89.41 18.67 5.04 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -168.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.513 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 99.4 mm-40 -59.41 -22.46 61.45 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.3 -26.05 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.427 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 98.49 29.47 7.42 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -101.74 159.75 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.787 -0.243 . . . . 0.0 111.458 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.1 t -77.22 131.11 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.478 ' N ' HD12 ' A' ' 75' ' ' LEU . 28.1 p -69.91 157.61 37.12 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.671 -178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.481 ' HA ' HE22 ' A' ' 27' ' ' GLN . 16.8 mp0 -73.17 168.65 22.95 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 167.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -53.95 131.42 44.42 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 N-CA-C 110.304 -0.691 . . . . 0.0 110.304 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -106.62 108.59 25.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.509 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 16.0 tptm -79.59 131.62 36.05 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.556 ' HG ' ' CD2' ' A' ' 91' ' ' HIS . 14.7 p -151.34 174.58 13.16 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.76 -172.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -54.81 -36.86 65.42 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.708 174.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -68.67 -41.49 79.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.628 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.9 -125.54 2.51 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.509 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 96.1 m-85 -109.97 128.28 55.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.111 0.455 . . . . 0.0 110.157 177.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.556 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 4.2 m-70 -108.37 146.63 32.74 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.906 173.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.0 125.44 73.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.435 ' N ' ' OG ' ' A' ' 81' ' ' SER . 88.5 mt -119.46 129.47 75.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.714 -171.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -112.34 131.33 55.59 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 169.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.513 ' CD ' ' HA ' ' A' ' 76' ' ' GLN . 79.2 ttt-85 -78.04 135.47 37.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 11' ' ' LYS . 56.0 tp -107.24 132.82 52.65 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.141 -173.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.387 0 CA-C-O 118.096 -1.391 . . . . 0.0 111.221 -177.399 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.0 mttp . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.552 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 15.7 mm -105.2 124.18 59.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 57' ' ' GLY . 62.0 mtpt -97.15 105.13 17.22 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 171.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.513 ' SG ' HG22 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -146.16 168.73 20.28 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -173.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.475 ' CB ' ' CE2' ' A' ' 36' ' ' PHE . 3.9 m -132.66 146.86 52.22 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.82 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.548 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -133.92 150.65 51.32 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.639 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 93.6 mt -123.62 126.72 73.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 44' ' ' SER . 42.1 tp -100.74 122.47 43.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.29 155.34 41.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.332 0.587 . . . . 0.0 110.915 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -65.29 -40.29 93.66 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.702 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB2' ' CG ' ' A' ' 22' ' ' GLU . 58.4 mttp -117.13 151.81 36.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.086 -168.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.07 -40.57 98.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.44 -0.8 . . . . 0.0 108.96 170.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.97 -37.49 93.92 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.474 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 94.4 mt-10 -64.73 -41.34 96.03 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.01 -42.66 98.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.993 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -62.22 -41.84 98.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.48 -49.89 73.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.384 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 23' ' ' ALA . 2.6 m -65.19 -40.82 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.807 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -56.65 -46.24 81.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -67.83 -41.85 82.39 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.315 0.579 . . . . 0.0 110.261 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.483 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 77.0 ttt180 -61.07 -39.43 89.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.922 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.65 -36.57 74.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -67.44 -13.61 62.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.378 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.95 -12.4 61.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.99 0.424 . . . . 0.0 110.116 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.97 16.64 47.0 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.256 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.59 147.38 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.283 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -66.25 133.82 51.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.087 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.639 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 54.3 t80 -58.62 -46.31 87.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.149 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.53 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.89 -36.14 92.99 Favored Glycine 0 C--O 1.25 1.154 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -60.2 -48.12 83.06 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.438 HD11 ' HD3' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -63.96 -40.1 95.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.987 176.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' CB ' ' C ' ' A' ' 53' ' ' ASP . . . -56.49 -47.94 78.22 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 37' ' ' GLY . 24.5 mtmm -64.77 -41.28 95.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.029 176.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.483 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 86.9 mt-10 -71.04 -56.83 5.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mt -76.77 -50.37 13.71 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 1.8 m -61.14 139.25 58.14 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.337 -161.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.0 pt -87.75 -4.52 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.874 172.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.542 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 59.4 t0 -89.77 96.65 10.78 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.189 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.0 -41.36 99.92 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.63 -45.1 90.86 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.548 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 39.6 m -63.89 -33.79 76.49 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.699 0.285 . . . . 0.0 110.622 174.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.63 97.48 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -70.3 -11.73 61.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.697 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 55' ' ' SER . 72.2 mmt-85 -113.03 9.28 18.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.097 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.53 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.4 m-20 53.61 30.8 11.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -174.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 60.48 1.42 1.73 Allowed Glycine 0 C--N 1.318 -0.438 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 53' ' ' ASP . 1.7 m -75.84 85.75 2.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.244 0.545 . . . . 0.0 110.578 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.85 -40.16 95.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.175 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 89.29 -149.25 20.58 Favored Glycine 0 C--N 1.322 -0.231 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -84.83 132.79 34.36 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.552 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 53.6 p90 -143.62 146.73 33.49 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.338 171.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.75 -171.7 37.49 Favored Glycine 0 C--N 1.314 -0.659 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 61' ' ' ARG . 50.6 mtp85 -69.64 139.32 53.56 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.411 ' N ' ' OE2' ' A' ' 69' ' ' GLU . . . 96.08 -27.25 17.39 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 176.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -65.32 -37.44 87.1 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 116.959 0.38 . . . . 0.0 111.669 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mmt -110.28 159.55 17.32 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.84 134.23 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.098 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HZ1' ' CD ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -45.58 -40.51 14.24 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -171.503 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.24 -43.37 56.74 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.654 0.903 . . . . 0.0 110.242 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CE1' HG12 ' A' ' 93' ' ' ILE . 48.5 t80 -61.99 -46.82 87.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.85 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.455 ' CD ' ' HZ1' ' A' ' 66' ' ' LYS . 81.4 mt-10 -64.42 -40.89 96.64 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.345 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -55.86 -47.26 77.64 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.826 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.46 77.92 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.496 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.422 ' O ' HD21 ' A' ' 75' ' ' LEU . . . -60.6 -46.48 90.08 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CD1' HD12 ' A' ' 10' ' ' ILE . 47.3 m-85 -62.61 -41.68 99.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.983 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -63.52 -41.7 98.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.545 ' CD2' ' C ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -83.56 1.08 43.81 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -174.734 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.419 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 7.3 mm-40 -51.24 -23.36 3.38 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.939 0.4 . . . . 0.0 110.162 177.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.31 -27.46 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.772 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.49 46.89 0.34 Allowed Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -117.37 170.89 8.35 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 t -100.41 117.29 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 170.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.5 p -62.73 151.02 39.68 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.399 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.26 170.95 3.0 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.0 131.47 45.67 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 N-CA-C 109.828 -0.874 . . . . 0.0 109.828 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.2 111.78 37.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -88.24 134.49 33.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.798 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.9 p -144.9 173.66 11.68 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.83 -31.26 66.46 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -67.01 -38.42 85.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.815 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.48 -145.74 14.5 Favored Glycine 0 C--N 1.322 -0.216 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -106.87 129.8 54.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -110.81 148.27 32.73 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.455 0.169 . . . . 0.0 110.561 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.0 t -117.9 128.22 75.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 167.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.513 HG22 ' SG ' ' A' ' 12' ' ' CYS . 72.8 mt -109.18 126.83 66.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.76 0.314 . . . . 0.0 110.441 -175.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.477 ' NZ ' ' O ' ' A' ' 95' ' ' ARG . 9.6 tptp -104.9 135.63 45.9 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 170.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.477 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -76.96 142.0 40.2 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.239 -178.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.6 tp -108.16 132.69 53.35 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.532 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.766 -172.582 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.7 mttp . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.627 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 41.9 mm -104.58 126.22 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HZ3' ' C ' ' A' ' 97' ' ' GLY . 60.6 mtpt -94.12 108.18 20.04 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 170.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -148.01 170.13 18.41 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.961 -171.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.554 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 20.3 m -130.63 147.35 52.3 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.537 175.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.529 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -134.71 152.47 51.79 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.879 0.371 . . . . 0.0 111.593 -175.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.2 mt -128.14 127.14 67.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 175.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 44' ' ' SER . 38.7 tp -99.28 123.09 43.29 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.25 154.36 28.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.156 0.503 . . . . 0.0 111.497 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.423 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 6.6 mttp -67.7 -42.23 82.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.621 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 68.3 mttm -124.53 149.8 46.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.64 -168.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -57.21 -38.84 74.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.164 171.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.75 -36.16 92.31 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.446 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 96.9 mt-10 -64.07 -41.05 97.47 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.357 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.417 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . . . -61.32 -45.52 94.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.595 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -61.84 -41.96 98.45 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.44 76.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.504 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.414 ' CG1' ' CD2' ' A' ' 43' ' ' LEU . 32.8 m -65.5 -37.72 80.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.784 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.598 ' NE2' ' HA ' ' A' ' 82' ' ' GLU . 79.0 mt-30 -59.32 -49.82 76.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.162 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -68.34 -38.52 81.58 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.446 ' HD3' ' CD1' ' A' ' 39' ' ' LEU . 73.5 ttt180 -61.97 -42.2 98.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.146 0.498 . . . . 0.0 109.874 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -43.41 95.36 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -12.78 36.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.958 175.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.72 -8.4 55.21 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.04 9.99 60.22 Favored Glycine 0 C--O 1.238 0.38 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -75.1 161.21 29.61 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.998 0.427 . . . . 0.0 111.348 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' O ' HD21 ' A' ' 39' ' ' LEU . 47.0 mttm -74.07 137.14 43.15 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.291 -177.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -59.14 -45.09 91.84 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.44 -39.06 96.76 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.281 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.33 -45.16 94.42 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.446 ' CD1' ' HD3' ' A' ' 29' ' ' ARG . 1.3 mm? -61.34 -42.1 98.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.09 173.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.505 ' C ' ' HG ' ' A' ' 44' ' ' SER . . . -61.56 -53.21 59.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.948 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HZ1' ' CG ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -69.02 -32.86 72.68 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.805 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 87.1 mt-10 -71.08 -41.21 70.96 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' CD2' ' CG1' ' A' ' 26' ' ' VAL . 4.5 mp -105.21 -67.97 0.89 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.505 ' HG ' ' C ' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -26.58 117.16 0.07 Allowed 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 114.084 -1.416 . . . . 0.0 112.984 -166.185 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.2 pt -90.68 -2.57 10.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.067 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -76.41 179.89 5.58 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.714 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.35 -118.73 0.55 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.736 -176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 52' ' ' ARG . . . -49.41 -43.13 34.94 Favored Glycine 0 C--N 1.321 -0.259 0 N-CA-C 112.153 -0.379 . . . . 0.0 112.153 -172.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -60.12 -34.24 73.24 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.366 -179.019 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.26 86.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.472 0.653 . . . . 0.0 109.271 175.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.23 -7.37 59.37 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.442 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 56.3 mtp85 -96.89 20.38 11.19 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.731 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.531 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 83.0 m-20 56.19 29.62 15.09 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -173.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 75.76 -13.26 7.04 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.689 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.1 p -66.33 95.08 0.29 Allowed 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.834 0.826 . . . . 0.0 112.199 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.58 -38.3 89.11 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.812 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.03 -147.19 18.75 Favored Glycine 0 C--N 1.317 -0.474 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 1.5 p90 -85.3 141.04 30.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.222 0.511 . . . . 0.0 111.385 177.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.627 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 49.9 p90 -147.28 151.65 36.98 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 171.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.31 176.94 27.05 Favored Glycine 0 C--O 1.241 0.59 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.438 ' HG2' ' CE2' ' A' ' 73' ' ' PHE . 83.6 mtm-85 -69.36 142.44 53.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 120.977 0.418 . . . . 0.0 110.705 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.85 -36.58 4.3 Favored Glycine 0 C--N 1.306 -1.124 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -63.1 -41.5 99.38 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.395 -0.474 . . . . 0.0 110.721 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.453 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 26.7 mmm -97.05 160.23 14.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.923 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.5 m -71.28 144.47 13.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -44.31 -51.51 19.36 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.73 -42.82 65.02 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.39 0.727 . . . . 0.0 110.391 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -62.16 -46.29 89.63 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.885 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -61.61 -42.51 98.99 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.493 ' CG ' ' HE ' ' A' ' 74' ' ' ARG . 11.8 t70 -55.81 -48.82 74.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.45 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.61 61.84 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.114 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.81 72.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.732 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.468 ' CD1' HD11 ' A' ' 10' ' ' ILE . 58.5 m-85 -67.01 -39.26 87.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.493 ' HE ' ' CG ' ' A' ' 70' ' ' ASP . 46.8 mtm105 -63.5 -39.19 93.79 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.225 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 81' ' ' SER . 73.9 mt -96.5 29.97 2.73 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.47 ' OE1' ' NE ' ' A' ' 95' ' ' ARG . 4.3 mm100 -52.47 -20.03 2.61 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.9 p -62.8 -31.31 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.881 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.32 -3.63 15.91 Favored Glycine 0 N--CA 1.475 1.299 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.274 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -67.4 153.13 44.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.997 0.399 . . . . 0.0 110.64 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.0 t -71.03 132.16 33.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 93' ' ' ILE . 10.8 p -75.66 155.93 35.31 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.083 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.598 ' HA ' ' NE2' ' A' ' 27' ' ' GLN . 4.1 mp0 -75.56 172.43 9.28 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HG3' ' CB ' ' A' ' 23' ' ' ALA . 75.3 Cg_exo -54.79 130.53 40.95 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 N-CA-C 109.036 -1.178 . . . . 0.0 109.036 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 58.5 t -105.01 114.32 44.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -83.37 132.24 35.01 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.428 ' OG ' ' NE2' ' A' ' 91' ' ' HIS . 60.6 p -141.12 172.01 13.28 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.45 -37.48 83.71 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -64.6 -42.54 95.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.384 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.87 -145.3 13.07 Favored Glycine 0 C--N 1.318 -0.421 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 73.8 m-85 -105.58 128.48 53.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.862 0.331 . . . . 0.0 111.352 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.529 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.1 m-70 -119.18 152.27 36.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.333 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -118.76 128.96 75.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 166.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.528 ' N ' ' OG ' ' A' ' 81' ' ' SER . 86.0 mt -122.12 133.27 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 119.74 -0.171 . . . . 0.0 111.369 -173.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -128.22 148.16 50.61 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 167.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.47 ' NE ' ' OE1' ' A' ' 76' ' ' GLN . 61.5 ttt-85 -79.16 142.21 36.55 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.012 0.435 . . . . 0.0 110.091 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 11' ' ' LYS . 50.1 tp -112.61 133.42 54.66 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.445 ' C ' ' HZ3' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.208 -1.477 0 CA-C-O 118.341 -1.255 . . . . 0.0 111.362 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 59' ' ' PHE . 25.5 mmtp . . . . . 0 N--CA 1.431 -1.413 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.1 mm -106.26 129.49 59.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -88.24 105.72 17.73 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -147.52 165.28 30.81 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.096 0.474 . . . . 0.0 111.76 -176.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.453 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 7.1 m -131.75 147.22 52.48 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.732 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.557 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -134.38 149.93 50.86 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.078 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.515 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 97.0 mt -125.67 128.64 72.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.134 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.0 tp -100.23 128.34 46.32 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.795 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.501 ' CG1' HD12 ' A' ' 43' ' ' LEU . 16.2 m -127.64 155.58 39.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.967 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 17.5 pttp -84.04 -22.25 31.34 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.833 176.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 37.3 mmtm -135.57 152.56 51.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -62.67 -37.99 88.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.947 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.55 -36.79 92.18 Favored Glycine 0 C--N 1.321 -0.276 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.419 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 96.0 mt-10 -65.35 -44.37 87.91 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -58.55 -48.96 79.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.238 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.87 -40.91 97.65 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.754 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.17 -48.53 76.16 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.255 -177.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' CG1' ' HG ' ' A' ' 43' ' ' LEU . 18.0 m -64.99 -39.57 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.246 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 81' ' ' SER . 83.3 mt-30 -60.22 -47.18 87.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.085 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.13 -41.26 81.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.133 0.492 . . . . 0.0 110.822 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.476 ' HD3' ' CD1' ' A' ' 39' ' ' LEU . 71.1 ttt180 -62.87 -38.55 91.31 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.73 177.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.16 -35.83 70.02 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -177.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 49.8 mmtt -61.52 -28.63 69.45 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.134 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.9 -21.94 45.94 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.942 0.401 . . . . 0.0 110.917 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.09 7.19 41.4 Favored Glycine 0 C--N 1.319 -0.385 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.474 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 31.9 mt-10 -76.18 156.59 33.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.152 177.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -72.52 141.38 48.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.708 0.766 . . . . 0.0 112.428 -176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 45.9 t80 -58.12 -44.78 87.92 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.14 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.439 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -61.19 -36.68 92.76 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.352 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.37 -48.04 83.08 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.476 ' CD1' ' HD3' ' A' ' 29' ' ' ARG . 4.3 mm? -62.05 -41.82 98.54 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.967 173.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.447 ' C ' ' HG ' ' A' ' 44' ' ' SER . . . -59.05 -50.32 74.52 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.153 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -43.26 88.29 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.642 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.435 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 87.1 mt-10 -70.94 -45.55 64.01 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -173.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.539 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -107.6 -39.12 5.71 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.447 ' HG ' ' C ' ' A' ' 40' ' ' ALA . 2.5 m -52.99 138.67 29.87 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.062 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.1 pt -91.72 -4.82 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.387 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.57 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 61.6 t0 -90.89 101.0 13.76 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.581 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -65.88 -43.8 93.11 Favored Glycine 0 C--N 1.318 -0.434 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.79 -45.24 91.45 Favored Glycine 0 C--O 1.239 0.453 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.57 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 70.2 m -64.21 -33.47 75.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.95 0.405 . . . . 0.0 110.213 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.45 -35.4 80.79 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 74.8 mmtt -61.9 -36.79 82.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 77.7 mtp85 -97.57 19.26 13.75 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.982 174.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.551 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.9 OUTLIER 44.67 42.37 5.74 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.679 178.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.83 -20.76 0.82 Allowed Glycine 0 C--N 1.31 -0.886 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 53' ' ' ASP . 10.3 m -67.91 79.47 0.21 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.527 0.679 . . . . 0.0 110.305 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.416 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 97.7 mt -62.56 -41.63 99.03 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.387 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.88 -147.12 18.46 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.04 104.16 14.72 Favored 'General case' 0 C--O 1.252 1.195 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.422 ' C ' ' HD2' ' A' ' 9' ' ' LYS . 47.5 p90 -119.0 148.1 43.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.712 177.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.82 -176.31 48.1 Favored Glycine 0 C--O 1.236 0.25 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.532 ' C ' ' H ' ' A' ' 63' ' ' LYS . 26.0 mtp180 -86.65 162.76 17.77 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.7 -21.42 1.57 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.724 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 61' ' ' ARG . 37.6 mmtm -65.1 -40.01 93.95 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -112.93 160.27 18.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.75 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 m -58.47 146.6 8.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.99 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 4.5 mtpp -45.13 -47.03 32.29 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.347 -177.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 66' ' ' LYS . 75.5 Cg_exo -55.47 -41.38 78.58 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 120.486 0.791 . . . . 0.0 110.609 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -61.28 -46.56 89.85 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.766 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.463 ' CD ' HH21 ' A' ' 61' ' ' ARG . 67.3 mt-10 -62.31 -46.97 86.35 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.618 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 74' ' ' ARG . 35.0 t70 -58.61 -45.61 88.78 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.394 -176.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.56 -46.13 89.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.96 88.0 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.032 0.444 . . . . 0.0 110.07 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.502 ' CZ ' ' HD2' ' A' ' 61' ' ' ARG . 51.6 m-85 -68.11 -36.68 80.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.326 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 70' ' ' ASP . 61.8 mtp180 -61.6 -45.26 94.84 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.204 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.9 mt -99.68 42.07 1.12 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.43 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 35.3 mt-30 -55.26 -21.1 13.01 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.413 173.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 p -61.96 -32.37 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.792 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 120.18 -3.96 12.6 Favored Glycine 0 N--CA 1.477 1.382 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.213 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -73.31 173.4 9.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 117.075 0.437 . . . . 0.0 111.377 -178.165 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.565 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 5.3 t -92.53 129.57 42.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.491 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 9.9 p -71.3 153.51 42.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.254 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 5.0 mp0 -64.52 169.81 4.58 Favored Pre-proline 0 CA--C 1.507 -0.686 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 172.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.457 ' N ' HE22 ' A' ' 27' ' ' GLN . 63.6 Cg_exo -53.31 130.53 38.84 Favored 'Trans proline' 0 C--N 1.295 -2.267 0 N-CA-C 109.596 -0.963 . . . . 0.0 109.596 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.2 107.74 23.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -78.31 133.38 37.63 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.398 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.4 p -140.19 167.93 21.0 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.532 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.6 pm0 -58.12 -36.38 72.85 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -63.99 -43.82 94.56 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.868 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.94 -148.9 16.79 Favored Glycine 0 C--N 1.311 -0.828 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -110.11 129.55 55.68 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.403 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 5.2 m-70 -109.5 151.91 26.13 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -117.85 126.03 74.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.69 127.33 75.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.648 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -110.96 143.14 42.08 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.474 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -78.59 142.47 37.27 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.066 178.006 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.2 tp -110.43 139.72 45.38 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.03 -175.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.372 0 CA-C-O 118.268 -1.295 . . . . 0.0 110.755 -178.287 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.4 mttp . . . . . 0 CA--C 1.515 -0.391 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.638 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 69.4 mt -106.9 128.35 61.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.606 ' HZ2' ' C ' ' A' ' 97' ' ' GLY . 48.3 mtpt -94.25 106.85 18.83 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -146.33 168.99 19.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.097 0.776 . . . . 0.0 113.097 -173.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.429 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 45.4 m -135.66 147.16 48.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.398 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.563 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -137.6 152.31 49.25 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.565 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 95.6 mt -121.63 126.21 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.96 1.304 . . . . 0.0 108.032 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.464 HD21 ' CG1' ' A' ' 45' ' ' ILE . 4.6 tt -105.28 123.54 48.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.3 m -135.87 155.63 36.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 120.804 0.335 . . . . 0.0 110.396 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.94 -22.35 33.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.158 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.55 137.55 43.2 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.774 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.52 -36.99 85.59 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.55 98.22 Favored Glycine 0 CA--C 1.51 -0.224 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.46 -43.97 92.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.58 93.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.282 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.93 -39.93 96.1 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.466 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.07 -46.0 89.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.573 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 27' ' ' GLN . 12.3 m -65.78 -38.82 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.953 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.542 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 3.1 tp-100 -54.68 -48.53 72.29 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.745 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -68.06 -39.88 82.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.713 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 8.1 tpt180 -63.08 -40.23 97.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.903 -174.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.05 -38.81 87.49 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.329 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.542 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 23.8 mmtm -64.29 -16.11 61.52 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.889 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.13 -9.6 58.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.84 12.14 62.65 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 96.6 mt-10 -83.99 153.11 24.06 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.786 -0.243 . . . . 0.0 111.054 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -64.75 132.51 49.79 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 121.623 0.725 . . . . 0.0 111.93 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.565 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 62.5 t80 -57.05 -44.9 83.45 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.096 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -59.11 -38.03 92.5 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.772 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 49.1 tttp -60.95 -47.1 87.99 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.888 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.82 -41.25 97.55 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.461 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.01 -50.56 72.98 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.858 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.26 -36.68 84.87 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.074 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 1.0 OUTLIER -72.48 -80.3 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.913 -174.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.29 -43.63 81.26 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -173.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.2 m -58.88 147.7 32.88 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.689 -162.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.464 ' CG1' HD21 ' A' ' 16' ' ' LEU . 46.0 pt -98.84 -5.21 9.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.824 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.581 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 62.0 t0 -85.21 93.67 8.72 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.576 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.26 -44.39 98.16 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.3 -41.84 72.17 Favored Glycine 0 C--N 1.324 -0.132 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.581 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 67.0 m -73.93 -33.37 63.91 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.934 174.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.14 -42.13 84.93 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.204 0.526 . . . . 0.0 110.68 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -62.34 -31.79 72.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -96.69 15.87 20.62 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.268 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 42.3 38.7 1.23 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.951 0.881 . . . . 0.0 112.134 -178.527 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.77 -11.81 9.8 Favored Glycine 0 C--O 1.236 0.231 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.652 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.1 m -67.93 80.38 0.21 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.4 . . . . 0.0 111.617 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.28 -40.56 97.71 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.95 -149.07 19.52 Favored Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.863 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.33 141.77 28.41 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.638 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.7 p90 -148.59 151.96 35.94 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.988 177.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.35 167.92 49.59 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.506 ' NH1' ' CE1' ' A' ' 73' ' ' PHE . 77.3 mtp85 -74.68 140.97 44.57 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.01 -29.57 10.97 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.193 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -40.53 97.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.526 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 9.0 mmm -80.83 160.76 24.71 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 m -63.21 136.51 26.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.562 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.29 -47.02 34.11 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.447 -171.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -56.61 -40.38 84.83 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.122 1.214 . . . . 0.0 110.77 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -60.76 -46.51 90.16 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.565 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.567 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 47.9 mt-10 -64.47 -38.37 90.8 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.527 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.8 -48.51 75.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.924 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.23 -40.48 71.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.559 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.84 92.45 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.836 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 69' ' ' GLU . 24.8 m-85 -66.39 -34.06 77.11 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.794 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -62.29 -44.75 95.8 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -174.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -97.37 34.53 1.78 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.629 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.424 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 53.0 mt-30 -56.14 -20.9 19.56 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.482 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.61 -29.71 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.768 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 121.35 -4.31 11.15 Favored Glycine 0 N--CA 1.471 0.988 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 80' ' ' VAL . 1.1 tp10 -64.95 166.94 8.43 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 122.781 0.432 . . . . 0.0 110.761 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.529 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 13.8 t -93.82 128.86 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 174.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' A' ' 93' ' ' ILE . 10.6 p -73.67 162.08 29.58 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.686 0.279 . . . . 0.0 111.609 -178.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.461 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 5.9 mp0 -79.56 -179.74 1.52 Allowed Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 173.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 82' ' ' GLU . 73.3 Cg_exo -57.63 133.5 56.93 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 CA-C-N 118.936 0.656 . . . . 0.0 110.761 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 47.3 t -111.46 102.96 14.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.657 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 135.14 48.37 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 p -146.56 172.98 12.74 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.504 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 2.0 pm0 -59.23 -37.67 78.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -65.21 -43.81 90.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.922 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 151.69 -151.72 23.6 Favored Glycine 0 C--N 1.317 -0.51 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 70.1 m-85 -98.89 129.06 45.22 Favored 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.38 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 5.0 m-70 -112.08 148.96 32.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.238 177.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.44 128.47 74.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 167.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.464 ' N ' ' OG ' ' A' ' 81' ' ' SER . 87.1 mt -119.34 130.5 73.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -173.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -115.73 143.52 45.26 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.438 ' NH2' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -78.41 143.61 36.63 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.837 -178.101 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 52.9 tp -96.61 133.01 41.65 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.606 ' C ' ' HZ2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.205 -1.657 0 CA-C-O 118.364 -1.242 . . . . 0.0 111.25 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 N--CA 1.439 -1.002 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -105.95 123.64 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.542 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -93.13 105.16 17.29 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -147.44 167.61 23.96 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.326 -0.95 . . . . 0.0 113.205 -171.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 4.1 m -130.88 141.16 50.29 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.066 -1.424 . . . . 0.0 107.997 174.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.451 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -135.75 150.45 49.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.534 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 91.5 mt -125.46 121.62 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 44' ' ' SER . 5.5 tt -101.47 121.42 41.92 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 29.3 m -133.88 150.97 32.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.568 0.699 . . . . 0.0 112.192 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.32 -38.38 84.84 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.355 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HB2' ' CG ' ' A' ' 22' ' ' GLU . 64.0 mttm -109.37 141.61 41.48 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.627 -173.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -64.6 -36.75 85.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.055 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.0 -36.22 92.55 Favored Glycine 0 C--O 1.238 0.357 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.439 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 94.6 mt-10 -65.55 -41.44 93.01 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.74 -44.52 93.74 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.685 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.1 mt -64.18 -39.46 94.04 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.099 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.54 71.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.29 -41.14 91.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.461 176.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.437 HE22 ' N ' ' A' ' 83' ' ' PRO . 84.0 mt-30 -59.48 -46.41 88.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.328 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -73.2 -38.57 66.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.432 HH21 ' CD ' ' A' ' 34' ' ' GLU . 53.8 ttt85 -65.01 -39.75 93.9 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.677 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.8 -25.44 41.46 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.405 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -61.46 -38.18 86.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -16.54 44.53 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.907 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.89 14.15 61.37 Favored Glycine 0 C--N 1.318 -0.43 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' CD ' HH21 ' A' ' 29' ' ' ARG . 36.0 mt-10 -69.43 159.73 32.69 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.687 174.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 49.7 tttp -64.39 129.12 38.67 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.368 0.604 . . . . 0.0 110.247 -174.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.534 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 61.7 t80 -56.35 -43.96 79.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.411 ' HA2' ' C ' ' A' ' 53' ' ' ASP . . . -60.42 -34.07 83.76 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.564 177.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 45.7 tttp -59.62 -48.45 81.6 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.604 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.53 -41.35 98.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.921 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.461 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -57.26 -49.68 75.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.45 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.568 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 68.0 mttm -64.1 -37.69 88.36 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.896 177.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -50.39 34.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.615 -172.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.2 mp -98.47 -48.6 4.96 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.2 m -55.64 142.14 35.01 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.338 -162.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.1 pt -94.45 -12.2 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.258 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 49' ' ' SER . 11.4 t0 -76.86 111.89 12.87 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.9 -40.22 64.49 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.9 -48.36 73.26 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 54' ' ' GLY . 78.9 p -62.06 -33.28 74.11 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.381 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.568 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -74.46 -48.24 28.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.005 0.431 . . . . 0.0 110.346 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -65.39 -36.36 83.72 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.233 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.439 ' NE ' ' O ' ' A' ' 55' ' ' SER . 13.8 mmm180 -94.68 7.48 45.65 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.994 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.582 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.0 OUTLIER 50.34 47.86 23.2 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 67.12 -40.04 0.2 Allowed Glycine 0 C--N 1.313 -0.742 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.946 -173.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.582 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -54.79 82.91 0.0 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.1 0.96 . . . . 0.0 111.73 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.55 -38.64 91.91 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.54 -152.09 20.66 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.73 133.61 34.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 54.2 p90 -146.61 151.8 37.87 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.15 178.47 46.43 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 45.8 mtp85 -73.46 152.53 40.71 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 122.764 0.426 . . . . 0.0 110.749 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.11 9.65 84.9 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.584 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.88 -19.28 15.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.421 ' HG3' ' CE2' ' A' ' 59' ' ' PHE . 1.4 mmm -126.39 161.33 28.13 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.76 136.85 20.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.081 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 1.7 tttm -44.5 -46.89 26.19 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 21.3 Cg_endo -59.71 -34.07 96.28 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 CA-C-N 119.161 0.736 . . . . 0.0 111.238 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -62.99 -50.15 71.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.915 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.404 ' HG3' ' HB2' ' A' ' 64' ' ' MET . 93.7 mt-10 -67.85 -43.82 78.59 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.811 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 7.2 t70 -57.74 -49.71 75.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.314 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.08 96.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.811 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.08 95.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.516 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.46 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 44.4 m-85 -64.99 -34.11 77.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.236 0.541 . . . . 0.0 111.362 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 79.9 mtp85 -62.62 -36.03 81.45 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.751 -176.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.9 mt -97.12 23.05 7.73 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -173.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.47 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 75.1 mt-30 -43.53 -25.1 0.14 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.381 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.35 -27.49 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 119.8 -2.18 13.48 Favored Glycine 0 N--CA 1.47 0.943 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.86 173.46 0.14 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.66 127.5 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.7 p -65.33 147.58 53.19 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.882 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.53 177.09 0.73 Allowed Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 168.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.437 ' N ' HE22 ' A' ' 27' ' ' GLN . 53.1 Cg_exo -54.42 133.51 56.7 Favored 'Trans proline' 0 C--N 1.283 -2.872 0 N-CA-C 109.991 -0.811 . . . . 0.0 109.991 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.42 128.66 74.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -98.75 129.92 45.2 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.488 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.478 ' HG ' ' CD2' ' A' ' 91' ' ' HIS . 86.8 p -114.41 -175.48 2.69 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.55 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.6 pm0 -69.59 -35.52 75.4 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -66.11 -45.32 81.54 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.95 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.59 -157.66 28.35 Favored Glycine 0 C--N 1.317 -0.492 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 87.0 m-85 -85.52 135.08 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.678 0.239 . . . . 0.0 110.483 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.478 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 44.9 m-70 -122.5 147.7 46.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.682 176.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.9 t -117.7 126.69 74.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 166.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.7 mt -119.94 125.86 74.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.586 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -113.69 143.8 44.01 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.513 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 2.4 tmm_? -78.7 141.23 38.07 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.939 -1.104 . . . . 0.0 110.181 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.432 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 48.2 tp -109.26 135.41 50.39 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.273 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.201 -1.939 0 CA-C-O 118.082 -1.399 . . . . 0.0 111.059 -178.903 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.49 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.33 145.61 97.31 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.651 1.567 . . . . 0.0 111.133 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.403 ' HG2' ' NH2' ' A' ' 61' ' ' ARG . 96.8 mtp -39.85 107.44 0.07 Allowed 'General case' 0 C--O 1.244 0.815 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.521 -175.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.65 21.06 79.82 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.428 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 12.1 p -73.69 -176.4 2.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.882 0.373 . . . . 0.0 110.68 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 97.9 mmm -62.64 -39.03 92.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.279 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.6 43.91 2.13 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.687 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 5' ' ' SER . 7.1 p-10 -82.79 -1.14 50.85 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.008 0.432 . . . . 0.0 110.708 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HG3' ' OD1' ' A' ' 8' ' ' ASP . 43.7 mttp -107.89 164.09 12.56 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.724 -172.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.487 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 70.6 mt -107.49 131.66 57.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' NZ ' ' CZ ' ' A' ' 58' ' ' TYR . 27.6 mtpp -91.92 106.2 18.28 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -145.81 168.34 21.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -176.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.502 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 4.2 m -129.27 146.95 51.08 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.353 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.461 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -147.21 151.39 36.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.299 0.571 . . . . 0.0 112.346 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.506 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 85.2 mt -122.12 124.6 71.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.534 HD12 ' CE1' ' A' ' 91' ' ' HIS . 6.1 tt -107.83 127.74 53.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.465 HG21 ' N ' ' A' ' 23' ' ' ALA . 27.6 m -137.11 153.61 29.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.431 0.634 . . . . 0.0 111.212 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -67.54 -39.96 85.0 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.475 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -103.48 148.89 25.39 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.478 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 86.0 mt-30 -62.09 -39.98 94.3 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.79 -38.27 91.8 Favored Glycine 0 CA--C 1.509 -0.281 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -65.54 -41.84 92.57 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -62.11 -42.35 99.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.849 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.47 -40.98 98.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.782 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.0 -49.47 71.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.738 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG21 ' N ' ' A' ' 27' ' ' GLN . 19.0 m -66.29 -42.49 90.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.198 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 81' ' ' SER . 99.1 mt-30 -61.66 -44.12 97.56 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.01 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.44 -44.85 74.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.066 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.515 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 43.0 ttt85 -66.63 -40.16 88.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.507 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.04 -24.7 26.06 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.312 0.577 . . . . 0.0 109.677 -178.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -62.35 -32.6 73.41 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.841 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.98 -7.99 20.19 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.722 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.84 25.84 40.06 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.515 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 87.1 mt-10 -81.54 157.23 24.87 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.506 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.06 131.6 50.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.545 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 58.1 t80 -56.96 -43.28 81.41 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.589 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -59.21 -36.8 90.31 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.707 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' HZ3' ' CD ' ' A' ' 42' ' ' GLU . 58.6 tttm -58.26 -48.0 81.81 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.027 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.44 -40.07 96.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.275 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.27 -43.21 95.53 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.758 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -64.15 -41.27 97.24 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.719 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' CD ' ' HZ3' ' A' ' 38' ' ' LYS . 96.3 mt-10 -77.76 -59.79 2.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.412 -175.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -49.46 6.34 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -172.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 t -56.53 138.25 52.18 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.903 -169.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.6 pt -92.79 -1.74 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.814 0.34 . . . . 0.0 110.227 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 50' ' ' ALA . 60.1 t0 -80.22 96.51 6.61 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.1 -53.43 44.98 Favored Glycine 0 C--N 1.321 -0.278 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.815 -173.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.38 -45.01 84.93 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 54' ' ' GLY . 17.5 m -70.41 -32.57 70.25 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.472 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' ASP . . . -62.79 -38.36 90.33 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 75.7 mmtt -60.79 -34.3 74.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HE ' ' HA ' ' A' ' 49' ' ' SER . 89.6 mtm180 -95.48 19.48 10.89 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.913 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.589 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 97.3 m-20 59.85 30.2 19.75 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 70.87 -7.75 5.14 Favored Glycine 0 C--N 1.305 -1.149 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 53' ' ' ASP . 2.3 m -70.72 91.09 0.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.433 0.635 . . . . 0.0 110.353 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.424 HD13 ' SG ' ' A' ' 12' ' ' CYS . 96.9 mt -62.35 -38.23 88.74 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 76.91 -133.15 13.01 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.483 ' CZ ' ' NZ ' ' A' ' 11' ' ' LYS . 57.4 m-85 -83.98 135.59 34.39 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 117.111 0.455 . . . . 0.0 109.897 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.487 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.9 p90 -144.18 149.32 36.25 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.779 168.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.82 174.89 55.12 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 -174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.543 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 47.6 mtm180 -74.54 145.66 43.26 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.8 60.17 8.11 Favored Glycine 0 C--O 1.246 0.905 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 61' ' ' ARG . 34.7 mmtm -133.25 -35.62 1.03 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.017 0.437 . . . . 0.0 110.458 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.408 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 77.7 mtm -119.44 159.83 23.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.99 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.1 133.57 7.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.277 -174.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.523 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -44.02 -47.34 22.45 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.901 -174.153 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 24.7 Cg_endo -57.87 -38.31 93.0 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 CA-C-N 118.767 0.595 . . . . 0.0 111.862 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.408 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 58.9 t80 -62.73 -49.97 72.96 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.771 177.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.62 -39.31 93.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.316 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.443 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 12.6 t70 -57.35 -48.68 78.38 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.115 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.62 95.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.783 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.07 83.21 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.09 0.472 . . . . 0.0 110.253 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -63.67 -42.85 98.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.879 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -63.54 -47.57 81.08 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.172 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' A' ' 77' ' ' VAL . 97.3 mt -98.04 33.41 2.15 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.501 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 71.8 mt-30 -54.28 -19.17 4.87 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.502 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 2.4 m -60.11 -40.73 84.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.332 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.475 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 121.66 7.36 8.15 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.893 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 149.37 41.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.5 t -71.35 128.97 35.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.598 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 11.3 p -79.24 155.72 28.45 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 123.29 0.369 . . . . 0.0 111.411 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' A' ' 82' ' ' GLU . 1.7 mp0 -66.52 161.95 54.45 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.531 ' N ' HE22 ' A' ' 27' ' ' GLN . 47.5 Cg_exo -55.37 129.74 36.82 Favored 'Trans proline' 0 C--N 1.295 -2.279 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.8 t -106.13 114.87 46.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -85.37 138.54 32.21 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.753 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.2 p -136.05 176.36 8.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -61.79 -32.7 73.01 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.67 -38.79 80.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.036 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.61 -146.97 16.06 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -176.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.478 ' CE1' ' HG2' ' A' ' 20' ' ' GLN . 82.9 m-85 -106.4 133.86 50.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.941 0.371 . . . . 0.0 110.709 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.534 ' CE1' HD12 ' A' ' 16' ' ' LEU . 3.9 m-70 -115.12 147.34 40.36 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.382 176.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 76.5 t -117.97 127.55 75.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 167.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.506 ' N ' ' OG ' ' A' ' 81' ' ' SER . 81.5 mt -115.97 130.7 70.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -171.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -120.61 149.89 41.76 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.383 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.502 ' NH2' ' O ' ' A' ' 77' ' ' VAL . 8.7 tmm_? -79.05 143.87 35.19 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.7 tp -117.15 135.42 53.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.382 0 CA-C-O 118.556 -1.135 . . . . 0.0 110.747 -177.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.683 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.2 144.9 99.48 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.051 1.834 . . . . 0.0 111.368 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.0 mmm -55.93 156.86 4.86 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.493 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.0 -39.48 2.98 Favored Glycine 0 C--N 1.315 -0.602 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' N ' ' A' ' 7' ' ' ALA . 1.5 m -63.19 128.63 36.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 93.5 mmm 44.81 17.68 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.216 0.323 . . . . 0.0 110.59 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.444 ' N ' ' C ' ' A' ' 5' ' ' SER . . . -64.09 -23.74 67.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.86 -35.67 75.27 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -91.09 158.29 16.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.011 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.499 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 45.6 mm -106.84 131.68 56.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' CG ' ' CE2' ' A' ' 58' ' ' TYR . 56.5 mtpt -87.95 105.91 17.77 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.6 ' SG ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -148.37 168.22 23.17 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.498 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 4.9 m -130.81 133.04 45.61 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.339 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.483 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -124.58 149.56 46.88 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.457 -176.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.578 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 95.2 mt -125.31 128.19 72.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.1 tp -103.47 128.56 50.63 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.472 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.516 ' CG1' HD11 ' A' ' 43' ' ' LEU . 28.8 m -129.1 154.4 39.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 123.743 0.652 . . . . 0.0 110.818 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -67.76 -41.08 83.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.187 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -127.5 156.43 42.18 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -169.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -60.59 -38.86 86.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.36 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.54 -38.42 91.14 Favored Glycine 0 N--CA 1.464 0.502 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.65 -42.12 91.8 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.14 82.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.686 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.57 -42.26 98.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.85 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.04 74.2 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.9 m -66.03 -41.07 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.749 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -59.31 -46.12 89.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.054 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 73.7 mm-40 -67.82 -38.59 83.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.158 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.445 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 22.7 ttp85 -64.9 -38.11 89.87 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.418 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -27.16 61.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 33.2 mmtp -61.11 -31.6 71.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.19 -21.73 48.7 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.176 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.82 20.69 53.09 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.34 164.36 13.76 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -65.6 130.5 43.5 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 56.6 t80 -55.92 -42.88 76.76 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -57.12 -39.3 89.64 Favored Glycine 0 C--N 1.311 -0.836 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.835 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -59.91 -45.7 91.71 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 0.7 OUTLIER -62.16 -41.2 98.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.938 173.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.449 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -61.83 -42.84 99.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.425 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -65.21 -44.84 87.04 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.454 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 95.0 mt-10 -70.23 -43.66 70.16 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -169.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.537 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -117.24 -40.49 3.08 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -169.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 m -45.82 133.54 8.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.1 pt -83.12 -14.95 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.571 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 33.2 t0 -80.4 92.42 5.82 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.308 174.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.8 -46.82 93.38 Favored Glycine 0 CA--C 1.507 -0.447 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.191 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.19 -46.99 84.56 Favored Glycine 0 C--N 1.319 -0.364 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.571 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 20.1 m -63.41 -34.05 76.88 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.322 174.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.98 85.86 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.359 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 18.6 mmtp -60.53 -40.21 90.68 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -96.67 16.09 19.95 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.281 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.569 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.9 m-20 63.1 32.91 14.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.663 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 70.65 -29.7 0.49 Allowed Glycine 0 C--N 1.31 -0.871 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 53' ' ' ASP . 53.6 m -55.31 98.59 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.717 0.77 . . . . 0.0 111.382 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.6 HD13 ' SG ' ' A' ' 12' ' ' CYS . 97.6 mt -65.07 -36.52 84.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.835 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 88.67 -145.05 18.61 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 -170.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.466 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 89.9 m-85 -83.09 134.03 35.03 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.499 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.3 p90 -144.04 150.23 37.88 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.629 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.53 165.55 22.49 Favored Glycine 0 C--O 1.24 0.493 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.485 ' HD2' ' CE1' ' A' ' 73' ' ' PHE . 76.9 mtp180 -81.05 160.54 24.5 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.641 0.376 . . . . 0.0 110.879 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.07 -51.61 1.13 Allowed Glycine 0 C--N 1.315 -0.615 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -64.23 -38.02 89.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.968 -0.616 . . . . 0.0 109.645 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.446 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 25.5 mmm -88.67 153.02 21.44 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.36 141.76 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.294 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.536 ' HZ2' ' CD ' ' A' ' 69' ' ' GLU . 15.8 mmtm -43.7 -51.28 16.78 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 36.3 Cg_endo -61.4 -32.49 89.09 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 120.231 0.62 . . . . 0.0 111.571 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 93' ' ' ILE . 47.7 t80 -62.62 -46.66 87.24 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' CD ' ' HZ2' ' A' ' 66' ' ' LYS . 93.9 mt-10 -63.9 -47.23 81.42 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.241 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.06 -41.82 93.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.74 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.431 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -64.59 -46.62 81.93 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.86 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.27 89.21 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.951 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.485 ' CE1' ' HD2' ' A' ' 61' ' ' ARG . 17.7 m-85 -61.82 -28.17 69.28 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.972 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 74' ' ' ARG . 2.1 mtm105 -64.46 -36.75 85.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.345 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.511 HD11 ' N ' ' A' ' 81' ' ' SER . 10.3 mt -87.91 21.84 2.55 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -167.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 73' ' ' PHE . 75.6 mt-30 -54.26 -34.56 61.07 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.84 -27.54 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.279 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.02 6.05 7.83 Favored Glycine 0 N--CA 1.475 1.278 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.435 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 80.2 mt-10 -55.57 173.94 0.11 Allowed 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.4 t -106.76 132.57 53.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 167.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.511 ' N ' HD11 ' A' ' 75' ' ' LEU . 99.7 p -66.32 163.21 18.56 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.227 0.537 . . . . 0.0 111.842 -172.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.69 161.19 70.18 Favored Pre-proline 0 N--CA 1.422 -1.866 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -56.94 133.89 60.94 Favored 'Trans proline' 0 C--N 1.294 -2.329 0 N-CA-C 109.784 -0.891 . . . . 0.0 109.784 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 42.6 t -117.97 125.64 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.534 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.8 tptp -88.98 137.47 32.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.94 0.4 . . . . 0.0 109.963 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.534 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 14.1 p -140.89 175.17 9.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -59.59 -39.77 85.25 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -65.15 -42.64 93.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.517 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.32 -137.34 5.75 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 4.6 m-85 -105.01 132.78 50.82 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 117.107 0.453 . . . . 0.0 111.963 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.446 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 44.5 m-70 -114.27 141.74 47.18 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.391 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.02 128.28 75.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 167.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.56 HG23 ' SG ' ' A' ' 12' ' ' CYS . 88.5 mt -121.1 131.22 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 116.917 -0.129 . . . . 0.0 110.76 -173.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -116.08 147.86 40.85 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 167.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.441 HH21 ' CA ' ' A' ' 97' ' ' GLY . 2.6 ttp180 -77.57 143.46 38.31 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.34 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.405 ' HB3' ' C ' ' A' ' 11' ' ' LYS . 46.5 tp -100.68 145.58 28.26 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.441 ' CA ' HH21 ' A' ' 95' ' ' ARG . . . . . . . . 0 C--O 1.207 -1.576 0 CA-C-O 118.356 -1.247 . . . . 0.0 110.683 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.586 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -59.63 142.13 98.28 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.134 1.889 . . . . 0.0 112.683 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.62 ' SD ' ' NH2' ' A' ' 61' ' ' ARG . 96.1 mmm -100.84 160.32 14.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.192 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' N ' ' OD2' ' A' ' 8' ' ' ASP . . . 77.01 18.31 78.86 Favored Glycine 0 C--N 1.315 -0.599 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.439 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 10.9 m -87.5 172.75 9.54 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.675 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.3 mmt -68.35 -39.16 81.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.333 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.86 5.1 10.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 4' ' ' GLY . 31.5 p-10 -66.17 -35.98 81.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.754 0.788 . . . . 0.0 108.918 176.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 5' ' ' SER . 27.1 mtmm -85.03 157.54 20.71 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.251 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 44.4 mm -106.34 129.87 58.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.599 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 62.2 mtpt -90.93 104.11 16.74 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -145.1 169.59 17.86 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.515 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 9.2 m -126.51 145.63 50.43 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.871 174.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.482 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -134.63 149.57 50.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.921 0.391 . . . . 0.0 111.597 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.513 HG13 ' CE2' ' A' ' 36' ' ' PHE . 94.4 mt -129.41 128.06 65.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.23 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 13.9 mt -94.61 128.68 41.41 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.412 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.13 154.72 35.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.704 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -66.28 -40.7 90.27 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.358 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -121.6 152.48 39.23 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.332 0.587 . . . . 0.0 112.502 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.48 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 53.6 tt0 -61.14 -40.95 95.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.489 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.06 -36.68 92.69 Favored Glycine 0 C--O 1.238 0.368 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.76 -42.14 97.86 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.76 -47.95 82.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.966 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 24' ' ' LEU . 4.5 mm? -61.52 -41.79 97.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.074 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.27 -51.83 66.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.574 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -68.97 -39.46 79.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.273 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.599 HE22 ' N ' ' A' ' 83' ' ' PRO . 67.8 mt-30 -55.4 -46.12 76.63 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 72.4 mm-40 -71.13 -35.29 71.67 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 175.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.587 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 74.9 ttt180 -60.28 -37.76 81.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.984 0.421 . . . . 0.0 110.025 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.12 -34.62 73.76 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 31.7 mmtp -62.53 -33.18 74.4 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.74 -24.72 64.25 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.441 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.82 -2.6 31.95 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.587 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 23.9 mt-10 -67.7 147.05 53.17 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.76 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.56 139.27 51.47 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CE2' HG13 ' A' ' 15' ' ' ILE . 52.3 t80 -58.21 -45.88 86.84 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.48 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.49 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.35 -35.66 91.98 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.263 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 25.3 tttm -60.22 -47.73 84.73 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.4 HD13 ' NH1' ' A' ' 29' ' ' ARG . 4.0 mm? -62.06 -40.81 97.03 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.501 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.502 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.11 -45.47 79.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -65.5 -38.83 90.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.558 173.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 78.3 mt-10 -69.78 -54.17 14.88 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.18 -17.5 6.15 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -169.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.502 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.1 m -48.99 127.26 13.94 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.311 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.9 pt -76.74 -14.05 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -86.72 92.17 8.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.17 -42.72 99.35 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.13 -48.18 69.57 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.482 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 38.4 m -64.58 -33.37 75.77 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.513 -0.404 . . . . 0.0 110.315 175.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.81 -30.09 71.21 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.574 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -61.28 -39.87 92.03 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 81.3 mtp180 -97.23 19.68 12.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.404 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.49 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 47.8 m-20 58.72 31.79 21.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.16 -14.44 3.9 Favored Glycine 0 C--N 1.31 -0.904 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 53' ' ' ASP . 20.2 m -69.19 90.88 0.49 Allowed 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.816 0.817 . . . . 0.0 111.313 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 93.9 mt -62.94 -38.76 92.34 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.216 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.94 -144.14 17.01 Favored Glycine 0 CA--C 1.503 -0.698 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -85.11 130.73 34.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.658 0.266 . . . . 0.0 110.827 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.491 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.8 p90 -144.89 152.87 40.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.876 0.369 . . . . 0.0 111.525 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.15 -173.31 37.33 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.62 ' NH2' ' SD ' ' A' ' 3' ' ' MET . 90.2 mtm-85 -81.96 154.78 25.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.69 -37.79 3.32 Favored Glycine 0 C--N 1.311 -0.852 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -63.0 -36.6 84.08 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.481 0.658 . . . . 0.0 109.476 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.433 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 3.7 mmm -104.62 155.64 18.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.281 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.74 154.35 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.463 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 13.7 mmtm -44.0 -55.0 10.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 40.0 Cg_endo -60.05 -34.69 94.54 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 CA-C-N 118.925 0.652 . . . . 0.0 111.074 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 64' ' ' MET . 10.5 t80 -63.12 -46.6 86.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.076 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.96 -41.72 99.61 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.714 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.9 -50.21 71.3 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.789 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.08 98.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.459 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.47 73.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.149 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -67.6 -38.73 84.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.039 0.447 . . . . 0.0 111.297 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.511 HH22 ' CD ' ' A' ' 82' ' ' GLU . 78.7 mtp180 -63.99 -41.18 97.6 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' CD1' ' CA ' ' A' ' 81' ' ' SER . 43.0 mt -97.92 23.58 7.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -171.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.421 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 88.5 mt-30 -54.03 -25.54 21.86 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.91 -29.64 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.032 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 122.12 -0.34 10.66 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.203 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -70.64 174.28 6.1 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -98.49 131.23 46.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.574 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.484 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 43.1 t -64.34 162.09 15.58 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.708 -176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' CD ' HH22 ' A' ' 74' ' ' ARG . 0.0 OUTLIER -72.91 163.11 70.84 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 165.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.599 ' N ' HE22 ' A' ' 27' ' ' GLN . 72.1 Cg_endo -61.82 140.19 84.21 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 N-CA-C 110.214 -0.725 . . . . 0.0 110.214 -175.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.3 t -123.16 100.47 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.813 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.5 tptp -80.05 130.23 35.1 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.481 174.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.596 ' HG ' ' CD2' ' A' ' 91' ' ' HIS . 52.8 p -129.14 -176.25 3.81 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.362 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -62.61 -39.78 94.87 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -66.37 -41.62 89.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.315 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.79 -150.63 21.9 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 20' ' ' GLN . 77.7 m-85 -99.16 118.88 36.87 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.596 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 34.9 m-70 -99.33 139.54 34.82 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 123.341 0.401 . . . . 0.0 110.319 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.0 t -114.93 125.44 72.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 168.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.2 mt -123.62 127.44 74.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.129 -170.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -120.79 143.36 48.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.458 ' HD2' ' N ' ' A' ' 96' ' ' LEU . 5.6 tmm_? -78.5 142.21 37.6 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.458 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -121.98 151.3 40.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.124 -179.113 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.627 0 CA-C-O 118.364 -1.242 . . . . 0.0 110.25 -178.786 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' O ' ' NH1' ' A' ' 61' ' ' ARG . . . . . . . . 0 CA--C 1.525 0.686 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.606 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 40.0 Cg_exo -59.45 145.72 97.11 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 122.248 1.965 . . . . 0.0 110.563 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.6 mtp -104.01 131.65 51.05 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.82 42.46 61.02 Favored Glycine 0 C--N 1.318 -0.42 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.5 t -135.69 174.51 10.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.9 0.381 . . . . 0.0 110.646 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.34 -39.13 93.69 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.43 24.12 2.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.775 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -62.28 -41.96 98.93 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.35 159.45 15.11 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.654 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.568 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 66.0 mt -105.34 127.61 59.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.604 ' HZ2' ' C ' ' A' ' 97' ' ' GLY . 9.2 mtpm? -94.87 107.51 19.53 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -147.54 169.64 19.15 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.914 -173.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.536 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.7 m -130.45 146.27 51.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.068 173.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.556 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -138.6 149.34 45.15 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.876 -178.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.515 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 94.9 mt -127.91 125.96 65.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.825 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' SER . 42.3 tp -97.88 115.45 28.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.37 152.34 18.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.527 0.68 . . . . 0.0 112.294 -174.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -66.87 -42.92 84.82 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.904 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.447 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 31.3 mmtp -119.37 150.42 40.19 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.817 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -60.03 -38.03 81.52 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.079 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.79 -36.09 92.23 Favored Glycine 0 C--N 1.322 -0.234 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 95.8 mt-10 -64.53 -43.64 93.36 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.4 ' CB ' HG21 ' A' ' 92' ' ' VAL . . . -58.43 -46.7 85.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.001 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.49 -41.03 98.57 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.281 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.95 92.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 m -68.39 -34.44 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.103 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 49.4 tt0 -59.32 -46.47 88.5 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.155 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.76 -41.65 74.9 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.472 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.575 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 76.1 ttt180 -60.77 -39.23 88.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.861 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.99 -39.82 91.12 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.954 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HZ1' ' CD ' ' A' ' 79' ' ' GLU . 17.7 mmtp -65.47 -9.54 26.58 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.34 -3.51 58.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.152 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.48 11.04 75.79 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.587 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.575 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 13.2 mt-10 -78.85 154.21 29.99 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.473 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 21.3 tptm -62.29 126.4 27.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.233 -176.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 58.2 t80 -58.04 -44.47 87.43 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.638 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -60.11 -37.74 93.3 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.942 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.49 ' CB ' ' HB3' ' A' ' 35' ' ' LYS . 44.6 tttp -61.23 -44.28 97.52 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.404 HD12 ' HD3' ' A' ' 29' ' ' ARG . 4.4 mm? -62.02 -41.46 98.11 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.295 172.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.415 ' C ' ' HG ' ' A' ' 44' ' ' SER . . . -57.17 -51.91 67.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.38 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -65.54 -39.43 91.75 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' A' ' 38' ' ' LYS . 92.2 mt-10 -70.08 -48.08 59.22 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.5 mp -98.26 -50.49 4.32 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 1.2 m -50.81 139.21 17.26 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.1 -1.409 . . . . 0.0 113.093 -161.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.1 pt -97.42 -2.34 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.672 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.605 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 32.2 t0 -89.19 94.11 9.81 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.828 174.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -62.26 -42.29 99.72 Favored Glycine 0 C--O 1.234 0.136 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.3 -42.09 63.27 Favored Glycine 0 N--CA 1.454 -0.136 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.605 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 15.9 m -72.46 -33.08 66.78 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.635 -0.282 . . . . 0.0 111.569 175.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.18 74.63 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.161 0.505 . . . . 0.0 110.512 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 10.4 mmtp -61.98 -41.85 98.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.29 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -98.67 9.1 44.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.406 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.638 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.5 m-20 63.63 33.12 13.46 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.078 0.466 . . . . 0.0 110.395 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.4 -14.61 5.13 Favored Glycine 0 C--N 1.31 -0.897 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -63.19 89.32 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.0 0.428 . . . . 0.0 110.955 -179.355 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.457 HD11 ' SG ' ' A' ' 12' ' ' CYS . 96.4 mt -63.4 -40.29 96.83 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 87.19 -151.31 23.47 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.91 131.07 34.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.028 0.414 . . . . 0.0 110.004 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.568 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 52.5 p90 -142.79 148.72 37.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.345 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.18 150.92 34.31 Favored Glycine 0 C--N 1.314 -0.67 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.606 ' NH2' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -69.94 144.32 52.43 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.56 0.219 . . . . 0.0 110.734 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.542 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 106.95 -20.77 33.01 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -175.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -62.69 -42.5 99.66 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.597 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 75.0 mtm -120.0 160.66 22.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.931 0.396 . . . . 0.0 111.961 -174.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.4 m -43.49 128.16 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.012 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.597 ' NZ ' ' O ' ' A' ' 64' ' ' MET . 1.9 mmtm -45.08 -46.5 30.35 Favored Pre-proline 0 C--N 1.308 -1.198 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.058 -173.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 30.0 Cg_endo -59.82 -35.3 94.52 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 CA-C-N 119.311 0.79 . . . . 0.0 111.451 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' A' ' 93' ' ' ILE . 54.3 t80 -61.76 -49.07 77.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.959 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 99.1 mt-10 -66.11 -41.49 90.49 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.572 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.85 -46.65 81.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.813 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.99 -38.5 88.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.854 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.33 -41.23 84.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.897 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.416 ' CE1' ' HA2' ' A' ' 1' ' ' GLY . 57.3 m-85 -64.69 -35.25 80.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.018 0.437 . . . . 0.0 111.386 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -58.8 -23.19 59.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.506 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.56 HD13 ' N ' ' A' ' 81' ' ' SER . 84.2 mt -96.92 4.94 51.34 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -171.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 95' ' ' ARG . 67.4 mm-40 -47.16 -20.41 0.18 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.57 -40.55 86.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 120.814 0.34 . . . . 0.0 110.124 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.95 48.49 0.24 Allowed Glycine 0 N--CA 1.465 0.615 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.472 ' CD ' ' HZ1' ' A' ' 31' ' ' LYS . 1.2 mm-40 -122.31 175.78 6.22 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.034 0.445 . . . . 0.0 112.166 -173.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.2 t -108.99 131.37 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.56 ' N ' HD13 ' A' ' 75' ' ' LEU . 6.4 p -75.51 163.19 27.64 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -173.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.33 165.33 45.47 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -55.84 130.96 43.18 Favored 'Trans proline' 0 C--N 1.293 -2.392 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.1 t -117.88 124.4 73.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 41.7 tttp -91.51 131.89 36.65 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.67 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.562 ' HG ' ' CD2' ' A' ' 91' ' ' HIS . 97.1 p -118.85 -172.05 2.21 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.2 pm0 -66.8 -38.8 87.2 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 6.0 m-30 -64.39 -46.89 81.33 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.978 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.85 -150.88 21.11 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 85' ' ' LYS . 10.9 m-85 -96.5 129.41 43.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.837 0.351 . . . . 0.0 111.381 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.562 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 41.9 m-70 -110.85 146.68 36.03 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.029 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.4 HG21 ' CB ' ' A' ' 23' ' ' ALA . 2.1 t -117.4 121.03 66.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 167.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.441 HG12 ' CE2' ' A' ' 68' ' ' PHE . 87.3 mt -113.1 127.82 70.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.428 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -115.43 145.13 42.86 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.409 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.475 ' HD2' ' O ' ' A' ' 75' ' ' LEU . 68.4 ttt-85 -79.5 139.37 37.62 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.024 177.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 55.8 tp -112.66 129.1 56.51 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.604 ' C ' ' HZ2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.206 -1.633 0 CA-C-O 118.376 -1.236 . . . . 0.0 112.152 -173.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.84 151.83 83.41 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 123.165 2.577 . . . . 0.0 112.059 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.5 mtp -61.73 148.51 42.63 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.02 38.5 0.87 Allowed Glycine 0 C--N 1.309 -0.917 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 18.6 p -139.69 159.39 42.28 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 95.3 mtp -63.89 -41.35 97.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.826 0.346 . . . . 0.0 111.432 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.9 -36.86 83.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.237 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.44 ' CG ' ' HZ1' ' A' ' 9' ' ' LYS . 1.2 p30 -64.94 -23.35 67.2 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.445 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.471 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 44.3 mmtm -75.08 167.17 22.43 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.27 176.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.92 129.13 62.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 48.7 mtpt -92.7 106.88 18.79 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -138.22 166.04 25.17 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.779 0.799 . . . . 0.0 112.933 -177.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.467 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 3.9 m -133.35 138.53 46.37 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.895 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.444 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -132.8 150.28 52.18 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.372 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.526 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 95.7 mt -125.09 127.22 72.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.621 177.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 44' ' ' SER . 51.2 tp -98.72 125.01 43.92 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 22' ' ' GLU . 33.6 m -118.06 151.85 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.389 0.614 . . . . 0.0 111.275 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -66.71 -40.62 88.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.201 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -133.77 158.84 42.31 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.866 -169.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.11 -39.75 87.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.488 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.81 -39.74 91.93 Favored Glycine 0 CA--C 1.507 -0.444 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.457 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 97.0 mt-10 -65.07 -43.59 91.7 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.836 176.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.36 81.94 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.124 0.488 . . . . 0.0 110.125 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.57 -42.93 99.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.214 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.87 80.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.75 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.442 HG21 ' N ' ' A' ' 27' ' ' GLN . 12.6 m -63.54 -41.39 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.778 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.463 HE22 ' HA ' ' A' ' 82' ' ' GLU . 94.7 mt-30 -55.92 -44.05 77.95 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -70.08 -41.71 73.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.322 0.582 . . . . 0.0 110.371 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 75.9 ttt180 -61.6 -38.36 87.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.941 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.75 -37.58 79.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 18.7 mmtm -62.72 -30.71 71.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.03 -23.94 56.3 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.876 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.22 13.09 25.71 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.02 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.531 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 33.0 mt-10 -80.74 150.2 29.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.151 0.475 . . . . 0.0 110.705 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -65.78 137.17 57.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.046 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.526 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 59.2 t80 -56.77 -45.19 82.25 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.597 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.64 -37.63 95.09 Favored Glycine 0 C--N 1.317 -0.503 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 65.6 tttm -58.31 -46.71 85.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.454 ' N ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -62.43 -41.14 98.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.529 174.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.455 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.48 -49.64 76.63 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.317 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.41 ' HZ2' ' CG ' ' A' ' 53' ' ' ASP . 43.1 mttp -64.68 -41.24 96.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.646 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 58.6 mt-10 -71.25 -44.2 65.76 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.489 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -113.1 -38.2 4.54 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -169.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.5 m -54.78 142.83 27.48 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.81 -173.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.3 pt -95.89 6.59 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.923 0.868 . . . . 0.0 109.449 171.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.632 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 25.2 t0 -91.53 113.96 26.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.02 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.74 -65.39 2.82 Favored Glycine 0 C--N 1.318 -0.46 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.59 -44.78 78.79 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.632 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 15.0 m -66.63 -34.32 77.62 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.808 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.92 90.56 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.174 0.512 . . . . 0.0 110.685 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -63.55 -33.68 76.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.007 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.0 16.72 21.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.103 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.597 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 19.6 m-20 60.02 35.5 21.47 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.447 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.45 -28.76 1.23 Allowed Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -56.38 91.41 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.918 0.39 . . . . 0.0 110.808 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.18 -39.05 93.54 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 104.32 -148.03 16.67 Favored Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.494 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 21.6 m-85 -84.54 130.67 34.72 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.471 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 44.4 p90 -146.65 149.98 34.54 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.989 174.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.82 -170.23 36.98 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -73.76 154.3 39.64 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 122.737 -0.273 . . . . 0.0 110.338 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.19 -33.96 5.6 Favored Glycine 0 C--N 1.313 -0.75 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.041 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -64.42 -41.28 96.69 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.791 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -108.57 160.64 15.76 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.302 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 18.4 m -64.04 152.13 8.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.429 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.5 OUTLIER -43.76 -57.55 5.7 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.465 -175.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 38.0 Cg_endo -58.91 -32.19 96.92 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 N-CA-C 110.557 -0.593 . . . . 0.0 110.557 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.454 ' CD2' HD13 ' A' ' 93' ' ' ILE . 27.1 t80 -61.74 -47.57 84.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.513 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -62.84 -45.41 92.74 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.115 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.29 -40.28 95.76 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.281 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.57 -41.47 96.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.932 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.04 -49.43 77.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.581 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -65.17 -38.03 89.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.226 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -64.93 -39.5 93.6 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.515 HD11 ' CA ' ' A' ' 81' ' ' SER . 44.0 mt -94.02 16.99 13.16 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.148 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.557 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 50.2 mt-30 -55.09 -19.67 7.91 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.958 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.24 -27.04 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.646 175.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.534 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 123.81 3.04 8.53 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 121.672 -0.299 . . . . 0.0 112.536 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.24 174.43 3.24 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -110.85 132.29 59.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 93' ' ' ILE . 0.3 OUTLIER -73.32 160.69 31.46 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -174.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.463 ' HA ' HE22 ' A' ' 27' ' ' GLN . 0.7 OUTLIER -70.73 175.84 2.35 Favored Pre-proline 0 N--CA 1.444 -0.733 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.94 134.25 61.17 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 CA-C-N 119.538 0.871 . . . . 0.0 109.868 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.47 126.67 74.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.567 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.9 tptp -97.56 135.58 39.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.25 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.567 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 60.5 p -135.03 169.89 16.74 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.581 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.7 pm0 -61.47 -34.02 74.74 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -63.35 -42.35 98.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.506 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.79 -146.17 13.35 Favored Glycine 0 C--N 1.321 -0.297 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.408 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -103.52 130.79 50.98 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 122.266 0.226 . . . . 0.0 110.522 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.534 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 35.9 m-70 -116.12 144.57 43.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.956 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.01 127.35 75.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 167.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.537 ' N ' ' OG ' ' A' ' 81' ' ' SER . 86.0 mt -120.16 129.49 75.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 122.572 -0.08 . . . . 0.0 110.833 -173.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.534 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 63.7 tttp -120.65 159.65 24.89 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.557 ' NE ' ' O ' ' A' ' 76' ' ' GLN . 27.7 ttt-85 -75.84 143.9 41.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.449 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 50.6 tp -108.77 142.06 39.87 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.198 -2.124 0 CA-C-O 118.09 -1.394 . . . . 0.0 112.135 -174.734 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.433 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -64.59 145.6 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.22 1.28 . . . . 0.0 111.535 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.4 mtp -112.33 151.73 29.38 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.399 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.77 5.17 78.52 Favored Glycine 0 C--N 1.317 -0.499 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -173.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.5 p -76.62 173.53 11.48 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.853 -0.673 . . . . 0.0 110.442 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.5 mmt -63.14 -36.08 82.44 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.09 -0.09 2.24 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.322 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -59.28 -36.09 74.92 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -109.75 149.0 30.43 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.322 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.581 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 21.1 mt -106.42 128.52 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -172.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.544 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 41.5 mtpt -90.72 104.57 17.14 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.603 ' SG ' HD11 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -148.11 167.38 25.14 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -175.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m -124.83 132.98 53.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.206 174.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.418 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -127.58 149.44 50.16 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.396 -175.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.531 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 92.6 mt -124.33 125.94 71.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.708 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 44' ' ' SER . 51.3 tp -103.67 125.74 50.36 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.86 155.13 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 121.107 0.479 . . . . 0.0 111.264 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.55 -22.85 34.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.462 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HB2' ' CG ' ' A' ' 22' ' ' GLU . 53.4 mmtt -112.14 140.92 46.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.896 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -64.05 -39.5 94.21 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.491 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.67 -35.76 90.24 Favored Glycine 0 N--CA 1.459 0.212 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.504 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 89.8 mt-10 -65.26 -42.83 92.88 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.56 -47.04 87.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.089 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.21 -41.93 98.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.955 0.407 . . . . 0.0 110.381 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.31 -50.68 72.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.193 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 27' ' ' GLN . 10.7 m -64.7 -41.78 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.777 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 81' ' ' SER . 80.7 mt-30 -58.75 -50.84 72.44 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.145 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -65.78 -37.91 87.59 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.319 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.493 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 67.1 ttt180 -63.42 -37.49 87.48 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.316 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 30' ' ' LEU . 1.3 mm? -61.56 -40.9 96.37 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 19.8 mmtp -63.32 -34.96 78.83 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.313 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.56 -24.24 65.26 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.538 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.52 6.93 26.67 Favored Glycine 0 N--CA 1.463 0.483 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.157 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 6.2 mt-10 -82.77 150.92 26.37 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.236 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -67.25 137.26 56.02 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.704 0.764 . . . . 0.0 112.021 -174.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.531 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 54.2 t80 -55.01 -43.0 73.23 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.602 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -59.35 -37.42 91.94 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.263 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.02 -47.82 84.26 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.67 -41.93 99.35 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.619 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.485 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -62.46 -43.47 98.74 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.053 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -63.3 -41.77 98.99 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -75.1 -82.11 0.07 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -174.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.23 -42.8 96.38 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -170.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.1 m -56.57 133.43 53.56 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.736 -162.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.3 pt -87.98 -7.47 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.131 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.41 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 54.4 t0 -84.34 94.45 8.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.513 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -59.51 -50.68 65.1 Favored Glycine 0 C--N 1.315 -0.618 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.31 -44.69 93.35 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.529 ' OG ' ' NH2' ' A' ' 52' ' ' ARG . 39.6 m -62.79 -33.7 75.74 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.467 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.43 -36.74 84.72 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 47.4 mmtm -61.8 -33.69 74.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.529 ' NH2' ' OG ' ' A' ' 49' ' ' SER . 76.5 mtm-85 -96.52 6.61 48.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.288 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.602 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 70.7 m-20 65.98 36.76 5.69 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.963 0.411 . . . . 0.0 110.152 -174.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 79.3 -20.66 4.75 Favored Glycine 0 C--N 1.317 -0.483 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -54.48 99.13 0.03 OUTLIER 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.374 0.607 . . . . 0.0 111.349 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.603 HD11 ' SG ' ' A' ' 12' ' ' CYS . 90.1 mt -68.73 -38.72 80.38 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.79 -145.17 17.73 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.544 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 11.1 m-85 -83.99 132.65 34.73 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.581 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 52.3 p90 -142.51 149.39 39.09 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.448 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.95 173.67 28.18 Favored Glycine 0 C--O 1.238 0.36 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -81.63 159.73 23.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.566 0.222 . . . . 0.0 110.937 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.67 -77.15 0.38 Allowed Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -61.73 -39.31 91.1 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.229 0.538 . . . . 0.0 109.873 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 68' ' ' PHE . 41.8 mmm -66.2 147.74 52.88 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.876 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.07 136.91 22.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.097 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.569 ' HZ1' ' CD ' ' A' ' 69' ' ' GLU . 9.3 mmtm -43.9 -50.24 19.69 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 29.5 Cg_endo -57.55 -36.61 98.59 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 CA-C-N 118.999 0.678 . . . . 0.0 110.797 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CE1' ' CE ' ' A' ' 64' ' ' MET . 31.8 t80 -63.13 -47.99 80.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.862 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.569 ' CD ' ' HZ1' ' A' ' 66' ' ' LYS . 98.0 mt-10 -64.26 -46.61 82.98 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.288 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 10.9 t70 -57.07 -48.26 78.99 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.236 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.57 96.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.27 -45.83 90.17 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.573 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.413 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 59.1 m-85 -63.16 -36.4 83.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.227 0.537 . . . . 0.0 111.126 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 94.7 mtt-85 -65.03 -22.34 66.97 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.289 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.556 HD11 ' N ' ' A' ' 81' ' ' SER . 73.0 mt -96.34 9.4 41.31 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.505 ' OE1' ' NH1' ' A' ' 95' ' ' ARG . 15.8 mm100 -43.42 -24.76 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 117.936 0.335 . . . . 0.0 111.75 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.98 -23.38 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.111 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 114.29 3.94 22.42 Favored Glycine 0 N--CA 1.47 0.91 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.91 175.48 7.29 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -172.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.21 131.09 56.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.147 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.556 ' N ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -74.34 153.21 39.4 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.161 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' C ' HE22 ' A' ' 27' ' ' GLN . 2.4 mp0 -68.1 171.3 5.83 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 167.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.507 ' N ' HE22 ' A' ' 27' ' ' GLN . 52.6 Cg_exo -54.51 132.66 52.41 Favored 'Trans proline' 0 C--N 1.289 -2.566 0 C-N-CA 120.399 0.733 . . . . 0.0 111.067 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.94 107.29 22.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.545 ' CG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 tmtp? -79.33 134.38 36.61 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.84 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 p -137.95 168.73 19.11 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.534 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -60.46 -34.28 73.78 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -67.25 -38.77 85.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.909 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.49 -154.83 25.85 Favored Glycine 0 C--N 1.314 -0.651 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.545 ' CE2' ' CG ' ' A' ' 85' ' ' LYS . 84.7 m-85 -104.69 126.86 52.19 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.418 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 7.7 m-70 -105.06 143.13 33.67 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.641 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.15 125.78 74.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.531 ' N ' ' OG ' ' A' ' 81' ' ' SER . 81.2 mt -115.9 129.41 72.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -110.05 140.81 43.68 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 168.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 76' ' ' GLN . 4.7 tpt180 -77.9 135.32 37.86 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.455 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 53.7 tp -121.7 145.63 47.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.616 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.211 -1.282 0 CA-C-O 118.342 -1.255 . . . . 0.0 110.859 -179.337 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.588 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.98 148.55 92.41 Favored 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.024 1.816 . . . . 0.0 110.779 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.7 mtp -56.14 141.52 40.28 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.403 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.77 -30.82 5.9 Favored Glycine 0 C--N 1.319 -0.384 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.442 ' N ' ' CE2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -68.83 93.03 0.52 Allowed 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 97.8 mtp -124.58 144.05 50.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.47 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.86 -24.76 67.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.296 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.578 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 32.2 t70 -61.75 -42.12 98.56 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -81.87 167.09 19.35 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.161 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.599 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 21.2 mm -105.86 126.6 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.581 ' HZ1' ' C ' ' A' ' 97' ' ' GLY . 56.8 mtpt -88.34 104.08 16.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.1 OUTLIER -148.77 168.31 23.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -175.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.423 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.9 m -131.13 146.35 52.31 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.594 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -140.18 150.31 44.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.516 HG13 ' CE2' ' A' ' 36' ' ' PHE . 91.3 mt -127.1 128.8 70.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.08 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -101.19 116.61 33.21 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -120.83 154.66 24.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.502 0.668 . . . . 0.0 111.29 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -65.9 -40.62 91.68 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.657 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -119.15 148.9 42.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.448 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -62.4 -40.69 97.32 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.124 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.52 -40.76 94.91 Favored Glycine 0 CA--C 1.511 -0.209 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -63.76 -44.45 93.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.11 -48.0 83.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.978 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.11 -41.01 99.28 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.138 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.05 -47.99 81.46 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.729 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.4 m -70.44 -32.89 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 81' ' ' SER . 48.6 tt0 -59.46 -48.18 82.62 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 77.9 mm-40 -71.12 -36.42 72.12 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.118 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -60.55 -37.94 82.9 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -27.15 64.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.252 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 33.6 mmtp -61.75 -38.73 89.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.12 -24.27 58.09 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.799 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.33 15.38 30.29 Favored Glycine 0 C--N 1.32 -0.356 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -58.9 140.82 54.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 17.0 tptm -56.1 127.38 30.31 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CE2' HG13 ' A' ' 15' ' ' ILE . 61.6 t80 -57.06 -43.52 82.15 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -60.45 -33.8 82.75 Favored Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.836 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 87.2 tttt -59.9 -48.64 80.88 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.04 -41.94 98.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.435 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.48 -48.68 76.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.444 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -64.38 -39.66 94.3 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.25 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.33 -45.17 66.71 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.77 -24.06 4.56 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -177.041 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 3.7 m -50.98 137.82 20.49 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.53 -173.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.4 pt -98.69 -5.22 9.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.317 0.579 . . . . 0.0 109.501 172.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.524 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 67.3 t0 -87.82 107.85 18.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.661 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.34 -43.64 96.58 Favored Glycine 0 C--N 1.318 -0.428 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.32 -49.46 68.37 Favored Glycine 0 CA--C 1.504 -0.654 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.594 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 16.2 m -60.58 -34.53 74.33 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.798 0.332 . . . . 0.0 110.409 174.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.14 85.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.261 0.553 . . . . 0.0 110.743 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.12 -39.45 94.06 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 55' ' ' SER . 80.2 mtp180 -98.09 25.47 6.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.086 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.462 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.6 OUTLIER 35.94 42.44 0.16 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.781 0.8 . . . . 0.0 112.659 -178.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.38 -15.87 4.17 Favored Glycine 0 C--N 1.315 -0.63 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.474 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ARG . 4.9 m -73.41 77.7 1.39 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.26 0.552 . . . . 0.0 110.796 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.58 -38.44 91.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.153 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.26 -141.67 21.6 Favored Glycine 0 CA--C 1.501 -0.786 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.8 139.99 30.83 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 55.2 p90 -144.77 152.89 41.04 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.802 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.5 172.66 36.28 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 8' ' ' ASP . 72.1 mtm-85 -84.69 148.68 26.27 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.017 0.437 . . . . 0.0 111.991 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.81 -56.13 0.48 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.019 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -61.4 -39.42 90.67 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.081 0.467 . . . . 0.0 111.129 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.442 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 76.0 mmm -79.99 153.74 28.69 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.67 -176.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 m -68.4 137.95 23.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.362 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -44.29 -52.5 16.47 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -173.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 31.3 Cg_endo -60.21 -32.44 94.42 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 CA-C-N 118.639 0.55 . . . . 0.0 111.284 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -62.19 -47.22 85.46 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 76.7 mt-10 -63.78 -43.19 97.09 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.817 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -56.25 -49.18 74.91 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.793 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.4 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -63.44 -42.72 98.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.859 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.67 -49.09 77.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.27 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 69' ' ' GLU . 32.1 m-85 -63.62 -38.96 93.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -61.64 -33.42 73.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.316 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 81' ' ' SER . 90.9 mt -89.12 5.71 43.33 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.517 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 15.5 mm100 -42.83 -24.08 0.06 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 118.219 0.463 . . . . 0.0 112.01 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -63.28 -26.22 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 120.798 0.332 . . . . 0.0 111.878 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 114.19 11.39 12.22 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -85.71 174.42 9.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.3 t -95.78 131.46 42.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.534 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 28.5 p -72.92 160.89 31.41 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 123.138 0.273 . . . . 0.0 111.71 -172.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.443 ' HA ' HE22 ' A' ' 27' ' ' GLN . 2.9 mt-10 -64.12 168.91 5.29 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 166.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -57.94 136.08 72.89 Favored 'Trans proline' 0 C--N 1.292 -2.422 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 45.2 t -117.52 130.04 73.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.45 ' HD2' ' CE1' ' A' ' 90' ' ' TYR . 82.9 tttt -110.65 131.75 54.78 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.989 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 p -143.72 -171.58 3.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.972 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 2.1 pm0 -66.09 -31.81 72.9 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -64.1 -37.92 89.2 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.805 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.85 -139.41 9.0 Favored Glycine 0 C--O 1.242 0.608 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.45 ' CE1' ' HD2' ' A' ' 85' ' ' LYS . 87.4 m-85 -106.98 126.89 52.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.447 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 2.0 m-70 -105.35 147.28 28.35 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.59 0.233 . . . . 0.0 111.097 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.3 t -117.5 126.69 74.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 167.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.4 mt -115.37 127.32 72.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.65 -176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -106.22 128.74 54.16 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.517 ' CD ' ' HA ' ' A' ' 76' ' ' GLN . 76.3 ttt-85 -77.65 139.22 39.44 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 118.644 -1.222 . . . . 0.0 109.266 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 50.6 tp -110.08 133.37 53.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.262 -175.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.581 ' C ' ' HZ1' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.573 0 CA-C-O 118.28 -1.289 . . . . 0.0 110.845 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.452 ' HA2' ' CE2' ' A' ' 58' ' ' TYR . . . . . . . . 0 CA--C 1.521 0.463 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.89 145.35 98.51 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.686 1.59 . . . . 0.0 111.171 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.6 tpp -61.3 139.54 58.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.31 -44.64 1.51 Allowed Glycine 0 C--N 1.313 -0.707 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.41 159.41 27.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 122.518 -0.401 . . . . 0.0 110.415 173.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 76.7 mtm -88.91 152.99 21.4 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.77 51.69 0.21 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -64.52 -38.0 89.48 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.609 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -93.42 158.96 15.46 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.532 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.5 mm -106.02 128.24 60.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 11.8 mtpp -89.43 107.07 18.86 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.5 167.26 22.92 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.874 -177.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.528 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.4 m -130.6 147.56 52.3 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.122 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.5 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -134.55 149.74 50.68 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.449 -179.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.556 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 96.1 mt -123.61 128.77 74.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.332 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.1 tp -103.11 123.5 46.79 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.412 ' CG1' HD11 ' A' ' 43' ' ' LEU . 16.2 m -124.1 147.9 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 123.657 0.598 . . . . 0.0 111.132 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -66.76 -42.54 86.0 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.403 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 25.9 mmtp -112.77 151.1 30.7 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -174.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -64.36 -34.89 79.2 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.871 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.22 -37.78 95.1 Favored Glycine 0 CA--C 1.509 -0.317 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.454 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 98.3 mt-10 -64.94 -41.92 95.1 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.75 -46.98 83.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.269 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.09 -42.54 99.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.366 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.07 73.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.3 m -65.18 -40.7 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.964 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 74.2 mt-30 -60.08 -47.3 86.43 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.712 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.516 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 57.0 mm-40 -66.48 -37.14 84.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.034 0.445 . . . . 0.0 110.827 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HD3' ' CD1' ' A' ' 39' ' ' LEU . 77.6 ttt180 -61.06 -41.11 96.0 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.417 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.09 -38.87 84.22 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.512 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 17.5 mmtp -61.04 -34.72 75.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.16 -10.03 37.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.116 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.68 -0.42 39.46 Favored Glycine 0 N--CA 1.462 0.379 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.771 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.478 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 7.3 mm-40 -65.38 142.52 58.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 29.9 mttm -72.58 141.83 48.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.283 0.564 . . . . 0.0 111.13 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 53.1 t80 -58.67 -45.45 89.36 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.02 -34.91 89.72 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.972 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 88.7 tttt -61.04 -47.35 86.77 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.485 ' CD1' ' HD3' ' A' ' 29' ' ' ARG . 4.2 mm? -62.96 -41.11 99.43 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.732 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 44' ' ' SER . . . -60.0 -50.05 75.27 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.85 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.441 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 68.2 mttm -65.85 -45.27 82.77 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.848 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 86.5 mt-10 -71.99 -44.59 63.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.524 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -112.43 -39.11 4.47 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -168.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 67.6 m -52.59 135.83 33.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.334 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.5 pt -87.88 -5.75 10.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.543 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -85.97 91.39 8.37 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.12 -43.59 99.22 Favored Glycine 0 C--N 1.313 -0.718 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.6 -44.21 78.87 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 54' ' ' GLY . 45.3 m -71.8 -33.63 68.71 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.733 175.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.78 91.55 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.787 0.803 . . . . 0.0 109.854 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.33 -37.33 82.89 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.206 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -97.58 20.57 11.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.944 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.0 OUTLIER 57.75 30.53 19.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.648 177.382 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 70.69 -8.1 4.63 Favored Glycine 0 C--N 1.306 -1.106 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -69.95 85.31 0.51 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.147 0.498 . . . . 0.0 110.58 -178.254 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.06 -39.86 95.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.826 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 89.46 -143.44 17.28 Favored Glycine 0 CA--C 1.507 -0.428 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.484 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 95.3 m-85 -83.61 132.92 34.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.409 ' CD1' ' HG3' ' A' ' 64' ' ' MET . 44.8 p90 -146.25 150.28 35.49 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.001 170.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.43 178.38 27.68 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HB3' ' NH1' ' A' ' 61' ' ' ARG . 8.4 mtm105 -75.38 154.78 37.02 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.59 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.81 -31.94 8.12 Favored Glycine 0 C--N 1.309 -0.957 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -11.14 54.54 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.494 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.409 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 10.0 mmm -125.08 156.61 37.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.94 150.77 6.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.849 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.464 ' NZ ' ' HB2' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -44.42 -54.5 12.03 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 38.0 Cg_endo -61.94 -34.14 81.99 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 120.163 0.575 . . . . 0.0 111.119 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -62.43 -47.87 82.17 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.476 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.63 -39.99 94.68 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.895 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.464 ' HB2' ' NZ ' ' A' ' 66' ' ' LYS . 27.6 t70 -56.03 -51.24 68.48 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.871 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.64 95.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.15 -50.98 70.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.342 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.451 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 59.2 m-85 -69.15 -38.45 78.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.773 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -66.61 -40.96 89.05 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 mt -98.1 33.46 2.15 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.478 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 71.0 mt-30 -51.24 -24.54 4.49 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.83 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.83 -31.88 48.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.508 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 123.47 -4.72 9.4 Favored Glycine 0 N--CA 1.469 0.873 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.086 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -60.69 147.33 42.49 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.897 0.379 . . . . 0.0 111.938 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 t -78.59 130.99 35.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 93' ' ' ILE . 10.5 p -74.3 153.44 39.35 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.6 mp0 -59.57 164.69 5.04 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.67 129.03 31.92 Favored 'Trans proline' 0 C--N 1.292 -2.43 0 N-CA-C 109.865 -0.86 . . . . 0.0 109.865 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 59.2 t -104.25 113.97 42.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.533 ' NZ ' ' OH ' ' A' ' 90' ' ' TYR . 41.7 tttp -81.85 138.27 35.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.441 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 19.3 p -150.6 166.47 30.19 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.44 -32.41 71.35 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.441 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 65.7 m-85 -64.48 -40.4 95.61 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.328 176.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.97 -149.85 21.91 Favored Glycine 0 C--N 1.318 -0.418 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.533 ' OH ' ' NZ ' ' A' ' 85' ' ' LYS . 82.7 m-85 -104.38 127.39 52.04 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.362 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.5 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.9 m-70 -111.35 151.18 28.72 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.224 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.67 114.09 44.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 168.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.402 ' N ' ' OG ' ' A' ' 81' ' ' SER . 75.7 mt -111.4 124.03 67.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.244 -172.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 30.1 tttp -114.56 139.01 49.94 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.514 172.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.478 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 1.4 tmm_? -78.9 141.58 37.5 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.398 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.407 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 50.2 tp -109.45 124.06 50.4 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.055 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.204 -1.725 0 CA-C-O 118.296 -1.28 . . . . 0.0 110.248 -177.366 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.265 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.64 141.84 97.92 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.405 1.403 . . . . 0.0 110.976 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.8 mtt -62.62 143.76 56.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.253 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.52 -20.06 52.03 Favored Glycine 0 C--N 1.319 -0.4 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -83.16 96.04 8.3 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.799 0.333 . . . . 0.0 110.177 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.7 mtp -95.61 138.31 33.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.159 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.05 9.09 32.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.861 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -61.52 -42.38 98.72 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -88.94 156.67 18.75 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.366 171.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 68.0 mt -104.72 126.32 59.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HZ3' ' C ' ' A' ' 97' ' ' GLY . 7.8 mtpm? -94.85 104.42 16.32 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.54 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.48 171.86 13.77 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -171.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.54 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 3.9 m -131.4 146.07 52.1 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.305 174.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -140.15 150.96 44.88 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.99 126.77 74.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.288 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 44' ' ' SER . 50.5 tp -101.85 122.37 43.86 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 23' ' ' ALA . 34.8 m -130.39 155.02 41.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.418 0.628 . . . . 0.0 111.106 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -66.38 -41.74 88.97 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.704 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.442 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 27.8 mtpp -118.81 151.6 37.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.447 -172.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -60.9 -37.23 81.52 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.29 -39.94 97.92 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 88.8 mt-10 -63.84 -46.02 86.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.44 ' N ' HG22 ' A' ' 17' ' ' VAL . . . -60.0 -49.37 77.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.443 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.72 -41.05 98.14 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.789 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.51 -49.35 75.0 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.885 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG12 ' CD2' ' A' ' 43' ' ' LEU . 9.4 m -68.21 -40.57 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.406 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.482 HE21 ' C ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -56.05 -42.81 77.18 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.079 -179.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 51.9 mm-40 -71.71 -35.03 70.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.183 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' CG ' ' HG3' ' A' ' 34' ' ' GLU . 12.3 ttm180 -62.07 -37.32 84.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.311 176.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.57 -36.25 78.05 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.871 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 28.4 mmtm -59.98 -36.65 77.62 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.68 -10.44 36.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.894 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.64 62.62 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.413 ' HG3' ' CG ' ' A' ' 29' ' ' ARG . 12.2 mm-40 -62.3 147.04 49.39 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 74.4 tttt -63.01 128.64 36.81 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -58.11 -45.16 87.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -58.25 -39.48 92.55 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.783 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 35' ' ' LYS . 49.2 tttp -59.46 -45.72 90.81 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 39' ' ' LEU . 4.2 mm? -61.66 -42.15 98.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.583 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.89 -49.84 74.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.324 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -64.64 -40.45 95.47 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.46 -47.02 58.3 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.69 -13.14 7.54 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.0 m -58.35 138.59 56.37 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.047 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.3 pt -90.65 -4.12 10.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.581 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 60.1 t0 -89.24 101.91 14.57 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.787 173.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.28 -45.3 96.77 Favored Glycine 0 C--N 1.317 -0.484 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.33 -43.38 89.73 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.581 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 63.6 m -63.49 -34.79 78.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.822 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.25 93.31 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.172 0.511 . . . . 0.0 109.973 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -64.37 -40.34 95.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.559 0.695 . . . . 0.0 109.248 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 84.0 mtp180 -97.27 10.3 39.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.051 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.54 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 21.3 m-20 57.68 29.86 17.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 71.67 0.85 42.72 Favored Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 m -68.45 83.07 0.26 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.119 0.485 . . . . 0.0 110.899 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.531 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 90.0 mt -63.4 -39.7 95.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.541 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 86.81 -149.08 22.1 Favored Glycine 0 C--N 1.318 -0.44 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.95 129.3 34.93 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.8 p90 -146.14 149.47 34.07 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.677 0.275 . . . . 0.0 110.767 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.86 -179.46 38.86 Favored Glycine 0 C--N 1.315 -0.636 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -78.27 153.28 31.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.433 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.41 -34.54 5.21 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.19 -36.85 85.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.051 0.453 . . . . 0.0 110.475 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.533 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 3.5 mmm -110.82 154.18 24.34 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.258 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 27.4 m -64.91 141.13 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.596 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.4 mtpm? -44.2 -48.81 24.06 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -172.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 30.4 Cg_endo -60.66 -32.2 92.95 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 CA-C-N 119.059 0.7 . . . . 0.0 111.264 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 64' ' ' MET . 37.9 t80 -61.85 -46.94 87.29 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -61.49 -45.31 94.76 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.465 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.43 ' OD2' ' NH2' ' A' ' 74' ' ' ARG . 13.0 t70 -56.93 -50.33 72.9 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.408 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.05 93.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.046 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.66 88.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.806 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -66.31 -40.43 89.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.464 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.43 ' NH2' ' OD2' ' A' ' 70' ' ' ASP . 50.9 mtm180 -64.07 -42.14 97.1 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.7 mt -97.95 31.77 2.59 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.473 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 48.6 mt-30 -55.81 -18.15 7.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.262 0.553 . . . . 0.0 109.943 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 p -58.1 -29.16 36.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.037 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.78 -3.01 15.03 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -69.51 161.21 29.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.887 0.375 . . . . 0.0 111.17 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.55 127.66 42.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.482 ' C ' HE21 ' A' ' 27' ' ' GLN . 10.5 p -77.53 159.28 29.43 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.265 0.555 . . . . 0.0 112.206 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -69.6 168.39 17.36 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.38 135.18 68.78 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 N-CA-C 110.136 -0.756 . . . . 0.0 110.136 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 40.4 t -116.49 126.82 74.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.506 ' HD3' ' CZ ' ' A' ' 90' ' ' TYR . 9.8 tptm -85.06 131.3 34.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.074 -177.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.8 p -135.53 170.07 16.53 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -56.26 -37.51 69.88 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -64.11 -43.82 94.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.152 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.04 -140.06 7.0 Favored Glycine 0 N--CA 1.465 0.601 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.506 ' CZ ' ' HD3' ' A' ' 85' ' ' LYS . 43.9 m-85 -106.28 130.88 54.05 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -110.45 146.27 36.2 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.124 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 67.4 t -117.54 127.51 74.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.473 ' N ' ' OG ' ' A' ' 81' ' ' SER . 82.8 mt -119.71 128.08 75.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.984 -173.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -120.13 141.26 50.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -79.1 143.84 35.14 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.941 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.415 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 52.2 tp -112.64 131.14 55.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.486 0.66 . . . . 0.0 110.216 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.483 ' C ' ' HZ3' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--N 1.293 -1.82 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.413 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 CA--C 1.527 0.83 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 32.0 Cg_exo -60.12 145.34 98.67 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 121.65 1.567 . . . . 0.0 111.186 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.9 mtp -37.04 121.78 0.81 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.456 -174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 38.33 30.2 0.08 OUTLIER Glycine 0 N--CA 1.468 0.811 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.402 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.409 ' CB ' ' HB2' ' A' ' 2' ' ' PRO . 7.4 m -104.64 119.7 39.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 116.878 0.339 . . . . 0.0 110.555 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.453 ' HB2' ' NZ ' ' A' ' 9' ' ' LYS . 99.9 mmm -66.1 110.01 2.81 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 9' ' ' LYS . . . -69.83 -9.22 53.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -173.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.33 46.23 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.02 0.438 . . . . 0.0 110.484 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 7' ' ' ALA . 50.4 mttp -136.09 167.49 21.14 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.371 -176.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.546 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 61.1 mt -111.46 131.49 62.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.511 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 46.3 mtpt -91.29 107.16 19.02 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' SG ' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -147.59 167.02 25.6 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.908 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.454 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 14.1 m -135.02 149.9 50.22 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.432 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.418 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -139.08 149.9 45.11 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 119.512 -0.875 . . . . 0.0 113.112 -177.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.486 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 96.5 mt -124.11 123.34 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.0 tp -94.41 127.2 40.16 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -129.89 150.64 34.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.129 0.49 . . . . 0.0 110.588 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -66.14 -40.64 90.77 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.296 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -121.17 152.32 38.9 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -172.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -62.06 -41.15 97.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.665 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.09 95.67 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.97 -42.09 98.75 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.13 -41.37 92.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.742 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.64 -42.46 99.61 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.029 0.442 . . . . 0.0 110.412 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.69 79.61 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.887 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.42 -40.75 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.926 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.452 ' NE2' ' C ' ' A' ' 81' ' ' SER . 81.0 mt-30 -59.5 -47.05 87.02 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.275 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -64.3 -44.49 91.45 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.567 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 71.4 ttt180 -65.58 -39.3 91.48 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.69 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.61 -28.92 61.5 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 69.0 mmtt -62.9 -30.12 71.29 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.79 -22.17 45.76 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.533 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.84 13.39 56.67 Favored Glycine 0 C--O 1.236 0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.135 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.567 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 73.9 mt-10 -66.31 154.46 39.93 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -60.19 126.71 28.56 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 66.0 t80 -59.11 -44.95 92.01 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -60.87 -37.77 94.25 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.472 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 60.1 tttm -60.23 -46.46 89.69 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -60.9 -36.91 80.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.932 178.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . -56.04 -50.86 69.76 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.501 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 45.4 mttp -62.76 -37.81 88.09 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 80.3 mm-40 -69.82 -46.65 65.19 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.422 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.45 -41.44 3.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 6.6 p -54.99 138.11 44.52 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.481 -168.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.3 pt -97.85 -5.03 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.134 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.521 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 57.3 t0 -84.45 93.09 8.22 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.19 -45.53 96.33 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.2 -44.91 74.76 Favored Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.521 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 73.9 m -70.74 -34.08 71.49 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.604 175.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -63.69 -25.32 68.16 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.886 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 30.6 mmtp -63.14 -36.97 85.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 8.3 mtm-85 -96.77 15.47 21.87 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.165 174.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.52 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 22.6 m-20 58.94 29.48 18.98 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.72 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 77.89 -5.15 54.78 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.95 84.06 1.73 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.501 0.667 . . . . 0.0 110.186 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 96.4 mt -62.91 -39.75 95.49 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.153 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.38 -142.92 18.35 Favored Glycine 0 CA--C 1.503 -0.667 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.511 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 19.8 m-85 -83.9 132.91 34.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.546 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 46.9 p90 -145.07 152.02 39.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.89 165.54 26.94 Favored Glycine 0 C--N 1.316 -0.53 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HD2' ' CZ ' ' A' ' 73' ' ' PHE . 60.0 mtp180 -77.32 157.96 30.42 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.496 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 129.11 -77.03 0.4 Allowed Glycine 0 N--CA 1.462 0.394 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -61.21 -38.01 85.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.393 0.615 . . . . 0.0 109.623 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.569 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 75.6 mmm -63.84 145.8 55.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.213 -176.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 m -73.71 130.66 35.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.657 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.611 ' HZ2' ' CD ' ' A' ' 69' ' ' GLU . 5.7 mmtm -45.05 -40.35 10.56 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.118 -174.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 32.8 Cg_exo -56.09 -41.57 75.47 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 120.445 0.763 . . . . 0.0 110.434 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 23.0 t80 -62.84 -47.1 84.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.598 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.611 ' CD ' ' HZ2' ' A' ' 66' ' ' LYS . 96.4 mt-10 -62.13 -43.2 99.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.59 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.03 -51.36 69.58 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.793 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.21 96.79 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.278 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.94 -47.6 84.5 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.492 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.473 ' CZ ' ' HD2' ' A' ' 61' ' ' ARG . 55.7 m-85 -66.62 -37.03 84.0 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.546 HH12 ' CD ' ' A' ' 82' ' ' GLU . 49.3 mtm180 -63.6 -35.92 82.12 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.563 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.501 HD11 ' CA ' ' A' ' 81' ' ' SER . 74.5 mt -97.24 21.38 10.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -171.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.509 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 70.0 mt-30 -52.27 -24.99 8.28 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.893 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 p -61.31 -26.51 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.647 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.17 5.43 19.64 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.489 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 1.8 mm-40 -75.6 173.85 10.49 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 t -104.22 127.5 58.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.584 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.501 ' CA ' HD11 ' A' ' 75' ' ' LEU . 60.0 p -68.14 151.02 47.63 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.546 ' CD ' HH12 ' A' ' 74' ' ' ARG . 1.2 mp0 -63.86 164.03 19.17 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 167.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -54.32 128.29 29.42 Favored 'Trans proline' 0 C--N 1.29 -2.521 0 N-CA-C 109.71 -0.919 . . . . 0.0 109.71 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 t -98.32 117.51 43.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -77.45 136.87 38.41 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.086 0.47 . . . . 0.0 110.844 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 10.3 p -153.89 167.35 30.01 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -57.02 -31.29 64.98 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.45 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 68.3 m-85 -63.58 -42.8 98.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.676 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.43 -132.81 4.45 Favored Glycine 0 C--O 1.239 0.426 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -107.42 127.66 53.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -108.03 140.71 40.8 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.889 172.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.98 115.88 51.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 171.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.4 mt -111.82 125.34 69.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.854 -171.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -113.1 139.74 48.46 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 3.2 tmm_? -78.87 141.78 37.37 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.238 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.505 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 58.6 tp -109.91 134.41 52.11 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.167 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.418 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.204 -1.735 0 CA-C-O 118.126 -1.374 . . . . 0.0 110.63 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.727 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.45 147.3 90.54 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.346 1.364 . . . . 0.0 111.194 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.7 mtm -106.1 152.91 22.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.345 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.31 -33.99 5.42 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 m -73.18 136.23 44.72 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.598 ' C ' ' H ' ' A' ' 8' ' ' ASP . 76.1 mtm -117.18 137.01 52.62 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.11 31.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.761 0.315 . . . . 0.0 111.324 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.598 ' H ' ' C ' ' A' ' 6' ' ' MET . 22.2 t70 -61.22 -45.55 94.08 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -110.39 163.03 14.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.87 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.462 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 39.8 mm -105.49 129.45 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' GLY . 36.0 mtpt -88.98 104.32 16.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 176.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.53 170.36 16.2 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.815 -176.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.52 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 3.6 m -128.29 137.69 52.08 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 114.319 -1.31 . . . . 0.0 107.743 175.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.49 149.6 51.72 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.994 -0.682 . . . . 0.0 112.459 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.504 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 90.0 mt -122.94 124.84 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 44' ' ' SER . 41.6 tp -104.85 123.54 47.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.79 154.29 40.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.25 0.547 . . . . 0.0 111.556 -176.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -70.43 -40.38 73.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.818 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.61 144.49 37.88 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -169.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.47 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 27.4 mt-30 -62.78 -39.35 93.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.614 175.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.25 -38.86 95.21 Favored Glycine 0 CA--C 1.509 -0.307 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -64.99 -44.5 89.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.223 0.535 . . . . 0.0 109.77 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.46 81.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.423 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 27' ' ' GLN . 91.4 mt -64.32 -40.06 95.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.13 -49.17 74.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.35 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.447 ' CG1' ' CD1' ' A' ' 43' ' ' LEU . 21.1 m -64.93 -38.05 81.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.944 176.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.645 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 2.2 mm-40 -54.23 -48.16 71.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.428 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -70.67 -43.44 69.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.251 0.548 . . . . 0.0 110.766 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.46 ' NE ' ' OE1' ' A' ' 34' ' ' GLU . 65.0 ttt180 -61.63 -39.43 91.28 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.001 -174.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -60.75 -34.29 74.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.153 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.645 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 23.9 mmtm -62.97 -34.12 76.84 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.82 -23.62 63.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.425 176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.09 1.45 54.68 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.103 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.46 ' OE1' ' NE ' ' A' ' 29' ' ' ARG . 55.1 mt-10 -65.58 155.78 34.74 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.35 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -61.62 126.58 27.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.082 -172.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.504 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 61.8 t80 -58.18 -45.24 87.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 174.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.09 -39.16 95.41 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.385 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -60.7 -43.58 97.63 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.031 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 39' ' ' LEU . 4.4 mm? -63.48 -40.96 98.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.697 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.445 ' CB ' ' C ' ' A' ' 53' ' ' ASP . . . -60.68 -43.32 97.83 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.424 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 31.6 mmtt -64.56 -36.46 84.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -70.44 -59.34 2.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.075 -172.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.447 ' CD1' ' CG1' ' A' ' 26' ' ' VAL . 1.8 mt -93.42 -57.4 2.61 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 43' ' ' LEU . 5.5 m -29.47 120.02 0.15 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.956 -1.474 . . . . 0.0 113.493 -165.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.5 pt -82.34 -12.0 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.482 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 53.0 t0 -82.16 95.08 7.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.8 174.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.05 -42.84 99.75 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.04 -45.36 81.95 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.482 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 54.1 m -69.16 -32.6 72.04 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.574 0.226 . . . . 0.0 110.724 175.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.424 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -63.12 -37.35 86.85 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.041 0.448 . . . . 0.0 109.999 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -63.73 -27.69 69.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.897 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 55' ' ' SER . 68.7 mtt-85 -95.94 5.61 50.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.081 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.445 ' C ' ' CB ' ' A' ' 40' ' ' ALA . 0.6 OUTLIER 58.06 33.0 22.72 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 79.65 -16.85 9.7 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -66.15 81.38 0.08 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.61 0.719 . . . . 0.0 110.932 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.6 mt -61.87 -41.07 97.42 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.417 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 91.19 -137.38 13.81 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 71.2 m-85 -84.16 137.82 33.32 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.462 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.0 p90 -146.66 148.29 31.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.872 0.367 . . . . 0.0 111.197 169.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.0 169.53 23.04 Favored Glycine 0 C--N 1.313 -0.715 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -80.38 156.32 26.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.673 0.273 . . . . 0.0 110.551 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.48 -52.27 0.75 Allowed Glycine 0 C--N 1.31 -0.862 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -60.93 -45.0 96.43 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.144 0.497 . . . . 0.0 110.387 174.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.6 mmm -88.25 148.09 24.51 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.659 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.51 139.15 21.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HZ1' ' CD ' ' A' ' 69' ' ' GLU . 11.2 mmtm -44.36 -40.97 9.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.53 -44.7 45.85 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 N-CA-C 110.37 -0.665 . . . . 0.0 110.37 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -62.6 -46.29 88.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.407 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.538 ' CD ' ' HZ1' ' A' ' 66' ' ' LYS . 99.3 mt-10 -62.21 -45.9 91.31 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.871 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 38.3 t70 -59.12 -45.99 89.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.099 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.56 90.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.245 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.03 -49.25 76.78 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -67.16 -38.16 85.01 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 51.8 mtp180 -61.52 -47.08 87.23 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.333 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.7 mt -100.28 34.58 2.32 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.484 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 49.4 mt-30 -53.52 -20.17 4.6 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.817 0.341 . . . . 0.0 110.845 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.73 -26.55 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.492 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.93 6.13 21.17 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -78.39 153.68 31.36 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.41 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 16.6 t -75.2 130.78 35.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.527 ' C ' HE21 ' A' ' 27' ' ' GLN . 89.4 p -72.2 154.17 41.18 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.359 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -63.5 165.19 12.29 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -56.1 131.3 45.05 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 N-CA-C 109.513 -0.995 . . . . 0.0 109.513 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 42.0 t -105.86 109.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -80.48 134.12 35.93 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 8.6 p -153.18 168.49 25.78 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -60.6 -29.96 69.53 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.422 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 56.2 m-85 -66.79 -38.79 87.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.479 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.03 -150.28 22.5 Favored Glycine 0 C--N 1.316 -0.579 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.47 ' CE1' ' HG2' ' A' ' 20' ' ' GLN . 58.5 m-85 -101.95 125.96 48.75 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -107.21 144.68 33.62 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.288 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.75 126.43 74.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 168.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.438 HG22 ' SG ' ' A' ' 12' ' ' CYS . 98.8 mt -117.64 129.33 74.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.804 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -119.68 140.67 50.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.484 ' HG3' ' HA ' ' A' ' 76' ' ' GLN . 2.5 tmm_? -78.85 143.96 35.47 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.997 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.419 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 57.2 tp -113.05 140.67 47.65 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.917 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.556 0 CA-C-O 118.267 -1.296 . . . . 0.0 110.571 -179.435 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.459 ' N ' ' CE1' ' A' ' 58' ' ' TYR . . . . . . . . 0 CA--C 1.524 0.639 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -61.3 148.74 92.11 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.688 2.259 . . . . 0.0 112.308 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.9 mtp -57.72 146.11 32.22 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.648 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.55 29.2 70.03 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -47.66 101.6 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.274 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.522 ' C ' ' H ' ' A' ' 8' ' ' ASP . 45.3 mtt -68.13 151.72 46.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.983 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.83 7.26 0.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.318 175.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 6' ' ' MET . 34.1 t70 -61.03 -41.11 95.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.75 161.4 24.56 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.236 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.487 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -107.38 128.1 62.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.537 ' HZ1' ' C ' ' A' ' 97' ' ' GLY . 62.3 mtpt -93.72 104.6 16.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -149.13 169.21 21.21 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.719 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.486 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 48.1 m -132.78 147.34 52.31 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.58 175.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.489 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -130.39 150.91 51.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -177.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.549 HG13 ' CE2' ' A' ' 36' ' ' PHE . 96.2 mt -127.82 124.4 62.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.521 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.4 tp -90.84 129.09 36.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.04 143.1 41.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 O-C-N 123.577 0.548 . . . . 0.0 110.834 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -65.6 -42.41 91.66 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.191 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -126.38 151.97 46.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.681 -169.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -60.25 -35.08 74.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.722 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.09 -38.3 94.13 Favored Glycine 0 C--N 1.321 -0.265 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.61 -41.7 92.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.66 -47.4 84.57 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.135 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.68 -41.93 99.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.168 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.02 72.67 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.726 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.17 -39.78 86.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.101 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.485 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 4.6 mm-40 -58.69 -47.8 83.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.958 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -65.71 -46.46 78.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.502 0.668 . . . . 0.0 110.097 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.463 ' NH1' ' OE1' ' A' ' 42' ' ' GLU . 72.8 ttt180 -63.65 -40.83 97.86 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.886 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.63 -32.64 65.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.485 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 29.6 mmtm -63.41 -13.05 35.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.466 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.16 -14.08 60.52 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.57 -1.92 60.37 Favored Glycine 0 C--O 1.243 0.667 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.58 148.72 32.42 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.322 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -71.78 142.19 49.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.958 0.885 . . . . 0.0 112.593 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.549 ' CE2' HG13 ' A' ' 15' ' ' ILE . 57.1 t80 -56.97 -45.04 83.16 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.116 -177.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.07 -37.5 94.01 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.69 -46.36 90.03 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.423 ' N ' HD21 ' A' ' 39' ' ' LEU . 3.0 mm? -61.62 -39.64 91.98 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.291 173.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . -58.77 -50.99 71.88 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.317 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -61.15 -42.56 98.77 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.106 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.463 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 70.7 mt-10 -70.23 -41.37 73.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -173.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.519 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.64 -28.53 3.86 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.482 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 10.1 p -59.92 135.54 57.73 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.681 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.0 pt -105.26 -6.78 9.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.293 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.432 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 59.0 t0 -83.85 97.2 9.07 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -55.98 -46.09 85.2 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -43.85 -56.37 5.13 Favored Glycine 0 C--O 1.237 0.313 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.491 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . 1.5 p -71.04 -32.92 69.8 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.44 73.75 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.147 0.498 . . . . 0.0 109.904 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 99.4 mttt -58.74 -36.01 73.63 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 177.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.443 ' NE ' ' O ' ' A' ' 55' ' ' SER . 61.1 mtp85 -98.3 7.57 46.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.396 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.445 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 79.9 m-20 58.71 31.76 21.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -173.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 49' ' ' SER . . . 75.85 -6.68 31.99 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.443 ' O ' ' NE ' ' A' ' 52' ' ' ARG . 1.1 m -66.59 72.86 0.09 Allowed 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.434 0.635 . . . . 0.0 110.913 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 54' ' ' GLY . 94.5 mt -63.69 -40.33 96.53 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.593 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.59 -145.04 22.6 Favored Glycine 0 N--CA 1.464 0.54 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.459 ' CE1' ' N ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER -83.95 129.08 34.93 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.071 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.517 ' CE1' ' HG3' ' A' ' 64' ' ' MET . 55.4 p90 -141.0 153.7 45.68 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.465 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.54 169.98 32.03 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.515 HH22 ' CG ' ' A' ' 8' ' ' ASP . 1.5 mtm105 -78.02 148.92 34.13 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 120.883 0.373 . . . . 0.0 111.004 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.16 -32.78 6.91 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -64.5 -37.35 87.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.842 0.353 . . . . 0.0 110.776 175.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.517 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 2.8 mmm -101.94 160.04 14.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.369 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 m -75.07 153.66 6.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -44.3 -50.0 22.82 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.99 -41.28 80.4 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 120.962 1.108 . . . . 0.0 110.828 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -62.36 -47.78 82.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.777 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.66 -38.68 91.83 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.227 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.06 -51.27 66.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.998 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.2 -41.49 94.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.196 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.83 78.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 -177.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -67.46 -35.47 79.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 0.0 111.258 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.537 HH21 ' CD ' ' A' ' 82' ' ' GLU . 43.9 mtp180 -60.38 -39.18 86.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.155 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.548 HD12 ' CB ' ' A' ' 81' ' ' SER . 44.8 mt -96.87 17.11 17.48 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.461 ' HA ' ' HD2' ' A' ' 95' ' ' ARG . 82.4 mt-30 -54.08 -22.46 10.9 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 117.943 -1.503 . . . . 0.0 110.842 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -59.4 -27.31 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.113 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 121.51 -2.17 11.24 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.44 174.26 9.85 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -173.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.4 t -96.89 133.41 38.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.325 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.548 ' CB ' HD12 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -68.36 152.74 44.99 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.193 -178.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.537 ' CD ' HH21 ' A' ' 74' ' ' ARG . 2.8 mp0 -65.16 177.25 0.66 Allowed Pre-proline 0 N--CA 1.427 -1.587 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 167.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -56.54 134.55 65.09 Favored 'Trans proline' 0 C--N 1.287 -2.694 0 N-CA-C 109.765 -0.898 . . . . 0.0 109.765 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 50.5 t -120.95 129.59 75.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -109.3 132.38 54.18 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.064 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.5 p -115.0 -171.25 1.91 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.107 171.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -67.04 -35.04 79.02 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 172.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 8.6 m-30 -63.36 -44.39 94.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.635 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.34 -143.82 9.96 Favored Glycine 0 C--N 1.321 -0.261 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 28.1 m-85 -102.14 134.28 45.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.943 0.401 . . . . 0.0 111.987 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.44 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 16.9 m-70 -118.4 150.1 40.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.023 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.8 t -117.51 125.7 74.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 164.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.496 ' O ' ' CD1' ' A' ' 75' ' ' LEU . 89.1 mt -123.55 131.86 72.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -171.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HG2' ' N ' ' A' ' 95' ' ' ARG . 43.4 tttm -123.53 152.32 41.91 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.485 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 79.1 ttt180 -77.35 137.77 38.94 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.7 tp -119.91 130.47 54.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.537 ' C ' ' HZ1' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.572 0 CA-C-O 118.769 -1.017 . . . . 0.0 112.188 -174.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.452 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.94 147.18 93.79 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.075 1.85 . . . . 0.0 111.181 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.0 mmt -59.35 141.74 53.79 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.8 -15.11 59.93 Favored Glycine 0 C--N 1.314 -0.647 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 58' ' ' TYR . 12.6 m -72.08 107.93 5.03 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.005 0.431 . . . . 0.0 110.292 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.44 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 67.0 mtt -110.2 118.05 35.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.162 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.11 79.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.05 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.55 -4.3 22.37 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.936 0.398 . . . . 0.0 110.861 -175.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.44 ' HD2' ' HB2' ' A' ' 6' ' ' MET . 63.1 mttp -111.63 172.77 6.69 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.222 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.451 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 58.4 mt -104.96 127.11 59.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -173.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 62.5 mtpt -91.94 106.05 18.16 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.431 ' SG ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -146.54 164.79 31.44 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.914 -175.176 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.8 m -127.51 135.67 50.68 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.079 -1.418 . . . . 0.0 108.354 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.457 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -130.61 149.23 52.37 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.698 -177.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.512 HG13 ' CE2' ' A' ' 36' ' ' PHE . 95.9 mt -128.44 127.72 67.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.142 176.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 44' ' ' SER . 41.4 tp -98.68 123.96 43.2 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.93 154.71 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.665 0.745 . . . . 0.0 111.052 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 6.7 mtmp? -65.75 -41.89 91.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.742 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -123.51 154.06 39.69 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.526 -167.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.404 ' HG3' ' CB ' ' A' ' 83' ' ' PRO . 58.2 tt0 -60.47 -40.84 92.7 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.032 175.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.44 -39.53 97.42 Favored Glycine 0 CA--C 1.508 -0.345 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 98.3 mt-10 -63.85 -42.78 97.5 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.89 99.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.364 177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.27 -41.61 99.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.851 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.67 -45.5 81.65 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.867 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG21 ' N ' ' A' ' 27' ' ' GLN . 21.0 m -70.82 -36.27 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.461 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 51.7 tt0 -58.49 -45.78 88.01 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.71 -41.01 88.65 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.503 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 15.9 tpt180 -59.94 -40.84 90.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.818 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.403 HD21 ' N ' ' A' ' 30' ' ' LEU . 1.4 mm? -61.7 -41.44 97.59 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.047 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 25.5 mmtp -67.72 -11.75 59.02 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.723 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.56 -11.17 59.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.1 10.84 63.88 Favored Glycine 0 C--O 1.238 0.372 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 91.2 mt-10 -86.15 155.86 20.59 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 57.0 mttm -67.37 139.02 57.16 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.381 0.61 . . . . 0.0 112.58 -175.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.512 ' CE2' HG13 ' A' ' 15' ' ' ILE . 52.7 t80 -58.42 -45.84 87.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.056 174.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.21 -35.07 91.02 Favored Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.53 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 49.1 tttm -60.65 -48.87 79.84 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.79 -41.57 99.33 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.064 175.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.467 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.49 -50.49 73.56 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.685 -176.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 67.8 mttm -65.23 -40.13 93.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.943 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' OE2' ' NZ ' ' A' ' 38' ' ' LYS . 95.8 mt-10 -71.0 -44.42 65.95 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -172.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.465 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -124.51 -19.35 5.45 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -174.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.467 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.7 m -55.73 140.21 42.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.38 -173.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.8 pt -86.03 -11.65 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.516 0.674 . . . . 0.0 109.227 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -88.2 115.17 25.49 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.068 173.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.24 -32.88 77.99 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.57 -42.83 85.36 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 54' ' ' GLY . 41.2 m -61.27 -35.44 77.29 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.538 176.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.64 -43.23 60.07 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.474 0.654 . . . . 0.0 110.525 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -66.29 -39.71 89.56 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.905 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.459 ' O ' ' N ' ' A' ' 55' ' ' SER . 21.5 mmm180 -96.05 4.25 52.75 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.425 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.0 OUTLIER 53.09 35.41 19.58 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -173.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 76.68 -36.85 1.41 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.461 -173.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -54.27 89.36 0.01 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.547 0.739 . . . . 0.0 112.041 -178.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.431 HD11 ' SG ' ' A' ' 12' ' ' CYS . 93.0 mt -63.65 -40.3 96.5 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.238 176.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 97.27 -147.45 18.66 Favored Glycine 0 CA--C 1.503 -0.693 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.502 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 4.8 m-85 -83.71 132.48 34.85 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.552 ' CD2' ' CE ' ' A' ' 64' ' ' MET . 54.7 p90 -146.56 150.65 35.93 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.807 173.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.99 -168.0 34.72 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.7 mtp85 -85.31 148.83 25.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.607 0.241 . . . . 0.0 110.876 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.82 -17.53 56.25 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 116.44 -0.346 . . . . 0.0 112.345 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -67.37 -37.88 83.86 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.181 0.515 . . . . 0.0 111.781 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.552 ' CE ' ' CD2' ' A' ' 59' ' ' PHE . 3.5 mpp? -118.43 161.73 19.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.322 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.8 m -58.01 136.64 21.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HZ2' ' CG ' ' A' ' 70' ' ' ASP . 8.0 tmtm? -44.76 -42.88 16.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -173.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.37 -43.42 58.84 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 CA-C-N 118.894 0.641 . . . . 0.0 110.608 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -63.09 -50.81 69.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.804 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.05 -41.15 87.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.501 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.488 ' CG ' ' HZ2' ' A' ' 66' ' ' LYS . 22.7 t70 -59.01 -44.3 91.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.957 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.31 84.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.493 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.05 89.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.48 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.444 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 46.6 m-85 -62.52 -29.74 70.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.637 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -65.3 -37.16 86.27 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' CA ' ' A' ' 81' ' ' SER . 76.8 mt -95.75 21.52 8.36 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -168.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.455 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 71.9 mt-30 -45.26 -24.98 0.32 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.469 0.176 . . . . 0.0 111.031 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.93 -31.24 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 123.02 0.42 9.71 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.387 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -68.14 174.46 3.86 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.34 129.67 62.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.431 ' CA ' HD12 ' A' ' 75' ' ' LEU . 82.5 p -64.47 155.41 32.82 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.113 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.16 169.46 16.4 Favored Pre-proline 0 N--CA 1.432 -1.354 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 164.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.404 ' CB ' ' HG3' ' A' ' 20' ' ' GLN . 67.5 Cg_exo -54.62 129.4 34.73 Favored 'Trans proline' 0 C--N 1.292 -2.398 0 CA-C-N 118.923 0.651 . . . . 0.0 110.482 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.9 t -107.66 108.28 24.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.215 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.407 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 65.7 tttp -81.95 133.46 35.31 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.581 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.502 ' HG ' ' CD2' ' A' ' 91' ' ' HIS . 60.1 p -138.29 179.79 6.25 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -61.08 -37.61 83.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 10.4 m-30 -63.29 -43.59 97.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.772 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.83 -139.27 6.72 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.407 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 26.2 m-85 -104.92 130.12 53.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.98 0.39 . . . . 0.0 111.038 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.502 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 15.7 m-70 -113.22 148.68 35.01 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.215 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 72.1 t -117.72 126.98 75.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 167.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.4 mt -118.46 123.39 71.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -107.76 140.83 40.24 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 169.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.628 ' NH1' ' O ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -78.74 138.75 38.39 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.91 176.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.628 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 53.3 tp -103.15 124.84 49.34 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.368 0 CA-C-O 118.272 -1.293 . . . . 0.0 112.005 -171.273 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.565 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.63 144.45 99.43 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.769 1.646 . . . . 0.0 111.736 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 mtt -48.57 138.15 10.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.635 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.57 78.32 Favored Glycine 0 C--N 1.318 -0.454 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.455 ' OG ' ' NZ ' ' A' ' 11' ' ' LYS . 1.9 m -103.55 118.5 36.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.444 ' C ' ' H ' ' A' ' 8' ' ' ASP . 36.0 ttm -107.16 107.59 18.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.47 -4.63 0.64 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.87 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 6' ' ' MET . 15.2 t70 -60.73 -31.46 70.77 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -121.55 163.94 18.05 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.186 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.613 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 71.8 mt -105.08 128.48 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' NZ ' ' OG ' ' A' ' 5' ' ' SER . 59.3 mtpt -91.57 109.49 20.79 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.44 ' SG ' HD11 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -141.04 164.61 29.82 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -174.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.8 m -127.39 140.7 52.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.479 173.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.43 ' CD2' ' C ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -136.33 150.77 49.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.316 0.579 . . . . 0.0 112.488 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.417 HG13 ' CE2' ' A' ' 36' ' ' PHE . 96.1 mt -128.98 126.52 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.323 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 13.8 mt -95.56 132.69 40.43 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.77 153.63 39.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 O-C-N 123.58 0.55 . . . . 0.0 109.684 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -65.07 -41.29 95.23 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.083 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 9.0 mtmp? -124.55 149.52 46.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -173.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 52.7 tt0 -63.0 -37.35 86.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.05 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.96 -38.73 93.2 Favored Glycine 0 C--O 1.242 0.645 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 93.6 mt-10 -63.77 -41.68 97.93 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 176.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.16 -47.22 84.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.168 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.83 -41.98 98.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.544 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.9 -50.72 72.65 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.752 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.38 -39.22 84.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.059 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 81' ' ' SER . 91.2 mt-30 -57.9 -46.81 84.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.217 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -63.42 -36.54 84.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.598 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 77.0 ttt180 -63.15 -39.42 94.62 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.493 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.41 -40.43 94.4 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 66.2 mmtt -60.83 -28.39 68.78 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.692 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.11 -21.22 66.45 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.419 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.93 -4.32 38.94 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.143 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.598 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 18.9 mt-10 -62.8 149.72 43.36 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.211 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 41.1 tttm -63.68 134.3 55.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.214 0.53 . . . . 0.0 110.927 -174.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.417 ' CE2' HG13 ' A' ' 15' ' ' ILE . 64.9 t80 -56.85 -45.24 82.55 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.562 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.03 -34.84 89.44 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.319 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 88.4 tttt -59.95 -46.65 88.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.57 -41.33 98.86 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.571 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.505 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.44 -47.43 84.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.442 ' HZ1' ' CG ' ' A' ' 53' ' ' ASP . 31.5 mmtp -65.69 -40.6 92.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.077 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 42.2 mt-10 -70.68 -54.12 13.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -172.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -118.21 -29.09 5.65 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -166.607 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.3 m -42.25 137.94 1.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.3 pt -83.32 -12.74 11.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.518 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 64.9 t0 -88.59 97.5 11.13 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.717 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -67.45 -45.89 74.64 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.74 -45.68 78.06 Favored Glycine 0 C--O 1.236 0.267 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.518 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 15.9 m -69.68 -32.67 71.43 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.562 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.62 68.81 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.419 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 48.9 mmtm -62.34 -37.68 86.59 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.431 HH21 ' HA ' ' A' ' 56' ' ' LEU . 89.7 mtm-85 -97.63 20.82 11.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.809 176.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.562 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 16.4 m-20 60.41 32.44 20.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.153 0.502 . . . . 0.0 109.733 -177.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 78.71 -8.54 41.99 Favored Glycine 0 C--N 1.307 -1.04 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.92 89.08 0.07 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.398 0.618 . . . . 0.0 110.36 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD11 ' SG ' ' A' ' 12' ' ' CYS . 91.5 mt -63.1 -41.3 99.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.874 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.39 -154.18 18.97 Favored Glycine 0 C--O 1.236 0.265 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -83.97 135.05 34.61 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.613 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 53.8 p90 -143.2 154.38 43.8 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.558 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.89 173.76 25.94 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH1' ' CZ ' ' A' ' 73' ' ' PHE . 51.5 mtp85 -71.33 138.62 49.41 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.512 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 86.65 -5.76 84.06 Favored Glycine 0 C--N 1.305 -1.16 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -68.42 -40.54 81.17 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.21 0.528 . . . . 0.0 109.734 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.444 ' HE1' ' CG ' ' A' ' 59' ' ' PHE . 76.4 mtm -123.41 161.95 23.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.707 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.5 m -51.67 140.04 6.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 -176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -44.54 -46.26 25.07 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.538 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.88 -46.26 34.66 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 120.643 0.896 . . . . 0.0 110.742 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -61.7 -49.23 77.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.454 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 96.1 mt-10 -65.72 -40.32 92.07 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.339 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.92 -44.49 91.3 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.85 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.39 -38.44 84.69 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.856 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.37 96.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.132 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.584 ' CZ ' ' NH1' ' A' ' 61' ' ' ARG . 39.3 m-85 -61.86 -32.02 72.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 120.794 0.33 . . . . 0.0 111.73 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -61.68 -37.28 83.5 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.741 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.608 HD13 ' N ' ' A' ' 81' ' ' SER . 72.0 mt -90.58 6.85 42.02 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.438 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 85.4 mt-30 -50.78 -27.35 7.05 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.962 -177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 p -62.95 -33.55 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.455 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 119.89 49.76 0.3 Allowed Glycine 0 N--CA 1.475 1.28 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.643 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.64 174.37 9.47 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -175.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.48 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 97.2 t -95.77 130.64 44.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.608 ' N ' HD13 ' A' ' 75' ' ' LEU . 6.2 p -78.61 163.3 25.6 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.019 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.408 ' CB ' ' HD2' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -68.77 169.78 10.13 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 82' ' ' GLU . 69.5 Cg_endo -62.46 141.5 86.97 Favored 'Trans proline' 0 C--N 1.297 -2.141 0 CA-C-N 118.885 0.638 . . . . 0.0 110.707 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.76 130.84 73.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.495 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 29.6 tptp -107.67 135.59 48.85 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.243 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.3 p -145.63 177.16 9.09 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.49 -31.38 70.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -62.1 -42.28 99.06 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.983 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 85' ' ' LYS . . . 152.09 -143.54 10.52 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.495 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 3.2 m-85 -105.24 129.5 53.6 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -109.37 147.5 32.64 Favored 'General case' 0 CA--C 1.501 -0.931 0 O-C-N 123.41 0.444 . . . . 0.0 110.148 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.6 t -118.11 126.55 75.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 163.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.434 ' HB ' ' OG ' ' A' ' 81' ' ' SER . 89.2 mt -115.62 129.92 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.668 -174.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -124.9 143.12 51.02 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.438 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 1.7 tmm_? -78.58 143.83 36.11 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.317 -174.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.402 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 53.8 tp -109.06 139.04 44.48 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.737 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.675 0 CA-C-O 118.249 -1.306 . . . . 0.0 110.332 -179.854 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.35 143.57 99.49 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.922 1.748 . . . . 0.0 111.633 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.2 mtp -112.95 144.98 41.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.55 6.84 88.21 Favored Glycine 0 C--N 1.319 -0.41 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 m -100.71 136.08 41.14 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.148 0.579 . . . . 0.0 111.172 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 77.8 mtm -124.09 148.61 46.99 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.87 -13.85 60.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.464 0.173 . . . . 0.0 111.188 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.43 -36.46 84.24 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -80.76 155.47 26.67 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.542 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.551 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 40.5 mm -106.96 128.35 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.196 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.55 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 46.0 mtpt -95.66 106.9 19.05 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -148.03 168.24 22.84 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.873 -1.131 . . . . 0.0 113.947 -175.003 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.509 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 19.4 m -135.31 143.97 46.47 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.235 173.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.486 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -138.97 151.77 47.14 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.499 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 89.1 mt -121.03 126.7 75.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -98.5 119.52 37.35 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.11 146.68 32.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.187 0.518 . . . . 0.0 111.605 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.33 -40.89 90.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.508 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 22.3 mmtp -109.96 148.24 31.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.869 -171.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -37.55 87.74 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.665 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.98 -37.1 93.85 Favored Glycine 0 C--O 1.227 -0.305 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.446 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 97.9 mt-10 -64.09 -44.69 91.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 -49.68 76.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.495 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.99 -41.48 97.48 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.263 0.554 . . . . 0.0 110.216 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.51 -47.19 82.63 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.521 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.1 m -70.2 -32.11 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.967 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.481 HE22 ' HA ' ' A' ' 82' ' ' GLU . 48.8 tt0 -61.35 -47.08 87.53 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -67.86 -43.43 79.46 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.939 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.523 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 75.0 ttt180 -60.7 -39.17 87.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.329 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -41.1 78.55 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.71 -26.9 68.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.737 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.72 -1.1 2.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.27 19.02 61.39 Favored Glycine 0 C--O 1.236 0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.143 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.523 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 28.3 mt-10 -87.1 144.68 26.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.526 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -64.12 139.89 58.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.413 0.625 . . . . 0.0 112.304 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.499 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 48.2 t80 -57.77 -45.53 85.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.24 -36.72 93.43 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.0 177.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -60.76 -44.64 96.49 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.426 HD11 ' NH1' ' A' ' 29' ' ' ARG . 4.6 mm? -62.66 -40.43 97.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.693 172.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.15 97.87 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.972 0.415 . . . . 0.0 110.144 -177.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' HZ3' ' CG ' ' A' ' 53' ' ' ASP . 13.1 mmtm -65.86 -44.09 86.46 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.897 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.451 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 74.6 mt-10 -71.4 -41.79 69.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.9 -70.39 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -170.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.4 t -33.59 128.48 0.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.449 -168.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.2 pt -91.05 -3.3 10.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.777 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 50' ' ' ALA . 54.6 t0 -79.09 94.73 5.39 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.09 -51.08 61.03 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -46.21 -53.41 9.34 Favored Glycine 0 C--N 1.322 -0.235 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.532 ' OG ' ' NH2' ' A' ' 52' ' ' ARG . 21.9 m -71.7 -32.24 67.59 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 46' ' ' ASP . . . -62.63 -38.35 89.89 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -61.79 -25.48 67.51 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.756 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.532 ' NH2' ' OG ' ' A' ' 49' ' ' SER . 93.1 mtm-85 -97.69 7.71 45.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.367 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.531 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER 59.71 34.1 22.0 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.536 0.684 . . . . 0.0 109.649 -173.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 79.27 -8.59 45.55 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.336 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 m -65.4 128.46 35.97 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.589 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -109.01 -28.77 8.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.985 0.421 . . . . 0.0 110.064 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 78.63 -146.87 30.41 Favored Glycine 0 CA--C 1.516 0.124 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.55 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 44.0 m-85 -84.32 133.27 34.55 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.551 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 52.1 p90 -144.43 145.91 32.18 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.76 179.25 38.39 Favored Glycine 0 C--N 1.316 -0.535 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -71.05 137.73 49.22 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.085 -0.558 . . . . 0.0 109.778 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.17 -22.76 32.31 Favored Glycine 0 C--N 1.305 -1.182 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.46 -41.4 84.75 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mmm -113.85 160.73 18.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.369 -170.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -63.73 142.67 16.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -43.43 -50.26 16.6 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.997 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.26 -42.18 69.71 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 N-CA-C 110.393 -0.657 . . . . 0.0 110.393 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -62.4 -47.93 81.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.454 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.1 -42.88 93.6 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.584 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.68 -40.68 93.05 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.241 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.07 -41.96 90.04 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.006 0.431 . . . . 0.0 110.114 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.87 97.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.395 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.412 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 46.5 m-85 -66.82 -34.13 77.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -62.99 -33.86 76.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 81' ' ' SER . 73.9 mt -89.41 18.67 5.04 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -168.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.513 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 99.4 mm-40 -59.41 -22.46 61.45 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.3 -26.05 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.427 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 98.49 29.47 7.42 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -101.74 159.75 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.787 -0.243 . . . . 0.0 111.458 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.1 t -77.22 131.11 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.478 ' N ' HD12 ' A' ' 75' ' ' LEU . 28.1 p -69.91 157.61 37.12 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.671 -178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.481 ' HA ' HE22 ' A' ' 27' ' ' GLN . 16.8 mp0 -73.17 168.65 22.95 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 167.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -53.95 131.42 44.42 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 N-CA-C 110.304 -0.691 . . . . 0.0 110.304 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -106.62 108.59 25.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.509 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 16.0 tptm -79.59 131.62 36.05 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.556 ' HG ' ' CD2' ' A' ' 91' ' ' HIS . 14.7 p -151.34 174.58 13.16 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.76 -172.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -54.81 -36.86 65.42 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.708 174.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -68.67 -41.49 79.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.628 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.9 -125.54 2.51 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.509 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 96.1 m-85 -109.97 128.28 55.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.111 0.455 . . . . 0.0 110.157 177.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.556 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 4.2 m-70 -108.37 146.63 32.74 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.906 173.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.0 125.44 73.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.435 ' N ' ' OG ' ' A' ' 81' ' ' SER . 88.5 mt -119.46 129.47 75.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.714 -171.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -112.34 131.33 55.59 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 169.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.513 ' CD ' ' HA ' ' A' ' 76' ' ' GLN . 79.2 ttt-85 -78.04 135.47 37.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 11' ' ' LYS . 56.0 tp -107.24 132.82 52.65 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.141 -173.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.387 0 CA-C-O 118.096 -1.391 . . . . 0.0 111.221 -177.399 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.846 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.99 144.24 69.22 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.09 1.86 . . . . 0.0 111.809 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.4 ' C ' ' H ' ' A' ' 5' ' ' SER . 39.2 mmt -84.63 155.81 21.84 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.17 0.51 . . . . 0.0 111.744 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.63 -17.51 14.75 Favored Glycine 0 C--O 1.235 0.183 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 3' ' ' MET . 1.1 m -63.53 155.69 28.67 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 49.5 ttp -58.76 -40.64 84.49 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 9' ' ' LYS . . . -80.14 24.43 0.42 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.14 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.415 ' OD1' ' HG3' ' A' ' 9' ' ' LYS . 24.3 p-10 -83.18 14.56 3.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.743 0.782 . . . . 0.0 109.959 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 7' ' ' ALA . 40.0 mttp -118.49 177.31 4.87 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.077 -175.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.552 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 15.7 mm -105.2 124.18 59.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 57' ' ' GLY . 62.0 mtpt -97.15 105.13 17.22 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 171.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.513 ' SG ' HG22 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -146.16 168.73 20.28 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -173.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.475 ' CB ' ' CE2' ' A' ' 36' ' ' PHE . 3.9 m -132.66 146.86 52.22 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.82 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.548 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -133.92 150.65 51.32 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.639 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 93.6 mt -123.62 126.72 73.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 44' ' ' SER . 42.1 tp -100.74 122.47 43.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.29 155.34 41.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.332 0.587 . . . . 0.0 110.915 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -65.29 -40.29 93.66 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.702 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB2' ' CG ' ' A' ' 22' ' ' GLU . 58.4 mttp -117.13 151.81 36.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.086 -168.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.07 -40.57 98.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.44 -0.8 . . . . 0.0 108.96 170.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.97 -37.49 93.92 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.474 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 94.4 mt-10 -64.73 -41.34 96.03 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.01 -42.66 98.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.993 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -62.22 -41.84 98.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.48 -49.89 73.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.384 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 23' ' ' ALA . 2.6 m -65.19 -40.82 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.807 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -56.65 -46.24 81.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -67.83 -41.85 82.39 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.315 0.579 . . . . 0.0 110.261 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.483 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 77.0 ttt180 -61.07 -39.43 89.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.922 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.65 -36.57 74.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -67.44 -13.61 62.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.378 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.95 -12.4 61.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.99 0.424 . . . . 0.0 110.116 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.97 16.64 47.0 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.256 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.59 147.38 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.283 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -66.25 133.82 51.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.087 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.639 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 54.3 t80 -58.62 -46.31 87.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.149 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.53 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.89 -36.14 92.99 Favored Glycine 0 C--O 1.25 1.154 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -60.2 -48.12 83.06 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.438 HD11 ' HD3' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -63.96 -40.1 95.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.987 176.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' CB ' ' C ' ' A' ' 53' ' ' ASP . . . -56.49 -47.94 78.22 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 37' ' ' GLY . 24.5 mtmm -64.77 -41.28 95.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.029 176.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.483 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 86.9 mt-10 -71.04 -56.83 5.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mt -76.77 -50.37 13.71 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 1.8 m -61.14 139.25 58.14 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.337 -161.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.0 pt -87.75 -4.52 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.874 172.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.542 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 59.4 t0 -89.77 96.65 10.78 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.189 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.0 -41.36 99.92 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.63 -45.1 90.86 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.548 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 39.6 m -63.89 -33.79 76.49 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.699 0.285 . . . . 0.0 110.622 174.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.63 97.48 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -70.3 -11.73 61.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.697 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 55' ' ' SER . 72.2 mmt-85 -113.03 9.28 18.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.097 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.53 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.4 m-20 53.61 30.8 11.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -174.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 60.48 1.42 1.73 Allowed Glycine 0 C--N 1.318 -0.438 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 53' ' ' ASP . 1.7 m -75.84 85.75 2.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.244 0.545 . . . . 0.0 110.578 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.85 -40.16 95.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.175 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 89.29 -149.25 20.58 Favored Glycine 0 C--N 1.322 -0.231 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -84.83 132.79 34.36 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.552 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 53.6 p90 -143.62 146.73 33.49 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.338 171.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.75 -171.7 37.49 Favored Glycine 0 C--N 1.314 -0.659 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 61' ' ' ARG . 50.6 mtp85 -69.64 139.32 53.56 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.411 ' N ' ' OE2' ' A' ' 69' ' ' GLU . . . 96.08 -27.25 17.39 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 176.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -65.32 -37.44 87.1 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 116.959 0.38 . . . . 0.0 111.669 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mmt -110.28 159.55 17.32 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.84 134.23 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.098 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HZ1' ' CD ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -45.58 -40.51 14.24 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -171.503 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.24 -43.37 56.74 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.654 0.903 . . . . 0.0 110.242 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CE1' HG12 ' A' ' 93' ' ' ILE . 48.5 t80 -61.99 -46.82 87.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.85 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.455 ' CD ' ' HZ1' ' A' ' 66' ' ' LYS . 81.4 mt-10 -64.42 -40.89 96.64 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.345 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -55.86 -47.26 77.64 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.826 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.46 77.92 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.496 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.422 ' O ' HD21 ' A' ' 75' ' ' LEU . . . -60.6 -46.48 90.08 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CD1' HD12 ' A' ' 10' ' ' ILE . 47.3 m-85 -62.61 -41.68 99.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.983 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -63.52 -41.7 98.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.545 ' CD2' ' C ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -83.56 1.08 43.81 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -174.734 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.419 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 7.3 mm-40 -51.24 -23.36 3.38 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.939 0.4 . . . . 0.0 110.162 177.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.31 -27.46 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.772 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.49 46.89 0.34 Allowed Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -117.37 170.89 8.35 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 t -100.41 117.29 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 170.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.5 p -62.73 151.02 39.68 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.399 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.26 170.95 3.0 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.0 131.47 45.67 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 N-CA-C 109.828 -0.874 . . . . 0.0 109.828 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.2 111.78 37.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -88.24 134.49 33.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.798 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.9 p -144.9 173.66 11.68 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.83 -31.26 66.46 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -67.01 -38.42 85.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.815 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.48 -145.74 14.5 Favored Glycine 0 C--N 1.322 -0.216 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -106.87 129.8 54.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -110.81 148.27 32.73 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.455 0.169 . . . . 0.0 110.561 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.0 t -117.9 128.22 75.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 167.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.513 HG22 ' SG ' ' A' ' 12' ' ' CYS . 72.8 mt -109.18 126.83 66.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.76 0.314 . . . . 0.0 110.441 -175.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.477 ' NZ ' ' O ' ' A' ' 95' ' ' ARG . 9.6 tptp -104.9 135.63 45.9 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 170.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.477 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -76.96 142.0 40.2 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.239 -178.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.6 tp -108.16 132.69 53.35 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.532 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.766 -172.582 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.803 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 5' ' ' SER . 53.7 Cg_exo -57.98 142.59 96.73 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.125 1.217 . . . . 0.0 111.415 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.4 mtp -47.94 124.54 7.62 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.55 -14.77 60.5 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -116.24 106.02 13.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.496 ' C ' ' H ' ' A' ' 8' ' ' ASP . 77.6 mtm -111.1 155.39 22.91 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.47 -5.89 0.39 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.834 0.349 . . . . 0.0 110.709 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 6' ' ' MET . 38.0 t70 -63.58 -34.69 78.37 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -81.18 157.16 25.36 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.589 172.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.627 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 41.9 mm -104.58 126.22 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HZ3' ' C ' ' A' ' 97' ' ' GLY . 60.6 mtpt -94.12 108.18 20.04 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 170.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -148.01 170.13 18.41 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.961 -171.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.554 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 20.3 m -130.63 147.35 52.3 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.537 175.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.529 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -134.71 152.47 51.79 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.879 0.371 . . . . 0.0 111.593 -175.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.2 mt -128.14 127.14 67.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 175.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 44' ' ' SER . 38.7 tp -99.28 123.09 43.29 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.25 154.36 28.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.156 0.503 . . . . 0.0 111.497 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.423 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 6.6 mttp -67.7 -42.23 82.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.621 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 68.3 mttm -124.53 149.8 46.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.64 -168.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -57.21 -38.84 74.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.164 171.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.75 -36.16 92.31 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.446 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 96.9 mt-10 -64.07 -41.05 97.47 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.357 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.417 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . . . -61.32 -45.52 94.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.595 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -61.84 -41.96 98.45 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.44 76.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.504 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.414 ' CG1' ' CD2' ' A' ' 43' ' ' LEU . 32.8 m -65.5 -37.72 80.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.784 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.598 ' NE2' ' HA ' ' A' ' 82' ' ' GLU . 79.0 mt-30 -59.32 -49.82 76.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.162 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -68.34 -38.52 81.58 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.446 ' HD3' ' CD1' ' A' ' 39' ' ' LEU . 73.5 ttt180 -61.97 -42.2 98.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.146 0.498 . . . . 0.0 109.874 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -43.41 95.36 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -12.78 36.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.958 175.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.72 -8.4 55.21 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.04 9.99 60.22 Favored Glycine 0 C--O 1.238 0.38 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -75.1 161.21 29.61 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.998 0.427 . . . . 0.0 111.348 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' O ' HD21 ' A' ' 39' ' ' LEU . 47.0 mttm -74.07 137.14 43.15 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.291 -177.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -59.14 -45.09 91.84 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.44 -39.06 96.76 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.281 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.33 -45.16 94.42 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.446 ' CD1' ' HD3' ' A' ' 29' ' ' ARG . 1.3 mm? -61.34 -42.1 98.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.09 173.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.505 ' C ' ' HG ' ' A' ' 44' ' ' SER . . . -61.56 -53.21 59.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.948 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HZ1' ' CG ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -69.02 -32.86 72.68 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.805 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 87.1 mt-10 -71.08 -41.21 70.96 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' CD2' ' CG1' ' A' ' 26' ' ' VAL . 4.5 mp -105.21 -67.97 0.89 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.505 ' HG ' ' C ' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -26.58 117.16 0.07 Allowed 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 114.084 -1.416 . . . . 0.0 112.984 -166.185 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.2 pt -90.68 -2.57 10.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.067 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -76.41 179.89 5.58 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.714 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.35 -118.73 0.55 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.736 -176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 52' ' ' ARG . . . -49.41 -43.13 34.94 Favored Glycine 0 C--N 1.321 -0.259 0 N-CA-C 112.153 -0.379 . . . . 0.0 112.153 -172.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -60.12 -34.24 73.24 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.366 -179.019 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.26 86.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.472 0.653 . . . . 0.0 109.271 175.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.23 -7.37 59.37 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.442 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 56.3 mtp85 -96.89 20.38 11.19 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.731 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.531 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 83.0 m-20 56.19 29.62 15.09 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -173.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 75.76 -13.26 7.04 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.689 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.1 p -66.33 95.08 0.29 Allowed 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.834 0.826 . . . . 0.0 112.199 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.58 -38.3 89.11 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.812 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.03 -147.19 18.75 Favored Glycine 0 C--N 1.317 -0.474 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 1.5 p90 -85.3 141.04 30.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.222 0.511 . . . . 0.0 111.385 177.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.627 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 49.9 p90 -147.28 151.65 36.98 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 171.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.31 176.94 27.05 Favored Glycine 0 C--O 1.241 0.59 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.438 ' HG2' ' CE2' ' A' ' 73' ' ' PHE . 83.6 mtm-85 -69.36 142.44 53.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 120.977 0.418 . . . . 0.0 110.705 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.85 -36.58 4.3 Favored Glycine 0 C--N 1.306 -1.124 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -63.1 -41.5 99.38 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.395 -0.474 . . . . 0.0 110.721 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.453 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 26.7 mmm -97.05 160.23 14.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.923 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.5 m -71.28 144.47 13.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -44.31 -51.51 19.36 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.73 -42.82 65.02 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.39 0.727 . . . . 0.0 110.391 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -62.16 -46.29 89.63 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.885 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -61.61 -42.51 98.99 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.493 ' CG ' ' HE ' ' A' ' 74' ' ' ARG . 11.8 t70 -55.81 -48.82 74.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.45 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.61 61.84 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.114 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.81 72.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.732 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.468 ' CD1' HD11 ' A' ' 10' ' ' ILE . 58.5 m-85 -67.01 -39.26 87.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.493 ' HE ' ' CG ' ' A' ' 70' ' ' ASP . 46.8 mtm105 -63.5 -39.19 93.79 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.225 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 81' ' ' SER . 73.9 mt -96.5 29.97 2.73 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.47 ' OE1' ' NE ' ' A' ' 95' ' ' ARG . 4.3 mm100 -52.47 -20.03 2.61 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.9 p -62.8 -31.31 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.881 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.32 -3.63 15.91 Favored Glycine 0 N--CA 1.475 1.299 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.274 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -67.4 153.13 44.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.997 0.399 . . . . 0.0 110.64 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.0 t -71.03 132.16 33.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 93' ' ' ILE . 10.8 p -75.66 155.93 35.31 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.083 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.598 ' HA ' ' NE2' ' A' ' 27' ' ' GLN . 4.1 mp0 -75.56 172.43 9.28 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HG3' ' CB ' ' A' ' 23' ' ' ALA . 75.3 Cg_exo -54.79 130.53 40.95 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 N-CA-C 109.036 -1.178 . . . . 0.0 109.036 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 58.5 t -105.01 114.32 44.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -83.37 132.24 35.01 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.428 ' OG ' ' NE2' ' A' ' 91' ' ' HIS . 60.6 p -141.12 172.01 13.28 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.45 -37.48 83.71 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -64.6 -42.54 95.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.384 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.87 -145.3 13.07 Favored Glycine 0 C--N 1.318 -0.421 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 73.8 m-85 -105.58 128.48 53.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.862 0.331 . . . . 0.0 111.352 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.529 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.1 m-70 -119.18 152.27 36.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.333 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -118.76 128.96 75.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 166.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.528 ' N ' ' OG ' ' A' ' 81' ' ' SER . 86.0 mt -122.12 133.27 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 119.74 -0.171 . . . . 0.0 111.369 -173.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -128.22 148.16 50.61 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 167.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.47 ' NE ' ' OE1' ' A' ' 76' ' ' GLN . 61.5 ttt-85 -79.16 142.21 36.55 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.012 0.435 . . . . 0.0 110.091 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 11' ' ' LYS . 50.1 tp -112.61 133.42 54.66 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.445 ' C ' ' HZ3' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.208 -1.477 0 CA-C-O 118.341 -1.255 . . . . 0.0 111.362 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.745 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.63 142.21 98.43 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.445 1.43 . . . . 0.0 111.339 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.3 mtt -78.17 151.26 33.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.649 0.261 . . . . 0.0 110.685 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.52 17.09 79.55 Favored Glycine 0 C--O 1.239 0.421 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.86 118.15 34.12 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.573 ' C ' ' H ' ' A' ' 8' ' ' ASP . 2.3 mpp? -97.12 174.0 6.97 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.73 42.05 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.071 0.463 . . . . 0.0 110.494 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 6' ' ' MET . 89.7 m-20 -62.46 -37.26 85.22 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 59' ' ' PHE . 25.5 mmtp -99.46 159.3 15.12 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.278 -1.783 . . . . 0.0 109.275 -174.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.1 mm -106.26 129.49 59.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -88.24 105.72 17.73 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -147.52 165.28 30.81 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.096 0.474 . . . . 0.0 111.76 -176.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.453 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 7.1 m -131.75 147.22 52.48 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.732 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.557 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -134.38 149.93 50.86 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.078 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.515 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 97.0 mt -125.67 128.64 72.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.134 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.0 tp -100.23 128.34 46.32 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.795 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.501 ' CG1' HD12 ' A' ' 43' ' ' LEU . 16.2 m -127.64 155.58 39.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.967 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 17.5 pttp -84.04 -22.25 31.34 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.833 176.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 37.3 mmtm -135.57 152.56 51.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -62.67 -37.99 88.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.947 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.55 -36.79 92.18 Favored Glycine 0 C--N 1.321 -0.276 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.419 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 96.0 mt-10 -65.35 -44.37 87.91 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -58.55 -48.96 79.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.238 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.87 -40.91 97.65 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.754 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.17 -48.53 76.16 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.255 -177.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' CG1' ' HG ' ' A' ' 43' ' ' LEU . 18.0 m -64.99 -39.57 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.246 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 81' ' ' SER . 83.3 mt-30 -60.22 -47.18 87.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.085 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.13 -41.26 81.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.133 0.492 . . . . 0.0 110.822 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.476 ' HD3' ' CD1' ' A' ' 39' ' ' LEU . 71.1 ttt180 -62.87 -38.55 91.31 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.73 177.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.16 -35.83 70.02 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -177.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 49.8 mmtt -61.52 -28.63 69.45 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.134 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.9 -21.94 45.94 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.942 0.401 . . . . 0.0 110.917 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.09 7.19 41.4 Favored Glycine 0 C--N 1.319 -0.385 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.474 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 31.9 mt-10 -76.18 156.59 33.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.152 177.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -72.52 141.38 48.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.708 0.766 . . . . 0.0 112.428 -176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 45.9 t80 -58.12 -44.78 87.92 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.14 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.439 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -61.19 -36.68 92.76 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.352 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.37 -48.04 83.08 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.476 ' CD1' ' HD3' ' A' ' 29' ' ' ARG . 4.3 mm? -62.05 -41.82 98.54 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.967 173.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.447 ' C ' ' HG ' ' A' ' 44' ' ' SER . . . -59.05 -50.32 74.52 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.153 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -43.26 88.29 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.642 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.435 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 87.1 mt-10 -70.94 -45.55 64.01 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -173.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.539 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -107.6 -39.12 5.71 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.447 ' HG ' ' C ' ' A' ' 40' ' ' ALA . 2.5 m -52.99 138.67 29.87 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.062 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.1 pt -91.72 -4.82 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.387 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.57 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 61.6 t0 -90.89 101.0 13.76 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.581 176.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -65.88 -43.8 93.11 Favored Glycine 0 C--N 1.318 -0.434 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.79 -45.24 91.45 Favored Glycine 0 C--O 1.239 0.453 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.57 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 70.2 m -64.21 -33.47 75.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.95 0.405 . . . . 0.0 110.213 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.45 -35.4 80.79 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 74.8 mmtt -61.9 -36.79 82.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 77.7 mtp85 -97.57 19.26 13.75 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.982 174.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.551 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.9 OUTLIER 44.67 42.37 5.74 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.679 178.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.83 -20.76 0.82 Allowed Glycine 0 C--N 1.31 -0.886 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 53' ' ' ASP . 10.3 m -67.91 79.47 0.21 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.527 0.679 . . . . 0.0 110.305 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.416 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 97.7 mt -62.56 -41.63 99.03 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.387 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.88 -147.12 18.46 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.04 104.16 14.72 Favored 'General case' 0 C--O 1.252 1.195 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.422 ' C ' ' HD2' ' A' ' 9' ' ' LYS . 47.5 p90 -119.0 148.1 43.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.712 177.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.82 -176.31 48.1 Favored Glycine 0 C--O 1.236 0.25 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.532 ' C ' ' H ' ' A' ' 63' ' ' LYS . 26.0 mtp180 -86.65 162.76 17.77 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.7 -21.42 1.57 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.724 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 61' ' ' ARG . 37.6 mmtm -65.1 -40.01 93.95 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -112.93 160.27 18.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.75 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 m -58.47 146.6 8.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.99 -176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 4.5 mtpp -45.13 -47.03 32.29 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.347 -177.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 66' ' ' LYS . 75.5 Cg_exo -55.47 -41.38 78.58 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 120.486 0.791 . . . . 0.0 110.609 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -61.28 -46.56 89.85 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.766 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.463 ' CD ' HH21 ' A' ' 61' ' ' ARG . 67.3 mt-10 -62.31 -46.97 86.35 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.618 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 74' ' ' ARG . 35.0 t70 -58.61 -45.61 88.78 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.394 -176.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.56 -46.13 89.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.96 88.0 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.032 0.444 . . . . 0.0 110.07 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.502 ' CZ ' ' HD2' ' A' ' 61' ' ' ARG . 51.6 m-85 -68.11 -36.68 80.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.326 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 70' ' ' ASP . 61.8 mtp180 -61.6 -45.26 94.84 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.204 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.9 mt -99.68 42.07 1.12 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.43 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 35.3 mt-30 -55.26 -21.1 13.01 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.413 173.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 p -61.96 -32.37 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.792 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 120.18 -3.96 12.6 Favored Glycine 0 N--CA 1.477 1.382 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.213 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -73.31 173.4 9.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 117.075 0.437 . . . . 0.0 111.377 -178.165 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.565 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 5.3 t -92.53 129.57 42.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.491 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 9.9 p -71.3 153.51 42.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.254 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 5.0 mp0 -64.52 169.81 4.58 Favored Pre-proline 0 CA--C 1.507 -0.686 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 172.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.457 ' N ' HE22 ' A' ' 27' ' ' GLN . 63.6 Cg_exo -53.31 130.53 38.84 Favored 'Trans proline' 0 C--N 1.295 -2.267 0 N-CA-C 109.596 -0.963 . . . . 0.0 109.596 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.2 107.74 23.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -78.31 133.38 37.63 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.398 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.4 p -140.19 167.93 21.0 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.532 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.6 pm0 -58.12 -36.38 72.85 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -63.99 -43.82 94.56 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.868 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.94 -148.9 16.79 Favored Glycine 0 C--N 1.311 -0.828 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -110.11 129.55 55.68 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.403 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 5.2 m-70 -109.5 151.91 26.13 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -117.85 126.03 74.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.69 127.33 75.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.648 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -110.96 143.14 42.08 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.474 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -78.59 142.47 37.27 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.066 178.006 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.2 tp -110.43 139.72 45.38 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.03 -175.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.372 0 CA-C-O 118.268 -1.295 . . . . 0.0 110.755 -178.287 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.404 ' HB2' ' OG ' ' A' ' 5' ' ' SER . 52.9 Cg_exo -58.21 140.15 93.19 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 121.739 1.626 . . . . 0.0 111.53 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.3 ttp -110.19 137.26 48.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.43 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.596 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . . . 75.86 6.72 82.74 Favored Glycine 0 C--N 1.321 -0.304 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 2' ' ' PRO . 0.9 OUTLIER -69.91 102.4 1.97 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.686 -0.257 . . . . 0.0 110.447 -178.235 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.6 mtp 31.13 -93.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.236 0.614 . . . . 0.0 112.142 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.02 -21.35 30.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.795 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.49 -36.09 82.61 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.596 ' NZ ' ' O ' ' A' ' 4' ' ' GLY . 51.4 mttp -75.24 152.09 38.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 171.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.638 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 69.4 mt -106.9 128.35 61.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.606 ' HZ2' ' C ' ' A' ' 97' ' ' GLY . 48.3 mtpt -94.25 106.85 18.83 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -146.33 168.99 19.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.097 0.776 . . . . 0.0 113.097 -173.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.429 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 45.4 m -135.66 147.16 48.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.398 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.563 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -137.6 152.31 49.25 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.565 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 95.6 mt -121.63 126.21 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.96 1.304 . . . . 0.0 108.032 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.464 HD21 ' CG1' ' A' ' 45' ' ' ILE . 4.6 tt -105.28 123.54 48.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.3 m -135.87 155.63 36.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 120.804 0.335 . . . . 0.0 110.396 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.94 -22.35 33.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.158 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.55 137.55 43.2 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.774 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.52 -36.99 85.59 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.55 98.22 Favored Glycine 0 CA--C 1.51 -0.224 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.46 -43.97 92.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.58 93.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.282 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.93 -39.93 96.1 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.466 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.07 -46.0 89.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.573 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 27' ' ' GLN . 12.3 m -65.78 -38.82 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.953 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.542 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 3.1 tp-100 -54.68 -48.53 72.29 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.745 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -68.06 -39.88 82.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.713 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 8.1 tpt180 -63.08 -40.23 97.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.903 -174.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.05 -38.81 87.49 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.329 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.542 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 23.8 mmtm -64.29 -16.11 61.52 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.889 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.13 -9.6 58.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.84 12.14 62.65 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 96.6 mt-10 -83.99 153.11 24.06 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.786 -0.243 . . . . 0.0 111.054 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -64.75 132.51 49.79 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 121.623 0.725 . . . . 0.0 111.93 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.565 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 62.5 t80 -57.05 -44.9 83.45 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.096 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -59.11 -38.03 92.5 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.772 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 49.1 tttp -60.95 -47.1 87.99 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.888 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.82 -41.25 97.55 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.01 -50.56 72.98 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.858 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.26 -36.68 84.87 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.074 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 1.0 OUTLIER -72.48 -80.3 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.913 -174.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.29 -43.63 81.26 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -173.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.2 m -58.88 147.7 32.88 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.689 -162.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.464 ' CG1' HD21 ' A' ' 16' ' ' LEU . 46.0 pt -98.84 -5.21 9.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.824 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.581 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 62.0 t0 -85.21 93.67 8.72 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.576 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.26 -44.39 98.16 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.3 -41.84 72.17 Favored Glycine 0 C--N 1.324 -0.132 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.581 ' HG ' ' CG ' ' A' ' 46' ' ' ASP . 67.0 m -73.93 -33.37 63.91 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.934 174.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.14 -42.13 84.93 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.204 0.526 . . . . 0.0 110.68 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -62.34 -31.79 72.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -96.69 15.87 20.62 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.268 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 42.3 38.7 1.23 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.951 0.881 . . . . 0.0 112.134 -178.527 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.77 -11.81 9.8 Favored Glycine 0 C--O 1.236 0.231 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.652 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.1 m -67.93 80.38 0.21 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.4 . . . . 0.0 111.617 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.28 -40.56 97.71 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.95 -149.07 19.52 Favored Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.863 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.33 141.77 28.41 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.638 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.7 p90 -148.59 151.96 35.94 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.988 177.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.35 167.92 49.59 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.506 ' NH1' ' CE1' ' A' ' 73' ' ' PHE . 77.3 mtp85 -74.68 140.97 44.57 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.01 -29.57 10.97 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.193 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -40.53 97.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.526 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 9.0 mmm -80.83 160.76 24.71 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 m -63.21 136.51 26.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.562 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.29 -47.02 34.11 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.447 -171.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -56.61 -40.38 84.83 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.122 1.214 . . . . 0.0 110.77 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -60.76 -46.51 90.16 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.565 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.567 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 47.9 mt-10 -64.47 -38.37 90.8 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.527 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.8 -48.51 75.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.924 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.23 -40.48 71.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.559 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.84 92.45 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.836 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 69' ' ' GLU . 24.8 m-85 -66.39 -34.06 77.11 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.794 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -62.29 -44.75 95.8 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -174.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -97.37 34.53 1.78 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.629 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.424 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 53.0 mt-30 -56.14 -20.9 19.56 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.482 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.61 -29.71 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.768 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 121.35 -4.31 11.15 Favored Glycine 0 N--CA 1.471 0.988 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 80' ' ' VAL . 1.1 tp10 -64.95 166.94 8.43 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 122.781 0.432 . . . . 0.0 110.761 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.529 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 13.8 t -93.82 128.86 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 174.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' A' ' 93' ' ' ILE . 10.6 p -73.67 162.08 29.58 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.686 0.279 . . . . 0.0 111.609 -178.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.461 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 5.9 mp0 -79.56 -179.74 1.52 Allowed Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 173.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 82' ' ' GLU . 73.3 Cg_exo -57.63 133.5 56.93 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 CA-C-N 118.936 0.656 . . . . 0.0 110.761 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 47.3 t -111.46 102.96 14.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.657 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 135.14 48.37 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 p -146.56 172.98 12.74 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.504 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 2.0 pm0 -59.23 -37.67 78.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -65.21 -43.81 90.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.922 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 151.69 -151.72 23.6 Favored Glycine 0 C--N 1.317 -0.51 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 70.1 m-85 -98.89 129.06 45.22 Favored 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.38 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 5.0 m-70 -112.08 148.96 32.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.238 177.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.44 128.47 74.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 167.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.464 ' N ' ' OG ' ' A' ' 81' ' ' SER . 87.1 mt -119.34 130.5 73.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -173.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -115.73 143.52 45.26 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.438 ' NH2' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -78.41 143.61 36.63 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.837 -178.101 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 52.9 tp -96.61 133.01 41.65 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.606 ' C ' ' HZ2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.205 -1.657 0 CA-C-O 118.364 -1.242 . . . . 0.0 111.25 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.55 150.42 83.98 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.012 1.808 . . . . 0.0 111.658 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.16 157.13 37.5 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.7 19.31 56.7 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 -170.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 94.2 p -76.31 169.65 17.82 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 113.902 -1.149 . . . . 0.0 111.124 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.2 mmm -64.95 -36.52 84.66 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.29 66.57 Favored 'General case' 0 C--O 1.228 -0.057 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.216 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.38 -35.24 78.56 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -85.85 154.92 21.21 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.072 168.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -105.95 123.64 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.542 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -93.13 105.16 17.29 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -147.44 167.61 23.96 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.326 -0.95 . . . . 0.0 113.205 -171.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 4.1 m -130.88 141.16 50.29 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.066 -1.424 . . . . 0.0 107.997 174.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.451 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -135.75 150.45 49.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.534 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 91.5 mt -125.46 121.62 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 44' ' ' SER . 5.5 tt -101.47 121.42 41.92 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 29.3 m -133.88 150.97 32.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.568 0.699 . . . . 0.0 112.192 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.32 -38.38 84.84 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.355 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HB2' ' CG ' ' A' ' 22' ' ' GLU . 64.0 mttm -109.37 141.61 41.48 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.627 -173.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -64.6 -36.75 85.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.055 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.0 -36.22 92.55 Favored Glycine 0 C--O 1.238 0.357 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.439 ' CG ' ' HB2' ' A' ' 19' ' ' LYS . 94.6 mt-10 -65.55 -41.44 93.01 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.74 -44.52 93.74 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.685 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.1 mt -64.18 -39.46 94.04 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.099 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.54 71.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.29 -41.14 91.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.461 176.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.437 HE22 ' N ' ' A' ' 83' ' ' PRO . 84.0 mt-30 -59.48 -46.41 88.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.328 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -73.2 -38.57 66.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.432 HH21 ' CD ' ' A' ' 34' ' ' GLU . 53.8 ttt85 -65.01 -39.75 93.9 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.677 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.8 -25.44 41.46 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.405 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -61.46 -38.18 86.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -16.54 44.53 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.907 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.89 14.15 61.37 Favored Glycine 0 C--N 1.318 -0.43 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' CD ' HH21 ' A' ' 29' ' ' ARG . 36.0 mt-10 -69.43 159.73 32.69 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.687 174.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 49.7 tttp -64.39 129.12 38.67 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.368 0.604 . . . . 0.0 110.247 -174.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.534 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 61.7 t80 -56.35 -43.96 79.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.411 ' HA2' ' C ' ' A' ' 53' ' ' ASP . . . -60.42 -34.07 83.76 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.564 177.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 45.7 tttp -59.62 -48.45 81.6 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.604 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.53 -41.35 98.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.921 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -57.26 -49.68 75.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.45 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.568 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 68.0 mttm -64.1 -37.69 88.36 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.896 177.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -50.39 34.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.615 -172.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.2 mp -98.47 -48.6 4.96 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 1.2 m -55.64 142.14 35.01 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.338 -162.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.1 pt -94.45 -12.2 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.258 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 49' ' ' SER . 11.4 t0 -76.86 111.89 12.87 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.9 -40.22 64.49 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.9 -48.36 73.26 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 54' ' ' GLY . 78.9 p -62.06 -33.28 74.11 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.381 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.568 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -74.46 -48.24 28.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.005 0.431 . . . . 0.0 110.346 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -65.39 -36.36 83.72 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.233 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' NE ' ' O ' ' A' ' 55' ' ' SER . 13.8 mmm180 -94.68 7.48 45.65 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.994 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.582 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.0 OUTLIER 50.34 47.86 23.2 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 67.12 -40.04 0.2 Allowed Glycine 0 C--N 1.313 -0.742 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.946 -173.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.582 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -54.79 82.91 0.0 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.1 0.96 . . . . 0.0 111.73 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.55 -38.64 91.91 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.54 -152.09 20.66 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.73 133.61 34.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 54.2 p90 -146.61 151.8 37.87 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.15 178.47 46.43 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 45.8 mtp85 -73.46 152.53 40.71 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 122.764 0.426 . . . . 0.0 110.749 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.11 9.65 84.9 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.584 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.88 -19.28 15.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.421 ' HG3' ' CE2' ' A' ' 59' ' ' PHE . 1.4 mmm -126.39 161.33 28.13 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.76 136.85 20.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.081 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 1.7 tttm -44.5 -46.89 26.19 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 21.3 Cg_endo -59.71 -34.07 96.28 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 CA-C-N 119.161 0.736 . . . . 0.0 111.238 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -62.99 -50.15 71.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.915 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.404 ' HG3' ' HB2' ' A' ' 64' ' ' MET . 93.7 mt-10 -67.85 -43.82 78.59 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.811 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 7.2 t70 -57.74 -49.71 75.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.314 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.08 96.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.811 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.08 95.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.516 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.46 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 44.4 m-85 -64.99 -34.11 77.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.236 0.541 . . . . 0.0 111.362 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 79.9 mtp85 -62.62 -36.03 81.45 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.751 -176.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.9 mt -97.12 23.05 7.73 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -173.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.47 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 75.1 mt-30 -43.53 -25.1 0.14 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.381 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.35 -27.49 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 119.8 -2.18 13.48 Favored Glycine 0 N--CA 1.47 0.943 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.86 173.46 0.14 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.66 127.5 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.7 p -65.33 147.58 53.19 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.882 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.53 177.09 0.73 Allowed Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 168.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.437 ' N ' HE22 ' A' ' 27' ' ' GLN . 53.1 Cg_exo -54.42 133.51 56.7 Favored 'Trans proline' 0 C--N 1.283 -2.872 0 N-CA-C 109.991 -0.811 . . . . 0.0 109.991 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.42 128.66 74.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -98.75 129.92 45.2 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.488 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.478 ' HG ' ' CD2' ' A' ' 91' ' ' HIS . 86.8 p -114.41 -175.48 2.69 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.55 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.6 pm0 -69.59 -35.52 75.4 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -66.11 -45.32 81.54 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.95 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.59 -157.66 28.35 Favored Glycine 0 C--N 1.317 -0.492 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 87.0 m-85 -85.52 135.08 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.678 0.239 . . . . 0.0 110.483 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.478 ' CD2' ' HG ' ' A' ' 86' ' ' SER . 44.9 m-70 -122.5 147.7 46.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.682 176.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.9 t -117.7 126.69 74.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 166.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.7 mt -119.94 125.86 74.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.586 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -113.69 143.8 44.01 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.513 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 2.4 tmm_? -78.7 141.23 38.07 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.939 -1.104 . . . . 0.0 110.181 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.432 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 48.2 tp -109.26 135.41 50.39 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.273 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.201 -1.939 0 CA-C-O 118.082 -1.399 . . . . 0.0 111.059 -178.903 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.7 mttp . . . . . 0 C--O 1.242 0.678 0 CA-C-O 120.586 0.232 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.775 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 70.6 mt -107.49 131.66 57.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 27.6 mtpp -91.92 106.2 18.28 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -145.81 168.34 21.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -176.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.502 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 4.2 m -129.27 146.95 51.08 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.353 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.491 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -147.21 151.39 36.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.299 0.571 . . . . 0.0 112.346 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.643 HG21 HG11 ' A' ' 26' ' ' VAL . 85.2 mt -122.12 124.6 71.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.546 HD22 ' CG1' ' A' ' 45' ' ' ILE . 6.1 tt -107.83 127.74 53.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.586 HG21 ' N ' ' A' ' 23' ' ' ALA . 27.6 m -137.11 153.61 29.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.431 0.634 . . . . 0.0 111.212 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.457 ' HG3' HD13 ' A' ' 45' ' ' ILE . 26.1 mtmm -67.54 -39.96 85.0 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.475 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 60.7 mttp -103.48 148.89 25.39 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.526 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 86.0 mt-30 -62.09 -39.98 94.3 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.79 -38.27 91.8 Favored Glycine 0 CA--C 1.509 -0.281 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 74.4 mt-10 -65.54 -41.84 92.57 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.586 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -62.11 -42.35 99.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.849 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 20' ' ' GLN . 3.1 mm? -62.47 -40.98 98.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.782 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.0 -49.47 71.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.738 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.813 HG12 HD13 ' A' ' 43' ' ' LEU . 19.0 m -66.29 -42.49 90.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.198 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 81' ' ' SER . 99.1 mt-30 -61.66 -44.12 97.56 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.01 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.44 -44.85 74.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.066 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.895 ' HD3' HD11 ' A' ' 39' ' ' LEU . 43.0 ttt85 -66.63 -40.16 88.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.507 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.425 ' CD2' ' HG ' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -55.04 -24.7 26.06 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.312 0.577 . . . . 0.0 109.677 -178.177 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 27' ' ' GLN . 31.7 mmtm -62.35 -32.6 73.41 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.841 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.98 -7.99 20.19 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.722 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.84 25.84 40.06 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 87.1 mt-10 -81.54 157.23 24.87 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.506 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' NZ ' ' OD2' ' A' ' 53' ' ' ASP . 64.5 tttm -62.06 131.6 50.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.545 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 58.1 t80 -56.96 -43.28 81.41 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.658 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -59.21 -36.8 90.31 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.707 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 58.6 tttm -58.26 -48.0 81.81 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.027 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.895 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.6 mm? -63.44 -40.07 96.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.275 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.27 -43.21 95.53 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.758 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 34.3 mmtm -64.15 -41.27 97.24 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.719 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.76 -59.79 2.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.412 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.813 HD13 HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -91.33 -49.46 6.34 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -172.292 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.613 ' HB2' HG23 ' A' ' 15' ' ' ILE . 5.6 t -56.53 138.25 52.18 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.903 -169.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.546 ' CG1' HD22 ' A' ' 16' ' ' LEU . 44.6 pt -92.79 -1.74 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.814 0.34 . . . . 0.0 110.227 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 50' ' ' ALA . 60.1 t0 -80.22 96.51 6.61 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.1 -53.43 44.98 Favored Glycine 0 C--N 1.321 -0.278 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.815 -173.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.38 -45.01 84.93 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 54' ' ' GLY . 17.5 m -70.41 -32.57 70.25 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.472 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -62.79 -38.36 90.33 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 75.7 mmtt -60.79 -34.3 74.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.513 ' HE ' ' HA ' ' A' ' 49' ' ' SER . 89.6 mtm180 -95.48 19.48 10.89 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.913 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.658 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 97.3 m-20 59.85 30.2 19.75 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 70.87 -7.75 5.14 Favored Glycine 0 C--N 1.305 -1.149 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.701 ' HB3' HD22 ' A' ' 96' ' ' LEU . 2.3 m -70.72 91.09 0.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.433 0.635 . . . . 0.0 110.353 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.468 HD23 ' NH2' ' A' ' 52' ' ' ARG . 96.9 mt -62.35 -38.23 88.74 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.64 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . 76.91 -133.15 13.01 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.502 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 57.4 m-85 -83.98 135.59 34.39 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 117.111 0.455 . . . . 0.0 109.897 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.587 ' CE1' HD12 ' A' ' 10' ' ' ILE . 47.9 p90 -144.18 149.32 36.25 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.779 168.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.82 174.89 55.12 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 -174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.543 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 47.6 mtm180 -74.54 145.66 43.26 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.8 60.17 8.11 Favored Glycine 0 C--O 1.246 0.905 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 61' ' ' ARG . 34.7 mmtm -133.25 -35.62 1.03 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.017 0.437 . . . . 0.0 110.458 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.408 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 77.7 mtm -119.44 159.83 23.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.99 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.705 HG11 ' HB2' ' A' ' 86' ' ' SER . 15.4 m -49.1 133.57 7.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.277 -174.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -44.02 -47.34 22.45 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.901 -174.153 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 24.7 Cg_endo -57.87 -38.31 93.0 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 CA-C-N 118.767 0.595 . . . . 0.0 111.862 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.692 ' HA ' HG11 ' A' ' 84' ' ' VAL . 58.9 t80 -62.73 -49.97 72.96 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.771 177.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.62 -39.31 93.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.316 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.511 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 12.6 t70 -57.35 -48.68 78.38 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.115 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.642 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -63.22 -39.62 95.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.783 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.07 83.21 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.09 0.472 . . . . 0.0 110.253 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.775 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 52.6 m-85 -63.67 -42.85 98.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.879 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.672 ' NH2' HD11 ' A' ' 75' ' ' LEU . 39.1 ttp180 -63.54 -47.57 81.08 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.172 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.672 HD11 ' NH2' ' A' ' 74' ' ' ARG . 97.3 mt -98.04 33.41 2.15 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.501 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 71.8 mt-30 -54.28 -19.17 4.87 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.502 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 2.4 m -60.11 -40.73 84.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.332 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.493 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 121.66 7.36 8.15 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.893 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 149.37 41.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.5 t -71.35 128.97 35.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.639 ' HB3' HD12 ' A' ' 75' ' ' LEU . 11.3 p -79.24 155.72 28.45 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 123.29 0.369 . . . . 0.0 111.411 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.7 mp0 -66.52 161.95 54.45 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.555 ' N ' HE22 ' A' ' 27' ' ' GLN . 47.5 Cg_exo -55.37 129.74 36.82 Favored 'Trans proline' 0 C--N 1.295 -2.279 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.692 HG11 ' HA ' ' A' ' 68' ' ' PHE . 96.8 t -106.13 114.87 46.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -85.37 138.54 32.21 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.753 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.705 ' HB2' HG11 ' A' ' 65' ' ' VAL . 63.2 p -136.05 176.36 8.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -61.79 -32.7 73.01 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.277 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.67 -38.79 80.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.036 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.61 -146.97 16.06 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -176.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.526 ' CE1' ' HG2' ' A' ' 20' ' ' GLN . 82.9 m-85 -106.4 133.86 50.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.941 0.371 . . . . 0.0 110.709 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.491 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.9 m-70 -115.12 147.34 40.36 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.382 176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 76.5 t -117.97 127.55 75.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 167.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.658 HD11 ' CD2' ' A' ' 68' ' ' PHE . 81.5 mt -115.97 130.7 70.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -171.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -120.61 149.89 41.76 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.383 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.502 ' NH2' ' O ' ' A' ' 77' ' ' VAL . 8.7 tmm_? -79.05 143.87 35.19 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.701 HD22 ' HB3' ' A' ' 55' ' ' SER . 64.7 tp -117.15 135.42 53.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.382 0 CA-C-O 118.556 -1.135 . . . . 0.0 110.747 -177.976 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.0 mttm . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.635 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 45.6 mm -106.84 131.68 56.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' CG ' ' CE2' ' A' ' 58' ' ' TYR . 56.5 mtpt -87.95 105.91 17.77 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.667 ' SG ' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -148.37 168.22 23.17 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.466 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.498 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 4.9 m -130.81 133.04 45.61 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.339 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.483 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -124.58 149.56 46.88 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.457 -176.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.614 ' CG2' HD12 ' A' ' 43' ' ' LEU . 95.2 mt -125.31 128.19 72.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.759 HD13 ' CE1' ' A' ' 91' ' ' HIS . 47.1 tp -103.47 128.56 50.63 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.472 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.072 HG12 HD11 ' A' ' 43' ' ' LEU . 28.8 m -129.1 154.4 39.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 123.743 0.652 . . . . 0.0 110.818 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -67.76 -41.08 83.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.187 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 47.0 mttp -127.5 156.43 42.18 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -169.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.4 ' O ' HD23 ' A' ' 24' ' ' LEU . 26.1 mt-30 -60.59 -38.86 86.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.36 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.54 -38.42 91.14 Favored Glycine 0 N--CA 1.464 0.502 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 99.5 mt-10 -65.65 -42.12 91.8 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.14 82.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.686 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 20' ' ' GLN . 1.2 mm? -61.57 -42.26 98.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.85 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.04 74.2 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.9 m -66.03 -41.07 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.749 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -59.31 -46.12 89.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.054 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.501 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 73.7 mm-40 -67.82 -38.59 83.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.158 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.445 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 22.7 ttp85 -64.9 -38.11 89.87 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.418 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.418 HD22 ' HG ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -57.07 -27.16 61.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 33.2 mmtp -61.11 -31.6 71.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.19 -21.73 48.7 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.176 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.82 20.69 53.09 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' OE1' ' NZ ' ' A' ' 38' ' ' LYS . 36.5 mt-10 -65.34 164.36 13.76 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.477 ' NZ ' ' OD2' ' A' ' 53' ' ' ASP . 63.4 tttm -65.6 130.5 43.5 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 174.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.587 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 56.6 t80 -55.92 -42.88 76.76 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.637 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -57.12 -39.3 89.64 Favored Glycine 0 C--N 1.311 -0.836 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.835 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.435 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 63.3 tttm -59.91 -45.7 91.71 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.418 ' HG ' HD22 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -62.16 -41.2 98.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.938 173.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.488 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -61.83 -42.84 99.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.425 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -65.21 -44.84 87.04 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.454 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 95.0 mt-10 -70.23 -43.66 70.16 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -169.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.072 HD11 HG12 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -117.24 -40.49 3.08 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -169.334 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.753 ' N ' HD13 ' A' ' 43' ' ' LEU . 1.4 m -45.82 133.54 8.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.489 HG13 HD23 ' A' ' 16' ' ' LEU . 46.1 pt -83.12 -14.95 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -80.4 92.42 5.82 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.308 174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.8 -46.82 93.38 Favored Glycine 0 CA--C 1.507 -0.447 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.191 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.19 -46.99 84.56 Favored Glycine 0 C--N 1.319 -0.364 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.483 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 20.1 m -63.41 -34.05 76.88 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.322 174.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -64.22 -36.98 85.86 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.359 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 18.6 mmtp -60.53 -40.21 90.68 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -96.67 16.09 19.95 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.281 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.637 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.9 m-20 63.1 32.91 14.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.663 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 70.65 -29.7 0.49 Allowed Glycine 0 C--N 1.31 -0.871 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 53' ' ' ASP . 53.6 m -55.31 98.59 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.717 0.77 . . . . 0.0 111.382 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.61 HD12 ' SG ' ' A' ' 12' ' ' CYS . 97.6 mt -65.07 -36.52 84.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.835 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 88.67 -145.05 18.61 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 -170.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.466 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 89.9 m-85 -83.09 134.03 35.03 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.504 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.3 p90 -144.04 150.23 37.88 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.629 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.53 165.55 22.49 Favored Glycine 0 C--O 1.24 0.493 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.493 ' HD2' ' CE1' ' A' ' 73' ' ' PHE . 76.9 mtp180 -81.05 160.54 24.5 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.641 0.376 . . . . 0.0 110.879 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.07 -51.61 1.13 Allowed Glycine 0 C--N 1.315 -0.615 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -64.23 -38.02 89.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.968 -0.616 . . . . 0.0 109.645 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.555 ' HE1' HD13 ' A' ' 56' ' ' LEU . 25.5 mmm -88.67 153.02 21.44 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.36 141.76 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.294 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 15.8 mmtm -43.7 -51.28 16.78 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.536 ' HB2' HG13 ' A' ' 84' ' ' VAL . 36.3 Cg_endo -61.4 -32.49 89.09 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 120.231 0.62 . . . . 0.0 111.571 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.673 ' CD2' HD11 ' A' ' 93' ' ' ILE . 47.7 t80 -62.62 -46.66 87.24 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.508 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 93.9 mt-10 -63.9 -47.23 81.42 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.241 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.06 -41.82 93.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.74 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.433 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -64.59 -46.62 81.93 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.86 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.531 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -62.5 -46.27 89.21 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.951 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.635 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 17.7 m-85 -61.82 -28.17 69.28 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.972 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.707 ' HB3' ' CZ ' ' A' ' 74' ' ' ARG . 2.1 mtm105 -64.46 -36.75 85.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.345 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.775 HD11 ' HB3' ' A' ' 81' ' ' SER . 10.3 mt -87.91 21.84 2.55 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -167.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 73' ' ' PHE . 75.6 mt-30 -54.26 -34.56 61.07 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.491 HG13 ' HG3' ' A' ' 79' ' ' GLU . 7.1 p -63.84 -27.54 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.279 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.02 6.05 7.83 Favored Glycine 0 N--CA 1.475 1.278 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.435 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.644 ' HB2' HD22 ' A' ' 75' ' ' LEU . 80.2 mt-10 -55.57 173.94 0.11 Allowed 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.4 t -106.76 132.57 53.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 167.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.775 ' HB3' HD11 ' A' ' 75' ' ' LEU . 99.7 p -66.32 163.21 18.56 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.227 0.537 . . . . 0.0 111.842 -172.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 3.5 mp0 -78.69 161.19 70.18 Favored Pre-proline 0 N--CA 1.422 -1.866 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -56.94 133.89 60.94 Favored 'Trans proline' 0 C--N 1.294 -2.329 0 N-CA-C 109.784 -0.891 . . . . 0.0 109.784 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 67' ' ' PRO . 42.6 t -117.97 125.64 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.534 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.8 tptp -88.98 137.47 32.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.94 0.4 . . . . 0.0 109.963 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.534 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 14.1 p -140.89 175.17 9.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -59.59 -39.77 85.25 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -65.15 -42.64 93.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.517 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.32 -137.34 5.75 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.664 ' O ' HD12 ' A' ' 16' ' ' LEU . 4.6 m-85 -105.01 132.78 50.82 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 117.107 0.453 . . . . 0.0 111.963 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.759 ' CE1' HD13 ' A' ' 16' ' ' LEU . 44.5 m-70 -114.27 141.74 47.18 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.391 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.02 128.28 75.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 167.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.673 HD11 ' CD2' ' A' ' 68' ' ' PHE . 88.5 mt -121.1 131.22 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 116.917 -0.129 . . . . 0.0 110.76 -173.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -116.08 147.86 40.85 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 167.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.46 HH21 ' CA ' ' A' ' 97' ' ' GLY . 2.6 ttp180 -77.57 143.46 38.31 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.34 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.421 ' HB3' ' C ' ' A' ' 11' ' ' LYS . 46.5 tp -100.68 145.58 28.26 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.46 ' CA ' HH21 ' A' ' 95' ' ' ARG . . . . . . . . 0 C--O 1.207 -1.576 0 CA-C-O 118.356 -1.247 . . . . 0.0 110.683 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm . . . . . 0 N--CA 1.441 -0.904 0 CA-C-O 120.765 0.317 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.58 HG13 ' HB1' ' A' ' 72' ' ' ALA . 44.4 mm -106.34 129.87 58.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.599 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 62.2 mtpt -90.93 104.11 16.74 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -145.1 169.59 17.86 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.069 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.515 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 9.2 m -126.51 145.63 50.43 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.871 174.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.482 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -134.63 149.57 50.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.921 0.391 . . . . 0.0 111.597 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.523 HG13 ' CE2' ' A' ' 36' ' ' PHE . 94.4 mt -129.41 128.06 65.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.23 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 46' ' ' ASP . 13.9 mt -94.61 128.68 41.41 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.412 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.13 154.72 35.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.704 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -66.28 -40.7 90.27 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.358 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 36.8 mtmm -121.6 152.48 39.23 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.332 0.587 . . . . 0.0 112.502 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.525 ' O ' HD23 ' A' ' 24' ' ' LEU . 53.6 tt0 -61.14 -40.95 95.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.489 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.06 -36.68 92.69 Favored Glycine 0 C--O 1.238 0.368 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 19' ' ' LYS . 98.9 mt-10 -63.76 -42.14 97.86 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 20' ' ' GLN . . . -58.76 -47.95 82.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.966 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 20' ' ' GLN . 4.5 mm? -61.52 -41.79 97.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.074 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.27 -51.83 66.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.574 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.021 HG11 HD21 ' A' ' 43' ' ' LEU . 18.6 m -68.97 -39.46 79.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.273 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.646 HE22 ' N ' ' A' ' 83' ' ' PRO . 67.8 mt-30 -55.4 -46.12 76.63 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 72.4 mm-40 -71.13 -35.29 71.67 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 175.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.612 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 74.9 ttt180 -60.28 -37.76 81.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.984 0.421 . . . . 0.0 110.025 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.12 -34.62 73.76 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 31.7 mmtp -62.53 -33.18 74.4 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.74 -24.72 64.25 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.441 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.82 -2.6 31.95 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.612 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 23.9 mt-10 -67.7 147.05 53.17 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.76 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.56 139.27 51.47 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CE2' HG13 ' A' ' 15' ' ' ILE . 52.3 t80 -58.21 -45.88 86.84 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.48 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.503 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.35 -35.66 91.98 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.263 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 25.3 tttm -60.22 -47.73 84.73 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.601 HD11 HH11 ' A' ' 29' ' ' ARG . 4.0 mm? -62.06 -40.81 97.03 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.501 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.546 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.11 -45.47 79.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 24.9 mmtm -65.5 -38.83 90.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.558 173.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 78.3 mt-10 -69.78 -54.17 14.88 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.021 HD21 HG11 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -124.18 -17.5 6.15 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -169.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.61 ' N ' HD12 ' A' ' 43' ' ' LEU . 1.1 m -48.99 127.26 13.94 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.311 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 45' ' ' ILE . 39.9 pt -76.74 -14.05 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.673 ' HB2' HD12 ' A' ' 16' ' ' LEU . 63.4 t0 -86.72 92.17 8.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.17 -42.72 99.35 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.13 -48.18 69.57 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.482 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 38.4 m -64.58 -33.37 75.77 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.513 -0.404 . . . . 0.0 110.315 175.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -62.81 -30.09 71.21 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.574 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -61.28 -39.87 92.03 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 81.3 mtp180 -97.23 19.68 12.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.404 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.503 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 47.8 m-20 58.72 31.79 21.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.16 -14.44 3.9 Favored Glycine 0 C--N 1.31 -0.904 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 13' ' ' SER . 20.2 m -69.19 90.88 0.49 Allowed 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.816 0.817 . . . . 0.0 111.313 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 56' ' ' LEU . 93.9 mt -62.94 -38.76 92.34 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.216 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.79 ' HA2' HD21 ' A' ' 96' ' ' LEU . . . 94.94 -144.14 17.01 Favored Glycine 0 CA--C 1.503 -0.698 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.4 ' H ' ' HD1' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -85.11 130.73 34.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.658 0.266 . . . . 0.0 110.827 -179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.495 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.8 p90 -144.89 152.87 40.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.876 0.369 . . . . 0.0 111.525 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.15 -173.31 37.33 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -81.96 154.78 25.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.69 -37.79 3.32 Favored Glycine 0 C--N 1.311 -0.852 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -63.0 -36.6 84.08 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.481 0.658 . . . . 0.0 109.476 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.474 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 3.7 mmm -104.62 155.64 18.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.281 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.74 154.35 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.463 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 13.7 mmtm -44.0 -55.0 10.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.661 ' HB2' HG13 ' A' ' 84' ' ' VAL . 40.0 Cg_endo -60.05 -34.69 94.54 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 CA-C-N 118.925 0.652 . . . . 0.0 111.074 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.594 ' CD2' HD11 ' A' ' 93' ' ' ILE . 10.5 t80 -63.12 -46.6 86.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.076 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.96 -41.72 99.61 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.714 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.9 -50.21 71.3 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.789 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.08 98.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.459 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB1' HG13 ' A' ' 10' ' ' ILE . . . -57.84 -50.47 73.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.149 -177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -67.6 -38.73 84.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.039 0.447 . . . . 0.0 111.297 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.529 HH22 ' CD ' ' A' ' 82' ' ' GLU . 78.7 mtp180 -63.99 -41.18 97.6 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.915 HD11 ' HA ' ' A' ' 81' ' ' SER . 43.0 mt -97.92 23.58 7.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -171.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.421 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 27.8 mt-30 -54.03 -25.54 21.86 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.91 -29.64 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.032 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 122.12 -0.34 10.66 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.203 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.718 ' HB2' HD22 ' A' ' 75' ' ' LEU . 19.4 mt-10 -70.64 174.28 6.1 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -174.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -98.49 131.23 46.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.574 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.915 ' HA ' HD11 ' A' ' 75' ' ' LEU . 43.1 t -64.34 162.09 15.58 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.708 -176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.529 ' CD ' HH22 ' A' ' 74' ' ' ARG . 0.0 OUTLIER -72.91 163.11 70.84 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 165.176 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.646 ' N ' HE22 ' A' ' 27' ' ' GLN . 72.1 Cg_endo -61.82 140.19 84.21 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 N-CA-C 110.214 -0.725 . . . . 0.0 110.214 -175.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' A' ' 67' ' ' PRO . 77.3 t -123.16 100.47 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.813 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.5 tptp -80.05 130.23 35.1 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.481 174.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.571 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 52.8 p -129.14 -176.25 3.81 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.362 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -62.61 -39.78 94.87 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -66.37 -41.62 89.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.315 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.79 -150.63 21.9 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.502 ' O ' HD23 ' A' ' 16' ' ' LEU . 77.7 m-85 -99.16 118.88 36.87 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.522 ' CE1' HD21 ' A' ' 16' ' ' LEU . 34.9 m-70 -99.33 139.54 34.82 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 123.341 0.401 . . . . 0.0 110.319 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.436 HG21 ' CG2' ' A' ' 26' ' ' VAL . 70.0 t -114.93 125.44 72.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 168.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.594 HD11 ' CD2' ' A' ' 68' ' ' PHE . 84.2 mt -123.62 127.44 74.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.129 -170.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -120.79 143.36 48.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.54 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 5.6 tmm_? -78.5 142.21 37.6 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.79 HD21 ' HA2' ' A' ' 57' ' ' GLY . 0.3 OUTLIER -121.98 151.3 40.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.124 -179.113 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.425 ' N ' HD12 ' A' ' 96' ' ' LEU . . . . . . . . 0 C--O 1.206 -1.627 0 CA-C-O 118.364 -1.242 . . . . 0.0 110.25 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.9 mttm . . . . . 0 N--CA 1.433 -1.316 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.83 HD11 ' CE2' ' A' ' 73' ' ' PHE . 66.0 mt -105.34 127.61 59.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' A' ' 11' ' ' LYS . 9.2 mtpm? -94.87 107.51 19.53 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.771 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -147.54 169.64 19.15 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.914 -173.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.536 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.7 m -130.45 146.27 51.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.068 173.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.556 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -138.6 149.34 45.15 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.876 -178.261 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.769 HG23 ' OG ' ' A' ' 44' ' ' SER . 94.9 mt -127.91 125.96 65.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.825 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 90' ' ' TYR . 42.3 tp -97.88 115.45 28.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.49 HG13 HG22 ' A' ' 15' ' ' ILE . 35.7 m -116.37 152.34 18.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.527 0.68 . . . . 0.0 112.294 -174.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -66.87 -42.92 84.82 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.904 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 31.3 mmtp -119.37 150.42 40.19 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.817 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -60.03 -38.03 81.52 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.079 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.79 -36.09 92.23 Favored Glycine 0 C--N 1.322 -0.234 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.483 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 95.8 mt-10 -64.53 -43.64 93.36 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -58.43 -46.7 85.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.001 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.49 -41.03 98.57 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.281 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.95 92.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.826 ' CG1' HD22 ' A' ' 43' ' ' LEU . 7.3 m -68.39 -34.44 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.103 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 18.7 tt0 -59.32 -46.47 88.5 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.155 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.76 -41.65 74.9 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.472 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.745 ' HD3' HD11 ' A' ' 39' ' ' LEU . 76.1 ttt180 -60.77 -39.23 88.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.861 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.99 -39.82 91.12 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.954 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 17.7 mmtp -65.47 -9.54 26.58 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -88.34 -3.51 58.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.152 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.48 11.04 75.79 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.587 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.596 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 13.2 mt-10 -78.85 154.21 29.99 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.473 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 21.3 tptm -62.29 126.4 27.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.233 -176.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.518 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 58.2 t80 -58.04 -44.47 87.43 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.643 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -60.11 -37.74 93.3 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.942 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 44.6 tttp -61.23 -44.28 97.52 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.82 HD12 HG12 ' A' ' 26' ' ' VAL . 4.4 mm? -62.02 -41.46 98.11 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.295 172.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -57.17 -51.91 67.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.38 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -65.54 -39.43 91.75 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' A' ' 38' ' ' LYS . 92.2 mt-10 -70.08 -48.08 59.22 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.826 HD22 ' CG1' ' A' ' 26' ' ' VAL . 9.5 mp -98.26 -50.49 4.32 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.769 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.2 m -50.81 139.21 17.26 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.1 -1.409 . . . . 0.0 113.093 -161.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.467 HG13 HD23 ' A' ' 16' ' ' LEU . 36.1 pt -97.42 -2.34 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.672 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -89.19 94.11 9.81 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.828 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -62.26 -42.29 99.72 Favored Glycine 0 C--O 1.234 0.136 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.3 -42.09 63.27 Favored Glycine 0 N--CA 1.454 -0.136 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.556 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 15.9 m -72.46 -33.08 66.78 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.635 -0.282 . . . . 0.0 111.569 175.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.18 74.63 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.161 0.505 . . . . 0.0 110.512 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 10.4 mmtp -61.98 -41.85 98.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.29 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -98.67 9.1 44.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.406 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.643 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.5 m-20 63.63 33.12 13.46 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.078 0.466 . . . . 0.0 110.395 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.4 -14.61 5.13 Favored Glycine 0 C--N 1.31 -0.897 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -63.19 89.32 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.0 0.428 . . . . 0.0 110.955 -179.355 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.771 HD12 ' SG ' ' A' ' 12' ' ' CYS . 96.4 mt -63.4 -40.29 96.83 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 87.19 -151.31 23.47 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.91 131.07 34.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.028 0.414 . . . . 0.0 110.004 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 52.5 p90 -142.79 148.72 37.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.345 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.18 150.92 34.31 Favored Glycine 0 C--N 1.314 -0.67 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.42 ' H ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -69.94 144.32 52.43 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.56 0.219 . . . . 0.0 110.734 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.58 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 106.95 -20.77 33.01 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -175.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -62.69 -42.5 99.66 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.608 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 75.0 mtm -120.0 160.66 22.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.931 0.396 . . . . 0.0 111.961 -174.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 68' ' ' PHE . 32.4 m -43.49 128.16 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.012 -177.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.608 ' NZ ' ' O ' ' A' ' 64' ' ' MET . 1.9 mmtm -45.08 -46.5 30.35 Favored Pre-proline 0 C--N 1.308 -1.198 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.058 -173.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 30.0 Cg_endo -59.82 -35.3 94.52 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 CA-C-N 119.311 0.79 . . . . 0.0 111.451 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' A' ' 93' ' ' ILE . 54.3 t80 -61.76 -49.07 77.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.959 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 99.1 mt-10 -66.11 -41.49 90.49 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.572 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.85 -46.65 81.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.813 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.99 -38.5 88.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.854 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.512 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -58.33 -41.23 84.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.897 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.83 ' CE2' HD11 ' A' ' 10' ' ' ILE . 57.3 m-85 -64.69 -35.25 80.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.018 0.437 . . . . 0.0 111.386 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -58.8 -23.19 59.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.506 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 81' ' ' SER . 84.2 mt -96.92 4.94 51.34 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -171.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.477 ' HA ' ' HD2' ' A' ' 95' ' ' ARG . 67.4 mm-40 -47.16 -20.41 0.18 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.57 -40.55 86.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 120.814 0.34 . . . . 0.0 110.124 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.95 48.49 0.24 Allowed Glycine 0 N--CA 1.465 0.615 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.451 ' OE1' ' N ' ' A' ' 80' ' ' VAL . 1.2 mm-40 -122.31 175.78 6.22 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.034 0.445 . . . . 0.0 112.166 -173.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 94' ' ' LYS . 75.2 t -108.99 131.37 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.703 ' HB3' HD11 ' A' ' 75' ' ' LEU . 6.4 p -75.51 163.19 27.64 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -173.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.33 165.33 45.47 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.596 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 63.5 Cg_exo -55.84 130.96 43.18 Favored 'Trans proline' 0 C--N 1.293 -2.392 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.1 t -117.88 124.4 73.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 41.7 tttp -91.51 131.89 36.65 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.67 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 97.1 p -118.85 -172.05 2.21 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.701 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.2 pm0 -66.8 -38.8 87.2 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 6.0 m-30 -64.39 -46.89 81.33 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.978 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.85 -150.88 21.11 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.592 ' O ' HD12 ' A' ' 16' ' ' LEU . 10.9 m-85 -96.5 129.41 43.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.837 0.351 . . . . 0.0 111.381 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -110.85 146.68 36.03 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.029 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.708 HG11 ' CG2' ' A' ' 26' ' ' VAL . 2.1 t -117.4 121.03 66.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 167.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.546 HD11 ' CD2' ' A' ' 68' ' ' PHE . 87.3 mt -113.1 127.82 70.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.428 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.455 ' HB2' HG22 ' A' ' 80' ' ' VAL . 59.5 tttm -115.43 145.13 42.86 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.409 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 75' ' ' LEU . 68.4 ttt-85 -79.5 139.37 37.62 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.024 177.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 55.8 tp -112.66 129.1 56.51 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.505 ' C ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.206 -1.633 0 CA-C-O 118.376 -1.236 . . . . 0.0 112.152 -173.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 44.3 mmtm . . . . . 0 N--CA 1.444 -0.764 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.682 HG21 ' HB1' ' A' ' 72' ' ' ALA . 43.5 mm -107.92 129.13 62.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 48.7 mtpt -92.7 106.88 18.79 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -138.22 166.04 25.17 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.779 0.799 . . . . 0.0 112.933 -177.42 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.467 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 3.9 m -133.35 138.53 46.37 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.895 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.47 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -132.8 150.28 52.18 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.372 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.705 HG23 ' OG ' ' A' ' 44' ' ' SER . 95.7 mt -125.09 127.22 72.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.621 177.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.754 HD12 ' O ' ' A' ' 90' ' ' TYR . 51.2 tp -98.72 125.01 43.92 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.944 HG12 HD11 ' A' ' 43' ' ' LEU . 33.6 m -118.06 151.85 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.389 0.614 . . . . 0.0 111.275 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.487 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 6.2 mttp -66.71 -40.62 88.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.201 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -133.77 158.84 42.31 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.866 -169.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -60.11 -39.75 87.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.488 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.81 -39.74 91.93 Favored Glycine 0 CA--C 1.507 -0.444 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.528 ' O ' HG13 ' A' ' 26' ' ' VAL . 97.0 mt-10 -65.07 -43.59 91.7 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.836 176.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -59.4 -48.36 81.94 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.124 0.488 . . . . 0.0 110.125 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.57 -42.93 99.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.214 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.87 80.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.75 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 22' ' ' GLU . 12.6 m -63.54 -41.39 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.778 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.513 HE22 ' HA ' ' A' ' 82' ' ' GLU . 94.7 mt-30 -55.92 -44.05 77.95 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -70.08 -41.71 73.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.322 0.582 . . . . 0.0 110.371 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 75.9 ttt180 -61.6 -38.36 87.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.941 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 36' ' ' PHE . 3.8 mm? -59.75 -37.58 79.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 18.7 mmtm -62.72 -30.71 71.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.03 -23.94 56.3 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.876 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.22 13.09 25.71 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.02 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.556 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 33.0 mt-10 -80.74 150.2 29.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.151 0.475 . . . . 0.0 110.705 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 61.1 tttm -65.78 137.17 57.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.046 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.606 ' HA ' HD11 ' A' ' 30' ' ' LEU . 59.2 t80 -56.77 -45.19 82.25 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.616 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.64 -37.63 95.09 Favored Glycine 0 C--N 1.317 -0.503 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 65.6 tttm -58.31 -46.71 85.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.491 HD11 ' HD3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -62.43 -41.14 98.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.529 174.096 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.48 -49.64 76.63 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.317 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.449 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 43.1 mttp -64.68 -41.24 96.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.646 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.504 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 58.6 mt-10 -71.25 -44.2 65.76 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.944 HD11 HG12 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -113.1 -38.2 4.54 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -169.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.705 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.5 m -54.78 142.83 27.48 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.81 -173.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.561 HG13 HD23 ' A' ' 16' ' ' LEU . 42.3 pt -95.89 6.59 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.923 0.868 . . . . 0.0 109.449 171.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 25.2 t0 -91.53 113.96 26.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.02 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.74 -65.39 2.82 Favored Glycine 0 C--N 1.318 -0.46 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.59 -44.78 78.79 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 54' ' ' GLY . 15.0 m -66.63 -34.32 77.62 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.808 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 46' ' ' ASP . . . -65.7 -38.92 90.56 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.174 0.512 . . . . 0.0 110.685 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -63.55 -33.68 76.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.007 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.0 16.72 21.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.103 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.616 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 19.6 m-20 60.02 35.5 21.47 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.447 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.45 -28.76 1.23 Allowed Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -56.38 91.41 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.918 0.39 . . . . 0.0 110.808 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.439 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 83.9 mt -63.18 -39.05 93.54 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . 104.32 -148.03 16.67 Favored Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.53 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 21.6 m-85 -84.54 130.67 34.72 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.487 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 44.4 p90 -146.65 149.98 34.54 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.989 174.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.82 -170.23 36.98 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -73.76 154.3 39.64 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 122.737 -0.273 . . . . 0.0 110.338 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.19 -33.96 5.6 Favored Glycine 0 C--N 1.313 -0.75 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.041 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -64.42 -41.28 96.69 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.791 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -108.57 160.64 15.76 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.302 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 18.4 m -64.04 152.13 8.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.429 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.519 ' NZ ' ' OD2' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -43.76 -57.55 5.7 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.465 -175.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 38.0 Cg_endo -58.91 -32.19 96.92 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 N-CA-C 110.557 -0.593 . . . . 0.0 110.557 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.608 ' CD2' HD11 ' A' ' 93' ' ' ILE . 27.1 t80 -61.74 -47.57 84.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.513 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -62.84 -45.41 92.74 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.115 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.519 ' OD2' ' NZ ' ' A' ' 66' ' ' LYS . 40.5 m-20 -62.29 -40.28 95.76 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.281 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.57 -41.47 96.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.932 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.682 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -59.04 -49.43 77.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.581 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CE1' HD11 ' A' ' 10' ' ' ILE . 62.6 m-85 -65.17 -38.03 89.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.226 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -64.93 -39.5 93.6 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.744 HD22 ' HB2' ' A' ' 79' ' ' GLU . 44.0 mt -94.02 16.99 13.16 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.148 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.557 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 50.2 mt-30 -55.09 -19.67 7.91 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.958 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.549 HG13 ' HG3' ' A' ' 79' ' ' GLU . 7.2 p -65.24 -27.04 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.646 175.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.498 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 123.81 3.04 8.53 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 121.672 -0.299 . . . . 0.0 112.536 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.744 ' HB2' HD22 ' A' ' 75' ' ' LEU . 47.9 mt-10 -67.24 174.43 3.24 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -110.85 132.29 59.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.576 ' HB3' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -73.32 160.69 31.46 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -174.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.513 ' HA ' HE22 ' A' ' 27' ' ' GLN . 0.7 OUTLIER -70.73 175.84 2.35 Favored Pre-proline 0 N--CA 1.444 -0.733 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.319 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.94 134.25 61.17 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 CA-C-N 119.538 0.871 . . . . 0.0 109.868 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.47 126.67 74.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.567 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.9 tptp -97.56 135.58 39.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.25 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.567 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 60.5 p -135.03 169.89 16.74 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.707 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.7 pm0 -61.47 -34.02 74.74 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -63.35 -42.35 98.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.506 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.79 -146.17 13.35 Favored Glycine 0 C--N 1.321 -0.297 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.408 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.754 ' O ' HD12 ' A' ' 16' ' ' LEU . 6.4 m-85 -103.52 130.79 50.98 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 122.266 0.226 . . . . 0.0 110.522 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.712 ' CE1' HD13 ' A' ' 16' ' ' LEU . 35.9 m-70 -116.12 144.57 43.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.956 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.01 127.35 75.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 167.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.608 HD11 ' CD2' ' A' ' 68' ' ' PHE . 86.0 mt -120.16 129.49 75.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 122.572 -0.08 . . . . 0.0 110.833 -173.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 63.7 tttp -120.65 159.65 24.89 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.557 ' NE ' ' O ' ' A' ' 76' ' ' GLN . 27.7 ttt-85 -75.84 143.9 41.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.471 HD23 ' HA2' ' A' ' 57' ' ' GLY . 50.6 tp -108.77 142.06 39.87 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.4 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.198 -2.124 0 CA-C-O 118.09 -1.394 . . . . 0.0 112.135 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 39.9 mttm . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.642 HD12 ' CE2' ' A' ' 59' ' ' PHE . 21.1 mt -106.42 128.52 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -172.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.544 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 41.5 mtpt -90.72 104.57 17.14 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.599 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -148.11 167.38 25.14 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -175.112 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m -124.83 132.98 53.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.206 174.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.479 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.58 149.44 50.16 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.396 -175.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.714 HG23 ' OG ' ' A' ' 44' ' ' SER . 92.6 mt -124.33 125.94 71.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.708 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.617 HD13 ' CE1' ' A' ' 91' ' ' HIS . 51.3 tp -103.67 125.74 50.36 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 90' ' ' TYR . 32.7 m -134.86 155.13 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 121.107 0.479 . . . . 0.0 111.264 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.55 -22.85 34.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.462 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 22' ' ' GLU . 53.4 mmtt -112.14 140.92 46.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.896 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -64.05 -39.5 94.21 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.491 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.67 -35.76 90.24 Favored Glycine 0 N--CA 1.459 0.212 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.625 ' HB3' HD23 ' A' ' 43' ' ' LEU . 89.8 mt-10 -65.26 -42.83 92.88 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.56 -47.04 87.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.089 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.21 -41.93 98.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.955 0.407 . . . . 0.0 110.381 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.31 -50.68 72.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.193 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.935 HG12 HD12 ' A' ' 39' ' ' LEU . 10.7 m -64.7 -41.78 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.777 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.565 HE22 ' HD3' ' A' ' 83' ' ' PRO . 20.0 mt-30 -58.75 -50.84 72.44 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.145 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -65.78 -37.91 87.59 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.319 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.702 ' HD3' HD11 ' A' ' 39' ' ' LEU . 67.1 ttt180 -63.42 -37.49 87.48 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.316 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.3 mm? -61.56 -40.9 96.37 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 19.8 mmtp -63.32 -34.96 78.83 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.313 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -60.56 -24.24 65.26 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.538 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.52 6.93 26.67 Favored Glycine 0 N--CA 1.463 0.483 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.157 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 6.2 mt-10 -82.77 150.92 26.37 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.236 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -67.25 137.26 56.02 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.704 0.764 . . . . 0.0 112.021 -174.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.572 ' HA ' HD21 ' A' ' 30' ' ' LEU . 54.2 t80 -55.01 -43.0 73.23 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.639 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -59.35 -37.42 91.94 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.263 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.02 -47.82 84.26 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.935 HD12 HG12 ' A' ' 26' ' ' VAL . 4.4 mm? -62.67 -41.93 99.35 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.619 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -62.46 -43.47 98.74 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.053 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -63.3 -41.77 98.99 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -75.1 -82.11 0.07 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -174.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.896 HD22 ' CG1' ' A' ' 26' ' ' VAL . 6.6 mp -64.23 -42.8 96.38 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -170.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.714 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.1 m -56.57 133.43 53.56 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.736 -162.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.469 HG13 HD23 ' A' ' 16' ' ' LEU . 44.3 pt -87.98 -7.47 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.131 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 49' ' ' SER . 54.4 t0 -84.34 94.45 8.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.532 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -59.51 -50.68 65.1 Favored Glycine 0 C--N 1.315 -0.618 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.31 -44.69 93.35 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 39.6 m -62.79 -33.7 75.74 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.467 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -63.43 -36.74 84.72 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 47.4 mmtm -61.8 -33.69 74.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.835 HH21 HD23 ' A' ' 56' ' ' LEU . 76.5 mtm-85 -96.52 6.61 48.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.288 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.639 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 70.7 m-20 65.98 36.76 5.69 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.963 0.411 . . . . 0.0 110.152 -174.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 -20.66 4.75 Favored Glycine 0 C--N 1.317 -0.483 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -54.48 99.13 0.03 OUTLIER 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.374 0.607 . . . . 0.0 111.349 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.835 HD23 HH21 ' A' ' 52' ' ' ARG . 90.1 mt -68.73 -38.72 80.38 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 90.79 -145.17 17.73 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 -172.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.544 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 11.1 m-85 -83.99 132.65 34.73 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.642 ' CE2' HD12 ' A' ' 10' ' ' ILE . 52.3 p90 -142.51 149.39 39.09 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.448 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.95 173.67 28.18 Favored Glycine 0 C--O 1.238 0.36 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -81.63 159.73 23.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.566 0.222 . . . . 0.0 110.937 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.67 -77.15 0.38 Allowed Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -61.73 -39.31 91.1 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.229 0.538 . . . . 0.0 109.873 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.467 ' HG3' ' CD2' ' A' ' 59' ' ' PHE . 41.8 mmm -66.2 147.74 52.88 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.876 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 68' ' ' PHE . 29.9 m -79.07 136.91 22.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.097 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 9.3 mmtm -43.9 -50.24 19.69 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.565 ' HB2' HG13 ' A' ' 84' ' ' VAL . 29.5 Cg_endo -57.55 -36.61 98.59 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 CA-C-N 118.999 0.678 . . . . 0.0 110.797 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.649 ' HA ' HG11 ' A' ' 84' ' ' VAL . 31.8 t80 -63.13 -47.99 80.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.862 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 98.0 mt-10 -64.26 -46.61 82.98 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.288 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 10.9 t70 -57.07 -48.26 78.99 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.236 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.57 96.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.48 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -59.27 -45.83 90.17 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.573 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.489 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 59.1 m-85 -63.16 -36.4 83.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.227 0.537 . . . . 0.0 111.126 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 94.7 mtt-85 -65.03 -22.34 66.97 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.289 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.589 HD11 ' CB ' ' A' ' 81' ' ' SER . 73.0 mt -96.34 9.4 41.31 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.573 ' OE1' ' NH1' ' A' ' 95' ' ' ARG . 15.8 mm100 -43.42 -24.76 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 117.936 0.335 . . . . 0.0 111.75 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.98 -23.38 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.111 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 114.29 3.94 22.42 Favored Glycine 0 N--CA 1.47 0.91 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.473 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -73.91 175.48 7.29 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -172.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.21 131.09 56.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.147 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.589 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -74.34 153.21 39.4 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.161 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 2.4 mp0 -68.1 171.3 5.83 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 167.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.565 ' HD3' HE22 ' A' ' 27' ' ' GLN . 52.6 Cg_exo -54.51 132.66 52.41 Favored 'Trans proline' 0 C--N 1.289 -2.566 0 C-N-CA 120.399 0.733 . . . . 0.0 111.067 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.649 HG11 ' HA ' ' A' ' 68' ' ' PHE . 60.8 t -109.94 107.29 22.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.545 ' CG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 tmtp? -79.33 134.38 36.61 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.84 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 p -137.95 168.73 19.11 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.638 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -60.46 -34.28 73.78 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -67.25 -38.77 85.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.909 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.49 -154.83 25.85 Favored Glycine 0 C--N 1.314 -0.651 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.545 ' CE2' ' CG ' ' A' ' 85' ' ' LYS . 84.7 m-85 -104.69 126.86 52.19 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.617 ' CE1' HD13 ' A' ' 16' ' ' LEU . 7.7 m-70 -105.06 143.13 33.67 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.641 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.15 125.78 74.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.593 HD11 ' CD2' ' A' ' 68' ' ' PHE . 81.2 mt -115.9 129.41 72.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -110.05 140.81 43.68 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 168.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.573 ' NH1' ' OE1' ' A' ' 76' ' ' GLN . 4.7 tpt180 -77.9 135.32 37.86 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.455 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 53.7 tp -121.7 145.63 47.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.616 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.402 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.211 -1.282 0 CA-C-O 118.342 -1.255 . . . . 0.0 110.859 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.7 mttm . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.94 HG21 ' HB1' ' A' ' 72' ' ' ALA . 21.2 mm -105.86 126.6 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.577 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 56.8 mtpt -88.34 104.08 16.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.1 OUTLIER -148.77 168.31 23.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -175.753 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.9 m -131.13 146.35 52.31 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.594 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -140.18 150.31 44.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.682 HG23 ' OG ' ' A' ' 44' ' ' SER . 91.3 mt -127.1 128.8 70.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.08 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -101.19 116.61 33.21 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.571 ' N ' HD13 ' A' ' 16' ' ' LEU . 35.8 m -120.83 154.66 24.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.502 0.668 . . . . 0.0 111.29 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -65.9 -40.62 91.68 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.657 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -119.15 148.9 42.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.448 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 48.8 mt-30 -62.4 -40.69 97.32 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.124 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.52 -40.76 94.91 Favored Glycine 0 CA--C 1.511 -0.209 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -63.76 -44.45 93.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' A' ' 92' ' ' VAL . . . -59.11 -48.0 83.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.978 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.11 -41.01 99.28 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.138 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.05 -47.99 81.46 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.729 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.564 HG12 HD12 ' A' ' 39' ' ' LEU . 28.4 m -70.44 -32.89 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 81' ' ' SER . 48.6 tt0 -59.46 -48.18 82.62 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 77.9 mm-40 -71.12 -36.42 72.12 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.118 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.865 ' HD2' HD11 ' A' ' 39' ' ' LEU . 42.4 ttm180 -60.55 -37.94 82.9 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -58.56 -27.15 64.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.252 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.499 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 33.6 mmtp -61.75 -38.73 89.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.12 -24.27 58.09 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.799 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.33 15.38 30.29 Favored Glycine 0 C--N 1.32 -0.356 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -58.9 140.82 54.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.532 ' NZ ' ' OD2' ' A' ' 53' ' ' ASP . 17.0 tptm -56.1 127.38 30.31 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CE2' HG13 ' A' ' 15' ' ' ILE . 61.6 t80 -57.06 -43.52 82.15 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -60.45 -33.8 82.75 Favored Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.836 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 87.2 tttt -59.9 -48.64 80.88 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.865 HD11 ' HD2' ' A' ' 29' ' ' ARG . 4.5 mm? -62.04 -41.94 98.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.435 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.514 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.48 -48.68 76.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.444 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -64.38 -39.66 94.3 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.25 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.584 ' C ' HD13 ' A' ' 43' ' ' LEU . 63.8 mm-40 -70.33 -45.17 66.71 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -171.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.843 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.77 -24.06 4.56 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -177.041 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.682 ' OG ' HG23 ' A' ' 15' ' ' ILE . 3.7 m -50.98 137.82 20.49 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.53 -173.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.54 ' CG1' HD12 ' A' ' 16' ' ' LEU . 39.4 pt -98.69 -5.22 9.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.317 0.579 . . . . 0.0 109.501 172.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.473 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 67.3 t0 -87.82 107.85 18.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.661 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -64.34 -43.64 96.58 Favored Glycine 0 C--N 1.318 -0.428 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.32 -49.46 68.37 Favored Glycine 0 CA--C 1.504 -0.654 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.594 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 16.2 m -60.58 -34.53 74.33 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.798 0.332 . . . . 0.0 110.409 174.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.14 85.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.261 0.553 . . . . 0.0 110.743 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 35.3 mmtp -64.12 -39.45 94.06 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 55' ' ' SER . 80.2 mtp180 -98.09 25.47 6.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.086 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.532 ' OD2' ' NZ ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER 35.94 42.44 0.16 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.781 0.8 . . . . 0.0 112.659 -178.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.38 -15.87 4.17 Favored Glycine 0 C--N 1.315 -0.63 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.474 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ARG . 4.9 m -73.41 77.7 1.39 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.26 0.552 . . . . 0.0 110.796 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.483 HD11 ' CD2' ' A' ' 14' ' ' HIS . 96.2 mt -64.58 -38.44 91.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.153 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.26 -141.67 21.6 Favored Glycine 0 CA--C 1.501 -0.786 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.577 ' CD1' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -85.8 139.99 30.83 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.575 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.606 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 55.2 p90 -144.77 152.89 41.04 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.802 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.5 172.66 36.28 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 72.1 mtm-85 -84.69 148.68 26.27 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.017 0.437 . . . . 0.0 111.991 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.81 -56.13 0.48 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.019 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -61.4 -39.42 90.67 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.081 0.467 . . . . 0.0 111.129 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.473 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 76.0 mmm -79.99 153.74 28.69 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.67 -176.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 m -68.4 137.95 23.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.362 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -44.29 -52.5 16.47 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -173.509 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.527 ' HB2' HG13 ' A' ' 84' ' ' VAL . 31.3 Cg_endo -60.21 -32.44 94.42 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 CA-C-N 118.639 0.55 . . . . 0.0 111.284 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.498 ' CD2' HD11 ' A' ' 93' ' ' ILE . 47.2 t80 -62.19 -47.22 85.46 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.543 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 76.7 mt-10 -63.78 -43.19 97.09 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.817 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -56.25 -49.18 74.91 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.793 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -63.44 -42.72 98.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.859 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.94 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -57.67 -49.09 77.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.27 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 69' ' ' GLU . 32.1 m-85 -63.62 -38.96 93.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -61.64 -33.42 73.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.316 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 ' HB3' ' A' ' 81' ' ' SER . 90.9 mt -89.12 5.71 43.33 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.531 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 15.5 mm100 -42.83 -24.08 0.06 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 118.219 0.463 . . . . 0.0 112.01 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -63.28 -26.22 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 120.798 0.332 . . . . 0.0 111.878 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.517 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 114.19 11.39 12.22 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -85.71 174.42 9.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.78 HG22 ' HD3' ' A' ' 94' ' ' LYS . 11.3 t -95.78 131.46 42.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.878 ' HB3' HD11 ' A' ' 75' ' ' LEU . 28.5 p -72.92 160.89 31.41 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 123.138 0.273 . . . . 0.0 111.71 -172.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.495 ' HA ' HE22 ' A' ' 27' ' ' GLN . 2.9 mt-10 -64.12 168.91 5.29 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 166.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -57.94 136.08 72.89 Favored 'Trans proline' 0 C--N 1.292 -2.422 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.527 HG13 ' HB2' ' A' ' 67' ' ' PRO . 45.2 t -117.52 130.04 73.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HD2' ' CE1' ' A' ' 90' ' ' TYR . 82.9 tttt -110.65 131.75 54.78 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.989 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 p -143.72 -171.58 3.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.972 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.7 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 2.1 pm0 -66.09 -31.81 72.9 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -64.1 -37.92 89.2 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.805 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 16' ' ' LEU . . . 142.85 -139.41 9.0 Favored Glycine 0 C--O 1.242 0.608 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 87.4 m-85 -106.98 126.89 52.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.472 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 2.0 m-70 -105.35 147.28 28.35 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.59 0.233 . . . . 0.0 111.097 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 73.3 t -117.5 126.69 74.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 167.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.498 HD11 ' CD2' ' A' ' 68' ' ' PHE . 91.4 mt -115.37 127.32 72.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.65 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.78 ' HD3' HG22 ' A' ' 80' ' ' VAL . 27.0 tptp -106.22 128.74 54.16 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.531 ' CD ' ' HA ' ' A' ' 76' ' ' GLN . 76.3 ttt-85 -77.65 139.22 39.44 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 118.644 -1.222 . . . . 0.0 109.266 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 50.6 tp -110.08 133.37 53.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.262 -175.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.47 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.573 0 CA-C-O 118.28 -1.289 . . . . 0.0 110.845 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.5 mttp . . . . . 0 CA--C 1.5 -0.964 0 CA-C-O 120.537 0.208 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.74 HG21 ' HB1' ' A' ' 72' ' ' ALA . 42.5 mm -106.02 128.24 60.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.525 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 11.8 mtpp -89.43 107.07 18.86 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.5 167.26 22.92 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.874 -177.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.528 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.4 m -130.6 147.56 52.3 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.122 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.55 149.74 50.68 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.449 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.639 HG23 ' OG ' ' A' ' 44' ' ' SER . 96.1 mt -123.61 128.77 74.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.332 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 45' ' ' ILE . 41.1 tp -103.11 123.5 46.79 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.021 HG12 HD11 ' A' ' 43' ' ' LEU . 16.2 m -124.1 147.9 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 123.657 0.598 . . . . 0.0 111.132 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -66.76 -42.54 86.0 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.403 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.497 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 25.9 mmtp -112.77 151.1 30.7 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -174.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -64.36 -34.89 79.2 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.871 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.22 -37.78 95.1 Favored Glycine 0 CA--C 1.509 -0.317 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.497 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 98.3 mt-10 -64.94 -41.92 95.1 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.54 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -57.75 -46.98 83.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.269 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.09 -42.54 99.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.366 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.07 73.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.677 ' O ' HD23 ' A' ' 30' ' ' LEU . 11.3 m -65.18 -40.7 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.964 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 32.2 mt-30 -60.08 -47.3 86.43 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.712 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.562 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 57.0 mm-40 -66.48 -37.14 84.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.034 0.445 . . . . 0.0 110.827 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.863 ' HD3' HD11 ' A' ' 39' ' ' LEU . 77.6 ttt180 -61.06 -41.11 96.0 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.417 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.681 HD11 ' HA ' ' A' ' 36' ' ' PHE . 4.1 mm? -60.09 -38.87 84.22 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.512 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 17.5 mmtp -61.04 -34.72 75.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.16 -10.03 37.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.116 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.68 -0.42 39.46 Favored Glycine 0 N--CA 1.462 0.379 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.771 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.652 ' O ' HD13 ' A' ' 30' ' ' LEU . 7.3 mm-40 -65.38 142.52 58.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 29.9 mttm -72.58 141.83 48.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.283 0.564 . . . . 0.0 111.13 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.681 ' HA ' HD11 ' A' ' 30' ' ' LEU . 53.1 t80 -58.67 -45.45 89.36 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -61.02 -34.91 89.72 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.972 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 88.7 tttt -61.04 -47.35 86.77 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.863 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.2 mm? -62.96 -41.11 99.43 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.732 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 44' ' ' SER . . . -60.0 -50.05 75.27 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.85 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.564 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 68.2 mttm -65.85 -45.27 82.77 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.848 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.485 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 86.5 mt-10 -71.99 -44.59 63.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.021 HD11 HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -112.43 -39.11 4.47 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -168.092 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.713 ' N ' HD13 ' A' ' 43' ' ' LEU . 67.6 m -52.59 135.83 33.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.334 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.621 HG13 HD23 ' A' ' 16' ' ' LEU . 42.5 pt -87.88 -5.75 10.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.543 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -85.97 91.39 8.37 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -61.12 -43.59 99.22 Favored Glycine 0 C--N 1.313 -0.718 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.6 -44.21 78.87 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.3 m -71.8 -33.63 68.71 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.733 175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -65.19 -38.78 91.55 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.787 0.803 . . . . 0.0 109.854 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.33 -37.33 82.89 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.206 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -97.58 20.57 11.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.944 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.564 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 57.75 30.53 19.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.648 177.382 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 70.69 -8.1 4.63 Favored Glycine 0 C--N 1.306 -1.106 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -69.95 85.31 0.51 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.147 0.498 . . . . 0.0 110.58 -178.254 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.06 -39.86 95.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.826 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 89.46 -143.44 17.28 Favored Glycine 0 CA--C 1.507 -0.428 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.525 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 95.3 m-85 -83.61 132.92 34.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.437 ' CD1' ' HG3' ' A' ' 64' ' ' MET . 44.8 p90 -146.25 150.28 35.49 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.001 170.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.43 178.38 27.68 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.459 ' HB3' ' NH1' ' A' ' 61' ' ' ARG . 8.4 mtm105 -75.38 154.78 37.02 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.59 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.81 -31.94 8.12 Favored Glycine 0 C--N 1.309 -0.957 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -11.14 54.54 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.494 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.437 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 10.0 mmm -125.08 156.61 37.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.94 150.77 6.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.849 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.529 ' NZ ' ' HB2' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -44.42 -54.5 12.03 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 38.0 Cg_endo -61.94 -34.14 81.99 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 120.163 0.575 . . . . 0.0 111.119 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CD2' HD11 ' A' ' 93' ' ' ILE . 38.3 t80 -62.43 -47.87 82.17 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.476 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.63 -39.99 94.68 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.895 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.529 ' HB2' ' NZ ' ' A' ' 66' ' ' LYS . 27.6 t70 -56.03 -51.24 68.48 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.871 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 81' ' ' SER . . . -64.7 -41.64 95.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.74 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -61.15 -50.98 70.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.342 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 10' ' ' ILE . 59.2 m-85 -69.15 -38.45 78.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.773 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -66.61 -40.96 89.05 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 81' ' ' SER . 50.3 mt -98.1 33.46 2.15 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.478 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 71.0 mt-30 -51.24 -24.54 4.49 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.83 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.431 HG13 ' H ' ' A' ' 79' ' ' GLU . 12.1 p -59.83 -31.88 48.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.514 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 123.47 -4.72 9.4 Favored Glycine 0 N--CA 1.469 0.873 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.086 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.431 ' H ' HG13 ' A' ' 77' ' ' VAL . 90.5 mt-10 -60.69 147.33 42.49 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.897 0.379 . . . . 0.0 111.938 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 t -78.59 130.99 35.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.455 ' HA ' HD11 ' A' ' 75' ' ' LEU . 10.5 p -74.3 153.44 39.35 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.659 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.6 mp0 -59.57 164.69 5.04 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.54 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 50.3 Cg_exo -53.67 129.03 31.92 Favored 'Trans proline' 0 C--N 1.292 -2.43 0 N-CA-C 109.865 -0.86 . . . . 0.0 109.865 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.448 HG21 HD12 ' A' ' 93' ' ' ILE . 59.2 t -104.25 113.97 42.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.533 ' NZ ' ' OH ' ' A' ' 90' ' ' TYR . 41.7 tttp -81.85 138.27 35.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 19.3 p -150.6 166.47 30.19 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.44 -32.41 71.35 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.439 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 65.7 m-85 -64.48 -40.4 95.61 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.328 176.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.97 -149.85 21.91 Favored Glycine 0 C--N 1.318 -0.418 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.533 ' OH ' ' NZ ' ' A' ' 85' ' ' LYS . 82.7 m-85 -104.38 127.39 52.04 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.362 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.502 ' CE1' HD13 ' A' ' 16' ' ' LEU . 3.9 m-70 -111.35 151.18 28.72 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.224 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.483 HG21 HG21 ' A' ' 26' ' ' VAL . 1.9 t -116.67 114.09 44.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 168.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.512 HD11 ' CD2' ' A' ' 68' ' ' PHE . 75.7 mt -111.4 124.03 67.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.244 -172.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 30.1 tttp -114.56 139.01 49.94 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.514 172.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.478 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 1.4 tmm_? -78.9 141.58 37.5 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.398 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.421 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 50.2 tp -109.45 124.06 50.4 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.055 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.204 -1.725 0 CA-C-O 118.296 -1.28 . . . . 0.0 110.248 -177.366 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.715 HD11 ' CE2' ' A' ' 73' ' ' PHE . 68.0 mt -104.72 126.32 59.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.517 ' NZ ' ' HA2' ' A' ' 97' ' ' GLY . 7.8 mtpm? -94.85 104.42 16.32 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.564 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -144.48 171.86 13.77 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -171.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.9 m -131.4 146.07 52.1 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.305 174.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.449 ' CG ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.15 150.96 44.88 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.59 HG23 ' OG ' ' A' ' 44' ' ' SER . 61.8 mt -121.99 126.77 74.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.288 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.637 HD13 ' CE1' ' A' ' 91' ' ' HIS . 50.5 tp -101.85 122.37 43.86 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.53 HG13 HG22 ' A' ' 15' ' ' ILE . 34.8 m -130.39 155.02 41.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.418 0.628 . . . . 0.0 111.106 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HG3' HG21 ' A' ' 45' ' ' ILE . 10.5 mtpt -66.38 -41.74 88.97 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.704 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 27.8 mtpp -118.81 151.6 37.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.447 -172.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -60.9 -37.23 81.52 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.29 -39.94 97.92 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 88.8 mt-10 -63.84 -46.02 86.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.579 ' HB1' ' CG2' ' A' ' 92' ' ' VAL . . . -60.0 -49.37 77.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.443 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 24' ' ' LEU . 97.2 mt -63.72 -41.05 98.14 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.789 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.51 -49.35 75.0 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.885 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.586 HG12 HD12 ' A' ' 39' ' ' LEU . 9.4 m -68.21 -40.57 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.406 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.517 HE21 ' C ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -56.05 -42.81 77.18 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.079 -179.389 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 51.9 mm-40 -71.71 -35.03 70.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.183 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.457 ' HG3' ' HG3' ' A' ' 34' ' ' GLU . 12.3 ttm180 -62.07 -37.32 84.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.311 176.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.563 HD23 ' O ' ' A' ' 26' ' ' VAL . 4.3 mm? -60.57 -36.25 78.05 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.871 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 28.4 mmtm -59.98 -36.65 77.62 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.68 -10.44 36.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.894 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.64 62.62 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 12.2 mm-40 -62.3 147.04 49.39 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 74.4 tttt -63.01 128.64 36.81 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.421 ' HA ' HD11 ' A' ' 30' ' ' LEU . 53.6 t80 -58.11 -45.16 87.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.592 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -58.25 -39.48 92.55 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.783 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 49.2 tttp -59.46 -45.72 90.81 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.586 HD12 HG12 ' A' ' 26' ' ' VAL . 4.2 mm? -61.66 -42.15 98.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.583 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.486 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.89 -49.84 74.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.324 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 31.8 mttp -64.64 -40.45 95.47 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -71.46 -47.02 58.3 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.748 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.69 -13.14 7.54 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.397 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.59 ' OG ' HG23 ' A' ' 15' ' ' ILE . 4.0 m -58.35 138.59 56.37 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.047 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.56 HG13 HD23 ' A' ' 16' ' ' LEU . 44.3 pt -90.65 -4.12 10.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -89.24 101.91 14.57 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.787 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.28 -45.3 96.77 Favored Glycine 0 C--N 1.317 -0.484 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.33 -43.38 89.73 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 54' ' ' GLY . 63.6 m -63.49 -34.79 78.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.822 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -64.76 -39.25 93.31 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.172 0.511 . . . . 0.0 109.973 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -64.37 -40.34 95.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.559 0.695 . . . . 0.0 109.248 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 84.0 mtp180 -97.27 10.3 39.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.051 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.592 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 21.3 m-20 57.68 29.86 17.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 71.67 0.85 42.72 Favored Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 1.3 m -68.45 83.07 0.26 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.119 0.485 . . . . 0.0 110.899 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.564 HD12 ' SG ' ' A' ' 12' ' ' CYS . 90.0 mt -63.4 -39.7 95.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.541 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 86.81 -149.08 22.1 Favored Glycine 0 C--N 1.318 -0.44 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.95 129.3 34.93 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.584 ' CE1' ' HG3' ' A' ' 64' ' ' MET . 45.8 p90 -146.14 149.47 34.07 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.677 0.275 . . . . 0.0 110.767 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.86 -179.46 38.86 Favored Glycine 0 C--N 1.315 -0.636 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -78.27 153.28 31.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.433 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.41 -34.54 5.21 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.19 -36.85 85.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.051 0.453 . . . . 0.0 110.475 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.584 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 3.5 mmm -110.82 154.18 24.34 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.258 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 27.4 m -64.91 141.13 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.596 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.4 mtpm? -44.2 -48.81 24.06 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -172.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 30.4 Cg_endo -60.66 -32.2 92.95 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 CA-C-N 119.059 0.7 . . . . 0.0 111.264 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.659 ' CD2' HD11 ' A' ' 93' ' ' ILE . 37.9 t80 -61.85 -46.94 87.29 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.463 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 99.7 mt-10 -61.49 -45.31 94.76 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.465 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.43 ' OD2' ' NH2' ' A' ' 74' ' ' ARG . 13.0 t70 -56.93 -50.33 72.9 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.408 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.05 93.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.046 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.586 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -61.77 -46.66 88.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.806 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.715 ' CE2' HD11 ' A' ' 10' ' ' ILE . 52.9 m-85 -66.31 -40.43 89.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.464 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 74' ' ' ARG . 50.9 mtm180 -64.07 -42.14 97.1 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.7 mt -97.95 31.77 2.59 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.513 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 48.6 mt-30 -55.81 -18.15 7.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.262 0.553 . . . . 0.0 109.943 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 79' ' ' GLU . 3.2 p -58.1 -29.16 36.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.037 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.405 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 118.78 -3.01 15.03 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' H ' HG13 ' A' ' 77' ' ' VAL . 79.9 mm-40 -69.51 161.21 29.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.887 0.375 . . . . 0.0 111.17 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.55 127.66 42.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.517 ' C ' HE21 ' A' ' 27' ' ' GLN . 10.5 p -77.53 159.28 29.43 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.265 0.555 . . . . 0.0 112.206 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -69.6 168.39 17.36 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.554 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 51.4 Cg_exo -56.38 135.18 68.78 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 N-CA-C 110.136 -0.756 . . . . 0.0 110.136 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 40.4 t -116.49 126.82 74.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HD3' ' CZ ' ' A' ' 90' ' ' TYR . 9.8 tptm -85.06 131.3 34.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.074 -177.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.8 p -135.53 170.07 16.53 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -56.26 -37.51 69.88 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -64.11 -43.82 94.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.152 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.04 -140.06 7.0 Favored Glycine 0 N--CA 1.465 0.601 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.58 ' O ' HD12 ' A' ' 16' ' ' LEU . 43.9 m-85 -106.28 130.88 54.05 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.637 ' CE1' HD13 ' A' ' 16' ' ' LEU . 6.8 m-70 -110.45 146.27 36.2 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.124 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.579 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 67.4 t -117.54 127.51 74.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.659 HD11 ' CD2' ' A' ' 68' ' ' PHE . 82.8 mt -119.71 128.08 75.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.984 -173.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.405 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 64.5 tttp -120.13 141.26 50.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -79.1 143.84 35.14 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.941 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 52.2 tp -112.64 131.14 55.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.486 0.66 . . . . 0.0 110.216 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.517 ' HA2' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--N 1.293 -1.82 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 mttp . . . . . 0 N--CA 1.443 -0.798 0 CA-C-O 120.761 0.315 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.854 HG21 ' HB1' ' A' ' 72' ' ' ALA . 61.1 mt -111.46 131.49 62.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.521 ' NZ ' ' OXT' ' A' ' 97' ' ' GLY . 46.3 mtpt -91.29 107.16 19.02 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' SG ' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -147.59 167.02 25.6 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.908 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.454 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 14.1 m -135.02 149.9 50.22 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.432 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.418 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -139.08 149.9 45.11 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 119.512 -0.875 . . . . 0.0 113.112 -177.763 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.735 HG23 ' HB3' ' A' ' 44' ' ' SER . 96.5 mt -124.11 123.34 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.608 HD12 ' O ' ' A' ' 90' ' ' TYR . 48.0 tp -94.41 127.2 40.16 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 90' ' ' TYR . 29.0 m -129.89 150.64 34.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.129 0.49 . . . . 0.0 110.588 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -66.14 -40.64 90.77 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.296 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -121.17 152.32 38.9 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -172.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.43 ' HG3' ' CG ' ' A' ' 83' ' ' PRO . 59.9 tt0 -62.06 -41.15 97.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.665 178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.09 95.67 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.97 -42.09 98.75 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.589 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -60.13 -41.37 92.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.742 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HA ' HE21 ' A' ' 27' ' ' GLN . 1.5 mm? -62.64 -42.46 99.61 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.029 0.442 . . . . 0.0 110.412 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.69 79.61 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.887 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 92' ' ' VAL . 31.1 m -64.42 -40.75 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.926 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.469 HE21 ' HA ' ' A' ' 24' ' ' LEU . 36.0 mt-30 -59.5 -47.05 87.02 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.275 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -64.3 -44.49 91.45 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.569 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 71.4 ttt180 -65.58 -39.3 91.48 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.69 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.884 HD22 HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -56.61 -28.92 61.5 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -177.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 69.0 mmtt -62.9 -30.12 71.29 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.79 -22.17 45.76 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.533 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.84 13.39 56.67 Favored Glycine 0 C--O 1.236 0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.135 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.569 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 73.9 mt-10 -66.31 154.46 39.93 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -60.19 126.71 28.56 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 66.0 t80 -59.11 -44.95 92.01 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -60.87 -37.77 94.25 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.472 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 60.1 tttm -60.23 -46.46 89.69 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.884 HD12 HD22 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.9 -36.91 80.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.932 178.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . -56.04 -50.86 69.76 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.501 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.46 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 45.4 mttp -62.76 -37.81 88.09 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 80.3 mm-40 -69.82 -46.65 65.19 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.422 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.564 HD22 ' CG1' ' A' ' 26' ' ' VAL . 1.7 mp -114.45 -41.44 3.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.735 ' HB3' HG23 ' A' ' 15' ' ' ILE . 6.6 p -54.99 138.11 44.52 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.481 -168.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.527 HG13 HD23 ' A' ' 16' ' ' LEU . 46.3 pt -97.85 -5.03 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.134 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -84.45 93.09 8.22 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.19 -45.53 96.33 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.2 -44.91 74.76 Favored Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.434 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 73.9 m -70.74 -34.08 71.49 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.604 175.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -63.69 -25.32 68.16 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.886 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 30.6 mmtp -63.14 -36.97 85.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 8.3 mtm-85 -96.77 15.47 21.87 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.165 174.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.582 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 22.6 m-20 58.94 29.48 18.98 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.72 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 49' ' ' SER . . . 77.89 -5.15 54.78 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -73.95 84.06 1.73 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.501 0.667 . . . . 0.0 110.186 178.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 96.4 mt -62.91 -39.75 95.49 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.153 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.433 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . 87.38 -142.92 18.35 Favored Glycine 0 CA--C 1.503 -0.667 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.511 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 19.8 m-85 -83.9 132.91 34.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.529 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 46.9 p90 -145.07 152.02 39.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.89 165.54 26.94 Favored Glycine 0 C--N 1.316 -0.53 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.496 ' HD2' ' CZ ' ' A' ' 73' ' ' PHE . 60.0 mtp180 -77.32 157.96 30.42 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.496 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 129.11 -77.03 0.4 Allowed Glycine 0 N--CA 1.462 0.394 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -61.21 -38.01 85.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.393 0.615 . . . . 0.0 109.623 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.569 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 75.6 mmm -63.84 145.8 55.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.213 -176.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG23 ' H ' ' A' ' 68' ' ' PHE . 13.3 m -73.71 130.66 35.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.657 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 64' ' ' MET . 5.7 mmtm -45.05 -40.35 10.56 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.118 -174.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 32.8 Cg_exo -56.09 -41.57 75.47 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 120.445 0.763 . . . . 0.0 110.434 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.593 ' CD2' HD11 ' A' ' 93' ' ' ILE . 23.0 t80 -62.84 -47.1 84.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.598 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.439 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 96.4 mt-10 -62.13 -43.2 99.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.59 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.03 -51.36 69.58 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.793 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -63.25 -40.21 96.79 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.278 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.854 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -58.94 -47.6 84.5 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.492 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.722 ' CE2' HD11 ' A' ' 10' ' ' ILE . 55.7 m-85 -66.62 -37.03 84.0 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.558 HH12 ' CD ' ' A' ' 82' ' ' GLU . 49.3 mtm180 -63.6 -35.92 82.12 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.563 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.64 HD11 ' CA ' ' A' ' 81' ' ' SER . 74.5 mt -97.24 21.38 10.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -171.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.509 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 70.0 mt-30 -52.27 -24.99 8.28 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.893 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 p -61.31 -26.51 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.647 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.433 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 115.17 5.43 19.64 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' A' ' 75' ' ' LEU . 1.8 mm-40 -75.6 173.85 10.49 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 t -104.22 127.5 58.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.584 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.64 ' CA ' HD11 ' A' ' 75' ' ' LEU . 60.0 p -68.14 151.02 47.63 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.558 ' CD ' HH12 ' A' ' 74' ' ' ARG . 1.2 mp0 -63.86 164.03 19.17 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 167.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 16.9 Cg_exo -54.32 128.29 29.42 Favored 'Trans proline' 0 C--N 1.29 -2.521 0 N-CA-C 109.71 -0.919 . . . . 0.0 109.71 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 91' ' ' HIS . 15.5 t -98.32 117.51 43.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -77.45 136.87 38.41 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.086 0.47 . . . . 0.0 110.844 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 10.3 p -153.89 167.35 30.01 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -57.02 -31.29 64.98 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.459 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 68.3 m-85 -63.58 -42.8 98.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.676 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.43 -132.81 4.45 Favored Glycine 0 C--O 1.239 0.426 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.608 ' O ' HD12 ' A' ' 16' ' ' LEU . 86.9 m-85 -107.42 127.66 53.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.545 ' O ' HG23 ' A' ' 84' ' ' VAL . 5.1 m-70 -108.03 140.71 40.8 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.889 172.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 26' ' ' VAL . 2.4 t -112.98 115.88 51.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 171.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.593 HD11 ' CD2' ' A' ' 68' ' ' PHE . 85.4 mt -111.82 125.34 69.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.854 -171.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 63.6 tttp -113.1 139.74 48.46 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 171.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 3.2 tmm_? -78.87 141.78 37.37 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.238 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.505 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 58.6 tp -109.91 134.41 52.11 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.167 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.521 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.204 -1.735 0 CA-C-O 118.126 -1.374 . . . . 0.0 110.63 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 mttm . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.825 HD11 ' CE2' ' A' ' 73' ' ' PHE . 39.8 mm -105.49 129.45 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.535 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 36.0 mtpt -88.98 104.32 16.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 176.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.53 170.36 16.2 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.815 -176.322 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.6 m -128.29 137.69 52.08 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 114.319 -1.31 . . . . 0.0 107.743 175.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.416 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -133.49 149.6 51.72 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.994 -0.682 . . . . 0.0 112.459 -178.712 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.505 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 90.0 mt -122.94 124.84 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.607 HD13 ' CE1' ' A' ' 91' ' ' HIS . 41.6 tp -104.85 123.54 47.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 43' ' ' LEU . 3.0 m -131.79 154.29 40.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.25 0.547 . . . . 0.0 111.556 -176.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -70.43 -40.38 73.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.818 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.61 144.49 37.88 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -169.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.488 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 27.4 mt-30 -62.78 -39.35 93.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.614 175.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.25 -38.86 95.21 Favored Glycine 0 CA--C 1.509 -0.307 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -64.99 -44.5 89.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.223 0.535 . . . . 0.0 109.77 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -60.71 -48.46 81.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.423 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.546 ' HA ' ' HB2' ' A' ' 27' ' ' GLN . 91.4 mt -64.32 -40.06 95.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.13 -49.17 74.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.35 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.708 HG12 HD12 ' A' ' 39' ' ' LEU . 21.1 m -64.93 -38.05 81.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.944 176.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.645 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 2.2 mm-40 -54.23 -48.16 71.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.428 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -70.67 -43.44 69.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.251 0.548 . . . . 0.0 110.766 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.776 ' HD3' HD11 ' A' ' 39' ' ' LEU . 65.0 ttt180 -61.63 -39.43 91.28 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.001 -174.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -60.75 -34.29 74.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.153 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.645 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 23.9 mmtm -62.97 -34.12 76.84 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.82 -23.62 63.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.425 176.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.09 1.45 54.68 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.103 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.46 ' OE1' ' NE ' ' A' ' 29' ' ' ARG . 55.1 mt-10 -65.58 155.78 34.74 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.35 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -61.62 126.58 27.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.082 -172.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.505 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 61.8 t80 -58.18 -45.24 87.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 174.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.41 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -60.09 -39.16 95.41 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.385 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -60.7 -43.58 97.63 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.031 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.776 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.4 mm? -63.48 -40.96 98.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.697 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.445 ' CB ' ' C ' ' A' ' 53' ' ' ASP . . . -60.68 -43.32 97.83 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 31.6 mmtt -64.56 -36.46 84.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -70.44 -59.34 2.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.075 -172.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.483 ' HB3' HG12 ' A' ' 17' ' ' VAL . 1.8 mt -93.42 -57.4 2.61 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.5 m -29.47 120.02 0.15 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.956 -1.474 . . . . 0.0 113.493 -165.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.408 HG13 HD23 ' A' ' 16' ' ' LEU . 41.5 pt -82.34 -12.0 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -82.16 95.08 7.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.8 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.05 -42.84 99.75 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.04 -45.36 81.95 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.1 m -69.16 -32.6 72.04 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.574 0.226 . . . . 0.0 110.724 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.424 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -63.12 -37.35 86.85 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.041 0.448 . . . . 0.0 109.999 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -63.73 -27.69 69.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.897 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 55' ' ' SER . 68.7 mtt-85 -95.94 5.61 50.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.081 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.467 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER 58.06 33.0 22.72 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.309 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 79.65 -16.85 9.7 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -66.15 81.38 0.08 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.61 0.719 . . . . 0.0 110.932 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.6 mt -61.87 -41.07 97.42 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.417 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 91.19 -137.38 13.81 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.535 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 71.2 m-85 -84.16 137.82 33.32 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.0 p90 -146.66 148.29 31.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.872 0.367 . . . . 0.0 111.197 169.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.0 169.53 23.04 Favored Glycine 0 C--N 1.313 -0.715 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -80.38 156.32 26.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.673 0.273 . . . . 0.0 110.551 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.48 -52.27 0.75 Allowed Glycine 0 C--N 1.31 -0.862 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -60.93 -45.0 96.43 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.144 0.497 . . . . 0.0 110.387 174.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.6 mmm -88.25 148.09 24.51 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.659 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.445 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.2 m -68.51 139.15 21.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' NZ ' ' OE1' ' A' ' 69' ' ' GLU . 11.2 mmtm -44.36 -40.97 9.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.53 -44.7 45.85 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 N-CA-C 110.37 -0.665 . . . . 0.0 110.37 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.615 ' CD2' HD11 ' A' ' 93' ' ' ILE . 41.0 t80 -62.6 -46.29 88.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.407 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.42 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 99.3 mt-10 -62.21 -45.9 91.31 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.871 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 38.3 t70 -59.12 -45.99 89.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.099 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.701 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -60.77 -46.56 90.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.245 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.575 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -62.03 -49.25 76.78 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.825 ' CE2' HD11 ' A' ' 10' ' ' ILE . 55.2 m-85 -67.16 -38.16 85.01 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 51.8 mtp180 -61.52 -47.08 87.23 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.333 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 81' ' ' SER . 42.7 mt -100.28 34.58 2.32 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.537 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 49.4 mt-30 -53.52 -20.17 4.6 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.817 0.341 . . . . 0.0 110.845 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.73 -26.55 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.492 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 113.93 6.13 21.17 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -78.39 153.68 31.36 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.41 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 16.6 t -75.2 130.78 35.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.566 ' C ' HE21 ' A' ' 27' ' ' GLN . 89.4 p -72.2 154.17 41.18 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.359 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -63.5 165.19 12.29 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -56.1 131.3 45.05 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 N-CA-C 109.513 -0.995 . . . . 0.0 109.513 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 42.0 t -105.86 109.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -80.48 134.12 35.93 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB2' HG21 ' A' ' 65' ' ' VAL . 8.6 p -153.18 168.49 25.78 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -60.6 -29.96 69.53 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.413 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 56.2 m-85 -66.79 -38.79 87.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.479 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.03 -150.28 22.5 Favored Glycine 0 C--N 1.316 -0.579 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.488 ' CE1' ' HG2' ' A' ' 20' ' ' GLN . 58.5 m-85 -101.95 125.96 48.75 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.607 ' CE1' HD13 ' A' ' 16' ' ' LEU . 3.3 m-70 -107.21 144.68 33.62 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.288 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.536 HG21 ' CG2' ' A' ' 26' ' ' VAL . 48.3 t -117.75 126.43 74.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 168.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.701 HD12 ' HB3' ' A' ' 71' ' ' ALA . 98.8 mt -117.64 129.33 74.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.804 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -119.68 140.67 50.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.537 ' HG3' ' HA ' ' A' ' 76' ' ' GLN . 2.5 tmm_? -78.85 143.96 35.47 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.997 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.425 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 57.2 tp -113.05 140.67 47.65 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.917 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.556 0 CA-C-O 118.267 -1.296 . . . . 0.0 110.571 -179.435 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.521 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -107.38 128.1 62.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' NZ ' ' OXT' ' A' ' 97' ' ' GLY . 62.3 mtpt -93.72 104.6 16.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -149.13 169.21 21.21 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.719 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.486 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 48.1 m -132.78 147.34 52.31 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.58 175.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.49 ' HB2' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -130.39 150.91 51.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -177.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.62 HG23 ' HB3' ' A' ' 44' ' ' SER . 96.2 mt -127.82 124.4 62.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.521 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 90' ' ' TYR . 37.4 tp -90.84 129.09 36.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.943 HG12 HD11 ' A' ' 43' ' ' LEU . 29.0 m -128.04 143.1 41.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 O-C-N 123.577 0.548 . . . . 0.0 110.834 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.691 ' HG3' HD13 ' A' ' 45' ' ' ILE . 1.6 mtpp -65.6 -42.41 91.66 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.191 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -126.38 151.97 46.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.681 -169.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -60.25 -35.08 74.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.722 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.09 -38.3 94.13 Favored Glycine 0 C--N 1.321 -0.265 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.61 -41.7 92.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -58.66 -47.4 84.57 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.135 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.68 -41.93 99.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.168 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.02 72.67 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.726 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.494 ' CG2' HG21 ' A' ' 92' ' ' VAL . 29.1 m -65.17 -39.78 86.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.101 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.537 ' O ' ' NZ ' ' A' ' 31' ' ' LYS . 4.6 mm-40 -58.69 -47.8 83.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.958 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -65.71 -46.46 78.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.502 0.668 . . . . 0.0 110.097 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.824 ' HD3' HD11 ' A' ' 39' ' ' LEU . 72.8 ttt180 -63.65 -40.83 97.86 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.886 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.473 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -56.63 -32.64 65.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -177.228 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 27' ' ' GLN . 29.6 mmtm -63.41 -13.05 35.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.466 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.16 -14.08 60.52 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.57 -1.92 60.37 Favored Glycine 0 C--O 1.243 0.667 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.58 148.72 32.42 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.322 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -71.78 142.19 49.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.958 0.885 . . . . 0.0 112.593 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.554 ' CE2' HG13 ' A' ' 15' ' ' ILE . 57.1 t80 -56.97 -45.04 83.16 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.116 -177.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.07 -37.5 94.01 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.69 -46.36 90.03 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.824 HD11 ' HD3' ' A' ' 29' ' ' ARG . 3.0 mm? -61.62 -39.64 91.98 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.291 173.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.546 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . -58.77 -50.99 71.88 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.317 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.491 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 62.3 mttm -61.15 -42.56 98.77 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.106 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.523 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 70.7 mt-10 -70.23 -41.37 73.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -173.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.943 HD11 HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -123.64 -28.53 3.86 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.663 ' N ' HD13 ' A' ' 43' ' ' LEU . 10.1 p -59.92 135.54 57.73 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.681 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.691 HD13 ' HG3' ' A' ' 18' ' ' LYS . 47.0 pt -105.26 -6.78 9.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.293 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.462 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 59.0 t0 -83.85 97.2 9.07 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -55.98 -46.09 85.2 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -43.85 -56.37 5.13 Favored Glycine 0 C--O 1.237 0.313 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.564 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . 1.5 p -71.04 -32.92 69.8 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -60.28 -34.44 73.75 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.147 0.498 . . . . 0.0 109.904 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 99.4 mttt -58.74 -36.01 73.63 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 177.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' O ' ' OG ' ' A' ' 55' ' ' SER . 61.1 mtp85 -98.3 7.57 46.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.396 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.491 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 79.9 m-20 58.71 31.76 21.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -173.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 49' ' ' SER . . . 75.85 -6.68 31.99 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 1.1 m -66.59 72.86 0.09 Allowed 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.434 0.635 . . . . 0.0 110.913 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 54' ' ' GLY . 94.5 mt -63.69 -40.33 96.53 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.593 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.59 -145.04 22.6 Favored Glycine 0 N--CA 1.464 0.54 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.95 129.08 34.93 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.585 ' CE1' ' HG3' ' A' ' 64' ' ' MET . 55.4 p90 -141.0 153.7 45.68 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.465 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.54 169.98 32.03 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.5 mtm105 -78.02 148.92 34.13 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 120.883 0.373 . . . . 0.0 111.004 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.16 -32.78 6.91 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -64.5 -37.35 87.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.842 0.353 . . . . 0.0 110.776 175.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 2.8 mmm -101.94 160.04 14.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.369 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 86' ' ' SER . 30.4 m -75.07 153.66 6.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -44.3 -50.0 22.82 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.99 -41.28 80.4 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 120.962 1.108 . . . . 0.0 110.828 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -62.36 -47.78 82.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.777 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.66 -38.68 91.83 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.227 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.06 -51.27 66.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.998 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 84' ' ' VAL . . . -65.2 -41.49 94.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.196 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.83 78.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 -177.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -67.46 -35.47 79.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 0.0 111.258 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.508 HH21 ' CD ' ' A' ' 82' ' ' GLU . 43.9 mtp180 -60.38 -39.18 86.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.155 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.615 HD11 ' CB ' ' A' ' 81' ' ' SER . 44.8 mt -96.87 17.11 17.48 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.496 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 82.4 mt-30 -54.08 -22.46 10.9 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 117.943 -1.503 . . . . 0.0 110.842 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -59.4 -27.31 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.113 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 121.51 -2.17 11.24 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.499 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -75.44 174.26 9.85 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -173.443 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.4 t -96.89 133.41 38.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.325 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.615 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -68.36 152.74 44.99 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.193 -178.688 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' CD ' HH21 ' A' ' 74' ' ' ARG . 2.8 mp0 -65.16 177.25 0.66 Allowed Pre-proline 0 N--CA 1.427 -1.587 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 167.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -56.54 134.55 65.09 Favored 'Trans proline' 0 C--N 1.287 -2.694 0 N-CA-C 109.765 -0.898 . . . . 0.0 109.765 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' ' 71' ' ' ALA . 50.5 t -120.95 129.59 75.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -109.3 132.38 54.18 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.064 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.576 ' HB2' HG21 ' A' ' 65' ' ' VAL . 66.5 p -115.0 -171.25 1.91 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.107 171.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -67.04 -35.04 79.02 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 172.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 8.6 m-30 -63.36 -44.39 94.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.635 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.34 -143.82 9.96 Favored Glycine 0 C--N 1.321 -0.261 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.586 ' O ' HD12 ' A' ' 16' ' ' LEU . 28.1 m-85 -102.14 134.28 45.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.943 0.401 . . . . 0.0 111.987 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.479 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 16.9 m-70 -118.4 150.1 40.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.023 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.494 HG21 ' CG2' ' A' ' 26' ' ' VAL . 75.8 t -117.51 125.7 74.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 164.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.496 ' O ' ' CD1' ' A' ' 75' ' ' LEU . 89.1 mt -123.55 131.86 72.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -171.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.492 ' HG2' ' N ' ' A' ' 95' ' ' ARG . 43.4 tttm -123.53 152.32 41.91 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.592 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 79.1 ttt180 -77.35 137.77 38.94 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 11' ' ' LYS . 53.7 tp -119.91 130.47 54.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.522 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.572 0 CA-C-O 118.769 -1.017 . . . . 0.0 112.188 -174.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 mttp . . . . . 0 N--CA 1.441 -0.9 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.804 HD12 ' CE2' ' A' ' 59' ' ' PHE . 58.4 mt -104.96 127.11 59.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -173.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.551 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 62.5 mtpt -91.94 106.05 18.16 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.442 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -146.54 164.79 31.44 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.914 -175.176 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.8 m -127.51 135.67 50.68 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.079 -1.418 . . . . 0.0 108.354 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.5 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -130.61 149.23 52.37 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.698 -177.075 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.66 HG23 ' OG ' ' A' ' 44' ' ' SER . 95.9 mt -128.44 127.72 67.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.142 176.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.636 HD23 HG13 ' A' ' 45' ' ' ILE . 41.4 tp -98.68 123.96 43.2 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.501 HG12 HD13 ' A' ' 43' ' ' LEU . 29.8 m -127.93 154.71 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.665 0.745 . . . . 0.0 111.052 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 6.7 mtmp? -65.75 -41.89 91.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.742 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 67.9 mttm -123.51 154.06 39.69 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.526 -167.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' A' ' 83' ' ' PRO . 58.2 tt0 -60.47 -40.84 92.7 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.032 175.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.44 -39.53 97.42 Favored Glycine 0 CA--C 1.508 -0.345 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 98.3 mt-10 -63.85 -42.78 97.5 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.649 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -61.73 -42.89 99.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.364 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.27 -41.61 99.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.851 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.67 -45.5 81.65 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.867 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.932 ' CG1' HD21 ' A' ' 43' ' ' LEU . 21.0 m -70.82 -36.27 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.461 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 18.6 tt0 -58.49 -45.78 88.01 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.71 -41.01 88.65 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.503 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.613 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 15.9 tpt180 -59.94 -40.84 90.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.818 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.474 HD11 ' CA ' ' A' ' 36' ' ' PHE . 1.4 mm? -61.7 -41.44 97.59 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.047 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 25.5 mmtp -67.72 -11.75 59.02 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.723 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -75.56 -11.17 59.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 174.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.1 10.84 63.88 Favored Glycine 0 C--O 1.238 0.372 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 91.2 mt-10 -86.15 155.86 20.59 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 57.0 mttm -67.37 139.02 57.16 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.381 0.61 . . . . 0.0 112.58 -175.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CE2' HG13 ' A' ' 15' ' ' ILE . 52.7 t80 -58.42 -45.84 87.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.056 174.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 53' ' ' ASP . . . -62.21 -35.07 91.02 Favored Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.53 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 49.1 tttm -60.65 -48.87 79.84 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.763 HD12 HG12 ' A' ' 26' ' ' VAL . 4.1 mm? -62.79 -41.57 99.33 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.064 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.504 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.49 -50.49 73.56 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.685 -176.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.557 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 67.8 mttm -65.23 -40.13 93.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.943 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.533 ' OE2' ' NZ ' ' A' ' 38' ' ' LYS . 95.8 mt-10 -71.0 -44.42 65.95 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -172.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.932 HD21 ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -124.51 -19.35 5.45 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -174.798 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.811 ' N ' HD12 ' A' ' 43' ' ' LEU . 1.7 m -55.73 140.21 42.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.38 -173.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.636 HG13 HD23 ' A' ' 16' ' ' LEU . 39.8 pt -86.03 -11.65 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.516 0.674 . . . . 0.0 109.227 176.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -88.2 115.17 25.49 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.068 173.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.24 -32.88 77.99 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 52' ' ' ARG . . . -55.57 -42.83 85.36 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 177.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 54' ' ' GLY . 41.2 m -61.27 -35.44 77.29 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.538 176.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . . . -73.64 -43.23 60.07 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.474 0.654 . . . . 0.0 110.525 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -66.29 -39.71 89.56 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.905 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 55' ' ' SER . 21.5 mmm180 -96.05 4.25 52.75 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.425 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.557 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 53.09 35.41 19.58 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -173.643 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 76.68 -36.85 1.41 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.461 -173.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -54.27 89.36 0.01 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.547 0.739 . . . . 0.0 112.041 -178.047 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.442 HD12 ' SG ' ' A' ' 12' ' ' CYS . 93.0 mt -63.65 -40.3 96.5 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.238 176.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 97.27 -147.45 18.66 Favored Glycine 0 CA--C 1.503 -0.693 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.551 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 4.8 m-85 -83.71 132.48 34.85 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.804 ' CE2' HD12 ' A' ' 10' ' ' ILE . 54.7 p90 -146.56 150.65 35.93 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.807 173.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.478 ' H ' ' HD3' ' A' ' 63' ' ' LYS . . . -95.99 -168.0 34.72 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 61' ' ' ARG . 53.7 mtp85 -85.31 148.83 25.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.607 0.241 . . . . 0.0 110.876 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 91.82 -17.53 56.25 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 116.44 -0.346 . . . . 0.0 112.345 176.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 60' ' ' GLY . 1.4 mptp? -67.37 -37.88 83.86 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.181 0.515 . . . . 0.0 111.781 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.552 ' CE ' ' CD2' ' A' ' 59' ' ' PHE . 3.5 mpp? -118.43 161.73 19.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.322 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 68' ' ' PHE . 19.8 m -58.01 136.64 21.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HZ2' ' HB2' ' A' ' 70' ' ' ASP . 8.0 tmtm? -44.76 -42.88 16.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -173.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.37 -43.42 58.84 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 CA-C-N 118.894 0.641 . . . . 0.0 110.608 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.432 ' CD1' HD11 ' A' ' 93' ' ' ILE . 67.8 t80 -63.09 -50.81 69.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.804 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 97.2 mt-10 -67.05 -41.15 87.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.501 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 66' ' ' LYS . 22.7 t70 -59.01 -44.3 91.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.957 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.31 84.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.493 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.05 89.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.48 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.624 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 46.6 m-85 -62.52 -29.74 70.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.637 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -65.3 -37.16 86.27 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.625 HD11 ' CA ' ' A' ' 81' ' ' SER . 76.8 mt -95.75 21.52 8.36 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -168.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.533 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 71.9 mt-30 -45.26 -24.98 0.32 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.469 0.176 . . . . 0.0 111.031 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.93 -31.24 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.607 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 123.02 0.42 9.71 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.387 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.546 ' HB3' HD22 ' A' ' 75' ' ' LEU . 1.1 mm-40 -68.14 174.46 3.86 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.34 129.67 62.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.625 ' CA ' HD11 ' A' ' 75' ' ' LEU . 82.5 p -64.47 155.41 32.82 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.113 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.16 169.46 16.4 Favored Pre-proline 0 N--CA 1.432 -1.354 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 164.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.649 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 67.5 Cg_exo -54.62 129.4 34.73 Favored 'Trans proline' 0 C--N 1.292 -2.398 0 CA-C-N 118.923 0.651 . . . . 0.0 110.482 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 91' ' ' HIS . 99.9 t -107.66 108.28 24.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.215 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 65.7 tttp -81.95 133.46 35.31 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.581 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.1 p -138.29 179.79 6.25 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -61.08 -37.61 83.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 10.4 m-30 -63.29 -43.59 97.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.772 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.83 -139.27 6.72 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.514 ' O ' HD12 ' A' ' 16' ' ' LEU . 26.2 m-85 -104.92 130.12 53.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.98 0.39 . . . . 0.0 111.038 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.568 ' CE1' HD13 ' A' ' 16' ' ' LEU . 15.7 m-70 -113.22 148.68 35.01 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.215 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.569 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 72.1 t -117.72 126.98 75.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 167.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.432 HD11 ' CD1' ' A' ' 68' ' ' PHE . 91.4 mt -118.46 123.39 71.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -107.76 140.83 40.24 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 169.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.628 ' NH1' ' O ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -78.74 138.75 38.39 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.91 176.805 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.628 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 53.3 tp -103.15 124.84 49.34 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.435 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.21 -1.368 0 CA-C-O 118.272 -1.293 . . . . 0.0 112.005 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.8 mttp . . . . . 0 N--CA 1.437 -1.108 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.9 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 71.8 mt -105.08 128.48 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' NZ ' ' O ' ' A' ' 97' ' ' GLY . 59.3 mtpt -91.57 109.49 20.79 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.445 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -141.04 164.61 29.82 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -174.792 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.8 m -127.39 140.7 52.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.479 173.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.43 ' CD2' ' C ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -136.33 150.77 49.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.316 0.579 . . . . 0.0 112.488 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.514 HG23 ' OG ' ' A' ' 44' ' ' SER . 96.1 mt -128.98 126.52 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.323 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' A' ' 46' ' ' ASP . 13.8 mt -95.56 132.69 40.43 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.109 HG12 HD21 ' A' ' 43' ' ' LEU . 34.9 m -129.77 153.63 39.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 O-C-N 123.58 0.55 . . . . 0.0 109.684 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -65.07 -41.29 95.23 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.083 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 9.0 mtmp? -124.55 149.52 46.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -173.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 52.7 tt0 -63.0 -37.35 86.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.05 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.96 -38.73 93.2 Favored Glycine 0 C--O 1.242 0.645 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 93.6 mt-10 -63.77 -41.68 97.93 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 176.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 20' ' ' GLN . . . -58.16 -47.22 84.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.168 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.83 -41.98 98.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.544 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.9 -50.72 72.65 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.752 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' HD23 ' A' ' 30' ' ' LEU . 14.9 m -65.38 -39.22 84.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.059 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 81' ' ' SER . 91.2 mt-30 -57.9 -46.81 84.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.217 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -63.42 -36.54 84.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.838 ' HD3' HD11 ' A' ' 39' ' ' LEU . 77.0 ttt180 -63.15 -39.42 94.62 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.493 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.753 HD11 ' HA ' ' A' ' 36' ' ' PHE . 4.3 mm? -61.41 -40.43 94.4 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 66.2 mmtt -60.83 -28.39 68.78 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.692 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -64.11 -21.22 66.45 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.419 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.93 -4.32 38.94 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.143 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.631 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 18.9 mt-10 -62.8 149.72 43.36 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.211 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 41.1 tttm -63.68 134.3 55.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.214 0.53 . . . . 0.0 110.927 -174.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.753 ' HA ' HD11 ' A' ' 30' ' ' LEU . 64.9 t80 -56.85 -45.24 82.55 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.566 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.03 -34.84 89.44 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.319 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 88.4 tttt -59.95 -46.65 88.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.838 HD11 ' HD3' ' A' ' 29' ' ' ARG . 3.9 mm? -62.57 -41.33 98.86 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.571 173.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.44 -47.43 84.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.446 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 31.5 mmtp -65.69 -40.6 92.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.077 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 42.2 mt-10 -70.68 -54.12 13.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -172.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.109 HD21 HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -118.21 -29.09 5.65 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -166.607 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.963 ' N ' HD13 ' A' ' 43' ' ' LEU . 1.3 m -42.25 137.94 1.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.3 pt -83.32 -12.74 11.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.552 ' HB2' HD12 ' A' ' 16' ' ' LEU . 64.9 t0 -88.59 97.5 11.13 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.717 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -67.45 -45.89 74.64 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.74 -45.68 78.06 Favored Glycine 0 C--O 1.236 0.267 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 54' ' ' GLY . 15.9 m -69.68 -32.67 71.43 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.562 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.62 68.81 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.419 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 48.9 mmtm -62.34 -37.68 86.59 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.453 ' O ' ' OG ' ' A' ' 55' ' ' SER . 89.7 mtm-85 -97.63 20.82 11.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.809 176.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.566 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 16.4 m-20 60.41 32.44 20.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.153 0.502 . . . . 0.0 109.733 -177.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 78.71 -8.54 41.99 Favored Glycine 0 C--N 1.307 -1.04 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -64.92 89.08 0.07 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.398 0.618 . . . . 0.0 110.36 179.127 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.449 ' HA ' HH21 ' A' ' 52' ' ' ARG . 91.5 mt -63.1 -41.3 99.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.874 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.39 -154.18 18.97 Favored Glycine 0 C--O 1.236 0.265 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -83.97 135.05 34.61 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 10' ' ' ILE . 53.8 p90 -143.2 154.38 43.8 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.558 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.89 173.76 25.94 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH1' ' CZ ' ' A' ' 73' ' ' PHE . 51.5 mtp85 -71.33 138.62 49.41 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.528 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 86.65 -5.76 84.06 Favored Glycine 0 C--N 1.305 -1.16 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -68.42 -40.54 81.17 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.21 0.528 . . . . 0.0 109.734 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.503 ' HE2' ' CG ' ' A' ' 59' ' ' PHE . 76.4 mtm -123.41 161.95 23.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.707 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.5 m -51.67 140.04 6.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -44.54 -46.26 25.07 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.538 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.88 -46.26 34.66 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 120.643 0.896 . . . . 0.0 110.742 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CD2' HD11 ' A' ' 93' ' ' ILE . 46.1 t80 -61.7 -49.23 77.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.454 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 96.1 mt-10 -65.72 -40.32 92.07 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.339 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.92 -44.49 91.3 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.85 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.422 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -67.39 -38.44 84.69 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.856 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.37 96.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.132 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.9 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 39.3 m-85 -61.86 -32.02 72.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 120.794 0.33 . . . . 0.0 111.73 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -61.68 -37.28 83.5 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.741 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.699 HD11 ' HB3' ' A' ' 81' ' ' SER . 72.0 mt -90.58 6.85 42.02 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.438 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 85.4 mt-30 -50.78 -27.35 7.05 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.962 -177.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 p -62.95 -33.55 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.455 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 119.89 49.76 0.3 Allowed Glycine 0 N--CA 1.475 1.28 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.643 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.664 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -128.64 174.37 9.47 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -175.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.45 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 97.2 t -95.77 130.64 44.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.699 ' HB3' HD11 ' A' ' 75' ' ' LEU . 6.2 p -78.61 163.3 25.6 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.019 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.505 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -68.77 169.78 10.13 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 69.5 Cg_endo -62.46 141.5 86.97 Favored 'Trans proline' 0 C--N 1.297 -2.141 0 CA-C-N 118.885 0.638 . . . . 0.0 110.707 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.76 130.84 73.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.497 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 29.6 tptp -107.67 135.59 48.85 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.243 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.3 p -145.63 177.16 9.09 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.49 -31.38 70.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -62.1 -42.28 99.06 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.983 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.436 ' O ' ' HD2' ' A' ' 85' ' ' LYS . . . 152.09 -143.54 10.52 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.548 ' O ' HD23 ' A' ' 16' ' ' LEU . 3.2 m-85 -105.24 129.5 53.6 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -109.37 147.5 32.64 Favored 'General case' 0 CA--C 1.501 -0.931 0 O-C-N 123.41 0.444 . . . . 0.0 110.148 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.6 t -118.11 126.55 75.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 163.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.54 HD11 ' CD2' ' A' ' 68' ' ' PHE . 89.2 mt -115.62 129.92 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.668 -174.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -124.9 143.12 51.02 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.438 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 1.7 tmm_? -78.58 143.83 36.11 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.317 -174.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.424 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 53.8 tp -109.06 139.04 44.48 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.737 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.436 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.205 -1.675 0 CA-C-O 118.249 -1.306 . . . . 0.0 110.332 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HD3' ' CA ' ' A' ' 60' ' ' GLY . 35.0 mmtp . . . . . 0 C--O 1.241 0.62 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.843 HG21 ' HB1' ' A' ' 72' ' ' ALA . 40.5 mm -106.96 128.35 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.196 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.55 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 46.0 mtpt -95.66 106.9 19.05 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -148.03 168.24 22.84 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.873 -1.131 . . . . 0.0 113.947 -175.003 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.509 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 19.4 m -135.31 143.97 46.47 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.235 173.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.51 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -138.97 151.77 47.14 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.746 HG23 ' HB2' ' A' ' 44' ' ' SER . 89.1 mt -121.03 126.7 75.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -98.5 119.52 37.35 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.755 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.607 ' N ' HD13 ' A' ' 16' ' ' LEU . 19.7 m -127.11 146.68 32.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.187 0.518 . . . . 0.0 111.605 -177.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.33 -40.89 90.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.508 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 22.3 mmtp -109.96 148.24 31.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.869 -171.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -37.55 87.74 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.665 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.98 -37.1 93.85 Favored Glycine 0 C--O 1.227 -0.305 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.513 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 97.9 mt-10 -64.09 -44.69 91.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -60.31 -49.68 76.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.495 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.99 -41.48 97.48 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.263 0.554 . . . . 0.0 110.216 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.51 -47.19 82.63 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.521 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.856 HG11 HD22 ' A' ' 43' ' ' LEU . 26.1 m -70.2 -32.11 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.967 176.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -61.35 -47.08 87.53 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -67.86 -43.43 79.46 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.939 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.926 ' HD3' HD11 ' A' ' 39' ' ' LEU . 75.0 ttt180 -60.7 -39.17 87.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.329 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.54 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -57.16 -41.1 78.55 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.71 -26.9 68.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.737 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -65.72 -1.1 2.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 177.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.27 19.02 61.39 Favored Glycine 0 C--O 1.236 0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.143 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 28.3 mt-10 -87.1 144.68 26.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.526 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 56.5 mttp -64.12 139.89 58.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.413 0.625 . . . . 0.0 112.304 -175.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.498 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 48.2 t80 -57.77 -45.53 85.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.552 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.24 -36.72 93.43 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.0 177.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 64.4 tttm -60.76 -44.64 96.49 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.926 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.6 mm? -62.66 -40.43 97.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.693 172.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.15 97.87 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.972 0.415 . . . . 0.0 110.144 -177.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.526 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 13.1 mmtm -65.86 -44.09 86.46 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.897 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.507 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 74.6 mt-10 -71.4 -41.79 69.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.856 HD22 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -111.9 -70.39 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -170.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.746 ' HB2' HG23 ' A' ' 15' ' ' ILE . 4.4 t -33.59 128.48 0.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.449 -168.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.2 pt -91.05 -3.3 10.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.777 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 50' ' ' ALA . 54.6 t0 -79.09 94.73 5.39 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.09 -51.08 61.03 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -46.21 -53.41 9.34 Favored Glycine 0 C--N 1.322 -0.235 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.541 ' OG ' ' NH2' ' A' ' 52' ' ' ARG . 21.9 m -71.7 -32.24 67.59 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 46' ' ' ASP . . . -62.63 -38.35 89.89 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -61.79 -25.48 67.51 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.756 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' NH2' ' OG ' ' A' ' 49' ' ' SER . 93.1 mtm-85 -97.69 7.71 45.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.367 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.552 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER 59.71 34.1 22.0 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.536 0.684 . . . . 0.0 109.649 -173.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 79.27 -8.59 45.55 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.336 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 m -65.4 128.46 35.97 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.589 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.58 HD12 ' SG ' ' A' ' 12' ' ' CYS . 83.1 mt -109.01 -28.77 8.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.985 0.421 . . . . 0.0 110.064 177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 78.63 -146.87 30.41 Favored Glycine 0 CA--C 1.516 0.124 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.55 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 44.0 m-85 -84.32 133.27 34.55 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.548 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 52.1 p90 -144.43 145.91 32.18 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.425 ' CA ' ' HD3' ' A' ' 9' ' ' LYS . . . -93.76 179.25 38.39 Favored Glycine 0 C--N 1.316 -0.535 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -71.05 137.73 49.22 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.085 -0.558 . . . . 0.0 109.778 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.17 -22.76 32.31 Favored Glycine 0 C--N 1.305 -1.182 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.46 -41.4 84.75 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.463 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 5.7 mmm -113.85 160.73 18.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.369 -170.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 86' ' ' SER . 30.7 m -63.73 142.67 16.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -43.43 -50.26 16.6 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.997 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.26 -42.18 69.71 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 N-CA-C 110.393 -0.657 . . . . 0.0 110.393 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CD2' HD11 ' A' ' 93' ' ' ILE . 40.0 t80 -62.4 -47.93 81.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.454 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 64' ' ' MET . 97.4 mt-10 -65.1 -42.88 93.6 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.584 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.68 -40.68 93.05 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.241 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.07 -41.96 90.04 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.006 0.431 . . . . 0.0 110.114 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.843 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.6 -42.87 97.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.395 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 10' ' ' ILE . 46.5 m-85 -66.82 -34.13 77.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -62.99 -33.86 76.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.896 HD11 ' HB3' ' A' ' 81' ' ' SER . 73.9 mt -89.41 18.67 5.04 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -168.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.508 ' NE2' HD12 ' A' ' 10' ' ' ILE . 99.4 mm-40 -59.41 -22.46 61.45 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.3 -26.05 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.427 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 98.49 29.47 7.42 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.58 ' O ' HD13 ' A' ' 75' ' ' LEU . 35.8 tt0 -101.74 159.75 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.787 -0.243 . . . . 0.0 111.458 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.43 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 20.1 t -77.22 131.11 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 172.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.896 ' HB3' HD11 ' A' ' 75' ' ' LEU . 28.1 p -69.91 157.61 37.12 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.671 -178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 16.8 mp0 -73.17 168.65 22.95 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 167.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.514 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 86.5 Cg_exo -53.95 131.42 44.42 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 N-CA-C 110.304 -0.691 . . . . 0.0 110.304 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 91' ' ' HIS . 46.0 t -106.62 108.59 25.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.521 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 16.0 tptm -79.59 131.62 36.05 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.46 ' HB2' HG21 ' A' ' 65' ' ' VAL . 14.7 p -151.34 174.58 13.16 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.76 -172.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -54.81 -36.86 65.42 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.708 174.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -68.67 -41.49 79.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.628 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.9 -125.54 2.51 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.521 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 96.1 m-85 -109.97 128.28 55.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.111 0.455 . . . . 0.0 110.157 177.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.51 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 4.2 m-70 -108.37 146.63 32.74 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.906 173.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.434 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 77.4 t -117.0 125.44 73.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 168.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.52 ' N ' ' OG ' ' A' ' 81' ' ' SER . 88.5 mt -119.46 129.47 75.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.714 -171.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -112.34 131.33 55.59 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 169.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.505 ' CD ' ' HA ' ' A' ' 76' ' ' GLN . 79.2 ttt-85 -78.04 135.47 37.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 11' ' ' LYS . 56.0 tp -107.24 132.82 52.65 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.141 -173.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.387 0 CA-C-O 118.096 -1.391 . . . . 0.0 111.221 -177.399 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.0 mttp . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.905 HG21 ' HB1' ' A' ' 72' ' ' ALA . 15.7 mm -105.2 124.18 59.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 97' ' ' GLY . 62.0 mtpt -97.15 105.13 17.22 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 171.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -146.16 168.73 20.28 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -173.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.9 m -132.66 146.86 52.22 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.82 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.586 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -133.92 150.65 51.32 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.656 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 93.6 mt -123.62 126.72 73.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 90' ' ' TYR . 42.1 tp -100.74 122.47 43.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.29 155.34 41.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.332 0.587 . . . . 0.0 110.915 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -65.29 -40.29 93.66 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.702 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.557 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 58.4 mttp -117.13 151.81 36.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.086 -168.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.429 ' O ' HD23 ' A' ' 24' ' ' LEU . 87.2 mt-30 -63.07 -40.57 98.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.44 -0.8 . . . . 0.0 108.96 170.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.97 -37.49 93.92 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.573 ' O ' HG13 ' A' ' 26' ' ' VAL . 94.4 mt-10 -64.73 -41.34 96.03 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.01 -42.66 98.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.993 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 20' ' ' GLN . 2.5 mm? -62.22 -41.84 98.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -56.48 -49.89 73.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.384 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.627 ' O ' HD23 ' A' ' 30' ' ' LEU . 2.6 m -65.19 -40.82 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.807 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 23' ' ' ALA . 22.2 mt-30 -56.65 -46.24 81.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -67.83 -41.85 82.39 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.315 0.579 . . . . 0.0 110.261 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.518 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 77.0 ttt180 -61.07 -39.43 89.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.922 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 26' ' ' VAL . 4.4 mm? -58.65 -36.57 74.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -67.44 -13.61 62.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.378 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -71.95 -12.4 61.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.99 0.424 . . . . 0.0 110.116 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.97 16.64 47.0 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.256 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 29' ' ' ARG . 34.2 mt-10 -82.59 147.38 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.283 176.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 41.9 tttm -66.25 133.82 51.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.087 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.656 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 54.3 t80 -58.62 -46.31 87.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.149 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.89 -36.14 92.99 Favored Glycine 0 C--O 1.25 1.154 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 62.3 tttm -60.2 -48.12 83.06 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.679 ' HB3' HD12 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -63.96 -40.1 95.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.987 176.692 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' CB ' ' C ' ' A' ' 53' ' ' ASP . . . -56.49 -47.94 78.22 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.477 ' NZ ' ' O ' ' A' ' 37' ' ' GLY . 24.5 mtmm -64.77 -41.28 95.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.029 176.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.518 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 86.9 mt-10 -71.04 -56.83 5.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.679 HD12 ' HB3' ' A' ' 39' ' ' LEU . 10.9 mt -76.77 -50.37 13.71 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.509 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.8 m -61.14 139.25 58.14 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.337 -161.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.549 HG13 HD23 ' A' ' 16' ' ' LEU . 45.0 pt -87.75 -4.52 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.874 172.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -89.77 96.65 10.78 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.189 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.0 -41.36 99.92 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.63 -45.1 90.86 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.586 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 39.6 m -63.89 -33.79 76.49 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.699 0.285 . . . . 0.0 110.622 174.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -62.57 -40.63 97.48 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 31.5 mmtp -70.3 -11.73 61.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.697 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 55' ' ' SER . 72.2 mmt-85 -113.03 9.28 18.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.097 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.4 m-20 53.61 30.8 11.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -174.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 60.48 1.42 1.73 Allowed Glycine 0 C--N 1.318 -0.438 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 53' ' ' ASP . 1.7 m -75.84 85.75 2.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.244 0.545 . . . . 0.0 110.578 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.624 HD13 ' CE ' ' A' ' 64' ' ' MET . 85.0 mt -63.85 -40.16 95.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.175 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.29 -149.25 20.58 Favored Glycine 0 C--N 1.322 -0.231 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.83 132.79 34.36 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 53.6 p90 -143.62 146.73 33.49 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.338 171.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.75 -171.7 37.49 Favored Glycine 0 C--N 1.314 -0.659 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.416 ' HD2' HH11 ' A' ' 61' ' ' ARG . 50.6 mtp85 -69.64 139.32 53.56 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.08 -27.25 17.39 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -65.32 -37.44 87.1 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 116.959 0.38 . . . . 0.0 111.669 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.624 ' CE ' HD13 ' A' ' 56' ' ' LEU . 3.3 mmt -110.28 159.55 17.32 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -176.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.84 134.23 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.098 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.458 ' NZ ' ' OE2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -45.58 -40.51 14.24 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -171.503 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.24 -43.37 56.74 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.654 0.903 . . . . 0.0 110.242 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CE1' HG12 ' A' ' 93' ' ' ILE . 48.5 t80 -61.99 -46.82 87.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.85 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.458 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 81.4 mt-10 -64.42 -40.89 96.64 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.345 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -55.86 -47.26 77.64 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.826 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.46 77.92 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.496 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.905 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.6 -46.48 90.08 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.638 ' CE1' HD11 ' A' ' 10' ' ' ILE . 47.3 m-85 -62.61 -41.68 99.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.983 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -63.52 -41.7 98.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.814 ' C ' HD23 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -83.56 1.08 43.81 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -174.734 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.644 ' NE2' HD13 ' A' ' 10' ' ' ILE . 7.3 mm-40 -51.24 -23.36 3.38 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.939 0.4 . . . . 0.0 110.162 177.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.445 HG13 ' HG2' ' A' ' 79' ' ' GLU . 7.4 p -59.31 -27.46 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.772 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 120.49 46.89 0.34 Allowed Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.445 ' HG2' HG13 ' A' ' 77' ' ' VAL . 49.3 mm-40 -117.37 170.89 8.35 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 t -100.41 117.29 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 170.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.5 p -62.73 151.02 39.68 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.399 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.26 170.95 3.0 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.0 131.47 45.67 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 N-CA-C 109.828 -0.874 . . . . 0.0 109.828 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 68' ' ' PHE . 18.5 t -107.2 111.78 37.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -88.24 134.49 33.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.798 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.9 p -144.9 173.66 11.68 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.7 pm0 -57.83 -31.26 66.46 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -67.01 -38.42 85.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.815 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.48 -145.74 14.5 Favored Glycine 0 C--N 1.322 -0.216 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.613 ' O ' HD12 ' A' ' 16' ' ' LEU . 91.3 m-85 -106.87 129.8 54.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.523 ' CE1' HD13 ' A' ' 16' ' ' LEU . 2.6 m-70 -110.81 148.27 32.73 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.455 0.169 . . . . 0.0 110.561 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.492 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 56.0 t -117.9 128.22 75.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 167.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.529 HG23 ' SG ' ' A' ' 12' ' ' CYS . 72.8 mt -109.18 126.83 66.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.76 0.314 . . . . 0.0 110.441 -175.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 95' ' ' ARG . 9.6 tptp -104.9 135.63 45.9 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 170.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.546 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -76.96 142.0 40.2 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.239 -178.646 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.6 tp -108.16 132.69 53.35 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.469 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.532 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.766 -172.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.7 mttp . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.755 HD11 ' CD1' ' A' ' 73' ' ' PHE . 41.9 mm -104.58 126.22 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 97' ' ' GLY . 60.6 mtpt -94.12 108.18 20.04 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 170.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -148.01 170.13 18.41 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.961 -171.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.554 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 20.3 m -130.63 147.35 52.3 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.537 175.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.563 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -134.71 152.47 51.79 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.879 0.371 . . . . 0.0 111.593 -175.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.555 HD13 ' HB3' ' A' ' 39' ' ' LEU . 86.2 mt -128.14 127.14 67.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 175.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 90' ' ' TYR . 38.7 tp -99.28 123.09 43.29 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.25 154.36 28.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.156 0.503 . . . . 0.0 111.497 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.423 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 6.6 mttp -67.7 -42.23 82.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.621 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 68.3 mttm -124.53 149.8 46.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.64 -168.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.425 ' O ' HD23 ' A' ' 24' ' ' LEU . 9.5 pt20 -57.21 -38.84 74.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.164 171.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.75 -36.16 92.31 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.478 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 96.9 mt-10 -64.07 -41.05 97.47 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.357 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -61.32 -45.52 94.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.595 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 20' ' ' GLN . 2.8 mm? -61.84 -41.96 98.45 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.44 76.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.504 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 43' ' ' LEU . 32.8 m -65.5 -37.72 80.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.784 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.609 ' NE2' ' HA ' ' A' ' 82' ' ' GLU . 79.0 mt-30 -59.32 -49.82 76.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.162 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.448 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 70.9 mm-40 -68.34 -38.52 81.58 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HD3' HD11 ' A' ' 39' ' ' LEU . 73.5 ttt180 -61.97 -42.2 98.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.146 0.498 . . . . 0.0 109.874 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -43.41 95.36 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.448 ' NZ ' ' OE2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -63.66 -12.78 36.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.958 175.385 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -72.72 -8.4 55.21 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.04 9.99 60.22 Favored Glycine 0 C--O 1.238 0.38 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -75.1 161.21 29.61 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.998 0.427 . . . . 0.0 111.348 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 47.0 mttm -74.07 137.14 43.15 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.291 -177.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -59.14 -45.09 91.84 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.44 -39.06 96.76 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.281 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 88.4 tttt -60.33 -45.16 94.42 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.705 HD11 ' HD3' ' A' ' 29' ' ' ARG . 1.3 mm? -61.34 -42.1 98.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.09 173.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -61.56 -53.21 59.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.948 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -69.02 -32.86 72.68 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.805 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.483 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 87.1 mt-10 -71.08 -41.21 70.96 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 26' ' ' VAL . 4.5 mp -105.21 -67.97 0.89 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -26.58 117.16 0.07 Allowed 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 114.084 -1.416 . . . . 0.0 112.984 -166.185 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.506 HG13 HD23 ' A' ' 16' ' ' LEU . 46.2 pt -90.68 -2.57 10.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.067 -177.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.409 ' CG ' ' HE2' ' A' ' 14' ' ' HIS . 1.2 p30 -76.41 179.89 5.58 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.714 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.35 -118.73 0.55 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.736 -176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 52' ' ' ARG . . . -49.41 -43.13 34.94 Favored Glycine 0 C--N 1.321 -0.259 0 N-CA-C 112.153 -0.379 . . . . 0.0 112.153 -172.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -60.12 -34.24 73.24 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.366 -179.019 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.26 86.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.472 0.653 . . . . 0.0 109.271 175.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.23 -7.37 59.37 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.442 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.463 ' O ' ' OG ' ' A' ' 55' ' ' SER . 56.3 mtp85 -96.89 20.38 11.19 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.731 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.537 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 83.0 m-20 56.19 29.62 15.09 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -173.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.76 -13.26 7.04 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.689 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 28.1 p -66.33 95.08 0.29 Allowed 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.834 0.826 . . . . 0.0 112.199 -177.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.535 HD12 ' SG ' ' A' ' 12' ' ' CYS . 92.7 mt -65.58 -38.3 89.11 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.812 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.03 -147.19 18.75 Favored Glycine 0 C--N 1.317 -0.474 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 1.5 p90 -85.3 141.04 30.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.222 0.511 . . . . 0.0 111.385 177.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.673 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 49.9 p90 -147.28 151.65 36.98 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 171.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.31 176.94 27.05 Favored Glycine 0 C--O 1.241 0.59 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' A' ' 73' ' ' PHE . 83.6 mtm-85 -69.36 142.44 53.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 120.977 0.418 . . . . 0.0 110.705 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.85 -36.58 4.3 Favored Glycine 0 C--N 1.306 -1.124 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -63.1 -41.5 99.38 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.395 -0.474 . . . . 0.0 110.721 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.486 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 26.7 mmm -97.05 160.23 14.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.923 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 68' ' ' PHE . 19.5 m -71.28 144.47 13.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -44.31 -51.51 19.36 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.73 -42.82 65.02 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.39 0.727 . . . . 0.0 110.391 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.559 ' CD2' HD11 ' A' ' 93' ' ' ILE . 35.4 t80 -62.16 -46.29 89.63 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.885 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -61.61 -42.51 98.99 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.523 ' CG ' ' HE ' ' A' ' 74' ' ' ARG . 11.8 t70 -55.81 -48.82 74.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.45 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.61 61.84 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.114 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.5 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.28 -50.81 72.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.732 -176.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.755 ' CD1' HD11 ' A' ' 10' ' ' ILE . 58.5 m-85 -67.01 -39.26 87.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HE ' ' CG ' ' A' ' 70' ' ' ASP . 46.8 mtm105 -63.5 -39.19 93.79 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.225 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.481 HD12 ' HB3' ' A' ' 81' ' ' SER . 73.9 mt -96.5 29.97 2.73 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.47 ' OE1' ' NE ' ' A' ' 95' ' ' ARG . 4.3 mm100 -52.47 -20.03 2.61 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.436 HG13 ' H ' ' A' ' 79' ' ' GLU . 12.9 p -62.8 -31.31 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.881 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.32 -3.63 15.91 Favored Glycine 0 N--CA 1.475 1.299 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.274 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' H ' HG13 ' A' ' 77' ' ' VAL . 19.8 tp10 -67.4 153.13 44.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.997 0.399 . . . . 0.0 110.64 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.0 t -71.03 132.16 33.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 93' ' ' ILE . 10.8 p -75.66 155.93 35.31 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.083 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.609 ' HA ' ' NE2' ' A' ' 27' ' ' GLN . 4.1 mp0 -75.56 172.43 9.28 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.612 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 75.3 Cg_exo -54.79 130.53 40.95 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 N-CA-C 109.036 -1.178 . . . . 0.0 109.036 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 58.5 t -105.01 114.32 44.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -83.37 132.24 35.01 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.6 p -141.12 172.01 13.28 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.45 -37.48 83.71 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -64.6 -42.54 95.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.384 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.87 -145.3 13.07 Favored Glycine 0 C--N 1.318 -0.421 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.569 ' O ' HD12 ' A' ' 16' ' ' LEU . 73.8 m-85 -105.58 128.48 53.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.862 0.331 . . . . 0.0 111.352 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.563 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.1 m-70 -119.18 152.27 36.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.333 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.53 HG21 ' CG2' ' A' ' 26' ' ' VAL . 62.9 t -118.76 128.96 75.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 166.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.559 HD11 ' CD2' ' A' ' 68' ' ' PHE . 86.0 mt -122.12 133.27 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 119.74 -0.171 . . . . 0.0 111.369 -173.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -128.22 148.16 50.61 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 167.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.47 ' NE ' ' OE1' ' A' ' 76' ' ' GLN . 61.5 ttt-85 -79.16 142.21 36.55 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.012 0.435 . . . . 0.0 110.091 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 50.1 tp -112.61 133.42 54.66 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.453 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.208 -1.477 0 CA-C-O 118.341 -1.255 . . . . 0.0 111.362 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HD2' ' C ' ' A' ' 59' ' ' PHE . 25.5 mmtp . . . . . 0 N--CA 1.431 -1.413 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.77 HG21 ' HB1' ' A' ' 72' ' ' ALA . 32.1 mm -106.26 129.49 59.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' NZ ' ' OXT' ' A' ' 97' ' ' GLY . 57.6 mtpt -88.24 105.72 17.73 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.549 ' SG ' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -147.52 165.28 30.81 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.096 0.474 . . . . 0.0 111.76 -176.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.453 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 7.1 m -131.75 147.22 52.48 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.732 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 149.93 50.86 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.681 ' CG2' HD12 ' A' ' 43' ' ' LEU . 97.0 mt -125.67 128.64 72.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.134 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.534 HD23 HG13 ' A' ' 45' ' ' ILE . 47.0 tp -100.23 128.34 46.32 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.795 -176.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.03 ' CG1' HD11 ' A' ' 43' ' ' LEU . 16.2 m -127.64 155.58 39.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.967 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 17.5 pttp -84.04 -22.25 31.34 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.833 176.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 37.3 mmtm -135.57 152.56 51.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -62.67 -37.99 88.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.947 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.55 -36.79 92.18 Favored Glycine 0 C--N 1.321 -0.276 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.491 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 96.0 mt-10 -65.35 -44.37 87.91 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -58.55 -48.96 79.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.238 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.683 HD23 ' NE2' ' A' ' 27' ' ' GLN . 30.0 mt -63.87 -40.91 97.65 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.754 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.17 -48.53 76.16 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.255 -177.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.538 HG12 HD12 ' A' ' 39' ' ' LEU . 18.0 m -64.99 -39.57 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.246 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.683 ' NE2' HD23 ' A' ' 24' ' ' LEU . 25.0 mt-30 -60.22 -47.18 87.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.085 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.13 -41.26 81.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.133 0.492 . . . . 0.0 110.822 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.974 ' HD3' HD11 ' A' ' 39' ' ' LEU . 71.1 ttt180 -62.87 -38.55 91.31 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.73 177.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.432 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.16 -35.83 70.02 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -177.66 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 79' ' ' GLU . 49.8 mmtt -61.52 -28.63 69.45 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.134 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.9 -21.94 45.94 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.942 0.401 . . . . 0.0 110.917 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.09 7.19 41.4 Favored Glycine 0 C--N 1.319 -0.385 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 31.9 mt-10 -76.18 156.59 33.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.152 177.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -72.52 141.38 48.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.708 0.766 . . . . 0.0 112.428 -176.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 45.9 t80 -58.12 -44.78 87.92 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.14 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -61.19 -36.68 92.76 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.352 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.442 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 88.3 tttt -61.37 -48.04 83.08 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.974 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.3 mm? -62.05 -41.82 98.54 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.967 173.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.469 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -59.05 -50.32 74.52 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.153 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -43.26 88.29 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.642 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 87.1 mt-10 -70.94 -45.55 64.01 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -173.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.03 HD11 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -107.6 -39.12 5.71 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.663 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.634 ' N ' HD13 ' A' ' 43' ' ' LEU . 2.5 m -52.99 138.67 29.87 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.062 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.534 HG13 HD23 ' A' ' 16' ' ' LEU . 42.1 pt -91.72 -4.82 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.387 173.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -90.89 101.0 13.76 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.581 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -65.88 -43.8 93.11 Favored Glycine 0 C--N 1.318 -0.434 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.79 -45.24 91.45 Favored Glycine 0 C--O 1.239 0.453 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.2 m -64.21 -33.47 75.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.95 0.405 . . . . 0.0 110.213 174.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -64.45 -35.4 80.79 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 74.8 mmtt -61.9 -36.79 82.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 77.7 mtp85 -97.57 19.26 13.75 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.982 174.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.9 OUTLIER 44.67 42.37 5.74 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.679 178.717 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 71.83 -20.76 0.82 Allowed Glycine 0 C--N 1.31 -0.886 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.55 ' H ' ' C ' ' A' ' 53' ' ' ASP . 10.3 m -67.91 79.47 0.21 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.527 0.679 . . . . 0.0 110.305 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.416 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 97.7 mt -62.56 -41.63 99.03 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.387 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.88 -147.12 18.46 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.04 104.16 14.72 Favored 'General case' 0 C--O 1.252 1.195 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.459 ' C ' ' HD2' ' A' ' 9' ' ' LYS . 47.5 p90 -119.0 148.1 43.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.712 177.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.82 -176.31 48.1 Favored Glycine 0 C--O 1.236 0.25 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.501 ' HD2' ' CZ ' ' A' ' 73' ' ' PHE . 26.0 mtp180 -86.65 162.76 17.77 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.7 -21.42 1.57 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.724 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 61' ' ' ARG . 37.6 mmtm -65.1 -40.01 93.95 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -112.93 160.27 18.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.75 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 11.5 m -58.47 146.6 8.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.99 -176.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 4.5 mtpp -45.13 -47.03 32.29 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.347 -177.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 66' ' ' LYS . 75.5 Cg_exo -55.47 -41.38 78.58 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 120.486 0.791 . . . . 0.0 110.609 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.669 ' CD2' HD11 ' A' ' 93' ' ' ILE . 50.6 t80 -61.28 -46.56 89.85 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.766 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 61' ' ' ARG . 67.3 mt-10 -62.31 -46.97 86.35 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.618 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 35.0 t70 -58.61 -45.61 88.78 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.394 -176.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.564 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -59.56 -46.13 89.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.77 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.25 -46.96 88.0 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.032 0.444 . . . . 0.0 110.07 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.759 ' CE1' HD11 ' A' ' 10' ' ' ILE . 51.6 m-85 -68.11 -36.68 80.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.326 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.454 ' NH2' ' OE2' ' A' ' 82' ' ' GLU . 61.8 mtp180 -61.6 -45.26 94.84 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.204 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 75' ' ' LEU . 93.9 mt -99.68 42.07 1.12 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -177.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.433 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 35.3 mt-30 -55.26 -21.1 13.01 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.413 173.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.489 HG13 ' H ' ' A' ' 79' ' ' GLU . 14.7 p -61.96 -32.37 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.792 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 120.18 -3.96 12.6 Favored Glycine 0 N--CA 1.477 1.382 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.213 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -73.31 173.4 9.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 117.075 0.437 . . . . 0.0 111.377 -178.165 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.555 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 5.3 t -92.53 129.57 42.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.418 ' HA ' HD11 ' A' ' 75' ' ' LEU . 9.9 p -71.3 153.51 42.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.254 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.454 ' OE2' ' NH2' ' A' ' 74' ' ' ARG . 5.0 mp0 -64.52 169.81 4.58 Favored Pre-proline 0 CA--C 1.507 -0.686 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 172.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 82' ' ' GLU . 63.6 Cg_exo -53.31 130.53 38.84 Favored 'Trans proline' 0 C--N 1.295 -2.267 0 N-CA-C 109.596 -0.963 . . . . 0.0 109.596 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.2 107.74 23.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -78.31 133.38 37.63 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.398 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.4 p -140.19 167.93 21.0 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.631 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.6 pm0 -58.12 -36.38 72.85 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -63.99 -43.82 94.56 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.868 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.94 -148.9 16.79 Favored Glycine 0 C--N 1.311 -0.828 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.439 ' HB2' HG23 ' A' ' 17' ' ' VAL . 93.8 m-85 -110.11 129.55 55.68 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.407 ' CE1' HD13 ' A' ' 16' ' ' LEU . 5.2 m-70 -109.5 151.91 26.13 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -117.85 126.03 74.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.669 HD11 ' CD2' ' A' ' 68' ' ' PHE . 96.1 mt -119.69 127.33 75.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.648 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.421 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 64.5 tttp -110.96 143.14 42.08 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 169.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.57 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -78.59 142.47 37.27 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.066 178.006 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.2 tp -110.43 139.72 45.38 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.03 -175.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.502 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.21 -1.372 0 CA-C-O 118.268 -1.295 . . . . 0.0 110.755 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.4 mttp . . . . . 0 CA--C 1.515 -0.391 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.853 HD11 ' CE1' ' A' ' 73' ' ' PHE . 69.4 mt -106.9 128.35 61.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' TYR . 48.3 mtpt -94.25 106.85 18.83 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -146.33 168.99 19.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.097 0.776 . . . . 0.0 113.097 -173.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.429 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 45.4 m -135.66 147.16 48.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.398 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.444 ' CG ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -137.6 152.31 49.25 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.109 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.888 HG23 ' OG ' ' A' ' 44' ' ' SER . 95.6 mt -121.63 126.21 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.96 1.304 . . . . 0.0 108.032 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 17' ' ' VAL . 4.6 tt -105.28 123.54 48.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.639 ' N ' HD23 ' A' ' 16' ' ' LEU . 31.3 m -135.87 155.63 36.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 120.804 0.335 . . . . 0.0 110.396 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.94 -22.35 33.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.158 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.55 137.55 43.2 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.774 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.52 -36.99 85.59 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.55 98.22 Favored Glycine 0 CA--C 1.51 -0.224 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.473 ' HB3' HD23 ' A' ' 43' ' ' LEU . 98.8 mt-10 -64.46 -43.97 92.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -60.4 -45.58 93.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.282 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.93 -39.93 96.1 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.466 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.07 -46.0 89.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.573 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.868 ' CG1' HD22 ' A' ' 43' ' ' LEU . 12.3 m -65.78 -38.82 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.953 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.542 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 3.1 tp-100 -54.68 -48.53 72.29 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.745 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -68.06 -39.88 82.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.713 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HG2' HD11 ' A' ' 39' ' ' LEU . 8.1 tpt180 -63.08 -40.23 97.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.903 -174.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.601 HD11 ' CA ' ' A' ' 36' ' ' PHE . 1.9 mm? -61.05 -38.81 87.49 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.329 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.542 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 23.8 mmtm -64.29 -16.11 61.52 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.889 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -72.13 -9.6 58.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 174.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.84 12.14 62.65 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 96.6 mt-10 -83.99 153.11 24.06 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.786 -0.243 . . . . 0.0 111.054 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -64.75 132.51 49.79 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 121.623 0.725 . . . . 0.0 111.93 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.601 ' CA ' HD11 ' A' ' 30' ' ' LEU . 62.5 t80 -57.05 -44.9 83.45 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.096 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -59.11 -38.03 92.5 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.772 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.494 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 49.1 tttp -60.95 -47.1 87.99 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.888 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 26' ' ' VAL . 4.4 mm? -61.82 -41.25 97.55 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.01 -50.56 72.98 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.858 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.26 -36.68 84.87 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.074 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.5 ' HB3' HD12 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -72.48 -80.3 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.913 -174.824 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.868 HD22 ' CG1' ' A' ' 26' ' ' VAL . 8.8 mp -67.29 -43.63 81.26 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -173.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.888 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.2 m -58.88 147.7 32.88 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.689 -162.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.451 ' CG1' HD22 ' A' ' 16' ' ' LEU . 46.0 pt -98.84 -5.21 9.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.824 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -85.21 93.67 8.72 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.576 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -61.26 -44.39 98.16 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.3 -41.84 72.17 Favored Glycine 0 C--N 1.324 -0.132 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.408 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 67.0 m -73.93 -33.37 63.91 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.934 174.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -67.14 -42.13 84.93 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.204 0.526 . . . . 0.0 110.68 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 35.3 mmtp -62.34 -31.79 72.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -96.69 15.87 20.62 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.268 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.491 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 42.3 38.7 1.23 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.951 0.881 . . . . 0.0 112.134 -178.527 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.77 -11.81 9.8 Favored Glycine 0 C--O 1.236 0.231 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.652 176.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.1 m -67.93 80.38 0.21 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.4 . . . . 0.0 111.617 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.444 HD11 ' CG ' ' A' ' 14' ' ' HIS . 96.0 mt -63.28 -40.56 97.71 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.95 -149.07 19.52 Favored Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.863 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.33 141.77 28.41 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.646 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.7 p90 -148.59 151.96 35.94 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.988 177.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.35 167.92 49.59 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.506 ' NH1' ' CE1' ' A' ' 73' ' ' PHE . 77.3 mtp85 -74.68 140.97 44.57 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.01 -29.57 10.97 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.193 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -40.53 97.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.583 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 9.0 mmm -80.83 160.76 24.71 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 68' ' ' PHE . 15.1 m -63.21 136.51 26.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.562 176.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -45.29 -47.02 34.11 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.447 -171.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -56.61 -40.38 84.83 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.122 1.214 . . . . 0.0 110.77 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.537 ' CD2' HD11 ' A' ' 93' ' ' ILE . 56.0 t80 -60.76 -46.51 90.16 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.565 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 47.9 mt-10 -64.47 -38.37 90.8 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.527 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.8 -48.51 75.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.924 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.23 -40.48 71.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.559 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.84 92.45 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.836 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.853 ' CE1' HD11 ' A' ' 10' ' ' ILE . 24.8 m-85 -66.39 -34.06 77.11 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.794 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.424 ' NH1' ' OE1' ' A' ' 82' ' ' GLU . 58.9 mtp180 -62.29 -44.75 95.8 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 81' ' ' SER . 0.1 OUTLIER -97.37 34.53 1.78 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.629 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.481 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 53.0 mt-30 -56.14 -20.9 19.56 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.482 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 79' ' ' GLU . 7.3 p -60.61 -29.71 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.768 176.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 121.35 -4.31 11.15 Favored Glycine 0 N--CA 1.471 0.988 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.589 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.1 tp10 -64.95 166.94 8.43 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 122.781 0.432 . . . . 0.0 110.761 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.583 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 13.8 t -93.82 128.86 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 174.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.638 ' HB3' HD13 ' A' ' 75' ' ' LEU . 10.6 p -73.67 162.08 29.58 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.686 0.279 . . . . 0.0 111.609 -178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 5.9 mp0 -79.56 -179.74 1.52 Allowed Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 173.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.633 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 73.3 Cg_exo -57.63 133.5 56.93 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 CA-C-N 118.936 0.656 . . . . 0.0 110.761 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 47.3 t -111.46 102.96 14.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.657 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 135.14 48.37 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 p -146.56 172.98 12.74 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.639 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 2.0 pm0 -59.23 -37.67 78.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.477 ' HB2' ' HE2' ' A' ' 91' ' ' HIS . 36.6 m-85 -65.21 -43.81 90.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.922 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 151.69 -151.72 23.6 Favored Glycine 0 C--N 1.317 -0.51 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 70.1 m-85 -98.89 129.06 45.22 Favored 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.38 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.477 ' HE2' ' HB2' ' A' ' 88' ' ' PHE . 5.0 m-70 -112.08 148.96 32.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.238 177.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.604 HG11 HG23 ' A' ' 26' ' ' VAL . 61.4 t -117.44 128.47 74.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 167.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 68' ' ' PHE . 87.1 mt -119.34 130.5 73.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -173.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HD2' HG22 ' A' ' 80' ' ' VAL . 59.5 tttm -115.73 143.52 45.26 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 168.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -78.41 143.61 36.63 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.837 -178.101 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.438 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 52.9 tp -96.61 133.01 41.65 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.419 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.205 -1.657 0 CA-C-O 118.364 -1.242 . . . . 0.0 111.25 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 N--CA 1.439 -1.002 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.459 HD12 ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -105.95 123.64 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.542 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -93.13 105.16 17.29 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -147.44 167.61 23.96 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.326 -0.95 . . . . 0.0 113.205 -171.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 4.1 m -130.88 141.16 50.29 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.066 -1.424 . . . . 0.0 107.997 174.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.482 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -135.75 150.45 49.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.822 HG23 ' OG ' ' A' ' 44' ' ' SER . 91.5 mt -125.46 121.62 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.552 HD22 ' CG1' ' A' ' 45' ' ' ILE . 5.5 tt -101.47 121.42 41.92 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.448 HG13 HG22 ' A' ' 15' ' ' ILE . 29.3 m -133.88 150.97 32.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.568 0.699 . . . . 0.0 112.192 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG3' HD13 ' A' ' 45' ' ' ILE . 99.2 mttt -67.32 -38.38 84.84 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.355 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.508 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 64.0 mttm -109.37 141.61 41.48 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.627 -173.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -64.6 -36.75 85.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.055 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.0 -36.22 92.55 Favored Glycine 0 C--O 1.238 0.357 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.583 ' HB3' HD23 ' A' ' 43' ' ' LEU . 94.6 mt-10 -65.55 -41.44 93.01 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.74 -44.52 93.74 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.685 176.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.548 HD23 ' NE2' ' A' ' 27' ' ' GLN . 23.1 mt -64.18 -39.46 94.04 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.099 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.54 71.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.031 HG13 HD22 ' A' ' 43' ' ' LEU . 18.5 m -64.29 -41.14 91.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.461 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.548 ' NE2' HD23 ' A' ' 24' ' ' LEU . 25.0 mt-30 -59.48 -46.41 88.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.328 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 71.0 mm-40 -73.2 -38.57 66.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.734 ' HD3' HD11 ' A' ' 39' ' ' LEU . 53.8 ttt85 -65.01 -39.75 93.9 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.677 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.574 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -55.8 -25.44 41.46 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.405 -178.579 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 27' ' ' GLN . 38.9 mmtm -61.46 -38.18 86.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -16.54 44.53 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.907 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.89 14.15 61.37 Favored Glycine 0 C--N 1.318 -0.43 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' CD ' HH21 ' A' ' 29' ' ' ARG . 36.0 mt-10 -69.43 159.73 32.69 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.687 174.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 49.7 tttp -64.39 129.12 38.67 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.368 0.604 . . . . 0.0 110.247 -174.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.574 ' HA ' HD21 ' A' ' 30' ' ' LEU . 61.7 t80 -56.35 -43.96 79.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.49 ' HA2' ' C ' ' A' ' 53' ' ' ASP . . . -60.42 -34.07 83.76 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.564 177.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 45.7 tttp -59.62 -48.45 81.6 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.604 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.734 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.4 mm? -62.53 -41.35 98.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.921 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -57.26 -49.68 75.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.45 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.547 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 68.0 mttm -64.1 -37.69 88.36 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.896 177.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.678 ' HB3' HD12 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -71.09 -50.39 34.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.615 -172.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.031 HD22 HG13 ' A' ' 26' ' ' VAL . 6.2 mp -98.47 -48.6 4.96 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -174.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.822 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.2 m -55.64 142.14 35.01 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.338 -162.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.552 ' CG1' HD22 ' A' ' 16' ' ' LEU . 46.1 pt -94.45 -12.2 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.258 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 49' ' ' SER . 11.4 t0 -76.86 111.89 12.87 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.9 -40.22 64.49 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.9 -48.36 73.26 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.464 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 78.9 p -62.06 -33.28 74.11 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.381 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.53 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -74.46 -48.24 28.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.005 0.431 . . . . 0.0 110.346 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -65.39 -36.36 83.72 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.233 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.439 ' NE ' ' O ' ' A' ' 55' ' ' SER . 13.8 mmm180 -94.68 7.48 45.65 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.994 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.0 OUTLIER 50.34 47.86 23.2 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 67.12 -40.04 0.2 Allowed Glycine 0 C--N 1.313 -0.742 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.946 -173.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.563 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -54.79 82.91 0.0 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.1 0.96 . . . . 0.0 111.73 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.55 -38.64 91.91 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.54 -152.09 20.66 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.73 133.61 34.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.459 ' CE2' HD12 ' A' ' 10' ' ' ILE . 54.2 p90 -146.61 151.8 37.87 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.15 178.47 46.43 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 61' ' ' ARG . 45.8 mtp85 -73.46 152.53 40.71 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 122.764 0.426 . . . . 0.0 110.749 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.402 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 82.11 9.65 84.9 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.584 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -100.88 -19.28 15.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 178.63 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.474 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 1.4 mmm -126.39 161.33 28.13 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.76 136.85 20.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.081 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 1.7 tttm -44.5 -46.89 26.19 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 21.3 Cg_endo -59.71 -34.07 96.28 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 CA-C-N 119.161 0.736 . . . . 0.0 111.238 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CD2' HD11 ' A' ' 93' ' ' ILE . 55.5 t80 -62.99 -50.15 71.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.915 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 64' ' ' MET . 93.7 mt-10 -67.85 -43.82 78.59 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.811 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 7.2 t70 -57.74 -49.71 75.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.314 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.08 96.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.811 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -64.53 -42.08 95.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.516 -176.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.465 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 44.4 m-85 -64.99 -34.11 77.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.236 0.541 . . . . 0.0 111.362 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 79.9 mtp85 -62.62 -36.03 81.45 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.751 -176.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.598 HD11 ' HA ' ' A' ' 81' ' ' SER . 68.9 mt -97.12 23.05 7.73 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -173.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.494 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 75.1 mt-30 -43.53 -25.1 0.14 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.381 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.429 HG13 ' H ' ' A' ' 79' ' ' GLU . 14.8 p -58.35 -27.49 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 119.8 -2.18 13.48 Favored Glycine 0 N--CA 1.47 0.943 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.429 ' H ' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -55.86 173.46 0.14 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.059 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.66 127.5 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.598 ' HA ' HD11 ' A' ' 75' ' ' LEU . 83.7 p -65.33 147.58 53.19 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.882 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.53 177.09 0.73 Allowed Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 168.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD3' HE22 ' A' ' 27' ' ' GLN . 53.1 Cg_exo -54.42 133.51 56.7 Favored 'Trans proline' 0 C--N 1.283 -2.872 0 N-CA-C 109.991 -0.811 . . . . 0.0 109.991 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 55.1 t -117.42 128.66 74.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -98.75 129.92 45.2 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.488 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.8 p -114.41 -175.48 2.69 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.719 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.6 pm0 -69.59 -35.52 75.4 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -66.11 -45.32 81.54 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.95 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.59 -157.66 28.35 Favored Glycine 0 C--N 1.317 -0.492 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 87.0 m-85 -85.52 135.08 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.678 0.239 . . . . 0.0 110.483 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.482 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 44.9 m-70 -122.5 147.7 46.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.682 176.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.51 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 60.9 t -117.7 126.69 74.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 166.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.51 HD11 ' CD2' ' A' ' 68' ' ' PHE . 87.7 mt -119.94 125.86 74.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.586 -174.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -113.69 143.8 44.01 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.632 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 2.4 tmm_? -78.7 141.23 38.07 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.939 -1.104 . . . . 0.0 110.181 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.432 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 48.2 tp -109.26 135.41 50.39 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.273 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.201 -1.939 0 CA-C-O 118.082 -1.399 . . . . 0.0 111.059 -178.903 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.49 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.33 145.61 97.31 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.651 1.567 . . . . 0.0 111.133 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.436 ' HG2' HH22 ' A' ' 61' ' ' ARG . 96.8 mtp -39.85 107.44 0.07 Allowed 'General case' 0 C--O 1.244 0.815 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.521 -175.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.65 21.06 79.82 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.428 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.463 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 12.1 p -73.69 -176.4 2.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.882 0.373 . . . . 0.0 110.68 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 97.9 mmm -62.64 -39.03 92.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.279 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.6 43.91 2.13 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.687 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.463 ' HB3' ' H ' ' A' ' 5' ' ' SER . 7.1 p-10 -82.79 -1.14 50.85 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.008 0.432 . . . . 0.0 110.708 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HG3' ' OD1' ' A' ' 8' ' ' ASP . 43.7 mttp -107.89 164.09 12.56 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.724 -172.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.775 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 70.6 mt -107.49 131.66 57.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 27.6 mtpp -91.92 106.2 18.28 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -145.81 168.34 21.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -176.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.502 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 4.2 m -129.27 146.95 51.08 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.353 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.491 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -147.21 151.39 36.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.299 0.571 . . . . 0.0 112.346 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.643 HG21 HG11 ' A' ' 26' ' ' VAL . 85.2 mt -122.12 124.6 71.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.546 HD22 ' CG1' ' A' ' 45' ' ' ILE . 6.1 tt -107.83 127.74 53.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.586 HG21 ' N ' ' A' ' 23' ' ' ALA . 27.6 m -137.11 153.61 29.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.431 0.634 . . . . 0.0 111.212 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.457 ' HG3' HD13 ' A' ' 45' ' ' ILE . 26.1 mtmm -67.54 -39.96 85.0 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.475 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 60.7 mttp -103.48 148.89 25.39 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.526 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 86.0 mt-30 -62.09 -39.98 94.3 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.79 -38.27 91.8 Favored Glycine 0 CA--C 1.509 -0.281 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 74.4 mt-10 -65.54 -41.84 92.57 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.586 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -62.11 -42.35 99.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.849 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 20' ' ' GLN . 3.1 mm? -62.47 -40.98 98.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.782 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.0 -49.47 71.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.738 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.813 HG12 HD13 ' A' ' 43' ' ' LEU . 19.0 m -66.29 -42.49 90.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.198 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 81' ' ' SER . 99.1 mt-30 -61.66 -44.12 97.56 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.01 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.44 -44.85 74.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.066 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.895 ' HD3' HD11 ' A' ' 39' ' ' LEU . 43.0 ttt85 -66.63 -40.16 88.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.507 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.425 ' CD2' ' HG ' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -55.04 -24.7 26.06 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.312 0.577 . . . . 0.0 109.677 -178.177 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 27' ' ' GLN . 31.7 mmtm -62.35 -32.6 73.41 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.841 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.98 -7.99 20.19 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.722 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.84 25.84 40.06 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 87.1 mt-10 -81.54 157.23 24.87 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.506 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' NZ ' ' OD2' ' A' ' 53' ' ' ASP . 64.5 tttm -62.06 131.6 50.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.545 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 58.1 t80 -56.96 -43.28 81.41 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.658 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -59.21 -36.8 90.31 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.707 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 58.6 tttm -58.26 -48.0 81.81 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.027 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.895 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.6 mm? -63.44 -40.07 96.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.275 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.27 -43.21 95.53 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.758 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 34.3 mmtm -64.15 -41.27 97.24 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.719 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.76 -59.79 2.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.412 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.813 HD13 HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -91.33 -49.46 6.34 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -172.292 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.613 ' HB2' HG23 ' A' ' 15' ' ' ILE . 5.6 t -56.53 138.25 52.18 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.903 -169.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.546 ' CG1' HD22 ' A' ' 16' ' ' LEU . 44.6 pt -92.79 -1.74 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.814 0.34 . . . . 0.0 110.227 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 50' ' ' ALA . 60.1 t0 -80.22 96.51 6.61 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.1 -53.43 44.98 Favored Glycine 0 C--N 1.321 -0.278 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.815 -173.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.38 -45.01 84.93 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 54' ' ' GLY . 17.5 m -70.41 -32.57 70.25 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.472 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -62.79 -38.36 90.33 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 75.7 mmtt -60.79 -34.3 74.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.513 ' HE ' ' HA ' ' A' ' 49' ' ' SER . 89.6 mtm180 -95.48 19.48 10.89 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.913 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.658 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 97.3 m-20 59.85 30.2 19.75 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 70.87 -7.75 5.14 Favored Glycine 0 C--N 1.305 -1.149 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.701 ' HB3' HD22 ' A' ' 96' ' ' LEU . 2.3 m -70.72 91.09 0.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.433 0.635 . . . . 0.0 110.353 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.468 HD23 ' NH2' ' A' ' 52' ' ' ARG . 96.9 mt -62.35 -38.23 88.74 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.64 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . 76.91 -133.15 13.01 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.502 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 57.4 m-85 -83.98 135.59 34.39 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 117.111 0.455 . . . . 0.0 109.897 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.587 ' CE1' HD12 ' A' ' 10' ' ' ILE . 47.9 p90 -144.18 149.32 36.25 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.779 168.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.82 174.89 55.12 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 -174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.543 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 47.6 mtm180 -74.54 145.66 43.26 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.8 60.17 8.11 Favored Glycine 0 C--O 1.246 0.905 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 61' ' ' ARG . 34.7 mmtm -133.25 -35.62 1.03 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.017 0.437 . . . . 0.0 110.458 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.408 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 77.7 mtm -119.44 159.83 23.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.99 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.705 HG11 ' HB2' ' A' ' 86' ' ' SER . 15.4 m -49.1 133.57 7.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.277 -174.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -44.02 -47.34 22.45 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.901 -174.153 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 24.7 Cg_endo -57.87 -38.31 93.0 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 CA-C-N 118.767 0.595 . . . . 0.0 111.862 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.692 ' HA ' HG11 ' A' ' 84' ' ' VAL . 58.9 t80 -62.73 -49.97 72.96 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.771 177.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.62 -39.31 93.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.316 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.511 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 12.6 t70 -57.35 -48.68 78.38 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.115 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.642 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -63.22 -39.62 95.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.783 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.07 83.21 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.09 0.472 . . . . 0.0 110.253 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.775 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 52.6 m-85 -63.67 -42.85 98.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.879 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.672 ' NH2' HD11 ' A' ' 75' ' ' LEU . 39.1 ttp180 -63.54 -47.57 81.08 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.172 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.672 HD11 ' NH2' ' A' ' 74' ' ' ARG . 97.3 mt -98.04 33.41 2.15 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.501 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 71.8 mt-30 -54.28 -19.17 4.87 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.502 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 2.4 m -60.11 -40.73 84.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.332 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.493 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 121.66 7.36 8.15 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.893 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 149.37 41.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.5 t -71.35 128.97 35.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.639 ' HB3' HD12 ' A' ' 75' ' ' LEU . 11.3 p -79.24 155.72 28.45 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 123.29 0.369 . . . . 0.0 111.411 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.7 mp0 -66.52 161.95 54.45 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.555 ' N ' HE22 ' A' ' 27' ' ' GLN . 47.5 Cg_exo -55.37 129.74 36.82 Favored 'Trans proline' 0 C--N 1.295 -2.279 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.692 HG11 ' HA ' ' A' ' 68' ' ' PHE . 96.8 t -106.13 114.87 46.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -85.37 138.54 32.21 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.753 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.705 ' HB2' HG11 ' A' ' 65' ' ' VAL . 63.2 p -136.05 176.36 8.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -61.79 -32.7 73.01 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.277 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.67 -38.79 80.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.036 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.61 -146.97 16.06 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -176.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.526 ' CE1' ' HG2' ' A' ' 20' ' ' GLN . 82.9 m-85 -106.4 133.86 50.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.941 0.371 . . . . 0.0 110.709 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.491 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.9 m-70 -115.12 147.34 40.36 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.382 176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 76.5 t -117.97 127.55 75.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 167.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.658 HD11 ' CD2' ' A' ' 68' ' ' PHE . 81.5 mt -115.97 130.7 70.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -171.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -120.61 149.89 41.76 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.383 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.502 ' NH2' ' O ' ' A' ' 77' ' ' VAL . 8.7 tmm_? -79.05 143.87 35.19 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.701 HD22 ' HB3' ' A' ' 55' ' ' SER . 64.7 tp -117.15 135.42 53.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.382 0 CA-C-O 118.556 -1.135 . . . . 0.0 110.747 -177.976 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.683 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.2 144.9 99.48 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.051 1.834 . . . . 0.0 111.368 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.0 mmm -55.93 156.86 4.86 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.493 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.0 -39.48 2.98 Favored Glycine 0 C--N 1.315 -0.602 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' N ' ' A' ' 7' ' ' ALA . 1.5 m -63.19 128.63 36.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 93.5 mmm 44.81 17.68 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.216 0.323 . . . . 0.0 110.59 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.444 ' N ' ' C ' ' A' ' 5' ' ' SER . . . -64.09 -23.74 67.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.86 -35.67 75.27 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -91.09 158.29 16.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.011 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.635 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 45.6 mm -106.84 131.68 56.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' CG ' ' CE2' ' A' ' 58' ' ' TYR . 56.5 mtpt -87.95 105.91 17.77 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.667 ' SG ' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -148.37 168.22 23.17 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.466 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.498 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 4.9 m -130.81 133.04 45.61 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.339 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.483 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -124.58 149.56 46.88 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.457 -176.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.614 ' CG2' HD12 ' A' ' 43' ' ' LEU . 95.2 mt -125.31 128.19 72.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.759 HD13 ' CE1' ' A' ' 91' ' ' HIS . 47.1 tp -103.47 128.56 50.63 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.472 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.072 HG12 HD11 ' A' ' 43' ' ' LEU . 28.8 m -129.1 154.4 39.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 123.743 0.652 . . . . 0.0 110.818 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -67.76 -41.08 83.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.187 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 47.0 mttp -127.5 156.43 42.18 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -169.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.4 ' O ' HD23 ' A' ' 24' ' ' LEU . 26.1 mt-30 -60.59 -38.86 86.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.36 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.54 -38.42 91.14 Favored Glycine 0 N--CA 1.464 0.502 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 99.5 mt-10 -65.65 -42.12 91.8 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.14 82.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.686 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 20' ' ' GLN . 1.2 mm? -61.57 -42.26 98.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.85 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.04 74.2 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.9 m -66.03 -41.07 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.749 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -59.31 -46.12 89.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.054 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.501 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 73.7 mm-40 -67.82 -38.59 83.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.158 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.445 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 22.7 ttp85 -64.9 -38.11 89.87 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.418 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.418 HD22 ' HG ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -57.07 -27.16 61.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 33.2 mmtp -61.11 -31.6 71.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.19 -21.73 48.7 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.176 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.82 20.69 53.09 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' OE1' ' NZ ' ' A' ' 38' ' ' LYS . 36.5 mt-10 -65.34 164.36 13.76 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.477 ' NZ ' ' OD2' ' A' ' 53' ' ' ASP . 63.4 tttm -65.6 130.5 43.5 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 174.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.587 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 56.6 t80 -55.92 -42.88 76.76 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.637 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -57.12 -39.3 89.64 Favored Glycine 0 C--N 1.311 -0.836 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.835 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.435 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 63.3 tttm -59.91 -45.7 91.71 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.418 ' HG ' HD22 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -62.16 -41.2 98.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.938 173.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.488 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -61.83 -42.84 99.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.425 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -65.21 -44.84 87.04 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.454 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 95.0 mt-10 -70.23 -43.66 70.16 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -169.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.072 HD11 HG12 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -117.24 -40.49 3.08 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -169.334 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.753 ' N ' HD13 ' A' ' 43' ' ' LEU . 1.4 m -45.82 133.54 8.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.489 HG13 HD23 ' A' ' 16' ' ' LEU . 46.1 pt -83.12 -14.95 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -80.4 92.42 5.82 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.308 174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.8 -46.82 93.38 Favored Glycine 0 CA--C 1.507 -0.447 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.191 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.19 -46.99 84.56 Favored Glycine 0 C--N 1.319 -0.364 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.483 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 20.1 m -63.41 -34.05 76.88 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.322 174.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -64.22 -36.98 85.86 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.359 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 18.6 mmtp -60.53 -40.21 90.68 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -96.67 16.09 19.95 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.281 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.637 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.9 m-20 63.1 32.91 14.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.663 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 70.65 -29.7 0.49 Allowed Glycine 0 C--N 1.31 -0.871 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 53' ' ' ASP . 53.6 m -55.31 98.59 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.717 0.77 . . . . 0.0 111.382 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.61 HD12 ' SG ' ' A' ' 12' ' ' CYS . 97.6 mt -65.07 -36.52 84.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.835 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 88.67 -145.05 18.61 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 -170.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.466 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 89.9 m-85 -83.09 134.03 35.03 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.504 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.3 p90 -144.04 150.23 37.88 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.629 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.53 165.55 22.49 Favored Glycine 0 C--O 1.24 0.493 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.493 ' HD2' ' CE1' ' A' ' 73' ' ' PHE . 76.9 mtp180 -81.05 160.54 24.5 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.641 0.376 . . . . 0.0 110.879 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.07 -51.61 1.13 Allowed Glycine 0 C--N 1.315 -0.615 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -64.23 -38.02 89.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.968 -0.616 . . . . 0.0 109.645 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.555 ' HE1' HD13 ' A' ' 56' ' ' LEU . 25.5 mmm -88.67 153.02 21.44 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.36 141.76 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.294 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 15.8 mmtm -43.7 -51.28 16.78 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.536 ' HB2' HG13 ' A' ' 84' ' ' VAL . 36.3 Cg_endo -61.4 -32.49 89.09 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 120.231 0.62 . . . . 0.0 111.571 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.673 ' CD2' HD11 ' A' ' 93' ' ' ILE . 47.7 t80 -62.62 -46.66 87.24 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.508 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 93.9 mt-10 -63.9 -47.23 81.42 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.241 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.06 -41.82 93.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.74 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.433 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -64.59 -46.62 81.93 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.86 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.531 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -62.5 -46.27 89.21 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.951 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.635 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 17.7 m-85 -61.82 -28.17 69.28 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.972 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.707 ' HB3' ' CZ ' ' A' ' 74' ' ' ARG . 2.1 mtm105 -64.46 -36.75 85.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.345 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.775 HD11 ' HB3' ' A' ' 81' ' ' SER . 10.3 mt -87.91 21.84 2.55 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -167.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 73' ' ' PHE . 75.6 mt-30 -54.26 -34.56 61.07 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.491 HG13 ' HG3' ' A' ' 79' ' ' GLU . 7.1 p -63.84 -27.54 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.279 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.02 6.05 7.83 Favored Glycine 0 N--CA 1.475 1.278 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.435 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.644 ' HB2' HD22 ' A' ' 75' ' ' LEU . 80.2 mt-10 -55.57 173.94 0.11 Allowed 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.4 t -106.76 132.57 53.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 167.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.775 ' HB3' HD11 ' A' ' 75' ' ' LEU . 99.7 p -66.32 163.21 18.56 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.227 0.537 . . . . 0.0 111.842 -172.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 3.5 mp0 -78.69 161.19 70.18 Favored Pre-proline 0 N--CA 1.422 -1.866 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -56.94 133.89 60.94 Favored 'Trans proline' 0 C--N 1.294 -2.329 0 N-CA-C 109.784 -0.891 . . . . 0.0 109.784 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 67' ' ' PRO . 42.6 t -117.97 125.64 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.534 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.8 tptp -88.98 137.47 32.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.94 0.4 . . . . 0.0 109.963 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.534 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 14.1 p -140.89 175.17 9.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -59.59 -39.77 85.25 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -65.15 -42.64 93.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.517 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.32 -137.34 5.75 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.664 ' O ' HD12 ' A' ' 16' ' ' LEU . 4.6 m-85 -105.01 132.78 50.82 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 117.107 0.453 . . . . 0.0 111.963 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.759 ' CE1' HD13 ' A' ' 16' ' ' LEU . 44.5 m-70 -114.27 141.74 47.18 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.391 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.02 128.28 75.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 167.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.673 HD11 ' CD2' ' A' ' 68' ' ' PHE . 88.5 mt -121.1 131.22 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 116.917 -0.129 . . . . 0.0 110.76 -173.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -116.08 147.86 40.85 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 167.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.46 HH21 ' CA ' ' A' ' 97' ' ' GLY . 2.6 ttp180 -77.57 143.46 38.31 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.34 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.421 ' HB3' ' C ' ' A' ' 11' ' ' LYS . 46.5 tp -100.68 145.58 28.26 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.46 ' CA ' HH21 ' A' ' 95' ' ' ARG . . . . . . . . 0 C--O 1.207 -1.576 0 CA-C-O 118.356 -1.247 . . . . 0.0 110.683 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.586 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -59.63 142.13 98.28 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.134 1.889 . . . . 0.0 112.683 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.62 ' SD ' ' NH2' ' A' ' 61' ' ' ARG . 96.1 mmm -100.84 160.32 14.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.192 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' N ' ' OD2' ' A' ' 8' ' ' ASP . . . 77.01 18.31 78.86 Favored Glycine 0 C--N 1.315 -0.599 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.439 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 10.9 m -87.5 172.75 9.54 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.675 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.3 mmt -68.35 -39.16 81.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.333 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.86 5.1 10.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.498 ' OD1' ' NZ ' ' A' ' 9' ' ' LYS . 31.5 p-10 -66.17 -35.98 81.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.754 0.788 . . . . 0.0 108.918 176.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.498 ' NZ ' ' OD1' ' A' ' 8' ' ' ASP . 27.1 mtmm -85.03 157.54 20.71 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.251 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.58 HG13 ' HB1' ' A' ' 72' ' ' ALA . 44.4 mm -106.34 129.87 58.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.599 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 62.2 mtpt -90.93 104.11 16.74 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -145.1 169.59 17.86 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.069 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.515 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 9.2 m -126.51 145.63 50.43 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.871 174.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.482 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -134.63 149.57 50.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.921 0.391 . . . . 0.0 111.597 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.523 HG13 ' CE2' ' A' ' 36' ' ' PHE . 94.4 mt -129.41 128.06 65.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.23 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 46' ' ' ASP . 13.9 mt -94.61 128.68 41.41 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.412 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.13 154.72 35.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.704 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -66.28 -40.7 90.27 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.358 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 36.8 mtmm -121.6 152.48 39.23 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.332 0.587 . . . . 0.0 112.502 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.525 ' O ' HD23 ' A' ' 24' ' ' LEU . 53.6 tt0 -61.14 -40.95 95.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.489 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.06 -36.68 92.69 Favored Glycine 0 C--O 1.238 0.368 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 19' ' ' LYS . 98.9 mt-10 -63.76 -42.14 97.86 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 20' ' ' GLN . . . -58.76 -47.95 82.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.966 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 20' ' ' GLN . 4.5 mm? -61.52 -41.79 97.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.074 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.27 -51.83 66.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.574 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.021 HG11 HD21 ' A' ' 43' ' ' LEU . 18.6 m -68.97 -39.46 79.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.273 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.646 HE22 ' N ' ' A' ' 83' ' ' PRO . 67.8 mt-30 -55.4 -46.12 76.63 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 72.4 mm-40 -71.13 -35.29 71.67 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 175.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.612 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 74.9 ttt180 -60.28 -37.76 81.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.984 0.421 . . . . 0.0 110.025 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.12 -34.62 73.76 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 31.7 mmtp -62.53 -33.18 74.4 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.74 -24.72 64.25 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.441 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.82 -2.6 31.95 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.612 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 23.9 mt-10 -67.7 147.05 53.17 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.76 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.56 139.27 51.47 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CE2' HG13 ' A' ' 15' ' ' ILE . 52.3 t80 -58.21 -45.88 86.84 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.48 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.503 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.35 -35.66 91.98 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.263 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 25.3 tttm -60.22 -47.73 84.73 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.601 HD11 HH11 ' A' ' 29' ' ' ARG . 4.0 mm? -62.06 -40.81 97.03 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.501 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.546 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.11 -45.47 79.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 24.9 mmtm -65.5 -38.83 90.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.558 173.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 78.3 mt-10 -69.78 -54.17 14.88 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.021 HD21 HG11 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -124.18 -17.5 6.15 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -169.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.61 ' N ' HD12 ' A' ' 43' ' ' LEU . 1.1 m -48.99 127.26 13.94 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.311 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 45' ' ' ILE . 39.9 pt -76.74 -14.05 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.673 ' HB2' HD12 ' A' ' 16' ' ' LEU . 63.4 t0 -86.72 92.17 8.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.17 -42.72 99.35 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.13 -48.18 69.57 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.482 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 38.4 m -64.58 -33.37 75.77 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.513 -0.404 . . . . 0.0 110.315 175.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -62.81 -30.09 71.21 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.574 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -61.28 -39.87 92.03 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 81.3 mtp180 -97.23 19.68 12.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.404 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.503 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 47.8 m-20 58.72 31.79 21.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.16 -14.44 3.9 Favored Glycine 0 C--N 1.31 -0.904 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 13' ' ' SER . 20.2 m -69.19 90.88 0.49 Allowed 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.816 0.817 . . . . 0.0 111.313 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 56' ' ' LEU . 93.9 mt -62.94 -38.76 92.34 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.216 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.79 ' HA2' HD21 ' A' ' 96' ' ' LEU . . . 94.94 -144.14 17.01 Favored Glycine 0 CA--C 1.503 -0.698 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.4 ' H ' ' HD1' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -85.11 130.73 34.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.658 0.266 . . . . 0.0 110.827 -179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.495 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.8 p90 -144.89 152.87 40.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.876 0.369 . . . . 0.0 111.525 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.15 -173.31 37.33 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.62 ' NH2' ' SD ' ' A' ' 3' ' ' MET . 90.2 mtm-85 -81.96 154.78 25.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.69 -37.79 3.32 Favored Glycine 0 C--N 1.311 -0.852 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -63.0 -36.6 84.08 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.481 0.658 . . . . 0.0 109.476 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.474 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 3.7 mmm -104.62 155.64 18.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.281 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.74 154.35 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.463 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 13.7 mmtm -44.0 -55.0 10.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.661 ' HB2' HG13 ' A' ' 84' ' ' VAL . 40.0 Cg_endo -60.05 -34.69 94.54 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 CA-C-N 118.925 0.652 . . . . 0.0 111.074 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.594 ' CD2' HD11 ' A' ' 93' ' ' ILE . 10.5 t80 -63.12 -46.6 86.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.076 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.96 -41.72 99.61 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.714 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.9 -50.21 71.3 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.789 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.08 98.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.459 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB1' HG13 ' A' ' 10' ' ' ILE . . . -57.84 -50.47 73.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.149 -177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -67.6 -38.73 84.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.039 0.447 . . . . 0.0 111.297 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.529 HH22 ' CD ' ' A' ' 82' ' ' GLU . 78.7 mtp180 -63.99 -41.18 97.6 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.915 HD11 ' HA ' ' A' ' 81' ' ' SER . 43.0 mt -97.92 23.58 7.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -171.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.421 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 27.8 mt-30 -54.03 -25.54 21.86 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.91 -29.64 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.032 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 122.12 -0.34 10.66 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.203 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.718 ' HB2' HD22 ' A' ' 75' ' ' LEU . 19.4 mt-10 -70.64 174.28 6.1 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -174.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -98.49 131.23 46.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.574 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.915 ' HA ' HD11 ' A' ' 75' ' ' LEU . 43.1 t -64.34 162.09 15.58 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.708 -176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.529 ' CD ' HH22 ' A' ' 74' ' ' ARG . 0.0 OUTLIER -72.91 163.11 70.84 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 165.176 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.646 ' N ' HE22 ' A' ' 27' ' ' GLN . 72.1 Cg_endo -61.82 140.19 84.21 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 N-CA-C 110.214 -0.725 . . . . 0.0 110.214 -175.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' A' ' 67' ' ' PRO . 77.3 t -123.16 100.47 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.813 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.5 tptp -80.05 130.23 35.1 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.481 174.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.571 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 52.8 p -129.14 -176.25 3.81 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.362 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -62.61 -39.78 94.87 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -66.37 -41.62 89.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.315 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.79 -150.63 21.9 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.502 ' O ' HD23 ' A' ' 16' ' ' LEU . 77.7 m-85 -99.16 118.88 36.87 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.522 ' CE1' HD21 ' A' ' 16' ' ' LEU . 34.9 m-70 -99.33 139.54 34.82 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 123.341 0.401 . . . . 0.0 110.319 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.436 HG21 ' CG2' ' A' ' 26' ' ' VAL . 70.0 t -114.93 125.44 72.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 168.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.594 HD11 ' CD2' ' A' ' 68' ' ' PHE . 84.2 mt -123.62 127.44 74.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.129 -170.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -120.79 143.36 48.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.54 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 5.6 tmm_? -78.5 142.21 37.6 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.79 HD21 ' HA2' ' A' ' 57' ' ' GLY . 0.3 OUTLIER -121.98 151.3 40.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.124 -179.113 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.425 ' N ' HD12 ' A' ' 96' ' ' LEU . . . . . . . . 0 C--O 1.206 -1.627 0 CA-C-O 118.364 -1.242 . . . . 0.0 110.25 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' O ' ' NH1' ' A' ' 61' ' ' ARG . . . . . . . . 0 CA--C 1.525 0.686 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.606 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 40.0 Cg_exo -59.45 145.72 97.11 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 122.248 1.965 . . . . 0.0 110.563 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.6 mtp -104.01 131.65 51.05 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.82 42.46 61.02 Favored Glycine 0 C--N 1.318 -0.42 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.469 ' H ' ' HB2' ' A' ' 8' ' ' ASP . 28.5 t -135.69 174.51 10.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.9 0.381 . . . . 0.0 110.646 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.34 -39.13 93.69 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.43 24.12 2.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.775 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.507 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 9.7 t70 -62.28 -41.96 98.93 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.35 159.45 15.11 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.654 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.83 HD11 ' CE2' ' A' ' 73' ' ' PHE . 66.0 mt -105.34 127.61 59.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' A' ' 11' ' ' LYS . 9.2 mtpm? -94.87 107.51 19.53 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.771 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -147.54 169.64 19.15 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.914 -173.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.536 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.7 m -130.45 146.27 51.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.068 173.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.556 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -138.6 149.34 45.15 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.876 -178.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.769 HG23 ' OG ' ' A' ' 44' ' ' SER . 94.9 mt -127.91 125.96 65.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.825 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 90' ' ' TYR . 42.3 tp -97.88 115.45 28.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.49 HG13 HG22 ' A' ' 15' ' ' ILE . 35.7 m -116.37 152.34 18.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.527 0.68 . . . . 0.0 112.294 -174.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -66.87 -42.92 84.82 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.904 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 31.3 mmtp -119.37 150.42 40.19 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.817 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -60.03 -38.03 81.52 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.079 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.79 -36.09 92.23 Favored Glycine 0 C--N 1.322 -0.234 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.483 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 95.8 mt-10 -64.53 -43.64 93.36 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -58.43 -46.7 85.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.001 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.49 -41.03 98.57 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.281 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.95 92.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.826 ' CG1' HD22 ' A' ' 43' ' ' LEU . 7.3 m -68.39 -34.44 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.103 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 18.7 tt0 -59.32 -46.47 88.5 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.155 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.76 -41.65 74.9 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.472 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.745 ' HD3' HD11 ' A' ' 39' ' ' LEU . 76.1 ttt180 -60.77 -39.23 88.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.861 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.99 -39.82 91.12 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.954 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 17.7 mmtp -65.47 -9.54 26.58 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -88.34 -3.51 58.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.152 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.48 11.04 75.79 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.587 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.596 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 13.2 mt-10 -78.85 154.21 29.99 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.473 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 21.3 tptm -62.29 126.4 27.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.233 -176.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.518 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 58.2 t80 -58.04 -44.47 87.43 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.643 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -60.11 -37.74 93.3 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.942 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 44.6 tttp -61.23 -44.28 97.52 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.82 HD12 HG12 ' A' ' 26' ' ' VAL . 4.4 mm? -62.02 -41.46 98.11 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.295 172.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -57.17 -51.91 67.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.38 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -65.54 -39.43 91.75 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' A' ' 38' ' ' LYS . 92.2 mt-10 -70.08 -48.08 59.22 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.826 HD22 ' CG1' ' A' ' 26' ' ' VAL . 9.5 mp -98.26 -50.49 4.32 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.769 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.2 m -50.81 139.21 17.26 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.1 -1.409 . . . . 0.0 113.093 -161.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.467 HG13 HD23 ' A' ' 16' ' ' LEU . 36.1 pt -97.42 -2.34 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.672 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -89.19 94.11 9.81 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.828 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -62.26 -42.29 99.72 Favored Glycine 0 C--O 1.234 0.136 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.3 -42.09 63.27 Favored Glycine 0 N--CA 1.454 -0.136 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.556 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 15.9 m -72.46 -33.08 66.78 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.635 -0.282 . . . . 0.0 111.569 175.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.18 74.63 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.161 0.505 . . . . 0.0 110.512 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 10.4 mmtp -61.98 -41.85 98.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.29 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -98.67 9.1 44.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.406 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.643 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.5 m-20 63.63 33.12 13.46 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.078 0.466 . . . . 0.0 110.395 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.4 -14.61 5.13 Favored Glycine 0 C--N 1.31 -0.897 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -63.19 89.32 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.0 0.428 . . . . 0.0 110.955 -179.355 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.771 HD12 ' SG ' ' A' ' 12' ' ' CYS . 96.4 mt -63.4 -40.29 96.83 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 87.19 -151.31 23.47 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.91 131.07 34.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.028 0.414 . . . . 0.0 110.004 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 52.5 p90 -142.79 148.72 37.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.345 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.18 150.92 34.31 Favored Glycine 0 C--N 1.314 -0.67 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.606 ' NH2' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -69.94 144.32 52.43 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.56 0.219 . . . . 0.0 110.734 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.58 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 106.95 -20.77 33.01 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -175.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -62.69 -42.5 99.66 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.608 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 75.0 mtm -120.0 160.66 22.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.931 0.396 . . . . 0.0 111.961 -174.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 68' ' ' PHE . 32.4 m -43.49 128.16 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.012 -177.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.608 ' NZ ' ' O ' ' A' ' 64' ' ' MET . 1.9 mmtm -45.08 -46.5 30.35 Favored Pre-proline 0 C--N 1.308 -1.198 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.058 -173.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 30.0 Cg_endo -59.82 -35.3 94.52 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 CA-C-N 119.311 0.79 . . . . 0.0 111.451 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' A' ' 93' ' ' ILE . 54.3 t80 -61.76 -49.07 77.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.959 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 99.1 mt-10 -66.11 -41.49 90.49 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.572 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.85 -46.65 81.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.813 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.99 -38.5 88.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.854 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.512 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -58.33 -41.23 84.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.897 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.83 ' CE2' HD11 ' A' ' 10' ' ' ILE . 57.3 m-85 -64.69 -35.25 80.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.018 0.437 . . . . 0.0 111.386 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -58.8 -23.19 59.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.506 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 81' ' ' SER . 84.2 mt -96.92 4.94 51.34 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -171.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.477 ' HA ' ' HD2' ' A' ' 95' ' ' ARG . 67.4 mm-40 -47.16 -20.41 0.18 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.57 -40.55 86.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 120.814 0.34 . . . . 0.0 110.124 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.95 48.49 0.24 Allowed Glycine 0 N--CA 1.465 0.615 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.451 ' OE1' ' N ' ' A' ' 80' ' ' VAL . 1.2 mm-40 -122.31 175.78 6.22 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.034 0.445 . . . . 0.0 112.166 -173.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 94' ' ' LYS . 75.2 t -108.99 131.37 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.703 ' HB3' HD11 ' A' ' 75' ' ' LEU . 6.4 p -75.51 163.19 27.64 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -173.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.33 165.33 45.47 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.596 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 63.5 Cg_exo -55.84 130.96 43.18 Favored 'Trans proline' 0 C--N 1.293 -2.392 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.1 t -117.88 124.4 73.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 41.7 tttp -91.51 131.89 36.65 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.67 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 97.1 p -118.85 -172.05 2.21 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.701 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.2 pm0 -66.8 -38.8 87.2 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 6.0 m-30 -64.39 -46.89 81.33 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.978 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.85 -150.88 21.11 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.592 ' O ' HD12 ' A' ' 16' ' ' LEU . 10.9 m-85 -96.5 129.41 43.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.837 0.351 . . . . 0.0 111.381 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -110.85 146.68 36.03 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.029 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.708 HG11 ' CG2' ' A' ' 26' ' ' VAL . 2.1 t -117.4 121.03 66.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 167.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.546 HD11 ' CD2' ' A' ' 68' ' ' PHE . 87.3 mt -113.1 127.82 70.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.428 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.455 ' HB2' HG22 ' A' ' 80' ' ' VAL . 59.5 tttm -115.43 145.13 42.86 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.409 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 75' ' ' LEU . 68.4 ttt-85 -79.5 139.37 37.62 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.024 177.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 55.8 tp -112.66 129.1 56.51 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.505 ' C ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.206 -1.633 0 CA-C-O 118.376 -1.236 . . . . 0.0 112.152 -173.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.84 151.83 83.41 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 123.165 2.577 . . . . 0.0 112.059 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.5 mtp -61.73 148.51 42.63 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.02 38.5 0.87 Allowed Glycine 0 C--N 1.309 -0.917 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.475 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 18.6 p -139.69 159.39 42.28 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 95.3 mtp -63.89 -41.35 97.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.826 0.346 . . . . 0.0 111.432 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.9 -36.86 83.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.237 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 5' ' ' SER . 1.2 p30 -64.94 -23.35 67.2 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.445 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 44.3 mmtm -75.08 167.17 22.43 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.27 176.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.682 HG21 ' HB1' ' A' ' 72' ' ' ALA . 43.5 mm -107.92 129.13 62.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 48.7 mtpt -92.7 106.88 18.79 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -138.22 166.04 25.17 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.779 0.799 . . . . 0.0 112.933 -177.42 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.467 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 3.9 m -133.35 138.53 46.37 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.895 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.47 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -132.8 150.28 52.18 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.372 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.705 HG23 ' OG ' ' A' ' 44' ' ' SER . 95.7 mt -125.09 127.22 72.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.621 177.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.754 HD12 ' O ' ' A' ' 90' ' ' TYR . 51.2 tp -98.72 125.01 43.92 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.944 HG12 HD11 ' A' ' 43' ' ' LEU . 33.6 m -118.06 151.85 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.389 0.614 . . . . 0.0 111.275 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.487 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 6.2 mttp -66.71 -40.62 88.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.201 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -133.77 158.84 42.31 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.866 -169.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -60.11 -39.75 87.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.488 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.81 -39.74 91.93 Favored Glycine 0 CA--C 1.507 -0.444 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.528 ' O ' HG13 ' A' ' 26' ' ' VAL . 97.0 mt-10 -65.07 -43.59 91.7 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.836 176.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -59.4 -48.36 81.94 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.124 0.488 . . . . 0.0 110.125 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.57 -42.93 99.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.214 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.87 80.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.75 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 22' ' ' GLU . 12.6 m -63.54 -41.39 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.778 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.513 HE22 ' HA ' ' A' ' 82' ' ' GLU . 94.7 mt-30 -55.92 -44.05 77.95 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -70.08 -41.71 73.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.322 0.582 . . . . 0.0 110.371 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 75.9 ttt180 -61.6 -38.36 87.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.941 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 36' ' ' PHE . 3.8 mm? -59.75 -37.58 79.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 18.7 mmtm -62.72 -30.71 71.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.03 -23.94 56.3 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.876 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.22 13.09 25.71 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.02 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.556 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 33.0 mt-10 -80.74 150.2 29.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.151 0.475 . . . . 0.0 110.705 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 61.1 tttm -65.78 137.17 57.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.046 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.606 ' HA ' HD11 ' A' ' 30' ' ' LEU . 59.2 t80 -56.77 -45.19 82.25 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.616 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.64 -37.63 95.09 Favored Glycine 0 C--N 1.317 -0.503 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 65.6 tttm -58.31 -46.71 85.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.491 HD11 ' HD3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -62.43 -41.14 98.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.529 174.096 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.48 -49.64 76.63 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.317 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.449 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 43.1 mttp -64.68 -41.24 96.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.646 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.504 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 58.6 mt-10 -71.25 -44.2 65.76 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.944 HD11 HG12 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -113.1 -38.2 4.54 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -169.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.705 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.5 m -54.78 142.83 27.48 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.81 -173.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.561 HG13 HD23 ' A' ' 16' ' ' LEU . 42.3 pt -95.89 6.59 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.923 0.868 . . . . 0.0 109.449 171.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 25.2 t0 -91.53 113.96 26.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.02 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.74 -65.39 2.82 Favored Glycine 0 C--N 1.318 -0.46 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.59 -44.78 78.79 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 54' ' ' GLY . 15.0 m -66.63 -34.32 77.62 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.808 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 46' ' ' ASP . . . -65.7 -38.92 90.56 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.174 0.512 . . . . 0.0 110.685 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -63.55 -33.68 76.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.007 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.0 16.72 21.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.103 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.616 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 19.6 m-20 60.02 35.5 21.47 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.447 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.45 -28.76 1.23 Allowed Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -56.38 91.41 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.918 0.39 . . . . 0.0 110.808 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.439 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 83.9 mt -63.18 -39.05 93.54 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . 104.32 -148.03 16.67 Favored Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.53 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 21.6 m-85 -84.54 130.67 34.72 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.487 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 44.4 p90 -146.65 149.98 34.54 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.989 174.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.82 -170.23 36.98 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -73.76 154.3 39.64 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 122.737 -0.273 . . . . 0.0 110.338 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.19 -33.96 5.6 Favored Glycine 0 C--N 1.313 -0.75 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.041 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -64.42 -41.28 96.69 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.791 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -108.57 160.64 15.76 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.302 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 18.4 m -64.04 152.13 8.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.429 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.519 ' NZ ' ' OD2' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -43.76 -57.55 5.7 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.465 -175.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 38.0 Cg_endo -58.91 -32.19 96.92 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 N-CA-C 110.557 -0.593 . . . . 0.0 110.557 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.608 ' CD2' HD11 ' A' ' 93' ' ' ILE . 27.1 t80 -61.74 -47.57 84.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.513 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -62.84 -45.41 92.74 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.115 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.519 ' OD2' ' NZ ' ' A' ' 66' ' ' LYS . 40.5 m-20 -62.29 -40.28 95.76 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.281 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.57 -41.47 96.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.932 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.682 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -59.04 -49.43 77.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.581 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CE1' HD11 ' A' ' 10' ' ' ILE . 62.6 m-85 -65.17 -38.03 89.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.226 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -64.93 -39.5 93.6 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.744 HD22 ' HB2' ' A' ' 79' ' ' GLU . 44.0 mt -94.02 16.99 13.16 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.148 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.557 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 50.2 mt-30 -55.09 -19.67 7.91 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.958 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.549 HG13 ' HG3' ' A' ' 79' ' ' GLU . 7.2 p -65.24 -27.04 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.646 175.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.498 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 123.81 3.04 8.53 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 121.672 -0.299 . . . . 0.0 112.536 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.744 ' HB2' HD22 ' A' ' 75' ' ' LEU . 47.9 mt-10 -67.24 174.43 3.24 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -110.85 132.29 59.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.576 ' HB3' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -73.32 160.69 31.46 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -174.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.513 ' HA ' HE22 ' A' ' 27' ' ' GLN . 0.7 OUTLIER -70.73 175.84 2.35 Favored Pre-proline 0 N--CA 1.444 -0.733 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.94 134.25 61.17 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 CA-C-N 119.538 0.871 . . . . 0.0 109.868 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.47 126.67 74.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.567 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.9 tptp -97.56 135.58 39.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.25 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.567 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 60.5 p -135.03 169.89 16.74 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.707 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.7 pm0 -61.47 -34.02 74.74 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -63.35 -42.35 98.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.506 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.79 -146.17 13.35 Favored Glycine 0 C--N 1.321 -0.297 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.408 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.754 ' O ' HD12 ' A' ' 16' ' ' LEU . 6.4 m-85 -103.52 130.79 50.98 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 122.266 0.226 . . . . 0.0 110.522 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.712 ' CE1' HD13 ' A' ' 16' ' ' LEU . 35.9 m-70 -116.12 144.57 43.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.956 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.01 127.35 75.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 167.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.608 HD11 ' CD2' ' A' ' 68' ' ' PHE . 86.0 mt -120.16 129.49 75.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 122.572 -0.08 . . . . 0.0 110.833 -173.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 63.7 tttp -120.65 159.65 24.89 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.557 ' NE ' ' O ' ' A' ' 76' ' ' GLN . 27.7 ttt-85 -75.84 143.9 41.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.471 HD23 ' HA2' ' A' ' 57' ' ' GLY . 50.6 tp -108.77 142.06 39.87 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.4 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.198 -2.124 0 CA-C-O 118.09 -1.394 . . . . 0.0 112.135 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.433 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -64.59 145.6 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.22 1.28 . . . . 0.0 111.535 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.4 mtp -112.33 151.73 29.38 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.399 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.77 5.17 78.52 Favored Glycine 0 C--N 1.317 -0.499 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -173.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.5 p -76.62 173.53 11.48 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.853 -0.673 . . . . 0.0 110.442 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.5 mmt -63.14 -36.08 82.44 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.09 -0.09 2.24 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.322 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -59.28 -36.09 74.92 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 39.9 mttm -109.75 149.0 30.43 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.322 -176.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.642 HD12 ' CE2' ' A' ' 59' ' ' PHE . 21.1 mt -106.42 128.52 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -172.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.544 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 41.5 mtpt -90.72 104.57 17.14 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.599 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -148.11 167.38 25.14 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -175.112 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m -124.83 132.98 53.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.206 174.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.479 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.58 149.44 50.16 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.396 -175.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.714 HG23 ' OG ' ' A' ' 44' ' ' SER . 92.6 mt -124.33 125.94 71.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.708 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.617 HD13 ' CE1' ' A' ' 91' ' ' HIS . 51.3 tp -103.67 125.74 50.36 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 90' ' ' TYR . 32.7 m -134.86 155.13 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 121.107 0.479 . . . . 0.0 111.264 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.55 -22.85 34.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.462 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 22' ' ' GLU . 53.4 mmtt -112.14 140.92 46.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.896 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -64.05 -39.5 94.21 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.491 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.67 -35.76 90.24 Favored Glycine 0 N--CA 1.459 0.212 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.625 ' HB3' HD23 ' A' ' 43' ' ' LEU . 89.8 mt-10 -65.26 -42.83 92.88 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.56 -47.04 87.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.089 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.21 -41.93 98.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.955 0.407 . . . . 0.0 110.381 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.31 -50.68 72.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.193 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.935 HG12 HD12 ' A' ' 39' ' ' LEU . 10.7 m -64.7 -41.78 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.777 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.565 HE22 ' HD3' ' A' ' 83' ' ' PRO . 20.0 mt-30 -58.75 -50.84 72.44 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.145 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -65.78 -37.91 87.59 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.319 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.702 ' HD3' HD11 ' A' ' 39' ' ' LEU . 67.1 ttt180 -63.42 -37.49 87.48 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.316 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.3 mm? -61.56 -40.9 96.37 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 19.8 mmtp -63.32 -34.96 78.83 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.313 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -60.56 -24.24 65.26 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.538 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.52 6.93 26.67 Favored Glycine 0 N--CA 1.463 0.483 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.157 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 6.2 mt-10 -82.77 150.92 26.37 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.236 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -67.25 137.26 56.02 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.704 0.764 . . . . 0.0 112.021 -174.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.572 ' HA ' HD21 ' A' ' 30' ' ' LEU . 54.2 t80 -55.01 -43.0 73.23 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.639 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -59.35 -37.42 91.94 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.263 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.02 -47.82 84.26 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.935 HD12 HG12 ' A' ' 26' ' ' VAL . 4.4 mm? -62.67 -41.93 99.35 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.619 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -62.46 -43.47 98.74 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.053 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -63.3 -41.77 98.99 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -75.1 -82.11 0.07 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -174.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.896 HD22 ' CG1' ' A' ' 26' ' ' VAL . 6.6 mp -64.23 -42.8 96.38 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -170.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.714 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.1 m -56.57 133.43 53.56 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.736 -162.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.469 HG13 HD23 ' A' ' 16' ' ' LEU . 44.3 pt -87.98 -7.47 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.131 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 49' ' ' SER . 54.4 t0 -84.34 94.45 8.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.532 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -59.51 -50.68 65.1 Favored Glycine 0 C--N 1.315 -0.618 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.31 -44.69 93.35 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 39.6 m -62.79 -33.7 75.74 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.467 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -63.43 -36.74 84.72 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 47.4 mmtm -61.8 -33.69 74.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.835 HH21 HD23 ' A' ' 56' ' ' LEU . 76.5 mtm-85 -96.52 6.61 48.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.288 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.639 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 70.7 m-20 65.98 36.76 5.69 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.963 0.411 . . . . 0.0 110.152 -174.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 -20.66 4.75 Favored Glycine 0 C--N 1.317 -0.483 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -54.48 99.13 0.03 OUTLIER 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.374 0.607 . . . . 0.0 111.349 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.835 HD23 HH21 ' A' ' 52' ' ' ARG . 90.1 mt -68.73 -38.72 80.38 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 90.79 -145.17 17.73 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 -172.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.544 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 11.1 m-85 -83.99 132.65 34.73 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.642 ' CE2' HD12 ' A' ' 10' ' ' ILE . 52.3 p90 -142.51 149.39 39.09 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.448 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.95 173.67 28.18 Favored Glycine 0 C--O 1.238 0.36 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -81.63 159.73 23.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.566 0.222 . . . . 0.0 110.937 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.67 -77.15 0.38 Allowed Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -61.73 -39.31 91.1 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.229 0.538 . . . . 0.0 109.873 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.467 ' HG3' ' CD2' ' A' ' 59' ' ' PHE . 41.8 mmm -66.2 147.74 52.88 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.876 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 68' ' ' PHE . 29.9 m -79.07 136.91 22.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.097 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 9.3 mmtm -43.9 -50.24 19.69 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.565 ' HB2' HG13 ' A' ' 84' ' ' VAL . 29.5 Cg_endo -57.55 -36.61 98.59 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 CA-C-N 118.999 0.678 . . . . 0.0 110.797 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.649 ' HA ' HG11 ' A' ' 84' ' ' VAL . 31.8 t80 -63.13 -47.99 80.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.862 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 98.0 mt-10 -64.26 -46.61 82.98 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.288 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 10.9 t70 -57.07 -48.26 78.99 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.236 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.57 96.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.48 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -59.27 -45.83 90.17 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.573 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.489 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 59.1 m-85 -63.16 -36.4 83.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.227 0.537 . . . . 0.0 111.126 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 94.7 mtt-85 -65.03 -22.34 66.97 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.289 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.589 HD11 ' CB ' ' A' ' 81' ' ' SER . 73.0 mt -96.34 9.4 41.31 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.573 ' OE1' ' NH1' ' A' ' 95' ' ' ARG . 15.8 mm100 -43.42 -24.76 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 117.936 0.335 . . . . 0.0 111.75 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.98 -23.38 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.111 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 114.29 3.94 22.42 Favored Glycine 0 N--CA 1.47 0.91 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.473 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -73.91 175.48 7.29 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -172.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.21 131.09 56.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.147 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.589 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -74.34 153.21 39.4 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.161 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 2.4 mp0 -68.1 171.3 5.83 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 167.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.565 ' HD3' HE22 ' A' ' 27' ' ' GLN . 52.6 Cg_exo -54.51 132.66 52.41 Favored 'Trans proline' 0 C--N 1.289 -2.566 0 C-N-CA 120.399 0.733 . . . . 0.0 111.067 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.649 HG11 ' HA ' ' A' ' 68' ' ' PHE . 60.8 t -109.94 107.29 22.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.545 ' CG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 tmtp? -79.33 134.38 36.61 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.84 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 p -137.95 168.73 19.11 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.638 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -60.46 -34.28 73.78 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -67.25 -38.77 85.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.909 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.49 -154.83 25.85 Favored Glycine 0 C--N 1.314 -0.651 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.545 ' CE2' ' CG ' ' A' ' 85' ' ' LYS . 84.7 m-85 -104.69 126.86 52.19 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.617 ' CE1' HD13 ' A' ' 16' ' ' LEU . 7.7 m-70 -105.06 143.13 33.67 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.641 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.15 125.78 74.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.593 HD11 ' CD2' ' A' ' 68' ' ' PHE . 81.2 mt -115.9 129.41 72.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -110.05 140.81 43.68 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 168.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.573 ' NH1' ' OE1' ' A' ' 76' ' ' GLN . 4.7 tpt180 -77.9 135.32 37.86 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.455 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 53.7 tp -121.7 145.63 47.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.616 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.402 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.211 -1.282 0 CA-C-O 118.342 -1.255 . . . . 0.0 110.859 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.588 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.414 ' O ' ' OG ' ' A' ' 5' ' ' SER . 32.6 Cg_exo -60.98 148.55 92.41 Favored 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.024 1.816 . . . . 0.0 110.779 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.7 mtp -56.14 141.52 40.28 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.403 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.77 -30.82 5.9 Favored Glycine 0 C--N 1.319 -0.384 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.442 ' N ' ' CE2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -68.83 93.03 0.52 Allowed 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 97.8 mtp -124.58 144.05 50.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.47 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.86 -24.76 67.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.296 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.578 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 32.2 t70 -61.75 -42.12 98.56 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -81.87 167.09 19.35 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.161 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.94 HG21 ' HB1' ' A' ' 72' ' ' ALA . 21.2 mm -105.86 126.6 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.577 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 56.8 mtpt -88.34 104.08 16.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.1 OUTLIER -148.77 168.31 23.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -175.753 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.9 m -131.13 146.35 52.31 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.594 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -140.18 150.31 44.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.682 HG23 ' OG ' ' A' ' 44' ' ' SER . 91.3 mt -127.1 128.8 70.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.08 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -101.19 116.61 33.21 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.571 ' N ' HD13 ' A' ' 16' ' ' LEU . 35.8 m -120.83 154.66 24.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.502 0.668 . . . . 0.0 111.29 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -65.9 -40.62 91.68 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.657 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -119.15 148.9 42.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.448 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 48.8 mt-30 -62.4 -40.69 97.32 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.124 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.52 -40.76 94.91 Favored Glycine 0 CA--C 1.511 -0.209 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -63.76 -44.45 93.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' A' ' 92' ' ' VAL . . . -59.11 -48.0 83.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.978 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.11 -41.01 99.28 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.138 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.05 -47.99 81.46 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.729 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.564 HG12 HD12 ' A' ' 39' ' ' LEU . 28.4 m -70.44 -32.89 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 81' ' ' SER . 48.6 tt0 -59.46 -48.18 82.62 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 77.9 mm-40 -71.12 -36.42 72.12 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.118 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.865 ' HD2' HD11 ' A' ' 39' ' ' LEU . 42.4 ttm180 -60.55 -37.94 82.9 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -58.56 -27.15 64.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.252 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.499 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 33.6 mmtp -61.75 -38.73 89.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.12 -24.27 58.09 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.799 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.33 15.38 30.29 Favored Glycine 0 C--N 1.32 -0.356 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -58.9 140.82 54.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.532 ' NZ ' ' OD2' ' A' ' 53' ' ' ASP . 17.0 tptm -56.1 127.38 30.31 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CE2' HG13 ' A' ' 15' ' ' ILE . 61.6 t80 -57.06 -43.52 82.15 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -60.45 -33.8 82.75 Favored Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.836 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 87.2 tttt -59.9 -48.64 80.88 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.865 HD11 ' HD2' ' A' ' 29' ' ' ARG . 4.5 mm? -62.04 -41.94 98.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.435 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.514 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.48 -48.68 76.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.444 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -64.38 -39.66 94.3 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.25 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.584 ' C ' HD13 ' A' ' 43' ' ' LEU . 63.8 mm-40 -70.33 -45.17 66.71 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -171.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.843 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.77 -24.06 4.56 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -177.041 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.682 ' OG ' HG23 ' A' ' 15' ' ' ILE . 3.7 m -50.98 137.82 20.49 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.53 -173.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.54 ' CG1' HD12 ' A' ' 16' ' ' LEU . 39.4 pt -98.69 -5.22 9.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.317 0.579 . . . . 0.0 109.501 172.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.473 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 67.3 t0 -87.82 107.85 18.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.661 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -64.34 -43.64 96.58 Favored Glycine 0 C--N 1.318 -0.428 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.32 -49.46 68.37 Favored Glycine 0 CA--C 1.504 -0.654 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.594 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 16.2 m -60.58 -34.53 74.33 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.798 0.332 . . . . 0.0 110.409 174.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.14 85.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.261 0.553 . . . . 0.0 110.743 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 35.3 mmtp -64.12 -39.45 94.06 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 55' ' ' SER . 80.2 mtp180 -98.09 25.47 6.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.086 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.532 ' OD2' ' NZ ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER 35.94 42.44 0.16 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.781 0.8 . . . . 0.0 112.659 -178.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.38 -15.87 4.17 Favored Glycine 0 C--N 1.315 -0.63 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.474 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ARG . 4.9 m -73.41 77.7 1.39 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.26 0.552 . . . . 0.0 110.796 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.483 HD11 ' CD2' ' A' ' 14' ' ' HIS . 96.2 mt -64.58 -38.44 91.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.153 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.26 -141.67 21.6 Favored Glycine 0 CA--C 1.501 -0.786 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.577 ' CD1' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -85.8 139.99 30.83 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.575 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.606 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 55.2 p90 -144.77 152.89 41.04 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.802 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.5 172.66 36.28 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 8' ' ' ASP . 72.1 mtm-85 -84.69 148.68 26.27 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.017 0.437 . . . . 0.0 111.991 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.81 -56.13 0.48 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.019 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -61.4 -39.42 90.67 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.081 0.467 . . . . 0.0 111.129 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.473 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 76.0 mmm -79.99 153.74 28.69 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.67 -176.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 m -68.4 137.95 23.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.362 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -44.29 -52.5 16.47 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -173.509 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.527 ' HB2' HG13 ' A' ' 84' ' ' VAL . 31.3 Cg_endo -60.21 -32.44 94.42 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 CA-C-N 118.639 0.55 . . . . 0.0 111.284 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.498 ' CD2' HD11 ' A' ' 93' ' ' ILE . 47.2 t80 -62.19 -47.22 85.46 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.543 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 76.7 mt-10 -63.78 -43.19 97.09 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.817 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -56.25 -49.18 74.91 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.793 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -63.44 -42.72 98.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.859 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.94 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -57.67 -49.09 77.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.27 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 69' ' ' GLU . 32.1 m-85 -63.62 -38.96 93.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -61.64 -33.42 73.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.316 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 ' HB3' ' A' ' 81' ' ' SER . 90.9 mt -89.12 5.71 43.33 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.531 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 15.5 mm100 -42.83 -24.08 0.06 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 118.219 0.463 . . . . 0.0 112.01 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -63.28 -26.22 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 120.798 0.332 . . . . 0.0 111.878 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.517 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 114.19 11.39 12.22 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -85.71 174.42 9.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.78 HG22 ' HD3' ' A' ' 94' ' ' LYS . 11.3 t -95.78 131.46 42.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.878 ' HB3' HD11 ' A' ' 75' ' ' LEU . 28.5 p -72.92 160.89 31.41 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 123.138 0.273 . . . . 0.0 111.71 -172.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.495 ' HA ' HE22 ' A' ' 27' ' ' GLN . 2.9 mt-10 -64.12 168.91 5.29 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 166.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -57.94 136.08 72.89 Favored 'Trans proline' 0 C--N 1.292 -2.422 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.527 HG13 ' HB2' ' A' ' 67' ' ' PRO . 45.2 t -117.52 130.04 73.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HD2' ' CE1' ' A' ' 90' ' ' TYR . 82.9 tttt -110.65 131.75 54.78 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.989 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 p -143.72 -171.58 3.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.972 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.7 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 2.1 pm0 -66.09 -31.81 72.9 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -64.1 -37.92 89.2 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.805 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 16' ' ' LEU . . . 142.85 -139.41 9.0 Favored Glycine 0 C--O 1.242 0.608 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 87.4 m-85 -106.98 126.89 52.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.472 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 2.0 m-70 -105.35 147.28 28.35 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.59 0.233 . . . . 0.0 111.097 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 73.3 t -117.5 126.69 74.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 167.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.498 HD11 ' CD2' ' A' ' 68' ' ' PHE . 91.4 mt -115.37 127.32 72.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.65 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.78 ' HD3' HG22 ' A' ' 80' ' ' VAL . 27.0 tptp -106.22 128.74 54.16 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.531 ' CD ' ' HA ' ' A' ' 76' ' ' GLN . 76.3 ttt-85 -77.65 139.22 39.44 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 118.644 -1.222 . . . . 0.0 109.266 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 50.6 tp -110.08 133.37 53.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.262 -175.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.47 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.573 0 CA-C-O 118.28 -1.289 . . . . 0.0 110.845 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.483 ' HA2' ' CE2' ' A' ' 58' ' ' TYR . . . . . . . . 0 CA--C 1.521 0.463 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.89 145.35 98.51 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.686 1.59 . . . . 0.0 111.171 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.6 tpp -61.3 139.54 58.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.31 -44.64 1.51 Allowed Glycine 0 C--N 1.313 -0.707 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.41 159.41 27.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 122.518 -0.401 . . . . 0.0 110.415 173.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 76.7 mtm -88.91 152.99 21.4 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.77 51.69 0.21 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -64.52 -38.0 89.48 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.609 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -93.42 158.96 15.46 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.532 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.74 HG21 ' HB1' ' A' ' 72' ' ' ALA . 42.5 mm -106.02 128.24 60.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.525 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 11.8 mtpp -89.43 107.07 18.86 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.5 167.26 22.92 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.874 -177.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.528 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.4 m -130.6 147.56 52.3 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.122 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.55 149.74 50.68 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.449 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.639 HG23 ' OG ' ' A' ' 44' ' ' SER . 96.1 mt -123.61 128.77 74.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.332 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 45' ' ' ILE . 41.1 tp -103.11 123.5 46.79 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.021 HG12 HD11 ' A' ' 43' ' ' LEU . 16.2 m -124.1 147.9 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 123.657 0.598 . . . . 0.0 111.132 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -66.76 -42.54 86.0 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.403 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.497 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 25.9 mmtp -112.77 151.1 30.7 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -174.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -64.36 -34.89 79.2 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.871 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.22 -37.78 95.1 Favored Glycine 0 CA--C 1.509 -0.317 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 98.3 mt-10 -64.94 -41.92 95.1 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.54 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -57.75 -46.98 83.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.269 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.09 -42.54 99.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.366 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.07 73.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.677 ' O ' HD23 ' A' ' 30' ' ' LEU . 11.3 m -65.18 -40.7 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.964 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 32.2 mt-30 -60.08 -47.3 86.43 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.712 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.562 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 57.0 mm-40 -66.48 -37.14 84.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.034 0.445 . . . . 0.0 110.827 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.863 ' HD3' HD11 ' A' ' 39' ' ' LEU . 77.6 ttt180 -61.06 -41.11 96.0 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.417 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.681 HD11 ' HA ' ' A' ' 36' ' ' PHE . 4.1 mm? -60.09 -38.87 84.22 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.512 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 17.5 mmtp -61.04 -34.72 75.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.16 -10.03 37.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.116 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.68 -0.42 39.46 Favored Glycine 0 N--CA 1.462 0.379 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.771 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.652 ' O ' HD13 ' A' ' 30' ' ' LEU . 7.3 mm-40 -65.38 142.52 58.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 29.9 mttm -72.58 141.83 48.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.283 0.564 . . . . 0.0 111.13 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.681 ' HA ' HD11 ' A' ' 30' ' ' LEU . 53.1 t80 -58.67 -45.45 89.36 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -61.02 -34.91 89.72 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.972 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 88.7 tttt -61.04 -47.35 86.77 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.863 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.2 mm? -62.96 -41.11 99.43 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.732 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 44' ' ' SER . . . -60.0 -50.05 75.27 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.85 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.564 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 68.2 mttm -65.85 -45.27 82.77 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.848 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 86.5 mt-10 -71.99 -44.59 63.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.021 HD11 HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -112.43 -39.11 4.47 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -168.092 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.713 ' N ' HD13 ' A' ' 43' ' ' LEU . 67.6 m -52.59 135.83 33.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.334 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.621 HG13 HD23 ' A' ' 16' ' ' LEU . 42.5 pt -87.88 -5.75 10.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.543 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -85.97 91.39 8.37 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -61.12 -43.59 99.22 Favored Glycine 0 C--N 1.313 -0.718 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.6 -44.21 78.87 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.3 m -71.8 -33.63 68.71 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.733 175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -65.19 -38.78 91.55 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.787 0.803 . . . . 0.0 109.854 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.33 -37.33 82.89 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.206 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -97.58 20.57 11.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.944 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.564 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 57.75 30.53 19.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.648 177.382 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 70.69 -8.1 4.63 Favored Glycine 0 C--N 1.306 -1.106 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -69.95 85.31 0.51 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.147 0.498 . . . . 0.0 110.58 -178.254 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.06 -39.86 95.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.826 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 89.46 -143.44 17.28 Favored Glycine 0 CA--C 1.507 -0.428 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.525 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 95.3 m-85 -83.61 132.92 34.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.437 ' CD1' ' HG3' ' A' ' 64' ' ' MET . 44.8 p90 -146.25 150.28 35.49 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.001 170.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.43 178.38 27.68 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.459 ' HB3' ' NH1' ' A' ' 61' ' ' ARG . 8.4 mtm105 -75.38 154.78 37.02 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.59 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.81 -31.94 8.12 Favored Glycine 0 C--N 1.309 -0.957 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -11.14 54.54 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.494 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.437 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 10.0 mmm -125.08 156.61 37.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.94 150.77 6.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.849 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.529 ' NZ ' ' HB2' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -44.42 -54.5 12.03 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 38.0 Cg_endo -61.94 -34.14 81.99 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 120.163 0.575 . . . . 0.0 111.119 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CD2' HD11 ' A' ' 93' ' ' ILE . 38.3 t80 -62.43 -47.87 82.17 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.476 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.63 -39.99 94.68 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.895 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.529 ' HB2' ' NZ ' ' A' ' 66' ' ' LYS . 27.6 t70 -56.03 -51.24 68.48 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.871 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 81' ' ' SER . . . -64.7 -41.64 95.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.74 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -61.15 -50.98 70.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.342 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 10' ' ' ILE . 59.2 m-85 -69.15 -38.45 78.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.773 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -66.61 -40.96 89.05 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 81' ' ' SER . 50.3 mt -98.1 33.46 2.15 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.478 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 71.0 mt-30 -51.24 -24.54 4.49 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.83 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.431 HG13 ' H ' ' A' ' 79' ' ' GLU . 12.1 p -59.83 -31.88 48.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.514 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 123.47 -4.72 9.4 Favored Glycine 0 N--CA 1.469 0.873 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.086 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.431 ' H ' HG13 ' A' ' 77' ' ' VAL . 90.5 mt-10 -60.69 147.33 42.49 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.897 0.379 . . . . 0.0 111.938 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 t -78.59 130.99 35.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.455 ' HA ' HD11 ' A' ' 75' ' ' LEU . 10.5 p -74.3 153.44 39.35 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.659 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.6 mp0 -59.57 164.69 5.04 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.54 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 50.3 Cg_exo -53.67 129.03 31.92 Favored 'Trans proline' 0 C--N 1.292 -2.43 0 N-CA-C 109.865 -0.86 . . . . 0.0 109.865 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.448 HG21 HD12 ' A' ' 93' ' ' ILE . 59.2 t -104.25 113.97 42.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.533 ' NZ ' ' OH ' ' A' ' 90' ' ' TYR . 41.7 tttp -81.85 138.27 35.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 19.3 p -150.6 166.47 30.19 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.44 -32.41 71.35 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.439 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 65.7 m-85 -64.48 -40.4 95.61 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.328 176.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.97 -149.85 21.91 Favored Glycine 0 C--N 1.318 -0.418 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.533 ' OH ' ' NZ ' ' A' ' 85' ' ' LYS . 82.7 m-85 -104.38 127.39 52.04 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.362 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.502 ' CE1' HD13 ' A' ' 16' ' ' LEU . 3.9 m-70 -111.35 151.18 28.72 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.224 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.483 HG21 HG21 ' A' ' 26' ' ' VAL . 1.9 t -116.67 114.09 44.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 168.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.512 HD11 ' CD2' ' A' ' 68' ' ' PHE . 75.7 mt -111.4 124.03 67.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.244 -172.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 30.1 tttp -114.56 139.01 49.94 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.514 172.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.478 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 1.4 tmm_? -78.9 141.58 37.5 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.398 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.421 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 50.2 tp -109.45 124.06 50.4 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.055 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.204 -1.725 0 CA-C-O 118.296 -1.28 . . . . 0.0 110.248 -177.366 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.265 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.64 141.84 97.92 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.405 1.403 . . . . 0.0 110.976 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.8 mtt -62.62 143.76 56.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.253 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.52 -20.06 52.03 Favored Glycine 0 C--N 1.319 -0.4 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -83.16 96.04 8.3 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.799 0.333 . . . . 0.0 110.177 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.7 mtp -95.61 138.31 33.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.159 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.05 9.09 32.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.861 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -61.52 -42.38 98.72 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -88.94 156.67 18.75 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.366 171.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.715 HD11 ' CE2' ' A' ' 73' ' ' PHE . 68.0 mt -104.72 126.32 59.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' NZ ' ' HA2' ' A' ' 97' ' ' GLY . 7.8 mtpm? -94.85 104.42 16.32 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.564 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -144.48 171.86 13.77 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -171.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.9 m -131.4 146.07 52.1 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.305 174.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.449 ' CG ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.15 150.96 44.88 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.59 HG23 ' OG ' ' A' ' 44' ' ' SER . 61.8 mt -121.99 126.77 74.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.288 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.637 HD13 ' CE1' ' A' ' 91' ' ' HIS . 50.5 tp -101.85 122.37 43.86 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.53 HG13 HG22 ' A' ' 15' ' ' ILE . 34.8 m -130.39 155.02 41.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.418 0.628 . . . . 0.0 111.106 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HG3' HG21 ' A' ' 45' ' ' ILE . 10.5 mtpt -66.38 -41.74 88.97 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.704 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 27.8 mtpp -118.81 151.6 37.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.447 -172.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -60.9 -37.23 81.52 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.29 -39.94 97.92 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 88.8 mt-10 -63.84 -46.02 86.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.579 ' HB1' ' CG2' ' A' ' 92' ' ' VAL . . . -60.0 -49.37 77.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.443 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 24' ' ' LEU . 97.2 mt -63.72 -41.05 98.14 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.789 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.51 -49.35 75.0 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.885 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.586 HG12 HD12 ' A' ' 39' ' ' LEU . 9.4 m -68.21 -40.57 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.406 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.517 HE21 ' C ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -56.05 -42.81 77.18 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.079 -179.389 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 51.9 mm-40 -71.71 -35.03 70.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.183 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.457 ' HG3' ' HG3' ' A' ' 34' ' ' GLU . 12.3 ttm180 -62.07 -37.32 84.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.311 176.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.563 HD23 ' O ' ' A' ' 26' ' ' VAL . 4.3 mm? -60.57 -36.25 78.05 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.871 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 28.4 mmtm -59.98 -36.65 77.62 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.68 -10.44 36.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.894 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.64 62.62 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 12.2 mm-40 -62.3 147.04 49.39 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 74.4 tttt -63.01 128.64 36.81 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.421 ' HA ' HD11 ' A' ' 30' ' ' LEU . 53.6 t80 -58.11 -45.16 87.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -58.25 -39.48 92.55 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.783 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 49.2 tttp -59.46 -45.72 90.81 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.586 HD12 HG12 ' A' ' 26' ' ' VAL . 4.2 mm? -61.66 -42.15 98.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.583 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.486 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.89 -49.84 74.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.324 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 31.8 mttp -64.64 -40.45 95.47 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -71.46 -47.02 58.3 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.748 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.69 -13.14 7.54 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.397 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.59 ' OG ' HG23 ' A' ' 15' ' ' ILE . 4.0 m -58.35 138.59 56.37 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.047 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.56 HG13 HD23 ' A' ' 16' ' ' LEU . 44.3 pt -90.65 -4.12 10.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -89.24 101.91 14.57 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.787 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.28 -45.3 96.77 Favored Glycine 0 C--N 1.317 -0.484 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.33 -43.38 89.73 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 54' ' ' GLY . 63.6 m -63.49 -34.79 78.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.822 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -64.76 -39.25 93.31 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.172 0.511 . . . . 0.0 109.973 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -64.37 -40.34 95.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.559 0.695 . . . . 0.0 109.248 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 84.0 mtp180 -97.27 10.3 39.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.051 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.592 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 21.3 m-20 57.68 29.86 17.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 71.67 0.85 42.72 Favored Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 1.3 m -68.45 83.07 0.26 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.119 0.485 . . . . 0.0 110.899 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.564 HD12 ' SG ' ' A' ' 12' ' ' CYS . 90.0 mt -63.4 -39.7 95.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.541 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 86.81 -149.08 22.1 Favored Glycine 0 C--N 1.318 -0.44 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.95 129.3 34.93 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.584 ' CE1' ' HG3' ' A' ' 64' ' ' MET . 45.8 p90 -146.14 149.47 34.07 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.677 0.275 . . . . 0.0 110.767 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.86 -179.46 38.86 Favored Glycine 0 C--N 1.315 -0.636 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -78.27 153.28 31.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.433 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.41 -34.54 5.21 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.19 -36.85 85.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.051 0.453 . . . . 0.0 110.475 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.584 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 3.5 mmm -110.82 154.18 24.34 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.258 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 27.4 m -64.91 141.13 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.596 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.4 mtpm? -44.2 -48.81 24.06 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -172.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 30.4 Cg_endo -60.66 -32.2 92.95 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 CA-C-N 119.059 0.7 . . . . 0.0 111.264 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.659 ' CD2' HD11 ' A' ' 93' ' ' ILE . 37.9 t80 -61.85 -46.94 87.29 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.463 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 99.7 mt-10 -61.49 -45.31 94.76 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.465 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.43 ' OD2' ' NH2' ' A' ' 74' ' ' ARG . 13.0 t70 -56.93 -50.33 72.9 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.408 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.05 93.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.046 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.586 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -61.77 -46.66 88.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.806 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.715 ' CE2' HD11 ' A' ' 10' ' ' ILE . 52.9 m-85 -66.31 -40.43 89.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.464 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 74' ' ' ARG . 50.9 mtm180 -64.07 -42.14 97.1 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.7 mt -97.95 31.77 2.59 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.513 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 48.6 mt-30 -55.81 -18.15 7.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.262 0.553 . . . . 0.0 109.943 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 79' ' ' GLU . 3.2 p -58.1 -29.16 36.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.037 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.405 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 118.78 -3.01 15.03 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' H ' HG13 ' A' ' 77' ' ' VAL . 79.9 mm-40 -69.51 161.21 29.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.887 0.375 . . . . 0.0 111.17 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.55 127.66 42.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.517 ' C ' HE21 ' A' ' 27' ' ' GLN . 10.5 p -77.53 159.28 29.43 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.265 0.555 . . . . 0.0 112.206 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -69.6 168.39 17.36 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.554 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 51.4 Cg_exo -56.38 135.18 68.78 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 N-CA-C 110.136 -0.756 . . . . 0.0 110.136 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 40.4 t -116.49 126.82 74.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HD3' ' CZ ' ' A' ' 90' ' ' TYR . 9.8 tptm -85.06 131.3 34.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.074 -177.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.8 p -135.53 170.07 16.53 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -56.26 -37.51 69.88 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -64.11 -43.82 94.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.152 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.04 -140.06 7.0 Favored Glycine 0 N--CA 1.465 0.601 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.58 ' O ' HD12 ' A' ' 16' ' ' LEU . 43.9 m-85 -106.28 130.88 54.05 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.637 ' CE1' HD13 ' A' ' 16' ' ' LEU . 6.8 m-70 -110.45 146.27 36.2 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.124 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.579 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 67.4 t -117.54 127.51 74.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.659 HD11 ' CD2' ' A' ' 68' ' ' PHE . 82.8 mt -119.71 128.08 75.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.984 -173.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.405 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 64.5 tttp -120.13 141.26 50.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -79.1 143.84 35.14 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.941 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 52.2 tp -112.64 131.14 55.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.486 0.66 . . . . 0.0 110.216 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.517 ' HA2' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--N 1.293 -1.82 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.413 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 CA--C 1.527 0.83 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.438 ' HB2' ' HB2' ' A' ' 5' ' ' SER . 32.0 Cg_exo -60.12 145.34 98.67 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 121.65 1.567 . . . . 0.0 111.186 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.9 mtp -37.04 121.78 0.81 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.456 -174.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 38.33 30.2 0.08 OUTLIER Glycine 0 N--CA 1.468 0.811 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.402 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 2' ' ' PRO . 7.4 m -104.64 119.7 39.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 116.878 0.339 . . . . 0.0 110.555 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 9' ' ' LYS . 99.9 mmm -66.1 110.01 2.81 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 9' ' ' LYS . . . -69.83 -9.22 53.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -173.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.33 46.23 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.02 0.438 . . . . 0.0 110.484 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 7' ' ' ALA . 50.4 mttp -136.09 167.49 21.14 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.371 -176.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.854 HG21 ' HB1' ' A' ' 72' ' ' ALA . 61.1 mt -111.46 131.49 62.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.521 ' NZ ' ' OXT' ' A' ' 97' ' ' GLY . 46.3 mtpt -91.29 107.16 19.02 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' SG ' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -147.59 167.02 25.6 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.908 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.454 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 14.1 m -135.02 149.9 50.22 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.432 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.418 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -139.08 149.9 45.11 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 119.512 -0.875 . . . . 0.0 113.112 -177.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.735 HG23 ' HB3' ' A' ' 44' ' ' SER . 96.5 mt -124.11 123.34 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.608 HD12 ' O ' ' A' ' 90' ' ' TYR . 48.0 tp -94.41 127.2 40.16 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 90' ' ' TYR . 29.0 m -129.89 150.64 34.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.129 0.49 . . . . 0.0 110.588 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -66.14 -40.64 90.77 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.296 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -121.17 152.32 38.9 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -172.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.43 ' HG3' ' CG ' ' A' ' 83' ' ' PRO . 59.9 tt0 -62.06 -41.15 97.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.665 178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.09 95.67 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.97 -42.09 98.75 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.589 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -60.13 -41.37 92.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.742 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HA ' HE21 ' A' ' 27' ' ' GLN . 1.5 mm? -62.64 -42.46 99.61 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.029 0.442 . . . . 0.0 110.412 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.69 79.61 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.887 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 92' ' ' VAL . 31.1 m -64.42 -40.75 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.926 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.469 HE21 ' HA ' ' A' ' 24' ' ' LEU . 36.0 mt-30 -59.5 -47.05 87.02 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.275 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -64.3 -44.49 91.45 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.569 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 71.4 ttt180 -65.58 -39.3 91.48 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.69 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.884 HD22 HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -56.61 -28.92 61.5 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -177.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 69.0 mmtt -62.9 -30.12 71.29 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.79 -22.17 45.76 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.533 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.84 13.39 56.67 Favored Glycine 0 C--O 1.236 0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.135 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.569 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 73.9 mt-10 -66.31 154.46 39.93 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -60.19 126.71 28.56 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 66.0 t80 -59.11 -44.95 92.01 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -60.87 -37.77 94.25 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.472 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 60.1 tttm -60.23 -46.46 89.69 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.884 HD12 HD22 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.9 -36.91 80.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.932 178.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . -56.04 -50.86 69.76 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.501 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.46 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 45.4 mttp -62.76 -37.81 88.09 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 80.3 mm-40 -69.82 -46.65 65.19 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.422 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.564 HD22 ' CG1' ' A' ' 26' ' ' VAL . 1.7 mp -114.45 -41.44 3.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.735 ' HB3' HG23 ' A' ' 15' ' ' ILE . 6.6 p -54.99 138.11 44.52 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.481 -168.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.527 HG13 HD23 ' A' ' 16' ' ' LEU . 46.3 pt -97.85 -5.03 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.134 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -84.45 93.09 8.22 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.19 -45.53 96.33 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.2 -44.91 74.76 Favored Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.434 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 73.9 m -70.74 -34.08 71.49 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.604 175.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -63.69 -25.32 68.16 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.886 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 30.6 mmtp -63.14 -36.97 85.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 8.3 mtm-85 -96.77 15.47 21.87 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.165 174.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.582 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 22.6 m-20 58.94 29.48 18.98 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.72 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 49' ' ' SER . . . 77.89 -5.15 54.78 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -73.95 84.06 1.73 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.501 0.667 . . . . 0.0 110.186 178.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 96.4 mt -62.91 -39.75 95.49 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.153 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.433 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . 87.38 -142.92 18.35 Favored Glycine 0 CA--C 1.503 -0.667 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.511 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 19.8 m-85 -83.9 132.91 34.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.529 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 46.9 p90 -145.07 152.02 39.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.89 165.54 26.94 Favored Glycine 0 C--N 1.316 -0.53 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.496 ' HD2' ' CZ ' ' A' ' 73' ' ' PHE . 60.0 mtp180 -77.32 157.96 30.42 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.496 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 129.11 -77.03 0.4 Allowed Glycine 0 N--CA 1.462 0.394 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -61.21 -38.01 85.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.393 0.615 . . . . 0.0 109.623 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.569 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 75.6 mmm -63.84 145.8 55.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.213 -176.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG23 ' H ' ' A' ' 68' ' ' PHE . 13.3 m -73.71 130.66 35.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.657 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 64' ' ' MET . 5.7 mmtm -45.05 -40.35 10.56 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.118 -174.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 32.8 Cg_exo -56.09 -41.57 75.47 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 120.445 0.763 . . . . 0.0 110.434 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.593 ' CD2' HD11 ' A' ' 93' ' ' ILE . 23.0 t80 -62.84 -47.1 84.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.598 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.439 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 96.4 mt-10 -62.13 -43.2 99.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.59 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.03 -51.36 69.58 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.793 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -63.25 -40.21 96.79 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.278 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.854 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -58.94 -47.6 84.5 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.492 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.722 ' CE2' HD11 ' A' ' 10' ' ' ILE . 55.7 m-85 -66.62 -37.03 84.0 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.558 HH12 ' CD ' ' A' ' 82' ' ' GLU . 49.3 mtm180 -63.6 -35.92 82.12 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.563 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.64 HD11 ' CA ' ' A' ' 81' ' ' SER . 74.5 mt -97.24 21.38 10.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -171.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.509 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 70.0 mt-30 -52.27 -24.99 8.28 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.893 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 p -61.31 -26.51 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.647 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.433 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 115.17 5.43 19.64 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' A' ' 75' ' ' LEU . 1.8 mm-40 -75.6 173.85 10.49 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 t -104.22 127.5 58.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.584 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.64 ' CA ' HD11 ' A' ' 75' ' ' LEU . 60.0 p -68.14 151.02 47.63 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.558 ' CD ' HH12 ' A' ' 74' ' ' ARG . 1.2 mp0 -63.86 164.03 19.17 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 167.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 16.9 Cg_exo -54.32 128.29 29.42 Favored 'Trans proline' 0 C--N 1.29 -2.521 0 N-CA-C 109.71 -0.919 . . . . 0.0 109.71 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 91' ' ' HIS . 15.5 t -98.32 117.51 43.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -77.45 136.87 38.41 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.086 0.47 . . . . 0.0 110.844 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 10.3 p -153.89 167.35 30.01 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -57.02 -31.29 64.98 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.459 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 68.3 m-85 -63.58 -42.8 98.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.676 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.43 -132.81 4.45 Favored Glycine 0 C--O 1.239 0.426 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.608 ' O ' HD12 ' A' ' 16' ' ' LEU . 86.9 m-85 -107.42 127.66 53.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.545 ' O ' HG23 ' A' ' 84' ' ' VAL . 5.1 m-70 -108.03 140.71 40.8 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.889 172.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 26' ' ' VAL . 2.4 t -112.98 115.88 51.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 171.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.593 HD11 ' CD2' ' A' ' 68' ' ' PHE . 85.4 mt -111.82 125.34 69.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.854 -171.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 63.6 tttp -113.1 139.74 48.46 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 171.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 3.2 tmm_? -78.87 141.78 37.37 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.238 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.505 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 58.6 tp -109.91 134.41 52.11 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.167 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.521 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.204 -1.735 0 CA-C-O 118.126 -1.374 . . . . 0.0 110.63 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.727 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.45 147.3 90.54 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.346 1.364 . . . . 0.0 111.194 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.7 mtm -106.1 152.91 22.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.345 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.31 -33.99 5.42 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 m -73.18 136.23 44.72 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.559 ' C ' ' H ' ' A' ' 8' ' ' ASP . 76.1 mtm -117.18 137.01 52.62 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.11 31.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.761 0.315 . . . . 0.0 111.324 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.559 ' H ' ' C ' ' A' ' 6' ' ' MET . 22.2 t70 -61.22 -45.55 94.08 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -110.39 163.03 14.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.87 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.825 HD11 ' CE2' ' A' ' 73' ' ' PHE . 39.8 mm -105.49 129.45 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.535 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 36.0 mtpt -88.98 104.32 16.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 176.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.53 170.36 16.2 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.815 -176.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.6 m -128.29 137.69 52.08 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 114.319 -1.31 . . . . 0.0 107.743 175.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.416 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -133.49 149.6 51.72 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.994 -0.682 . . . . 0.0 112.459 -178.712 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.505 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 90.0 mt -122.94 124.84 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.607 HD13 ' CE1' ' A' ' 91' ' ' HIS . 41.6 tp -104.85 123.54 47.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 43' ' ' LEU . 3.0 m -131.79 154.29 40.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.25 0.547 . . . . 0.0 111.556 -176.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -70.43 -40.38 73.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.818 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.61 144.49 37.88 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -169.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.488 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 27.4 mt-30 -62.78 -39.35 93.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.614 175.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.25 -38.86 95.21 Favored Glycine 0 CA--C 1.509 -0.307 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -64.99 -44.5 89.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.223 0.535 . . . . 0.0 109.77 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -60.71 -48.46 81.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.423 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.546 ' HA ' ' HB2' ' A' ' 27' ' ' GLN . 91.4 mt -64.32 -40.06 95.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.13 -49.17 74.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.35 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.708 HG12 HD12 ' A' ' 39' ' ' LEU . 21.1 m -64.93 -38.05 81.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.944 176.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.645 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 2.2 mm-40 -54.23 -48.16 71.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.428 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -70.67 -43.44 69.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.251 0.548 . . . . 0.0 110.766 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.776 ' HD3' HD11 ' A' ' 39' ' ' LEU . 65.0 ttt180 -61.63 -39.43 91.28 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.001 -174.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -60.75 -34.29 74.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.153 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.645 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 23.9 mmtm -62.97 -34.12 76.84 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.82 -23.62 63.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.425 176.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.09 1.45 54.68 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.103 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.46 ' OE1' ' NE ' ' A' ' 29' ' ' ARG . 55.1 mt-10 -65.58 155.78 34.74 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.35 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -61.62 126.58 27.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.082 -172.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.505 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 61.8 t80 -58.18 -45.24 87.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 174.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.41 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -60.09 -39.16 95.41 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.385 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -60.7 -43.58 97.63 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.031 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.776 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.4 mm? -63.48 -40.96 98.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.697 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.445 ' CB ' ' C ' ' A' ' 53' ' ' ASP . . . -60.68 -43.32 97.83 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 31.6 mmtt -64.56 -36.46 84.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -70.44 -59.34 2.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.075 -172.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.483 ' HB3' HG12 ' A' ' 17' ' ' VAL . 1.8 mt -93.42 -57.4 2.61 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.5 m -29.47 120.02 0.15 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.956 -1.474 . . . . 0.0 113.493 -165.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.408 HG13 HD23 ' A' ' 16' ' ' LEU . 41.5 pt -82.34 -12.0 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -82.16 95.08 7.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.8 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.05 -42.84 99.75 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.04 -45.36 81.95 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.1 m -69.16 -32.6 72.04 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.574 0.226 . . . . 0.0 110.724 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.424 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -63.12 -37.35 86.85 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.041 0.448 . . . . 0.0 109.999 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -63.73 -27.69 69.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.897 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 55' ' ' SER . 68.7 mtt-85 -95.94 5.61 50.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.081 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER 58.06 33.0 22.72 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.309 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 79.65 -16.85 9.7 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -66.15 81.38 0.08 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.61 0.719 . . . . 0.0 110.932 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.6 mt -61.87 -41.07 97.42 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.417 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 91.19 -137.38 13.81 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.535 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 71.2 m-85 -84.16 137.82 33.32 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.0 p90 -146.66 148.29 31.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.872 0.367 . . . . 0.0 111.197 169.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.0 169.53 23.04 Favored Glycine 0 C--N 1.313 -0.715 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -80.38 156.32 26.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.673 0.273 . . . . 0.0 110.551 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.48 -52.27 0.75 Allowed Glycine 0 C--N 1.31 -0.862 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -60.93 -45.0 96.43 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.144 0.497 . . . . 0.0 110.387 174.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.6 mmm -88.25 148.09 24.51 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.659 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.445 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.2 m -68.51 139.15 21.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' NZ ' ' OE1' ' A' ' 69' ' ' GLU . 11.2 mmtm -44.36 -40.97 9.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.53 -44.7 45.85 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 N-CA-C 110.37 -0.665 . . . . 0.0 110.37 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.615 ' CD2' HD11 ' A' ' 93' ' ' ILE . 41.0 t80 -62.6 -46.29 88.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.407 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.42 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 99.3 mt-10 -62.21 -45.9 91.31 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.871 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 38.3 t70 -59.12 -45.99 89.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.099 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.701 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -60.77 -46.56 90.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.245 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.575 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -62.03 -49.25 76.78 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.825 ' CE2' HD11 ' A' ' 10' ' ' ILE . 55.2 m-85 -67.16 -38.16 85.01 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 51.8 mtp180 -61.52 -47.08 87.23 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.333 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 81' ' ' SER . 42.7 mt -100.28 34.58 2.32 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.537 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 49.4 mt-30 -53.52 -20.17 4.6 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.817 0.341 . . . . 0.0 110.845 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.73 -26.55 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.492 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 113.93 6.13 21.17 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -78.39 153.68 31.36 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.41 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 16.6 t -75.2 130.78 35.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.566 ' C ' HE21 ' A' ' 27' ' ' GLN . 89.4 p -72.2 154.17 41.18 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.359 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -63.5 165.19 12.29 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -56.1 131.3 45.05 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 N-CA-C 109.513 -0.995 . . . . 0.0 109.513 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 42.0 t -105.86 109.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -80.48 134.12 35.93 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB2' HG21 ' A' ' 65' ' ' VAL . 8.6 p -153.18 168.49 25.78 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -60.6 -29.96 69.53 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.413 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 56.2 m-85 -66.79 -38.79 87.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.479 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.03 -150.28 22.5 Favored Glycine 0 C--N 1.316 -0.579 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.488 ' CE1' ' HG2' ' A' ' 20' ' ' GLN . 58.5 m-85 -101.95 125.96 48.75 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.607 ' CE1' HD13 ' A' ' 16' ' ' LEU . 3.3 m-70 -107.21 144.68 33.62 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.288 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.536 HG21 ' CG2' ' A' ' 26' ' ' VAL . 48.3 t -117.75 126.43 74.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 168.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.701 HD12 ' HB3' ' A' ' 71' ' ' ALA . 98.8 mt -117.64 129.33 74.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.804 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -119.68 140.67 50.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.537 ' HG3' ' HA ' ' A' ' 76' ' ' GLN . 2.5 tmm_? -78.85 143.96 35.47 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.997 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.425 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 57.2 tp -113.05 140.67 47.65 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.917 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.556 0 CA-C-O 118.267 -1.296 . . . . 0.0 110.571 -179.435 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.639 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -61.3 148.74 92.11 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.688 2.259 . . . . 0.0 112.308 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.9 mtp -57.72 146.11 32.22 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.648 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.55 29.2 70.03 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -47.66 101.6 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.274 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.481 ' C ' ' H ' ' A' ' 8' ' ' ASP . 45.3 mtt -68.13 151.72 46.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.983 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.83 7.26 0.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.318 175.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.484 ' CG ' HH22 ' A' ' 61' ' ' ARG . 34.1 t70 -61.03 -41.11 95.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.75 161.4 24.56 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.236 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.521 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -107.38 128.1 62.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' NZ ' ' OXT' ' A' ' 97' ' ' GLY . 62.3 mtpt -93.72 104.6 16.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -149.13 169.21 21.21 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.719 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.486 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 48.1 m -132.78 147.34 52.31 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.58 175.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.49 ' HB2' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -130.39 150.91 51.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -177.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.62 HG23 ' HB3' ' A' ' 44' ' ' SER . 96.2 mt -127.82 124.4 62.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.521 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 90' ' ' TYR . 37.4 tp -90.84 129.09 36.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.943 HG12 HD11 ' A' ' 43' ' ' LEU . 29.0 m -128.04 143.1 41.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 O-C-N 123.577 0.548 . . . . 0.0 110.834 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.691 ' HG3' HD13 ' A' ' 45' ' ' ILE . 1.6 mtpp -65.6 -42.41 91.66 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.191 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -126.38 151.97 46.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.681 -169.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -60.25 -35.08 74.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.722 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.09 -38.3 94.13 Favored Glycine 0 C--N 1.321 -0.265 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.61 -41.7 92.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -58.66 -47.4 84.57 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.135 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.68 -41.93 99.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.168 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.02 72.67 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.726 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.494 ' CG2' HG21 ' A' ' 92' ' ' VAL . 29.1 m -65.17 -39.78 86.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.101 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.537 ' O ' ' NZ ' ' A' ' 31' ' ' LYS . 4.6 mm-40 -58.69 -47.8 83.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.958 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -65.71 -46.46 78.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.502 0.668 . . . . 0.0 110.097 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.824 ' HD3' HD11 ' A' ' 39' ' ' LEU . 72.8 ttt180 -63.65 -40.83 97.86 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.886 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.473 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -56.63 -32.64 65.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -177.228 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 27' ' ' GLN . 29.6 mmtm -63.41 -13.05 35.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.466 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.16 -14.08 60.52 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.57 -1.92 60.37 Favored Glycine 0 C--O 1.243 0.667 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.58 148.72 32.42 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.322 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -71.78 142.19 49.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.958 0.885 . . . . 0.0 112.593 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.554 ' CE2' HG13 ' A' ' 15' ' ' ILE . 57.1 t80 -56.97 -45.04 83.16 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.116 -177.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.07 -37.5 94.01 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.69 -46.36 90.03 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.824 HD11 ' HD3' ' A' ' 29' ' ' ARG . 3.0 mm? -61.62 -39.64 91.98 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.291 173.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.546 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . -58.77 -50.99 71.88 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.317 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.491 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 62.3 mttm -61.15 -42.56 98.77 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.106 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.523 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 70.7 mt-10 -70.23 -41.37 73.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -173.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.943 HD11 HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -123.64 -28.53 3.86 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.663 ' N ' HD13 ' A' ' 43' ' ' LEU . 10.1 p -59.92 135.54 57.73 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.681 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.691 HD13 ' HG3' ' A' ' 18' ' ' LYS . 47.0 pt -105.26 -6.78 9.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.293 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.462 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 59.0 t0 -83.85 97.2 9.07 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -55.98 -46.09 85.2 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -43.85 -56.37 5.13 Favored Glycine 0 C--O 1.237 0.313 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.564 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . 1.5 p -71.04 -32.92 69.8 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -60.28 -34.44 73.75 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.147 0.498 . . . . 0.0 109.904 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 99.4 mttt -58.74 -36.01 73.63 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 177.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' O ' ' OG ' ' A' ' 55' ' ' SER . 61.1 mtp85 -98.3 7.57 46.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.396 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.491 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 79.9 m-20 58.71 31.76 21.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -173.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 49' ' ' SER . . . 75.85 -6.68 31.99 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 1.1 m -66.59 72.86 0.09 Allowed 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.434 0.635 . . . . 0.0 110.913 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 54' ' ' GLY . 94.5 mt -63.69 -40.33 96.53 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.593 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.59 -145.04 22.6 Favored Glycine 0 N--CA 1.464 0.54 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.95 129.08 34.93 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.585 ' CE1' ' HG3' ' A' ' 64' ' ' MET . 55.4 p90 -141.0 153.7 45.68 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.465 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.54 169.98 32.03 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.484 HH22 ' CG ' ' A' ' 8' ' ' ASP . 1.5 mtm105 -78.02 148.92 34.13 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 120.883 0.373 . . . . 0.0 111.004 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.16 -32.78 6.91 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -64.5 -37.35 87.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.842 0.353 . . . . 0.0 110.776 175.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 2.8 mmm -101.94 160.04 14.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.369 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 86' ' ' SER . 30.4 m -75.07 153.66 6.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -44.3 -50.0 22.82 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.99 -41.28 80.4 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 120.962 1.108 . . . . 0.0 110.828 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -62.36 -47.78 82.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.777 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.66 -38.68 91.83 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.227 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.06 -51.27 66.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.998 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 84' ' ' VAL . . . -65.2 -41.49 94.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.196 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.83 78.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 -177.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -67.46 -35.47 79.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 0.0 111.258 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.508 HH21 ' CD ' ' A' ' 82' ' ' GLU . 43.9 mtp180 -60.38 -39.18 86.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.155 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.615 HD11 ' CB ' ' A' ' 81' ' ' SER . 44.8 mt -96.87 17.11 17.48 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.496 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 82.4 mt-30 -54.08 -22.46 10.9 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 117.943 -1.503 . . . . 0.0 110.842 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -59.4 -27.31 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.113 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 121.51 -2.17 11.24 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.499 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -75.44 174.26 9.85 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -173.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.4 t -96.89 133.41 38.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.325 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.615 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -68.36 152.74 44.99 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.193 -178.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' CD ' HH21 ' A' ' 74' ' ' ARG . 2.8 mp0 -65.16 177.25 0.66 Allowed Pre-proline 0 N--CA 1.427 -1.587 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 167.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -56.54 134.55 65.09 Favored 'Trans proline' 0 C--N 1.287 -2.694 0 N-CA-C 109.765 -0.898 . . . . 0.0 109.765 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' ' 71' ' ' ALA . 50.5 t -120.95 129.59 75.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -109.3 132.38 54.18 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.064 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.576 ' HB2' HG21 ' A' ' 65' ' ' VAL . 66.5 p -115.0 -171.25 1.91 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.107 171.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -67.04 -35.04 79.02 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 172.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 8.6 m-30 -63.36 -44.39 94.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.635 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.34 -143.82 9.96 Favored Glycine 0 C--N 1.321 -0.261 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.586 ' O ' HD12 ' A' ' 16' ' ' LEU . 28.1 m-85 -102.14 134.28 45.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.943 0.401 . . . . 0.0 111.987 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.479 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 16.9 m-70 -118.4 150.1 40.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.023 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.494 HG21 ' CG2' ' A' ' 26' ' ' VAL . 75.8 t -117.51 125.7 74.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 164.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.496 ' O ' ' CD1' ' A' ' 75' ' ' LEU . 89.1 mt -123.55 131.86 72.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -171.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.492 ' HG2' ' N ' ' A' ' 95' ' ' ARG . 43.4 tttm -123.53 152.32 41.91 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.592 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 79.1 ttt180 -77.35 137.77 38.94 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 11' ' ' LYS . 53.7 tp -119.91 130.47 54.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.522 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.572 0 CA-C-O 118.769 -1.017 . . . . 0.0 112.188 -174.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.452 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.94 147.18 93.79 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.075 1.85 . . . . 0.0 111.181 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.0 mmt -59.35 141.74 53.79 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.8 -15.11 59.93 Favored Glycine 0 C--N 1.314 -0.647 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 58' ' ' TYR . 12.6 m -72.08 107.93 5.03 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.005 0.431 . . . . 0.0 110.292 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.52 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 67.0 mtt -110.2 118.05 35.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.162 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.11 79.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.05 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.55 -4.3 22.37 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.936 0.398 . . . . 0.0 110.861 -175.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.52 ' HD2' ' HB2' ' A' ' 6' ' ' MET . 63.1 mttp -111.63 172.77 6.69 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.222 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.804 HD12 ' CE2' ' A' ' 59' ' ' PHE . 58.4 mt -104.96 127.11 59.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -173.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.551 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 62.5 mtpt -91.94 106.05 18.16 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.442 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -146.54 164.79 31.44 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.914 -175.176 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.8 m -127.51 135.67 50.68 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.079 -1.418 . . . . 0.0 108.354 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.5 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -130.61 149.23 52.37 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.698 -177.075 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.66 HG23 ' OG ' ' A' ' 44' ' ' SER . 95.9 mt -128.44 127.72 67.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.142 176.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.636 HD23 HG13 ' A' ' 45' ' ' ILE . 41.4 tp -98.68 123.96 43.2 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.501 HG12 HD13 ' A' ' 43' ' ' LEU . 29.8 m -127.93 154.71 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.665 0.745 . . . . 0.0 111.052 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 6.7 mtmp? -65.75 -41.89 91.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.742 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 67.9 mttm -123.51 154.06 39.69 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.526 -167.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' A' ' 83' ' ' PRO . 58.2 tt0 -60.47 -40.84 92.7 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.032 175.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.44 -39.53 97.42 Favored Glycine 0 CA--C 1.508 -0.345 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 98.3 mt-10 -63.85 -42.78 97.5 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.649 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -61.73 -42.89 99.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.364 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.27 -41.61 99.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.851 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.67 -45.5 81.65 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.867 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.932 ' CG1' HD21 ' A' ' 43' ' ' LEU . 21.0 m -70.82 -36.27 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.461 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 18.6 tt0 -58.49 -45.78 88.01 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.71 -41.01 88.65 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.503 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.613 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 15.9 tpt180 -59.94 -40.84 90.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.818 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.474 HD11 ' CA ' ' A' ' 36' ' ' PHE . 1.4 mm? -61.7 -41.44 97.59 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.047 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 25.5 mmtp -67.72 -11.75 59.02 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.723 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -75.56 -11.17 59.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 174.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.1 10.84 63.88 Favored Glycine 0 C--O 1.238 0.372 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 91.2 mt-10 -86.15 155.86 20.59 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 57.0 mttm -67.37 139.02 57.16 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.381 0.61 . . . . 0.0 112.58 -175.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CE2' HG13 ' A' ' 15' ' ' ILE . 52.7 t80 -58.42 -45.84 87.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.056 174.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 53' ' ' ASP . . . -62.21 -35.07 91.02 Favored Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.53 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 49.1 tttm -60.65 -48.87 79.84 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.763 HD12 HG12 ' A' ' 26' ' ' VAL . 4.1 mm? -62.79 -41.57 99.33 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.064 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.504 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.49 -50.49 73.56 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.685 -176.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.557 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 67.8 mttm -65.23 -40.13 93.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.943 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' OE2' ' NZ ' ' A' ' 38' ' ' LYS . 95.8 mt-10 -71.0 -44.42 65.95 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -172.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.932 HD21 ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -124.51 -19.35 5.45 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -174.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.811 ' N ' HD12 ' A' ' 43' ' ' LEU . 1.7 m -55.73 140.21 42.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.38 -173.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.636 HG13 HD23 ' A' ' 16' ' ' LEU . 39.8 pt -86.03 -11.65 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.516 0.674 . . . . 0.0 109.227 176.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -88.2 115.17 25.49 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.068 173.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.24 -32.88 77.99 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 52' ' ' ARG . . . -55.57 -42.83 85.36 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 177.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 54' ' ' GLY . 41.2 m -61.27 -35.44 77.29 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.538 176.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . . . -73.64 -43.23 60.07 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.474 0.654 . . . . 0.0 110.525 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -66.29 -39.71 89.56 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.905 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 55' ' ' SER . 21.5 mmm180 -96.05 4.25 52.75 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.425 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.557 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 53.09 35.41 19.58 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -173.643 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 76.68 -36.85 1.41 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.461 -173.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -54.27 89.36 0.01 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.547 0.739 . . . . 0.0 112.041 -178.047 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.442 HD12 ' SG ' ' A' ' 12' ' ' CYS . 93.0 mt -63.65 -40.3 96.5 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.238 176.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 97.27 -147.45 18.66 Favored Glycine 0 CA--C 1.503 -0.693 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.551 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 4.8 m-85 -83.71 132.48 34.85 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.804 ' CE2' HD12 ' A' ' 10' ' ' ILE . 54.7 p90 -146.56 150.65 35.93 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.807 173.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.478 ' H ' ' HD3' ' A' ' 63' ' ' LYS . . . -95.99 -168.0 34.72 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 61' ' ' ARG . 53.7 mtp85 -85.31 148.83 25.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.607 0.241 . . . . 0.0 110.876 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 91.82 -17.53 56.25 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 116.44 -0.346 . . . . 0.0 112.345 176.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 60' ' ' GLY . 1.4 mptp? -67.37 -37.88 83.86 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.181 0.515 . . . . 0.0 111.781 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.552 ' CE ' ' CD2' ' A' ' 59' ' ' PHE . 3.5 mpp? -118.43 161.73 19.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.322 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 68' ' ' PHE . 19.8 m -58.01 136.64 21.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HZ2' ' HB2' ' A' ' 70' ' ' ASP . 8.0 tmtm? -44.76 -42.88 16.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -173.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.37 -43.42 58.84 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 CA-C-N 118.894 0.641 . . . . 0.0 110.608 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.432 ' CD1' HD11 ' A' ' 93' ' ' ILE . 67.8 t80 -63.09 -50.81 69.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.804 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 97.2 mt-10 -67.05 -41.15 87.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.501 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 66' ' ' LYS . 22.7 t70 -59.01 -44.3 91.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.957 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.31 84.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.493 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.05 89.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.48 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.624 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 46.6 m-85 -62.52 -29.74 70.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.637 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -65.3 -37.16 86.27 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.625 HD11 ' CA ' ' A' ' 81' ' ' SER . 76.8 mt -95.75 21.52 8.36 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -168.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.533 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 71.9 mt-30 -45.26 -24.98 0.32 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.469 0.176 . . . . 0.0 111.031 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.93 -31.24 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.607 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 123.02 0.42 9.71 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.387 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.546 ' HB3' HD22 ' A' ' 75' ' ' LEU . 1.1 mm-40 -68.14 174.46 3.86 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.34 129.67 62.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.625 ' CA ' HD11 ' A' ' 75' ' ' LEU . 82.5 p -64.47 155.41 32.82 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.113 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.16 169.46 16.4 Favored Pre-proline 0 N--CA 1.432 -1.354 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 164.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.649 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 67.5 Cg_exo -54.62 129.4 34.73 Favored 'Trans proline' 0 C--N 1.292 -2.398 0 CA-C-N 118.923 0.651 . . . . 0.0 110.482 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 91' ' ' HIS . 99.9 t -107.66 108.28 24.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.215 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 65.7 tttp -81.95 133.46 35.31 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.581 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.1 p -138.29 179.79 6.25 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -61.08 -37.61 83.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 10.4 m-30 -63.29 -43.59 97.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.772 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.83 -139.27 6.72 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.514 ' O ' HD12 ' A' ' 16' ' ' LEU . 26.2 m-85 -104.92 130.12 53.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.98 0.39 . . . . 0.0 111.038 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.568 ' CE1' HD13 ' A' ' 16' ' ' LEU . 15.7 m-70 -113.22 148.68 35.01 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.215 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.569 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 72.1 t -117.72 126.98 75.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 167.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.432 HD11 ' CD1' ' A' ' 68' ' ' PHE . 91.4 mt -118.46 123.39 71.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -107.76 140.83 40.24 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 169.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.628 ' NH1' ' O ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -78.74 138.75 38.39 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.91 176.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.628 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 53.3 tp -103.15 124.84 49.34 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.435 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.21 -1.368 0 CA-C-O 118.272 -1.293 . . . . 0.0 112.005 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.565 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.63 144.45 99.43 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.769 1.646 . . . . 0.0 111.736 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 mtt -48.57 138.15 10.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.635 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.57 78.32 Favored Glycine 0 C--N 1.318 -0.454 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.42 ' CB ' ' HD2' ' A' ' 11' ' ' LYS . 1.9 m -103.55 118.5 36.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 36.0 ttm -107.16 107.59 18.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.47 -4.63 0.64 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.87 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.73 -31.46 70.77 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -121.55 163.94 18.05 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.186 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.9 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 71.8 mt -105.08 128.48 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HD2' ' CB ' ' A' ' 5' ' ' SER . 59.3 mtpt -91.57 109.49 20.79 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.445 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -141.04 164.61 29.82 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -174.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.8 m -127.39 140.7 52.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.479 173.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.43 ' CD2' ' C ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -136.33 150.77 49.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.316 0.579 . . . . 0.0 112.488 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.514 HG23 ' OG ' ' A' ' 44' ' ' SER . 96.1 mt -128.98 126.52 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.323 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' A' ' 46' ' ' ASP . 13.8 mt -95.56 132.69 40.43 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.109 HG12 HD21 ' A' ' 43' ' ' LEU . 34.9 m -129.77 153.63 39.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 O-C-N 123.58 0.55 . . . . 0.0 109.684 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -65.07 -41.29 95.23 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.083 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 9.0 mtmp? -124.55 149.52 46.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -173.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 52.7 tt0 -63.0 -37.35 86.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.05 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.96 -38.73 93.2 Favored Glycine 0 C--O 1.242 0.645 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 93.6 mt-10 -63.77 -41.68 97.93 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 176.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 20' ' ' GLN . . . -58.16 -47.22 84.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.168 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.83 -41.98 98.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.544 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.9 -50.72 72.65 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.752 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' HD23 ' A' ' 30' ' ' LEU . 14.9 m -65.38 -39.22 84.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.059 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 81' ' ' SER . 91.2 mt-30 -57.9 -46.81 84.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.217 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -63.42 -36.54 84.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.838 ' HD3' HD11 ' A' ' 39' ' ' LEU . 77.0 ttt180 -63.15 -39.42 94.62 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.493 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.753 HD11 ' HA ' ' A' ' 36' ' ' PHE . 4.3 mm? -61.41 -40.43 94.4 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 66.2 mmtt -60.83 -28.39 68.78 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.692 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -64.11 -21.22 66.45 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.419 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.93 -4.32 38.94 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.143 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.631 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 18.9 mt-10 -62.8 149.72 43.36 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.211 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 41.1 tttm -63.68 134.3 55.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.214 0.53 . . . . 0.0 110.927 -174.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.753 ' HA ' HD11 ' A' ' 30' ' ' LEU . 64.9 t80 -56.85 -45.24 82.55 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.566 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.03 -34.84 89.44 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.319 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 88.4 tttt -59.95 -46.65 88.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.838 HD11 ' HD3' ' A' ' 29' ' ' ARG . 3.9 mm? -62.57 -41.33 98.86 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.571 173.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.44 -47.43 84.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 31.5 mmtp -65.69 -40.6 92.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.077 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 42.2 mt-10 -70.68 -54.12 13.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -172.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.109 HD21 HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -118.21 -29.09 5.65 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -166.607 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.963 ' N ' HD13 ' A' ' 43' ' ' LEU . 1.3 m -42.25 137.94 1.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.3 pt -83.32 -12.74 11.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.552 ' HB2' HD12 ' A' ' 16' ' ' LEU . 64.9 t0 -88.59 97.5 11.13 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.717 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -67.45 -45.89 74.64 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.74 -45.68 78.06 Favored Glycine 0 C--O 1.236 0.267 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 54' ' ' GLY . 15.9 m -69.68 -32.67 71.43 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.562 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.62 68.81 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.419 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 48.9 mmtm -62.34 -37.68 86.59 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.453 ' O ' ' OG ' ' A' ' 55' ' ' SER . 89.7 mtm-85 -97.63 20.82 11.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.809 176.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.566 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 16.4 m-20 60.41 32.44 20.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.153 0.502 . . . . 0.0 109.733 -177.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 78.71 -8.54 41.99 Favored Glycine 0 C--N 1.307 -1.04 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -64.92 89.08 0.07 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.398 0.618 . . . . 0.0 110.36 179.127 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.449 ' HA ' HH21 ' A' ' 52' ' ' ARG . 91.5 mt -63.1 -41.3 99.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.874 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.39 -154.18 18.97 Favored Glycine 0 C--O 1.236 0.265 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -83.97 135.05 34.61 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 10' ' ' ILE . 53.8 p90 -143.2 154.38 43.8 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.558 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.89 173.76 25.94 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH1' ' CZ ' ' A' ' 73' ' ' PHE . 51.5 mtp85 -71.33 138.62 49.41 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.528 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 86.65 -5.76 84.06 Favored Glycine 0 C--N 1.305 -1.16 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -68.42 -40.54 81.17 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.21 0.528 . . . . 0.0 109.734 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.503 ' HE2' ' CG ' ' A' ' 59' ' ' PHE . 76.4 mtm -123.41 161.95 23.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.707 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.521 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.5 m -51.67 140.04 6.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -44.54 -46.26 25.07 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.538 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.88 -46.26 34.66 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 120.643 0.896 . . . . 0.0 110.742 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CD2' HD11 ' A' ' 93' ' ' ILE . 46.1 t80 -61.7 -49.23 77.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.454 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 96.1 mt-10 -65.72 -40.32 92.07 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.339 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.92 -44.49 91.3 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.85 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.422 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -67.39 -38.44 84.69 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.856 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.37 96.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.132 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.9 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 39.3 m-85 -61.86 -32.02 72.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 120.794 0.33 . . . . 0.0 111.73 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -61.68 -37.28 83.5 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.741 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.699 HD11 ' HB3' ' A' ' 81' ' ' SER . 72.0 mt -90.58 6.85 42.02 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.438 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 85.4 mt-30 -50.78 -27.35 7.05 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.962 -177.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 p -62.95 -33.55 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.455 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 119.89 49.76 0.3 Allowed Glycine 0 N--CA 1.475 1.28 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.643 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.664 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -128.64 174.37 9.47 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -175.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.45 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 97.2 t -95.77 130.64 44.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.699 ' HB3' HD11 ' A' ' 75' ' ' LEU . 6.2 p -78.61 163.3 25.6 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.019 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.505 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -68.77 169.78 10.13 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 69.5 Cg_endo -62.46 141.5 86.97 Favored 'Trans proline' 0 C--N 1.297 -2.141 0 CA-C-N 118.885 0.638 . . . . 0.0 110.707 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.76 130.84 73.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.497 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 29.6 tptp -107.67 135.59 48.85 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.243 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.3 p -145.63 177.16 9.09 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.49 -31.38 70.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -62.1 -42.28 99.06 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.983 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.436 ' O ' ' HD2' ' A' ' 85' ' ' LYS . . . 152.09 -143.54 10.52 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.548 ' O ' HD23 ' A' ' 16' ' ' LEU . 3.2 m-85 -105.24 129.5 53.6 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -109.37 147.5 32.64 Favored 'General case' 0 CA--C 1.501 -0.931 0 O-C-N 123.41 0.444 . . . . 0.0 110.148 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.6 t -118.11 126.55 75.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 163.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.54 HD11 ' CD2' ' A' ' 68' ' ' PHE . 89.2 mt -115.62 129.92 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.668 -174.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -124.9 143.12 51.02 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.438 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 1.7 tmm_? -78.58 143.83 36.11 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.317 -174.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.424 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 53.8 tp -109.06 139.04 44.48 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.737 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.675 0 CA-C-O 118.249 -1.306 . . . . 0.0 110.332 -179.854 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.35 143.57 99.49 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.922 1.748 . . . . 0.0 111.633 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.2 mtp -112.95 144.98 41.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.55 6.84 88.21 Favored Glycine 0 C--N 1.319 -0.41 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 m -100.71 136.08 41.14 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.148 0.579 . . . . 0.0 111.172 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 77.8 mtm -124.09 148.61 46.99 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.87 -13.85 60.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.464 0.173 . . . . 0.0 111.188 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.43 -36.46 84.24 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HD3' ' CA ' ' A' ' 60' ' ' GLY . 35.0 mmtp -80.76 155.47 26.67 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.542 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.843 HG21 ' HB1' ' A' ' 72' ' ' ALA . 40.5 mm -106.96 128.35 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.196 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.55 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 46.0 mtpt -95.66 106.9 19.05 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -148.03 168.24 22.84 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.873 -1.131 . . . . 0.0 113.947 -175.003 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.509 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 19.4 m -135.31 143.97 46.47 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.235 173.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.51 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -138.97 151.77 47.14 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.746 HG23 ' HB2' ' A' ' 44' ' ' SER . 89.1 mt -121.03 126.7 75.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -98.5 119.52 37.35 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.607 ' N ' HD13 ' A' ' 16' ' ' LEU . 19.7 m -127.11 146.68 32.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.187 0.518 . . . . 0.0 111.605 -177.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.33 -40.89 90.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.508 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 22.3 mmtp -109.96 148.24 31.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.869 -171.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -37.55 87.74 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.665 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.98 -37.1 93.85 Favored Glycine 0 C--O 1.227 -0.305 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.513 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 97.9 mt-10 -64.09 -44.69 91.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -60.31 -49.68 76.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.495 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.99 -41.48 97.48 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.263 0.554 . . . . 0.0 110.216 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.51 -47.19 82.63 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.521 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.856 HG11 HD22 ' A' ' 43' ' ' LEU . 26.1 m -70.2 -32.11 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.967 176.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -61.35 -47.08 87.53 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -67.86 -43.43 79.46 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.939 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.926 ' HD3' HD11 ' A' ' 39' ' ' LEU . 75.0 ttt180 -60.7 -39.17 87.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.329 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.54 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -57.16 -41.1 78.55 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.71 -26.9 68.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.737 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -65.72 -1.1 2.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 177.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.27 19.02 61.39 Favored Glycine 0 C--O 1.236 0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.143 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 28.3 mt-10 -87.1 144.68 26.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.526 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 56.5 mttp -64.12 139.89 58.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.413 0.625 . . . . 0.0 112.304 -175.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.498 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 48.2 t80 -57.77 -45.53 85.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.552 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.24 -36.72 93.43 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.0 177.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 64.4 tttm -60.76 -44.64 96.49 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.926 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.6 mm? -62.66 -40.43 97.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.693 172.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.15 97.87 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.972 0.415 . . . . 0.0 110.144 -177.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.526 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 13.1 mmtm -65.86 -44.09 86.46 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.897 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.507 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 74.6 mt-10 -71.4 -41.79 69.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.856 HD22 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -111.9 -70.39 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -170.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.746 ' HB2' HG23 ' A' ' 15' ' ' ILE . 4.4 t -33.59 128.48 0.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.449 -168.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.2 pt -91.05 -3.3 10.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.777 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 50' ' ' ALA . 54.6 t0 -79.09 94.73 5.39 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.09 -51.08 61.03 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -46.21 -53.41 9.34 Favored Glycine 0 C--N 1.322 -0.235 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.541 ' OG ' ' NH2' ' A' ' 52' ' ' ARG . 21.9 m -71.7 -32.24 67.59 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 46' ' ' ASP . . . -62.63 -38.35 89.89 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -61.79 -25.48 67.51 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.756 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' NH2' ' OG ' ' A' ' 49' ' ' SER . 93.1 mtm-85 -97.69 7.71 45.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.367 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.552 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER 59.71 34.1 22.0 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.536 0.684 . . . . 0.0 109.649 -173.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 79.27 -8.59 45.55 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.336 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 m -65.4 128.46 35.97 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.589 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.58 HD12 ' SG ' ' A' ' 12' ' ' CYS . 83.1 mt -109.01 -28.77 8.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.985 0.421 . . . . 0.0 110.064 177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 78.63 -146.87 30.41 Favored Glycine 0 CA--C 1.516 0.124 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.55 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 44.0 m-85 -84.32 133.27 34.55 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.548 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 52.1 p90 -144.43 145.91 32.18 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.425 ' CA ' ' HD3' ' A' ' 9' ' ' LYS . . . -93.76 179.25 38.39 Favored Glycine 0 C--N 1.316 -0.535 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -71.05 137.73 49.22 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.085 -0.558 . . . . 0.0 109.778 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.17 -22.76 32.31 Favored Glycine 0 C--N 1.305 -1.182 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.46 -41.4 84.75 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.463 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 5.7 mmm -113.85 160.73 18.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.369 -170.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 86' ' ' SER . 30.7 m -63.73 142.67 16.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -43.43 -50.26 16.6 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.997 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.26 -42.18 69.71 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 N-CA-C 110.393 -0.657 . . . . 0.0 110.393 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CD2' HD11 ' A' ' 93' ' ' ILE . 40.0 t80 -62.4 -47.93 81.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.454 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 64' ' ' MET . 97.4 mt-10 -65.1 -42.88 93.6 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.584 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.68 -40.68 93.05 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.241 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.07 -41.96 90.04 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.006 0.431 . . . . 0.0 110.114 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.843 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.6 -42.87 97.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.395 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 10' ' ' ILE . 46.5 m-85 -66.82 -34.13 77.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -62.99 -33.86 76.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.896 HD11 ' HB3' ' A' ' 81' ' ' SER . 73.9 mt -89.41 18.67 5.04 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -168.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.508 ' NE2' HD12 ' A' ' 10' ' ' ILE . 99.4 mm-40 -59.41 -22.46 61.45 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.3 -26.05 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.427 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 98.49 29.47 7.42 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.58 ' O ' HD13 ' A' ' 75' ' ' LEU . 35.8 tt0 -101.74 159.75 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.787 -0.243 . . . . 0.0 111.458 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.43 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 20.1 t -77.22 131.11 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 172.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.896 ' HB3' HD11 ' A' ' 75' ' ' LEU . 28.1 p -69.91 157.61 37.12 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.671 -178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 16.8 mp0 -73.17 168.65 22.95 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 167.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.514 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 86.5 Cg_exo -53.95 131.42 44.42 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 N-CA-C 110.304 -0.691 . . . . 0.0 110.304 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 91' ' ' HIS . 46.0 t -106.62 108.59 25.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.521 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 16.0 tptm -79.59 131.62 36.05 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.46 ' HB2' HG21 ' A' ' 65' ' ' VAL . 14.7 p -151.34 174.58 13.16 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.76 -172.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -54.81 -36.86 65.42 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.708 174.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -68.67 -41.49 79.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.628 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.9 -125.54 2.51 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.521 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 96.1 m-85 -109.97 128.28 55.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.111 0.455 . . . . 0.0 110.157 177.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.51 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 4.2 m-70 -108.37 146.63 32.74 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.906 173.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.434 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 77.4 t -117.0 125.44 73.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 168.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.52 ' N ' ' OG ' ' A' ' 81' ' ' SER . 88.5 mt -119.46 129.47 75.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.714 -171.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -112.34 131.33 55.59 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 169.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.505 ' CD ' ' HA ' ' A' ' 76' ' ' GLN . 79.2 ttt-85 -78.04 135.47 37.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 11' ' ' LYS . 56.0 tp -107.24 132.82 52.65 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.141 -173.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.387 0 CA-C-O 118.096 -1.391 . . . . 0.0 111.221 -177.399 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.846 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.99 144.24 69.22 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.09 1.86 . . . . 0.0 111.809 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.414 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 39.2 mmt -84.63 155.81 21.84 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.17 0.51 . . . . 0.0 111.744 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.63 -17.51 14.75 Favored Glycine 0 C--O 1.235 0.183 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -63.53 155.69 28.67 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 49.5 ttp -58.76 -40.64 84.49 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' A' ' 9' ' ' LYS . . . -80.14 24.43 0.42 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.14 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.483 ' OD1' ' HG3' ' A' ' 9' ' ' LYS . 24.3 p-10 -83.18 14.56 3.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.743 0.782 . . . . 0.0 109.959 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.483 ' HG3' ' OD1' ' A' ' 8' ' ' ASP . 40.0 mttp -118.49 177.31 4.87 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.077 -175.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.905 HG21 ' HB1' ' A' ' 72' ' ' ALA . 15.7 mm -105.2 124.18 59.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 97' ' ' GLY . 62.0 mtpt -97.15 105.13 17.22 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 171.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -146.16 168.73 20.28 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -173.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.9 m -132.66 146.86 52.22 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.82 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.586 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -133.92 150.65 51.32 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.656 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 93.6 mt -123.62 126.72 73.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 90' ' ' TYR . 42.1 tp -100.74 122.47 43.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.29 155.34 41.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.332 0.587 . . . . 0.0 110.915 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -65.29 -40.29 93.66 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.702 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.557 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 58.4 mttp -117.13 151.81 36.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.086 -168.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.429 ' O ' HD23 ' A' ' 24' ' ' LEU . 87.2 mt-30 -63.07 -40.57 98.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.44 -0.8 . . . . 0.0 108.96 170.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.97 -37.49 93.92 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.573 ' O ' HG13 ' A' ' 26' ' ' VAL . 94.4 mt-10 -64.73 -41.34 96.03 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.01 -42.66 98.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.993 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 20' ' ' GLN . 2.5 mm? -62.22 -41.84 98.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -56.48 -49.89 73.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.384 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.627 ' O ' HD23 ' A' ' 30' ' ' LEU . 2.6 m -65.19 -40.82 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.807 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 23' ' ' ALA . 22.2 mt-30 -56.65 -46.24 81.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -67.83 -41.85 82.39 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.315 0.579 . . . . 0.0 110.261 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.518 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 77.0 ttt180 -61.07 -39.43 89.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.922 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 26' ' ' VAL . 4.4 mm? -58.65 -36.57 74.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -67.44 -13.61 62.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.378 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -71.95 -12.4 61.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.99 0.424 . . . . 0.0 110.116 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.97 16.64 47.0 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.256 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 29' ' ' ARG . 34.2 mt-10 -82.59 147.38 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.283 176.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 41.9 tttm -66.25 133.82 51.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.087 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.656 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 54.3 t80 -58.62 -46.31 87.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.149 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.89 -36.14 92.99 Favored Glycine 0 C--O 1.25 1.154 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 62.3 tttm -60.2 -48.12 83.06 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.679 ' HB3' HD12 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -63.96 -40.1 95.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.987 176.692 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' CB ' ' C ' ' A' ' 53' ' ' ASP . . . -56.49 -47.94 78.22 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.477 ' NZ ' ' O ' ' A' ' 37' ' ' GLY . 24.5 mtmm -64.77 -41.28 95.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.029 176.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.518 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 86.9 mt-10 -71.04 -56.83 5.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.679 HD12 ' HB3' ' A' ' 39' ' ' LEU . 10.9 mt -76.77 -50.37 13.71 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.509 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.8 m -61.14 139.25 58.14 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.337 -161.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.549 HG13 HD23 ' A' ' 16' ' ' LEU . 45.0 pt -87.75 -4.52 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.874 172.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -89.77 96.65 10.78 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.189 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.0 -41.36 99.92 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.63 -45.1 90.86 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.586 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 39.6 m -63.89 -33.79 76.49 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.699 0.285 . . . . 0.0 110.622 174.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -62.57 -40.63 97.48 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 31.5 mmtp -70.3 -11.73 61.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.697 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 55' ' ' SER . 72.2 mmt-85 -113.03 9.28 18.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.097 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.4 m-20 53.61 30.8 11.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -174.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 60.48 1.42 1.73 Allowed Glycine 0 C--N 1.318 -0.438 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 53' ' ' ASP . 1.7 m -75.84 85.75 2.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.244 0.545 . . . . 0.0 110.578 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.624 HD13 ' CE ' ' A' ' 64' ' ' MET . 85.0 mt -63.85 -40.16 95.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.175 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.29 -149.25 20.58 Favored Glycine 0 C--N 1.322 -0.231 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.83 132.79 34.36 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 53.6 p90 -143.62 146.73 33.49 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.338 171.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.75 -171.7 37.49 Favored Glycine 0 C--N 1.314 -0.659 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.416 ' HD2' HH11 ' A' ' 61' ' ' ARG . 50.6 mtp85 -69.64 139.32 53.56 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.08 -27.25 17.39 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -65.32 -37.44 87.1 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 116.959 0.38 . . . . 0.0 111.669 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.624 ' CE ' HD13 ' A' ' 56' ' ' LEU . 3.3 mmt -110.28 159.55 17.32 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -176.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.84 134.23 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.098 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' NZ ' ' OE2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -45.58 -40.51 14.24 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -171.503 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.24 -43.37 56.74 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.654 0.903 . . . . 0.0 110.242 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CE1' HG12 ' A' ' 93' ' ' ILE . 48.5 t80 -61.99 -46.82 87.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.85 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.458 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 81.4 mt-10 -64.42 -40.89 96.64 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.345 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -55.86 -47.26 77.64 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.826 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.46 77.92 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.496 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.905 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.6 -46.48 90.08 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.638 ' CE1' HD11 ' A' ' 10' ' ' ILE . 47.3 m-85 -62.61 -41.68 99.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.983 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -63.52 -41.7 98.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.814 ' C ' HD23 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -83.56 1.08 43.81 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -174.734 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.644 ' NE2' HD13 ' A' ' 10' ' ' ILE . 7.3 mm-40 -51.24 -23.36 3.38 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.939 0.4 . . . . 0.0 110.162 177.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.445 HG13 ' HG2' ' A' ' 79' ' ' GLU . 7.4 p -59.31 -27.46 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.772 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 120.49 46.89 0.34 Allowed Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.445 ' HG2' HG13 ' A' ' 77' ' ' VAL . 49.3 mm-40 -117.37 170.89 8.35 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 t -100.41 117.29 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 170.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.5 p -62.73 151.02 39.68 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.399 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.26 170.95 3.0 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.0 131.47 45.67 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 N-CA-C 109.828 -0.874 . . . . 0.0 109.828 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 68' ' ' PHE . 18.5 t -107.2 111.78 37.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -88.24 134.49 33.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.798 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.9 p -144.9 173.66 11.68 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.7 pm0 -57.83 -31.26 66.46 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -67.01 -38.42 85.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.815 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.48 -145.74 14.5 Favored Glycine 0 C--N 1.322 -0.216 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.613 ' O ' HD12 ' A' ' 16' ' ' LEU . 91.3 m-85 -106.87 129.8 54.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.523 ' CE1' HD13 ' A' ' 16' ' ' LEU . 2.6 m-70 -110.81 148.27 32.73 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.455 0.169 . . . . 0.0 110.561 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.492 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 56.0 t -117.9 128.22 75.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 167.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.529 HG23 ' SG ' ' A' ' 12' ' ' CYS . 72.8 mt -109.18 126.83 66.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.76 0.314 . . . . 0.0 110.441 -175.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 95' ' ' ARG . 9.6 tptp -104.9 135.63 45.9 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 170.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.546 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -76.96 142.0 40.2 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.239 -178.646 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.6 tp -108.16 132.69 53.35 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.469 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.532 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.766 -172.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.803 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.98 142.59 96.73 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.125 1.217 . . . . 0.0 111.415 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.4 mtp -47.94 124.54 7.62 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.55 -14.77 60.5 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.24 106.02 13.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.41 ' C ' ' N ' ' A' ' 8' ' ' ASP . 77.6 mtm -111.1 155.39 22.91 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.47 -5.89 0.39 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.834 0.349 . . . . 0.0 110.709 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 6' ' ' MET . 38.0 t70 -63.58 -34.69 78.37 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -81.18 157.16 25.36 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.589 172.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.755 HD11 ' CD1' ' A' ' 73' ' ' PHE . 41.9 mm -104.58 126.22 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 97' ' ' GLY . 60.6 mtpt -94.12 108.18 20.04 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 170.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -148.01 170.13 18.41 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.961 -171.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.554 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 20.3 m -130.63 147.35 52.3 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.537 175.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.563 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -134.71 152.47 51.79 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.879 0.371 . . . . 0.0 111.593 -175.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.555 HD13 ' HB3' ' A' ' 39' ' ' LEU . 86.2 mt -128.14 127.14 67.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 175.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 90' ' ' TYR . 38.7 tp -99.28 123.09 43.29 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.25 154.36 28.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.156 0.503 . . . . 0.0 111.497 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.423 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 6.6 mttp -67.7 -42.23 82.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.621 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 68.3 mttm -124.53 149.8 46.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.64 -168.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.425 ' O ' HD23 ' A' ' 24' ' ' LEU . 9.5 pt20 -57.21 -38.84 74.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.164 171.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.75 -36.16 92.31 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.478 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 96.9 mt-10 -64.07 -41.05 97.47 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.357 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -61.32 -45.52 94.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.595 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 20' ' ' GLN . 2.8 mm? -61.84 -41.96 98.45 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.44 76.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.504 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 43' ' ' LEU . 32.8 m -65.5 -37.72 80.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.784 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.609 ' NE2' ' HA ' ' A' ' 82' ' ' GLU . 79.0 mt-30 -59.32 -49.82 76.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.162 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.448 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 70.9 mm-40 -68.34 -38.52 81.58 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HD3' HD11 ' A' ' 39' ' ' LEU . 73.5 ttt180 -61.97 -42.2 98.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.146 0.498 . . . . 0.0 109.874 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -43.41 95.36 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.448 ' NZ ' ' OE2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -63.66 -12.78 36.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.958 175.385 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -72.72 -8.4 55.21 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.04 9.99 60.22 Favored Glycine 0 C--O 1.238 0.38 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -75.1 161.21 29.61 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.998 0.427 . . . . 0.0 111.348 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 47.0 mttm -74.07 137.14 43.15 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.291 -177.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -59.14 -45.09 91.84 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.44 -39.06 96.76 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.281 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 88.4 tttt -60.33 -45.16 94.42 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.705 HD11 ' HD3' ' A' ' 29' ' ' ARG . 1.3 mm? -61.34 -42.1 98.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.09 173.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -61.56 -53.21 59.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.948 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -69.02 -32.86 72.68 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.805 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.483 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 87.1 mt-10 -71.08 -41.21 70.96 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 26' ' ' VAL . 4.5 mp -105.21 -67.97 0.89 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -26.58 117.16 0.07 Allowed 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 114.084 -1.416 . . . . 0.0 112.984 -166.185 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.506 HG13 HD23 ' A' ' 16' ' ' LEU . 46.2 pt -90.68 -2.57 10.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.067 -177.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.409 ' CG ' ' HE2' ' A' ' 14' ' ' HIS . 1.2 p30 -76.41 179.89 5.58 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.714 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.35 -118.73 0.55 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.736 -176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 52' ' ' ARG . . . -49.41 -43.13 34.94 Favored Glycine 0 C--N 1.321 -0.259 0 N-CA-C 112.153 -0.379 . . . . 0.0 112.153 -172.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -60.12 -34.24 73.24 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.366 -179.019 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.26 86.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.472 0.653 . . . . 0.0 109.271 175.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.23 -7.37 59.37 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.442 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.463 ' O ' ' OG ' ' A' ' 55' ' ' SER . 56.3 mtp85 -96.89 20.38 11.19 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.731 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.537 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 83.0 m-20 56.19 29.62 15.09 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -173.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.76 -13.26 7.04 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.689 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 28.1 p -66.33 95.08 0.29 Allowed 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.834 0.826 . . . . 0.0 112.199 -177.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.535 HD12 ' SG ' ' A' ' 12' ' ' CYS . 92.7 mt -65.58 -38.3 89.11 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.812 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.03 -147.19 18.75 Favored Glycine 0 C--N 1.317 -0.474 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 1.5 p90 -85.3 141.04 30.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.222 0.511 . . . . 0.0 111.385 177.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.673 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 49.9 p90 -147.28 151.65 36.98 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 171.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.31 176.94 27.05 Favored Glycine 0 C--O 1.241 0.59 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' A' ' 73' ' ' PHE . 83.6 mtm-85 -69.36 142.44 53.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 120.977 0.418 . . . . 0.0 110.705 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.85 -36.58 4.3 Favored Glycine 0 C--N 1.306 -1.124 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -63.1 -41.5 99.38 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.395 -0.474 . . . . 0.0 110.721 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.486 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 26.7 mmm -97.05 160.23 14.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.923 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 68' ' ' PHE . 19.5 m -71.28 144.47 13.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -44.31 -51.51 19.36 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.73 -42.82 65.02 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.39 0.727 . . . . 0.0 110.391 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.559 ' CD2' HD11 ' A' ' 93' ' ' ILE . 35.4 t80 -62.16 -46.29 89.63 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.885 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -61.61 -42.51 98.99 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.523 ' CG ' ' HE ' ' A' ' 74' ' ' ARG . 11.8 t70 -55.81 -48.82 74.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.45 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.61 61.84 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.114 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.5 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.28 -50.81 72.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.732 -176.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.755 ' CD1' HD11 ' A' ' 10' ' ' ILE . 58.5 m-85 -67.01 -39.26 87.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HE ' ' CG ' ' A' ' 70' ' ' ASP . 46.8 mtm105 -63.5 -39.19 93.79 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.225 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.481 HD12 ' HB3' ' A' ' 81' ' ' SER . 73.9 mt -96.5 29.97 2.73 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.47 ' OE1' ' NE ' ' A' ' 95' ' ' ARG . 4.3 mm100 -52.47 -20.03 2.61 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.436 HG13 ' H ' ' A' ' 79' ' ' GLU . 12.9 p -62.8 -31.31 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.881 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.32 -3.63 15.91 Favored Glycine 0 N--CA 1.475 1.299 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.274 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' H ' HG13 ' A' ' 77' ' ' VAL . 19.8 tp10 -67.4 153.13 44.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.997 0.399 . . . . 0.0 110.64 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.0 t -71.03 132.16 33.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 93' ' ' ILE . 10.8 p -75.66 155.93 35.31 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.083 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.609 ' HA ' ' NE2' ' A' ' 27' ' ' GLN . 4.1 mp0 -75.56 172.43 9.28 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.612 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 75.3 Cg_exo -54.79 130.53 40.95 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 N-CA-C 109.036 -1.178 . . . . 0.0 109.036 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 58.5 t -105.01 114.32 44.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -83.37 132.24 35.01 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.6 p -141.12 172.01 13.28 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.45 -37.48 83.71 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -64.6 -42.54 95.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.384 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.87 -145.3 13.07 Favored Glycine 0 C--N 1.318 -0.421 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.569 ' O ' HD12 ' A' ' 16' ' ' LEU . 73.8 m-85 -105.58 128.48 53.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.862 0.331 . . . . 0.0 111.352 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.563 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.1 m-70 -119.18 152.27 36.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.333 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.53 HG21 ' CG2' ' A' ' 26' ' ' VAL . 62.9 t -118.76 128.96 75.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 166.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.559 HD11 ' CD2' ' A' ' 68' ' ' PHE . 86.0 mt -122.12 133.27 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 119.74 -0.171 . . . . 0.0 111.369 -173.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -128.22 148.16 50.61 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 167.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.47 ' NE ' ' OE1' ' A' ' 76' ' ' GLN . 61.5 ttt-85 -79.16 142.21 36.55 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.012 0.435 . . . . 0.0 110.091 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 50.1 tp -112.61 133.42 54.66 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.453 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.208 -1.477 0 CA-C-O 118.341 -1.255 . . . . 0.0 111.362 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.745 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.63 142.21 98.43 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.445 1.43 . . . . 0.0 111.339 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.3 mtt -78.17 151.26 33.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.649 0.261 . . . . 0.0 110.685 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.52 17.09 79.55 Favored Glycine 0 C--O 1.239 0.421 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.86 118.15 34.12 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.561 ' C ' ' H ' ' A' ' 8' ' ' ASP . 2.3 mpp? -97.12 174.0 6.97 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.73 42.05 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.071 0.463 . . . . 0.0 110.494 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 6' ' ' MET . 89.7 m-20 -62.46 -37.26 85.22 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HD2' ' C ' ' A' ' 59' ' ' PHE . 25.5 mmtp -99.46 159.3 15.12 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.278 -1.783 . . . . 0.0 109.275 -174.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.77 HG21 ' HB1' ' A' ' 72' ' ' ALA . 32.1 mm -106.26 129.49 59.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' NZ ' ' OXT' ' A' ' 97' ' ' GLY . 57.6 mtpt -88.24 105.72 17.73 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.549 ' SG ' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -147.52 165.28 30.81 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.096 0.474 . . . . 0.0 111.76 -176.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.453 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 7.1 m -131.75 147.22 52.48 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.732 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 149.93 50.86 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.681 ' CG2' HD12 ' A' ' 43' ' ' LEU . 97.0 mt -125.67 128.64 72.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.134 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.534 HD23 HG13 ' A' ' 45' ' ' ILE . 47.0 tp -100.23 128.34 46.32 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.795 -176.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.03 ' CG1' HD11 ' A' ' 43' ' ' LEU . 16.2 m -127.64 155.58 39.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.967 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 17.5 pttp -84.04 -22.25 31.34 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.833 176.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 37.3 mmtm -135.57 152.56 51.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -62.67 -37.99 88.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.947 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.55 -36.79 92.18 Favored Glycine 0 C--N 1.321 -0.276 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.491 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 96.0 mt-10 -65.35 -44.37 87.91 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -58.55 -48.96 79.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.238 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.683 HD23 ' NE2' ' A' ' 27' ' ' GLN . 30.0 mt -63.87 -40.91 97.65 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.754 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.17 -48.53 76.16 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.255 -177.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.538 HG12 HD12 ' A' ' 39' ' ' LEU . 18.0 m -64.99 -39.57 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.246 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.683 ' NE2' HD23 ' A' ' 24' ' ' LEU . 25.0 mt-30 -60.22 -47.18 87.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.085 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.13 -41.26 81.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.133 0.492 . . . . 0.0 110.822 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.974 ' HD3' HD11 ' A' ' 39' ' ' LEU . 71.1 ttt180 -62.87 -38.55 91.31 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.73 177.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.432 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.16 -35.83 70.02 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -177.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 79' ' ' GLU . 49.8 mmtt -61.52 -28.63 69.45 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.134 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.9 -21.94 45.94 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.942 0.401 . . . . 0.0 110.917 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.09 7.19 41.4 Favored Glycine 0 C--N 1.319 -0.385 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 31.9 mt-10 -76.18 156.59 33.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.152 177.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -72.52 141.38 48.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.708 0.766 . . . . 0.0 112.428 -176.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 45.9 t80 -58.12 -44.78 87.92 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.14 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -61.19 -36.68 92.76 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.352 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.442 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 88.3 tttt -61.37 -48.04 83.08 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.974 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.3 mm? -62.05 -41.82 98.54 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.967 173.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.469 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -59.05 -50.32 74.52 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.153 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -43.26 88.29 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.642 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 87.1 mt-10 -70.94 -45.55 64.01 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -173.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.03 HD11 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -107.6 -39.12 5.71 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.663 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.634 ' N ' HD13 ' A' ' 43' ' ' LEU . 2.5 m -52.99 138.67 29.87 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.062 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.534 HG13 HD23 ' A' ' 16' ' ' LEU . 42.1 pt -91.72 -4.82 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.387 173.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -90.89 101.0 13.76 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.581 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -65.88 -43.8 93.11 Favored Glycine 0 C--N 1.318 -0.434 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.79 -45.24 91.45 Favored Glycine 0 C--O 1.239 0.453 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.2 m -64.21 -33.47 75.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.95 0.405 . . . . 0.0 110.213 174.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -64.45 -35.4 80.79 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 74.8 mmtt -61.9 -36.79 82.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 77.7 mtp85 -97.57 19.26 13.75 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.982 174.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.9 OUTLIER 44.67 42.37 5.74 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.679 178.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 71.83 -20.76 0.82 Allowed Glycine 0 C--N 1.31 -0.886 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.55 ' H ' ' C ' ' A' ' 53' ' ' ASP . 10.3 m -67.91 79.47 0.21 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.527 0.679 . . . . 0.0 110.305 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.416 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 97.7 mt -62.56 -41.63 99.03 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.387 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.88 -147.12 18.46 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.04 104.16 14.72 Favored 'General case' 0 C--O 1.252 1.195 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.459 ' C ' ' HD2' ' A' ' 9' ' ' LYS . 47.5 p90 -119.0 148.1 43.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.712 177.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.82 -176.31 48.1 Favored Glycine 0 C--O 1.236 0.25 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.501 ' HD2' ' CZ ' ' A' ' 73' ' ' PHE . 26.0 mtp180 -86.65 162.76 17.77 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.7 -21.42 1.57 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.724 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 61' ' ' ARG . 37.6 mmtm -65.1 -40.01 93.95 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -112.93 160.27 18.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.75 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 11.5 m -58.47 146.6 8.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.99 -176.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 4.5 mtpp -45.13 -47.03 32.29 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.347 -177.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 66' ' ' LYS . 75.5 Cg_exo -55.47 -41.38 78.58 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 120.486 0.791 . . . . 0.0 110.609 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.669 ' CD2' HD11 ' A' ' 93' ' ' ILE . 50.6 t80 -61.28 -46.56 89.85 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.766 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 61' ' ' ARG . 67.3 mt-10 -62.31 -46.97 86.35 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.618 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 35.0 t70 -58.61 -45.61 88.78 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.394 -176.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.564 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -59.56 -46.13 89.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.77 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.25 -46.96 88.0 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.032 0.444 . . . . 0.0 110.07 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.759 ' CE1' HD11 ' A' ' 10' ' ' ILE . 51.6 m-85 -68.11 -36.68 80.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.326 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.454 ' NH2' ' OE2' ' A' ' 82' ' ' GLU . 61.8 mtp180 -61.6 -45.26 94.84 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.204 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 75' ' ' LEU . 93.9 mt -99.68 42.07 1.12 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -177.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.433 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 35.3 mt-30 -55.26 -21.1 13.01 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.413 173.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.489 HG13 ' H ' ' A' ' 79' ' ' GLU . 14.7 p -61.96 -32.37 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.792 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 120.18 -3.96 12.6 Favored Glycine 0 N--CA 1.477 1.382 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.213 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -73.31 173.4 9.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 117.075 0.437 . . . . 0.0 111.377 -178.165 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.555 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 5.3 t -92.53 129.57 42.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.418 ' HA ' HD11 ' A' ' 75' ' ' LEU . 9.9 p -71.3 153.51 42.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.254 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.454 ' OE2' ' NH2' ' A' ' 74' ' ' ARG . 5.0 mp0 -64.52 169.81 4.58 Favored Pre-proline 0 CA--C 1.507 -0.686 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 172.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 82' ' ' GLU . 63.6 Cg_exo -53.31 130.53 38.84 Favored 'Trans proline' 0 C--N 1.295 -2.267 0 N-CA-C 109.596 -0.963 . . . . 0.0 109.596 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.2 107.74 23.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -78.31 133.38 37.63 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.398 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.4 p -140.19 167.93 21.0 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.631 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.6 pm0 -58.12 -36.38 72.85 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -63.99 -43.82 94.56 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.868 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.94 -148.9 16.79 Favored Glycine 0 C--N 1.311 -0.828 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.439 ' HB2' HG23 ' A' ' 17' ' ' VAL . 93.8 m-85 -110.11 129.55 55.68 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.407 ' CE1' HD13 ' A' ' 16' ' ' LEU . 5.2 m-70 -109.5 151.91 26.13 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -117.85 126.03 74.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.669 HD11 ' CD2' ' A' ' 68' ' ' PHE . 96.1 mt -119.69 127.33 75.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.648 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.421 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 64.5 tttp -110.96 143.14 42.08 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 169.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.57 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -78.59 142.47 37.27 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.066 178.006 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.2 tp -110.43 139.72 45.38 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.03 -175.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.502 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.21 -1.372 0 CA-C-O 118.268 -1.295 . . . . 0.0 110.755 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.462 ' HB2' ' OG ' ' A' ' 5' ' ' SER . 52.9 Cg_exo -58.21 140.15 93.19 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 121.739 1.626 . . . . 0.0 111.53 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.3 ttp -110.19 137.26 48.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.43 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.596 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . . . 75.86 6.72 82.74 Favored Glycine 0 C--N 1.321 -0.304 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 2' ' ' PRO . 0.9 OUTLIER -69.91 102.4 1.97 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.686 -0.257 . . . . 0.0 110.447 -178.235 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.6 mtp 31.13 -93.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.236 0.614 . . . . 0.0 112.142 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.02 -21.35 30.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.795 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.49 -36.09 82.61 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.596 ' NZ ' ' O ' ' A' ' 4' ' ' GLY . 51.4 mttp -75.24 152.09 38.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 171.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.853 HD11 ' CE1' ' A' ' 73' ' ' PHE . 69.4 mt -106.9 128.35 61.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' TYR . 48.3 mtpt -94.25 106.85 18.83 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -146.33 168.99 19.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.097 0.776 . . . . 0.0 113.097 -173.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.429 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 45.4 m -135.66 147.16 48.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.398 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.444 ' CG ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -137.6 152.31 49.25 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.109 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.888 HG23 ' OG ' ' A' ' 44' ' ' SER . 95.6 mt -121.63 126.21 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.96 1.304 . . . . 0.0 108.032 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 17' ' ' VAL . 4.6 tt -105.28 123.54 48.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.639 ' N ' HD23 ' A' ' 16' ' ' LEU . 31.3 m -135.87 155.63 36.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 120.804 0.335 . . . . 0.0 110.396 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.94 -22.35 33.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.158 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.55 137.55 43.2 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.774 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.52 -36.99 85.59 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.55 98.22 Favored Glycine 0 CA--C 1.51 -0.224 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.473 ' HB3' HD23 ' A' ' 43' ' ' LEU . 98.8 mt-10 -64.46 -43.97 92.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -60.4 -45.58 93.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.282 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.93 -39.93 96.1 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.466 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.07 -46.0 89.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.573 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.868 ' CG1' HD22 ' A' ' 43' ' ' LEU . 12.3 m -65.78 -38.82 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.953 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.542 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 3.1 tp-100 -54.68 -48.53 72.29 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.745 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -68.06 -39.88 82.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.713 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HG2' HD11 ' A' ' 39' ' ' LEU . 8.1 tpt180 -63.08 -40.23 97.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.903 -174.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.601 HD11 ' CA ' ' A' ' 36' ' ' PHE . 1.9 mm? -61.05 -38.81 87.49 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.329 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.542 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 23.8 mmtm -64.29 -16.11 61.52 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.889 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -72.13 -9.6 58.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 174.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.84 12.14 62.65 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 96.6 mt-10 -83.99 153.11 24.06 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.786 -0.243 . . . . 0.0 111.054 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -64.75 132.51 49.79 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 121.623 0.725 . . . . 0.0 111.93 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.601 ' CA ' HD11 ' A' ' 30' ' ' LEU . 62.5 t80 -57.05 -44.9 83.45 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.096 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -59.11 -38.03 92.5 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.772 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.494 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 49.1 tttp -60.95 -47.1 87.99 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.888 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 26' ' ' VAL . 4.4 mm? -61.82 -41.25 97.55 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.01 -50.56 72.98 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.858 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.26 -36.68 84.87 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.074 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.5 ' HB3' HD12 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -72.48 -80.3 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.913 -174.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.868 HD22 ' CG1' ' A' ' 26' ' ' VAL . 8.8 mp -67.29 -43.63 81.26 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -173.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.888 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.2 m -58.88 147.7 32.88 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.689 -162.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.451 ' CG1' HD22 ' A' ' 16' ' ' LEU . 46.0 pt -98.84 -5.21 9.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.824 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -85.21 93.67 8.72 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.576 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -61.26 -44.39 98.16 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.3 -41.84 72.17 Favored Glycine 0 C--N 1.324 -0.132 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.408 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 67.0 m -73.93 -33.37 63.91 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.934 174.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -67.14 -42.13 84.93 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.204 0.526 . . . . 0.0 110.68 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 35.3 mmtp -62.34 -31.79 72.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -96.69 15.87 20.62 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.268 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.491 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 42.3 38.7 1.23 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.951 0.881 . . . . 0.0 112.134 -178.527 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.77 -11.81 9.8 Favored Glycine 0 C--O 1.236 0.231 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.652 176.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.1 m -67.93 80.38 0.21 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.4 . . . . 0.0 111.617 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.444 HD11 ' CG ' ' A' ' 14' ' ' HIS . 96.0 mt -63.28 -40.56 97.71 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.95 -149.07 19.52 Favored Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.863 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.33 141.77 28.41 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.646 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.7 p90 -148.59 151.96 35.94 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.988 177.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.35 167.92 49.59 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.506 ' NH1' ' CE1' ' A' ' 73' ' ' PHE . 77.3 mtp85 -74.68 140.97 44.57 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.01 -29.57 10.97 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.193 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -40.53 97.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.583 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 9.0 mmm -80.83 160.76 24.71 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 68' ' ' PHE . 15.1 m -63.21 136.51 26.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.562 176.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -45.29 -47.02 34.11 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.447 -171.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -56.61 -40.38 84.83 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.122 1.214 . . . . 0.0 110.77 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.537 ' CD2' HD11 ' A' ' 93' ' ' ILE . 56.0 t80 -60.76 -46.51 90.16 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.565 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 47.9 mt-10 -64.47 -38.37 90.8 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.527 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.8 -48.51 75.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.924 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.23 -40.48 71.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.559 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.84 92.45 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.836 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.853 ' CE1' HD11 ' A' ' 10' ' ' ILE . 24.8 m-85 -66.39 -34.06 77.11 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.794 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' NH1' ' OE1' ' A' ' 82' ' ' GLU . 58.9 mtp180 -62.29 -44.75 95.8 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 81' ' ' SER . 0.1 OUTLIER -97.37 34.53 1.78 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.629 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.481 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 53.0 mt-30 -56.14 -20.9 19.56 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.482 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 79' ' ' GLU . 7.3 p -60.61 -29.71 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.768 176.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 121.35 -4.31 11.15 Favored Glycine 0 N--CA 1.471 0.988 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.589 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.1 tp10 -64.95 166.94 8.43 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 122.781 0.432 . . . . 0.0 110.761 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.583 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 13.8 t -93.82 128.86 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 174.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.638 ' HB3' HD13 ' A' ' 75' ' ' LEU . 10.6 p -73.67 162.08 29.58 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.686 0.279 . . . . 0.0 111.609 -178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 5.9 mp0 -79.56 -179.74 1.52 Allowed Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 173.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.633 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 73.3 Cg_exo -57.63 133.5 56.93 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 CA-C-N 118.936 0.656 . . . . 0.0 110.761 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 47.3 t -111.46 102.96 14.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.657 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 135.14 48.37 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 p -146.56 172.98 12.74 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.639 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 2.0 pm0 -59.23 -37.67 78.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.477 ' HB2' ' HE2' ' A' ' 91' ' ' HIS . 36.6 m-85 -65.21 -43.81 90.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.922 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 151.69 -151.72 23.6 Favored Glycine 0 C--N 1.317 -0.51 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 70.1 m-85 -98.89 129.06 45.22 Favored 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.38 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.477 ' HE2' ' HB2' ' A' ' 88' ' ' PHE . 5.0 m-70 -112.08 148.96 32.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.238 177.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.604 HG11 HG23 ' A' ' 26' ' ' VAL . 61.4 t -117.44 128.47 74.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 167.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 68' ' ' PHE . 87.1 mt -119.34 130.5 73.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -173.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HD2' HG22 ' A' ' 80' ' ' VAL . 59.5 tttm -115.73 143.52 45.26 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 168.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -78.41 143.61 36.63 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.837 -178.101 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.438 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 52.9 tp -96.61 133.01 41.65 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.419 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.205 -1.657 0 CA-C-O 118.364 -1.242 . . . . 0.0 111.25 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.55 150.42 83.98 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.012 1.808 . . . . 0.0 111.658 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.16 157.13 37.5 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.7 19.31 56.7 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 -170.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 8' ' ' ASP . 94.2 p -76.31 169.65 17.82 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 113.902 -1.149 . . . . 0.0 111.124 -177.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.2 mmm -64.95 -36.52 84.66 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.29 66.57 Favored 'General case' 0 C--O 1.228 -0.057 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.216 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 5' ' ' SER . 2.3 m-20 -62.38 -35.24 78.56 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -85.85 154.92 21.21 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.072 168.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.459 HD12 ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -105.95 123.64 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.542 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -93.13 105.16 17.29 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -147.44 167.61 23.96 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.326 -0.95 . . . . 0.0 113.205 -171.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 4.1 m -130.88 141.16 50.29 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.066 -1.424 . . . . 0.0 107.997 174.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.482 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -135.75 150.45 49.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.822 HG23 ' OG ' ' A' ' 44' ' ' SER . 91.5 mt -125.46 121.62 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.552 HD22 ' CG1' ' A' ' 45' ' ' ILE . 5.5 tt -101.47 121.42 41.92 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.448 HG13 HG22 ' A' ' 15' ' ' ILE . 29.3 m -133.88 150.97 32.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.568 0.699 . . . . 0.0 112.192 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG3' HD13 ' A' ' 45' ' ' ILE . 99.2 mttt -67.32 -38.38 84.84 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.355 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.508 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 64.0 mttm -109.37 141.61 41.48 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.627 -173.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -64.6 -36.75 85.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.055 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.0 -36.22 92.55 Favored Glycine 0 C--O 1.238 0.357 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.583 ' HB3' HD23 ' A' ' 43' ' ' LEU . 94.6 mt-10 -65.55 -41.44 93.01 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.74 -44.52 93.74 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.685 176.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.548 HD23 ' NE2' ' A' ' 27' ' ' GLN . 23.1 mt -64.18 -39.46 94.04 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.099 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.54 71.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.031 HG13 HD22 ' A' ' 43' ' ' LEU . 18.5 m -64.29 -41.14 91.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.461 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.548 ' NE2' HD23 ' A' ' 24' ' ' LEU . 25.0 mt-30 -59.48 -46.41 88.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.328 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 71.0 mm-40 -73.2 -38.57 66.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.734 ' HD3' HD11 ' A' ' 39' ' ' LEU . 53.8 ttt85 -65.01 -39.75 93.9 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.677 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.574 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -55.8 -25.44 41.46 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.405 -178.579 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 27' ' ' GLN . 38.9 mmtm -61.46 -38.18 86.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -16.54 44.53 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.907 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.89 14.15 61.37 Favored Glycine 0 C--N 1.318 -0.43 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' CD ' HH21 ' A' ' 29' ' ' ARG . 36.0 mt-10 -69.43 159.73 32.69 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.687 174.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 49.7 tttp -64.39 129.12 38.67 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.368 0.604 . . . . 0.0 110.247 -174.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' HA ' HD21 ' A' ' 30' ' ' LEU . 61.7 t80 -56.35 -43.96 79.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.49 ' HA2' ' C ' ' A' ' 53' ' ' ASP . . . -60.42 -34.07 83.76 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.564 177.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 45.7 tttp -59.62 -48.45 81.6 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.604 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.734 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.4 mm? -62.53 -41.35 98.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.921 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -57.26 -49.68 75.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.45 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.547 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 68.0 mttm -64.1 -37.69 88.36 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.896 177.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.678 ' HB3' HD12 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -71.09 -50.39 34.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.615 -172.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.031 HD22 HG13 ' A' ' 26' ' ' VAL . 6.2 mp -98.47 -48.6 4.96 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -174.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.822 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.2 m -55.64 142.14 35.01 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.338 -162.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.552 ' CG1' HD22 ' A' ' 16' ' ' LEU . 46.1 pt -94.45 -12.2 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.258 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 49' ' ' SER . 11.4 t0 -76.86 111.89 12.87 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.9 -40.22 64.49 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.9 -48.36 73.26 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.464 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 78.9 p -62.06 -33.28 74.11 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.381 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.53 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -74.46 -48.24 28.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.005 0.431 . . . . 0.0 110.346 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -65.39 -36.36 83.72 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.233 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' NE ' ' O ' ' A' ' 55' ' ' SER . 13.8 mmm180 -94.68 7.48 45.65 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.994 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.0 OUTLIER 50.34 47.86 23.2 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 67.12 -40.04 0.2 Allowed Glycine 0 C--N 1.313 -0.742 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.946 -173.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.563 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -54.79 82.91 0.0 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.1 0.96 . . . . 0.0 111.73 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.55 -38.64 91.91 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.54 -152.09 20.66 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.73 133.61 34.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.459 ' CE2' HD12 ' A' ' 10' ' ' ILE . 54.2 p90 -146.61 151.8 37.87 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.15 178.47 46.43 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 61' ' ' ARG . 45.8 mtp85 -73.46 152.53 40.71 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 122.764 0.426 . . . . 0.0 110.749 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.402 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 82.11 9.65 84.9 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.584 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -100.88 -19.28 15.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 178.63 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.474 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 1.4 mmm -126.39 161.33 28.13 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.76 136.85 20.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.081 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 1.7 tttm -44.5 -46.89 26.19 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 21.3 Cg_endo -59.71 -34.07 96.28 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 CA-C-N 119.161 0.736 . . . . 0.0 111.238 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CD2' HD11 ' A' ' 93' ' ' ILE . 55.5 t80 -62.99 -50.15 71.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.915 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 64' ' ' MET . 93.7 mt-10 -67.85 -43.82 78.59 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.811 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 7.2 t70 -57.74 -49.71 75.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.314 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.08 96.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.811 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -64.53 -42.08 95.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.516 -176.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.465 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 44.4 m-85 -64.99 -34.11 77.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.236 0.541 . . . . 0.0 111.362 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 79.9 mtp85 -62.62 -36.03 81.45 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.751 -176.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.598 HD11 ' HA ' ' A' ' 81' ' ' SER . 68.9 mt -97.12 23.05 7.73 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -173.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.494 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 75.1 mt-30 -43.53 -25.1 0.14 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.381 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.429 HG13 ' H ' ' A' ' 79' ' ' GLU . 14.8 p -58.35 -27.49 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 119.8 -2.18 13.48 Favored Glycine 0 N--CA 1.47 0.943 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.429 ' H ' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -55.86 173.46 0.14 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.059 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.66 127.5 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.598 ' HA ' HD11 ' A' ' 75' ' ' LEU . 83.7 p -65.33 147.58 53.19 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.882 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.53 177.09 0.73 Allowed Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 168.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD3' HE22 ' A' ' 27' ' ' GLN . 53.1 Cg_exo -54.42 133.51 56.7 Favored 'Trans proline' 0 C--N 1.283 -2.872 0 N-CA-C 109.991 -0.811 . . . . 0.0 109.991 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 55.1 t -117.42 128.66 74.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -98.75 129.92 45.2 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.488 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.8 p -114.41 -175.48 2.69 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.719 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.6 pm0 -69.59 -35.52 75.4 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -66.11 -45.32 81.54 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.95 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.59 -157.66 28.35 Favored Glycine 0 C--N 1.317 -0.492 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 87.0 m-85 -85.52 135.08 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.678 0.239 . . . . 0.0 110.483 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.482 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 44.9 m-70 -122.5 147.7 46.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.682 176.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.51 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 60.9 t -117.7 126.69 74.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 166.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.51 HD11 ' CD2' ' A' ' 68' ' ' PHE . 87.7 mt -119.94 125.86 74.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.586 -174.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -113.69 143.8 44.01 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.632 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 2.4 tmm_? -78.7 141.23 38.07 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.939 -1.104 . . . . 0.0 110.181 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.432 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 48.2 tp -109.26 135.41 50.39 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.273 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.201 -1.939 0 CA-C-O 118.082 -1.399 . . . . 0.0 111.059 -178.903 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.7 mttp . . . . . 0 C--O 1.242 0.678 0 CA-C-O 120.586 0.232 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.775 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 70.6 mt -107.49 131.66 57.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 27.6 mtpp -91.92 106.2 18.28 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -145.81 168.34 21.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -176.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.502 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 4.2 m -129.27 146.95 51.08 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.353 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.491 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -147.21 151.39 36.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.299 0.571 . . . . 0.0 112.346 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.643 HG21 HG11 ' A' ' 26' ' ' VAL . 85.2 mt -122.12 124.6 71.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.546 HD22 ' CG1' ' A' ' 45' ' ' ILE . 6.1 tt -107.83 127.74 53.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.586 HG21 ' N ' ' A' ' 23' ' ' ALA . 27.6 m -137.11 153.61 29.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.431 0.634 . . . . 0.0 111.212 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.457 ' HG3' HD13 ' A' ' 45' ' ' ILE . 26.1 mtmm -67.54 -39.96 85.0 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.475 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 60.7 mttp -103.48 148.89 25.39 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.526 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 86.0 mt-30 -62.09 -39.98 94.3 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.79 -38.27 91.8 Favored Glycine 0 CA--C 1.509 -0.281 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 74.4 mt-10 -65.54 -41.84 92.57 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.586 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -62.11 -42.35 99.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.849 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 20' ' ' GLN . 3.1 mm? -62.47 -40.98 98.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.782 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.0 -49.47 71.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.738 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.813 HG12 HD13 ' A' ' 43' ' ' LEU . 19.0 m -66.29 -42.49 90.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.198 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 81' ' ' SER . 99.1 mt-30 -61.66 -44.12 97.56 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.01 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.44 -44.85 74.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.066 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.895 ' HD3' HD11 ' A' ' 39' ' ' LEU . 43.0 ttt85 -66.63 -40.16 88.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.507 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.425 ' CD2' ' HG ' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -55.04 -24.7 26.06 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.312 0.577 . . . . 0.0 109.677 -178.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 27' ' ' GLN . 31.7 mmtm -62.35 -32.6 73.41 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.841 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.98 -7.99 20.19 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.722 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.84 25.84 40.06 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 87.1 mt-10 -81.54 157.23 24.87 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.506 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' NZ ' ' OD2' ' A' ' 53' ' ' ASP . 64.5 tttm -62.06 131.6 50.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.545 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 58.1 t80 -56.96 -43.28 81.41 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.658 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -59.21 -36.8 90.31 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.707 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 58.6 tttm -58.26 -48.0 81.81 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.027 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.895 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.6 mm? -63.44 -40.07 96.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.275 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.27 -43.21 95.53 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.758 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 34.3 mmtm -64.15 -41.27 97.24 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.719 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.76 -59.79 2.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.412 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.813 HD13 HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -91.33 -49.46 6.34 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -172.292 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.613 ' HB2' HG23 ' A' ' 15' ' ' ILE . 5.6 t -56.53 138.25 52.18 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.903 -169.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.546 ' CG1' HD22 ' A' ' 16' ' ' LEU . 44.6 pt -92.79 -1.74 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.814 0.34 . . . . 0.0 110.227 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 50' ' ' ALA . 60.1 t0 -80.22 96.51 6.61 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.1 -53.43 44.98 Favored Glycine 0 C--N 1.321 -0.278 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.815 -173.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.38 -45.01 84.93 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 54' ' ' GLY . 17.5 m -70.41 -32.57 70.25 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.472 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -62.79 -38.36 90.33 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 75.7 mmtt -60.79 -34.3 74.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.513 ' HE ' ' HA ' ' A' ' 49' ' ' SER . 89.6 mtm180 -95.48 19.48 10.89 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.913 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.658 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 97.3 m-20 59.85 30.2 19.75 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 70.87 -7.75 5.14 Favored Glycine 0 C--N 1.305 -1.149 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.701 ' HB3' HD22 ' A' ' 96' ' ' LEU . 2.3 m -70.72 91.09 0.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.433 0.635 . . . . 0.0 110.353 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.468 HD23 ' NH2' ' A' ' 52' ' ' ARG . 96.9 mt -62.35 -38.23 88.74 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.64 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . 76.91 -133.15 13.01 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.502 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 57.4 m-85 -83.98 135.59 34.39 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 117.111 0.455 . . . . 0.0 109.897 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.587 ' CE1' HD12 ' A' ' 10' ' ' ILE . 47.9 p90 -144.18 149.32 36.25 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.779 168.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.82 174.89 55.12 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 -174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.543 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 47.6 mtm180 -74.54 145.66 43.26 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.8 60.17 8.11 Favored Glycine 0 C--O 1.246 0.905 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 61' ' ' ARG . 34.7 mmtm -133.25 -35.62 1.03 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.017 0.437 . . . . 0.0 110.458 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.408 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 77.7 mtm -119.44 159.83 23.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.99 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.705 HG11 ' HB2' ' A' ' 86' ' ' SER . 15.4 m -49.1 133.57 7.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.277 -174.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -44.02 -47.34 22.45 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.901 -174.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 24.7 Cg_endo -57.87 -38.31 93.0 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 CA-C-N 118.767 0.595 . . . . 0.0 111.862 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.692 ' HA ' HG11 ' A' ' 84' ' ' VAL . 58.9 t80 -62.73 -49.97 72.96 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.771 177.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.62 -39.31 93.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.316 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.511 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 12.6 t70 -57.35 -48.68 78.38 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.115 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.642 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -63.22 -39.62 95.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.783 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.07 83.21 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.09 0.472 . . . . 0.0 110.253 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.775 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 52.6 m-85 -63.67 -42.85 98.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.879 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.672 ' NH2' HD11 ' A' ' 75' ' ' LEU . 39.1 ttp180 -63.54 -47.57 81.08 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.172 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.672 HD11 ' NH2' ' A' ' 74' ' ' ARG . 97.3 mt -98.04 33.41 2.15 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.501 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 71.8 mt-30 -54.28 -19.17 4.87 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.502 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 2.4 m -60.11 -40.73 84.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.332 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.493 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 121.66 7.36 8.15 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.893 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 149.37 41.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.5 t -71.35 128.97 35.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.639 ' HB3' HD12 ' A' ' 75' ' ' LEU . 11.3 p -79.24 155.72 28.45 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 123.29 0.369 . . . . 0.0 111.411 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.7 mp0 -66.52 161.95 54.45 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.555 ' N ' HE22 ' A' ' 27' ' ' GLN . 47.5 Cg_exo -55.37 129.74 36.82 Favored 'Trans proline' 0 C--N 1.295 -2.279 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.692 HG11 ' HA ' ' A' ' 68' ' ' PHE . 96.8 t -106.13 114.87 46.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -85.37 138.54 32.21 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.753 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.705 ' HB2' HG11 ' A' ' 65' ' ' VAL . 63.2 p -136.05 176.36 8.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -61.79 -32.7 73.01 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.67 -38.79 80.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.036 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.61 -146.97 16.06 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -176.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.526 ' CE1' ' HG2' ' A' ' 20' ' ' GLN . 82.9 m-85 -106.4 133.86 50.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.941 0.371 . . . . 0.0 110.709 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.491 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.9 m-70 -115.12 147.34 40.36 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.382 176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 76.5 t -117.97 127.55 75.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 167.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.658 HD11 ' CD2' ' A' ' 68' ' ' PHE . 81.5 mt -115.97 130.7 70.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -171.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -120.61 149.89 41.76 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.383 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.502 ' NH2' ' O ' ' A' ' 77' ' ' VAL . 8.7 tmm_? -79.05 143.87 35.19 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.701 HD22 ' HB3' ' A' ' 55' ' ' SER . 64.7 tp -117.15 135.42 53.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.382 0 CA-C-O 118.556 -1.135 . . . . 0.0 110.747 -177.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.0 mttm . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.635 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 45.6 mm -106.84 131.68 56.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' CG ' ' CE2' ' A' ' 58' ' ' TYR . 56.5 mtpt -87.95 105.91 17.77 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.667 ' SG ' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -148.37 168.22 23.17 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.498 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 4.9 m -130.81 133.04 45.61 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.339 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.483 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -124.58 149.56 46.88 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.457 -176.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.614 ' CG2' HD12 ' A' ' 43' ' ' LEU . 95.2 mt -125.31 128.19 72.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.759 HD13 ' CE1' ' A' ' 91' ' ' HIS . 47.1 tp -103.47 128.56 50.63 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.472 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.072 HG12 HD11 ' A' ' 43' ' ' LEU . 28.8 m -129.1 154.4 39.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 123.743 0.652 . . . . 0.0 110.818 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -67.76 -41.08 83.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.187 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 47.0 mttp -127.5 156.43 42.18 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -169.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.4 ' O ' HD23 ' A' ' 24' ' ' LEU . 26.1 mt-30 -60.59 -38.86 86.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.36 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.54 -38.42 91.14 Favored Glycine 0 N--CA 1.464 0.502 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 99.5 mt-10 -65.65 -42.12 91.8 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.14 82.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.686 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 20' ' ' GLN . 1.2 mm? -61.57 -42.26 98.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.85 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.04 74.2 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.9 m -66.03 -41.07 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.749 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -59.31 -46.12 89.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.054 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.501 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 73.7 mm-40 -67.82 -38.59 83.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.158 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.445 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 22.7 ttp85 -64.9 -38.11 89.87 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.418 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.418 HD22 ' HG ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -57.07 -27.16 61.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 33.2 mmtp -61.11 -31.6 71.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.19 -21.73 48.7 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.176 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.82 20.69 53.09 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' OE1' ' NZ ' ' A' ' 38' ' ' LYS . 36.5 mt-10 -65.34 164.36 13.76 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.477 ' NZ ' ' OD2' ' A' ' 53' ' ' ASP . 63.4 tttm -65.6 130.5 43.5 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 174.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.587 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 56.6 t80 -55.92 -42.88 76.76 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.637 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -57.12 -39.3 89.64 Favored Glycine 0 C--N 1.311 -0.836 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.835 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.435 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 63.3 tttm -59.91 -45.7 91.71 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.418 ' HG ' HD22 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -62.16 -41.2 98.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.938 173.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.488 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -61.83 -42.84 99.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.425 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -65.21 -44.84 87.04 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.454 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 95.0 mt-10 -70.23 -43.66 70.16 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -169.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.072 HD11 HG12 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -117.24 -40.49 3.08 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -169.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.753 ' N ' HD13 ' A' ' 43' ' ' LEU . 1.4 m -45.82 133.54 8.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.489 HG13 HD23 ' A' ' 16' ' ' LEU . 46.1 pt -83.12 -14.95 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -80.4 92.42 5.82 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.308 174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.8 -46.82 93.38 Favored Glycine 0 CA--C 1.507 -0.447 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.191 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.19 -46.99 84.56 Favored Glycine 0 C--N 1.319 -0.364 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.483 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 20.1 m -63.41 -34.05 76.88 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.322 174.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -64.22 -36.98 85.86 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.359 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 18.6 mmtp -60.53 -40.21 90.68 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -96.67 16.09 19.95 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.281 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.637 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.9 m-20 63.1 32.91 14.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.663 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 70.65 -29.7 0.49 Allowed Glycine 0 C--N 1.31 -0.871 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 53' ' ' ASP . 53.6 m -55.31 98.59 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.717 0.77 . . . . 0.0 111.382 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.61 HD12 ' SG ' ' A' ' 12' ' ' CYS . 97.6 mt -65.07 -36.52 84.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.835 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 88.67 -145.05 18.61 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 -170.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.466 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 89.9 m-85 -83.09 134.03 35.03 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.504 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.3 p90 -144.04 150.23 37.88 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.629 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.53 165.55 22.49 Favored Glycine 0 C--O 1.24 0.493 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.493 ' HD2' ' CE1' ' A' ' 73' ' ' PHE . 76.9 mtp180 -81.05 160.54 24.5 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.641 0.376 . . . . 0.0 110.879 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.07 -51.61 1.13 Allowed Glycine 0 C--N 1.315 -0.615 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -64.23 -38.02 89.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.968 -0.616 . . . . 0.0 109.645 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.555 ' HE1' HD13 ' A' ' 56' ' ' LEU . 25.5 mmm -88.67 153.02 21.44 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.36 141.76 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.294 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 15.8 mmtm -43.7 -51.28 16.78 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.536 ' HB2' HG13 ' A' ' 84' ' ' VAL . 36.3 Cg_endo -61.4 -32.49 89.09 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 120.231 0.62 . . . . 0.0 111.571 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.673 ' CD2' HD11 ' A' ' 93' ' ' ILE . 47.7 t80 -62.62 -46.66 87.24 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.508 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 93.9 mt-10 -63.9 -47.23 81.42 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.241 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.06 -41.82 93.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.74 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.433 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -64.59 -46.62 81.93 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.86 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.531 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -62.5 -46.27 89.21 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.951 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.635 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 17.7 m-85 -61.82 -28.17 69.28 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.972 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.707 ' CZ ' ' HB3' ' A' ' 74' ' ' ARG . 2.1 mtm105 -64.46 -36.75 85.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.345 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.775 HD11 ' HB3' ' A' ' 81' ' ' SER . 10.3 mt -87.91 21.84 2.55 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -167.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 73' ' ' PHE . 75.6 mt-30 -54.26 -34.56 61.07 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.491 HG13 ' HG3' ' A' ' 79' ' ' GLU . 7.1 p -63.84 -27.54 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.279 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.02 6.05 7.83 Favored Glycine 0 N--CA 1.475 1.278 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.435 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.644 ' HB2' HD22 ' A' ' 75' ' ' LEU . 80.2 mt-10 -55.57 173.94 0.11 Allowed 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.4 t -106.76 132.57 53.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 167.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.775 ' HB3' HD11 ' A' ' 75' ' ' LEU . 99.7 p -66.32 163.21 18.56 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.227 0.537 . . . . 0.0 111.842 -172.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.573 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 3.5 mp0 -78.69 161.19 70.18 Favored Pre-proline 0 N--CA 1.422 -1.866 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -56.94 133.89 60.94 Favored 'Trans proline' 0 C--N 1.294 -2.329 0 N-CA-C 109.784 -0.891 . . . . 0.0 109.784 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 67' ' ' PRO . 42.6 t -117.97 125.64 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.534 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.8 tptp -88.98 137.47 32.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.94 0.4 . . . . 0.0 109.963 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.534 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 14.1 p -140.89 175.17 9.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -59.59 -39.77 85.25 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -65.15 -42.64 93.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.517 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.32 -137.34 5.75 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.664 ' O ' HD12 ' A' ' 16' ' ' LEU . 4.6 m-85 -105.01 132.78 50.82 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 117.107 0.453 . . . . 0.0 111.963 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.759 ' CE1' HD13 ' A' ' 16' ' ' LEU . 44.5 m-70 -114.27 141.74 47.18 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.391 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.02 128.28 75.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 167.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.673 HD11 ' CD2' ' A' ' 68' ' ' PHE . 88.5 mt -121.1 131.22 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 116.917 -0.129 . . . . 0.0 110.76 -173.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -116.08 147.86 40.85 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 167.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.46 HH21 ' CA ' ' A' ' 97' ' ' GLY . 2.6 ttp180 -77.57 143.46 38.31 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.34 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.421 ' HB3' ' C ' ' A' ' 11' ' ' LYS . 46.5 tp -100.68 145.58 28.26 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.46 ' CA ' HH21 ' A' ' 95' ' ' ARG . . . . . . . . 0 C--O 1.207 -1.576 0 CA-C-O 118.356 -1.247 . . . . 0.0 110.683 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm . . . . . 0 N--CA 1.441 -0.904 0 CA-C-O 120.765 0.317 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.58 HG13 ' HB1' ' A' ' 72' ' ' ALA . 44.4 mm -106.34 129.87 58.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.599 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 62.2 mtpt -90.93 104.11 16.74 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -145.1 169.59 17.86 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.515 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 9.2 m -126.51 145.63 50.43 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.871 174.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.482 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -134.63 149.57 50.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.921 0.391 . . . . 0.0 111.597 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.523 HG13 ' CE2' ' A' ' 36' ' ' PHE . 94.4 mt -129.41 128.06 65.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.23 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 46' ' ' ASP . 13.9 mt -94.61 128.68 41.41 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.412 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.13 154.72 35.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.704 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -66.28 -40.7 90.27 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.358 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 36.8 mtmm -121.6 152.48 39.23 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.332 0.587 . . . . 0.0 112.502 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.525 ' O ' HD23 ' A' ' 24' ' ' LEU . 53.6 tt0 -61.14 -40.95 95.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.489 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.06 -36.68 92.69 Favored Glycine 0 C--O 1.238 0.368 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 19' ' ' LYS . 98.9 mt-10 -63.76 -42.14 97.86 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 20' ' ' GLN . . . -58.76 -47.95 82.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.966 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 20' ' ' GLN . 4.5 mm? -61.52 -41.79 97.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.074 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.27 -51.83 66.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.574 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.021 HG11 HD21 ' A' ' 43' ' ' LEU . 18.6 m -68.97 -39.46 79.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.273 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.646 HE22 ' N ' ' A' ' 83' ' ' PRO . 67.8 mt-30 -55.4 -46.12 76.63 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 72.4 mm-40 -71.13 -35.29 71.67 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 175.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.612 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 74.9 ttt180 -60.28 -37.76 81.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.984 0.421 . . . . 0.0 110.025 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.12 -34.62 73.76 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 31.7 mmtp -62.53 -33.18 74.4 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.74 -24.72 64.25 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.441 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.82 -2.6 31.95 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.612 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 23.9 mt-10 -67.7 147.05 53.17 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.76 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.56 139.27 51.47 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CE2' HG13 ' A' ' 15' ' ' ILE . 52.3 t80 -58.21 -45.88 86.84 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.48 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.503 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.35 -35.66 91.98 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.263 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 25.3 tttm -60.22 -47.73 84.73 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.601 HD11 HH11 ' A' ' 29' ' ' ARG . 4.0 mm? -62.06 -40.81 97.03 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.501 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.546 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.11 -45.47 79.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 24.9 mmtm -65.5 -38.83 90.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.558 173.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 78.3 mt-10 -69.78 -54.17 14.88 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.021 HD21 HG11 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -124.18 -17.5 6.15 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -169.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.61 ' N ' HD12 ' A' ' 43' ' ' LEU . 1.1 m -48.99 127.26 13.94 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.311 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 45' ' ' ILE . 39.9 pt -76.74 -14.05 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.673 ' HB2' HD12 ' A' ' 16' ' ' LEU . 63.4 t0 -86.72 92.17 8.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.17 -42.72 99.35 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.13 -48.18 69.57 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.482 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 38.4 m -64.58 -33.37 75.77 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.513 -0.404 . . . . 0.0 110.315 175.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -62.81 -30.09 71.21 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.574 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -61.28 -39.87 92.03 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 81.3 mtp180 -97.23 19.68 12.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.404 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.503 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 47.8 m-20 58.72 31.79 21.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.16 -14.44 3.9 Favored Glycine 0 C--N 1.31 -0.904 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 13' ' ' SER . 20.2 m -69.19 90.88 0.49 Allowed 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.816 0.817 . . . . 0.0 111.313 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 56' ' ' LEU . 93.9 mt -62.94 -38.76 92.34 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.216 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.79 ' HA2' HD21 ' A' ' 96' ' ' LEU . . . 94.94 -144.14 17.01 Favored Glycine 0 CA--C 1.503 -0.698 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.4 ' H ' ' HD1' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -85.11 130.73 34.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.658 0.266 . . . . 0.0 110.827 -179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.495 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.8 p90 -144.89 152.87 40.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.876 0.369 . . . . 0.0 111.525 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.15 -173.31 37.33 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -81.96 154.78 25.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.69 -37.79 3.32 Favored Glycine 0 C--N 1.311 -0.852 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -63.0 -36.6 84.08 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.481 0.658 . . . . 0.0 109.476 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.474 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 3.7 mmm -104.62 155.64 18.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.281 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.74 154.35 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.463 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 13.7 mmtm -44.0 -55.0 10.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.661 ' HB2' HG13 ' A' ' 84' ' ' VAL . 40.0 Cg_endo -60.05 -34.69 94.54 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 CA-C-N 118.925 0.652 . . . . 0.0 111.074 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.594 ' CD2' HD11 ' A' ' 93' ' ' ILE . 10.5 t80 -63.12 -46.6 86.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.076 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.96 -41.72 99.61 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.714 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.9 -50.21 71.3 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.789 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.08 98.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.459 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB1' HG13 ' A' ' 10' ' ' ILE . . . -57.84 -50.47 73.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.149 -177.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -67.6 -38.73 84.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.039 0.447 . . . . 0.0 111.297 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.529 HH22 ' CD ' ' A' ' 82' ' ' GLU . 78.7 mtp180 -63.99 -41.18 97.6 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.915 HD11 ' HA ' ' A' ' 81' ' ' SER . 43.0 mt -97.92 23.58 7.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -171.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.421 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 88.5 mt-30 -54.03 -25.54 21.86 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.91 -29.64 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.032 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 122.12 -0.34 10.66 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.203 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.718 ' HB2' HD22 ' A' ' 75' ' ' LEU . 19.4 mt-10 -70.64 174.28 6.1 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -174.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -98.49 131.23 46.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.574 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.915 ' HA ' HD11 ' A' ' 75' ' ' LEU . 43.1 t -64.34 162.09 15.58 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.708 -176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.529 ' CD ' HH22 ' A' ' 74' ' ' ARG . 0.0 OUTLIER -72.91 163.11 70.84 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 165.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.646 ' N ' HE22 ' A' ' 27' ' ' GLN . 72.1 Cg_endo -61.82 140.19 84.21 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 N-CA-C 110.214 -0.725 . . . . 0.0 110.214 -175.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' A' ' 67' ' ' PRO . 77.3 t -123.16 100.47 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.813 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.5 tptp -80.05 130.23 35.1 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.481 174.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.571 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 52.8 p -129.14 -176.25 3.81 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.362 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -62.61 -39.78 94.87 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -66.37 -41.62 89.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.315 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.79 -150.63 21.9 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.502 ' O ' HD23 ' A' ' 16' ' ' LEU . 77.7 m-85 -99.16 118.88 36.87 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.522 ' CE1' HD21 ' A' ' 16' ' ' LEU . 34.9 m-70 -99.33 139.54 34.82 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 123.341 0.401 . . . . 0.0 110.319 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.436 HG21 ' CG2' ' A' ' 26' ' ' VAL . 70.0 t -114.93 125.44 72.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 168.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.594 HD11 ' CD2' ' A' ' 68' ' ' PHE . 84.2 mt -123.62 127.44 74.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.129 -170.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -120.79 143.36 48.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.54 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 5.6 tmm_? -78.5 142.21 37.6 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.79 HD21 ' HA2' ' A' ' 57' ' ' GLY . 0.3 OUTLIER -121.98 151.3 40.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.124 -179.113 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.425 ' N ' HD12 ' A' ' 96' ' ' LEU . . . . . . . . 0 C--O 1.206 -1.627 0 CA-C-O 118.364 -1.242 . . . . 0.0 110.25 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.9 mttm . . . . . 0 N--CA 1.433 -1.316 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.83 HD11 ' CE2' ' A' ' 73' ' ' PHE . 66.0 mt -105.34 127.61 59.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.562 ' HB3' ' NZ ' ' A' ' 11' ' ' LYS . 9.2 mtpm? -94.87 107.51 19.53 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.771 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -147.54 169.64 19.15 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.914 -173.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.536 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.7 m -130.45 146.27 51.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.068 173.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.556 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -138.6 149.34 45.15 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.876 -178.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.769 HG23 ' OG ' ' A' ' 44' ' ' SER . 94.9 mt -127.91 125.96 65.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.825 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 90' ' ' TYR . 42.3 tp -97.88 115.45 28.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.49 HG13 HG22 ' A' ' 15' ' ' ILE . 35.7 m -116.37 152.34 18.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.527 0.68 . . . . 0.0 112.294 -174.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -66.87 -42.92 84.82 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.904 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 31.3 mmtp -119.37 150.42 40.19 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.817 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -60.03 -38.03 81.52 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.079 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.79 -36.09 92.23 Favored Glycine 0 C--N 1.322 -0.234 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.483 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 95.8 mt-10 -64.53 -43.64 93.36 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -58.43 -46.7 85.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.001 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.49 -41.03 98.57 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.281 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.95 92.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.826 ' CG1' HD22 ' A' ' 43' ' ' LEU . 7.3 m -68.39 -34.44 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.103 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 49.4 tt0 -59.32 -46.47 88.5 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.155 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.76 -41.65 74.9 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.472 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.745 ' HD3' HD11 ' A' ' 39' ' ' LEU . 76.1 ttt180 -60.77 -39.23 88.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.861 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.99 -39.82 91.12 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.954 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 17.7 mmtp -65.47 -9.54 26.58 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -88.34 -3.51 58.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.152 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.48 11.04 75.79 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.587 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.596 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 13.2 mt-10 -78.85 154.21 29.99 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.473 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 21.3 tptm -62.29 126.4 27.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.233 -176.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.518 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 58.2 t80 -58.04 -44.47 87.43 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.643 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -60.11 -37.74 93.3 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.942 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 44.6 tttp -61.23 -44.28 97.52 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.82 HD12 HG12 ' A' ' 26' ' ' VAL . 4.4 mm? -62.02 -41.46 98.11 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.295 172.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -57.17 -51.91 67.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.38 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -65.54 -39.43 91.75 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' A' ' 38' ' ' LYS . 92.2 mt-10 -70.08 -48.08 59.22 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.826 HD22 ' CG1' ' A' ' 26' ' ' VAL . 9.5 mp -98.26 -50.49 4.32 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.769 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.2 m -50.81 139.21 17.26 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.1 -1.409 . . . . 0.0 113.093 -161.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.467 HG13 HD23 ' A' ' 16' ' ' LEU . 36.1 pt -97.42 -2.34 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.672 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -89.19 94.11 9.81 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.828 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -62.26 -42.29 99.72 Favored Glycine 0 C--O 1.234 0.136 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.3 -42.09 63.27 Favored Glycine 0 N--CA 1.454 -0.136 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.556 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 15.9 m -72.46 -33.08 66.78 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.635 -0.282 . . . . 0.0 111.569 175.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.18 74.63 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.161 0.505 . . . . 0.0 110.512 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 10.4 mmtp -61.98 -41.85 98.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.29 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -98.67 9.1 44.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.406 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.643 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.5 m-20 63.63 33.12 13.46 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.078 0.466 . . . . 0.0 110.395 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.4 -14.61 5.13 Favored Glycine 0 C--N 1.31 -0.897 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -63.19 89.32 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.0 0.428 . . . . 0.0 110.955 -179.355 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.771 HD12 ' SG ' ' A' ' 12' ' ' CYS . 96.4 mt -63.4 -40.29 96.83 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 87.19 -151.31 23.47 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.91 131.07 34.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.028 0.414 . . . . 0.0 110.004 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 52.5 p90 -142.79 148.72 37.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.345 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.18 150.92 34.31 Favored Glycine 0 C--N 1.314 -0.67 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.42 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -69.94 144.32 52.43 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.56 0.219 . . . . 0.0 110.734 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.58 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 106.95 -20.77 33.01 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -175.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -62.69 -42.5 99.66 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.608 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 75.0 mtm -120.0 160.66 22.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.931 0.396 . . . . 0.0 111.961 -174.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 68' ' ' PHE . 32.4 m -43.49 128.16 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.012 -177.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.608 ' NZ ' ' O ' ' A' ' 64' ' ' MET . 1.9 mmtm -45.08 -46.5 30.35 Favored Pre-proline 0 C--N 1.308 -1.198 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.058 -173.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 30.0 Cg_endo -59.82 -35.3 94.52 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 CA-C-N 119.311 0.79 . . . . 0.0 111.451 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' A' ' 93' ' ' ILE . 54.3 t80 -61.76 -49.07 77.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.959 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 99.1 mt-10 -66.11 -41.49 90.49 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.572 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.85 -46.65 81.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.813 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.99 -38.5 88.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.854 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.512 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -58.33 -41.23 84.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.897 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.83 ' CE2' HD11 ' A' ' 10' ' ' ILE . 57.3 m-85 -64.69 -35.25 80.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.018 0.437 . . . . 0.0 111.386 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -58.8 -23.19 59.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.506 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 81' ' ' SER . 84.2 mt -96.92 4.94 51.34 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -171.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.477 ' HA ' ' HD2' ' A' ' 95' ' ' ARG . 67.4 mm-40 -47.16 -20.41 0.18 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.57 -40.55 86.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 120.814 0.34 . . . . 0.0 110.124 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.95 48.49 0.24 Allowed Glycine 0 N--CA 1.465 0.615 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.451 ' OE1' ' N ' ' A' ' 80' ' ' VAL . 1.2 mm-40 -122.31 175.78 6.22 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.034 0.445 . . . . 0.0 112.166 -173.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 94' ' ' LYS . 75.2 t -108.99 131.37 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.703 ' HB3' HD11 ' A' ' 75' ' ' LEU . 6.4 p -75.51 163.19 27.64 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -173.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.33 165.33 45.47 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.596 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 63.5 Cg_exo -55.84 130.96 43.18 Favored 'Trans proline' 0 C--N 1.293 -2.392 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.1 t -117.88 124.4 73.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 41.7 tttp -91.51 131.89 36.65 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.67 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 97.1 p -118.85 -172.05 2.21 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.701 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 1.2 pm0 -66.8 -38.8 87.2 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 6.0 m-30 -64.39 -46.89 81.33 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.978 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.85 -150.88 21.11 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.592 ' O ' HD12 ' A' ' 16' ' ' LEU . 10.9 m-85 -96.5 129.41 43.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.837 0.351 . . . . 0.0 111.381 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -110.85 146.68 36.03 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.029 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.708 HG11 ' CG2' ' A' ' 26' ' ' VAL . 2.1 t -117.4 121.03 66.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 167.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.546 HD11 ' CD2' ' A' ' 68' ' ' PHE . 87.3 mt -113.1 127.82 70.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.428 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.455 ' HB2' HG22 ' A' ' 80' ' ' VAL . 59.5 tttm -115.43 145.13 42.86 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.409 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 75' ' ' LEU . 68.4 ttt-85 -79.5 139.37 37.62 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.024 177.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 55.8 tp -112.66 129.1 56.51 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.505 ' C ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.206 -1.633 0 CA-C-O 118.376 -1.236 . . . . 0.0 112.152 -173.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 44.3 mmtm . . . . . 0 N--CA 1.444 -0.764 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.682 HG21 ' HB1' ' A' ' 72' ' ' ALA . 43.5 mm -107.92 129.13 62.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 48.7 mtpt -92.7 106.88 18.79 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -138.22 166.04 25.17 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.779 0.799 . . . . 0.0 112.933 -177.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.467 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 3.9 m -133.35 138.53 46.37 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.895 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.47 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -132.8 150.28 52.18 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.372 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.705 HG23 ' OG ' ' A' ' 44' ' ' SER . 95.7 mt -125.09 127.22 72.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.621 177.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.754 HD12 ' O ' ' A' ' 90' ' ' TYR . 51.2 tp -98.72 125.01 43.92 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.944 HG12 HD11 ' A' ' 43' ' ' LEU . 33.6 m -118.06 151.85 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.389 0.614 . . . . 0.0 111.275 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.487 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 6.2 mttp -66.71 -40.62 88.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.201 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -133.77 158.84 42.31 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.866 -169.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.11 -39.75 87.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.488 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.81 -39.74 91.93 Favored Glycine 0 CA--C 1.507 -0.444 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.528 ' O ' HG13 ' A' ' 26' ' ' VAL . 97.0 mt-10 -65.07 -43.59 91.7 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.836 176.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -59.4 -48.36 81.94 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.124 0.488 . . . . 0.0 110.125 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.57 -42.93 99.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.214 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.87 80.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.75 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 22' ' ' GLU . 12.6 m -63.54 -41.39 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.778 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.513 HE22 ' HA ' ' A' ' 82' ' ' GLU . 94.7 mt-30 -55.92 -44.05 77.95 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -70.08 -41.71 73.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.322 0.582 . . . . 0.0 110.371 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 75.9 ttt180 -61.6 -38.36 87.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.941 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 36' ' ' PHE . 3.8 mm? -59.75 -37.58 79.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 18.7 mmtm -62.72 -30.71 71.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.03 -23.94 56.3 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.876 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.22 13.09 25.71 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.02 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.556 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 33.0 mt-10 -80.74 150.2 29.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.151 0.475 . . . . 0.0 110.705 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 61.1 tttm -65.78 137.17 57.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.046 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.606 ' HA ' HD11 ' A' ' 30' ' ' LEU . 59.2 t80 -56.77 -45.19 82.25 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.616 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.64 -37.63 95.09 Favored Glycine 0 C--N 1.317 -0.503 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 65.6 tttm -58.31 -46.71 85.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.491 HD11 ' HD3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -62.43 -41.14 98.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.529 174.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.48 -49.64 76.63 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.317 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.449 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 43.1 mttp -64.68 -41.24 96.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.646 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.504 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 58.6 mt-10 -71.25 -44.2 65.76 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.944 HD11 HG12 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -113.1 -38.2 4.54 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -169.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.705 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.5 m -54.78 142.83 27.48 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.81 -173.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.561 HG13 HD23 ' A' ' 16' ' ' LEU . 42.3 pt -95.89 6.59 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.923 0.868 . . . . 0.0 109.449 171.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 25.2 t0 -91.53 113.96 26.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.02 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.74 -65.39 2.82 Favored Glycine 0 C--N 1.318 -0.46 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.59 -44.78 78.79 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 54' ' ' GLY . 15.0 m -66.63 -34.32 77.62 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.808 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 46' ' ' ASP . . . -65.7 -38.92 90.56 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.174 0.512 . . . . 0.0 110.685 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -63.55 -33.68 76.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.007 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.0 16.72 21.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.103 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.616 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 19.6 m-20 60.02 35.5 21.47 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.447 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.45 -28.76 1.23 Allowed Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -56.38 91.41 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.918 0.39 . . . . 0.0 110.808 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.439 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 83.9 mt -63.18 -39.05 93.54 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . 104.32 -148.03 16.67 Favored Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.53 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 21.6 m-85 -84.54 130.67 34.72 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.487 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 44.4 p90 -146.65 149.98 34.54 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.989 174.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.82 -170.23 36.98 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -73.76 154.3 39.64 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 122.737 -0.273 . . . . 0.0 110.338 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.19 -33.96 5.6 Favored Glycine 0 C--N 1.313 -0.75 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.041 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -64.42 -41.28 96.69 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.791 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -108.57 160.64 15.76 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.302 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 18.4 m -64.04 152.13 8.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.429 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.519 ' NZ ' ' OD2' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -43.76 -57.55 5.7 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.465 -175.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 38.0 Cg_endo -58.91 -32.19 96.92 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 N-CA-C 110.557 -0.593 . . . . 0.0 110.557 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.608 ' CD2' HD11 ' A' ' 93' ' ' ILE . 27.1 t80 -61.74 -47.57 84.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.513 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -62.84 -45.41 92.74 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.115 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.519 ' OD2' ' NZ ' ' A' ' 66' ' ' LYS . 40.5 m-20 -62.29 -40.28 95.76 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.281 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.57 -41.47 96.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.932 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.682 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -59.04 -49.43 77.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.581 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CE1' HD11 ' A' ' 10' ' ' ILE . 62.6 m-85 -65.17 -38.03 89.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.226 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -64.93 -39.5 93.6 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.744 HD22 ' HB2' ' A' ' 79' ' ' GLU . 44.0 mt -94.02 16.99 13.16 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.148 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.557 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 50.2 mt-30 -55.09 -19.67 7.91 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.958 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.549 HG13 ' HG3' ' A' ' 79' ' ' GLU . 7.2 p -65.24 -27.04 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.646 175.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.498 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 123.81 3.04 8.53 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 121.672 -0.299 . . . . 0.0 112.536 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.744 ' HB2' HD22 ' A' ' 75' ' ' LEU . 47.9 mt-10 -67.24 174.43 3.24 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -110.85 132.29 59.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.576 ' HB3' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -73.32 160.69 31.46 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -174.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.513 ' HA ' HE22 ' A' ' 27' ' ' GLN . 0.7 OUTLIER -70.73 175.84 2.35 Favored Pre-proline 0 N--CA 1.444 -0.733 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.94 134.25 61.17 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 CA-C-N 119.538 0.871 . . . . 0.0 109.868 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.47 126.67 74.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.567 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.9 tptp -97.56 135.58 39.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.25 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.567 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 60.5 p -135.03 169.89 16.74 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.707 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 1.7 pm0 -61.47 -34.02 74.74 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -63.35 -42.35 98.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.506 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.79 -146.17 13.35 Favored Glycine 0 C--N 1.321 -0.297 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.408 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.754 ' O ' HD12 ' A' ' 16' ' ' LEU . 6.4 m-85 -103.52 130.79 50.98 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 122.266 0.226 . . . . 0.0 110.522 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.712 ' CE1' HD13 ' A' ' 16' ' ' LEU . 35.9 m-70 -116.12 144.57 43.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.956 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.01 127.35 75.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 167.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.608 HD11 ' CD2' ' A' ' 68' ' ' PHE . 86.0 mt -120.16 129.49 75.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 122.572 -0.08 . . . . 0.0 110.833 -173.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 63.7 tttp -120.65 159.65 24.89 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.557 ' NE ' ' O ' ' A' ' 76' ' ' GLN . 27.7 ttt-85 -75.84 143.9 41.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.471 HD23 ' HA2' ' A' ' 57' ' ' GLY . 50.6 tp -108.77 142.06 39.87 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.4 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.198 -2.124 0 CA-C-O 118.09 -1.394 . . . . 0.0 112.135 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 39.9 mttm . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.642 HD12 ' CE2' ' A' ' 59' ' ' PHE . 21.1 mt -106.42 128.52 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -172.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.544 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 41.5 mtpt -90.72 104.57 17.14 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.599 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -148.11 167.38 25.14 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -175.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m -124.83 132.98 53.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.206 174.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.479 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.58 149.44 50.16 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.396 -175.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.714 HG23 ' OG ' ' A' ' 44' ' ' SER . 92.6 mt -124.33 125.94 71.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.708 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.617 HD13 ' CE1' ' A' ' 91' ' ' HIS . 51.3 tp -103.67 125.74 50.36 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 90' ' ' TYR . 32.7 m -134.86 155.13 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 121.107 0.479 . . . . 0.0 111.264 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.55 -22.85 34.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.462 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 22' ' ' GLU . 53.4 mmtt -112.14 140.92 46.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.896 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -64.05 -39.5 94.21 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.491 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.67 -35.76 90.24 Favored Glycine 0 N--CA 1.459 0.212 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.625 ' HB3' HD23 ' A' ' 43' ' ' LEU . 89.8 mt-10 -65.26 -42.83 92.88 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.56 -47.04 87.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.089 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.21 -41.93 98.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.955 0.407 . . . . 0.0 110.381 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.31 -50.68 72.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.193 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.935 HG12 HD12 ' A' ' 39' ' ' LEU . 10.7 m -64.7 -41.78 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.777 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.621 HE21 HG22 ' A' ' 92' ' ' VAL . 80.7 mt-30 -58.75 -50.84 72.44 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.145 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -65.78 -37.91 87.59 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.319 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.702 ' HD3' HD11 ' A' ' 39' ' ' LEU . 67.1 ttt180 -63.42 -37.49 87.48 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.316 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.3 mm? -61.56 -40.9 96.37 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 19.8 mmtp -63.32 -34.96 78.83 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.313 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -60.56 -24.24 65.26 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.538 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.52 6.93 26.67 Favored Glycine 0 N--CA 1.463 0.483 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.157 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 6.2 mt-10 -82.77 150.92 26.37 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.236 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -67.25 137.26 56.02 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.704 0.764 . . . . 0.0 112.021 -174.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.572 ' HA ' HD21 ' A' ' 30' ' ' LEU . 54.2 t80 -55.01 -43.0 73.23 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.639 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -59.35 -37.42 91.94 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.263 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.02 -47.82 84.26 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.935 HD12 HG12 ' A' ' 26' ' ' VAL . 4.4 mm? -62.67 -41.93 99.35 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.619 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -62.46 -43.47 98.74 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.053 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -63.3 -41.77 98.99 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -75.1 -82.11 0.07 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -174.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.896 HD22 ' CG1' ' A' ' 26' ' ' VAL . 6.6 mp -64.23 -42.8 96.38 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -170.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.714 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.1 m -56.57 133.43 53.56 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.736 -162.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.469 HG13 HD23 ' A' ' 16' ' ' LEU . 44.3 pt -87.98 -7.47 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.131 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 49' ' ' SER . 54.4 t0 -84.34 94.45 8.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.532 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -59.51 -50.68 65.1 Favored Glycine 0 C--N 1.315 -0.618 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.31 -44.69 93.35 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 39.6 m -62.79 -33.7 75.74 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.467 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -63.43 -36.74 84.72 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 47.4 mmtm -61.8 -33.69 74.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.835 HH21 HD23 ' A' ' 56' ' ' LEU . 76.5 mtm-85 -96.52 6.61 48.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.288 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.639 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 70.7 m-20 65.98 36.76 5.69 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.963 0.411 . . . . 0.0 110.152 -174.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 -20.66 4.75 Favored Glycine 0 C--N 1.317 -0.483 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -54.48 99.13 0.03 OUTLIER 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.374 0.607 . . . . 0.0 111.349 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.835 HD23 HH21 ' A' ' 52' ' ' ARG . 90.1 mt -68.73 -38.72 80.38 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 90.79 -145.17 17.73 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 -172.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.544 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 11.1 m-85 -83.99 132.65 34.73 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.642 ' CE2' HD12 ' A' ' 10' ' ' ILE . 52.3 p90 -142.51 149.39 39.09 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.448 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.95 173.67 28.18 Favored Glycine 0 C--O 1.238 0.36 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -81.63 159.73 23.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.566 0.222 . . . . 0.0 110.937 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.67 -77.15 0.38 Allowed Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -61.73 -39.31 91.1 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.229 0.538 . . . . 0.0 109.873 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.467 ' HG3' ' CD2' ' A' ' 59' ' ' PHE . 41.8 mmm -66.2 147.74 52.88 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.876 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 68' ' ' PHE . 29.9 m -79.07 136.91 22.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.097 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 9.3 mmtm -43.9 -50.24 19.69 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.565 ' HB2' HG13 ' A' ' 84' ' ' VAL . 29.5 Cg_endo -57.55 -36.61 98.59 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 CA-C-N 118.999 0.678 . . . . 0.0 110.797 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.649 ' HA ' HG11 ' A' ' 84' ' ' VAL . 31.8 t80 -63.13 -47.99 80.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.862 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 98.0 mt-10 -64.26 -46.61 82.98 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.288 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 10.9 t70 -57.07 -48.26 78.99 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.236 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.57 96.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.48 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -59.27 -45.83 90.17 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.573 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.489 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 59.1 m-85 -63.16 -36.4 83.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.227 0.537 . . . . 0.0 111.126 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 94.7 mtt-85 -65.03 -22.34 66.97 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.289 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.589 HD11 ' CB ' ' A' ' 81' ' ' SER . 73.0 mt -96.34 9.4 41.31 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.573 ' OE1' ' NH1' ' A' ' 95' ' ' ARG . 15.8 mm100 -43.42 -24.76 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 117.936 0.335 . . . . 0.0 111.75 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.98 -23.38 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.111 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 114.29 3.94 22.42 Favored Glycine 0 N--CA 1.47 0.91 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.473 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -73.91 175.48 7.29 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -172.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.21 131.09 56.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.147 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.589 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -74.34 153.21 39.4 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.161 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.439 ' C ' HE22 ' A' ' 27' ' ' GLN . 2.4 mp0 -68.1 171.3 5.83 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 167.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.544 ' N ' HE22 ' A' ' 27' ' ' GLN . 52.6 Cg_exo -54.51 132.66 52.41 Favored 'Trans proline' 0 C--N 1.289 -2.566 0 C-N-CA 120.399 0.733 . . . . 0.0 111.067 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.649 HG11 ' HA ' ' A' ' 68' ' ' PHE . 60.8 t -109.94 107.29 22.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.545 ' CG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 tmtp? -79.33 134.38 36.61 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.84 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 p -137.95 168.73 19.11 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.638 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -60.46 -34.28 73.78 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -67.25 -38.77 85.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.909 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.49 -154.83 25.85 Favored Glycine 0 C--N 1.314 -0.651 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.545 ' CE2' ' CG ' ' A' ' 85' ' ' LYS . 84.7 m-85 -104.69 126.86 52.19 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.617 ' CE1' HD13 ' A' ' 16' ' ' LEU . 7.7 m-70 -105.06 143.13 33.67 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.641 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.621 HG22 HE21 ' A' ' 27' ' ' GLN . 54.2 t -117.15 125.78 74.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.593 HD11 ' CD2' ' A' ' 68' ' ' PHE . 81.2 mt -115.9 129.41 72.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -110.05 140.81 43.68 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 168.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.573 ' NH1' ' OE1' ' A' ' 76' ' ' GLN . 4.7 tpt180 -77.9 135.32 37.86 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.455 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 53.7 tp -121.7 145.63 47.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.616 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.402 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.211 -1.282 0 CA-C-O 118.342 -1.255 . . . . 0.0 110.859 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.7 mttm . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.94 HG21 ' HB1' ' A' ' 72' ' ' ALA . 21.2 mm -105.86 126.6 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.577 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 56.8 mtpt -88.34 104.08 16.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.1 OUTLIER -148.77 168.31 23.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -175.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.9 m -131.13 146.35 52.31 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.594 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -140.18 150.31 44.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.682 HG23 ' OG ' ' A' ' 44' ' ' SER . 91.3 mt -127.1 128.8 70.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.08 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -101.19 116.61 33.21 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.571 ' N ' HD13 ' A' ' 16' ' ' LEU . 35.8 m -120.83 154.66 24.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.502 0.668 . . . . 0.0 111.29 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -65.9 -40.62 91.68 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.657 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -119.15 148.9 42.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.448 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 48.8 mt-30 -62.4 -40.69 97.32 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.124 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.52 -40.76 94.91 Favored Glycine 0 CA--C 1.511 -0.209 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -63.76 -44.45 93.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' A' ' 92' ' ' VAL . . . -59.11 -48.0 83.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.978 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.11 -41.01 99.28 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.138 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.05 -47.99 81.46 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.729 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.564 HG12 HD12 ' A' ' 39' ' ' LEU . 28.4 m -70.44 -32.89 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 81' ' ' SER . 48.6 tt0 -59.46 -48.18 82.62 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 77.9 mm-40 -71.12 -36.42 72.12 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.118 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.865 ' HD2' HD11 ' A' ' 39' ' ' LEU . 42.4 ttm180 -60.55 -37.94 82.9 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -58.56 -27.15 64.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.252 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.499 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 33.6 mmtp -61.75 -38.73 89.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.12 -24.27 58.09 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.799 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.33 15.38 30.29 Favored Glycine 0 C--N 1.32 -0.356 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -58.9 140.82 54.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.532 ' NZ ' ' OD2' ' A' ' 53' ' ' ASP . 17.0 tptm -56.1 127.38 30.31 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CE2' HG13 ' A' ' 15' ' ' ILE . 61.6 t80 -57.06 -43.52 82.15 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -60.45 -33.8 82.75 Favored Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.836 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 87.2 tttt -59.9 -48.64 80.88 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.865 HD11 ' HD2' ' A' ' 29' ' ' ARG . 4.5 mm? -62.04 -41.94 98.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.435 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.514 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.48 -48.68 76.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.444 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -64.38 -39.66 94.3 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.25 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.584 ' C ' HD13 ' A' ' 43' ' ' LEU . 63.8 mm-40 -70.33 -45.17 66.71 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -171.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.843 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.77 -24.06 4.56 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -177.041 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.682 ' OG ' HG23 ' A' ' 15' ' ' ILE . 3.7 m -50.98 137.82 20.49 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.53 -173.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.54 ' CG1' HD12 ' A' ' 16' ' ' LEU . 39.4 pt -98.69 -5.22 9.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.317 0.579 . . . . 0.0 109.501 172.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.473 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 67.3 t0 -87.82 107.85 18.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.661 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -64.34 -43.64 96.58 Favored Glycine 0 C--N 1.318 -0.428 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.32 -49.46 68.37 Favored Glycine 0 CA--C 1.504 -0.654 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.594 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 16.2 m -60.58 -34.53 74.33 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.798 0.332 . . . . 0.0 110.409 174.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.14 85.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.261 0.553 . . . . 0.0 110.743 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 35.3 mmtp -64.12 -39.45 94.06 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 55' ' ' SER . 80.2 mtp180 -98.09 25.47 6.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.086 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.532 ' OD2' ' NZ ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER 35.94 42.44 0.16 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.781 0.8 . . . . 0.0 112.659 -178.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.38 -15.87 4.17 Favored Glycine 0 C--N 1.315 -0.63 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.474 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ARG . 4.9 m -73.41 77.7 1.39 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.26 0.552 . . . . 0.0 110.796 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.483 HD11 ' CD2' ' A' ' 14' ' ' HIS . 96.2 mt -64.58 -38.44 91.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.153 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.26 -141.67 21.6 Favored Glycine 0 CA--C 1.501 -0.786 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.577 ' CD1' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -85.8 139.99 30.83 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.606 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 55.2 p90 -144.77 152.89 41.04 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.802 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.5 172.66 36.28 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 72.1 mtm-85 -84.69 148.68 26.27 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.017 0.437 . . . . 0.0 111.991 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.81 -56.13 0.48 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.019 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -61.4 -39.42 90.67 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.081 0.467 . . . . 0.0 111.129 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.473 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 76.0 mmm -79.99 153.74 28.69 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.67 -176.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 m -68.4 137.95 23.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.362 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -44.29 -52.5 16.47 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -173.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.527 ' HB2' HG13 ' A' ' 84' ' ' VAL . 31.3 Cg_endo -60.21 -32.44 94.42 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 CA-C-N 118.639 0.55 . . . . 0.0 111.284 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.498 ' CD2' HD11 ' A' ' 93' ' ' ILE . 47.2 t80 -62.19 -47.22 85.46 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.543 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 76.7 mt-10 -63.78 -43.19 97.09 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.817 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -56.25 -49.18 74.91 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.793 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -63.44 -42.72 98.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.859 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.94 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -57.67 -49.09 77.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.27 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 69' ' ' GLU . 32.1 m-85 -63.62 -38.96 93.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -61.64 -33.42 73.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.316 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 ' HB3' ' A' ' 81' ' ' SER . 90.9 mt -89.12 5.71 43.33 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.531 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 15.5 mm100 -42.83 -24.08 0.06 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 118.219 0.463 . . . . 0.0 112.01 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -63.28 -26.22 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 120.798 0.332 . . . . 0.0 111.878 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.517 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 114.19 11.39 12.22 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -85.71 174.42 9.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.78 HG22 ' HD3' ' A' ' 94' ' ' LYS . 11.3 t -95.78 131.46 42.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.878 ' HB3' HD11 ' A' ' 75' ' ' LEU . 28.5 p -72.92 160.89 31.41 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 123.138 0.273 . . . . 0.0 111.71 -172.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.495 ' HA ' HE22 ' A' ' 27' ' ' GLN . 2.9 mt-10 -64.12 168.91 5.29 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 166.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -57.94 136.08 72.89 Favored 'Trans proline' 0 C--N 1.292 -2.422 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.527 HG13 ' HB2' ' A' ' 67' ' ' PRO . 45.2 t -117.52 130.04 73.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HD2' ' CE1' ' A' ' 90' ' ' TYR . 82.9 tttt -110.65 131.75 54.78 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.989 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 p -143.72 -171.58 3.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.972 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.7 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 2.1 pm0 -66.09 -31.81 72.9 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -64.1 -37.92 89.2 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.805 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 16' ' ' LEU . . . 142.85 -139.41 9.0 Favored Glycine 0 C--O 1.242 0.608 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 87.4 m-85 -106.98 126.89 52.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.472 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 2.0 m-70 -105.35 147.28 28.35 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.59 0.233 . . . . 0.0 111.097 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 73.3 t -117.5 126.69 74.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 167.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.498 HD11 ' CD2' ' A' ' 68' ' ' PHE . 91.4 mt -115.37 127.32 72.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.65 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.78 ' HD3' HG22 ' A' ' 80' ' ' VAL . 27.0 tptp -106.22 128.74 54.16 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.531 ' CD ' ' HA ' ' A' ' 76' ' ' GLN . 76.3 ttt-85 -77.65 139.22 39.44 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 118.644 -1.222 . . . . 0.0 109.266 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 50.6 tp -110.08 133.37 53.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.262 -175.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.47 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.573 0 CA-C-O 118.28 -1.289 . . . . 0.0 110.845 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.5 mttp . . . . . 0 CA--C 1.5 -0.964 0 CA-C-O 120.537 0.208 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.74 HG21 ' HB1' ' A' ' 72' ' ' ALA . 42.5 mm -106.02 128.24 60.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.525 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 11.8 mtpp -89.43 107.07 18.86 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.5 167.26 22.92 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.874 -177.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.528 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.4 m -130.6 147.56 52.3 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.122 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.538 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -134.55 149.74 50.68 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.449 -179.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.639 HG23 ' OG ' ' A' ' 44' ' ' SER . 96.1 mt -123.61 128.77 74.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.332 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 45' ' ' ILE . 41.1 tp -103.11 123.5 46.79 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.021 HG12 HD11 ' A' ' 43' ' ' LEU . 16.2 m -124.1 147.9 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 123.657 0.598 . . . . 0.0 111.132 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -66.76 -42.54 86.0 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.403 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.497 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 25.9 mmtp -112.77 151.1 30.7 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -174.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -64.36 -34.89 79.2 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.871 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.22 -37.78 95.1 Favored Glycine 0 CA--C 1.509 -0.317 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.497 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 98.3 mt-10 -64.94 -41.92 95.1 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.54 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -57.75 -46.98 83.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.269 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.09 -42.54 99.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.366 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.07 73.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.677 ' O ' HD23 ' A' ' 30' ' ' LEU . 11.3 m -65.18 -40.7 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.964 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.506 HE21 HG13 ' A' ' 92' ' ' VAL . 74.2 mt-30 -60.08 -47.3 86.43 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.712 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.562 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 57.0 mm-40 -66.48 -37.14 84.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.034 0.445 . . . . 0.0 110.827 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.863 ' HD3' HD11 ' A' ' 39' ' ' LEU . 77.6 ttt180 -61.06 -41.11 96.0 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.417 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.681 HD11 ' HA ' ' A' ' 36' ' ' PHE . 4.1 mm? -60.09 -38.87 84.22 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.512 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 17.5 mmtp -61.04 -34.72 75.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.16 -10.03 37.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.116 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.68 -0.42 39.46 Favored Glycine 0 N--CA 1.462 0.379 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.771 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.652 ' O ' HD13 ' A' ' 30' ' ' LEU . 7.3 mm-40 -65.38 142.52 58.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 29.9 mttm -72.58 141.83 48.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.283 0.564 . . . . 0.0 111.13 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.681 ' HA ' HD11 ' A' ' 30' ' ' LEU . 53.1 t80 -58.67 -45.45 89.36 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -61.02 -34.91 89.72 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.972 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 88.7 tttt -61.04 -47.35 86.77 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.863 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.2 mm? -62.96 -41.11 99.43 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.732 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 44' ' ' SER . . . -60.0 -50.05 75.27 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.85 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.564 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 68.2 mttm -65.85 -45.27 82.77 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.848 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.485 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 86.5 mt-10 -71.99 -44.59 63.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.021 HD11 HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -112.43 -39.11 4.47 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -168.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.713 ' N ' HD13 ' A' ' 43' ' ' LEU . 67.6 m -52.59 135.83 33.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.334 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.621 HG13 HD23 ' A' ' 16' ' ' LEU . 42.5 pt -87.88 -5.75 10.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.543 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -85.97 91.39 8.37 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -61.12 -43.59 99.22 Favored Glycine 0 C--N 1.313 -0.718 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.6 -44.21 78.87 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.3 m -71.8 -33.63 68.71 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.733 175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -65.19 -38.78 91.55 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.787 0.803 . . . . 0.0 109.854 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.33 -37.33 82.89 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.206 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -97.58 20.57 11.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.944 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.564 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 57.75 30.53 19.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.648 177.382 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 70.69 -8.1 4.63 Favored Glycine 0 C--N 1.306 -1.106 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -69.95 85.31 0.51 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.147 0.498 . . . . 0.0 110.58 -178.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.06 -39.86 95.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.826 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 89.46 -143.44 17.28 Favored Glycine 0 CA--C 1.507 -0.428 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.525 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 95.3 m-85 -83.61 132.92 34.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.437 ' CD1' ' HG3' ' A' ' 64' ' ' MET . 44.8 p90 -146.25 150.28 35.49 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.001 170.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.43 178.38 27.68 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.459 ' HB3' ' NH1' ' A' ' 61' ' ' ARG . 8.4 mtm105 -75.38 154.78 37.02 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.59 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.81 -31.94 8.12 Favored Glycine 0 C--N 1.309 -0.957 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -11.14 54.54 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.494 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.437 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 10.0 mmm -125.08 156.61 37.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.94 150.77 6.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.849 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.529 ' NZ ' ' HB2' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -44.42 -54.5 12.03 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 38.0 Cg_endo -61.94 -34.14 81.99 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 120.163 0.575 . . . . 0.0 111.119 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CD2' HD11 ' A' ' 93' ' ' ILE . 38.3 t80 -62.43 -47.87 82.17 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.476 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.63 -39.99 94.68 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.895 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.529 ' HB2' ' NZ ' ' A' ' 66' ' ' LYS . 27.6 t70 -56.03 -51.24 68.48 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.871 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 81' ' ' SER . . . -64.7 -41.64 95.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.74 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -61.15 -50.98 70.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.342 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 10' ' ' ILE . 59.2 m-85 -69.15 -38.45 78.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.773 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -66.61 -40.96 89.05 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 81' ' ' SER . 50.3 mt -98.1 33.46 2.15 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.478 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 71.0 mt-30 -51.24 -24.54 4.49 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.83 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.431 HG13 ' H ' ' A' ' 79' ' ' GLU . 12.1 p -59.83 -31.88 48.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.514 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 123.47 -4.72 9.4 Favored Glycine 0 N--CA 1.469 0.873 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.086 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.431 ' H ' HG13 ' A' ' 77' ' ' VAL . 90.5 mt-10 -60.69 147.33 42.49 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.897 0.379 . . . . 0.0 111.938 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 t -78.59 130.99 35.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.455 ' HA ' HD11 ' A' ' 75' ' ' LEU . 10.5 p -74.3 153.44 39.35 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.659 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.6 mp0 -59.57 164.69 5.04 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.54 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 50.3 Cg_exo -53.67 129.03 31.92 Favored 'Trans proline' 0 C--N 1.292 -2.43 0 N-CA-C 109.865 -0.86 . . . . 0.0 109.865 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.448 HG21 HD12 ' A' ' 93' ' ' ILE . 59.2 t -104.25 113.97 42.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.533 ' NZ ' ' OH ' ' A' ' 90' ' ' TYR . 41.7 tttp -81.85 138.27 35.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 19.3 p -150.6 166.47 30.19 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.44 -32.41 71.35 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.439 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 65.7 m-85 -64.48 -40.4 95.61 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.328 176.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.97 -149.85 21.91 Favored Glycine 0 C--N 1.318 -0.418 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.533 ' OH ' ' NZ ' ' A' ' 85' ' ' LYS . 82.7 m-85 -104.38 127.39 52.04 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.362 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.538 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.9 m-70 -111.35 151.18 28.72 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.224 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.506 HG13 HE21 ' A' ' 27' ' ' GLN . 1.9 t -116.67 114.09 44.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 168.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.512 HD11 ' CD2' ' A' ' 68' ' ' PHE . 75.7 mt -111.4 124.03 67.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.244 -172.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 30.1 tttp -114.56 139.01 49.94 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.514 172.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.478 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 1.4 tmm_? -78.9 141.58 37.5 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.398 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.421 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 50.2 tp -109.45 124.06 50.4 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.055 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.204 -1.725 0 CA-C-O 118.296 -1.28 . . . . 0.0 110.248 -177.366 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.715 HD11 ' CE2' ' A' ' 73' ' ' PHE . 68.0 mt -104.72 126.32 59.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.517 ' NZ ' ' HA2' ' A' ' 97' ' ' GLY . 7.8 mtpm? -94.85 104.42 16.32 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.564 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -144.48 171.86 13.77 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -171.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.9 m -131.4 146.07 52.1 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.305 174.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.449 ' CG ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.15 150.96 44.88 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.59 HG23 ' OG ' ' A' ' 44' ' ' SER . 61.8 mt -121.99 126.77 74.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.288 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.637 HD13 ' CE1' ' A' ' 91' ' ' HIS . 50.5 tp -101.85 122.37 43.86 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.53 HG13 HG22 ' A' ' 15' ' ' ILE . 34.8 m -130.39 155.02 41.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.418 0.628 . . . . 0.0 111.106 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HG3' HG21 ' A' ' 45' ' ' ILE . 10.5 mtpt -66.38 -41.74 88.97 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.704 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 27.8 mtpp -118.81 151.6 37.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.447 -172.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -60.9 -37.23 81.52 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.29 -39.94 97.92 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 88.8 mt-10 -63.84 -46.02 86.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.579 ' HB1' ' CG2' ' A' ' 92' ' ' VAL . . . -60.0 -49.37 77.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.443 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 24' ' ' LEU . 97.2 mt -63.72 -41.05 98.14 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.789 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.51 -49.35 75.0 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.885 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.586 HG12 HD12 ' A' ' 39' ' ' LEU . 9.4 m -68.21 -40.57 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.406 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.517 HE21 ' C ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -56.05 -42.81 77.18 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.079 -179.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 51.9 mm-40 -71.71 -35.03 70.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.183 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.457 ' HG3' ' HG3' ' A' ' 34' ' ' GLU . 12.3 ttm180 -62.07 -37.32 84.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.311 176.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.563 HD23 ' O ' ' A' ' 26' ' ' VAL . 4.3 mm? -60.57 -36.25 78.05 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.871 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 28.4 mmtm -59.98 -36.65 77.62 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.68 -10.44 36.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.894 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.64 62.62 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 12.2 mm-40 -62.3 147.04 49.39 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 74.4 tttt -63.01 128.64 36.81 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.421 ' HA ' HD11 ' A' ' 30' ' ' LEU . 53.6 t80 -58.11 -45.16 87.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.592 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -58.25 -39.48 92.55 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.783 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 49.2 tttp -59.46 -45.72 90.81 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.586 HD12 HG12 ' A' ' 26' ' ' VAL . 4.2 mm? -61.66 -42.15 98.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.583 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.486 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.89 -49.84 74.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.324 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 31.8 mttp -64.64 -40.45 95.47 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -71.46 -47.02 58.3 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.748 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.69 -13.14 7.54 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.59 ' OG ' HG23 ' A' ' 15' ' ' ILE . 4.0 m -58.35 138.59 56.37 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.047 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.56 HG13 HD23 ' A' ' 16' ' ' LEU . 44.3 pt -90.65 -4.12 10.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -89.24 101.91 14.57 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.787 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.28 -45.3 96.77 Favored Glycine 0 C--N 1.317 -0.484 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.33 -43.38 89.73 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 54' ' ' GLY . 63.6 m -63.49 -34.79 78.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.822 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -64.76 -39.25 93.31 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.172 0.511 . . . . 0.0 109.973 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -64.37 -40.34 95.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.559 0.695 . . . . 0.0 109.248 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 84.0 mtp180 -97.27 10.3 39.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.051 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.592 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 21.3 m-20 57.68 29.86 17.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 71.67 0.85 42.72 Favored Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 1.3 m -68.45 83.07 0.26 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.119 0.485 . . . . 0.0 110.899 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.564 HD12 ' SG ' ' A' ' 12' ' ' CYS . 90.0 mt -63.4 -39.7 95.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.541 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 86.81 -149.08 22.1 Favored Glycine 0 C--N 1.318 -0.44 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.95 129.3 34.93 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.584 ' CE1' ' HG3' ' A' ' 64' ' ' MET . 45.8 p90 -146.14 149.47 34.07 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.677 0.275 . . . . 0.0 110.767 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.86 -179.46 38.86 Favored Glycine 0 C--N 1.315 -0.636 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -78.27 153.28 31.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.433 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.41 -34.54 5.21 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.19 -36.85 85.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.051 0.453 . . . . 0.0 110.475 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.584 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 3.5 mmm -110.82 154.18 24.34 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.258 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 27.4 m -64.91 141.13 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.596 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.4 mtpm? -44.2 -48.81 24.06 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -172.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 30.4 Cg_endo -60.66 -32.2 92.95 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 CA-C-N 119.059 0.7 . . . . 0.0 111.264 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.659 ' CD2' HD11 ' A' ' 93' ' ' ILE . 37.9 t80 -61.85 -46.94 87.29 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.463 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 99.7 mt-10 -61.49 -45.31 94.76 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.465 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.43 ' OD2' ' NH2' ' A' ' 74' ' ' ARG . 13.0 t70 -56.93 -50.33 72.9 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.408 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.05 93.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.046 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.586 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -61.77 -46.66 88.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.806 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.715 ' CE2' HD11 ' A' ' 10' ' ' ILE . 52.9 m-85 -66.31 -40.43 89.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.464 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 74' ' ' ARG . 50.9 mtm180 -64.07 -42.14 97.1 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.7 mt -97.95 31.77 2.59 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.513 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 48.6 mt-30 -55.81 -18.15 7.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.262 0.553 . . . . 0.0 109.943 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 79' ' ' GLU . 3.2 p -58.1 -29.16 36.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.037 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.405 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 118.78 -3.01 15.03 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' H ' HG13 ' A' ' 77' ' ' VAL . 79.9 mm-40 -69.51 161.21 29.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.887 0.375 . . . . 0.0 111.17 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.55 127.66 42.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.517 ' C ' HE21 ' A' ' 27' ' ' GLN . 10.5 p -77.53 159.28 29.43 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.265 0.555 . . . . 0.0 112.206 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -69.6 168.39 17.36 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.554 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 51.4 Cg_exo -56.38 135.18 68.78 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 N-CA-C 110.136 -0.756 . . . . 0.0 110.136 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 40.4 t -116.49 126.82 74.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HD3' ' CZ ' ' A' ' 90' ' ' TYR . 9.8 tptm -85.06 131.3 34.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.074 -177.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.8 p -135.53 170.07 16.53 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -56.26 -37.51 69.88 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -64.11 -43.82 94.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.152 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.04 -140.06 7.0 Favored Glycine 0 N--CA 1.465 0.601 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.58 ' O ' HD12 ' A' ' 16' ' ' LEU . 43.9 m-85 -106.28 130.88 54.05 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.637 ' CE1' HD13 ' A' ' 16' ' ' LEU . 6.8 m-70 -110.45 146.27 36.2 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.124 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.579 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 67.4 t -117.54 127.51 74.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.659 HD11 ' CD2' ' A' ' 68' ' ' PHE . 82.8 mt -119.71 128.08 75.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.984 -173.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.405 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 64.5 tttp -120.13 141.26 50.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -79.1 143.84 35.14 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.941 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 52.2 tp -112.64 131.14 55.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.486 0.66 . . . . 0.0 110.216 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.517 ' HA2' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--N 1.293 -1.82 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 mttp . . . . . 0 N--CA 1.443 -0.798 0 CA-C-O 120.761 0.315 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.854 HG21 ' HB1' ' A' ' 72' ' ' ALA . 61.1 mt -111.46 131.49 62.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.521 ' NZ ' ' OXT' ' A' ' 97' ' ' GLY . 46.3 mtpt -91.29 107.16 19.02 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' SG ' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -147.59 167.02 25.6 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.908 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.454 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 14.1 m -135.02 149.9 50.22 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.432 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.418 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -139.08 149.9 45.11 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 119.512 -0.875 . . . . 0.0 113.112 -177.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.735 HG23 ' HB3' ' A' ' 44' ' ' SER . 96.5 mt -124.11 123.34 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.608 HD12 ' O ' ' A' ' 90' ' ' TYR . 48.0 tp -94.41 127.2 40.16 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 90' ' ' TYR . 29.0 m -129.89 150.64 34.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.129 0.49 . . . . 0.0 110.588 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -66.14 -40.64 90.77 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.296 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -121.17 152.32 38.9 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -172.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.43 ' HG3' ' CG ' ' A' ' 83' ' ' PRO . 59.9 tt0 -62.06 -41.15 97.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.665 178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.09 95.67 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.97 -42.09 98.75 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.589 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -60.13 -41.37 92.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.742 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.64 -42.46 99.61 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.029 0.442 . . . . 0.0 110.412 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.69 79.61 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.887 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 92' ' ' VAL . 31.1 m -64.42 -40.75 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.926 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 81.0 mt-30 -59.5 -47.05 87.02 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.275 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -64.3 -44.49 91.45 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.569 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 71.4 ttt180 -65.58 -39.3 91.48 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.69 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.884 HD22 HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -56.61 -28.92 61.5 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -177.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 69.0 mmtt -62.9 -30.12 71.29 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.79 -22.17 45.76 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.533 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.84 13.39 56.67 Favored Glycine 0 C--O 1.236 0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.135 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.569 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 73.9 mt-10 -66.31 154.46 39.93 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -60.19 126.71 28.56 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 66.0 t80 -59.11 -44.95 92.01 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -60.87 -37.77 94.25 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.472 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 60.1 tttm -60.23 -46.46 89.69 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.884 HD12 HD22 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.9 -36.91 80.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.932 178.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . -56.04 -50.86 69.76 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.501 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.46 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 45.4 mttp -62.76 -37.81 88.09 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 80.3 mm-40 -69.82 -46.65 65.19 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.422 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.564 HD22 ' CG1' ' A' ' 26' ' ' VAL . 1.7 mp -114.45 -41.44 3.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.735 ' HB3' HG23 ' A' ' 15' ' ' ILE . 6.6 p -54.99 138.11 44.52 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.481 -168.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.527 HG13 HD23 ' A' ' 16' ' ' LEU . 46.3 pt -97.85 -5.03 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.134 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -84.45 93.09 8.22 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.19 -45.53 96.33 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.2 -44.91 74.76 Favored Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.434 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 73.9 m -70.74 -34.08 71.49 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.604 175.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -63.69 -25.32 68.16 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.886 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 30.6 mmtp -63.14 -36.97 85.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 8.3 mtm-85 -96.77 15.47 21.87 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.165 174.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.582 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 22.6 m-20 58.94 29.48 18.98 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.72 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 49' ' ' SER . . . 77.89 -5.15 54.78 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -73.95 84.06 1.73 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.501 0.667 . . . . 0.0 110.186 178.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 96.4 mt -62.91 -39.75 95.49 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.153 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.433 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . 87.38 -142.92 18.35 Favored Glycine 0 CA--C 1.503 -0.667 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.511 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 19.8 m-85 -83.9 132.91 34.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.529 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 46.9 p90 -145.07 152.02 39.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.89 165.54 26.94 Favored Glycine 0 C--N 1.316 -0.53 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.496 ' HD2' ' CZ ' ' A' ' 73' ' ' PHE . 60.0 mtp180 -77.32 157.96 30.42 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.496 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 129.11 -77.03 0.4 Allowed Glycine 0 N--CA 1.462 0.394 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -61.21 -38.01 85.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.393 0.615 . . . . 0.0 109.623 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.569 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 75.6 mmm -63.84 145.8 55.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.213 -176.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG23 ' H ' ' A' ' 68' ' ' PHE . 13.3 m -73.71 130.66 35.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.657 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 64' ' ' MET . 5.7 mmtm -45.05 -40.35 10.56 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.118 -174.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 32.8 Cg_exo -56.09 -41.57 75.47 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 120.445 0.763 . . . . 0.0 110.434 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.593 ' CD2' HD11 ' A' ' 93' ' ' ILE . 23.0 t80 -62.84 -47.1 84.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.598 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.439 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 96.4 mt-10 -62.13 -43.2 99.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.59 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.03 -51.36 69.58 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.793 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -63.25 -40.21 96.79 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.278 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.854 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -58.94 -47.6 84.5 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.492 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.722 ' CE2' HD11 ' A' ' 10' ' ' ILE . 55.7 m-85 -66.62 -37.03 84.0 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.558 HH12 ' CD ' ' A' ' 82' ' ' GLU . 49.3 mtm180 -63.6 -35.92 82.12 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.563 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.64 HD11 ' CA ' ' A' ' 81' ' ' SER . 74.5 mt -97.24 21.38 10.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -171.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.509 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 70.0 mt-30 -52.27 -24.99 8.28 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.893 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 p -61.31 -26.51 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.647 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.433 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 115.17 5.43 19.64 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' A' ' 75' ' ' LEU . 1.8 mm-40 -75.6 173.85 10.49 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 t -104.22 127.5 58.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.584 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.64 ' CA ' HD11 ' A' ' 75' ' ' LEU . 60.0 p -68.14 151.02 47.63 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.558 ' CD ' HH12 ' A' ' 74' ' ' ARG . 1.2 mp0 -63.86 164.03 19.17 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 167.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 16.9 Cg_exo -54.32 128.29 29.42 Favored 'Trans proline' 0 C--N 1.29 -2.521 0 N-CA-C 109.71 -0.919 . . . . 0.0 109.71 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 91' ' ' HIS . 15.5 t -98.32 117.51 43.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -77.45 136.87 38.41 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.086 0.47 . . . . 0.0 110.844 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 10.3 p -153.89 167.35 30.01 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -57.02 -31.29 64.98 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.459 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 68.3 m-85 -63.58 -42.8 98.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.676 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.43 -132.81 4.45 Favored Glycine 0 C--O 1.239 0.426 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.608 ' O ' HD12 ' A' ' 16' ' ' LEU . 86.9 m-85 -107.42 127.66 53.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.545 ' O ' HG23 ' A' ' 84' ' ' VAL . 5.1 m-70 -108.03 140.71 40.8 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.889 172.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 26' ' ' VAL . 2.4 t -112.98 115.88 51.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 171.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.593 HD11 ' CD2' ' A' ' 68' ' ' PHE . 85.4 mt -111.82 125.34 69.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.854 -171.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 63.6 tttp -113.1 139.74 48.46 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 171.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 3.2 tmm_? -78.87 141.78 37.37 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.238 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.505 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 58.6 tp -109.91 134.41 52.11 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.167 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.521 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.204 -1.735 0 CA-C-O 118.126 -1.374 . . . . 0.0 110.63 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 mttm . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.825 HD11 ' CE2' ' A' ' 73' ' ' PHE . 39.8 mm -105.49 129.45 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.535 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 36.0 mtpt -88.98 104.32 16.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 176.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.53 170.36 16.2 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.815 -176.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.6 m -128.29 137.69 52.08 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 114.319 -1.31 . . . . 0.0 107.743 175.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.416 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -133.49 149.6 51.72 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.994 -0.682 . . . . 0.0 112.459 -178.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.505 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 90.0 mt -122.94 124.84 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.607 HD13 ' CE1' ' A' ' 91' ' ' HIS . 41.6 tp -104.85 123.54 47.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 43' ' ' LEU . 3.0 m -131.79 154.29 40.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.25 0.547 . . . . 0.0 111.556 -176.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -70.43 -40.38 73.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.818 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.61 144.49 37.88 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -169.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.488 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 27.4 mt-30 -62.78 -39.35 93.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.614 175.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.25 -38.86 95.21 Favored Glycine 0 CA--C 1.509 -0.307 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -64.99 -44.5 89.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.223 0.535 . . . . 0.0 109.77 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -60.71 -48.46 81.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.423 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.546 ' HA ' ' HB2' ' A' ' 27' ' ' GLN . 91.4 mt -64.32 -40.06 95.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.13 -49.17 74.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.35 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.708 HG12 HD12 ' A' ' 39' ' ' LEU . 21.1 m -64.93 -38.05 81.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.944 176.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.645 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 2.2 mm-40 -54.23 -48.16 71.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.428 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -70.67 -43.44 69.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.251 0.548 . . . . 0.0 110.766 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.776 ' HD3' HD11 ' A' ' 39' ' ' LEU . 65.0 ttt180 -61.63 -39.43 91.28 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.001 -174.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -60.75 -34.29 74.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.153 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.645 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 23.9 mmtm -62.97 -34.12 76.84 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.82 -23.62 63.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.425 176.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.09 1.45 54.68 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.103 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.46 ' OE1' ' NE ' ' A' ' 29' ' ' ARG . 55.1 mt-10 -65.58 155.78 34.74 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.35 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -61.62 126.58 27.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.082 -172.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.505 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 61.8 t80 -58.18 -45.24 87.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 174.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.41 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -60.09 -39.16 95.41 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.385 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -60.7 -43.58 97.63 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.031 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.776 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.4 mm? -63.48 -40.96 98.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.697 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.445 ' CB ' ' C ' ' A' ' 53' ' ' ASP . . . -60.68 -43.32 97.83 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 31.6 mmtt -64.56 -36.46 84.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -70.44 -59.34 2.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.075 -172.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.483 ' HB3' HG12 ' A' ' 17' ' ' VAL . 1.8 mt -93.42 -57.4 2.61 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.5 m -29.47 120.02 0.15 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.956 -1.474 . . . . 0.0 113.493 -165.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.408 HG13 HD23 ' A' ' 16' ' ' LEU . 41.5 pt -82.34 -12.0 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -82.16 95.08 7.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.8 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.05 -42.84 99.75 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.04 -45.36 81.95 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.1 m -69.16 -32.6 72.04 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.574 0.226 . . . . 0.0 110.724 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.424 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -63.12 -37.35 86.85 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.041 0.448 . . . . 0.0 109.999 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -63.73 -27.69 69.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.897 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 55' ' ' SER . 68.7 mtt-85 -95.94 5.61 50.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.081 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.467 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER 58.06 33.0 22.72 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 79.65 -16.85 9.7 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -66.15 81.38 0.08 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.61 0.719 . . . . 0.0 110.932 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.6 mt -61.87 -41.07 97.42 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.417 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 91.19 -137.38 13.81 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.535 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 71.2 m-85 -84.16 137.82 33.32 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.0 p90 -146.66 148.29 31.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.872 0.367 . . . . 0.0 111.197 169.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.0 169.53 23.04 Favored Glycine 0 C--N 1.313 -0.715 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -80.38 156.32 26.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.673 0.273 . . . . 0.0 110.551 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.48 -52.27 0.75 Allowed Glycine 0 C--N 1.31 -0.862 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -60.93 -45.0 96.43 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.144 0.497 . . . . 0.0 110.387 174.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.6 mmm -88.25 148.09 24.51 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.659 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.445 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.2 m -68.51 139.15 21.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' NZ ' ' OE1' ' A' ' 69' ' ' GLU . 11.2 mmtm -44.36 -40.97 9.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.53 -44.7 45.85 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 N-CA-C 110.37 -0.665 . . . . 0.0 110.37 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.615 ' CD2' HD11 ' A' ' 93' ' ' ILE . 41.0 t80 -62.6 -46.29 88.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.407 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.42 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 99.3 mt-10 -62.21 -45.9 91.31 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.871 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 38.3 t70 -59.12 -45.99 89.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.099 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.701 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -60.77 -46.56 90.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.245 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.575 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -62.03 -49.25 76.78 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.825 ' CE2' HD11 ' A' ' 10' ' ' ILE . 55.2 m-85 -67.16 -38.16 85.01 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 51.8 mtp180 -61.52 -47.08 87.23 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.333 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 81' ' ' SER . 42.7 mt -100.28 34.58 2.32 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.537 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 49.4 mt-30 -53.52 -20.17 4.6 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.817 0.341 . . . . 0.0 110.845 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.73 -26.55 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.492 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 113.93 6.13 21.17 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -78.39 153.68 31.36 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.41 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 16.6 t -75.2 130.78 35.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.566 ' C ' HE21 ' A' ' 27' ' ' GLN . 89.4 p -72.2 154.17 41.18 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.359 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -63.5 165.19 12.29 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -56.1 131.3 45.05 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 N-CA-C 109.513 -0.995 . . . . 0.0 109.513 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 42.0 t -105.86 109.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -80.48 134.12 35.93 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB2' HG21 ' A' ' 65' ' ' VAL . 8.6 p -153.18 168.49 25.78 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -60.6 -29.96 69.53 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.413 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 56.2 m-85 -66.79 -38.79 87.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.479 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.03 -150.28 22.5 Favored Glycine 0 C--N 1.316 -0.579 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.488 ' CE1' ' HG2' ' A' ' 20' ' ' GLN . 58.5 m-85 -101.95 125.96 48.75 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.607 ' CE1' HD13 ' A' ' 16' ' ' LEU . 3.3 m-70 -107.21 144.68 33.62 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.288 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.536 HG21 ' CG2' ' A' ' 26' ' ' VAL . 48.3 t -117.75 126.43 74.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 168.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.701 HD12 ' HB3' ' A' ' 71' ' ' ALA . 98.8 mt -117.64 129.33 74.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.804 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -119.68 140.67 50.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.537 ' HG3' ' HA ' ' A' ' 76' ' ' GLN . 2.5 tmm_? -78.85 143.96 35.47 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.997 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.425 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 57.2 tp -113.05 140.67 47.65 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.917 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.556 0 CA-C-O 118.267 -1.296 . . . . 0.0 110.571 -179.435 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.521 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -107.38 128.1 62.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' NZ ' ' OXT' ' A' ' 97' ' ' GLY . 62.3 mtpt -93.72 104.6 16.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -149.13 169.21 21.21 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.719 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.486 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 48.1 m -132.78 147.34 52.31 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.58 175.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.49 ' HB2' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -130.39 150.91 51.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -177.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.62 HG23 ' HB3' ' A' ' 44' ' ' SER . 96.2 mt -127.82 124.4 62.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.521 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 90' ' ' TYR . 37.4 tp -90.84 129.09 36.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.943 HG12 HD11 ' A' ' 43' ' ' LEU . 29.0 m -128.04 143.1 41.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 O-C-N 123.577 0.548 . . . . 0.0 110.834 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.691 ' HG3' HD13 ' A' ' 45' ' ' ILE . 1.6 mtpp -65.6 -42.41 91.66 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.191 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -126.38 151.97 46.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.681 -169.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -60.25 -35.08 74.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.722 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.09 -38.3 94.13 Favored Glycine 0 C--N 1.321 -0.265 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.61 -41.7 92.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -58.66 -47.4 84.57 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.135 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.68 -41.93 99.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.168 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.02 72.67 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.726 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.494 ' CG2' HG21 ' A' ' 92' ' ' VAL . 29.1 m -65.17 -39.78 86.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.101 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.537 ' O ' ' NZ ' ' A' ' 31' ' ' LYS . 4.6 mm-40 -58.69 -47.8 83.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.958 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -65.71 -46.46 78.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.502 0.668 . . . . 0.0 110.097 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.824 ' HD3' HD11 ' A' ' 39' ' ' LEU . 72.8 ttt180 -63.65 -40.83 97.86 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.886 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -56.63 -32.64 65.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -177.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 27' ' ' GLN . 29.6 mmtm -63.41 -13.05 35.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.466 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.16 -14.08 60.52 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.57 -1.92 60.37 Favored Glycine 0 C--O 1.243 0.667 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.58 148.72 32.42 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.322 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -71.78 142.19 49.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.958 0.885 . . . . 0.0 112.593 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.554 ' CE2' HG13 ' A' ' 15' ' ' ILE . 57.1 t80 -56.97 -45.04 83.16 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.116 -177.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.07 -37.5 94.01 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.69 -46.36 90.03 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.824 HD11 ' HD3' ' A' ' 29' ' ' ARG . 3.0 mm? -61.62 -39.64 91.98 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.291 173.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.546 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . -58.77 -50.99 71.88 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.317 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.491 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 62.3 mttm -61.15 -42.56 98.77 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.106 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.523 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 70.7 mt-10 -70.23 -41.37 73.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -173.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.943 HD11 HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -123.64 -28.53 3.86 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.663 ' N ' HD13 ' A' ' 43' ' ' LEU . 10.1 p -59.92 135.54 57.73 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.681 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.691 HD13 ' HG3' ' A' ' 18' ' ' LYS . 47.0 pt -105.26 -6.78 9.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.293 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.462 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 59.0 t0 -83.85 97.2 9.07 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -55.98 -46.09 85.2 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -43.85 -56.37 5.13 Favored Glycine 0 C--O 1.237 0.313 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.564 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . 1.5 p -71.04 -32.92 69.8 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -60.28 -34.44 73.75 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.147 0.498 . . . . 0.0 109.904 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 99.4 mttt -58.74 -36.01 73.63 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 177.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' O ' ' OG ' ' A' ' 55' ' ' SER . 61.1 mtp85 -98.3 7.57 46.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.396 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.491 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 79.9 m-20 58.71 31.76 21.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -173.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 49' ' ' SER . . . 75.85 -6.68 31.99 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 1.1 m -66.59 72.86 0.09 Allowed 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.434 0.635 . . . . 0.0 110.913 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 54' ' ' GLY . 94.5 mt -63.69 -40.33 96.53 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.593 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.59 -145.04 22.6 Favored Glycine 0 N--CA 1.464 0.54 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.95 129.08 34.93 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.585 ' CE1' ' HG3' ' A' ' 64' ' ' MET . 55.4 p90 -141.0 153.7 45.68 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.465 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.54 169.98 32.03 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.5 mtm105 -78.02 148.92 34.13 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 120.883 0.373 . . . . 0.0 111.004 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.16 -32.78 6.91 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -64.5 -37.35 87.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.842 0.353 . . . . 0.0 110.776 175.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 2.8 mmm -101.94 160.04 14.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.369 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 86' ' ' SER . 30.4 m -75.07 153.66 6.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -44.3 -50.0 22.82 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.99 -41.28 80.4 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 120.962 1.108 . . . . 0.0 110.828 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -62.36 -47.78 82.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.777 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.66 -38.68 91.83 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.227 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.06 -51.27 66.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.998 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 84' ' ' VAL . . . -65.2 -41.49 94.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.196 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.83 78.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 -177.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -67.46 -35.47 79.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 0.0 111.258 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.508 HH21 ' CD ' ' A' ' 82' ' ' GLU . 43.9 mtp180 -60.38 -39.18 86.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.155 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.615 HD11 ' CB ' ' A' ' 81' ' ' SER . 44.8 mt -96.87 17.11 17.48 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.496 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 82.4 mt-30 -54.08 -22.46 10.9 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 117.943 -1.503 . . . . 0.0 110.842 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -59.4 -27.31 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.113 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 121.51 -2.17 11.24 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.499 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -75.44 174.26 9.85 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -173.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.4 t -96.89 133.41 38.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.325 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.615 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -68.36 152.74 44.99 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.193 -178.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' CD ' HH21 ' A' ' 74' ' ' ARG . 2.8 mp0 -65.16 177.25 0.66 Allowed Pre-proline 0 N--CA 1.427 -1.587 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 167.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -56.54 134.55 65.09 Favored 'Trans proline' 0 C--N 1.287 -2.694 0 N-CA-C 109.765 -0.898 . . . . 0.0 109.765 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' ' 71' ' ' ALA . 50.5 t -120.95 129.59 75.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -109.3 132.38 54.18 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.064 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.576 ' HB2' HG21 ' A' ' 65' ' ' VAL . 66.5 p -115.0 -171.25 1.91 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.107 171.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -67.04 -35.04 79.02 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 172.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 8.6 m-30 -63.36 -44.39 94.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.635 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.34 -143.82 9.96 Favored Glycine 0 C--N 1.321 -0.261 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.586 ' O ' HD12 ' A' ' 16' ' ' LEU . 28.1 m-85 -102.14 134.28 45.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.943 0.401 . . . . 0.0 111.987 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.479 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 16.9 m-70 -118.4 150.1 40.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.023 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.494 HG21 ' CG2' ' A' ' 26' ' ' VAL . 75.8 t -117.51 125.7 74.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 164.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.496 ' O ' ' CD1' ' A' ' 75' ' ' LEU . 89.1 mt -123.55 131.86 72.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -171.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.492 ' HG2' ' N ' ' A' ' 95' ' ' ARG . 43.4 tttm -123.53 152.32 41.91 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.592 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 79.1 ttt180 -77.35 137.77 38.94 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 11' ' ' LYS . 53.7 tp -119.91 130.47 54.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.522 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.572 0 CA-C-O 118.769 -1.017 . . . . 0.0 112.188 -174.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 mttp . . . . . 0 N--CA 1.441 -0.9 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.804 HD12 ' CE2' ' A' ' 59' ' ' PHE . 58.4 mt -104.96 127.11 59.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -173.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.551 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 62.5 mtpt -91.94 106.05 18.16 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.442 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -146.54 164.79 31.44 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.914 -175.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.8 m -127.51 135.67 50.68 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.079 -1.418 . . . . 0.0 108.354 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.5 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -130.61 149.23 52.37 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.698 -177.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.66 HG23 ' OG ' ' A' ' 44' ' ' SER . 95.9 mt -128.44 127.72 67.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.142 176.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.636 HD23 HG13 ' A' ' 45' ' ' ILE . 41.4 tp -98.68 123.96 43.2 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.501 HG12 HD13 ' A' ' 43' ' ' LEU . 29.8 m -127.93 154.71 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.665 0.745 . . . . 0.0 111.052 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 6.7 mtmp? -65.75 -41.89 91.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.742 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 67.9 mttm -123.51 154.06 39.69 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.526 -167.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' A' ' 83' ' ' PRO . 58.2 tt0 -60.47 -40.84 92.7 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.032 175.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.44 -39.53 97.42 Favored Glycine 0 CA--C 1.508 -0.345 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 98.3 mt-10 -63.85 -42.78 97.5 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.649 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -61.73 -42.89 99.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.364 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.27 -41.61 99.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.851 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.67 -45.5 81.65 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.867 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.932 ' CG1' HD21 ' A' ' 43' ' ' LEU . 21.0 m -70.82 -36.27 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.461 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.436 HE22 ' HG3' ' A' ' 82' ' ' GLU . 51.7 tt0 -58.49 -45.78 88.01 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.71 -41.01 88.65 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.503 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.613 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 15.9 tpt180 -59.94 -40.84 90.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.818 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.474 HD11 ' CA ' ' A' ' 36' ' ' PHE . 1.4 mm? -61.7 -41.44 97.59 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.047 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 25.5 mmtp -67.72 -11.75 59.02 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.723 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -75.56 -11.17 59.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 174.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.1 10.84 63.88 Favored Glycine 0 C--O 1.238 0.372 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 91.2 mt-10 -86.15 155.86 20.59 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 57.0 mttm -67.37 139.02 57.16 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.381 0.61 . . . . 0.0 112.58 -175.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CE2' HG13 ' A' ' 15' ' ' ILE . 52.7 t80 -58.42 -45.84 87.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.056 174.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 53' ' ' ASP . . . -62.21 -35.07 91.02 Favored Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.53 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 49.1 tttm -60.65 -48.87 79.84 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.763 HD12 HG12 ' A' ' 26' ' ' VAL . 4.1 mm? -62.79 -41.57 99.33 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.064 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.504 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.49 -50.49 73.56 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.685 -176.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.557 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 67.8 mttm -65.23 -40.13 93.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.943 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.533 ' OE2' ' NZ ' ' A' ' 38' ' ' LYS . 95.8 mt-10 -71.0 -44.42 65.95 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -172.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.932 HD21 ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -124.51 -19.35 5.45 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -174.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.811 ' N ' HD12 ' A' ' 43' ' ' LEU . 1.7 m -55.73 140.21 42.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.38 -173.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.636 HG13 HD23 ' A' ' 16' ' ' LEU . 39.8 pt -86.03 -11.65 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.516 0.674 . . . . 0.0 109.227 176.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -88.2 115.17 25.49 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.068 173.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.24 -32.88 77.99 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 52' ' ' ARG . . . -55.57 -42.83 85.36 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 177.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 54' ' ' GLY . 41.2 m -61.27 -35.44 77.29 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.538 176.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . . . -73.64 -43.23 60.07 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.474 0.654 . . . . 0.0 110.525 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -66.29 -39.71 89.56 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.905 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 55' ' ' SER . 21.5 mmm180 -96.05 4.25 52.75 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.425 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.557 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 53.09 35.41 19.58 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -173.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 76.68 -36.85 1.41 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.461 -173.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -54.27 89.36 0.01 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.547 0.739 . . . . 0.0 112.041 -178.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.442 HD12 ' SG ' ' A' ' 12' ' ' CYS . 93.0 mt -63.65 -40.3 96.5 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.238 176.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 97.27 -147.45 18.66 Favored Glycine 0 CA--C 1.503 -0.693 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.551 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 4.8 m-85 -83.71 132.48 34.85 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.804 ' CE2' HD12 ' A' ' 10' ' ' ILE . 54.7 p90 -146.56 150.65 35.93 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.807 173.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.478 ' H ' ' HD3' ' A' ' 63' ' ' LYS . . . -95.99 -168.0 34.72 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 61' ' ' ARG . 53.7 mtp85 -85.31 148.83 25.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.607 0.241 . . . . 0.0 110.876 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 91.82 -17.53 56.25 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 116.44 -0.346 . . . . 0.0 112.345 176.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 60' ' ' GLY . 1.4 mptp? -67.37 -37.88 83.86 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.181 0.515 . . . . 0.0 111.781 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.552 ' CE ' ' CD2' ' A' ' 59' ' ' PHE . 3.5 mpp? -118.43 161.73 19.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.322 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 68' ' ' PHE . 19.8 m -58.01 136.64 21.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HZ2' ' HB2' ' A' ' 70' ' ' ASP . 8.0 tmtm? -44.76 -42.88 16.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -173.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.37 -43.42 58.84 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 CA-C-N 118.894 0.641 . . . . 0.0 110.608 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.432 ' CD1' HD11 ' A' ' 93' ' ' ILE . 67.8 t80 -63.09 -50.81 69.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.804 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 97.2 mt-10 -67.05 -41.15 87.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.501 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 66' ' ' LYS . 22.7 t70 -59.01 -44.3 91.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.957 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.31 84.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.493 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.05 89.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.48 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.624 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 46.6 m-85 -62.52 -29.74 70.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.637 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -65.3 -37.16 86.27 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.625 HD11 ' CA ' ' A' ' 81' ' ' SER . 76.8 mt -95.75 21.52 8.36 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -168.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.533 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 71.9 mt-30 -45.26 -24.98 0.32 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.469 0.176 . . . . 0.0 111.031 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.93 -31.24 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.607 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 123.02 0.42 9.71 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.387 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.546 ' HB3' HD22 ' A' ' 75' ' ' LEU . 1.1 mm-40 -68.14 174.46 3.86 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.34 129.67 62.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.625 ' CA ' HD11 ' A' ' 75' ' ' LEU . 82.5 p -64.47 155.41 32.82 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.113 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.436 ' HG3' HE22 ' A' ' 27' ' ' GLN . 0.9 OUTLIER -72.16 169.46 16.4 Favored Pre-proline 0 N--CA 1.432 -1.354 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 164.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.649 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 67.5 Cg_exo -54.62 129.4 34.73 Favored 'Trans proline' 0 C--N 1.292 -2.398 0 CA-C-N 118.923 0.651 . . . . 0.0 110.482 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 91' ' ' HIS . 99.9 t -107.66 108.28 24.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.215 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 65.7 tttp -81.95 133.46 35.31 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.581 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.1 p -138.29 179.79 6.25 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -61.08 -37.61 83.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 10.4 m-30 -63.29 -43.59 97.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.772 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.83 -139.27 6.72 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.514 ' O ' HD12 ' A' ' 16' ' ' LEU . 26.2 m-85 -104.92 130.12 53.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.98 0.39 . . . . 0.0 111.038 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.568 ' CE1' HD13 ' A' ' 16' ' ' LEU . 15.7 m-70 -113.22 148.68 35.01 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.215 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.569 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 72.1 t -117.72 126.98 75.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 167.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.432 HD11 ' CD1' ' A' ' 68' ' ' PHE . 91.4 mt -118.46 123.39 71.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -107.76 140.83 40.24 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 169.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.628 ' NH1' ' O ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -78.74 138.75 38.39 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.91 176.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.628 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 53.3 tp -103.15 124.84 49.34 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.435 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.21 -1.368 0 CA-C-O 118.272 -1.293 . . . . 0.0 112.005 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.8 mttp . . . . . 0 N--CA 1.437 -1.108 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.9 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 71.8 mt -105.08 128.48 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' NZ ' ' O ' ' A' ' 97' ' ' GLY . 59.3 mtpt -91.57 109.49 20.79 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.445 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -141.04 164.61 29.82 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -174.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.8 m -127.39 140.7 52.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.479 173.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.43 ' CD2' ' C ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -136.33 150.77 49.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.316 0.579 . . . . 0.0 112.488 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.514 HG23 ' OG ' ' A' ' 44' ' ' SER . 96.1 mt -128.98 126.52 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.323 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' A' ' 46' ' ' ASP . 13.8 mt -95.56 132.69 40.43 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.109 HG12 HD21 ' A' ' 43' ' ' LEU . 34.9 m -129.77 153.63 39.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 O-C-N 123.58 0.55 . . . . 0.0 109.684 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -65.07 -41.29 95.23 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.083 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 9.0 mtmp? -124.55 149.52 46.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -173.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 52.7 tt0 -63.0 -37.35 86.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.05 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.96 -38.73 93.2 Favored Glycine 0 C--O 1.242 0.645 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 93.6 mt-10 -63.77 -41.68 97.93 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 176.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 20' ' ' GLN . . . -58.16 -47.22 84.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.168 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.83 -41.98 98.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.544 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.9 -50.72 72.65 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.752 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' HD23 ' A' ' 30' ' ' LEU . 14.9 m -65.38 -39.22 84.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.059 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 81' ' ' SER . 91.2 mt-30 -57.9 -46.81 84.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.217 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -63.42 -36.54 84.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.838 ' HD3' HD11 ' A' ' 39' ' ' LEU . 77.0 ttt180 -63.15 -39.42 94.62 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.493 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.753 HD11 ' HA ' ' A' ' 36' ' ' PHE . 4.3 mm? -61.41 -40.43 94.4 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 66.2 mmtt -60.83 -28.39 68.78 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.692 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -64.11 -21.22 66.45 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.419 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.93 -4.32 38.94 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.143 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.631 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 18.9 mt-10 -62.8 149.72 43.36 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.211 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 41.1 tttm -63.68 134.3 55.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.214 0.53 . . . . 0.0 110.927 -174.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.753 ' HA ' HD11 ' A' ' 30' ' ' LEU . 64.9 t80 -56.85 -45.24 82.55 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.566 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.03 -34.84 89.44 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.319 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 88.4 tttt -59.95 -46.65 88.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.838 HD11 ' HD3' ' A' ' 29' ' ' ARG . 3.9 mm? -62.57 -41.33 98.86 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.571 173.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.44 -47.43 84.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.446 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 31.5 mmtp -65.69 -40.6 92.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.077 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 42.2 mt-10 -70.68 -54.12 13.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -172.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.109 HD21 HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -118.21 -29.09 5.65 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -166.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.963 ' N ' HD13 ' A' ' 43' ' ' LEU . 1.3 m -42.25 137.94 1.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.3 pt -83.32 -12.74 11.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.552 ' HB2' HD12 ' A' ' 16' ' ' LEU . 64.9 t0 -88.59 97.5 11.13 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.717 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -67.45 -45.89 74.64 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.74 -45.68 78.06 Favored Glycine 0 C--O 1.236 0.267 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 54' ' ' GLY . 15.9 m -69.68 -32.67 71.43 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.562 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.62 68.81 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.419 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 48.9 mmtm -62.34 -37.68 86.59 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.453 ' O ' ' OG ' ' A' ' 55' ' ' SER . 89.7 mtm-85 -97.63 20.82 11.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.809 176.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.566 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 16.4 m-20 60.41 32.44 20.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.153 0.502 . . . . 0.0 109.733 -177.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 78.71 -8.54 41.99 Favored Glycine 0 C--N 1.307 -1.04 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -64.92 89.08 0.07 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.398 0.618 . . . . 0.0 110.36 179.127 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.449 ' HA ' HH21 ' A' ' 52' ' ' ARG . 91.5 mt -63.1 -41.3 99.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.874 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.39 -154.18 18.97 Favored Glycine 0 C--O 1.236 0.265 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -83.97 135.05 34.61 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 10' ' ' ILE . 53.8 p90 -143.2 154.38 43.8 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.558 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.89 173.76 25.94 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH1' ' CZ ' ' A' ' 73' ' ' PHE . 51.5 mtp85 -71.33 138.62 49.41 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.528 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 86.65 -5.76 84.06 Favored Glycine 0 C--N 1.305 -1.16 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -68.42 -40.54 81.17 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.21 0.528 . . . . 0.0 109.734 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.503 ' HE2' ' CG ' ' A' ' 59' ' ' PHE . 76.4 mtm -123.41 161.95 23.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.707 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.5 m -51.67 140.04 6.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -44.54 -46.26 25.07 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.538 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.88 -46.26 34.66 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 120.643 0.896 . . . . 0.0 110.742 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CD2' HD11 ' A' ' 93' ' ' ILE . 46.1 t80 -61.7 -49.23 77.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.454 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 96.1 mt-10 -65.72 -40.32 92.07 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.339 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.92 -44.49 91.3 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.85 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.422 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -67.39 -38.44 84.69 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.856 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.37 96.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.132 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.9 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 39.3 m-85 -61.86 -32.02 72.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 120.794 0.33 . . . . 0.0 111.73 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -61.68 -37.28 83.5 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.741 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.699 HD11 ' HB3' ' A' ' 81' ' ' SER . 72.0 mt -90.58 6.85 42.02 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.438 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 85.4 mt-30 -50.78 -27.35 7.05 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.962 -177.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 p -62.95 -33.55 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.455 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 119.89 49.76 0.3 Allowed Glycine 0 N--CA 1.475 1.28 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.643 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.664 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -128.64 174.37 9.47 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -175.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.45 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 97.2 t -95.77 130.64 44.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.699 ' HB3' HD11 ' A' ' 75' ' ' LEU . 6.2 p -78.61 163.3 25.6 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.019 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.505 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -68.77 169.78 10.13 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 69.5 Cg_endo -62.46 141.5 86.97 Favored 'Trans proline' 0 C--N 1.297 -2.141 0 CA-C-N 118.885 0.638 . . . . 0.0 110.707 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.76 130.84 73.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.497 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 29.6 tptp -107.67 135.59 48.85 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.243 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.3 p -145.63 177.16 9.09 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.49 -31.38 70.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -62.1 -42.28 99.06 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.983 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.436 ' O ' ' HD2' ' A' ' 85' ' ' LYS . . . 152.09 -143.54 10.52 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.548 ' O ' HD23 ' A' ' 16' ' ' LEU . 3.2 m-85 -105.24 129.5 53.6 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -109.37 147.5 32.64 Favored 'General case' 0 CA--C 1.501 -0.931 0 O-C-N 123.41 0.444 . . . . 0.0 110.148 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.6 t -118.11 126.55 75.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 163.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.54 HD11 ' CD2' ' A' ' 68' ' ' PHE . 89.2 mt -115.62 129.92 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.668 -174.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -124.9 143.12 51.02 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.438 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 1.7 tmm_? -78.58 143.83 36.11 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.317 -174.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.424 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 53.8 tp -109.06 139.04 44.48 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.737 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.436 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.205 -1.675 0 CA-C-O 118.249 -1.306 . . . . 0.0 110.332 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HD3' ' CA ' ' A' ' 60' ' ' GLY . 35.0 mmtp . . . . . 0 C--O 1.241 0.62 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.843 HG21 ' HB1' ' A' ' 72' ' ' ALA . 40.5 mm -106.96 128.35 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.196 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.55 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 46.0 mtpt -95.66 106.9 19.05 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -148.03 168.24 22.84 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.873 -1.131 . . . . 0.0 113.947 -175.003 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.509 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 19.4 m -135.31 143.97 46.47 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.235 173.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.51 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -138.97 151.77 47.14 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.746 HG23 ' HB2' ' A' ' 44' ' ' SER . 89.1 mt -121.03 126.7 75.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -98.5 119.52 37.35 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.607 ' N ' HD13 ' A' ' 16' ' ' LEU . 19.7 m -127.11 146.68 32.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.187 0.518 . . . . 0.0 111.605 -177.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.33 -40.89 90.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.508 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 22.3 mmtp -109.96 148.24 31.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.869 -171.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -37.55 87.74 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.665 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.98 -37.1 93.85 Favored Glycine 0 C--O 1.227 -0.305 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.513 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 97.9 mt-10 -64.09 -44.69 91.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -60.31 -49.68 76.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.495 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.99 -41.48 97.48 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.263 0.554 . . . . 0.0 110.216 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.51 -47.19 82.63 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.521 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.856 HG11 HD22 ' A' ' 43' ' ' LEU . 26.1 m -70.2 -32.11 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.967 176.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.567 HE22 ' HA ' ' A' ' 82' ' ' GLU . 48.8 tt0 -61.35 -47.08 87.53 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -67.86 -43.43 79.46 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.939 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.926 ' HD3' HD11 ' A' ' 39' ' ' LEU . 75.0 ttt180 -60.7 -39.17 87.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.329 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -57.16 -41.1 78.55 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.71 -26.9 68.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.737 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -65.72 -1.1 2.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 177.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.27 19.02 61.39 Favored Glycine 0 C--O 1.236 0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.143 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 28.3 mt-10 -87.1 144.68 26.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.526 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 56.5 mttp -64.12 139.89 58.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.413 0.625 . . . . 0.0 112.304 -175.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.498 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 48.2 t80 -57.77 -45.53 85.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.552 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.24 -36.72 93.43 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.0 177.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 64.4 tttm -60.76 -44.64 96.49 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.926 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.6 mm? -62.66 -40.43 97.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.693 172.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.15 97.87 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.972 0.415 . . . . 0.0 110.144 -177.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.526 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 13.1 mmtm -65.86 -44.09 86.46 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.897 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.507 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 74.6 mt-10 -71.4 -41.79 69.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.856 HD22 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -111.9 -70.39 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -170.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.746 ' HB2' HG23 ' A' ' 15' ' ' ILE . 4.4 t -33.59 128.48 0.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.449 -168.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.2 pt -91.05 -3.3 10.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.777 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 50' ' ' ALA . 54.6 t0 -79.09 94.73 5.39 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.09 -51.08 61.03 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -46.21 -53.41 9.34 Favored Glycine 0 C--N 1.322 -0.235 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.541 ' OG ' ' NH2' ' A' ' 52' ' ' ARG . 21.9 m -71.7 -32.24 67.59 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 46' ' ' ASP . . . -62.63 -38.35 89.89 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -61.79 -25.48 67.51 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.756 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' NH2' ' OG ' ' A' ' 49' ' ' SER . 93.1 mtm-85 -97.69 7.71 45.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.367 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.552 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER 59.71 34.1 22.0 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.536 0.684 . . . . 0.0 109.649 -173.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 79.27 -8.59 45.55 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.336 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 m -65.4 128.46 35.97 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.589 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.58 HD12 ' SG ' ' A' ' 12' ' ' CYS . 83.1 mt -109.01 -28.77 8.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.985 0.421 . . . . 0.0 110.064 177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 78.63 -146.87 30.41 Favored Glycine 0 CA--C 1.516 0.124 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.55 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 44.0 m-85 -84.32 133.27 34.55 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.548 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 52.1 p90 -144.43 145.91 32.18 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.425 ' CA ' ' HD3' ' A' ' 9' ' ' LYS . . . -93.76 179.25 38.39 Favored Glycine 0 C--N 1.316 -0.535 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -71.05 137.73 49.22 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.085 -0.558 . . . . 0.0 109.778 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.17 -22.76 32.31 Favored Glycine 0 C--N 1.305 -1.182 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.46 -41.4 84.75 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.463 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 5.7 mmm -113.85 160.73 18.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.369 -170.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 86' ' ' SER . 30.7 m -63.73 142.67 16.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -43.43 -50.26 16.6 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.997 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.26 -42.18 69.71 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 N-CA-C 110.393 -0.657 . . . . 0.0 110.393 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CD2' HD11 ' A' ' 93' ' ' ILE . 40.0 t80 -62.4 -47.93 81.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.454 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 64' ' ' MET . 97.4 mt-10 -65.1 -42.88 93.6 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.584 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.68 -40.68 93.05 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.241 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.07 -41.96 90.04 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.006 0.431 . . . . 0.0 110.114 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.843 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.6 -42.87 97.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.395 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 10' ' ' ILE . 46.5 m-85 -66.82 -34.13 77.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -62.99 -33.86 76.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.896 HD11 ' HB3' ' A' ' 81' ' ' SER . 73.9 mt -89.41 18.67 5.04 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -168.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.508 ' NE2' HD12 ' A' ' 10' ' ' ILE . 99.4 mm-40 -59.41 -22.46 61.45 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.3 -26.05 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.427 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 98.49 29.47 7.42 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.58 ' O ' HD13 ' A' ' 75' ' ' LEU . 35.8 tt0 -101.74 159.75 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.787 -0.243 . . . . 0.0 111.458 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.43 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 20.1 t -77.22 131.11 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 172.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.896 ' HB3' HD11 ' A' ' 75' ' ' LEU . 28.1 p -69.91 157.61 37.12 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.671 -178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.567 ' HA ' HE22 ' A' ' 27' ' ' GLN . 16.8 mp0 -73.17 168.65 22.95 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 167.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.514 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 86.5 Cg_exo -53.95 131.42 44.42 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 N-CA-C 110.304 -0.691 . . . . 0.0 110.304 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 91' ' ' HIS . 46.0 t -106.62 108.59 25.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.521 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 16.0 tptm -79.59 131.62 36.05 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.46 ' HB2' HG21 ' A' ' 65' ' ' VAL . 14.7 p -151.34 174.58 13.16 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.76 -172.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -54.81 -36.86 65.42 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.708 174.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -68.67 -41.49 79.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.628 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.9 -125.54 2.51 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.521 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 96.1 m-85 -109.97 128.28 55.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.111 0.455 . . . . 0.0 110.157 177.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.51 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 4.2 m-70 -108.37 146.63 32.74 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.906 173.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.434 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 77.4 t -117.0 125.44 73.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 168.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.52 ' N ' ' OG ' ' A' ' 81' ' ' SER . 88.5 mt -119.46 129.47 75.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.714 -171.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -112.34 131.33 55.59 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 169.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.505 ' CD ' ' HA ' ' A' ' 76' ' ' GLN . 79.2 ttt-85 -78.04 135.47 37.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 11' ' ' LYS . 56.0 tp -107.24 132.82 52.65 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.141 -173.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.387 0 CA-C-O 118.096 -1.391 . . . . 0.0 111.221 -177.399 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.0 mttp . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.905 HG21 ' HB1' ' A' ' 72' ' ' ALA . 15.7 mm -105.2 124.18 59.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 97' ' ' GLY . 62.0 mtpt -97.15 105.13 17.22 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 171.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -146.16 168.73 20.28 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -173.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.9 m -132.66 146.86 52.22 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.82 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.586 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -133.92 150.65 51.32 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.656 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 93.6 mt -123.62 126.72 73.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 90' ' ' TYR . 42.1 tp -100.74 122.47 43.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.29 155.34 41.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.332 0.587 . . . . 0.0 110.915 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -65.29 -40.29 93.66 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.702 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.557 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 58.4 mttp -117.13 151.81 36.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.086 -168.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.429 ' O ' HD23 ' A' ' 24' ' ' LEU . 87.2 mt-30 -63.07 -40.57 98.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.44 -0.8 . . . . 0.0 108.96 170.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.97 -37.49 93.92 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.573 ' O ' HG13 ' A' ' 26' ' ' VAL . 94.4 mt-10 -64.73 -41.34 96.03 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.01 -42.66 98.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.993 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 20' ' ' GLN . 2.5 mm? -62.22 -41.84 98.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -56.48 -49.89 73.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.384 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.627 ' O ' HD23 ' A' ' 30' ' ' LEU . 2.6 m -65.19 -40.82 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.807 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.412 HE22 ' HA ' ' A' ' 82' ' ' GLU . 83.4 mt-30 -56.65 -46.24 81.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -67.83 -41.85 82.39 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.315 0.579 . . . . 0.0 110.261 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.518 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 77.0 ttt180 -61.07 -39.43 89.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.922 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 26' ' ' VAL . 4.4 mm? -58.65 -36.57 74.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -67.44 -13.61 62.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.378 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -71.95 -12.4 61.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.99 0.424 . . . . 0.0 110.116 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.97 16.64 47.0 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.256 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 29' ' ' ARG . 34.2 mt-10 -82.59 147.38 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.283 176.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 41.9 tttm -66.25 133.82 51.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.087 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.656 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 54.3 t80 -58.62 -46.31 87.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.149 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.89 -36.14 92.99 Favored Glycine 0 C--O 1.25 1.154 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 62.3 tttm -60.2 -48.12 83.06 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.679 ' HB3' HD12 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -63.96 -40.1 95.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.987 176.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' CB ' ' C ' ' A' ' 53' ' ' ASP . . . -56.49 -47.94 78.22 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.477 ' NZ ' ' O ' ' A' ' 37' ' ' GLY . 24.5 mtmm -64.77 -41.28 95.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.029 176.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.518 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 86.9 mt-10 -71.04 -56.83 5.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.679 HD12 ' HB3' ' A' ' 39' ' ' LEU . 10.9 mt -76.77 -50.37 13.71 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.509 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.8 m -61.14 139.25 58.14 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.337 -161.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.549 HG13 HD23 ' A' ' 16' ' ' LEU . 45.0 pt -87.75 -4.52 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.874 172.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -89.77 96.65 10.78 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.189 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.0 -41.36 99.92 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.63 -45.1 90.86 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.586 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 39.6 m -63.89 -33.79 76.49 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.699 0.285 . . . . 0.0 110.622 174.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -62.57 -40.63 97.48 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 31.5 mmtp -70.3 -11.73 61.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.697 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 55' ' ' SER . 72.2 mmt-85 -113.03 9.28 18.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.097 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.4 m-20 53.61 30.8 11.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -174.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 60.48 1.42 1.73 Allowed Glycine 0 C--N 1.318 -0.438 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 53' ' ' ASP . 1.7 m -75.84 85.75 2.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.244 0.545 . . . . 0.0 110.578 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.624 HD13 ' CE ' ' A' ' 64' ' ' MET . 85.0 mt -63.85 -40.16 95.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.175 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.29 -149.25 20.58 Favored Glycine 0 C--N 1.322 -0.231 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.83 132.79 34.36 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 53.6 p90 -143.62 146.73 33.49 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.338 171.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.75 -171.7 37.49 Favored Glycine 0 C--N 1.314 -0.659 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 61' ' ' ARG . 50.6 mtp85 -69.64 139.32 53.56 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.08 -27.25 17.39 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -65.32 -37.44 87.1 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 116.959 0.38 . . . . 0.0 111.669 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.624 ' CE ' HD13 ' A' ' 56' ' ' LEU . 3.3 mmt -110.28 159.55 17.32 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -176.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.84 134.23 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.098 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.458 ' NZ ' ' OE2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -45.58 -40.51 14.24 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -171.503 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.24 -43.37 56.74 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.654 0.903 . . . . 0.0 110.242 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CE1' HG12 ' A' ' 93' ' ' ILE . 48.5 t80 -61.99 -46.82 87.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.85 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.458 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 81.4 mt-10 -64.42 -40.89 96.64 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.345 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -55.86 -47.26 77.64 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.826 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.46 77.92 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.496 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.905 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.6 -46.48 90.08 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.638 ' CE1' HD11 ' A' ' 10' ' ' ILE . 47.3 m-85 -62.61 -41.68 99.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.983 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -63.52 -41.7 98.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.814 ' C ' HD23 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -83.56 1.08 43.81 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -174.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.644 ' NE2' HD13 ' A' ' 10' ' ' ILE . 7.3 mm-40 -51.24 -23.36 3.38 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.939 0.4 . . . . 0.0 110.162 177.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.445 HG13 ' HG2' ' A' ' 79' ' ' GLU . 7.4 p -59.31 -27.46 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.772 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 120.49 46.89 0.34 Allowed Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.445 ' HG2' HG13 ' A' ' 77' ' ' VAL . 49.3 mm-40 -117.37 170.89 8.35 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 t -100.41 117.29 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 170.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.5 p -62.73 151.02 39.68 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.399 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.412 ' HA ' HE22 ' A' ' 27' ' ' GLN . 0.1 OUTLIER -64.26 170.95 3.0 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.0 131.47 45.67 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 N-CA-C 109.828 -0.874 . . . . 0.0 109.828 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 68' ' ' PHE . 18.5 t -107.2 111.78 37.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -88.24 134.49 33.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.798 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.9 p -144.9 173.66 11.68 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.7 pm0 -57.83 -31.26 66.46 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -67.01 -38.42 85.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.815 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.48 -145.74 14.5 Favored Glycine 0 C--N 1.322 -0.216 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.613 ' O ' HD12 ' A' ' 16' ' ' LEU . 91.3 m-85 -106.87 129.8 54.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.523 ' CE1' HD13 ' A' ' 16' ' ' LEU . 2.6 m-70 -110.81 148.27 32.73 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.455 0.169 . . . . 0.0 110.561 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.492 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 56.0 t -117.9 128.22 75.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 167.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.529 HG23 ' SG ' ' A' ' 12' ' ' CYS . 72.8 mt -109.18 126.83 66.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.76 0.314 . . . . 0.0 110.441 -175.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 95' ' ' ARG . 9.6 tptp -104.9 135.63 45.9 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 170.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.546 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -76.96 142.0 40.2 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.239 -178.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.6 tp -108.16 132.69 53.35 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.469 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.532 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.766 -172.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.7 mttp . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.755 HD11 ' CD1' ' A' ' 73' ' ' PHE . 41.9 mm -104.58 126.22 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 97' ' ' GLY . 60.6 mtpt -94.12 108.18 20.04 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 170.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -148.01 170.13 18.41 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.961 -171.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.554 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 20.3 m -130.63 147.35 52.3 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.537 175.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.563 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -134.71 152.47 51.79 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.879 0.371 . . . . 0.0 111.593 -175.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.555 HD13 ' HB3' ' A' ' 39' ' ' LEU . 86.2 mt -128.14 127.14 67.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 175.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 90' ' ' TYR . 38.7 tp -99.28 123.09 43.29 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.25 154.36 28.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.156 0.503 . . . . 0.0 111.497 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.423 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 6.6 mttp -67.7 -42.23 82.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.621 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 68.3 mttm -124.53 149.8 46.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.64 -168.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.425 ' O ' HD23 ' A' ' 24' ' ' LEU . 9.5 pt20 -57.21 -38.84 74.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.164 171.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.75 -36.16 92.31 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.478 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 96.9 mt-10 -64.07 -41.05 97.47 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.357 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -61.32 -45.52 94.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.595 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 20' ' ' GLN . 2.8 mm? -61.84 -41.96 98.45 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.44 76.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.504 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 43' ' ' LEU . 32.8 m -65.5 -37.72 80.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.784 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.609 ' NE2' ' HA ' ' A' ' 82' ' ' GLU . 79.0 mt-30 -59.32 -49.82 76.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.162 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.448 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 70.9 mm-40 -68.34 -38.52 81.58 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HD3' HD11 ' A' ' 39' ' ' LEU . 73.5 ttt180 -61.97 -42.2 98.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.146 0.498 . . . . 0.0 109.874 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -43.41 95.36 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.448 ' NZ ' ' OE2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -63.66 -12.78 36.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.958 175.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -72.72 -8.4 55.21 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.04 9.99 60.22 Favored Glycine 0 C--O 1.238 0.38 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -75.1 161.21 29.61 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.998 0.427 . . . . 0.0 111.348 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 47.0 mttm -74.07 137.14 43.15 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.291 -177.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -59.14 -45.09 91.84 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.537 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.44 -39.06 96.76 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.281 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 88.4 tttt -60.33 -45.16 94.42 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.705 HD11 ' HD3' ' A' ' 29' ' ' ARG . 1.3 mm? -61.34 -42.1 98.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.09 173.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -61.56 -53.21 59.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.948 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -69.02 -32.86 72.68 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.805 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.483 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 87.1 mt-10 -71.08 -41.21 70.96 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 26' ' ' VAL . 4.5 mp -105.21 -67.97 0.89 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -26.58 117.16 0.07 Allowed 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 114.084 -1.416 . . . . 0.0 112.984 -166.185 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.506 HG13 HD23 ' A' ' 16' ' ' LEU . 46.2 pt -90.68 -2.57 10.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.067 -177.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.409 ' CG ' ' HE2' ' A' ' 14' ' ' HIS . 1.2 p30 -76.41 179.89 5.58 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.714 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.35 -118.73 0.55 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.736 -176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 52' ' ' ARG . . . -49.41 -43.13 34.94 Favored Glycine 0 C--N 1.321 -0.259 0 N-CA-C 112.153 -0.379 . . . . 0.0 112.153 -172.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -60.12 -34.24 73.24 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.366 -179.019 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.26 86.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.472 0.653 . . . . 0.0 109.271 175.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.23 -7.37 59.37 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.442 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.463 ' O ' ' OG ' ' A' ' 55' ' ' SER . 56.3 mtp85 -96.89 20.38 11.19 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.731 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.537 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 83.0 m-20 56.19 29.62 15.09 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -173.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.76 -13.26 7.04 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.689 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 28.1 p -66.33 95.08 0.29 Allowed 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.834 0.826 . . . . 0.0 112.199 -177.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.535 HD12 ' SG ' ' A' ' 12' ' ' CYS . 92.7 mt -65.58 -38.3 89.11 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.812 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.03 -147.19 18.75 Favored Glycine 0 C--N 1.317 -0.474 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 1.5 p90 -85.3 141.04 30.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.222 0.511 . . . . 0.0 111.385 177.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.673 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 49.9 p90 -147.28 151.65 36.98 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 171.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.31 176.94 27.05 Favored Glycine 0 C--O 1.241 0.59 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' A' ' 73' ' ' PHE . 83.6 mtm-85 -69.36 142.44 53.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 120.977 0.418 . . . . 0.0 110.705 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.85 -36.58 4.3 Favored Glycine 0 C--N 1.306 -1.124 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -63.1 -41.5 99.38 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.395 -0.474 . . . . 0.0 110.721 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.486 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 26.7 mmm -97.05 160.23 14.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.923 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 68' ' ' PHE . 19.5 m -71.28 144.47 13.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -44.31 -51.51 19.36 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.73 -42.82 65.02 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.39 0.727 . . . . 0.0 110.391 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.559 ' CD2' HD11 ' A' ' 93' ' ' ILE . 35.4 t80 -62.16 -46.29 89.63 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.885 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -61.61 -42.51 98.99 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.523 ' CG ' ' HE ' ' A' ' 74' ' ' ARG . 11.8 t70 -55.81 -48.82 74.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.45 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.61 61.84 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.114 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.5 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.28 -50.81 72.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.732 -176.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.755 ' CD1' HD11 ' A' ' 10' ' ' ILE . 58.5 m-85 -67.01 -39.26 87.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HE ' ' CG ' ' A' ' 70' ' ' ASP . 46.8 mtm105 -63.5 -39.19 93.79 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.225 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.481 HD12 ' HB3' ' A' ' 81' ' ' SER . 73.9 mt -96.5 29.97 2.73 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.47 ' OE1' ' NE ' ' A' ' 95' ' ' ARG . 4.3 mm100 -52.47 -20.03 2.61 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.436 HG13 ' H ' ' A' ' 79' ' ' GLU . 12.9 p -62.8 -31.31 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.881 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.32 -3.63 15.91 Favored Glycine 0 N--CA 1.475 1.299 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.274 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' H ' HG13 ' A' ' 77' ' ' VAL . 19.8 tp10 -67.4 153.13 44.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.997 0.399 . . . . 0.0 110.64 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.0 t -71.03 132.16 33.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 93' ' ' ILE . 10.8 p -75.66 155.93 35.31 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.083 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.609 ' HA ' ' NE2' ' A' ' 27' ' ' GLN . 4.1 mp0 -75.56 172.43 9.28 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.612 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 75.3 Cg_exo -54.79 130.53 40.95 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 N-CA-C 109.036 -1.178 . . . . 0.0 109.036 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 58.5 t -105.01 114.32 44.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -83.37 132.24 35.01 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.6 p -141.12 172.01 13.28 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.45 -37.48 83.71 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -64.6 -42.54 95.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.384 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.87 -145.3 13.07 Favored Glycine 0 C--N 1.318 -0.421 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.569 ' O ' HD12 ' A' ' 16' ' ' LEU . 73.8 m-85 -105.58 128.48 53.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.862 0.331 . . . . 0.0 111.352 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.563 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.1 m-70 -119.18 152.27 36.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.333 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.53 HG21 ' CG2' ' A' ' 26' ' ' VAL . 62.9 t -118.76 128.96 75.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 166.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.559 HD11 ' CD2' ' A' ' 68' ' ' PHE . 86.0 mt -122.12 133.27 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 119.74 -0.171 . . . . 0.0 111.369 -173.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -128.22 148.16 50.61 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 167.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.47 ' NE ' ' OE1' ' A' ' 76' ' ' GLN . 61.5 ttt-85 -79.16 142.21 36.55 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.012 0.435 . . . . 0.0 110.091 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 50.1 tp -112.61 133.42 54.66 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.453 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.208 -1.477 0 CA-C-O 118.341 -1.255 . . . . 0.0 111.362 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HD2' ' C ' ' A' ' 59' ' ' PHE . 25.5 mmtp . . . . . 0 N--CA 1.431 -1.413 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.77 HG21 ' HB1' ' A' ' 72' ' ' ALA . 32.1 mm -106.26 129.49 59.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' NZ ' ' OXT' ' A' ' 97' ' ' GLY . 57.6 mtpt -88.24 105.72 17.73 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.549 ' SG ' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -147.52 165.28 30.81 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.096 0.474 . . . . 0.0 111.76 -176.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.453 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 7.1 m -131.75 147.22 52.48 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.732 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 149.93 50.86 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.681 ' CG2' HD12 ' A' ' 43' ' ' LEU . 97.0 mt -125.67 128.64 72.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.134 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.534 HD23 HG13 ' A' ' 45' ' ' ILE . 47.0 tp -100.23 128.34 46.32 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.795 -176.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.03 ' CG1' HD11 ' A' ' 43' ' ' LEU . 16.2 m -127.64 155.58 39.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.967 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 17.5 pttp -84.04 -22.25 31.34 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.833 176.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 19' ' ' LYS . 37.3 mmtm -135.57 152.56 51.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -62.67 -37.99 88.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.947 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.55 -36.79 92.18 Favored Glycine 0 C--N 1.321 -0.276 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.491 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 96.0 mt-10 -65.35 -44.37 87.91 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -58.55 -48.96 79.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.238 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.533 HD23 ' OE1' ' A' ' 27' ' ' GLN . 30.0 mt -63.87 -40.91 97.65 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.754 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.17 -48.53 76.16 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.255 -177.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.538 HG12 HD12 ' A' ' 39' ' ' LEU . 18.0 m -64.99 -39.57 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.246 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.562 HE21 HG22 ' A' ' 92' ' ' VAL . 83.3 mt-30 -60.22 -47.18 87.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.085 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.13 -41.26 81.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.133 0.492 . . . . 0.0 110.822 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.974 ' HD3' HD11 ' A' ' 39' ' ' LEU . 71.1 ttt180 -62.87 -38.55 91.31 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.73 177.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.16 -35.83 70.02 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -177.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 79' ' ' GLU . 49.8 mmtt -61.52 -28.63 69.45 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.134 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.9 -21.94 45.94 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.942 0.401 . . . . 0.0 110.917 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.09 7.19 41.4 Favored Glycine 0 C--N 1.319 -0.385 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 31.9 mt-10 -76.18 156.59 33.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.152 177.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -72.52 141.38 48.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.708 0.766 . . . . 0.0 112.428 -176.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 45.9 t80 -58.12 -44.78 87.92 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.14 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -61.19 -36.68 92.76 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.352 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.442 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 88.3 tttt -61.37 -48.04 83.08 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.974 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.3 mm? -62.05 -41.82 98.54 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.967 173.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.469 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -59.05 -50.32 74.52 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.153 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -43.26 88.29 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.642 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 87.1 mt-10 -70.94 -45.55 64.01 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -173.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.03 HD11 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -107.6 -39.12 5.71 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.634 ' N ' HD13 ' A' ' 43' ' ' LEU . 2.5 m -52.99 138.67 29.87 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.062 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.534 HG13 HD23 ' A' ' 16' ' ' LEU . 42.1 pt -91.72 -4.82 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.387 173.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -90.89 101.0 13.76 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.581 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -65.88 -43.8 93.11 Favored Glycine 0 C--N 1.318 -0.434 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.79 -45.24 91.45 Favored Glycine 0 C--O 1.239 0.453 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.2 m -64.21 -33.47 75.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.95 0.405 . . . . 0.0 110.213 174.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -64.45 -35.4 80.79 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 74.8 mmtt -61.9 -36.79 82.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 77.7 mtp85 -97.57 19.26 13.75 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.982 174.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.9 OUTLIER 44.67 42.37 5.74 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.679 178.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 71.83 -20.76 0.82 Allowed Glycine 0 C--N 1.31 -0.886 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.55 ' H ' ' C ' ' A' ' 53' ' ' ASP . 10.3 m -67.91 79.47 0.21 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.527 0.679 . . . . 0.0 110.305 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.416 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 97.7 mt -62.56 -41.63 99.03 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.387 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.88 -147.12 18.46 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.04 104.16 14.72 Favored 'General case' 0 C--O 1.252 1.195 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.459 ' C ' ' HD2' ' A' ' 9' ' ' LYS . 47.5 p90 -119.0 148.1 43.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.712 177.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.82 -176.31 48.1 Favored Glycine 0 C--O 1.236 0.25 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.501 ' HD2' ' CZ ' ' A' ' 73' ' ' PHE . 26.0 mtp180 -86.65 162.76 17.77 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.7 -21.42 1.57 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.724 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 61' ' ' ARG . 37.6 mmtm -65.1 -40.01 93.95 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -112.93 160.27 18.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.75 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 11.5 m -58.47 146.6 8.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.99 -176.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 4.5 mtpp -45.13 -47.03 32.29 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.347 -177.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 66' ' ' LYS . 75.5 Cg_exo -55.47 -41.38 78.58 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 120.486 0.791 . . . . 0.0 110.609 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.669 ' CD2' HD11 ' A' ' 93' ' ' ILE . 50.6 t80 -61.28 -46.56 89.85 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.766 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 61' ' ' ARG . 67.3 mt-10 -62.31 -46.97 86.35 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.618 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 35.0 t70 -58.61 -45.61 88.78 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.394 -176.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.564 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -59.56 -46.13 89.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.77 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.25 -46.96 88.0 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.032 0.444 . . . . 0.0 110.07 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.759 ' CE1' HD11 ' A' ' 10' ' ' ILE . 51.6 m-85 -68.11 -36.68 80.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.326 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.454 ' NH2' ' OE2' ' A' ' 82' ' ' GLU . 61.8 mtp180 -61.6 -45.26 94.84 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.204 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 75' ' ' LEU . 93.9 mt -99.68 42.07 1.12 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -177.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.433 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 35.3 mt-30 -55.26 -21.1 13.01 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.413 173.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.489 HG13 ' H ' ' A' ' 79' ' ' GLU . 14.7 p -61.96 -32.37 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.792 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 120.18 -3.96 12.6 Favored Glycine 0 N--CA 1.477 1.382 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.213 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -73.31 173.4 9.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 117.075 0.437 . . . . 0.0 111.377 -178.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.555 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 5.3 t -92.53 129.57 42.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.491 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 9.9 p -71.3 153.51 42.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.254 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.454 ' C ' HE22 ' A' ' 27' ' ' GLN . 5.0 mp0 -64.52 169.81 4.58 Favored Pre-proline 0 CA--C 1.507 -0.686 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 172.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.491 ' N ' HE22 ' A' ' 27' ' ' GLN . 63.6 Cg_exo -53.31 130.53 38.84 Favored 'Trans proline' 0 C--N 1.295 -2.267 0 N-CA-C 109.596 -0.963 . . . . 0.0 109.596 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.2 107.74 23.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -78.31 133.38 37.63 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.398 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.4 p -140.19 167.93 21.0 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 1.6 pm0 -58.12 -36.38 72.85 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -63.99 -43.82 94.56 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.868 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.94 -148.9 16.79 Favored Glycine 0 C--N 1.311 -0.828 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.439 ' HB2' HG23 ' A' ' 17' ' ' VAL . 93.8 m-85 -110.11 129.55 55.68 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.407 ' CE1' HD13 ' A' ' 16' ' ' LEU . 5.2 m-70 -109.5 151.91 26.13 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.562 HG22 HE21 ' A' ' 27' ' ' GLN . 60.1 t -117.85 126.03 74.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.669 HD11 ' CD2' ' A' ' 68' ' ' PHE . 96.1 mt -119.69 127.33 75.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.648 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.421 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 64.5 tttp -110.96 143.14 42.08 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 169.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.57 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -78.59 142.47 37.27 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.066 178.006 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.2 tp -110.43 139.72 45.38 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.03 -175.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.502 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.21 -1.372 0 CA-C-O 118.268 -1.295 . . . . 0.0 110.755 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.4 mttp . . . . . 0 CA--C 1.515 -0.391 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.853 HD11 ' CE1' ' A' ' 73' ' ' PHE . 69.4 mt -106.9 128.35 61.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' TYR . 48.3 mtpt -94.25 106.85 18.83 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -146.33 168.99 19.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.097 0.776 . . . . 0.0 113.097 -173.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.429 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 45.4 m -135.66 147.16 48.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.398 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.444 ' CG ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -137.6 152.31 49.25 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.888 HG23 ' OG ' ' A' ' 44' ' ' SER . 95.6 mt -121.63 126.21 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.96 1.304 . . . . 0.0 108.032 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 17' ' ' VAL . 4.6 tt -105.28 123.54 48.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.639 ' N ' HD23 ' A' ' 16' ' ' LEU . 31.3 m -135.87 155.63 36.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 120.804 0.335 . . . . 0.0 110.396 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.94 -22.35 33.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.158 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.55 137.55 43.2 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.774 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.52 -36.99 85.59 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.55 98.22 Favored Glycine 0 CA--C 1.51 -0.224 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.473 ' HB3' HD23 ' A' ' 43' ' ' LEU . 98.8 mt-10 -64.46 -43.97 92.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -60.4 -45.58 93.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.282 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.93 -39.93 96.1 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.466 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.07 -46.0 89.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.573 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.868 ' CG1' HD22 ' A' ' 43' ' ' LEU . 12.3 m -65.78 -38.82 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.953 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.542 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 3.1 tp-100 -54.68 -48.53 72.29 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.745 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -68.06 -39.88 82.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.713 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HG2' HD11 ' A' ' 39' ' ' LEU . 8.1 tpt180 -63.08 -40.23 97.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.903 -174.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.601 HD11 ' CA ' ' A' ' 36' ' ' PHE . 1.9 mm? -61.05 -38.81 87.49 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.329 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.542 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 23.8 mmtm -64.29 -16.11 61.52 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.889 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -72.13 -9.6 58.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 174.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.84 12.14 62.65 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 96.6 mt-10 -83.99 153.11 24.06 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.786 -0.243 . . . . 0.0 111.054 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -64.75 132.51 49.79 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 121.623 0.725 . . . . 0.0 111.93 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.601 ' CA ' HD11 ' A' ' 30' ' ' LEU . 62.5 t80 -57.05 -44.9 83.45 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.096 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -59.11 -38.03 92.5 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.772 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.494 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 49.1 tttp -60.95 -47.1 87.99 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.888 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 26' ' ' VAL . 4.4 mm? -61.82 -41.25 97.55 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.01 -50.56 72.98 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.858 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.26 -36.68 84.87 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.074 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.5 ' HB3' HD12 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -72.48 -80.3 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.913 -174.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.868 HD22 ' CG1' ' A' ' 26' ' ' VAL . 8.8 mp -67.29 -43.63 81.26 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -173.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.888 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.2 m -58.88 147.7 32.88 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.689 -162.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.451 ' CG1' HD22 ' A' ' 16' ' ' LEU . 46.0 pt -98.84 -5.21 9.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.824 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -85.21 93.67 8.72 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.576 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -61.26 -44.39 98.16 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.3 -41.84 72.17 Favored Glycine 0 C--N 1.324 -0.132 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.408 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 67.0 m -73.93 -33.37 63.91 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.934 174.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -67.14 -42.13 84.93 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.204 0.526 . . . . 0.0 110.68 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 35.3 mmtp -62.34 -31.79 72.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -96.69 15.87 20.62 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.268 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.491 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 42.3 38.7 1.23 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.951 0.881 . . . . 0.0 112.134 -178.527 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.77 -11.81 9.8 Favored Glycine 0 C--O 1.236 0.231 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.652 176.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.1 m -67.93 80.38 0.21 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.4 . . . . 0.0 111.617 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.444 HD11 ' CG ' ' A' ' 14' ' ' HIS . 96.0 mt -63.28 -40.56 97.71 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.95 -149.07 19.52 Favored Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.863 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.553 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.33 141.77 28.41 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.646 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.7 p90 -148.59 151.96 35.94 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.988 177.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.35 167.92 49.59 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.506 ' NH1' ' CE1' ' A' ' 73' ' ' PHE . 77.3 mtp85 -74.68 140.97 44.57 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.01 -29.57 10.97 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.193 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -40.53 97.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.583 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 9.0 mmm -80.83 160.76 24.71 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 68' ' ' PHE . 15.1 m -63.21 136.51 26.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.562 176.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -45.29 -47.02 34.11 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.447 -171.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -56.61 -40.38 84.83 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.122 1.214 . . . . 0.0 110.77 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.537 ' CD2' HD11 ' A' ' 93' ' ' ILE . 56.0 t80 -60.76 -46.51 90.16 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.565 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 47.9 mt-10 -64.47 -38.37 90.8 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.527 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.8 -48.51 75.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.924 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.23 -40.48 71.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.559 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.84 92.45 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.836 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.853 ' CE1' HD11 ' A' ' 10' ' ' ILE . 24.8 m-85 -66.39 -34.06 77.11 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.794 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.424 ' NH1' ' OE1' ' A' ' 82' ' ' GLU . 58.9 mtp180 -62.29 -44.75 95.8 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 81' ' ' SER . 0.1 OUTLIER -97.37 34.53 1.78 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.629 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.481 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 53.0 mt-30 -56.14 -20.9 19.56 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.482 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 79' ' ' GLU . 7.3 p -60.61 -29.71 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.768 176.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 121.35 -4.31 11.15 Favored Glycine 0 N--CA 1.471 0.988 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.589 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.1 tp10 -64.95 166.94 8.43 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 122.781 0.432 . . . . 0.0 110.761 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.583 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 13.8 t -93.82 128.86 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 174.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.638 ' HB3' HD13 ' A' ' 75' ' ' LEU . 10.6 p -73.67 162.08 29.58 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.686 0.279 . . . . 0.0 111.609 -178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 5.9 mp0 -79.56 -179.74 1.52 Allowed Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 173.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.633 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 73.3 Cg_exo -57.63 133.5 56.93 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 CA-C-N 118.936 0.656 . . . . 0.0 110.761 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 47.3 t -111.46 102.96 14.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.657 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 135.14 48.37 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 p -146.56 172.98 12.74 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.639 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 2.0 pm0 -59.23 -37.67 78.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.477 ' HB2' ' HE2' ' A' ' 91' ' ' HIS . 36.6 m-85 -65.21 -43.81 90.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.922 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 151.69 -151.72 23.6 Favored Glycine 0 C--N 1.317 -0.51 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 70.1 m-85 -98.89 129.06 45.22 Favored 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.38 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.477 ' HE2' ' HB2' ' A' ' 88' ' ' PHE . 5.0 m-70 -112.08 148.96 32.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.238 177.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.604 HG11 HG23 ' A' ' 26' ' ' VAL . 61.4 t -117.44 128.47 74.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 167.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 68' ' ' PHE . 87.1 mt -119.34 130.5 73.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -173.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HD2' HG22 ' A' ' 80' ' ' VAL . 59.5 tttm -115.73 143.52 45.26 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 168.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -78.41 143.61 36.63 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.837 -178.101 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.438 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 52.9 tp -96.61 133.01 41.65 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.419 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.205 -1.657 0 CA-C-O 118.364 -1.242 . . . . 0.0 111.25 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 N--CA 1.439 -1.002 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.459 HD12 ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -105.95 123.64 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -93.13 105.16 17.29 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -147.44 167.61 23.96 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.326 -0.95 . . . . 0.0 113.205 -171.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 4.1 m -130.88 141.16 50.29 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.066 -1.424 . . . . 0.0 107.997 174.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.482 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -135.75 150.45 49.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.822 HG23 ' OG ' ' A' ' 44' ' ' SER . 91.5 mt -125.46 121.62 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.552 HD22 ' CG1' ' A' ' 45' ' ' ILE . 5.5 tt -101.47 121.42 41.92 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.448 HG13 HG22 ' A' ' 15' ' ' ILE . 29.3 m -133.88 150.97 32.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.568 0.699 . . . . 0.0 112.192 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG3' HD13 ' A' ' 45' ' ' ILE . 99.2 mttt -67.32 -38.38 84.84 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.355 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.508 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 64.0 mttm -109.37 141.61 41.48 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.627 -173.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -64.6 -36.75 85.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.055 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.0 -36.22 92.55 Favored Glycine 0 C--O 1.238 0.357 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.583 ' HB3' HD23 ' A' ' 43' ' ' LEU . 94.6 mt-10 -65.55 -41.44 93.01 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.74 -44.52 93.74 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.685 176.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.1 mt -64.18 -39.46 94.04 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.099 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.54 71.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.031 HG13 HD22 ' A' ' 43' ' ' LEU . 18.5 m -64.29 -41.14 91.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.461 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.474 HE22 ' N ' ' A' ' 83' ' ' PRO . 84.0 mt-30 -59.48 -46.41 88.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.328 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 71.0 mm-40 -73.2 -38.57 66.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.734 ' HD3' HD11 ' A' ' 39' ' ' LEU . 53.8 ttt85 -65.01 -39.75 93.9 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.677 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.574 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -55.8 -25.44 41.46 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.405 -178.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 27' ' ' GLN . 38.9 mmtm -61.46 -38.18 86.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -16.54 44.53 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.907 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.89 14.15 61.37 Favored Glycine 0 C--N 1.318 -0.43 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' CD ' HH21 ' A' ' 29' ' ' ARG . 36.0 mt-10 -69.43 159.73 32.69 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.687 174.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 49.7 tttp -64.39 129.12 38.67 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.368 0.604 . . . . 0.0 110.247 -174.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.574 ' HA ' HD21 ' A' ' 30' ' ' LEU . 61.7 t80 -56.35 -43.96 79.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.49 ' HA2' ' C ' ' A' ' 53' ' ' ASP . . . -60.42 -34.07 83.76 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.564 177.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 45.7 tttp -59.62 -48.45 81.6 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.604 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.734 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.4 mm? -62.53 -41.35 98.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.921 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -57.26 -49.68 75.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.45 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.547 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 68.0 mttm -64.1 -37.69 88.36 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.896 177.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.678 ' HB3' HD12 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -71.09 -50.39 34.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.615 -172.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.031 HD22 HG13 ' A' ' 26' ' ' VAL . 6.2 mp -98.47 -48.6 4.96 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -174.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.822 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.2 m -55.64 142.14 35.01 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.338 -162.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.552 ' CG1' HD22 ' A' ' 16' ' ' LEU . 46.1 pt -94.45 -12.2 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.258 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 49' ' ' SER . 11.4 t0 -76.86 111.89 12.87 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.9 -40.22 64.49 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.9 -48.36 73.26 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.464 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 78.9 p -62.06 -33.28 74.11 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.381 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.53 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -74.46 -48.24 28.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.005 0.431 . . . . 0.0 110.346 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -65.39 -36.36 83.72 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.233 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.439 ' NE ' ' O ' ' A' ' 55' ' ' SER . 13.8 mmm180 -94.68 7.48 45.65 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.994 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.0 OUTLIER 50.34 47.86 23.2 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 67.12 -40.04 0.2 Allowed Glycine 0 C--N 1.313 -0.742 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.946 -173.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.563 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -54.79 82.91 0.0 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.1 0.96 . . . . 0.0 111.73 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.55 -38.64 91.91 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.54 -152.09 20.66 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.73 133.61 34.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.459 ' CE2' HD12 ' A' ' 10' ' ' ILE . 54.2 p90 -146.61 151.8 37.87 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.15 178.47 46.43 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 61' ' ' ARG . 45.8 mtp85 -73.46 152.53 40.71 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 122.764 0.426 . . . . 0.0 110.749 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.402 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 82.11 9.65 84.9 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.584 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -100.88 -19.28 15.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 178.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.474 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 1.4 mmm -126.39 161.33 28.13 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.76 136.85 20.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.081 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 1.7 tttm -44.5 -46.89 26.19 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 21.3 Cg_endo -59.71 -34.07 96.28 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 CA-C-N 119.161 0.736 . . . . 0.0 111.238 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CD2' HD11 ' A' ' 93' ' ' ILE . 55.5 t80 -62.99 -50.15 71.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.915 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 64' ' ' MET . 93.7 mt-10 -67.85 -43.82 78.59 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.811 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 7.2 t70 -57.74 -49.71 75.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.314 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.08 96.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.811 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -64.53 -42.08 95.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.516 -176.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.465 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 44.4 m-85 -64.99 -34.11 77.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.236 0.541 . . . . 0.0 111.362 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 79.9 mtp85 -62.62 -36.03 81.45 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.751 -176.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.598 HD11 ' HA ' ' A' ' 81' ' ' SER . 68.9 mt -97.12 23.05 7.73 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -173.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.494 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 75.1 mt-30 -43.53 -25.1 0.14 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.381 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.429 HG13 ' H ' ' A' ' 79' ' ' GLU . 14.8 p -58.35 -27.49 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 119.8 -2.18 13.48 Favored Glycine 0 N--CA 1.47 0.943 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.429 ' H ' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -55.86 173.46 0.14 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.66 127.5 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.598 ' HA ' HD11 ' A' ' 75' ' ' LEU . 83.7 p -65.33 147.58 53.19 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.882 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.414 ' C ' HE22 ' A' ' 27' ' ' GLN . 1.7 mp0 -65.53 177.09 0.73 Allowed Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 168.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.474 ' N ' HE22 ' A' ' 27' ' ' GLN . 53.1 Cg_exo -54.42 133.51 56.7 Favored 'Trans proline' 0 C--N 1.283 -2.872 0 N-CA-C 109.991 -0.811 . . . . 0.0 109.991 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 55.1 t -117.42 128.66 74.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -98.75 129.92 45.2 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.488 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.8 p -114.41 -175.48 2.69 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.719 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 1.6 pm0 -69.59 -35.52 75.4 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -66.11 -45.32 81.54 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.95 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.59 -157.66 28.35 Favored Glycine 0 C--N 1.317 -0.492 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 87.0 m-85 -85.52 135.08 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.678 0.239 . . . . 0.0 110.483 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.482 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 44.9 m-70 -122.5 147.7 46.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.682 176.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.51 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 60.9 t -117.7 126.69 74.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 166.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.51 HD11 ' CD2' ' A' ' 68' ' ' PHE . 87.7 mt -119.94 125.86 74.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.586 -174.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -113.69 143.8 44.01 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.632 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 2.4 tmm_? -78.7 141.23 38.07 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.939 -1.104 . . . . 0.0 110.181 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.432 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 48.2 tp -109.26 135.41 50.39 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.273 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.201 -1.939 0 CA-C-O 118.082 -1.399 . . . . 0.0 111.059 -178.903 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.49 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.33 145.61 97.31 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.651 1.567 . . . . 0.0 111.133 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.436 ' HG2' HH22 ' A' ' 61' ' ' ARG . 96.8 mtp -39.85 107.44 0.07 Allowed 'General case' 0 C--O 1.244 0.815 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.521 -175.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.65 21.06 79.82 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.428 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.463 ' H ' ' HB3' ' A' ' 8' ' ' ASP . 12.1 p -73.69 -176.4 2.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.882 0.373 . . . . 0.0 110.68 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 97.9 mmm -62.64 -39.03 92.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.279 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.6 43.91 2.13 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.687 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.463 ' HB3' ' H ' ' A' ' 5' ' ' SER . 7.1 p-10 -82.79 -1.14 50.85 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.008 0.432 . . . . 0.0 110.708 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HG3' ' OD1' ' A' ' 8' ' ' ASP . 43.7 mttp -107.89 164.09 12.56 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.724 -172.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.775 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 70.6 mt -107.49 131.66 57.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 27.6 mtpp -91.92 106.2 18.28 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -145.81 168.34 21.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -176.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.502 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 4.2 m -129.27 146.95 51.08 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.353 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.491 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -147.21 151.39 36.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.299 0.571 . . . . 0.0 112.346 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.643 HG21 HG11 ' A' ' 26' ' ' VAL . 85.2 mt -122.12 124.6 71.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.546 HD22 ' CG1' ' A' ' 45' ' ' ILE . 6.1 tt -107.83 127.74 53.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.586 HG21 ' N ' ' A' ' 23' ' ' ALA . 27.6 m -137.11 153.61 29.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.431 0.634 . . . . 0.0 111.212 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.457 ' HG3' HD13 ' A' ' 45' ' ' ILE . 26.1 mtmm -67.54 -39.96 85.0 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.475 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 60.7 mttp -103.48 148.89 25.39 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.526 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 86.0 mt-30 -62.09 -39.98 94.3 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.79 -38.27 91.8 Favored Glycine 0 CA--C 1.509 -0.281 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 74.4 mt-10 -65.54 -41.84 92.57 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.586 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -62.11 -42.35 99.14 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.849 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 20' ' ' GLN . 3.1 mm? -62.47 -40.98 98.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.782 174.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.0 -49.47 71.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.738 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.813 HG12 HD13 ' A' ' 43' ' ' LEU . 19.0 m -66.29 -42.49 90.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.198 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 81' ' ' SER . 99.1 mt-30 -61.66 -44.12 97.56 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.01 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.44 -44.85 74.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.066 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.895 ' HD3' HD11 ' A' ' 39' ' ' LEU . 43.0 ttt85 -66.63 -40.16 88.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.507 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.425 ' CD2' ' HG ' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -55.04 -24.7 26.06 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.312 0.577 . . . . 0.0 109.677 -178.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 27' ' ' GLN . 31.7 mmtm -62.35 -32.6 73.41 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.841 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.98 -7.99 20.19 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.722 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.84 25.84 40.06 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 87.1 mt-10 -81.54 157.23 24.87 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.506 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' NZ ' ' OD2' ' A' ' 53' ' ' ASP . 64.5 tttm -62.06 131.6 50.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.545 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 58.1 t80 -56.96 -43.28 81.41 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.658 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -59.21 -36.8 90.31 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.707 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 58.6 tttm -58.26 -48.0 81.81 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.027 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.895 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.6 mm? -63.44 -40.07 96.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.275 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.27 -43.21 95.53 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.758 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 34.3 mmtm -64.15 -41.27 97.24 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.719 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.76 -59.79 2.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.412 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.813 HD13 HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -91.33 -49.46 6.34 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -172.292 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.613 ' HB2' HG23 ' A' ' 15' ' ' ILE . 5.6 t -56.53 138.25 52.18 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.903 -169.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.546 ' CG1' HD22 ' A' ' 16' ' ' LEU . 44.6 pt -92.79 -1.74 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.814 0.34 . . . . 0.0 110.227 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 50' ' ' ALA . 60.1 t0 -80.22 96.51 6.61 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.1 -53.43 44.98 Favored Glycine 0 C--N 1.321 -0.278 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.815 -173.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.38 -45.01 84.93 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 54' ' ' GLY . 17.5 m -70.41 -32.57 70.25 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.472 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -62.79 -38.36 90.33 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 174.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 75.7 mmtt -60.79 -34.3 74.28 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 174.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.513 ' HE ' ' HA ' ' A' ' 49' ' ' SER . 89.6 mtm180 -95.48 19.48 10.89 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.913 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.658 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 97.3 m-20 59.85 30.2 19.75 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 70.87 -7.75 5.14 Favored Glycine 0 C--N 1.305 -1.149 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.701 ' HB3' HD22 ' A' ' 96' ' ' LEU . 2.3 m -70.72 91.09 0.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.433 0.635 . . . . 0.0 110.353 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.468 HD23 ' NH2' ' A' ' 52' ' ' ARG . 96.9 mt -62.35 -38.23 88.74 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.64 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . 76.91 -133.15 13.01 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.502 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 57.4 m-85 -83.98 135.59 34.39 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 117.111 0.455 . . . . 0.0 109.897 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.587 ' CE1' HD12 ' A' ' 10' ' ' ILE . 47.9 p90 -144.18 149.32 36.25 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.779 168.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.82 174.89 55.12 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 -174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.543 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 47.6 mtm180 -74.54 145.66 43.26 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.8 60.17 8.11 Favored Glycine 0 C--O 1.246 0.905 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 61' ' ' ARG . 34.7 mmtm -133.25 -35.62 1.03 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.017 0.437 . . . . 0.0 110.458 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.408 ' SD ' ' CE1' ' A' ' 68' ' ' PHE . 77.7 mtm -119.44 159.83 23.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.99 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.705 HG11 ' HB2' ' A' ' 86' ' ' SER . 15.4 m -49.1 133.57 7.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.277 -174.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -44.02 -47.34 22.45 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.901 -174.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 24.7 Cg_endo -57.87 -38.31 93.0 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 CA-C-N 118.767 0.595 . . . . 0.0 111.862 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.692 ' HA ' HG11 ' A' ' 84' ' ' VAL . 58.9 t80 -62.73 -49.97 72.96 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.771 177.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.62 -39.31 93.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.316 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.511 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 12.6 t70 -57.35 -48.68 78.38 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.115 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.642 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -63.22 -39.62 95.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.783 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.07 83.21 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.09 0.472 . . . . 0.0 110.253 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.775 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 52.6 m-85 -63.67 -42.85 98.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.879 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.672 ' NH2' HD11 ' A' ' 75' ' ' LEU . 39.1 ttp180 -63.54 -47.57 81.08 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.172 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.672 HD11 ' NH2' ' A' ' 74' ' ' ARG . 97.3 mt -98.04 33.41 2.15 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.501 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 71.8 mt-30 -54.28 -19.17 4.87 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.502 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 2.4 m -60.11 -40.73 84.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.332 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.493 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 121.66 7.36 8.15 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.893 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 149.37 41.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.5 t -71.35 128.97 35.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.639 ' HB3' HD12 ' A' ' 75' ' ' LEU . 11.3 p -79.24 155.72 28.45 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 123.29 0.369 . . . . 0.0 111.411 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.7 mp0 -66.52 161.95 54.45 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.555 ' N ' HE22 ' A' ' 27' ' ' GLN . 47.5 Cg_exo -55.37 129.74 36.82 Favored 'Trans proline' 0 C--N 1.295 -2.279 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.692 HG11 ' HA ' ' A' ' 68' ' ' PHE . 96.8 t -106.13 114.87 46.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -85.37 138.54 32.21 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.753 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.705 ' HB2' HG11 ' A' ' 65' ' ' VAL . 63.2 p -136.05 176.36 8.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -61.79 -32.7 73.01 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.67 -38.79 80.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.036 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.61 -146.97 16.06 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -176.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.526 ' CE1' ' HG2' ' A' ' 20' ' ' GLN . 82.9 m-85 -106.4 133.86 50.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.941 0.371 . . . . 0.0 110.709 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.491 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.9 m-70 -115.12 147.34 40.36 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.382 176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 76.5 t -117.97 127.55 75.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 167.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.658 HD11 ' CD2' ' A' ' 68' ' ' PHE . 81.5 mt -115.97 130.7 70.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -171.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -120.61 149.89 41.76 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.383 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.502 ' NH2' ' O ' ' A' ' 77' ' ' VAL . 8.7 tmm_? -79.05 143.87 35.19 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.701 HD22 ' HB3' ' A' ' 55' ' ' SER . 64.7 tp -117.15 135.42 53.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.382 0 CA-C-O 118.556 -1.135 . . . . 0.0 110.747 -177.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.683 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.2 144.9 99.48 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.051 1.834 . . . . 0.0 111.368 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.0 mmm -55.93 156.86 4.86 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.493 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.0 -39.48 2.98 Favored Glycine 0 C--N 1.315 -0.602 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' N ' ' A' ' 7' ' ' ALA . 1.5 m -63.19 128.63 36.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 93.5 mmm 44.81 17.68 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.216 0.323 . . . . 0.0 110.59 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.444 ' N ' ' C ' ' A' ' 5' ' ' SER . . . -64.09 -23.74 67.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.86 -35.67 75.27 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -91.09 158.29 16.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.011 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.635 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 45.6 mm -106.84 131.68 56.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' CG ' ' CE2' ' A' ' 58' ' ' TYR . 56.5 mtpt -87.95 105.91 17.77 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.667 ' SG ' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -148.37 168.22 23.17 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.498 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 4.9 m -130.81 133.04 45.61 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.339 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.483 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -124.58 149.56 46.88 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.457 -176.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.614 ' CG2' HD12 ' A' ' 43' ' ' LEU . 95.2 mt -125.31 128.19 72.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.759 HD13 ' CE1' ' A' ' 91' ' ' HIS . 47.1 tp -103.47 128.56 50.63 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.472 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.072 HG12 HD11 ' A' ' 43' ' ' LEU . 28.8 m -129.1 154.4 39.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 123.743 0.652 . . . . 0.0 110.818 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -67.76 -41.08 83.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.187 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 47.0 mttp -127.5 156.43 42.18 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -169.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.4 ' O ' HD23 ' A' ' 24' ' ' LEU . 26.1 mt-30 -60.59 -38.86 86.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.36 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.54 -38.42 91.14 Favored Glycine 0 N--CA 1.464 0.502 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 99.5 mt-10 -65.65 -42.12 91.8 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.14 82.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.686 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 20' ' ' GLN . 1.2 mm? -61.57 -42.26 98.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.85 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.04 74.2 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.095 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.9 m -66.03 -41.07 88.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.749 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -59.31 -46.12 89.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.054 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.501 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 73.7 mm-40 -67.82 -38.59 83.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.158 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.445 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 22.7 ttp85 -64.9 -38.11 89.87 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.418 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.418 HD22 ' HG ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -57.07 -27.16 61.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 33.2 mmtp -61.11 -31.6 71.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.19 -21.73 48.7 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.176 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.82 20.69 53.09 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' OE1' ' NZ ' ' A' ' 38' ' ' LYS . 36.5 mt-10 -65.34 164.36 13.76 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.477 ' NZ ' ' OD2' ' A' ' 53' ' ' ASP . 63.4 tttm -65.6 130.5 43.5 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 174.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.587 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 56.6 t80 -55.92 -42.88 76.76 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.637 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -57.12 -39.3 89.64 Favored Glycine 0 C--N 1.311 -0.836 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.835 177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.435 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 63.3 tttm -59.91 -45.7 91.71 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.418 ' HG ' HD22 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -62.16 -41.2 98.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.938 173.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.488 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -61.83 -42.84 99.53 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.425 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -65.21 -44.84 87.04 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.454 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 95.0 mt-10 -70.23 -43.66 70.16 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -169.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.072 HD11 HG12 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -117.24 -40.49 3.08 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -169.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.753 ' N ' HD13 ' A' ' 43' ' ' LEU . 1.4 m -45.82 133.54 8.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.489 HG13 HD23 ' A' ' 16' ' ' LEU . 46.1 pt -83.12 -14.95 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -80.4 92.42 5.82 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.308 174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.8 -46.82 93.38 Favored Glycine 0 CA--C 1.507 -0.447 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.191 -174.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.19 -46.99 84.56 Favored Glycine 0 C--N 1.319 -0.364 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.483 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 20.1 m -63.41 -34.05 76.88 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.322 174.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -64.22 -36.98 85.86 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.359 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 18.6 mmtp -60.53 -40.21 90.68 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -96.67 16.09 19.95 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.281 -174.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.637 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.9 m-20 63.1 32.91 14.97 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.663 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 70.65 -29.7 0.49 Allowed Glycine 0 C--N 1.31 -0.871 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 53' ' ' ASP . 53.6 m -55.31 98.59 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.717 0.77 . . . . 0.0 111.382 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.61 HD12 ' SG ' ' A' ' 12' ' ' CYS . 97.6 mt -65.07 -36.52 84.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.835 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 88.67 -145.05 18.61 Favored Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 -170.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.466 ' CE2' ' CG ' ' A' ' 11' ' ' LYS . 89.9 m-85 -83.09 134.03 35.03 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.504 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.3 p90 -144.04 150.23 37.88 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.629 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.53 165.55 22.49 Favored Glycine 0 C--O 1.24 0.493 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.493 ' HD2' ' CE1' ' A' ' 73' ' ' PHE . 76.9 mtp180 -81.05 160.54 24.5 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.641 0.376 . . . . 0.0 110.879 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.07 -51.61 1.13 Allowed Glycine 0 C--N 1.315 -0.615 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -64.23 -38.02 89.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.968 -0.616 . . . . 0.0 109.645 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.555 ' HE1' HD13 ' A' ' 56' ' ' LEU . 25.5 mmm -88.67 153.02 21.44 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.36 141.76 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.294 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 15.8 mmtm -43.7 -51.28 16.78 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.536 ' HB2' HG13 ' A' ' 84' ' ' VAL . 36.3 Cg_endo -61.4 -32.49 89.09 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 120.231 0.62 . . . . 0.0 111.571 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.673 ' CD2' HD11 ' A' ' 93' ' ' ILE . 47.7 t80 -62.62 -46.66 87.24 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.508 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 93.9 mt-10 -63.9 -47.23 81.42 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.241 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.06 -41.82 93.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.74 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.433 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -64.59 -46.62 81.93 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.86 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.531 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -62.5 -46.27 89.21 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.951 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.635 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 17.7 m-85 -61.82 -28.17 69.28 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.972 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.707 ' CZ ' ' HB3' ' A' ' 74' ' ' ARG . 2.1 mtm105 -64.46 -36.75 85.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.345 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.775 HD11 ' HB3' ' A' ' 81' ' ' SER . 10.3 mt -87.91 21.84 2.55 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -167.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 73' ' ' PHE . 75.6 mt-30 -54.26 -34.56 61.07 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.491 HG13 ' HG3' ' A' ' 79' ' ' GLU . 7.1 p -63.84 -27.54 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.279 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.02 6.05 7.83 Favored Glycine 0 N--CA 1.475 1.278 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.435 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.644 ' HB2' HD22 ' A' ' 75' ' ' LEU . 80.2 mt-10 -55.57 173.94 0.11 Allowed 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.4 t -106.76 132.57 53.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 167.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.775 ' HB3' HD11 ' A' ' 75' ' ' LEU . 99.7 p -66.32 163.21 18.56 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.227 0.537 . . . . 0.0 111.842 -172.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 3.5 mp0 -78.69 161.19 70.18 Favored Pre-proline 0 N--CA 1.422 -1.866 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -56.94 133.89 60.94 Favored 'Trans proline' 0 C--N 1.294 -2.329 0 N-CA-C 109.784 -0.891 . . . . 0.0 109.784 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 67' ' ' PRO . 42.6 t -117.97 125.64 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.534 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.8 tptp -88.98 137.47 32.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.94 0.4 . . . . 0.0 109.963 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.534 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 14.1 p -140.89 175.17 9.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -59.59 -39.77 85.25 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -65.15 -42.64 93.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.517 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.32 -137.34 5.75 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.664 ' O ' HD12 ' A' ' 16' ' ' LEU . 4.6 m-85 -105.01 132.78 50.82 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 117.107 0.453 . . . . 0.0 111.963 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.759 ' CE1' HD13 ' A' ' 16' ' ' LEU . 44.5 m-70 -114.27 141.74 47.18 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.391 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.3 t -118.02 128.28 75.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 167.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.673 HD11 ' CD2' ' A' ' 68' ' ' PHE . 88.5 mt -121.1 131.22 73.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 116.917 -0.129 . . . . 0.0 110.76 -173.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -116.08 147.86 40.85 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 167.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.46 HH21 ' CA ' ' A' ' 97' ' ' GLY . 2.6 ttp180 -77.57 143.46 38.31 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.34 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.421 ' HB3' ' C ' ' A' ' 11' ' ' LYS . 46.5 tp -100.68 145.58 28.26 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.46 ' CA ' HH21 ' A' ' 95' ' ' ARG . . . . . . . . 0 C--O 1.207 -1.576 0 CA-C-O 118.356 -1.247 . . . . 0.0 110.683 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.586 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -59.63 142.13 98.28 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.134 1.889 . . . . 0.0 112.683 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.62 ' SD ' ' NH2' ' A' ' 61' ' ' ARG . 96.1 mmm -100.84 160.32 14.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.192 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' N ' ' OD2' ' A' ' 8' ' ' ASP . . . 77.01 18.31 78.86 Favored Glycine 0 C--N 1.315 -0.599 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.439 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . 10.9 m -87.5 172.75 9.54 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.675 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.3 mmt -68.35 -39.16 81.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.333 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.86 5.1 10.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.498 ' OD1' ' NZ ' ' A' ' 9' ' ' LYS . 31.5 p-10 -66.17 -35.98 81.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.754 0.788 . . . . 0.0 108.918 176.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.498 ' NZ ' ' OD1' ' A' ' 8' ' ' ASP . 27.1 mtmm -85.03 157.54 20.71 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.251 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.58 HG13 ' HB1' ' A' ' 72' ' ' ALA . 44.4 mm -106.34 129.87 58.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.599 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 62.2 mtpt -90.93 104.11 16.74 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -145.1 169.59 17.86 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.515 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 9.2 m -126.51 145.63 50.43 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.871 174.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.482 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -134.63 149.57 50.57 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.921 0.391 . . . . 0.0 111.597 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.523 HG13 ' CE2' ' A' ' 36' ' ' PHE . 94.4 mt -129.41 128.06 65.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.23 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 46' ' ' ASP . 13.9 mt -94.61 128.68 41.41 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.412 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.13 154.72 35.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.704 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -66.28 -40.7 90.27 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.358 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 36.8 mtmm -121.6 152.48 39.23 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.332 0.587 . . . . 0.0 112.502 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.525 ' O ' HD23 ' A' ' 24' ' ' LEU . 53.6 tt0 -61.14 -40.95 95.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.489 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.06 -36.68 92.69 Favored Glycine 0 C--O 1.238 0.368 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.425 ' OE2' ' NZ ' ' A' ' 19' ' ' LYS . 98.9 mt-10 -63.76 -42.14 97.86 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 20' ' ' GLN . . . -58.76 -47.95 82.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.966 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 20' ' ' GLN . 4.5 mm? -61.52 -41.79 97.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.074 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.27 -51.83 66.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.574 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.021 HG11 HD21 ' A' ' 43' ' ' LEU . 18.6 m -68.97 -39.46 79.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.273 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.646 HE22 ' N ' ' A' ' 83' ' ' PRO . 67.8 mt-30 -55.4 -46.12 76.63 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 72.4 mm-40 -71.13 -35.29 71.67 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 175.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.612 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 74.9 ttt180 -60.28 -37.76 81.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.984 0.421 . . . . 0.0 110.025 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.12 -34.62 73.76 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.552 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 31.7 mmtp -62.53 -33.18 74.4 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.74 -24.72 64.25 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.441 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.82 -2.6 31.95 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.612 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 23.9 mt-10 -67.7 147.05 53.17 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.76 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.56 139.27 51.47 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CE2' HG13 ' A' ' 15' ' ' ILE . 52.3 t80 -58.21 -45.88 86.84 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.48 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.503 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.35 -35.66 91.98 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.263 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 25.3 tttm -60.22 -47.73 84.73 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.601 HD11 HH11 ' A' ' 29' ' ' ARG . 4.0 mm? -62.06 -40.81 97.03 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.501 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.546 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.11 -45.47 79.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 24.9 mmtm -65.5 -38.83 90.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.558 173.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 78.3 mt-10 -69.78 -54.17 14.88 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.021 HD21 HG11 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -124.18 -17.5 6.15 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -169.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.61 ' N ' HD12 ' A' ' 43' ' ' LEU . 1.1 m -48.99 127.26 13.94 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.311 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 45' ' ' ILE . 39.9 pt -76.74 -14.05 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.673 ' HB2' HD12 ' A' ' 16' ' ' LEU . 63.4 t0 -86.72 92.17 8.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.17 -42.72 99.35 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.13 -48.18 69.57 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.482 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 38.4 m -64.58 -33.37 75.77 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.513 -0.404 . . . . 0.0 110.315 175.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -62.81 -30.09 71.21 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.574 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -61.28 -39.87 92.03 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 81.3 mtp180 -97.23 19.68 12.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.404 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.503 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 47.8 m-20 58.72 31.79 21.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.16 -14.44 3.9 Favored Glycine 0 C--N 1.31 -0.904 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 13' ' ' SER . 20.2 m -69.19 90.88 0.49 Allowed 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.816 0.817 . . . . 0.0 111.313 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 56' ' ' LEU . 93.9 mt -62.94 -38.76 92.34 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.216 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.79 ' HA2' HD21 ' A' ' 96' ' ' LEU . . . 94.94 -144.14 17.01 Favored Glycine 0 CA--C 1.503 -0.698 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.4 ' H ' ' HD1' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -85.11 130.73 34.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.658 0.266 . . . . 0.0 110.827 -179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.495 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.8 p90 -144.89 152.87 40.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.876 0.369 . . . . 0.0 111.525 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.15 -173.31 37.33 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.62 ' NH2' ' SD ' ' A' ' 3' ' ' MET . 90.2 mtm-85 -81.96 154.78 25.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.69 -37.79 3.32 Favored Glycine 0 C--N 1.311 -0.852 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -63.0 -36.6 84.08 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.481 0.658 . . . . 0.0 109.476 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.474 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 3.7 mmm -104.62 155.64 18.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.281 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.74 154.35 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.463 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 13.7 mmtm -44.0 -55.0 10.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.661 ' HB2' HG13 ' A' ' 84' ' ' VAL . 40.0 Cg_endo -60.05 -34.69 94.54 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 CA-C-N 118.925 0.652 . . . . 0.0 111.074 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.594 ' CD2' HD11 ' A' ' 93' ' ' ILE . 10.5 t80 -63.12 -46.6 86.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.076 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.96 -41.72 99.61 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.714 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.9 -50.21 71.3 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.789 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.08 98.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.459 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB1' HG13 ' A' ' 10' ' ' ILE . . . -57.84 -50.47 73.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.149 -177.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -67.6 -38.73 84.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.039 0.447 . . . . 0.0 111.297 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.529 HH22 ' CD ' ' A' ' 82' ' ' GLU . 78.7 mtp180 -63.99 -41.18 97.6 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.915 HD11 ' HA ' ' A' ' 81' ' ' SER . 43.0 mt -97.92 23.58 7.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -171.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.421 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 88.5 mt-30 -54.03 -25.54 21.86 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.91 -29.64 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.032 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 122.12 -0.34 10.66 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.203 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.718 ' HB2' HD22 ' A' ' 75' ' ' LEU . 19.4 mt-10 -70.64 174.28 6.1 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -174.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -98.49 131.23 46.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.574 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.915 ' HA ' HD11 ' A' ' 75' ' ' LEU . 43.1 t -64.34 162.09 15.58 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.708 -176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.529 ' CD ' HH22 ' A' ' 74' ' ' ARG . 0.0 OUTLIER -72.91 163.11 70.84 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 165.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.646 ' N ' HE22 ' A' ' 27' ' ' GLN . 72.1 Cg_endo -61.82 140.19 84.21 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 N-CA-C 110.214 -0.725 . . . . 0.0 110.214 -175.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' A' ' 67' ' ' PRO . 77.3 t -123.16 100.47 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.813 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.5 tptp -80.05 130.23 35.1 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.481 174.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.571 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 52.8 p -129.14 -176.25 3.81 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.362 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -62.61 -39.78 94.87 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -66.37 -41.62 89.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.315 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.79 -150.63 21.9 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.502 ' O ' HD23 ' A' ' 16' ' ' LEU . 77.7 m-85 -99.16 118.88 36.87 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.522 ' CE1' HD21 ' A' ' 16' ' ' LEU . 34.9 m-70 -99.33 139.54 34.82 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 123.341 0.401 . . . . 0.0 110.319 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.436 HG21 ' CG2' ' A' ' 26' ' ' VAL . 70.0 t -114.93 125.44 72.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 168.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.594 HD11 ' CD2' ' A' ' 68' ' ' PHE . 84.2 mt -123.62 127.44 74.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.129 -170.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -120.79 143.36 48.88 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.54 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 5.6 tmm_? -78.5 142.21 37.6 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.79 HD21 ' HA2' ' A' ' 57' ' ' GLY . 0.3 OUTLIER -121.98 151.3 40.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.124 -179.113 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.425 ' N ' HD12 ' A' ' 96' ' ' LEU . . . . . . . . 0 C--O 1.206 -1.627 0 CA-C-O 118.364 -1.242 . . . . 0.0 110.25 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' O ' ' NH1' ' A' ' 61' ' ' ARG . . . . . . . . 0 CA--C 1.525 0.686 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.606 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 40.0 Cg_exo -59.45 145.72 97.11 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 122.248 1.965 . . . . 0.0 110.563 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.6 mtp -104.01 131.65 51.05 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.82 42.46 61.02 Favored Glycine 0 C--N 1.318 -0.42 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.469 ' H ' ' HB2' ' A' ' 8' ' ' ASP . 28.5 t -135.69 174.51 10.53 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.9 0.381 . . . . 0.0 110.646 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 78.3 mtm -63.34 -39.13 93.69 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.43 24.12 2.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.775 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.507 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 9.7 t70 -62.28 -41.96 98.93 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.35 159.45 15.11 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.654 172.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.83 HD11 ' CE2' ' A' ' 73' ' ' PHE . 66.0 mt -105.34 127.61 59.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.562 ' HB3' ' NZ ' ' A' ' 11' ' ' LYS . 9.2 mtpm? -94.87 107.51 19.53 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.771 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -147.54 169.64 19.15 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.914 -173.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.536 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.7 m -130.45 146.27 51.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.068 173.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.556 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -138.6 149.34 45.15 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.876 -178.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.769 HG23 ' OG ' ' A' ' 44' ' ' SER . 94.9 mt -127.91 125.96 65.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.825 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 90' ' ' TYR . 42.3 tp -97.88 115.45 28.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.49 HG13 HG22 ' A' ' 15' ' ' ILE . 35.7 m -116.37 152.34 18.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.527 0.68 . . . . 0.0 112.294 -174.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -66.87 -42.92 84.82 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.904 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 31.3 mmtp -119.37 150.42 40.19 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.817 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -60.03 -38.03 81.52 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.079 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.79 -36.09 92.23 Favored Glycine 0 C--N 1.322 -0.234 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.483 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 95.8 mt-10 -64.53 -43.64 93.36 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -58.43 -46.7 85.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.001 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.49 -41.03 98.57 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.281 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.95 92.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.826 ' CG1' HD22 ' A' ' 43' ' ' LEU . 7.3 m -68.39 -34.44 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.103 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 49.4 tt0 -59.32 -46.47 88.5 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.155 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.76 -41.65 74.9 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.472 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.745 ' HD3' HD11 ' A' ' 39' ' ' LEU . 76.1 ttt180 -60.77 -39.23 88.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.861 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.99 -39.82 91.12 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.954 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 17.7 mmtp -65.47 -9.54 26.58 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -88.34 -3.51 58.83 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.152 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.48 11.04 75.79 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.587 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.596 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 13.2 mt-10 -78.85 154.21 29.99 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.473 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 21.3 tptm -62.29 126.4 27.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.233 -176.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.518 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 58.2 t80 -58.04 -44.47 87.43 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.643 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -60.11 -37.74 93.3 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.942 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 44.6 tttp -61.23 -44.28 97.52 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.82 HD12 HG12 ' A' ' 26' ' ' VAL . 4.4 mm? -62.02 -41.46 98.11 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.295 172.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -57.17 -51.91 67.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.38 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -65.54 -39.43 91.75 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' A' ' 38' ' ' LYS . 92.2 mt-10 -70.08 -48.08 59.22 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.826 HD22 ' CG1' ' A' ' 26' ' ' VAL . 9.5 mp -98.26 -50.49 4.32 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.769 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.2 m -50.81 139.21 17.26 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.1 -1.409 . . . . 0.0 113.093 -161.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.467 HG13 HD23 ' A' ' 16' ' ' LEU . 36.1 pt -97.42 -2.34 10.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.672 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -89.19 94.11 9.81 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.828 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -62.26 -42.29 99.72 Favored Glycine 0 C--O 1.234 0.136 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.3 -42.09 63.27 Favored Glycine 0 N--CA 1.454 -0.136 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.556 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 15.9 m -72.46 -33.08 66.78 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.635 -0.282 . . . . 0.0 111.569 175.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.77 -33.18 74.63 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.161 0.505 . . . . 0.0 110.512 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 10.4 mmtp -61.98 -41.85 98.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.29 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -98.67 9.1 44.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.406 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.643 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.5 m-20 63.63 33.12 13.46 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.078 0.466 . . . . 0.0 110.395 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.4 -14.61 5.13 Favored Glycine 0 C--N 1.31 -0.897 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -63.19 89.32 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.0 0.428 . . . . 0.0 110.955 -179.355 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.771 HD12 ' SG ' ' A' ' 12' ' ' CYS . 96.4 mt -63.4 -40.29 96.83 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 87.19 -151.31 23.47 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.91 131.07 34.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.028 0.414 . . . . 0.0 110.004 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 52.5 p90 -142.79 148.72 37.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.345 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.18 150.92 34.31 Favored Glycine 0 C--N 1.314 -0.67 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.606 ' NH2' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -69.94 144.32 52.43 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.56 0.219 . . . . 0.0 110.734 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.58 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 106.95 -20.77 33.01 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -175.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -62.69 -42.5 99.66 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.608 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 75.0 mtm -120.0 160.66 22.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.931 0.396 . . . . 0.0 111.961 -174.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 68' ' ' PHE . 32.4 m -43.49 128.16 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.012 -177.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.608 ' NZ ' ' O ' ' A' ' 64' ' ' MET . 1.9 mmtm -45.08 -46.5 30.35 Favored Pre-proline 0 C--N 1.308 -1.198 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.058 -173.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 30.0 Cg_endo -59.82 -35.3 94.52 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 CA-C-N 119.311 0.79 . . . . 0.0 111.451 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' A' ' 93' ' ' ILE . 54.3 t80 -61.76 -49.07 77.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.959 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 99.1 mt-10 -66.11 -41.49 90.49 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.572 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.85 -46.65 81.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.813 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.99 -38.5 88.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.854 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.512 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -58.33 -41.23 84.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.897 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.83 ' CE2' HD11 ' A' ' 10' ' ' ILE . 57.3 m-85 -64.69 -35.25 80.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.018 0.437 . . . . 0.0 111.386 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -58.8 -23.19 59.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.506 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 81' ' ' SER . 84.2 mt -96.92 4.94 51.34 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -171.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.477 ' HA ' ' HD2' ' A' ' 95' ' ' ARG . 67.4 mm-40 -47.16 -20.41 0.18 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.57 -40.55 86.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 120.814 0.34 . . . . 0.0 110.124 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 122.95 48.49 0.24 Allowed Glycine 0 N--CA 1.465 0.615 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.451 ' OE1' ' N ' ' A' ' 80' ' ' VAL . 1.2 mm-40 -122.31 175.78 6.22 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.034 0.445 . . . . 0.0 112.166 -173.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 94' ' ' LYS . 75.2 t -108.99 131.37 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.703 ' HB3' HD11 ' A' ' 75' ' ' LEU . 6.4 p -75.51 163.19 27.64 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -173.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -70.33 165.33 45.47 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.596 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 63.5 Cg_exo -55.84 130.96 43.18 Favored 'Trans proline' 0 C--N 1.293 -2.392 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.1 t -117.88 124.4 73.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 41.7 tttp -91.51 131.89 36.65 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.67 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 97.1 p -118.85 -172.05 2.21 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.701 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 1.2 pm0 -66.8 -38.8 87.2 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 88' ' ' PHE . 6.0 m-30 -64.39 -46.89 81.33 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.978 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.85 -150.88 21.11 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.592 ' O ' HD12 ' A' ' 16' ' ' LEU . 10.9 m-85 -96.5 129.41 43.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.837 0.351 . . . . 0.0 111.381 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -110.85 146.68 36.03 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.029 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.708 HG11 ' CG2' ' A' ' 26' ' ' VAL . 2.1 t -117.4 121.03 66.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 167.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.546 HD11 ' CD2' ' A' ' 68' ' ' PHE . 87.3 mt -113.1 127.82 70.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.428 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.455 ' HB2' HG22 ' A' ' 80' ' ' VAL . 59.5 tttm -115.43 145.13 42.86 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.409 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 75' ' ' LEU . 68.4 ttt-85 -79.5 139.37 37.62 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.024 177.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 55.8 tp -112.66 129.1 56.51 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.505 ' C ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.206 -1.633 0 CA-C-O 118.376 -1.236 . . . . 0.0 112.152 -173.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.84 151.83 83.41 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 123.165 2.577 . . . . 0.0 112.059 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.5 mtp -61.73 148.51 42.63 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.02 38.5 0.87 Allowed Glycine 0 C--N 1.309 -0.917 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.475 ' O ' ' HG2' ' A' ' 9' ' ' LYS . 18.6 p -139.69 159.39 42.28 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 95.3 mtp -63.89 -41.35 97.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.826 0.346 . . . . 0.0 111.432 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.9 -36.86 83.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.237 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 5' ' ' SER . 1.2 p30 -64.94 -23.35 67.2 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.445 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 44.3 mmtm -75.08 167.17 22.43 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.27 176.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.682 HG21 ' HB1' ' A' ' 72' ' ' ALA . 43.5 mm -107.92 129.13 62.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 48.7 mtpt -92.7 106.88 18.79 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 175.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -138.22 166.04 25.17 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.779 0.799 . . . . 0.0 112.933 -177.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.467 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 3.9 m -133.35 138.53 46.37 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.895 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.47 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -132.8 150.28 52.18 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.372 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.705 HG23 ' OG ' ' A' ' 44' ' ' SER . 95.7 mt -125.09 127.22 72.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.621 177.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.754 HD12 ' O ' ' A' ' 90' ' ' TYR . 51.2 tp -98.72 125.01 43.92 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.944 HG12 HD11 ' A' ' 43' ' ' LEU . 33.6 m -118.06 151.85 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.389 0.614 . . . . 0.0 111.275 -176.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.487 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 6.2 mttp -66.71 -40.62 88.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.201 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -133.77 158.84 42.31 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.866 -169.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.11 -39.75 87.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.488 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.81 -39.74 91.93 Favored Glycine 0 CA--C 1.507 -0.444 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.528 ' O ' HG13 ' A' ' 26' ' ' VAL . 97.0 mt-10 -65.07 -43.59 91.7 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.836 176.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.657 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -59.4 -48.36 81.94 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.124 0.488 . . . . 0.0 110.125 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.57 -42.93 99.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.214 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.87 80.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.75 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 22' ' ' GLU . 12.6 m -63.54 -41.39 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.778 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.513 HE22 ' HA ' ' A' ' 82' ' ' GLU . 94.7 mt-30 -55.92 -44.05 77.95 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -70.08 -41.71 73.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.322 0.582 . . . . 0.0 110.371 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 75.9 ttt180 -61.6 -38.36 87.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.941 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 36' ' ' PHE . 3.8 mm? -59.75 -37.58 79.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 18.7 mmtm -62.72 -30.71 71.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.03 -23.94 56.3 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.876 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.22 13.09 25.71 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.02 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.556 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 33.0 mt-10 -80.74 150.2 29.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.151 0.475 . . . . 0.0 110.705 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 61.1 tttm -65.78 137.17 57.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.046 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.606 ' HA ' HD11 ' A' ' 30' ' ' LEU . 59.2 t80 -56.77 -45.19 82.25 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.616 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.64 -37.63 95.09 Favored Glycine 0 C--N 1.317 -0.503 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 65.6 tttm -58.31 -46.71 85.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.491 HD11 ' HD3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -62.43 -41.14 98.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.529 174.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.48 -49.64 76.63 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.317 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.449 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 43.1 mttp -64.68 -41.24 96.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.646 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.504 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 58.6 mt-10 -71.25 -44.2 65.76 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.944 HD11 HG12 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -113.1 -38.2 4.54 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -169.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.705 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.5 m -54.78 142.83 27.48 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.81 -173.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.561 HG13 HD23 ' A' ' 16' ' ' LEU . 42.3 pt -95.89 6.59 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.923 0.868 . . . . 0.0 109.449 171.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 25.2 t0 -91.53 113.96 26.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.02 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.74 -65.39 2.82 Favored Glycine 0 C--N 1.318 -0.46 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.59 -44.78 78.79 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 54' ' ' GLY . 15.0 m -66.63 -34.32 77.62 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.808 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 46' ' ' ASP . . . -65.7 -38.92 90.56 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.174 0.512 . . . . 0.0 110.685 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -63.55 -33.68 76.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.007 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -99.0 16.72 21.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.103 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.616 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 19.6 m-20 60.02 35.5 21.47 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.447 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.45 -28.76 1.23 Allowed Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -56.38 91.41 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.918 0.39 . . . . 0.0 110.808 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.439 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 83.9 mt -63.18 -39.05 93.54 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . 104.32 -148.03 16.67 Favored Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.53 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 21.6 m-85 -84.54 130.67 34.72 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.487 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 44.4 p90 -146.65 149.98 34.54 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.989 174.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.82 -170.23 36.98 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -73.76 154.3 39.64 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 122.737 -0.273 . . . . 0.0 110.338 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.19 -33.96 5.6 Favored Glycine 0 C--N 1.313 -0.75 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.041 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -64.42 -41.28 96.69 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.791 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -108.57 160.64 15.76 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.302 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 18.4 m -64.04 152.13 8.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.429 -176.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.519 ' NZ ' ' OD2' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -43.76 -57.55 5.7 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.465 -175.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 38.0 Cg_endo -58.91 -32.19 96.92 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 N-CA-C 110.557 -0.593 . . . . 0.0 110.557 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.608 ' CD2' HD11 ' A' ' 93' ' ' ILE . 27.1 t80 -61.74 -47.57 84.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.513 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -62.84 -45.41 92.74 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.115 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.519 ' OD2' ' NZ ' ' A' ' 66' ' ' LYS . 40.5 m-20 -62.29 -40.28 95.76 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.281 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.57 -41.47 96.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.932 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.682 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -59.04 -49.43 77.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.581 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CE1' HD11 ' A' ' 10' ' ' ILE . 62.6 m-85 -65.17 -38.03 89.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.226 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -64.93 -39.5 93.6 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.744 HD22 ' HB2' ' A' ' 79' ' ' GLU . 44.0 mt -94.02 16.99 13.16 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.148 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.557 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 50.2 mt-30 -55.09 -19.67 7.91 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.958 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.549 HG13 ' HG3' ' A' ' 79' ' ' GLU . 7.2 p -65.24 -27.04 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.646 175.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.498 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 123.81 3.04 8.53 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 121.672 -0.299 . . . . 0.0 112.536 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.744 ' HB2' HD22 ' A' ' 75' ' ' LEU . 47.9 mt-10 -67.24 174.43 3.24 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.1 t -110.85 132.29 59.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.576 ' HB3' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -73.32 160.69 31.46 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -174.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.513 ' HA ' HE22 ' A' ' 27' ' ' GLN . 0.7 OUTLIER -70.73 175.84 2.35 Favored Pre-proline 0 N--CA 1.444 -0.733 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 170.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.94 134.25 61.17 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 CA-C-N 119.538 0.871 . . . . 0.0 109.868 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.47 126.67 74.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.567 ' NZ ' ' O ' ' A' ' 86' ' ' SER . 29.9 tptp -97.56 135.58 39.19 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.25 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.567 ' O ' ' NZ ' ' A' ' 85' ' ' LYS . 60.5 p -135.03 169.89 16.74 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.707 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 1.7 pm0 -61.47 -34.02 74.74 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -63.35 -42.35 98.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.506 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.79 -146.17 13.35 Favored Glycine 0 C--N 1.321 -0.297 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.408 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.754 ' O ' HD12 ' A' ' 16' ' ' LEU . 6.4 m-85 -103.52 130.79 50.98 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 122.266 0.226 . . . . 0.0 110.522 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.712 ' CE1' HD13 ' A' ' 16' ' ' LEU . 35.9 m-70 -116.12 144.57 43.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.956 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.01 127.35 75.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 167.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.608 HD11 ' CD2' ' A' ' 68' ' ' PHE . 86.0 mt -120.16 129.49 75.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 122.572 -0.08 . . . . 0.0 110.833 -173.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 63.7 tttp -120.65 159.65 24.89 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.557 ' NE ' ' O ' ' A' ' 76' ' ' GLN . 27.7 ttt-85 -75.84 143.9 41.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.471 HD23 ' HA2' ' A' ' 57' ' ' GLY . 50.6 tp -108.77 142.06 39.87 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.4 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.198 -2.124 0 CA-C-O 118.09 -1.394 . . . . 0.0 112.135 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.433 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -64.59 145.6 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.22 1.28 . . . . 0.0 111.535 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.4 mtp -112.33 151.73 29.38 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.399 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.77 5.17 78.52 Favored Glycine 0 C--N 1.317 -0.499 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -173.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.5 p -76.62 173.53 11.48 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.853 -0.673 . . . . 0.0 110.442 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.5 mmt -63.14 -36.08 82.44 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.09 -0.09 2.24 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.322 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -59.28 -36.09 74.92 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' PHE . 39.9 mttm -109.75 149.0 30.43 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.322 -176.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.642 HD12 ' CE2' ' A' ' 59' ' ' PHE . 21.1 mt -106.42 128.52 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.264 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -172.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.544 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 41.5 mtpt -90.72 104.57 17.14 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.599 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -148.11 167.38 25.14 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -175.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m -124.83 132.98 53.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.206 174.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.479 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -127.58 149.44 50.16 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.396 -175.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.714 HG23 ' OG ' ' A' ' 44' ' ' SER . 92.6 mt -124.33 125.94 71.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.708 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.617 HD13 ' CE1' ' A' ' 91' ' ' HIS . 51.3 tp -103.67 125.74 50.36 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 90' ' ' TYR . 32.7 m -134.86 155.13 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 121.107 0.479 . . . . 0.0 111.264 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.55 -22.85 34.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.462 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 22' ' ' GLU . 53.4 mmtt -112.14 140.92 46.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.896 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -64.05 -39.5 94.21 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.491 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.67 -35.76 90.24 Favored Glycine 0 N--CA 1.459 0.212 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.625 ' HB3' HD23 ' A' ' 43' ' ' LEU . 89.8 mt-10 -65.26 -42.83 92.88 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.56 -47.04 87.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.089 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -62.21 -41.93 98.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.955 0.407 . . . . 0.0 110.381 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.31 -50.68 72.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.193 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.935 HG12 HD12 ' A' ' 39' ' ' LEU . 10.7 m -64.7 -41.78 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.777 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.621 HE21 HG22 ' A' ' 92' ' ' VAL . 80.7 mt-30 -58.75 -50.84 72.44 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.145 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -65.78 -37.91 87.59 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.319 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.702 ' HD3' HD11 ' A' ' 39' ' ' LEU . 67.1 ttt180 -63.42 -37.49 87.48 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.316 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.3 mm? -61.56 -40.9 96.37 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 19.8 mmtp -63.32 -34.96 78.83 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.313 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -60.56 -24.24 65.26 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.538 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.52 6.93 26.67 Favored Glycine 0 N--CA 1.463 0.483 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.157 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 6.2 mt-10 -82.77 150.92 26.37 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.236 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -67.25 137.26 56.02 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.704 0.764 . . . . 0.0 112.021 -174.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.572 ' HA ' HD21 ' A' ' 30' ' ' LEU . 54.2 t80 -55.01 -43.0 73.23 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.639 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -59.35 -37.42 91.94 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.263 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.02 -47.82 84.26 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.935 HD12 HG12 ' A' ' 26' ' ' VAL . 4.4 mm? -62.67 -41.93 99.35 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.619 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -62.46 -43.47 98.74 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.053 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -63.3 -41.77 98.99 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -75.1 -82.11 0.07 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -174.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.896 HD22 ' CG1' ' A' ' 26' ' ' VAL . 6.6 mp -64.23 -42.8 96.38 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -170.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.714 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.1 m -56.57 133.43 53.56 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.736 -162.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.469 HG13 HD23 ' A' ' 16' ' ' LEU . 44.3 pt -87.98 -7.47 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.131 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 49' ' ' SER . 54.4 t0 -84.34 94.45 8.47 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.532 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -59.51 -50.68 65.1 Favored Glycine 0 C--N 1.315 -0.618 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.31 -44.69 93.35 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 39.6 m -62.79 -33.7 75.74 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.467 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -63.43 -36.74 84.72 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 47.4 mmtm -61.8 -33.69 74.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.835 HH21 HD23 ' A' ' 56' ' ' LEU . 76.5 mtm-85 -96.52 6.61 48.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.288 -175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.639 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 70.7 m-20 65.98 36.76 5.69 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.963 0.411 . . . . 0.0 110.152 -174.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 -20.66 4.75 Favored Glycine 0 C--N 1.317 -0.483 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -54.48 99.13 0.03 OUTLIER 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.374 0.607 . . . . 0.0 111.349 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.835 HD23 HH21 ' A' ' 52' ' ' ARG . 90.1 mt -68.73 -38.72 80.38 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 90.79 -145.17 17.73 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 -172.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.544 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 11.1 m-85 -83.99 132.65 34.73 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.642 ' CE2' HD12 ' A' ' 10' ' ' ILE . 52.3 p90 -142.51 149.39 39.09 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.448 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.95 173.67 28.18 Favored Glycine 0 C--O 1.238 0.36 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -81.63 159.73 23.95 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.566 0.222 . . . . 0.0 110.937 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.67 -77.15 0.38 Allowed Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -61.73 -39.31 91.1 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.229 0.538 . . . . 0.0 109.873 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.467 ' HG3' ' CD2' ' A' ' 59' ' ' PHE . 41.8 mmm -66.2 147.74 52.88 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.876 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 68' ' ' PHE . 29.9 m -79.07 136.91 22.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.097 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 9.3 mmtm -43.9 -50.24 19.69 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.565 ' HB2' HG13 ' A' ' 84' ' ' VAL . 29.5 Cg_endo -57.55 -36.61 98.59 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 CA-C-N 118.999 0.678 . . . . 0.0 110.797 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.649 ' HA ' HG11 ' A' ' 84' ' ' VAL . 31.8 t80 -63.13 -47.99 80.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.862 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 98.0 mt-10 -64.26 -46.61 82.98 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.288 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 10.9 t70 -57.07 -48.26 78.99 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.236 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.57 96.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.48 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -59.27 -45.83 90.17 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.573 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.489 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 59.1 m-85 -63.16 -36.4 83.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.227 0.537 . . . . 0.0 111.126 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 94.7 mtt-85 -65.03 -22.34 66.97 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.289 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.589 HD11 ' CB ' ' A' ' 81' ' ' SER . 73.0 mt -96.34 9.4 41.31 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.573 ' OE1' ' NH1' ' A' ' 95' ' ' ARG . 15.8 mm100 -43.42 -24.76 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 117.936 0.335 . . . . 0.0 111.75 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.98 -23.38 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.111 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 114.29 3.94 22.42 Favored Glycine 0 N--CA 1.47 0.91 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.473 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -73.91 175.48 7.29 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -172.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.21 131.09 56.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.147 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.589 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -74.34 153.21 39.4 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.161 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.439 ' C ' HE22 ' A' ' 27' ' ' GLN . 2.4 mp0 -68.1 171.3 5.83 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 167.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.544 ' N ' HE22 ' A' ' 27' ' ' GLN . 52.6 Cg_exo -54.51 132.66 52.41 Favored 'Trans proline' 0 C--N 1.289 -2.566 0 C-N-CA 120.399 0.733 . . . . 0.0 111.067 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.649 HG11 ' HA ' ' A' ' 68' ' ' PHE . 60.8 t -109.94 107.29 22.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.545 ' CG ' ' CE2' ' A' ' 90' ' ' TYR . 1.6 tmtp? -79.33 134.38 36.61 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.84 -175.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 p -137.95 168.73 19.11 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.638 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -60.46 -34.28 73.78 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -67.25 -38.77 85.72 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.909 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.49 -154.83 25.85 Favored Glycine 0 C--N 1.314 -0.651 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.545 ' CE2' ' CG ' ' A' ' 85' ' ' LYS . 84.7 m-85 -104.69 126.86 52.19 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.617 ' CE1' HD13 ' A' ' 16' ' ' LEU . 7.7 m-70 -105.06 143.13 33.67 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.641 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.621 HG22 HE21 ' A' ' 27' ' ' GLN . 54.2 t -117.15 125.78 74.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 169.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.593 HD11 ' CD2' ' A' ' 68' ' ' PHE . 81.2 mt -115.9 129.41 72.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -110.05 140.81 43.68 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 168.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.573 ' NH1' ' OE1' ' A' ' 76' ' ' GLN . 4.7 tpt180 -77.9 135.32 37.86 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.455 ' O ' ' NE ' ' A' ' 95' ' ' ARG . 53.7 tp -121.7 145.63 47.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.616 -172.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.402 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.211 -1.282 0 CA-C-O 118.342 -1.255 . . . . 0.0 110.859 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.588 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.414 ' O ' ' OG ' ' A' ' 5' ' ' SER . 32.6 Cg_exo -60.98 148.55 92.41 Favored 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.024 1.816 . . . . 0.0 110.779 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.7 mtp -56.14 141.52 40.28 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.403 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.77 -30.82 5.9 Favored Glycine 0 C--N 1.319 -0.384 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.442 ' N ' ' CE2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -68.83 93.03 0.52 Allowed 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 97.8 mtp -124.58 144.05 50.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.47 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.86 -24.76 67.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.296 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.578 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 32.2 t70 -61.75 -42.12 98.56 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -81.87 167.09 19.35 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.161 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.94 HG21 ' HB1' ' A' ' 72' ' ' ALA . 21.2 mm -105.86 126.6 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.577 ' HG2' ' CD1' ' A' ' 58' ' ' TYR . 56.8 mtpt -88.34 104.08 16.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.1 OUTLIER -148.77 168.31 23.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -175.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.9 m -131.13 146.35 52.31 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.594 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -140.18 150.31 44.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.682 HG23 ' OG ' ' A' ' 44' ' ' SER . 91.3 mt -127.1 128.8 70.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.08 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -101.19 116.61 33.21 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.571 ' N ' HD13 ' A' ' 16' ' ' LEU . 35.8 m -120.83 154.66 24.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.502 0.668 . . . . 0.0 111.29 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -65.9 -40.62 91.68 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.657 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -119.15 148.9 42.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.448 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 48.8 mt-30 -62.4 -40.69 97.32 Favored 'General case' 0 CA--C 1.51 -0.558 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.124 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.52 -40.76 94.91 Favored Glycine 0 CA--C 1.511 -0.209 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -63.76 -44.45 93.4 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' A' ' 92' ' ' VAL . . . -59.11 -48.0 83.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.978 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.11 -41.01 99.28 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.138 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.05 -47.99 81.46 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.729 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.564 HG12 HD12 ' A' ' 39' ' ' LEU . 28.4 m -70.44 -32.89 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 81' ' ' SER . 48.6 tt0 -59.46 -48.18 82.62 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 77.9 mm-40 -71.12 -36.42 72.12 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.118 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.865 ' HD2' HD11 ' A' ' 39' ' ' LEU . 42.4 ttm180 -60.55 -37.94 82.9 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -58.56 -27.15 64.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.252 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.499 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 33.6 mmtp -61.75 -38.73 89.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.12 -24.27 58.09 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.799 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.33 15.38 30.29 Favored Glycine 0 C--N 1.32 -0.356 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -58.9 140.82 54.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.532 ' NZ ' ' OD2' ' A' ' 53' ' ' ASP . 17.0 tptm -56.1 127.38 30.31 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CE2' HG13 ' A' ' 15' ' ' ILE . 61.6 t80 -57.06 -43.52 82.15 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -60.45 -33.8 82.75 Favored Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.836 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 87.2 tttt -59.9 -48.64 80.88 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.865 HD11 ' HD2' ' A' ' 29' ' ' ARG . 4.5 mm? -62.04 -41.94 98.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.435 175.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.514 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.48 -48.68 76.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.444 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -64.38 -39.66 94.3 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.25 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.584 ' C ' HD13 ' A' ' 43' ' ' LEU . 63.8 mm-40 -70.33 -45.17 66.71 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -171.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.843 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.77 -24.06 4.56 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -177.041 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.682 ' OG ' HG23 ' A' ' 15' ' ' ILE . 3.7 m -50.98 137.82 20.49 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.53 -173.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.54 ' CG1' HD12 ' A' ' 16' ' ' LEU . 39.4 pt -98.69 -5.22 9.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.317 0.579 . . . . 0.0 109.501 172.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.473 ' CG ' ' HG ' ' A' ' 49' ' ' SER . 67.3 t0 -87.82 107.85 18.87 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.661 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -64.34 -43.64 96.58 Favored Glycine 0 C--N 1.318 -0.428 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.32 -49.46 68.37 Favored Glycine 0 CA--C 1.504 -0.654 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.594 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 16.2 m -60.58 -34.53 74.33 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.798 0.332 . . . . 0.0 110.409 174.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.03 -38.14 85.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.261 0.553 . . . . 0.0 110.743 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 35.3 mmtp -64.12 -39.45 94.06 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 55' ' ' SER . 80.2 mtp180 -98.09 25.47 6.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.086 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.532 ' OD2' ' NZ ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER 35.94 42.44 0.16 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.781 0.8 . . . . 0.0 112.659 -178.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.38 -15.87 4.17 Favored Glycine 0 C--N 1.315 -0.63 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.474 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ARG . 4.9 m -73.41 77.7 1.39 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.26 0.552 . . . . 0.0 110.796 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.483 HD11 ' CD2' ' A' ' 14' ' ' HIS . 96.2 mt -64.58 -38.44 91.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.153 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.26 -141.67 21.6 Favored Glycine 0 CA--C 1.501 -0.786 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.577 ' CD1' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -85.8 139.99 30.83 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.606 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 55.2 p90 -144.77 152.89 41.04 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.802 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.5 172.66 36.28 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 8' ' ' ASP . 72.1 mtm-85 -84.69 148.68 26.27 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.017 0.437 . . . . 0.0 111.991 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.81 -56.13 0.48 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.019 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -61.4 -39.42 90.67 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.081 0.467 . . . . 0.0 111.129 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.473 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 76.0 mmm -79.99 153.74 28.69 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.67 -176.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 m -68.4 137.95 23.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.362 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -44.29 -52.5 16.47 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -173.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.527 ' HB2' HG13 ' A' ' 84' ' ' VAL . 31.3 Cg_endo -60.21 -32.44 94.42 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 CA-C-N 118.639 0.55 . . . . 0.0 111.284 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.498 ' CD2' HD11 ' A' ' 93' ' ' ILE . 47.2 t80 -62.19 -47.22 85.46 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.543 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 76.7 mt-10 -63.78 -43.19 97.09 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.817 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -56.25 -49.18 74.91 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.793 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -63.44 -42.72 98.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.859 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.94 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -57.67 -49.09 77.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.27 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 69' ' ' GLU . 32.1 m-85 -63.62 -38.96 93.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -61.64 -33.42 73.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.316 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 ' HB3' ' A' ' 81' ' ' SER . 90.9 mt -89.12 5.71 43.33 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.531 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 15.5 mm100 -42.83 -24.08 0.06 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 118.219 0.463 . . . . 0.0 112.01 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -63.28 -26.22 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 120.798 0.332 . . . . 0.0 111.878 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.517 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 114.19 11.39 12.22 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.681 -0.567 . . . . 0.0 111.681 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -85.71 174.42 9.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -172.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.78 HG22 ' HD3' ' A' ' 94' ' ' LYS . 11.3 t -95.78 131.46 42.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.878 ' HB3' HD11 ' A' ' 75' ' ' LEU . 28.5 p -72.92 160.89 31.41 Favored 'General case' 0 CA--C 1.497 -1.082 0 O-C-N 123.138 0.273 . . . . 0.0 111.71 -172.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.495 ' HA ' HE22 ' A' ' 27' ' ' GLN . 2.9 mt-10 -64.12 168.91 5.29 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 166.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -57.94 136.08 72.89 Favored 'Trans proline' 0 C--N 1.292 -2.422 0 N-CA-C 109.606 -0.959 . . . . 0.0 109.606 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.527 HG13 ' HB2' ' A' ' 67' ' ' PRO . 45.2 t -117.52 130.04 73.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HD2' ' CE1' ' A' ' 90' ' ' TYR . 82.9 tttt -110.65 131.75 54.78 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.989 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.3 p -143.72 -171.58 3.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.972 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.7 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 2.1 pm0 -66.09 -31.81 72.9 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -64.1 -37.92 89.2 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.805 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 16' ' ' LEU . . . 142.85 -139.41 9.0 Favored Glycine 0 C--O 1.242 0.608 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 87.4 m-85 -106.98 126.89 52.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.472 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 2.0 m-70 -105.35 147.28 28.35 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.59 0.233 . . . . 0.0 111.097 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 73.3 t -117.5 126.69 74.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 167.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.498 HD11 ' CD2' ' A' ' 68' ' ' PHE . 91.4 mt -115.37 127.32 72.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.65 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.78 ' HD3' HG22 ' A' ' 80' ' ' VAL . 27.0 tptp -106.22 128.74 54.16 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.531 ' CD ' ' HA ' ' A' ' 76' ' ' GLN . 76.3 ttt-85 -77.65 139.22 39.44 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 118.644 -1.222 . . . . 0.0 109.266 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 50.6 tp -110.08 133.37 53.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.262 -175.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.47 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.573 0 CA-C-O 118.28 -1.289 . . . . 0.0 110.845 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.483 ' HA2' ' CE2' ' A' ' 58' ' ' TYR . . . . . . . . 0 CA--C 1.521 0.463 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.89 145.35 98.51 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.686 1.59 . . . . 0.0 111.171 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.6 tpp -61.3 139.54 58.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.31 -44.64 1.51 Allowed Glycine 0 C--N 1.313 -0.707 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.41 159.41 27.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 122.518 -0.401 . . . . 0.0 110.415 173.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 76.7 mtm -88.91 152.99 21.4 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.77 51.69 0.21 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -64.52 -38.0 89.48 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.609 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -93.42 158.96 15.46 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.532 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.74 HG21 ' HB1' ' A' ' 72' ' ' ALA . 42.5 mm -106.02 128.24 60.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.525 ' HD2' ' CE2' ' A' ' 58' ' ' TYR . 11.8 mtpp -89.43 107.07 18.86 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.5 167.26 22.92 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.874 -177.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.528 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 5.4 m -130.6 147.56 52.3 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.122 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.538 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -134.55 149.74 50.68 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.449 -179.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.639 HG23 ' OG ' ' A' ' 44' ' ' SER . 96.1 mt -123.61 128.77 74.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.332 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 45' ' ' ILE . 41.1 tp -103.11 123.5 46.79 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.021 HG12 HD11 ' A' ' 43' ' ' LEU . 16.2 m -124.1 147.9 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 123.657 0.598 . . . . 0.0 111.132 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -66.76 -42.54 86.0 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.403 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.497 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 25.9 mmtp -112.77 151.1 30.7 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -174.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -64.36 -34.89 79.2 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.871 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.22 -37.78 95.1 Favored Glycine 0 CA--C 1.509 -0.317 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 98.3 mt-10 -64.94 -41.92 95.1 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.54 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -57.75 -46.98 83.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.269 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.09 -42.54 99.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.366 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.07 73.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.677 ' O ' HD23 ' A' ' 30' ' ' LEU . 11.3 m -65.18 -40.7 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.964 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.506 HE21 HG13 ' A' ' 92' ' ' VAL . 74.2 mt-30 -60.08 -47.3 86.43 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.712 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.562 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 57.0 mm-40 -66.48 -37.14 84.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.034 0.445 . . . . 0.0 110.827 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.863 ' HD3' HD11 ' A' ' 39' ' ' LEU . 77.6 ttt180 -61.06 -41.11 96.0 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.417 175.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.681 HD11 ' HA ' ' A' ' 36' ' ' PHE . 4.1 mm? -60.09 -38.87 84.22 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.512 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 17.5 mmtp -61.04 -34.72 75.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.16 -10.03 37.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.116 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.68 -0.42 39.46 Favored Glycine 0 N--CA 1.462 0.379 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.771 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.652 ' O ' HD13 ' A' ' 30' ' ' LEU . 7.3 mm-40 -65.38 142.52 58.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 29.9 mttm -72.58 141.83 48.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.283 0.564 . . . . 0.0 111.13 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.681 ' HA ' HD11 ' A' ' 30' ' ' LEU . 53.1 t80 -58.67 -45.45 89.36 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -61.02 -34.91 89.72 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.972 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 88.7 tttt -61.04 -47.35 86.77 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.863 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.2 mm? -62.96 -41.11 99.43 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.732 174.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 44' ' ' SER . . . -60.0 -50.05 75.27 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.85 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.564 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 68.2 mttm -65.85 -45.27 82.77 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.848 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 86.5 mt-10 -71.99 -44.59 63.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.021 HD11 HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -112.43 -39.11 4.47 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -168.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.713 ' N ' HD13 ' A' ' 43' ' ' LEU . 67.6 m -52.59 135.83 33.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.334 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.621 HG13 HD23 ' A' ' 16' ' ' LEU . 42.5 pt -87.88 -5.75 10.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.543 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -85.97 91.39 8.37 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -61.12 -43.59 99.22 Favored Glycine 0 C--N 1.313 -0.718 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.6 -44.21 78.87 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.3 m -71.8 -33.63 68.71 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.733 175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -65.19 -38.78 91.55 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.787 0.803 . . . . 0.0 109.854 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.33 -37.33 82.89 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.206 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -97.58 20.57 11.6 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.944 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.564 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 57.75 30.53 19.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.648 177.382 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 70.69 -8.1 4.63 Favored Glycine 0 C--N 1.306 -1.106 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -69.95 85.31 0.51 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.147 0.498 . . . . 0.0 110.58 -178.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.06 -39.86 95.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.826 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 89.46 -143.44 17.28 Favored Glycine 0 CA--C 1.507 -0.428 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.525 ' CE2' ' HD2' ' A' ' 11' ' ' LYS . 95.3 m-85 -83.61 132.92 34.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.437 ' CD1' ' HG3' ' A' ' 64' ' ' MET . 44.8 p90 -146.25 150.28 35.49 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.001 170.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.43 178.38 27.68 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.459 ' HB3' ' NH1' ' A' ' 61' ' ' ARG . 8.4 mtm105 -75.38 154.78 37.02 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.59 177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.81 -31.94 8.12 Favored Glycine 0 C--N 1.309 -0.957 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -11.14 54.54 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.494 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.437 ' HG3' ' CD1' ' A' ' 59' ' ' PHE . 10.0 mmm -125.08 156.61 37.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.94 150.77 6.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.849 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.529 ' NZ ' ' HB2' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -44.42 -54.5 12.03 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 38.0 Cg_endo -61.94 -34.14 81.99 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 120.163 0.575 . . . . 0.0 111.119 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CD2' HD11 ' A' ' 93' ' ' ILE . 38.3 t80 -62.43 -47.87 82.17 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.476 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.63 -39.99 94.68 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.895 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.529 ' HB2' ' NZ ' ' A' ' 66' ' ' LYS . 27.6 t70 -56.03 -51.24 68.48 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.871 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 81' ' ' SER . . . -64.7 -41.64 95.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.025 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.74 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -61.15 -50.98 70.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.342 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 10' ' ' ILE . 59.2 m-85 -69.15 -38.45 78.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.773 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -66.61 -40.96 89.05 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 81' ' ' SER . 50.3 mt -98.1 33.46 2.15 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.478 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 71.0 mt-30 -51.24 -24.54 4.49 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.83 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.431 HG13 ' H ' ' A' ' 79' ' ' GLU . 12.1 p -59.83 -31.88 48.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.514 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 123.47 -4.72 9.4 Favored Glycine 0 N--CA 1.469 0.873 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.086 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.431 ' H ' HG13 ' A' ' 77' ' ' VAL . 90.5 mt-10 -60.69 147.33 42.49 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.897 0.379 . . . . 0.0 111.938 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 t -78.59 130.99 35.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.455 ' HA ' HD11 ' A' ' 75' ' ' LEU . 10.5 p -74.3 153.44 39.35 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.659 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.6 mp0 -59.57 164.69 5.04 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.54 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 50.3 Cg_exo -53.67 129.03 31.92 Favored 'Trans proline' 0 C--N 1.292 -2.43 0 N-CA-C 109.865 -0.86 . . . . 0.0 109.865 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.448 HG21 HD12 ' A' ' 93' ' ' ILE . 59.2 t -104.25 113.97 42.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.533 ' NZ ' ' OH ' ' A' ' 90' ' ' TYR . 41.7 tttp -81.85 138.27 35.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 19.3 p -150.6 166.47 30.19 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.44 -32.41 71.35 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.439 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 65.7 m-85 -64.48 -40.4 95.61 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.328 176.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.97 -149.85 21.91 Favored Glycine 0 C--N 1.318 -0.418 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.533 ' OH ' ' NZ ' ' A' ' 85' ' ' LYS . 82.7 m-85 -104.38 127.39 52.04 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.362 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.538 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.9 m-70 -111.35 151.18 28.72 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.224 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.506 HG13 HE21 ' A' ' 27' ' ' GLN . 1.9 t -116.67 114.09 44.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 168.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.512 HD11 ' CD2' ' A' ' 68' ' ' PHE . 75.7 mt -111.4 124.03 67.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.244 -172.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 30.1 tttp -114.56 139.01 49.94 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.514 172.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.478 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 1.4 tmm_? -78.9 141.58 37.5 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.398 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.421 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 50.2 tp -109.45 124.06 50.4 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.055 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.204 -1.725 0 CA-C-O 118.296 -1.28 . . . . 0.0 110.248 -177.366 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.265 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.64 141.84 97.92 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.405 1.403 . . . . 0.0 110.976 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.8 mtt -62.62 143.76 56.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.253 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.52 -20.06 52.03 Favored Glycine 0 C--N 1.319 -0.4 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -83.16 96.04 8.3 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.799 0.333 . . . . 0.0 110.177 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.7 mtp -95.61 138.31 33.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.159 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.05 9.09 32.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.861 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -61.52 -42.38 98.72 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -88.94 156.67 18.75 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.647 -1.615 . . . . 0.0 107.366 171.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.715 HD11 ' CE2' ' A' ' 73' ' ' PHE . 68.0 mt -104.72 126.32 59.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' NZ ' ' HA2' ' A' ' 97' ' ' GLY . 7.8 mtpm? -94.85 104.42 16.32 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.564 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -144.48 171.86 13.77 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -171.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.9 m -131.4 146.07 52.1 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.305 174.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.449 ' CG ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.15 150.96 44.88 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.59 HG23 ' OG ' ' A' ' 44' ' ' SER . 61.8 mt -121.99 126.77 74.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.288 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.637 HD13 ' CE1' ' A' ' 91' ' ' HIS . 50.5 tp -101.85 122.37 43.86 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.53 HG13 HG22 ' A' ' 15' ' ' ILE . 34.8 m -130.39 155.02 41.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.418 0.628 . . . . 0.0 111.106 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HG3' HG21 ' A' ' 45' ' ' ILE . 10.5 mtpt -66.38 -41.74 88.97 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.704 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 27.8 mtpp -118.81 151.6 37.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.447 -172.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -60.9 -37.23 81.52 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.29 -39.94 97.92 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 88.8 mt-10 -63.84 -46.02 86.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.579 ' HB1' ' CG2' ' A' ' 92' ' ' VAL . . . -60.0 -49.37 77.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.443 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 24' ' ' LEU . 97.2 mt -63.72 -41.05 98.14 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.789 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.51 -49.35 75.0 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.885 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.586 HG12 HD12 ' A' ' 39' ' ' LEU . 9.4 m -68.21 -40.57 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.406 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.517 HE21 ' C ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -56.05 -42.81 77.18 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.079 -179.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 51.9 mm-40 -71.71 -35.03 70.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.183 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.457 ' HG3' ' HG3' ' A' ' 34' ' ' GLU . 12.3 ttm180 -62.07 -37.32 84.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.311 176.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.563 HD23 ' O ' ' A' ' 26' ' ' VAL . 4.3 mm? -60.57 -36.25 78.05 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.871 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 28.4 mmtm -59.98 -36.65 77.62 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.68 -10.44 36.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.894 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.64 62.62 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HG3' ' HG3' ' A' ' 29' ' ' ARG . 12.2 mm-40 -62.3 147.04 49.39 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 74.4 tttt -63.01 128.64 36.81 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.421 ' HA ' HD11 ' A' ' 30' ' ' LEU . 53.6 t80 -58.11 -45.16 87.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -58.25 -39.48 92.55 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.783 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 49.2 tttp -59.46 -45.72 90.81 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.586 HD12 HG12 ' A' ' 26' ' ' VAL . 4.2 mm? -61.66 -42.15 98.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.583 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.486 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -56.89 -49.84 74.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.324 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 50' ' ' ALA . 31.8 mttp -64.64 -40.45 95.47 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -71.46 -47.02 58.3 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.748 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -123.69 -13.14 7.54 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.59 ' OG ' HG23 ' A' ' 15' ' ' ILE . 4.0 m -58.35 138.59 56.37 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.047 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.56 HG13 HD23 ' A' ' 16' ' ' LEU . 44.3 pt -90.65 -4.12 10.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 174.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -89.24 101.91 14.57 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.787 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.28 -45.3 96.77 Favored Glycine 0 C--N 1.317 -0.484 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.33 -43.38 89.73 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 54' ' ' GLY . 63.6 m -63.49 -34.79 78.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.822 175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -64.76 -39.25 93.31 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.172 0.511 . . . . 0.0 109.973 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -64.37 -40.34 95.66 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.559 0.695 . . . . 0.0 109.248 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 84.0 mtp180 -97.27 10.3 39.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.051 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.592 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 21.3 m-20 57.68 29.86 17.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 71.67 0.85 42.72 Favored Glycine 0 C--N 1.311 -0.81 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 1.3 m -68.45 83.07 0.26 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.119 0.485 . . . . 0.0 110.899 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.564 HD12 ' SG ' ' A' ' 12' ' ' CYS . 90.0 mt -63.4 -39.7 95.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.541 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 86.81 -149.08 22.1 Favored Glycine 0 C--N 1.318 -0.44 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.95 129.3 34.93 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.584 ' CE1' ' HG3' ' A' ' 64' ' ' MET . 45.8 p90 -146.14 149.47 34.07 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.677 0.275 . . . . 0.0 110.767 176.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.86 -179.46 38.86 Favored Glycine 0 C--N 1.315 -0.636 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -78.27 153.28 31.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.433 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.41 -34.54 5.21 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.19 -36.85 85.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.051 0.453 . . . . 0.0 110.475 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.584 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 3.5 mmm -110.82 154.18 24.34 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.258 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 27.4 m -64.91 141.13 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.596 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.4 mtpm? -44.2 -48.81 24.06 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -172.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 30.4 Cg_endo -60.66 -32.2 92.95 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 CA-C-N 119.059 0.7 . . . . 0.0 111.264 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.659 ' CD2' HD11 ' A' ' 93' ' ' ILE . 37.9 t80 -61.85 -46.94 87.29 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.463 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 99.7 mt-10 -61.49 -45.31 94.76 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.465 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.43 ' OD2' ' NH2' ' A' ' 74' ' ' ARG . 13.0 t70 -56.93 -50.33 72.9 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.408 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.05 93.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.046 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.586 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -61.77 -46.66 88.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.806 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.715 ' CE2' HD11 ' A' ' 10' ' ' ILE . 52.9 m-85 -66.31 -40.43 89.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.464 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 74' ' ' ARG . 50.9 mtm180 -64.07 -42.14 97.1 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.7 mt -97.95 31.77 2.59 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.513 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 48.6 mt-30 -55.81 -18.15 7.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.262 0.553 . . . . 0.0 109.943 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 79' ' ' GLU . 3.2 p -58.1 -29.16 36.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.037 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.405 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 118.78 -3.01 15.03 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' H ' HG13 ' A' ' 77' ' ' VAL . 79.9 mm-40 -69.51 161.21 29.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.887 0.375 . . . . 0.0 111.17 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.55 127.66 42.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.517 ' C ' HE21 ' A' ' 27' ' ' GLN . 10.5 p -77.53 159.28 29.43 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.265 0.555 . . . . 0.0 112.206 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -69.6 168.39 17.36 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.554 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 51.4 Cg_exo -56.38 135.18 68.78 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 N-CA-C 110.136 -0.756 . . . . 0.0 110.136 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 40.4 t -116.49 126.82 74.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HD3' ' CZ ' ' A' ' 90' ' ' TYR . 9.8 tptm -85.06 131.3 34.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.074 -177.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.8 p -135.53 170.07 16.53 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -56.26 -37.51 69.88 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -64.11 -43.82 94.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.152 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.04 -140.06 7.0 Favored Glycine 0 N--CA 1.465 0.601 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.58 ' O ' HD12 ' A' ' 16' ' ' LEU . 43.9 m-85 -106.28 130.88 54.05 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.637 ' CE1' HD13 ' A' ' 16' ' ' LEU . 6.8 m-70 -110.45 146.27 36.2 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.124 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.579 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 67.4 t -117.54 127.51 74.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 168.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.659 HD11 ' CD2' ' A' ' 68' ' ' PHE . 82.8 mt -119.71 128.08 75.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.984 -173.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.405 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 64.5 tttp -120.13 141.26 50.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -79.1 143.84 35.14 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.941 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 52.2 tp -112.64 131.14 55.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.486 0.66 . . . . 0.0 110.216 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.517 ' HA2' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--N 1.293 -1.82 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.413 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 CA--C 1.527 0.83 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.438 ' HB2' ' HB2' ' A' ' 5' ' ' SER . 32.0 Cg_exo -60.12 145.34 98.67 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 121.65 1.567 . . . . 0.0 111.186 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.9 mtp -37.04 121.78 0.81 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.456 -174.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 38.33 30.2 0.08 OUTLIER Glycine 0 N--CA 1.468 0.811 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.402 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 2' ' ' PRO . 7.4 m -104.64 119.7 39.59 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 116.878 0.339 . . . . 0.0 110.555 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.476 ' HB2' ' NZ ' ' A' ' 9' ' ' LYS . 99.9 mmm -66.1 110.01 2.81 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 9' ' ' LYS . . . -69.83 -9.22 53.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -173.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.33 46.23 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.02 0.438 . . . . 0.0 110.484 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 7' ' ' ALA . 50.4 mttp -136.09 167.49 21.14 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.371 -176.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.854 HG21 ' HB1' ' A' ' 72' ' ' ALA . 61.1 mt -111.46 131.49 62.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.521 ' NZ ' ' OXT' ' A' ' 97' ' ' GLY . 46.3 mtpt -91.29 107.16 19.02 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' SG ' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -147.59 167.02 25.6 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.908 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.454 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 14.1 m -135.02 149.9 50.22 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.432 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.418 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -139.08 149.9 45.11 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 119.512 -0.875 . . . . 0.0 113.112 -177.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.735 HG23 ' HB3' ' A' ' 44' ' ' SER . 96.5 mt -124.11 123.34 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.608 HD12 ' O ' ' A' ' 90' ' ' TYR . 48.0 tp -94.41 127.2 40.16 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 90' ' ' TYR . 29.0 m -129.89 150.64 34.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.129 0.49 . . . . 0.0 110.588 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -66.14 -40.64 90.77 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.296 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -121.17 152.32 38.9 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -172.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.43 ' HG3' ' CG ' ' A' ' 83' ' ' PRO . 59.9 tt0 -62.06 -41.15 97.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.665 178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.09 95.67 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.97 -42.09 98.75 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.589 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -60.13 -41.37 92.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.742 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.64 -42.46 99.61 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.029 0.442 . . . . 0.0 110.412 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.69 79.61 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.887 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 92' ' ' VAL . 31.1 m -64.42 -40.75 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.926 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 81.0 mt-30 -59.5 -47.05 87.02 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.275 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -64.3 -44.49 91.45 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.569 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 71.4 ttt180 -65.58 -39.3 91.48 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.69 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.884 HD22 HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -56.61 -28.92 61.5 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -177.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 69.0 mmtt -62.9 -30.12 71.29 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.79 -22.17 45.76 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.533 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.84 13.39 56.67 Favored Glycine 0 C--O 1.236 0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.135 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.569 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 73.9 mt-10 -66.31 154.46 39.93 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -60.19 126.71 28.56 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 66.0 t80 -59.11 -44.95 92.01 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -60.87 -37.77 94.25 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.472 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 60.1 tttm -60.23 -46.46 89.69 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.884 HD12 HD22 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.9 -36.91 80.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.932 178.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . -56.04 -50.86 69.76 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.501 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.46 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 45.4 mttp -62.76 -37.81 88.09 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 80.3 mm-40 -69.82 -46.65 65.19 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.422 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.564 HD22 ' CG1' ' A' ' 26' ' ' VAL . 1.7 mp -114.45 -41.44 3.45 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.735 ' HB3' HG23 ' A' ' 15' ' ' ILE . 6.6 p -54.99 138.11 44.52 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.481 -168.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.527 HG13 HD23 ' A' ' 16' ' ' LEU . 46.3 pt -97.85 -5.03 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.134 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -84.45 93.09 8.22 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -61.19 -45.53 96.33 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.2 -44.91 74.76 Favored Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.434 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 73.9 m -70.74 -34.08 71.49 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.604 175.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -63.69 -25.32 68.16 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.886 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 30.6 mmtp -63.14 -36.97 85.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 8.3 mtm-85 -96.77 15.47 21.87 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.165 174.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.582 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 22.6 m-20 58.94 29.48 18.98 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.72 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 49' ' ' SER . . . 77.89 -5.15 54.78 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -73.95 84.06 1.73 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.501 0.667 . . . . 0.0 110.186 178.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 96.4 mt -62.91 -39.75 95.49 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.153 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.433 ' HA2' HD23 ' A' ' 96' ' ' LEU . . . 87.38 -142.92 18.35 Favored Glycine 0 CA--C 1.503 -0.667 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.511 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 19.8 m-85 -83.9 132.91 34.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.529 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 46.9 p90 -145.07 152.02 39.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.89 165.54 26.94 Favored Glycine 0 C--N 1.316 -0.53 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.496 ' HD2' ' CZ ' ' A' ' 73' ' ' PHE . 60.0 mtp180 -77.32 157.96 30.42 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.496 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 129.11 -77.03 0.4 Allowed Glycine 0 N--CA 1.462 0.394 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -61.21 -38.01 85.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.393 0.615 . . . . 0.0 109.623 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.569 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 75.6 mmm -63.84 145.8 55.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.213 -176.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG23 ' H ' ' A' ' 68' ' ' PHE . 13.3 m -73.71 130.66 35.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.657 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 64' ' ' MET . 5.7 mmtm -45.05 -40.35 10.56 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.118 -174.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 32.8 Cg_exo -56.09 -41.57 75.47 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 120.445 0.763 . . . . 0.0 110.434 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.593 ' CD2' HD11 ' A' ' 93' ' ' ILE . 23.0 t80 -62.84 -47.1 84.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.598 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.439 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 96.4 mt-10 -62.13 -43.2 99.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.59 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.03 -51.36 69.58 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.793 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -63.25 -40.21 96.79 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.278 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.854 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -58.94 -47.6 84.5 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.492 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.722 ' CE2' HD11 ' A' ' 10' ' ' ILE . 55.7 m-85 -66.62 -37.03 84.0 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.558 HH12 ' CD ' ' A' ' 82' ' ' GLU . 49.3 mtm180 -63.6 -35.92 82.12 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.563 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.64 HD11 ' CA ' ' A' ' 81' ' ' SER . 74.5 mt -97.24 21.38 10.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -171.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.509 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 70.0 mt-30 -52.27 -24.99 8.28 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.893 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 p -61.31 -26.51 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.647 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.433 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . 115.17 5.43 19.64 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' A' ' 75' ' ' LEU . 1.8 mm-40 -75.6 173.85 10.49 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 t -104.22 127.5 58.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.584 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.64 ' CA ' HD11 ' A' ' 75' ' ' LEU . 60.0 p -68.14 151.02 47.63 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.558 ' CD ' HH12 ' A' ' 74' ' ' ARG . 1.2 mp0 -63.86 164.03 19.17 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 167.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 16.9 Cg_exo -54.32 128.29 29.42 Favored 'Trans proline' 0 C--N 1.29 -2.521 0 N-CA-C 109.71 -0.919 . . . . 0.0 109.71 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 91' ' ' HIS . 15.5 t -98.32 117.51 43.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -77.45 136.87 38.41 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.086 0.47 . . . . 0.0 110.844 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 88' ' ' PHE . 10.3 p -153.89 167.35 30.01 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -57.02 -31.29 64.98 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.459 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 68.3 m-85 -63.58 -42.8 98.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.676 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.43 -132.81 4.45 Favored Glycine 0 C--O 1.239 0.426 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.608 ' O ' HD12 ' A' ' 16' ' ' LEU . 86.9 m-85 -107.42 127.66 53.79 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.545 ' O ' HG23 ' A' ' 84' ' ' VAL . 5.1 m-70 -108.03 140.71 40.8 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.889 172.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 26' ' ' VAL . 2.4 t -112.98 115.88 51.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 171.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.593 HD11 ' CD2' ' A' ' 68' ' ' PHE . 85.4 mt -111.82 125.34 69.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.854 -171.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 63.6 tttp -113.1 139.74 48.46 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 171.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 3.2 tmm_? -78.87 141.78 37.37 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.238 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.505 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 58.6 tp -109.91 134.41 52.11 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.167 -175.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.521 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.204 -1.735 0 CA-C-O 118.126 -1.374 . . . . 0.0 110.63 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.727 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.45 147.3 90.54 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.346 1.364 . . . . 0.0 111.194 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.7 mtm -106.1 152.91 22.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.345 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.31 -33.99 5.42 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 m -73.18 136.23 44.72 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.559 ' C ' ' H ' ' A' ' 8' ' ' ASP . 76.1 mtm -117.18 137.01 52.62 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.11 31.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.761 0.315 . . . . 0.0 111.324 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.559 ' H ' ' C ' ' A' ' 6' ' ' MET . 22.2 t70 -61.22 -45.55 94.08 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -110.39 163.03 14.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.87 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.825 HD11 ' CE2' ' A' ' 73' ' ' PHE . 39.8 mm -105.49 129.45 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.535 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 36.0 mtpt -88.98 104.32 16.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 176.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -144.53 170.36 16.2 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.815 -176.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.6 m -128.29 137.69 52.08 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 114.319 -1.31 . . . . 0.0 107.743 175.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.416 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -133.49 149.6 51.72 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.994 -0.682 . . . . 0.0 112.459 -178.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.505 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 90.0 mt -122.94 124.84 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.607 HD13 ' CE1' ' A' ' 91' ' ' HIS . 41.6 tp -104.85 123.54 47.89 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 43' ' ' LEU . 3.0 m -131.79 154.29 40.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.25 0.547 . . . . 0.0 111.556 -176.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -70.43 -40.38 73.81 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.818 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.61 144.49 37.88 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -169.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.488 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 27.4 mt-30 -62.78 -39.35 93.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.614 175.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.25 -38.86 95.21 Favored Glycine 0 CA--C 1.509 -0.307 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -64.99 -44.5 89.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.223 0.535 . . . . 0.0 109.77 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -60.71 -48.46 81.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.423 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.546 ' HA ' ' HB2' ' A' ' 27' ' ' GLN . 91.4 mt -64.32 -40.06 95.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 177.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.13 -49.17 74.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.35 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.708 HG12 HD12 ' A' ' 39' ' ' LEU . 21.1 m -64.93 -38.05 81.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.944 176.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.645 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 2.2 mm-40 -54.23 -48.16 71.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.428 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -70.67 -43.44 69.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.251 0.548 . . . . 0.0 110.766 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.776 ' HD3' HD11 ' A' ' 39' ' ' LEU . 65.0 ttt180 -61.63 -39.43 91.28 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.001 -174.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -60.75 -34.29 74.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.153 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.645 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 23.9 mmtm -62.97 -34.12 76.84 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.82 -23.62 63.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.425 176.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.09 1.45 54.68 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.103 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.46 ' OE1' ' NE ' ' A' ' 29' ' ' ARG . 55.1 mt-10 -65.58 155.78 34.74 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.35 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -61.62 126.58 27.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.082 -172.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.505 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 61.8 t80 -58.18 -45.24 87.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 174.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.41 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -60.09 -39.16 95.41 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.385 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -60.7 -43.58 97.63 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.031 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.776 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.4 mm? -63.48 -40.96 98.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.697 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.445 ' CB ' ' C ' ' A' ' 53' ' ' ASP . . . -60.68 -43.32 97.83 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 31.6 mmtt -64.56 -36.46 84.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -70.44 -59.34 2.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.075 -172.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.483 ' HB3' HG12 ' A' ' 17' ' ' VAL . 1.8 mt -93.42 -57.4 2.61 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 5.5 m -29.47 120.02 0.15 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.956 -1.474 . . . . 0.0 113.493 -165.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.408 HG13 HD23 ' A' ' 16' ' ' LEU . 41.5 pt -82.34 -12.0 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -82.16 95.08 7.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.8 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.05 -42.84 99.75 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.04 -45.36 81.95 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.1 m -69.16 -32.6 72.04 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.574 0.226 . . . . 0.0 110.724 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.424 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -63.12 -37.35 86.85 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.041 0.448 . . . . 0.0 109.999 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -63.73 -27.69 69.37 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.897 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 55' ' ' SER . 68.7 mtt-85 -95.94 5.61 50.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.081 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 0.6 OUTLIER 58.06 33.0 22.72 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 79.65 -16.85 9.7 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 0.7 OUTLIER -66.15 81.38 0.08 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.61 0.719 . . . . 0.0 110.932 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.6 mt -61.87 -41.07 97.42 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.417 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 91.19 -137.38 13.81 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.535 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 71.2 m-85 -84.16 137.82 33.32 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 45.0 p90 -146.66 148.29 31.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.872 0.367 . . . . 0.0 111.197 169.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.0 169.53 23.04 Favored Glycine 0 C--N 1.313 -0.715 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -80.38 156.32 26.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.673 0.273 . . . . 0.0 110.551 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.48 -52.27 0.75 Allowed Glycine 0 C--N 1.31 -0.862 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -60.93 -45.0 96.43 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.144 0.497 . . . . 0.0 110.387 174.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.6 mmm -88.25 148.09 24.51 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.659 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.445 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.2 m -68.51 139.15 21.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' NZ ' ' OE1' ' A' ' 69' ' ' GLU . 11.2 mmtm -44.36 -40.97 9.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -175.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.53 -44.7 45.85 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 N-CA-C 110.37 -0.665 . . . . 0.0 110.37 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.615 ' CD2' HD11 ' A' ' 93' ' ' ILE . 41.0 t80 -62.6 -46.29 88.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.407 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.42 ' OE1' ' NZ ' ' A' ' 66' ' ' LYS . 99.3 mt-10 -62.21 -45.9 91.31 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.871 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 38.3 t70 -59.12 -45.99 89.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.099 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.701 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -60.77 -46.56 90.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.245 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.575 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -62.03 -49.25 76.78 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.825 ' CE2' HD11 ' A' ' 10' ' ' ILE . 55.2 m-85 -67.16 -38.16 85.01 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 51.8 mtp180 -61.52 -47.08 87.23 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.333 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 81' ' ' SER . 42.7 mt -100.28 34.58 2.32 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.537 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 49.4 mt-30 -53.52 -20.17 4.6 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.817 0.341 . . . . 0.0 110.845 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.73 -26.55 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.492 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 113.93 6.13 21.17 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -78.39 153.68 31.36 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.41 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 16.6 t -75.2 130.78 35.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.566 ' C ' HE21 ' A' ' 27' ' ' GLN . 89.4 p -72.2 154.17 41.18 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.359 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -63.5 165.19 12.29 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -56.1 131.3 45.05 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 N-CA-C 109.513 -0.995 . . . . 0.0 109.513 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 42.0 t -105.86 109.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -80.48 134.12 35.93 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB2' HG21 ' A' ' 65' ' ' VAL . 8.6 p -153.18 168.49 25.78 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -60.6 -29.96 69.53 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.413 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 56.2 m-85 -66.79 -38.79 87.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.479 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.03 -150.28 22.5 Favored Glycine 0 C--N 1.316 -0.579 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.488 ' CE1' ' HG2' ' A' ' 20' ' ' GLN . 58.5 m-85 -101.95 125.96 48.75 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.607 ' CE1' HD13 ' A' ' 16' ' ' LEU . 3.3 m-70 -107.21 144.68 33.62 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.288 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.536 HG21 ' CG2' ' A' ' 26' ' ' VAL . 48.3 t -117.75 126.43 74.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 168.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.701 HD12 ' HB3' ' A' ' 71' ' ' ALA . 98.8 mt -117.64 129.33 74.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.804 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -119.68 140.67 50.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.537 ' HG3' ' HA ' ' A' ' 76' ' ' GLN . 2.5 tmm_? -78.85 143.96 35.47 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.997 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.425 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 57.2 tp -113.05 140.67 47.65 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.917 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.556 0 CA-C-O 118.267 -1.296 . . . . 0.0 110.571 -179.435 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.639 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -61.3 148.74 92.11 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.688 2.259 . . . . 0.0 112.308 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.9 mtp -57.72 146.11 32.22 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.648 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.55 29.2 70.03 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -47.66 101.6 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.274 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.481 ' C ' ' H ' ' A' ' 8' ' ' ASP . 45.3 mtt -68.13 151.72 46.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.983 -176.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.83 7.26 0.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.318 175.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.484 ' CG ' HH22 ' A' ' 61' ' ' ARG . 34.1 t70 -61.03 -41.11 95.95 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.75 161.4 24.56 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.236 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.521 ' HB ' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -107.38 128.1 62.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' NZ ' ' OXT' ' A' ' 97' ' ' GLY . 62.3 mtpt -93.72 104.6 16.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -149.13 169.21 21.21 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.719 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.486 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 48.1 m -132.78 147.34 52.31 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.58 175.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.49 ' HB2' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -130.39 150.91 51.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -177.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.62 HG23 ' HB3' ' A' ' 44' ' ' SER . 96.2 mt -127.82 124.4 62.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.521 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 90' ' ' TYR . 37.4 tp -90.84 129.09 36.93 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.943 HG12 HD11 ' A' ' 43' ' ' LEU . 29.0 m -128.04 143.1 41.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 O-C-N 123.577 0.548 . . . . 0.0 110.834 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.691 ' HG3' HD13 ' A' ' 45' ' ' ILE . 1.6 mtpp -65.6 -42.41 91.66 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.191 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -126.38 151.97 46.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.681 -169.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -60.25 -35.08 74.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.722 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.09 -38.3 94.13 Favored Glycine 0 C--N 1.321 -0.265 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.61 -41.7 92.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HB2' HG21 ' A' ' 17' ' ' VAL . . . -58.66 -47.4 84.57 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.135 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.68 -41.93 99.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.168 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.02 72.67 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.726 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.494 ' CG2' HG21 ' A' ' 92' ' ' VAL . 29.1 m -65.17 -39.78 86.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.101 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.537 ' O ' ' NZ ' ' A' ' 31' ' ' LYS . 4.6 mm-40 -58.69 -47.8 83.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.958 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -65.71 -46.46 78.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.502 0.668 . . . . 0.0 110.097 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.824 ' HD3' HD11 ' A' ' 39' ' ' LEU . 72.8 ttt180 -63.65 -40.83 97.86 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.886 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -56.63 -32.64 65.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -177.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 27' ' ' GLN . 29.6 mmtm -63.41 -13.05 35.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.466 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.16 -14.08 60.52 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.57 -1.92 60.37 Favored Glycine 0 C--O 1.243 0.667 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.58 148.72 32.42 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.322 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -71.78 142.19 49.71 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.958 0.885 . . . . 0.0 112.593 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.554 ' CE2' HG13 ' A' ' 15' ' ' ILE . 57.1 t80 -56.97 -45.04 83.16 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.116 -177.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.07 -37.5 94.01 Favored Glycine 0 C--O 1.239 0.409 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 177.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.69 -46.36 90.03 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.824 HD11 ' HD3' ' A' ' 29' ' ' ARG . 3.0 mm? -61.62 -39.64 91.98 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.291 173.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.546 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . -58.77 -50.99 71.88 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.317 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.491 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 62.3 mttm -61.15 -42.56 98.77 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.106 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.523 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 70.7 mt-10 -70.23 -41.37 73.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -173.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.943 HD11 HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -123.64 -28.53 3.86 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.663 ' N ' HD13 ' A' ' 43' ' ' LEU . 10.1 p -59.92 135.54 57.73 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.681 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.691 HD13 ' HG3' ' A' ' 18' ' ' LYS . 47.0 pt -105.26 -6.78 9.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.293 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.462 ' HB3' ' OG ' ' A' ' 49' ' ' SER . 59.0 t0 -83.85 97.2 9.07 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -55.98 -46.09 85.2 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -43.85 -56.37 5.13 Favored Glycine 0 C--O 1.237 0.313 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.564 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . 1.5 p -71.04 -32.92 69.8 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -60.28 -34.44 73.75 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.147 0.498 . . . . 0.0 109.904 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 47' ' ' GLY . 99.4 mttt -58.74 -36.01 73.63 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 177.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' O ' ' OG ' ' A' ' 55' ' ' SER . 61.1 mtp85 -98.3 7.57 46.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.396 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.491 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 79.9 m-20 58.71 31.76 21.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -173.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 49' ' ' SER . . . 75.85 -6.68 31.99 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 1.1 m -66.59 72.86 0.09 Allowed 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.434 0.635 . . . . 0.0 110.913 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 54' ' ' GLY . 94.5 mt -63.69 -40.33 96.53 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.593 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.59 -145.04 22.6 Favored Glycine 0 N--CA 1.464 0.54 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.95 129.08 34.93 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.585 ' CE1' ' HG3' ' A' ' 64' ' ' MET . 55.4 p90 -141.0 153.7 45.68 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.465 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -92.54 169.98 32.03 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.484 HH22 ' CG ' ' A' ' 8' ' ' ASP . 1.5 mtm105 -78.02 148.92 34.13 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 120.883 0.373 . . . . 0.0 111.004 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.16 -32.78 6.91 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -64.5 -37.35 87.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.842 0.353 . . . . 0.0 110.776 175.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 2.8 mmm -101.94 160.04 14.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.369 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 86' ' ' SER . 30.4 m -75.07 153.66 6.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -44.3 -50.0 22.82 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.99 -41.28 80.4 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 120.962 1.108 . . . . 0.0 110.828 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -62.36 -47.78 82.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.777 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -64.66 -38.68 91.83 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.227 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.06 -51.27 66.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.998 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 84' ' ' VAL . . . -65.2 -41.49 94.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.196 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.83 78.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 -177.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -67.46 -35.47 79.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 0.0 111.258 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.508 HH21 ' CD ' ' A' ' 82' ' ' GLU . 43.9 mtp180 -60.38 -39.18 86.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.155 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.615 HD11 ' CB ' ' A' ' 81' ' ' SER . 44.8 mt -96.87 17.11 17.48 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.496 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 82.4 mt-30 -54.08 -22.46 10.9 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 117.943 -1.503 . . . . 0.0 110.842 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 p -59.4 -27.31 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.113 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 121.51 -2.17 11.24 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.499 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -75.44 174.26 9.85 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -173.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.4 t -96.89 133.41 38.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.325 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.615 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -68.36 152.74 44.99 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.193 -178.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' CD ' HH21 ' A' ' 74' ' ' ARG . 2.8 mp0 -65.16 177.25 0.66 Allowed Pre-proline 0 N--CA 1.427 -1.587 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 167.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -56.54 134.55 65.09 Favored 'Trans proline' 0 C--N 1.287 -2.694 0 N-CA-C 109.765 -0.898 . . . . 0.0 109.765 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' ' 71' ' ' ALA . 50.5 t -120.95 129.59 75.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -109.3 132.38 54.18 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.064 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.576 ' HB2' HG21 ' A' ' 65' ' ' VAL . 66.5 p -115.0 -171.25 1.91 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.107 171.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -67.04 -35.04 79.02 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 172.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 8.6 m-30 -63.36 -44.39 94.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.635 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.34 -143.82 9.96 Favored Glycine 0 C--N 1.321 -0.261 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.586 ' O ' HD12 ' A' ' 16' ' ' LEU . 28.1 m-85 -102.14 134.28 45.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.943 0.401 . . . . 0.0 111.987 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.479 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 16.9 m-70 -118.4 150.1 40.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.023 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.494 HG21 ' CG2' ' A' ' 26' ' ' VAL . 75.8 t -117.51 125.7 74.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 164.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.496 ' O ' ' CD1' ' A' ' 75' ' ' LEU . 89.1 mt -123.55 131.86 72.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -171.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.492 ' HG2' ' N ' ' A' ' 95' ' ' ARG . 43.4 tttm -123.53 152.32 41.91 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.592 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 79.1 ttt180 -77.35 137.77 38.94 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 11' ' ' LYS . 53.7 tp -119.91 130.47 54.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.522 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.572 0 CA-C-O 118.769 -1.017 . . . . 0.0 112.188 -174.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.452 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.94 147.18 93.79 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.075 1.85 . . . . 0.0 111.181 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.0 mmt -59.35 141.74 53.79 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.8 -15.11 59.93 Favored Glycine 0 C--N 1.314 -0.647 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 58' ' ' TYR . 12.6 m -72.08 107.93 5.03 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.005 0.431 . . . . 0.0 110.292 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.52 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 67.0 mtt -110.2 118.05 35.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.162 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.11 79.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.05 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.55 -4.3 22.37 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.936 0.398 . . . . 0.0 110.861 -175.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.52 ' HD2' ' HB2' ' A' ' 6' ' ' MET . 63.1 mttp -111.63 172.77 6.69 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.222 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.804 HD12 ' CE2' ' A' ' 59' ' ' PHE . 58.4 mt -104.96 127.11 59.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -173.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.551 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 62.5 mtpt -91.94 106.05 18.16 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.442 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -146.54 164.79 31.44 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.914 -175.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.8 m -127.51 135.67 50.68 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.079 -1.418 . . . . 0.0 108.354 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.5 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -130.61 149.23 52.37 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.698 -177.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.66 HG23 ' OG ' ' A' ' 44' ' ' SER . 95.9 mt -128.44 127.72 67.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.142 176.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.636 HD23 HG13 ' A' ' 45' ' ' ILE . 41.4 tp -98.68 123.96 43.2 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.501 HG12 HD13 ' A' ' 43' ' ' LEU . 29.8 m -127.93 154.71 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.665 0.745 . . . . 0.0 111.052 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 6.7 mtmp? -65.75 -41.89 91.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.742 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 67.9 mttm -123.51 154.06 39.69 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.526 -167.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' A' ' 83' ' ' PRO . 58.2 tt0 -60.47 -40.84 92.7 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.032 175.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.44 -39.53 97.42 Favored Glycine 0 CA--C 1.508 -0.345 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 98.3 mt-10 -63.85 -42.78 97.5 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.649 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -61.73 -42.89 99.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.364 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.27 -41.61 99.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.851 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.67 -45.5 81.65 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.867 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.932 ' CG1' HD21 ' A' ' 43' ' ' LEU . 21.0 m -70.82 -36.27 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.461 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.436 HE22 ' HG3' ' A' ' 82' ' ' GLU . 51.7 tt0 -58.49 -45.78 88.01 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.71 -41.01 88.65 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.503 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.613 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 15.9 tpt180 -59.94 -40.84 90.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.818 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.474 HD11 ' CA ' ' A' ' 36' ' ' PHE . 1.4 mm? -61.7 -41.44 97.59 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.047 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 25.5 mmtp -67.72 -11.75 59.02 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.723 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -75.56 -11.17 59.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 174.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.1 10.84 63.88 Favored Glycine 0 C--O 1.238 0.372 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 91.2 mt-10 -86.15 155.86 20.59 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 57.0 mttm -67.37 139.02 57.16 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.381 0.61 . . . . 0.0 112.58 -175.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' CE2' HG13 ' A' ' 15' ' ' ILE . 52.7 t80 -58.42 -45.84 87.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.056 174.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 53' ' ' ASP . . . -62.21 -35.07 91.02 Favored Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.53 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 49.1 tttm -60.65 -48.87 79.84 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.763 HD12 HG12 ' A' ' 26' ' ' VAL . 4.1 mm? -62.79 -41.57 99.33 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.064 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.504 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.49 -50.49 73.56 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.685 -176.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.557 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 67.8 mttm -65.23 -40.13 93.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.943 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' OE2' ' NZ ' ' A' ' 38' ' ' LYS . 95.8 mt-10 -71.0 -44.42 65.95 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -172.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.932 HD21 ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -124.51 -19.35 5.45 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -174.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.811 ' N ' HD12 ' A' ' 43' ' ' LEU . 1.7 m -55.73 140.21 42.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.38 -173.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.636 HG13 HD23 ' A' ' 16' ' ' LEU . 39.8 pt -86.03 -11.65 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.516 0.674 . . . . 0.0 109.227 176.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -88.2 115.17 25.49 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.068 173.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.24 -32.88 77.99 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 52' ' ' ARG . . . -55.57 -42.83 85.36 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 177.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 54' ' ' GLY . 41.2 m -61.27 -35.44 77.29 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.538 176.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . . . -73.64 -43.23 60.07 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.474 0.654 . . . . 0.0 110.525 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -66.29 -39.71 89.56 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.905 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 55' ' ' SER . 21.5 mmm180 -96.05 4.25 52.75 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.425 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.557 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 53.09 35.41 19.58 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -173.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 76.68 -36.85 1.41 Allowed Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.461 -173.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -54.27 89.36 0.01 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.547 0.739 . . . . 0.0 112.041 -178.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.442 HD12 ' SG ' ' A' ' 12' ' ' CYS . 93.0 mt -63.65 -40.3 96.5 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.238 176.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 97.27 -147.45 18.66 Favored Glycine 0 CA--C 1.503 -0.693 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.551 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 4.8 m-85 -83.71 132.48 34.85 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.804 ' CE2' HD12 ' A' ' 10' ' ' ILE . 54.7 p90 -146.56 150.65 35.93 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.807 173.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.478 ' H ' ' HD3' ' A' ' 63' ' ' LYS . . . -95.99 -168.0 34.72 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 61' ' ' ARG . 53.7 mtp85 -85.31 148.83 25.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.607 0.241 . . . . 0.0 110.876 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 91.82 -17.53 56.25 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 116.44 -0.346 . . . . 0.0 112.345 176.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 60' ' ' GLY . 1.4 mptp? -67.37 -37.88 83.86 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.181 0.515 . . . . 0.0 111.781 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.552 ' CE ' ' CD2' ' A' ' 59' ' ' PHE . 3.5 mpp? -118.43 161.73 19.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.322 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 68' ' ' PHE . 19.8 m -58.01 136.64 21.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.513 ' HZ2' ' HB2' ' A' ' 70' ' ' ASP . 8.0 tmtm? -44.76 -42.88 16.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -173.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.37 -43.42 58.84 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 CA-C-N 118.894 0.641 . . . . 0.0 110.608 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.432 ' CD1' HD11 ' A' ' 93' ' ' ILE . 67.8 t80 -63.09 -50.81 69.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.804 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 97.2 mt-10 -67.05 -41.15 87.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.501 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.513 ' HB2' ' HZ2' ' A' ' 66' ' ' LYS . 22.7 t70 -59.01 -44.3 91.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.957 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.31 84.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.493 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.05 89.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.48 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.624 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 46.6 m-85 -62.52 -29.74 70.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.637 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -65.3 -37.16 86.27 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.625 HD11 ' CA ' ' A' ' 81' ' ' SER . 76.8 mt -95.75 21.52 8.36 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -168.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.533 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 71.9 mt-30 -45.26 -24.98 0.32 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.469 0.176 . . . . 0.0 111.031 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.93 -31.24 50.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.607 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 123.02 0.42 9.71 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.387 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.546 ' HB3' HD22 ' A' ' 75' ' ' LEU . 1.1 mm-40 -68.14 174.46 3.86 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.34 129.67 62.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.625 ' CA ' HD11 ' A' ' 75' ' ' LEU . 82.5 p -64.47 155.41 32.82 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.113 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.436 ' HG3' HE22 ' A' ' 27' ' ' GLN . 0.9 OUTLIER -72.16 169.46 16.4 Favored Pre-proline 0 N--CA 1.432 -1.354 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 164.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.649 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 67.5 Cg_exo -54.62 129.4 34.73 Favored 'Trans proline' 0 C--N 1.292 -2.398 0 CA-C-N 118.923 0.651 . . . . 0.0 110.482 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 91' ' ' HIS . 99.9 t -107.66 108.28 24.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.215 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 65.7 tttp -81.95 133.46 35.31 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.581 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.1 p -138.29 179.79 6.25 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -61.08 -37.61 83.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 10.4 m-30 -63.29 -43.59 97.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.772 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.83 -139.27 6.72 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.514 ' O ' HD12 ' A' ' 16' ' ' LEU . 26.2 m-85 -104.92 130.12 53.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.98 0.39 . . . . 0.0 111.038 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.568 ' CE1' HD13 ' A' ' 16' ' ' LEU . 15.7 m-70 -113.22 148.68 35.01 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.215 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.569 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 72.1 t -117.72 126.98 75.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 167.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.432 HD11 ' CD1' ' A' ' 68' ' ' PHE . 91.4 mt -118.46 123.39 71.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -107.76 140.83 40.24 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 169.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.628 ' NH1' ' O ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -78.74 138.75 38.39 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.91 176.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.628 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 53.3 tp -103.15 124.84 49.34 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.435 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.21 -1.368 0 CA-C-O 118.272 -1.293 . . . . 0.0 112.005 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.565 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.63 144.45 99.43 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.769 1.646 . . . . 0.0 111.736 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 mtt -48.57 138.15 10.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.635 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.57 78.32 Favored Glycine 0 C--N 1.318 -0.454 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.42 ' CB ' ' HD2' ' A' ' 11' ' ' LYS . 1.9 m -103.55 118.5 36.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 36.0 ttm -107.16 107.59 18.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.47 -4.63 0.64 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.87 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -60.73 -31.46 70.77 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -121.55 163.94 18.05 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.186 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.9 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 71.8 mt -105.08 128.48 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HD2' ' CB ' ' A' ' 5' ' ' SER . 59.3 mtpt -91.57 109.49 20.79 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.445 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -141.04 164.61 29.82 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -174.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.8 m -127.39 140.7 52.0 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.479 173.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.43 ' CD2' ' C ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -136.33 150.77 49.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.316 0.579 . . . . 0.0 112.488 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.514 HG23 ' OG ' ' A' ' 44' ' ' SER . 96.1 mt -128.98 126.52 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.323 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' A' ' 46' ' ' ASP . 13.8 mt -95.56 132.69 40.43 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.109 HG12 HD21 ' A' ' 43' ' ' LEU . 34.9 m -129.77 153.63 39.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 O-C-N 123.58 0.55 . . . . 0.0 109.684 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -65.07 -41.29 95.23 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.083 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 9.0 mtmp? -124.55 149.52 46.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -173.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 52.7 tt0 -63.0 -37.35 86.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.05 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.96 -38.73 93.2 Favored Glycine 0 C--O 1.242 0.645 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 93.6 mt-10 -63.77 -41.68 97.93 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 176.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 20' ' ' GLN . . . -58.16 -47.22 84.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.168 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.83 -41.98 98.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.544 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.9 -50.72 72.65 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.752 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' HD23 ' A' ' 30' ' ' LEU . 14.9 m -65.38 -39.22 84.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.059 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 81' ' ' SER . 91.2 mt-30 -57.9 -46.81 84.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.217 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -63.42 -36.54 84.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.838 ' HD3' HD11 ' A' ' 39' ' ' LEU . 77.0 ttt180 -63.15 -39.42 94.62 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.493 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.753 HD11 ' HA ' ' A' ' 36' ' ' PHE . 4.3 mm? -61.41 -40.43 94.4 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 66.2 mmtt -60.83 -28.39 68.78 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.692 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -64.11 -21.22 66.45 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.419 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.93 -4.32 38.94 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.143 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.631 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 18.9 mt-10 -62.8 149.72 43.36 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.211 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 41.1 tttm -63.68 134.3 55.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.214 0.53 . . . . 0.0 110.927 -174.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.753 ' HA ' HD11 ' A' ' 30' ' ' LEU . 64.9 t80 -56.85 -45.24 82.55 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.566 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.03 -34.84 89.44 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.319 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 88.4 tttt -59.95 -46.65 88.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.838 HD11 ' HD3' ' A' ' 29' ' ' ARG . 3.9 mm? -62.57 -41.33 98.86 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.571 173.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.44 -47.43 84.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 31.5 mmtp -65.69 -40.6 92.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.077 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 42.2 mt-10 -70.68 -54.12 13.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -172.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.109 HD21 HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -118.21 -29.09 5.65 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -166.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.963 ' N ' HD13 ' A' ' 43' ' ' LEU . 1.3 m -42.25 137.94 1.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.3 pt -83.32 -12.74 11.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.552 ' HB2' HD12 ' A' ' 16' ' ' LEU . 64.9 t0 -88.59 97.5 11.13 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.717 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -67.45 -45.89 74.64 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.74 -45.68 78.06 Favored Glycine 0 C--O 1.236 0.267 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 54' ' ' GLY . 15.9 m -69.68 -32.67 71.43 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.562 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.79 -26.62 68.81 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.419 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 48.9 mmtm -62.34 -37.68 86.59 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.453 ' O ' ' OG ' ' A' ' 55' ' ' SER . 89.7 mtm-85 -97.63 20.82 11.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.809 176.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.566 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 16.4 m-20 60.41 32.44 20.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.153 0.502 . . . . 0.0 109.733 -177.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 78.71 -8.54 41.99 Favored Glycine 0 C--N 1.307 -1.04 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -64.92 89.08 0.07 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.398 0.618 . . . . 0.0 110.36 179.127 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.449 ' HA ' HH21 ' A' ' 52' ' ' ARG . 91.5 mt -63.1 -41.3 99.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.874 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.39 -154.18 18.97 Favored Glycine 0 C--O 1.236 0.265 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -83.97 135.05 34.61 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 10' ' ' ILE . 53.8 p90 -143.2 154.38 43.8 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.558 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.89 173.76 25.94 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH1' ' CZ ' ' A' ' 73' ' ' PHE . 51.5 mtp85 -71.33 138.62 49.41 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.528 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 86.65 -5.76 84.06 Favored Glycine 0 C--N 1.305 -1.16 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -68.42 -40.54 81.17 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.21 0.528 . . . . 0.0 109.734 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.503 ' HE2' ' CG ' ' A' ' 59' ' ' PHE . 76.4 mtm -123.41 161.95 23.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.707 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.521 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.5 m -51.67 140.04 6.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -44.54 -46.26 25.07 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.538 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.88 -46.26 34.66 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 120.643 0.896 . . . . 0.0 110.742 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CD2' HD11 ' A' ' 93' ' ' ILE . 46.1 t80 -61.7 -49.23 77.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.454 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 62' ' ' GLY . 96.1 mt-10 -65.72 -40.32 92.07 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.339 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.92 -44.49 91.3 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.85 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.422 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -67.39 -38.44 84.69 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.856 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.37 96.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 112.132 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.9 ' CZ ' HD11 ' A' ' 10' ' ' ILE . 39.3 m-85 -61.86 -32.02 72.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 120.794 0.33 . . . . 0.0 111.73 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -61.68 -37.28 83.5 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.741 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.699 HD11 ' HB3' ' A' ' 81' ' ' SER . 72.0 mt -90.58 6.85 42.02 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.438 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 85.4 mt-30 -50.78 -27.35 7.05 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.962 -177.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 p -62.95 -33.55 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.455 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 119.89 49.76 0.3 Allowed Glycine 0 N--CA 1.475 1.28 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.643 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.664 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -128.64 174.37 9.47 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -175.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.45 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 97.2 t -95.77 130.64 44.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.699 ' HB3' HD11 ' A' ' 75' ' ' LEU . 6.2 p -78.61 163.3 25.6 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.019 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.505 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -68.77 169.78 10.13 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 69.5 Cg_endo -62.46 141.5 86.97 Favored 'Trans proline' 0 C--N 1.297 -2.141 0 CA-C-N 118.885 0.638 . . . . 0.0 110.707 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.76 130.84 73.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.497 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 29.6 tptp -107.67 135.59 48.85 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.243 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.3 p -145.63 177.16 9.09 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.49 -31.38 70.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -62.1 -42.28 99.06 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.983 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.436 ' O ' ' HD2' ' A' ' 85' ' ' LYS . . . 152.09 -143.54 10.52 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.548 ' O ' HD23 ' A' ' 16' ' ' LEU . 3.2 m-85 -105.24 129.5 53.6 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -109.37 147.5 32.64 Favored 'General case' 0 CA--C 1.501 -0.931 0 O-C-N 123.41 0.444 . . . . 0.0 110.148 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.6 t -118.11 126.55 75.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 163.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.54 HD11 ' CD2' ' A' ' 68' ' ' PHE . 89.2 mt -115.62 129.92 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.668 -174.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -124.9 143.12 51.02 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.438 ' NH2' ' O ' ' A' ' 76' ' ' GLN . 1.7 tmm_? -78.58 143.83 36.11 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.317 -174.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.424 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 53.8 tp -109.06 139.04 44.48 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.737 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.675 0 CA-C-O 118.249 -1.306 . . . . 0.0 110.332 -179.854 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.35 143.57 99.49 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.922 1.748 . . . . 0.0 111.633 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.2 mtp -112.95 144.98 41.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.55 6.84 88.21 Favored Glycine 0 C--N 1.319 -0.41 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 m -100.71 136.08 41.14 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.148 0.579 . . . . 0.0 111.172 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 77.8 mtm -124.09 148.61 46.99 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.87 -13.85 60.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.464 0.173 . . . . 0.0 111.188 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.43 -36.46 84.24 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HD3' ' CA ' ' A' ' 60' ' ' GLY . 35.0 mmtp -80.76 155.47 26.67 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.542 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.843 HG21 ' HB1' ' A' ' 72' ' ' ALA . 40.5 mm -106.96 128.35 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.196 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.55 ' NZ ' ' OH ' ' A' ' 58' ' ' TYR . 46.0 mtpt -95.66 106.9 19.05 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -148.03 168.24 22.84 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.873 -1.131 . . . . 0.0 113.947 -175.003 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.509 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 19.4 m -135.31 143.97 46.47 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.235 173.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.51 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -138.97 151.77 47.14 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.746 HG23 ' HB2' ' A' ' 44' ' ' SER . 89.1 mt -121.03 126.7 75.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -98.5 119.52 37.35 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.607 ' N ' HD13 ' A' ' 16' ' ' LEU . 19.7 m -127.11 146.68 32.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.187 0.518 . . . . 0.0 111.605 -177.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.33 -40.89 90.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.508 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 22.3 mmtp -109.96 148.24 31.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.869 -171.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -37.55 87.74 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.665 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.98 -37.1 93.85 Favored Glycine 0 C--O 1.227 -0.305 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.513 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 97.9 mt-10 -64.09 -44.69 91.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -60.31 -49.68 76.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.495 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.8 mt -63.99 -41.48 97.48 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.263 0.554 . . . . 0.0 110.216 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.51 -47.19 82.63 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.521 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.856 HG11 HD22 ' A' ' 43' ' ' LEU . 26.1 m -70.2 -32.11 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.967 176.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.567 HE22 ' HA ' ' A' ' 82' ' ' GLU . 48.8 tt0 -61.35 -47.08 87.53 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -67.86 -43.43 79.46 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.939 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.926 ' HD3' HD11 ' A' ' 39' ' ' LEU . 75.0 ttt180 -60.7 -39.17 87.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.329 -177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -57.16 -41.1 78.55 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.71 -26.9 68.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.737 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -65.72 -1.1 2.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 177.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.27 19.02 61.39 Favored Glycine 0 C--O 1.236 0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.143 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 28.3 mt-10 -87.1 144.68 26.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.526 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 56.5 mttp -64.12 139.89 58.81 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.413 0.625 . . . . 0.0 112.304 -175.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.498 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 48.2 t80 -57.77 -45.53 85.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.552 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.24 -36.72 93.43 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.0 177.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 64.4 tttm -60.76 -44.64 96.49 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.926 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.6 mm? -62.66 -40.43 97.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.693 172.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.15 97.87 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.972 0.415 . . . . 0.0 110.144 -177.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.526 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 13.1 mmtm -65.86 -44.09 86.46 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.897 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.507 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 74.6 mt-10 -71.4 -41.79 69.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.856 HD22 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -111.9 -70.39 0.81 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -170.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.746 ' HB2' HG23 ' A' ' 15' ' ' ILE . 4.4 t -33.59 128.48 0.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.449 -168.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.2 pt -91.05 -3.3 10.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.777 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 50' ' ' ALA . 54.6 t0 -79.09 94.73 5.39 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.09 -51.08 61.03 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -46.21 -53.41 9.34 Favored Glycine 0 C--N 1.322 -0.235 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.541 ' OG ' ' NH2' ' A' ' 52' ' ' ARG . 21.9 m -71.7 -32.24 67.59 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 176.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 46' ' ' ASP . . . -62.63 -38.35 89.89 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -61.79 -25.48 67.51 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.756 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' NH2' ' OG ' ' A' ' 49' ' ' SER . 93.1 mtm-85 -97.69 7.71 45.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.367 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.552 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER 59.71 34.1 22.0 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.536 0.684 . . . . 0.0 109.649 -173.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 79.27 -8.59 45.55 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.336 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 m -65.4 128.46 35.97 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.589 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.58 HD12 ' SG ' ' A' ' 12' ' ' CYS . 83.1 mt -109.01 -28.77 8.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.985 0.421 . . . . 0.0 110.064 177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 78.63 -146.87 30.41 Favored Glycine 0 CA--C 1.516 0.124 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.55 ' OH ' ' NZ ' ' A' ' 11' ' ' LYS . 44.0 m-85 -84.32 133.27 34.55 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.548 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 52.1 p90 -144.43 145.91 32.18 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.425 ' CA ' ' HD3' ' A' ' 9' ' ' LYS . . . -93.76 179.25 38.39 Favored Glycine 0 C--N 1.316 -0.535 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -71.05 137.73 49.22 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.085 -0.558 . . . . 0.0 109.778 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.17 -22.76 32.31 Favored Glycine 0 C--N 1.305 -1.182 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.46 -41.4 84.75 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.463 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 5.7 mmm -113.85 160.73 18.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.369 -170.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 86' ' ' SER . 30.7 m -63.73 142.67 16.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -43.43 -50.26 16.6 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.997 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.26 -42.18 69.71 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 N-CA-C 110.393 -0.657 . . . . 0.0 110.393 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CD2' HD11 ' A' ' 93' ' ' ILE . 40.0 t80 -62.4 -47.93 81.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.454 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 64' ' ' MET . 97.4 mt-10 -65.1 -42.88 93.6 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.584 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.68 -40.68 93.05 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.241 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.07 -41.96 90.04 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.006 0.431 . . . . 0.0 110.114 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.843 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.6 -42.87 97.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.395 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 10' ' ' ILE . 46.5 m-85 -66.82 -34.13 77.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -62.99 -33.86 76.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.896 HD11 ' HB3' ' A' ' 81' ' ' SER . 73.9 mt -89.41 18.67 5.04 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -168.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.508 ' NE2' HD12 ' A' ' 10' ' ' ILE . 99.4 mm-40 -59.41 -22.46 61.45 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.3 -26.05 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.427 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 98.49 29.47 7.42 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.58 ' O ' HD13 ' A' ' 75' ' ' LEU . 35.8 tt0 -101.74 159.75 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.787 -0.243 . . . . 0.0 111.458 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.43 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 20.1 t -77.22 131.11 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 172.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.896 ' HB3' HD11 ' A' ' 75' ' ' LEU . 28.1 p -69.91 157.61 37.12 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.671 -178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.567 ' HA ' HE22 ' A' ' 27' ' ' GLN . 16.8 mp0 -73.17 168.65 22.95 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 167.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.514 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 86.5 Cg_exo -53.95 131.42 44.42 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 N-CA-C 110.304 -0.691 . . . . 0.0 110.304 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 91' ' ' HIS . 46.0 t -106.62 108.59 25.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.521 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 16.0 tptm -79.59 131.62 36.05 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.46 ' HB2' HG21 ' A' ' 65' ' ' VAL . 14.7 p -151.34 174.58 13.16 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.76 -172.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -54.81 -36.86 65.42 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.708 174.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -68.67 -41.49 79.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.628 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.9 -125.54 2.51 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.521 ' CE2' ' HD3' ' A' ' 85' ' ' LYS . 96.1 m-85 -109.97 128.28 55.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.111 0.455 . . . . 0.0 110.157 177.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.51 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 4.2 m-70 -108.37 146.63 32.74 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.906 173.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.434 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 77.4 t -117.0 125.44 73.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 168.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.52 ' N ' ' OG ' ' A' ' 81' ' ' SER . 88.5 mt -119.46 129.47 75.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.864 -0.335 . . . . 0.0 111.714 -171.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -112.34 131.33 55.59 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 169.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.505 ' CD ' ' HA ' ' A' ' 76' ' ' GLN . 79.2 ttt-85 -78.04 135.47 37.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 11' ' ' LYS . 56.0 tp -107.24 132.82 52.65 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.141 -173.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.387 0 CA-C-O 118.096 -1.391 . . . . 0.0 111.221 -177.399 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.846 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.99 144.24 69.22 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.09 1.86 . . . . 0.0 111.809 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.414 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 39.2 mmt -84.63 155.81 21.84 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.17 0.51 . . . . 0.0 111.744 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.63 -17.51 14.75 Favored Glycine 0 C--O 1.235 0.183 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -63.53 155.69 28.67 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 49.5 ttp -58.76 -40.64 84.49 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' A' ' 9' ' ' LYS . . . -80.14 24.43 0.42 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.14 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.483 ' OD1' ' HG3' ' A' ' 9' ' ' LYS . 24.3 p-10 -83.18 14.56 3.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.743 0.782 . . . . 0.0 109.959 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.483 ' HG3' ' OD1' ' A' ' 8' ' ' ASP . 40.0 mttp -118.49 177.31 4.87 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.077 -175.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.905 HG21 ' HB1' ' A' ' 72' ' ' ALA . 15.7 mm -105.2 124.18 59.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' NZ ' ' O ' ' A' ' 97' ' ' GLY . 62.0 mtpt -97.15 105.13 17.22 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 171.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -146.16 168.73 20.28 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -173.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.9 m -132.66 146.86 52.22 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.82 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.586 ' NE2' ' OG ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -133.92 150.65 51.32 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.656 HG13 ' CZ ' ' A' ' 36' ' ' PHE . 93.6 mt -123.62 126.72 73.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 90' ' ' TYR . 42.1 tp -100.74 122.47 43.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.29 155.34 41.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.332 0.587 . . . . 0.0 110.915 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -65.29 -40.29 93.66 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.702 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.557 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 58.4 mttp -117.13 151.81 36.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.086 -168.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.429 ' O ' HD23 ' A' ' 24' ' ' LEU . 87.2 mt-30 -63.07 -40.57 98.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.44 -0.8 . . . . 0.0 108.96 170.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.97 -37.49 93.92 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.573 ' O ' HG13 ' A' ' 26' ' ' VAL . 94.4 mt-10 -64.73 -41.34 96.03 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.01 -42.66 98.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.993 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 20' ' ' GLN . 2.5 mm? -62.22 -41.84 98.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -56.48 -49.89 73.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.384 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.627 ' O ' HD23 ' A' ' 30' ' ' LEU . 2.6 m -65.19 -40.82 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.807 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.412 HE22 ' HA ' ' A' ' 82' ' ' GLU . 83.4 mt-30 -56.65 -46.24 81.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -67.83 -41.85 82.39 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.315 0.579 . . . . 0.0 110.261 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.518 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 77.0 ttt180 -61.07 -39.43 89.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.922 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 26' ' ' VAL . 4.4 mm? -58.65 -36.57 74.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -67.44 -13.61 62.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.378 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -71.95 -12.4 61.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.99 0.424 . . . . 0.0 110.116 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.97 16.64 47.0 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.256 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 29' ' ' ARG . 34.2 mt-10 -82.59 147.38 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.283 176.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 41.9 tttm -66.25 133.82 51.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.087 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.656 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 54.3 t80 -58.62 -46.31 87.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.149 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -62.89 -36.14 92.99 Favored Glycine 0 C--O 1.25 1.154 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 62.3 tttm -60.2 -48.12 83.06 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.679 ' HB3' HD12 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -63.96 -40.1 95.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.987 176.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' CB ' ' C ' ' A' ' 53' ' ' ASP . . . -56.49 -47.94 78.22 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.477 ' NZ ' ' O ' ' A' ' 37' ' ' GLY . 24.5 mtmm -64.77 -41.28 95.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.029 176.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.518 ' OE1' ' NH2' ' A' ' 29' ' ' ARG . 86.9 mt-10 -71.04 -56.83 5.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.679 HD12 ' HB3' ' A' ' 39' ' ' LEU . 10.9 mt -76.77 -50.37 13.71 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.509 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.8 m -61.14 139.25 58.14 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.337 -161.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.549 HG13 HD23 ' A' ' 16' ' ' LEU . 45.0 pt -87.75 -4.52 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.874 172.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -89.77 96.65 10.78 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.189 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.0 -41.36 99.92 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.63 -45.1 90.86 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.586 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 39.6 m -63.89 -33.79 76.49 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.699 0.285 . . . . 0.0 110.622 174.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -62.57 -40.63 97.48 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 31.5 mmtp -70.3 -11.73 61.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.697 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 55' ' ' SER . 72.2 mmt-85 -113.03 9.28 18.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.097 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 85.4 m-20 53.61 30.8 11.43 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -174.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 60.48 1.42 1.73 Allowed Glycine 0 C--N 1.318 -0.438 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -175.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 53' ' ' ASP . 1.7 m -75.84 85.75 2.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.244 0.545 . . . . 0.0 110.578 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.624 HD13 ' CE ' ' A' ' 64' ' ' MET . 85.0 mt -63.85 -40.16 95.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.175 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.29 -149.25 20.58 Favored Glycine 0 C--N 1.322 -0.231 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.83 132.79 34.36 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 53.6 p90 -143.62 146.73 33.49 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.338 171.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.75 -171.7 37.49 Favored Glycine 0 C--N 1.314 -0.659 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 61' ' ' ARG . 50.6 mtp85 -69.64 139.32 53.56 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.08 -27.25 17.39 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -65.32 -37.44 87.1 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 116.959 0.38 . . . . 0.0 111.669 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.624 ' CE ' HD13 ' A' ' 56' ' ' LEU . 3.3 mmt -110.28 159.55 17.32 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -176.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.84 134.23 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.098 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' NZ ' ' OE2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -45.58 -40.51 14.24 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -171.503 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.24 -43.37 56.74 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.654 0.903 . . . . 0.0 110.242 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CE1' HG12 ' A' ' 93' ' ' ILE . 48.5 t80 -61.99 -46.82 87.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.85 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.458 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 81.4 mt-10 -64.42 -40.89 96.64 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.345 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -55.86 -47.26 77.64 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.826 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.46 77.92 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.496 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.905 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.6 -46.48 90.08 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.638 ' CE1' HD11 ' A' ' 10' ' ' ILE . 47.3 m-85 -62.61 -41.68 99.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.983 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -63.52 -41.7 98.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.814 ' C ' HD23 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -83.56 1.08 43.81 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -174.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.644 ' NE2' HD13 ' A' ' 10' ' ' ILE . 7.3 mm-40 -51.24 -23.36 3.38 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.939 0.4 . . . . 0.0 110.162 177.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.445 HG13 ' HG2' ' A' ' 79' ' ' GLU . 7.4 p -59.31 -27.46 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.772 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 120.49 46.89 0.34 Allowed Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.445 ' HG2' HG13 ' A' ' 77' ' ' VAL . 49.3 mm-40 -117.37 170.89 8.35 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 t -100.41 117.29 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 170.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.5 p -62.73 151.02 39.68 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.399 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.412 ' HA ' HE22 ' A' ' 27' ' ' GLN . 0.1 OUTLIER -64.26 170.95 3.0 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.0 131.47 45.67 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 N-CA-C 109.828 -0.874 . . . . 0.0 109.828 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 68' ' ' PHE . 18.5 t -107.2 111.78 37.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -88.24 134.49 33.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.798 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.9 p -144.9 173.66 11.68 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.7 pm0 -57.83 -31.26 66.46 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -67.01 -38.42 85.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.815 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.48 -145.74 14.5 Favored Glycine 0 C--N 1.322 -0.216 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.613 ' O ' HD12 ' A' ' 16' ' ' LEU . 91.3 m-85 -106.87 129.8 54.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.523 ' CE1' HD13 ' A' ' 16' ' ' LEU . 2.6 m-70 -110.81 148.27 32.73 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.455 0.169 . . . . 0.0 110.561 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.492 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 56.0 t -117.9 128.22 75.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 167.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.529 HG23 ' SG ' ' A' ' 12' ' ' CYS . 72.8 mt -109.18 126.83 66.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.76 0.314 . . . . 0.0 110.441 -175.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 95' ' ' ARG . 9.6 tptp -104.9 135.63 45.9 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 170.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.546 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -76.96 142.0 40.2 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.239 -178.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.6 tp -108.16 132.69 53.35 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.469 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.207 -1.532 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.766 -172.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.803 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.98 142.59 96.73 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.125 1.217 . . . . 0.0 111.415 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.4 mtp -47.94 124.54 7.62 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.55 -14.77 60.5 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.24 106.02 13.22 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.41 ' C ' ' N ' ' A' ' 8' ' ' ASP . 77.6 mtm -111.1 155.39 22.91 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.47 -5.89 0.39 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.834 0.349 . . . . 0.0 110.709 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 6' ' ' MET . 38.0 t70 -63.58 -34.69 78.37 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -81.18 157.16 25.36 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.589 172.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.755 HD11 ' CD1' ' A' ' 73' ' ' PHE . 41.9 mm -104.58 126.22 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 97' ' ' GLY . 60.6 mtpt -94.12 108.18 20.04 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 170.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -148.01 170.13 18.41 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.961 -171.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.554 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 20.3 m -130.63 147.35 52.3 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.537 175.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.563 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -134.71 152.47 51.79 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.879 0.371 . . . . 0.0 111.593 -175.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.555 HD13 ' HB3' ' A' ' 39' ' ' LEU . 86.2 mt -128.14 127.14 67.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 175.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 90' ' ' TYR . 38.7 tp -99.28 123.09 43.29 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.25 154.36 28.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.156 0.503 . . . . 0.0 111.497 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.423 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 6.6 mttp -67.7 -42.23 82.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.621 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 68.3 mttm -124.53 149.8 46.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.64 -168.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.425 ' O ' HD23 ' A' ' 24' ' ' LEU . 9.5 pt20 -57.21 -38.84 74.32 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.164 171.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.75 -36.16 92.31 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.478 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 96.9 mt-10 -64.07 -41.05 97.47 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.357 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -61.32 -45.52 94.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.595 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 20' ' ' GLN . 2.8 mm? -61.84 -41.96 98.45 Favored 'General case' 0 C--O 1.248 1.008 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.44 76.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.504 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 43' ' ' LEU . 32.8 m -65.5 -37.72 80.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.784 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.609 ' NE2' ' HA ' ' A' ' 82' ' ' GLU . 79.0 mt-30 -59.32 -49.82 76.35 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.162 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.448 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 70.9 mm-40 -68.34 -38.52 81.58 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.705 ' HD3' HD11 ' A' ' 39' ' ' LEU . 73.5 ttt180 -61.97 -42.2 98.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.146 0.498 . . . . 0.0 109.874 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -43.41 95.36 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.448 ' NZ ' ' OE2' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -63.66 -12.78 36.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.958 175.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -72.72 -8.4 55.21 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.04 9.99 60.22 Favored Glycine 0 C--O 1.238 0.38 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -75.1 161.21 29.61 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.998 0.427 . . . . 0.0 111.348 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 47.0 mttm -74.07 137.14 43.15 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.291 -177.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -59.14 -45.09 91.84 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.537 ' CA ' ' HB3' ' A' ' 53' ' ' ASP . . . -61.44 -39.06 96.76 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.281 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 88.4 tttt -60.33 -45.16 94.42 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.705 HD11 ' HD3' ' A' ' 29' ' ' ARG . 1.3 mm? -61.34 -42.1 98.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.09 173.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -61.56 -53.21 59.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.948 -175.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -69.02 -32.86 72.68 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.805 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.483 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 87.1 mt-10 -71.08 -41.21 70.96 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 26' ' ' VAL . 4.5 mp -105.21 -67.97 0.89 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -26.58 117.16 0.07 Allowed 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 114.084 -1.416 . . . . 0.0 112.984 -166.185 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.506 HG13 HD23 ' A' ' 16' ' ' LEU . 46.2 pt -90.68 -2.57 10.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.067 -177.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.409 ' CG ' ' HE2' ' A' ' 14' ' ' HIS . 1.2 p30 -76.41 179.89 5.58 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.714 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.35 -118.73 0.55 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.736 -176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 52' ' ' ARG . . . -49.41 -43.13 34.94 Favored Glycine 0 C--N 1.321 -0.259 0 N-CA-C 112.153 -0.379 . . . . 0.0 112.153 -172.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -60.12 -34.24 73.24 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.366 -179.019 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.26 86.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.472 0.653 . . . . 0.0 109.271 175.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.23 -7.37 59.37 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.442 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.463 ' O ' ' OG ' ' A' ' 55' ' ' SER . 56.3 mtp85 -96.89 20.38 11.19 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.731 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.537 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 83.0 m-20 56.19 29.62 15.09 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -173.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.76 -13.26 7.04 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.689 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 52' ' ' ARG . 28.1 p -66.33 95.08 0.29 Allowed 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.834 0.826 . . . . 0.0 112.199 -177.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.535 HD12 ' SG ' ' A' ' 12' ' ' CYS . 92.7 mt -65.58 -38.3 89.11 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.812 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.03 -147.19 18.75 Favored Glycine 0 C--N 1.317 -0.474 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 1.5 p90 -85.3 141.04 30.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.222 0.511 . . . . 0.0 111.385 177.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.673 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 49.9 p90 -147.28 151.65 36.98 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 171.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.31 176.94 27.05 Favored Glycine 0 C--O 1.241 0.59 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' A' ' 73' ' ' PHE . 83.6 mtm-85 -69.36 142.44 53.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 120.977 0.418 . . . . 0.0 110.705 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.85 -36.58 4.3 Favored Glycine 0 C--N 1.306 -1.124 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -63.1 -41.5 99.38 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.395 -0.474 . . . . 0.0 110.721 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.486 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 26.7 mmm -97.05 160.23 14.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.923 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 68' ' ' PHE . 19.5 m -71.28 144.47 13.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -44.31 -51.51 19.36 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.73 -42.82 65.02 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 120.39 0.727 . . . . 0.0 110.391 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.559 ' CD2' HD11 ' A' ' 93' ' ' ILE . 35.4 t80 -62.16 -46.29 89.63 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.885 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -61.61 -42.51 98.99 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.523 ' CG ' ' HE ' ' A' ' 74' ' ' ARG . 11.8 t70 -55.81 -48.82 74.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.45 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.61 61.84 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.114 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.5 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.28 -50.81 72.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.732 -176.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.755 ' CD1' HD11 ' A' ' 10' ' ' ILE . 58.5 m-85 -67.01 -39.26 87.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HE ' ' CG ' ' A' ' 70' ' ' ASP . 46.8 mtm105 -63.5 -39.19 93.79 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.225 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.481 HD12 ' HB3' ' A' ' 81' ' ' SER . 73.9 mt -96.5 29.97 2.73 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.47 ' OE1' ' NE ' ' A' ' 95' ' ' ARG . 4.3 mm100 -52.47 -20.03 2.61 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.436 HG13 ' H ' ' A' ' 79' ' ' GLU . 12.9 p -62.8 -31.31 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.881 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 118.32 -3.63 15.91 Favored Glycine 0 N--CA 1.475 1.299 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.274 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' H ' HG13 ' A' ' 77' ' ' VAL . 19.8 tp10 -67.4 153.13 44.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.997 0.399 . . . . 0.0 110.64 -177.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.0 t -71.03 132.16 33.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 93' ' ' ILE . 10.8 p -75.66 155.93 35.31 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.083 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.609 ' HA ' ' NE2' ' A' ' 27' ' ' GLN . 4.1 mp0 -75.56 172.43 9.28 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 173.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.612 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 75.3 Cg_exo -54.79 130.53 40.95 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 N-CA-C 109.036 -1.178 . . . . 0.0 109.036 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 58.5 t -105.01 114.32 44.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -83.37 132.24 35.01 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.6 p -141.12 172.01 13.28 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.45 -37.48 83.71 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -64.6 -42.54 95.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.384 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.87 -145.3 13.07 Favored Glycine 0 C--N 1.318 -0.421 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.569 ' O ' HD12 ' A' ' 16' ' ' LEU . 73.8 m-85 -105.58 128.48 53.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.862 0.331 . . . . 0.0 111.352 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.563 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 3.1 m-70 -119.18 152.27 36.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.333 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.53 HG21 ' CG2' ' A' ' 26' ' ' VAL . 62.9 t -118.76 128.96 75.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 166.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.559 HD11 ' CD2' ' A' ' 68' ' ' PHE . 86.0 mt -122.12 133.27 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 119.74 -0.171 . . . . 0.0 111.369 -173.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -128.22 148.16 50.61 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 167.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.47 ' NE ' ' OE1' ' A' ' 76' ' ' GLN . 61.5 ttt-85 -79.16 142.21 36.55 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.012 0.435 . . . . 0.0 110.091 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 50.1 tp -112.61 133.42 54.66 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.453 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.208 -1.477 0 CA-C-O 118.341 -1.255 . . . . 0.0 111.362 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.745 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.63 142.21 98.43 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.445 1.43 . . . . 0.0 111.339 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.3 mtt -78.17 151.26 33.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.649 0.261 . . . . 0.0 110.685 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.52 17.09 79.55 Favored Glycine 0 C--O 1.239 0.421 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.86 118.15 34.12 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.561 ' C ' ' H ' ' A' ' 8' ' ' ASP . 2.3 mpp? -97.12 174.0 6.97 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.73 42.05 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.071 0.463 . . . . 0.0 110.494 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 6' ' ' MET . 89.7 m-20 -62.46 -37.26 85.22 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HD2' ' C ' ' A' ' 59' ' ' PHE . 25.5 mmtp -99.46 159.3 15.12 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.278 -1.783 . . . . 0.0 109.275 -174.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.77 HG21 ' HB1' ' A' ' 72' ' ' ALA . 32.1 mm -106.26 129.49 59.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' NZ ' ' OXT' ' A' ' 97' ' ' GLY . 57.6 mtpt -88.24 105.72 17.73 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.549 ' SG ' HG23 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -147.52 165.28 30.81 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.096 0.474 . . . . 0.0 111.76 -176.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.453 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 7.1 m -131.75 147.22 52.48 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.732 176.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 149.93 50.86 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.681 ' CG2' HD12 ' A' ' 43' ' ' LEU . 97.0 mt -125.67 128.64 72.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.134 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.534 HD23 HG13 ' A' ' 45' ' ' ILE . 47.0 tp -100.23 128.34 46.32 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.795 -176.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.03 ' CG1' HD11 ' A' ' 43' ' ' LEU . 16.2 m -127.64 155.58 39.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.967 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 17.5 pttp -84.04 -22.25 31.34 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.833 176.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 19' ' ' LYS . 37.3 mmtm -135.57 152.56 51.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -62.67 -37.99 88.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.947 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.55 -36.79 92.18 Favored Glycine 0 C--N 1.321 -0.276 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.491 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 96.0 mt-10 -65.35 -44.37 87.91 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -58.55 -48.96 79.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.238 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.533 HD23 ' OE1' ' A' ' 27' ' ' GLN . 30.0 mt -63.87 -40.91 97.65 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.754 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.17 -48.53 76.16 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.255 -177.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.538 HG12 HD12 ' A' ' 39' ' ' LEU . 18.0 m -64.99 -39.57 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.246 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.562 HE21 HG22 ' A' ' 92' ' ' VAL . 83.3 mt-30 -60.22 -47.18 87.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.085 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.13 -41.26 81.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.133 0.492 . . . . 0.0 110.822 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.974 ' HD3' HD11 ' A' ' 39' ' ' LEU . 71.1 ttt180 -62.87 -38.55 91.31 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.73 177.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -57.16 -35.83 70.02 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -177.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 79' ' ' GLU . 49.8 mmtt -61.52 -28.63 69.45 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.134 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.9 -21.94 45.94 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.942 0.401 . . . . 0.0 110.917 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.09 7.19 41.4 Favored Glycine 0 C--N 1.319 -0.385 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 31.9 mt-10 -76.18 156.59 33.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.152 177.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -72.52 141.38 48.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.708 0.766 . . . . 0.0 112.428 -176.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CZ ' HG13 ' A' ' 15' ' ' ILE . 45.9 t80 -58.12 -44.78 87.92 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.14 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -61.19 -36.68 92.76 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.352 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.442 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 88.3 tttt -61.37 -48.04 83.08 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.974 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.3 mm? -62.05 -41.82 98.54 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.967 173.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.469 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -59.05 -50.32 74.52 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.153 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -43.26 88.29 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.642 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' A' ' 29' ' ' ARG . 87.1 mt-10 -70.94 -45.55 64.01 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -173.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.03 HD11 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -107.6 -39.12 5.71 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.634 ' N ' HD13 ' A' ' 43' ' ' LEU . 2.5 m -52.99 138.67 29.87 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.062 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.534 HG13 HD23 ' A' ' 16' ' ' LEU . 42.1 pt -91.72 -4.82 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.387 173.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -90.89 101.0 13.76 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.581 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 51' ' ' LYS . . . -65.88 -43.8 93.11 Favored Glycine 0 C--N 1.318 -0.434 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.79 -45.24 91.45 Favored Glycine 0 C--O 1.239 0.453 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.2 m -64.21 -33.47 75.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.95 0.405 . . . . 0.0 110.213 174.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -64.45 -35.4 80.79 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 74.8 mmtt -61.9 -36.79 82.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' NH2' ' O ' ' A' ' 56' ' ' LEU . 77.7 mtp85 -97.57 19.26 13.75 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.982 174.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.9 OUTLIER 44.67 42.37 5.74 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.679 178.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 71.83 -20.76 0.82 Allowed Glycine 0 C--N 1.31 -0.886 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.55 ' H ' ' C ' ' A' ' 53' ' ' ASP . 10.3 m -67.91 79.47 0.21 Allowed 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.527 0.679 . . . . 0.0 110.305 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.416 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 97.7 mt -62.56 -41.63 99.03 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.387 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.88 -147.12 18.46 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.04 104.16 14.72 Favored 'General case' 0 C--O 1.252 1.195 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.459 ' C ' ' HD2' ' A' ' 9' ' ' LYS . 47.5 p90 -119.0 148.1 43.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.712 177.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.82 -176.31 48.1 Favored Glycine 0 C--O 1.236 0.25 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.501 ' HD2' ' CZ ' ' A' ' 73' ' ' PHE . 26.0 mtp180 -86.65 162.76 17.77 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.7 -21.42 1.57 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.724 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 61' ' ' ARG . 37.6 mmtm -65.1 -40.01 93.95 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -112.93 160.27 18.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.75 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 11.5 m -58.47 146.6 8.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.99 -176.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 4.5 mtpp -45.13 -47.03 32.29 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.347 -177.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 66' ' ' LYS . 75.5 Cg_exo -55.47 -41.38 78.58 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 120.486 0.791 . . . . 0.0 110.609 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.669 ' CD2' HD11 ' A' ' 93' ' ' ILE . 50.6 t80 -61.28 -46.56 89.85 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.766 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 61' ' ' ARG . 67.3 mt-10 -62.31 -46.97 86.35 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.618 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 35.0 t70 -58.61 -45.61 88.78 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.394 -176.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.564 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -59.56 -46.13 89.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.77 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -60.25 -46.96 88.0 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.032 0.444 . . . . 0.0 110.07 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.759 ' CE1' HD11 ' A' ' 10' ' ' ILE . 51.6 m-85 -68.11 -36.68 80.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.326 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.454 ' NH2' ' OE2' ' A' ' 82' ' ' GLU . 61.8 mtp180 -61.6 -45.26 94.84 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.204 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 75' ' ' LEU . 93.9 mt -99.68 42.07 1.12 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -177.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.433 ' HA ' ' CD ' ' A' ' 95' ' ' ARG . 35.3 mt-30 -55.26 -21.1 13.01 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.413 173.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.489 HG13 ' H ' ' A' ' 79' ' ' GLU . 14.7 p -61.96 -32.37 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.792 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 120.18 -3.96 12.6 Favored Glycine 0 N--CA 1.477 1.382 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.213 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -73.31 173.4 9.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 117.075 0.437 . . . . 0.0 111.377 -178.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.555 ' H ' ' CD ' ' A' ' 79' ' ' GLU . 5.3 t -92.53 129.57 42.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.491 ' O ' ' NE2' ' A' ' 27' ' ' GLN . 9.9 p -71.3 153.51 42.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.254 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.454 ' C ' HE22 ' A' ' 27' ' ' GLN . 5.0 mp0 -64.52 169.81 4.58 Favored Pre-proline 0 CA--C 1.507 -0.686 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 172.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.491 ' N ' HE22 ' A' ' 27' ' ' GLN . 63.6 Cg_exo -53.31 130.53 38.84 Favored 'Trans proline' 0 C--N 1.295 -2.267 0 N-CA-C 109.596 -0.963 . . . . 0.0 109.596 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.2 107.74 23.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -78.31 133.38 37.63 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.398 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.4 p -140.19 167.93 21.0 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 1.6 pm0 -58.12 -36.38 72.85 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -63.99 -43.82 94.56 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.868 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.94 -148.9 16.79 Favored Glycine 0 C--N 1.311 -0.828 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.439 ' HB2' HG23 ' A' ' 17' ' ' VAL . 93.8 m-85 -110.11 129.55 55.68 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.407 ' CE1' HD13 ' A' ' 16' ' ' LEU . 5.2 m-70 -109.5 151.91 26.13 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.562 HG22 HE21 ' A' ' 27' ' ' GLN . 60.1 t -117.85 126.03 74.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.669 HD11 ' CD2' ' A' ' 68' ' ' PHE . 96.1 mt -119.69 127.33 75.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.648 -176.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.421 ' NZ ' ' O ' ' A' ' 78' ' ' GLY . 64.5 tttp -110.96 143.14 42.08 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 169.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.57 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -78.59 142.47 37.27 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.066 178.006 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.2 tp -110.43 139.72 45.38 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.03 -175.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.502 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.21 -1.372 0 CA-C-O 118.268 -1.295 . . . . 0.0 110.755 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.605 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.462 ' HB2' ' OG ' ' A' ' 5' ' ' SER . 52.9 Cg_exo -58.21 140.15 93.19 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 121.739 1.626 . . . . 0.0 111.53 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.3 ttp -110.19 137.26 48.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.43 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.596 ' O ' ' NZ ' ' A' ' 9' ' ' LYS . . . 75.86 6.72 82.74 Favored Glycine 0 C--N 1.321 -0.304 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 2' ' ' PRO . 0.9 OUTLIER -69.91 102.4 1.97 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.686 -0.257 . . . . 0.0 110.447 -178.235 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.6 mtp 31.13 -93.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.236 0.614 . . . . 0.0 112.142 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.02 -21.35 30.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.795 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -63.49 -36.09 82.61 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.596 ' NZ ' ' O ' ' A' ' 4' ' ' GLY . 51.4 mttp -75.24 152.09 38.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 171.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.853 HD11 ' CE1' ' A' ' 73' ' ' PHE . 69.4 mt -106.9 128.35 61.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' TYR . 48.3 mtpt -94.25 106.85 18.83 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -146.33 168.99 19.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.097 0.776 . . . . 0.0 113.097 -173.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.429 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 45.4 m -135.66 147.16 48.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.398 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.444 ' CG ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -137.6 152.31 49.25 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.888 HG23 ' OG ' ' A' ' 44' ' ' SER . 95.6 mt -121.63 126.21 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 124.96 1.304 . . . . 0.0 108.032 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 17' ' ' VAL . 4.6 tt -105.28 123.54 48.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.639 ' N ' HD23 ' A' ' 16' ' ' LEU . 31.3 m -135.87 155.63 36.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 120.804 0.335 . . . . 0.0 110.396 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.94 -22.35 33.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.158 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.55 137.55 43.2 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.774 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.52 -36.99 85.59 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.55 98.22 Favored Glycine 0 CA--C 1.51 -0.224 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.473 ' HB3' HD23 ' A' ' 43' ' ' LEU . 98.8 mt-10 -64.46 -43.97 92.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.633 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . . . -60.4 -45.58 93.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.282 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.93 -39.93 96.1 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.466 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.07 -46.0 89.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.573 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.868 ' CG1' HD22 ' A' ' 43' ' ' LEU . 12.3 m -65.78 -38.82 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.953 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.542 ' OE1' ' NZ ' ' A' ' 31' ' ' LYS . 3.1 tp-100 -54.68 -48.53 72.29 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.745 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -68.06 -39.88 82.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.713 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HG2' HD11 ' A' ' 39' ' ' LEU . 8.1 tpt180 -63.08 -40.23 97.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.903 -174.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.601 HD11 ' CA ' ' A' ' 36' ' ' PHE . 1.9 mm? -61.05 -38.81 87.49 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.329 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.542 ' NZ ' ' OE1' ' A' ' 27' ' ' GLN . 23.8 mmtm -64.29 -16.11 61.52 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.889 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -72.13 -9.6 58.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 174.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.84 12.14 62.65 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CD ' ' HE ' ' A' ' 29' ' ' ARG . 96.6 mt-10 -83.99 153.11 24.06 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.786 -0.243 . . . . 0.0 111.054 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -64.75 132.51 49.79 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 121.623 0.725 . . . . 0.0 111.93 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.601 ' CA ' HD11 ' A' ' 30' ' ' LEU . 62.5 t80 -57.05 -44.9 83.45 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.096 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 53' ' ' ASP . . . -59.11 -38.03 92.5 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.772 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.494 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 49.1 tttp -60.95 -47.1 87.99 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.888 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 26' ' ' VAL . 4.4 mm? -61.82 -41.25 97.55 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.472 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -58.01 -50.56 72.98 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.858 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.26 -36.68 84.87 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.074 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.5 ' HB3' HD12 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -72.48 -80.3 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.913 -174.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.868 HD22 ' CG1' ' A' ' 26' ' ' VAL . 8.8 mp -67.29 -43.63 81.26 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -173.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.888 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.2 m -58.88 147.7 32.88 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.689 -162.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.451 ' CG1' HD22 ' A' ' 16' ' ' LEU . 46.0 pt -98.84 -5.21 9.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.824 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -85.21 93.67 8.72 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.576 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 50' ' ' ALA . . . -61.26 -44.39 98.16 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.3 -41.84 72.17 Favored Glycine 0 C--N 1.324 -0.132 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.408 ' OG ' ' NE2' ' A' ' 14' ' ' HIS . 67.0 m -73.93 -33.37 63.91 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.934 174.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -67.14 -42.13 84.93 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.204 0.526 . . . . 0.0 110.68 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 35.3 mmtp -62.34 -31.79 72.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -96.69 15.87 20.62 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.268 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.491 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 42.3 38.7 1.23 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.951 0.881 . . . . 0.0 112.134 -178.527 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 75.77 -11.81 9.8 Favored Glycine 0 C--O 1.236 0.231 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.652 176.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.1 m -67.93 80.38 0.21 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.4 . . . . 0.0 111.617 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.444 HD11 ' CG ' ' A' ' 14' ' ' HIS . 96.0 mt -63.28 -40.56 97.71 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.95 -149.07 19.52 Favored Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.863 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.553 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.33 141.77 28.41 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.646 ' CZ ' ' HB ' ' A' ' 10' ' ' ILE . 47.7 p90 -148.59 151.96 35.94 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.988 177.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.35 167.92 49.59 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.506 ' NH1' ' CE1' ' A' ' 73' ' ' PHE . 77.3 mtp85 -74.68 140.97 44.57 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.01 -29.57 10.97 Favored Glycine 0 C--N 1.305 -1.18 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.193 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -40.53 97.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.583 ' HG3' ' CE1' ' A' ' 59' ' ' PHE . 9.0 mmm -80.83 160.76 24.71 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 68' ' ' PHE . 15.1 m -63.21 136.51 26.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 119.04 -1.064 . . . . 0.0 108.562 176.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -45.29 -47.02 34.11 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.447 -171.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -56.61 -40.38 84.83 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.122 1.214 . . . . 0.0 110.77 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.537 ' CD2' HD11 ' A' ' 93' ' ' ILE . 56.0 t80 -60.76 -46.51 90.16 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.565 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 47.9 mt-10 -64.47 -38.37 90.8 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.527 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.8 -48.51 75.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.924 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.23 -40.48 71.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.559 174.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.84 92.45 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.836 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.853 ' CE1' HD11 ' A' ' 10' ' ' ILE . 24.8 m-85 -66.39 -34.06 77.11 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.794 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' NH1' ' OE1' ' A' ' 82' ' ' GLU . 58.9 mtp180 -62.29 -44.75 95.8 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 81' ' ' SER . 0.1 OUTLIER -97.37 34.53 1.78 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.629 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.481 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 53.0 mt-30 -56.14 -20.9 19.56 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.482 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 79' ' ' GLU . 7.3 p -60.61 -29.71 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.768 176.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 121.35 -4.31 11.15 Favored Glycine 0 N--CA 1.471 0.988 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.589 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.1 tp10 -64.95 166.94 8.43 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 122.781 0.432 . . . . 0.0 110.761 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.583 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 13.8 t -93.82 128.86 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 174.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.638 ' HB3' HD13 ' A' ' 75' ' ' LEU . 10.6 p -73.67 162.08 29.58 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.686 0.279 . . . . 0.0 111.609 -178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 5.9 mp0 -79.56 -179.74 1.52 Allowed Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 173.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.633 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 73.3 Cg_exo -57.63 133.5 56.93 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 CA-C-N 118.936 0.656 . . . . 0.0 110.761 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 47.3 t -111.46 102.96 14.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.657 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 135.14 48.37 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 p -146.56 172.98 12.74 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.639 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 2.0 pm0 -59.23 -37.67 78.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 171.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.477 ' HB2' ' HE2' ' A' ' 91' ' ' HIS . 36.6 m-85 -65.21 -43.81 90.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.922 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 151.69 -151.72 23.6 Favored Glycine 0 C--N 1.317 -0.51 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 70.1 m-85 -98.89 129.06 45.22 Favored 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.38 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.477 ' HE2' ' HB2' ' A' ' 88' ' ' PHE . 5.0 m-70 -112.08 148.96 32.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.238 177.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.604 HG11 HG23 ' A' ' 26' ' ' VAL . 61.4 t -117.44 128.47 74.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 167.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 68' ' ' PHE . 87.1 mt -119.34 130.5 73.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -173.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HD2' HG22 ' A' ' 80' ' ' VAL . 59.5 tttm -115.73 143.52 45.26 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 168.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -78.41 143.61 36.63 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.837 -178.101 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.438 ' O ' ' NH2' ' A' ' 95' ' ' ARG . 52.9 tp -96.61 133.01 41.65 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.419 ' OXT' ' NZ ' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.205 -1.657 0 CA-C-O 118.364 -1.242 . . . . 0.0 111.25 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.55 150.42 83.98 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.012 1.808 . . . . 0.0 111.658 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.16 157.13 37.5 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.7 19.31 56.7 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 -170.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 8' ' ' ASP . 94.2 p -76.31 169.65 17.82 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 113.902 -1.149 . . . . 0.0 111.124 -177.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 98.2 mmm -64.95 -36.52 84.66 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.29 66.57 Favored 'General case' 0 C--O 1.228 -0.057 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.216 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 5' ' ' SER . 2.3 m-20 -62.38 -35.24 78.56 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -85.85 154.92 21.21 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.072 168.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.459 HD12 ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -105.95 123.64 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -93.13 105.16 17.29 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -147.44 167.61 23.96 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.326 -0.95 . . . . 0.0 113.205 -171.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 4.1 m -130.88 141.16 50.29 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.066 -1.424 . . . . 0.0 107.997 174.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.482 ' CE1' ' HD1' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -135.75 150.45 49.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -176.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.822 HG23 ' OG ' ' A' ' 44' ' ' SER . 91.5 mt -125.46 121.62 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.552 HD22 ' CG1' ' A' ' 45' ' ' ILE . 5.5 tt -101.47 121.42 41.92 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.448 HG13 HG22 ' A' ' 15' ' ' ILE . 29.3 m -133.88 150.97 32.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.568 0.699 . . . . 0.0 112.192 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG3' HD13 ' A' ' 45' ' ' ILE . 99.2 mttt -67.32 -38.38 84.84 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.355 176.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.508 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 64.0 mttm -109.37 141.61 41.48 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.627 -173.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -64.6 -36.75 85.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.055 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.0 -36.22 92.55 Favored Glycine 0 C--O 1.238 0.357 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.583 ' HB3' HD23 ' A' ' 43' ' ' LEU . 94.6 mt-10 -65.55 -41.44 93.01 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.74 -44.52 93.74 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.685 176.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.1 mt -64.18 -39.46 94.04 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.099 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.16 -49.54 71.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.031 HG13 HD22 ' A' ' 43' ' ' LEU . 18.5 m -64.29 -41.14 91.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.461 176.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.474 HE22 ' N ' ' A' ' 83' ' ' PRO . 84.0 mt-30 -59.48 -46.41 88.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.328 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HA ' ' HG2' ' A' ' 31' ' ' LYS . 71.0 mm-40 -73.2 -38.57 66.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.734 ' HD3' HD11 ' A' ' 39' ' ' LEU . 53.8 ttt85 -65.01 -39.75 93.9 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.677 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.574 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -55.8 -25.44 41.46 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.405 -178.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 27' ' ' GLN . 38.9 mmtm -61.46 -38.18 86.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.01 -16.54 44.53 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.907 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.89 14.15 61.37 Favored Glycine 0 C--N 1.318 -0.43 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' CD ' HH21 ' A' ' 29' ' ' ARG . 36.0 mt-10 -69.43 159.73 32.69 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.687 174.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 49.7 tttp -64.39 129.12 38.67 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.368 0.604 . . . . 0.0 110.247 -174.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' HA ' HD21 ' A' ' 30' ' ' LEU . 61.7 t80 -56.35 -43.96 79.61 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.49 ' HA2' ' C ' ' A' ' 53' ' ' ASP . . . -60.42 -34.07 83.76 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.564 177.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 45.7 tttp -59.62 -48.45 81.6 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.604 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.734 HD11 ' HD3' ' A' ' 29' ' ' ARG . 4.4 mm? -62.53 -41.35 98.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.921 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HA ' ' OG ' ' A' ' 44' ' ' SER . . . -57.26 -49.68 75.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.45 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.547 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 68.0 mttm -64.1 -37.69 88.36 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.896 177.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.678 ' HB3' HD12 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -71.09 -50.39 34.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.615 -172.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.031 HD22 HG13 ' A' ' 26' ' ' VAL . 6.2 mp -98.47 -48.6 4.96 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -174.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.822 ' OG ' HG23 ' A' ' 15' ' ' ILE . 1.2 m -55.64 142.14 35.01 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.443 -1.253 . . . . 0.0 112.338 -162.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.552 ' CG1' HD22 ' A' ' 16' ' ' LEU . 46.1 pt -94.45 -12.2 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.258 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 49' ' ' SER . 11.4 t0 -76.86 111.89 12.87 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.9 -40.22 64.49 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -55.9 -48.36 73.26 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.464 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 78.9 p -62.06 -33.28 74.11 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.381 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.53 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . -74.46 -48.24 28.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.005 0.431 . . . . 0.0 110.346 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -65.39 -36.36 83.72 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.233 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' NE ' ' O ' ' A' ' 55' ' ' SER . 13.8 mmm180 -94.68 7.48 45.65 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.994 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 55' ' ' SER . 0.0 OUTLIER 50.34 47.86 23.2 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 67.12 -40.04 0.2 Allowed Glycine 0 C--N 1.313 -0.742 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.946 -173.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.563 ' H ' ' C ' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -54.79 82.91 0.0 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.1 0.96 . . . . 0.0 111.73 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.55 -38.64 91.91 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.54 -152.09 20.66 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.73 133.61 34.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.459 ' CE2' HD12 ' A' ' 10' ' ' ILE . 54.2 p90 -146.61 151.8 37.87 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.15 178.47 46.43 Favored Glycine 0 C--N 1.312 -0.798 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 61' ' ' ARG . 45.8 mtp85 -73.46 152.53 40.71 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 122.764 0.426 . . . . 0.0 110.749 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.402 ' H ' ' CD ' ' A' ' 69' ' ' GLU . . . 82.11 9.65 84.9 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.584 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -100.88 -19.28 15.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 178.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.474 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 1.4 mmm -126.39 161.33 28.13 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.76 136.85 20.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.081 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 1.7 tttm -44.5 -46.89 26.19 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 21.3 Cg_endo -59.71 -34.07 96.28 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 CA-C-N 119.161 0.736 . . . . 0.0 111.238 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CD2' HD11 ' A' ' 93' ' ' ILE . 55.5 t80 -62.99 -50.15 71.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.915 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 64' ' ' MET . 93.7 mt-10 -67.85 -43.82 78.59 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.811 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 7.2 t70 -57.74 -49.71 75.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.314 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.08 96.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.811 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 10' ' ' ILE . . . -64.53 -42.08 95.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.516 -176.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.465 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 44.4 m-85 -64.99 -34.11 77.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.236 0.541 . . . . 0.0 111.362 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 79.9 mtp85 -62.62 -36.03 81.45 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.751 -176.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.598 HD11 ' HA ' ' A' ' 81' ' ' SER . 68.9 mt -97.12 23.05 7.73 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -173.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.494 ' HA ' ' HG3' ' A' ' 95' ' ' ARG . 75.1 mt-30 -43.53 -25.1 0.14 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.381 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.429 HG13 ' H ' ' A' ' 79' ' ' GLU . 14.8 p -58.35 -27.49 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 119.8 -2.18 13.48 Favored Glycine 0 N--CA 1.47 0.943 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.429 ' H ' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -55.86 173.46 0.14 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.66 127.5 65.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.598 ' HA ' HD11 ' A' ' 75' ' ' LEU . 83.7 p -65.33 147.58 53.19 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.882 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.414 ' C ' HE22 ' A' ' 27' ' ' GLN . 1.7 mp0 -65.53 177.09 0.73 Allowed Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 168.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.474 ' N ' HE22 ' A' ' 27' ' ' GLN . 53.1 Cg_exo -54.42 133.51 56.7 Favored 'Trans proline' 0 C--N 1.283 -2.872 0 N-CA-C 109.991 -0.811 . . . . 0.0 109.991 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 55.1 t -117.42 128.66 74.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -98.75 129.92 45.2 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.488 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 86.8 p -114.41 -175.48 2.69 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.719 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 1.6 pm0 -69.59 -35.52 75.4 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -66.11 -45.32 81.54 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.95 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.59 -157.66 28.35 Favored Glycine 0 C--N 1.317 -0.492 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 87.0 m-85 -85.52 135.08 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.678 0.239 . . . . 0.0 110.483 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.482 ' HD1' ' CE1' ' A' ' 14' ' ' HIS . 44.9 m-70 -122.5 147.7 46.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.761 -0.199 . . . . 0.0 110.682 176.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.51 ' CG2' ' HB1' ' A' ' 23' ' ' ALA . 60.9 t -117.7 126.69 74.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 166.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.51 HD11 ' CD2' ' A' ' 68' ' ' PHE . 87.7 mt -119.94 125.86 74.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.586 -174.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -113.69 143.8 44.01 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.632 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 2.4 tmm_? -78.7 141.23 38.07 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 118.939 -1.104 . . . . 0.0 110.181 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.432 ' O ' ' NH1' ' A' ' 95' ' ' ARG . 48.2 tp -109.26 135.41 50.39 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.273 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.201 -1.939 0 CA-C-O 118.082 -1.399 . . . . 0.0 111.059 -178.903 . . . . . . . . 0 0 . 1 stop_ save_